Citrus Sinensis ID: 005033

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------72
Protein Sequence
MPSRPLSPSSYNNLAKPSFVNKTRVLFLILTISSSVVIVFTFLYFLYHLWYNLVNRSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQELSGNLATATETPAISTPVDSAHEVDFALALQASSSSNNSRCYNVRALNLNSLNYNANIASESEVKSGNGKGKEVSGVDLGAVDWTSKFVAYEDELSSVDHSKELNVNANSVNDEAASTKQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPSTNPDWDEEKKSTNEKIELDNSTPLDNLEDGHEPQLQELGFGKLEKGFEKKESKWKKNRKKRHKKMQEWWKEEHLDEISKKSSKLKKLETKWKKGFKIPHFDLARRFHFHRRNKFREQNQDDCDANGEFSFRRGWRKKNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKGEMDLPPVPFEFSPSPSKLYGKSRQKQKPNAD
Secondary Structure (PSIPRED)
cccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEEccccEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEEEEEcccEEEEEEEccccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHccccccEEccccccccccccccccccccccccccccccccccccccEEEcccccccccHHHcccccccccccccccccccccccccHHHHHcccccccccccccHHHHHccccccccccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHcccccccccccccccccccccccccccccccccccccccccccEEEccccccccHHHHHHHHHHHHHHcccHHHHHHHccccHHHHHccccccccccccccccccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccEEccccccccccccccccccccccHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccHEEEEHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccEEcHHHHHHHHccccHHccccccccccEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHcHcHHEEEEEEcccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccEEccccccccEEEEEEEcccccccHHHHHccccccHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHccccHHcccccccccccHHHHHHHHHHHHcccHcccccHHHHHHHHHccHHHHccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHcccccHHcccccccccccEEcccccEEEEEEEccccccccHHHHHHHHHHHHHHHccHHHHHcccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEccccccEEEEcccccccccccccHccccHHEcccccccEEEEEEEccccccHHHHHccccccHHHHHHHHHEEHHHHccccccccccccccccHHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mpsrplspssynnlakpsfvnkTRVLFLILTISSSVVIVFTFLYFLYHLWYNLVnrsrtipfdsnaplklQRFTYKELKnatndfdeanvigkggsgtVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFlhfgcdppvihgdikpsnvlldsdcrgkvsdfglsrikvegefgmdlfsqDLGKSQELWKSQElsgnlatatetpaistpvdsaHEVDFALALQassssnnsrcynvralnlnslnynaniasesevksgngkgkevsgvdlgavdwtsKFVAyedelssvdhskelnvnansvndeaastkqwgkdwwwrqdgsgelcskDYVMEWigsqicpstnpdwdeekkstnekieldnstpldnledghepqlqelgfgklEKGFEKKESKWKKNRKKRHKKMQEWWKEEHLDEISKKSSKLKKLETKwkkgfkiphfdlaRRFHFHRrnkfreqnqddcdangefsfrrgwrkknknsmgsdmwsgdlfsrelssttsmrgtlcyvapeyggcgylmekadiySLGVLILVIVsgrrplhvlaspmklEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTClqktpelrpdigETVRILkgemdlppvpfefspspsklygksrqkqkpnad
Flexible Loop (DISEMBL)
mpsrplspssynnlakpsfVNKTRVLFLILTISSSVVIVFTFLYFLYHLWYNLVNRSRTIPFDSNAPLKLQRFTYKELKNatndfdeanvigkggSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNelqilgglrSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQELSGNLATATETPAISTPVDSAHEVDFALALQassssnnsrCYNVRALNLNSLNYNANIAsesevksgngkgKEVSGVDLGAVDWTSKFVAYEDELssvdhskelnvnansvndeaastkqwgkdwwwrQDGSGELCSKDYVMEWIGSqicpstnpdwDEEKKSTNEKIELDNSTPLDNLEDGHEPqlqelgfgklekgfekkeskwkknrkkrHKKMqewwkeehldeiskkssklKKLEtkwkkgfkiphfdlaRRFHFHRrnkfreqnqddcdangefsfrrgwrkknknsmgsdmwsgDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALtclqktpelrpDIGETVRILKGEMDLPPVPFefspspsklygksrqkqkpnad
Low Complexity Region (SEG)
MPSRPLSPSSYNNLAKPSFVNKTRVLFLILTISSSVVIVFTFLYFLYHLWYNLVNRSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQELSGNLATATETPAISTPVDSAHEVDFALALQAssssnnsRCYNVRalnlnslnynaniaSESEVKSGNGKGKEVSGVDLGAVDWTSKFVAYEDELSSVDHSKELNVNANSVNDEAASTKQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPSTNPDWDEEKKSTNEKIELDNSTPLDNLEDGHEPQLQelgfgklekgfekkeskwkknrkkrhkkmqeWWKEEHLDEIskkssklkkletkwkkgfkIPHFDLArrfhfhrrNKFREQNQDDCDANGEFSFRRGWRKKNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKGEMDLppvpfefspspsKLYGKSRQKQKPNAD
Disordered region (IsUnstruct)
*****************SFVNKTRVLFLILTISSSVVIVFTFLYFLYHLWYNLVNRSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQD*************************************FAL***********RCYNVRALNLNSLNYNAN******************GVDLGAVDWTSKFVAYEDE***********************TKQWGKDWWWRQDGSGELCSKDYVMEWIGSQICP****************************************************************************************ETKWKKGFKIPHFDLARRFHFHRRN************************************************SMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKG*******************************
Disordered Region (DISOPRED)
*PSRPLS*********************ILTISSSVVIVFTFLYFLYHLWYN*******************RFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKR**********EFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQELSGNLATATETPAISTPVDSAHEVDFAL***ASSSSNNSRCYNVRALNLNSLNYNANIASESEVK**********GVDL******************************************************************************************************************************WKKNRKKRHKKMQEWWKEEHLDEI*****************FKIPHFDLARRFHFHRRNKFREQNQDDCDANGEFSFRR*********MGSDMWSGDLF*****STTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLH*****MK*EKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKGEM*****************************
Disordered Region (DISEMBL)
**********YNNLAKPSFVNKTRVLFLILTISSSVVIVFTFLYFLYHLWYNLVNRSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQELSGNLATATETPAISTPVDSAHEVDFALALQASSSSNNSRCYNVRALNLNSLNYNANIASE************VSGVDLGAVDWTSKFVAYEDELSSVDHSKELNVNANSVN********WGKDWWWRQDGSGELCSKDYVMEWIGSQICPSTNPDWDEEKKSTNEKIELDNSTPLDNLEDGHEPQLQELGFGKLEKGF********************WWKEEHLDEISKKSSKLKKLETKWKKGFKIPHFDLARRFHFHRRNKFREQNQDDCDANGEFSFRRGWRKKNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKGEMDLPPVPFEFSPSPS***************
Disordered Region (DISPRO)
*****LS**************KTRVLFLILTISSSVVIVFTFLYFLYHLWYNLV***********APLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQELSGNLATATETPAISTPVDSAHEVDFALALQASSSSNNSRCYNVRALNLNSLNYNANIASESEVKSGNGKGKEVSGVDLGAVDWTSKFVAYEDELSSVDHSK*****************************************WIGSQICPSTNPDWDEEKKSTNEKIELDNSTPLDNLEDGHEPQLQELGFGKLEKGFEKKESKWKKNRKKRHKKMQEWWKEEHLDEISKKSSKLKKLETKWKKGFKIPHFDLARRFHFHRRNKFREQNQDDCDANGEFSFRRGWRKKNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKGEMDLPP*P***********************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPSRPLSPSSYNNLAKPSFVNKTRVLFLILTISSSVVIVFTFLYFLYHLWYNLVNRSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQELSGNLATATETPAISTPVDSAHEVDFALALQASSSSNNSRCYNVRALNLNSLNYNANIASESEVKSGNGKGKEVSGVDLGAVDWTSKFVAYEDELSSVDHSKELNVNANSVNDEAASTKQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPSTNPDWDEEKKSTNEKIELDNSTPLDNLEDGHEPQLQELGFGKLEKGFEKKESKWKKNRKKRHKKMQEWWxxxxxxxxxxxxxxxxxxxxxWKKGFKIPHFDLARRFHFHRRNKFREQNQDDCDANGEFSFRRGWRKKNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKGEMDLPPVPFEFSPSPSKLYGKSRQKQKPNAD
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	718	2.2.26 [Sep-21-2011]
Q9SAH3	692	Putative receptor-like pr	yes	no	0.926	0.960	0.609	0.0
O64639	683	Receptor-like serine/thre	no	no	0.887	0.932	0.353	4e-94
Q9ASQ6	1019	Probable LRR receptor-lik	no	no	0.220	0.155	0.484	9e-39
Q9LK03	717	Proline-rich receptor-lik	no	no	0.233	0.234	0.449	2e-38
Q9LV48	652	Proline-rich receptor-lik	no	no	0.233	0.257	0.455	3e-38
Q9STJ8	651	Receptor-like serine/thre	no	no	0.487	0.537	0.294	1e-37
Q9FX99	663	Probable receptor-like pr	no	no	0.246	0.266	0.435	3e-37
Q1PEM5	513	Proline-rich receptor-lik	no	no	0.320	0.448	0.361	3e-37
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.257	0.260	0.394	3e-37
Q9C821	509	Proline-rich receptor-lik	no	no	0.214	0.302	0.45	1e-36

>sp|Q9SAH3|Y1887_ARATH Putative receptor-like protein kinase At1g80870 OS=Arabidopsis thaliana GN=At1g80870 PE=1 SV=1

 Score =  791 bits (2044), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 451/740 (60%), Positives = 530/740 (71%), Gaps = 75/740 (10%)

Query: 1   MPSRPLSPSSYNNLAKPS-FVNKTRVLFLILTISSSVVIVFTFLYFLYHLWYNLVNRSRT 59
           MPSRP       N  +P  F N+T+ LFLILTISSS+VI F  LYF+YHLW +L+NRSRT
Sbjct: 1   MPSRP-------NPTRPKLFHNRTKTLFLILTISSSLVIFFAILYFIYHLWISLLNRSRT 53

Query: 60  IPFDSNA--PLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDT 117
           IPFD  A  PLKLQ FTYKELK ATNDFDE+NVIGKGGSGTVF GI RDGKL A+KRLD 
Sbjct: 54  IPFDVAAASPLKLQLFTYKELKLATNDFDESNVIGKGGSGTVFRGITRDGKLFAVKRLDN 113

Query: 118 FSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNL 176
            S+QTE EFQNELQILGGL+S FLVTLLGYC+E+N R L+YEYMPNKSLQE+LF+ DG+ 
Sbjct: 114 LSIQTETEFQNELQILGGLKSSFLVTLLGYCVEKNHRFLIYEYMPNKSLQELLFNEDGDS 173

Query: 177 VLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVE 236
            L W +RF II+DVAKALEF+HFGCDPPVIHGDIKPSNVLLDS+ R K+SDFGLSR+KVE
Sbjct: 174 CLNWERRFGIILDVAKALEFMHFGCDPPVIHGDIKPSNVLLDSEFRAKISDFGLSRVKVE 233

Query: 237 GEFGMDLFSQDLGKSQELWKSQELSGNLA-TATETPAISTPVDSAHEVDFALALQASSSS 295
           G +G+DLFSQ            ELSGN    +T   AI TP  + HEVDFALALQASSSS
Sbjct: 234 GGYGVDLFSQ------------ELSGNFGGESTPQTAIGTP--THHEVDFALALQASSSS 279

Query: 296 NNSRCY-NVRALNLNSLNYNANIASESEVKSGNGKGKEVSGVDLGAVDWTSKFVAYEDEL 354
            NSR   N++ ++LNS++   +         G  KGKEVS             ++ ED  
Sbjct: 280 KNSRTSRNIKEMSLNSMSLAMD---------GETKGKEVS---------NDVVLSCEDH- 320

Query: 355 SSVDHSKELNV-NANSVNDEAASTKQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPSTN 413
              D  KE+N+ + NSV D    +KQWG+DWWW+Q+GSGELCSKDYV EWIGSQI  + N
Sbjct: 321 -EFDQGKEMNLLSPNSVLDLGKGSKQWGRDWWWKQEGSGELCSKDYVREWIGSQI-DTAN 378

Query: 414 PDWDEEKKSTNEKIELDNST-PLDNLEDGHEPQLQELGFGKLEKGFEKKE-----SKWKK 467
           PDWD++KK      EL  ST  +D  E   E  L E  F  LE+ F K+E     +K  K
Sbjct: 379 PDWDDDKKVITTP-ELGVSTRTIDKAEHRDESGLNESRFDTLEEKFAKEEISERKNKRSK 437

Query: 468 NRKKRHKKMQEWWKEEHLDEISKKSSKLKKLETKWKKGFKIPHFDLARRFHFHRRNKFRE 527
           N+KK+H+ M+EWWKEE   E      K+  L  K+K   K PHF    R+ F ++ +   
Sbjct: 438 NKKKKHRNMEEWWKEEEHQEEMNNKKKIGVLRIKFKNHLKFPHF----RYCFRQKGENSV 493

Query: 528 QNQDDCDANGEFSFRRGWRKKNK-----------NSMGSDMWSGDLFSRELSSTTSMRGT 576
            +++  +A GEFSFRRGWR+K+             SMGS+MWSGDLFSRELSSTTSMRGT
Sbjct: 494 HDREG-EAAGEFSFRRGWRRKSNSSSKKKKKNNNGSMGSEMWSGDLFSRELSSTTSMRGT 552

Query: 577 LCYVAPEYGG-CGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLA 635
           LCY+APEYGG C YLMEK DIYS GVLILVIVSGRRPLHVLASPMKLEKANL+SWCR LA
Sbjct: 553 LCYIAPEYGGGCCYLMEKGDIYSFGVLILVIVSGRRPLHVLASPMKLEKANLVSWCRQLA 612

Query: 636 QAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKGEMDLPPVP 695
           Q+GN+LELVDE+LKD YNKE+A LCINLAL CLQK PELRPD+ E VRIL+GEMD+    
Sbjct: 613 QSGNVLELVDEKLKDGYNKEEAGLCINLALACLQKAPELRPDVSEVVRILRGEMDISSTA 672

Query: 696 FEFSPS-PSKLYGKSRQKQK 714
           FEFSPS P K+YG SR K++
Sbjct: 673 FEFSPSPPGKVYG-SRSKRR 691

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O64639|Y2559_ARATH Receptor-like serine/threonine-protein kinase At2g45590 OS=Arabidopsis thaliana GN=At2g45590 PE=2 SV=1

 Score =  346 bits (888), Expect = 4e-94,   Method: Compositional matrix adjust.
 Identities = 269/760 (35%), Positives = 390/760 (51%), Gaps = 123/760 (16%)

Query: 1   MPSRPLSPSSYNNLAKPSFVNKTRVLF--LILTISSSVVIVFTFLYFLYHLWYNLVNRSR 58
           MPSR LSP     L     V+     F  L L I+ S+ +    L  +  L Y  + R+R
Sbjct: 1   MPSR-LSPPDIPPLQPTPTVSDGHHRFQTLPLIIAGSLTLTGVLLILVTLLIYRRLYRNR 59

Query: 59  TIPFD----SNAPLKLQ--RFTYKELKNATNDFDEANVIGKGGSGTVFLG-IARDGKLLA 111
           T P D    S +P   Q  RF+Y +L+ ATN F E+  +G GG G+V+       G  LA
Sbjct: 60  TAPSDLISNSKSPQHYQCRRFSYSQLRRATNSFSESTHLGHGGFGSVYKADFPSGGDSLA 119

Query: 112 IKRLDTF--SLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKR--ILVYEYMPNKSL 166
           +K +DT   SLQ EREF NEL +   L  SP +V+LLG+  +R  R  ILVYE M N+SL
Sbjct: 120 VKVMDTSAGSLQGEREFHNELSLSSHLIGSPHVVSLLGFSSDRRGRKLILVYELMANRSL 179

Query: 167 QEMLFSDGNL-VLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKV 225
           Q+ L     + ++ W++RFEI  D+AK +EFLH  CDP +IHGDIKPSN+LLDSD + K+
Sbjct: 180 QDALLDRKCVELMDWNKRFEIATDIAKGIEFLHHCCDPIIIHGDIKPSNILLDSDFKAKI 239

Query: 226 SDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQELSGNLATATETPAISTPVDSAHEVDF 285
            DFGL+R+K E +F   +  ++  KS+++     +  N +   ET ++ T  +  + V  
Sbjct: 240 GDFGLARVKSE-DFDTRILIEEEDKSKDV-----VEDNGSILEETESVITVFEEGNNV-- 291

Query: 286 ALALQASSSSNNSRCYNVRALNLNSLNYNANIASESEVKSGNGKGKEVSGVDLGAVDWTS 345
                               +NL+      ++ +E+    G   G  +S  +      T 
Sbjct: 292 --------------------VNLSPETCGISVLTETVASPGEKSG--LSPENCAVSILTV 329

Query: 346 KFVAYEDELSSVDHSKELNVNA---NSVNDEAASTKQWGK-DWWWRQDGSG-------EL 394
           +  A    ++S+   +   ++      ++ E++  K   K DWWW+QD +G         
Sbjct: 330 EVGAASPAMASIPSPETCAISVLTDTGLSPESSKLKVGSKRDWWWKQDNNGGSRGGIESG 389

Query: 395 CSKDYVMEWIGSQICPSTNPDWDEEKKSTNEKIELDNSTPLDNLEDGHEPQLQELGFGKL 454
             KDYVMEWIGS+I         ++++ +N K  ++N                  G G  
Sbjct: 390 SVKDYVMEWIGSEI---------KKERPSNNKEWINN------------------GDGSS 422

Query: 455 EKGFEKKESKWKKNRKKRHKKMQEWWKEEHLDEISKKS-----------SKLKKLETKWK 503
               +KK+ K +K R        EWWKEE  +E+++K            S +  +++ + 
Sbjct: 423 SVSKKKKKEKKRKPR--------EWWKEEFCEELTRKKRKKKKKKKRGLSSISSIDSWFH 474

Query: 504 KGFKIPHFDLARRFHFHRRNKFREQNQDDCD-----ANGEFSFRRGWRKKNKNSMGSDMW 558
           +       D A   H H  N  + + ++  D      +GE     G     KNS  S +W
Sbjct: 475 RD------DGASSVHDHNLNPTKRKKRNSIDWWVDGLSGELKSVMG----KKNSQDSGLW 524

Query: 559 SGDLFSRE--LSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVL 616
                 +   +SST SMRGT+CY+APE GG G L EK D+YS GVL+LV+VSGRRPL V 
Sbjct: 525 CDVNVQKSGGVSSTPSMRGTVCYIAPECGGGGVLSEKCDVYSFGVLLLVLVSGRRPLQVT 584

Query: 617 ASPM-KLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELR 675
           ASPM + E+ANLISW + LA  G +LELVD+ +     KEQA LCI +AL CLQ++P  R
Sbjct: 585 ASPMSEFERANLISWAKQLACNGKLLELVDKSIH-SLEKEQAVLCITIALLCLQRSPVKR 643

Query: 676 PDIGETVRILKGEMDLPPVPFEFSPSPSKLYG-KSRQKQK 714
           P + E V +L G  + P +PFEFSPSP   +  KSR+K +
Sbjct: 644 PTMKEIVEMLSGVSEPPHLPFEFSPSPPMGFPFKSRKKAR 683

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3

 Score =  162 bits (410), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 78/161 (48%), Positives = 113/161 (70%)

Query: 73  FTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQI 132
           F++++L+ ATN+FD+AN +G+GG G+VF G   DG ++A+K+L + S Q  REF NE+ +
Sbjct: 661 FSWRQLQTATNNFDQANKLGEGGFGSVFKGELSDGTIIAVKQLSSKSSQGNREFVNEIGM 720

Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           + GL  P LV L G C+ER++ +LVYEYM N SL   LF   +L L W+ R +I + +A+
Sbjct: 721 ISGLNHPNLVKLYGCCVERDQLLLVYEYMENNSLALALFGQNSLKLDWAARQKICVGIAR 780

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            LEFLH G    ++H DIK +NVLLD+D   K+SDFGL+R+
Sbjct: 781 GLEFLHDGSAMRMVHRDIKTTNVLLDTDLNAKISDFGLARL 821

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  161 bits (407), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 80/178 (44%), Positives = 113/178 (63%), Gaps = 10/178 (5%)

Query: 73  FTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQI 132
           F Y+EL  ATN F EAN++G+GG G VF G+ R+GK +A+K+L   S Q EREFQ E+ I
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401

Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           +  +    LV L+GYC+   +R+LVYE++PN +L+  L   G   ++WS R +I +  AK
Sbjct: 402 ISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIAVGSAK 461

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI----------KVEGEFG 240
            L +LH  C+P +IH DIK SN+L+D     KV+DFGL++I          +V G FG
Sbjct: 462 GLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 519

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  160 bits (406), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 81/178 (45%), Positives = 113/178 (63%), Gaps = 10/178 (5%)

Query: 73  FTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQI 132
           FTY+EL  ATN F EAN++G+GG G V  GI   GK +A+K+L   S Q EREFQ E++I
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327

Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           +  +    LV+L+GYCM   +R+LVYE++PN +L+  L   G   ++WS R +I +  AK
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSAK 387

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI----------KVEGEFG 240
            L +LH  C+P +IH DIK SN+L+D     KV+DFGL++I          +V G FG
Sbjct: 388 GLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 445

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9STJ8|Y4539_ARATH Receptor-like serine/threonine-protein kinase At4g25390 OS=Arabidopsis thaliana GN=At4g25390 PE=1 SV=1

 Score =  158 bits (400), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 126/428 (29%), Positives = 199/428 (46%), Gaps = 78/428 (18%)

Query: 1   MPSRPLSP-----------SSYNNLAKPSFVNKTRVLFLILTISSSVVIVFTFLYFLYHL 49
           MPSR +S            SS    A     NKT  +F    ++ +    F+ L+    +
Sbjct: 1   MPSRSISAPVPVLAPAPIVSSLVPAAPSGHQNKTTRIFPPFVVAGAGA-GFS-LFITLSV 58

Query: 50  WYNLVNRSRTIPFDSNAPLKLQ-----RFTYKELKNATNDFDEANVIGKGGSGTVFLGIA 104
            +   +R R+ P   NA    +      F+Y  L+ AT  F +AN +G+GG G VF G  
Sbjct: 59  CFCKFSRKRSSPPAENASSSPRRPSPREFSYSSLRRATGSFSQANRLGQGGFGVVFRGTI 118

Query: 105 RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKR--ILVYEYMP 162
             G+ +A+K +D+ SLQ E EFQNEL     L SP +V ++G+  +R +R  +LVY+ M 
Sbjct: 119 SGGENVAVKVMDSGSLQGEGEFQNELFFAAKLDSPHVVPVIGFSHDRKRRRLLLVYKLMD 178

Query: 163 NKSLQE-MLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC 221
           N +LQ+ +L      ++ W++RF + +++A  ++ LH   +PPVIHGDIKPSNVLLDS  
Sbjct: 179 NGNLQDALLHRRCPELMDWNRRFLVAVNIADGIKHLH-SLEPPVIHGDIKPSNVLLDSLF 237

Query: 222 RGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQELSGNLATATETPAISTPVDSAH 281
             K++DFGL+R+K E                E+  + E  G+ +   E  ++ T V    
Sbjct: 238 SAKIADFGLARLKAE--------------QVEISVAPERDGDGSMVEEVESVVTTVTGYE 283

Query: 282 EVDFALALQASSSSNNSRCYNVRALNLNSLNYNANIASESEVKSGNGKGKEVSGVDLGAV 341
           + +F L  Q+  S                      +A      S + +   V  V     
Sbjct: 284 DFNFGLVDQSPES----------------------VAKVPGSVSASPEATTVVSV----- 316

Query: 342 DWTSKFVAYEDELSSVDHSKELNVNANSVNDEAASTKQWGKDWWWRQDGSGELCS-KDYV 400
                         S +  ++ + +  SV       +   KDWWW+Q+ + E    K+YV
Sbjct: 317 --------------SPEMGEKTDEDGGSVVVMKKGKESESKDWWWKQESNVERGRVKEYV 362

Query: 401 MEWIGSQI 408
           M+WIGS++
Sbjct: 363 MQWIGSEV 370

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FX99|Y1497_ARATH Probable receptor-like protein kinase At1g49730 OS=Arabidopsis thaliana GN=At1g49730 PE=1 SV=1

 Score =  157 bits (397), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 78/179 (43%), Positives = 114/179 (63%), Gaps = 2/179 (1%)

Query: 70  LQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNE 129
            ++F+YKE+ NATNDF+   VIG+GG GTV+     DG + A+K+++  S Q E++F  E
Sbjct: 314 FRKFSYKEMTNATNDFN--TVIGQGGFGTVYKAEFNDGLIAAVKKMNKVSEQAEQDFCRE 371

Query: 130 LQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMD 189
           + +L  L    LV L G+C+ + +R LVY+YM N SL++ L + G     W  R +I +D
Sbjct: 372 IGLLAKLHHRNLVALKGFCINKKERFLVYDYMKNGSLKDHLHAIGKPPPSWGTRMKIAID 431

Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDL 248
           VA ALE+LHF CDPP+ H DIK SN+LLD +   K+SDFGL+    +G    +  + D+
Sbjct: 432 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLSDFGLAHSSRDGSVCFEPVNTDI 490

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2

 Score =  157 bits (397), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 90/249 (36%), Positives = 137/249 (55%), Gaps = 19/249 (7%)

Query: 2   PSRPLSPSSYNNLAKPSFVNKTRVLFLILTISSSVVIVFTFLYFLYHLWYNLVNRSRTIP 61
           P   LSP S + L+  + V         ++I   V  V T ++FL        +++   P
Sbjct: 109 PGFSLSPPSPSRLSTGAVVG--------ISIGGGV-FVLTLIFFLCKKKRPRDDKALPAP 159

Query: 62  FDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ 121
                 +    FTY EL  ATN F EAN++G+GG G V+ GI  +G  +A+K+L   S Q
Sbjct: 160 IGLVLGIHQSTFTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQ 219

Query: 122 TEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWS 181
            E+EFQ E+ I+  +    LV+L+GYC+   +R+LVYE++PN +L+  L   G   ++WS
Sbjct: 220 GEKEFQAEVNIISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHGKGRPTMEWS 279

Query: 182 QRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI-------- 233
            R +I +  +K L +LH  C+P +IH DIK +N+L+D     KV+DFGL++I        
Sbjct: 280 LRLKIAVSSSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTHV 339

Query: 234 --KVEGEFG 240
             +V G FG
Sbjct: 340 STRVMGTFG 348

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  157 bits (397), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 77/195 (39%), Positives = 121/195 (62%), Gaps = 10/195 (5%)

Query: 56  RSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRL 115
           RS + P  +        FTY+EL + T  F + N++G+GG G V+ G   DGKL+A+K+L
Sbjct: 324 RSGSAPDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQL 383

Query: 116 DTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGN 175
              S Q +REF+ E++I+  +    LV+L+GYC+  ++R+L+YEY+PN++L+  L   G 
Sbjct: 384 KVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGR 443

Query: 176 LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI-- 233
            VL+W++R  I +  AK L +LH  C P +IH DIK +N+LLD +   +V+DFGL+++  
Sbjct: 444 PVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLND 503

Query: 234 --------KVEGEFG 240
                   +V G FG
Sbjct: 504 STQTHVSTRVMGTFG 518

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1

 Score =  155 bits (391), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 72/160 (45%), Positives = 108/160 (67%)

Query: 73  FTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQI 132
           FTY++L  AT++F   N++G+GG G V  G+  DG L+AIK+L + S Q EREFQ E+Q 
Sbjct: 131 FTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAEIQT 190

Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           +  +    LV+LLGYC+   +R+LVYE++PNK+L+  L      V++WS+R +I +  AK
Sbjct: 191 ISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALGAAK 250

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            L +LH  C+P  IH D+K +N+L+D     K++DFGL+R
Sbjct: 251 GLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLAR 290

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	718
224072735	717	predicted protein [Populus trichocarpa]	0.994	0.995	0.790	0.0
356550669	712	PREDICTED: putative receptor-like protei	0.981	0.990	0.739	0.0
356557213	712	PREDICTED: putative receptor-like protei	0.977	0.985	0.737	0.0
358346449	726	Receptor-like protein kinase [Medicago t	0.981	0.971	0.696	0.0
449436189	720	PREDICTED: putative receptor-like protei	0.986	0.983	0.686	0.0
255543329	532	protein with unknown function [Ricinus c	0.736	0.994	0.764	0.0
15220862	692	protein kinase-like protein [Arabidopsis	0.926	0.960	0.609	0.0
297842777	698	kinase family protein [Arabidopsis lyrat	0.937	0.964	0.600	0.0
224115844	458	predicted protein [Populus trichocarpa]	0.629	0.986	0.750	0.0
147767779	398	hypothetical protein VITISV_001341 [Viti	0.504	0.909	0.743	1e-141

>gi|224072735|ref|XP_002303855.1| predicted protein [Populus trichocarpa] gi|222841287|gb|EEE78834.1| predicted protein [Populus trichocarpa]

 Score = 1136 bits (2938), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 570/721 (79%), Positives = 636/721 (88%), Gaps = 7/721 (0%)

Query: 1   MPSRPLSPSSYNNLAKPSFVNKTRVLFLILTISSSVVIVFTFLYFLYHLWYNLVNRSRTI 60
           MPSRPLSPS   +  +PSF+ KTR+LFL LTIS+SV+++ T LYF+YHLW  LVNRSRTI
Sbjct: 1   MPSRPLSPSF--DHPRPSFLTKTRILFLTLTISASVILILTILYFVYHLWCTLVNRSRTI 58

Query: 61  PFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL 120
           PFDS+APLKLQRF+YKELK ATNDFD+AN+IGKGGS TVF GIARDGKL AIKRLD  SL
Sbjct: 59  PFDSSAPLKLQRFSYKELKIATNDFDDANIIGKGGSATVFRGIARDGKLYAIKRLDALSL 118

Query: 121 QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKW 180
           Q+EREFQNELQILGGLRSPFLV LLGYC+E+NKR+LVYEY+PNKSLQE+LF DG+L L W
Sbjct: 119 QSEREFQNELQILGGLRSPFLVILLGYCVEKNKRLLVYEYVPNKSLQELLFGDGHLSLCW 178

Query: 181 SQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFG 240
            +RF II+DVAKALEFLH GCDPPVIHGD+KPSNVLLD D R K+SDFGLSRIKVEGEFG
Sbjct: 179 ERRFNIILDVAKALEFLHLGCDPPVIHGDVKPSNVLLDFDMRAKISDFGLSRIKVEGEFG 238

Query: 241 MDLFSQDLGKSQELWKSQELSGNLATATETPAISTPVDSAHEVDFALALQASSSSNNSR- 299
           +DLFSQDLGKSQELWKSQELSGNL    ETPAI TPV+S HEVDFALALQASSSS NSR 
Sbjct: 239 VDLFSQDLGKSQELWKSQELSGNLTP--ETPAIGTPVESCHEVDFALALQASSSSKNSRT 296

Query: 300 CYNVRALNLNSLNYNANIASESEVKSGNGKGKEVSGVDLGAVDWTSKFVAYEDELSSVDH 359
           CYNV+ALNLNS+NYNANIA ES+VK GNGKGKEVS VD+G  DW  +FV Y+DE  S DH
Sbjct: 297 CYNVKALNLNSVNYNANIAGESDVKVGNGKGKEVSSVDIGGDDWNCRFVPYDDEFCSNDH 356

Query: 360 SKELNVNANSVNDEAASTKQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPSTNPDWDEE 419
           SKELN N+ SV D++AS+KQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPSTNPDW++E
Sbjct: 357 SKELNCNSFSVVDDSASSKQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPSTNPDWEDE 416

Query: 420 KKSTNEKIELDNSTPLDNLEDGHEP-QLQELGFGKLEKGFEKKESKWKKNRKKRHKKMQE 478
           KKST E+ E+  S  LD L D +EP +L++  F  L +GFEKKES+ +KNR+K+++KMQE
Sbjct: 417 KKSTPERTEMRRSVALDKLADANEPPRLKDFKFENLVRGFEKKESRGRKNRRKKNRKMQE 476

Query: 479 WWKEEHLDEISKKSSKLKKLETKWKKGFKIPHFDLARRFHFHRRNKFREQNQDDCDANGE 538
           WWKEEHLDEI+KK SKLK LETKW+KGFKIPHFDL RRF FHRR K  EQNQ++ D NGE
Sbjct: 477 WWKEEHLDEINKKGSKLKNLETKWRKGFKIPHFDLGRRFRFHRRKKLGEQNQNETDQNGE 536

Query: 539 FSFRRGWRKKNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYS 598
           FSFRRGW+KKN  S GSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYS
Sbjct: 537 FSFRRGWKKKNLQSAGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYS 596

Query: 599 LGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQAS 658
           LGVLILVIVSGRRPLHVLASPMKLEKANLISWCR LAQ GNILELVDER+KD++NKEQAS
Sbjct: 597 LGVLILVIVSGRRPLHVLASPMKLEKANLISWCRQLAQTGNILELVDERMKDEHNKEQAS 656

Query: 659 LCINLALTCLQKTPELRPDIGETVRILKGEMDLPPVPFEFSPS-PSKLYGKSRQKQKPNA 717
           LCINLALTCLQ+ PELRPDIGE V+ILKGEMDLP +PFEFSPS PSKL+ +SR+KQK NA
Sbjct: 657 LCINLALTCLQRMPELRPDIGEIVKILKGEMDLPHLPFEFSPSPPSKLFSRSRRKQKSNA 716

Query: 718 D 718
           +
Sbjct: 717 E 717

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356550669|ref|XP_003543707.1| PREDICTED: putative receptor-like protein kinase At1g80870-like [Glycine max]

 Score = 1070 bits (2766), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 536/725 (73%), Positives = 614/725 (84%), Gaps = 20/725 (2%)

Query: 1   MPSRPLSPSSYNNLAKPSFVNKTRVLFLILTISSSVVIVFTFLYFLYHLWYNLVNRSRTI 60
           MPSRP  P++           KT+ LFL LTIS+ VVI  + LYFLYHLW++LV+R++TI
Sbjct: 1   MPSRPFPPTN---------PTKTKALFLALTISACVVIFCSILYFLYHLWHSLVHRAKTI 51

Query: 61  PFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL 120
           PFD++APLKLQRF+YK+LK ATN FD ANVIGKGGSGTVF GI +DGKL+AIKRLDT SL
Sbjct: 52  PFDASAPLKLQRFSYKDLKQATNGFDTANVIGKGGSGTVFRGILKDGKLIAIKRLDTLSL 111

Query: 121 QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD--GNLVL 178
           Q+EREFQNELQILGGLRSPFLVTLLGYC+E+NKR+LVYEYMPN+SLQE LF D  G L L
Sbjct: 112 QSEREFQNELQILGGLRSPFLVTLLGYCVEKNKRVLVYEYMPNRSLQESLFGDDGGGLSL 171

Query: 179 KWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
            W  RF I++DVA+ALEFLH GCDPPVIHGDIKPSNVL+DS+ RGK+SDFGLSRIKVEGE
Sbjct: 172 SWGSRFCIMLDVARALEFLHLGCDPPVIHGDIKPSNVLIDSEWRGKISDFGLSRIKVEGE 231

Query: 239 FGMDLFSQDLGKSQELWKSQELSGNLATATETPAISTPVDSAHEVDFALALQASSSSNNS 298
           FG+DLFSQDLG+SQ+LWKSQELSGNL TA   PA+ TPV++  EVDFALALQASSSS NS
Sbjct: 232 FGVDLFSQDLGRSQDLWKSQELSGNL-TAETPPALGTPVENVSEVDFALALQASSSSKNS 290

Query: 299 R-CYNVRALNLNSLNYNANIASESEVKSGNGKGKEVSGVDLGAVDWTSKFVAYEDELSSV 357
           R C+NV+ALNLNSLNYNANIA+E+E++S N KGKEVS +D    DW  KF   +DELSS+
Sbjct: 291 RTCFNVKALNLNSLNYNANIATETEIRSVNAKGKEVSALDRD--DWNGKFFPCDDELSSI 348

Query: 358 DHSKELNVNANS-VNDEAASTKQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPSTNPDW 416
           D+SKEL V+A+  V+DE A+ KQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPS N DW
Sbjct: 349 DYSKELTVSASPLVDDEKANGKQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPS-NADW 407

Query: 417 DEEKKSTNEKIELDNSTPLDNLEDGHEPQLQELGFGK--LEKGFEKKESKWKKNRKKRHK 474
           D+ K + + K+EL+NS P D   D   PQ Q  G G    + G EKKES+ KKN KK+H+
Sbjct: 408 DDGKNNVHAKVELENSNPKDKDHDAIAPQPQVFGIGHNTTDNGVEKKESRGKKNHKKKHR 467

Query: 475 KMQEWWKEEHLDEISKKSSKLKKLETKWKKGFKIPHFDLARRFHFHRRNKFREQNQDDCD 534
           KMQEWW+EEHL E+SKK+SKLK L TKWKKG K+PHFDL RRF+  RR KF E+ +++CD
Sbjct: 468 KMQEWWREEHLAELSKKTSKLKNLHTKWKKGLKVPHFDLGRRFYLCRRKKFGEEGENECD 527

Query: 535 ANGEFSFRRGWRKKNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKA 594
            NGEFSFRRGW+KK+ +S+GSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCG+LMEKA
Sbjct: 528 QNGEFSFRRGWKKKSTHSIGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGFLMEKA 587

Query: 595 DIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNK 654
           DIYS GVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLK+DY K
Sbjct: 588 DIYSFGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKEDYKK 647

Query: 655 EQASLCINLALTCLQKTPELRPDIGETVRILKGEMDLPPVPFEFSPS-PSKLYGKSRQKQ 713
           EQASLCINLAL CLQK PELRPDIG+ V+ILKGEM+LPP+PFEFSPS PSKLY +SR+K 
Sbjct: 648 EQASLCINLALICLQKIPELRPDIGDIVKILKGEMELPPLPFEFSPSPPSKLYSRSRRKP 707

Query: 714 KPNAD 718
           K  A+
Sbjct: 708 KGTAE 712

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356557213|ref|XP_003546912.1| PREDICTED: putative receptor-like protein kinase At1g80870-like [Glycine max]

 Score = 1068 bits (2762), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 531/720 (73%), Positives = 607/720 (84%), Gaps = 18/720 (2%)

Query: 1   MPSRPLSPSSYNNLAKPSFVNKTRVLFLILTISSSVVIVFTFLYFLYHLWYNLVNRSRTI 60
           MPSRP  P++           KT+ LFL LTIS+ VVI  + LYFLYHLW++LV+R++TI
Sbjct: 1   MPSRPFPPTN---------PTKTKALFLALTISACVVIFCSILYFLYHLWHSLVHRAKTI 51

Query: 61  PFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL 120
           PFD++APLKLQRF+YK+LK ATN FD ANVIGKGGSGTVF GI +DGKL+AIKRLD  SL
Sbjct: 52  PFDASAPLKLQRFSYKDLKQATNGFDTANVIGKGGSGTVFRGILKDGKLIAIKRLDALSL 111

Query: 121 QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKW 180
           Q+EREFQNELQILGGLRSPFLVTLLGYC+E+N+R+LVYEY+PN+SLQE LF D  + L W
Sbjct: 112 QSEREFQNELQILGGLRSPFLVTLLGYCVEKNRRVLVYEYIPNRSLQESLFGDEGMSLSW 171

Query: 181 SQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFG 240
             R  II+DVA+ALEFLH GCDPPVIHGDIKPSNVL+DS+ RGK+SDFGLSRIKVEGEFG
Sbjct: 172 ESRLCIILDVARALEFLHLGCDPPVIHGDIKPSNVLIDSEWRGKISDFGLSRIKVEGEFG 231

Query: 241 MDLFSQDLGKSQELWKSQELSGNLATAT-ETPAISTPVDSAHEVDFALALQASSSSNNSR 299
           +DLFSQDLG+SQ+LWKSQELSGNL   T ETPAI TP++S  EVDFALALQASSSS NSR
Sbjct: 232 VDLFSQDLGRSQDLWKSQELSGNLTNLTAETPAIGTPIESVSEVDFALALQASSSSKNSR 291

Query: 300 -CYNVRALNLNSLNYNANIASESEVKSGNGKGKEVSGVDLGAVDWTSKFVAYEDELSSVD 358
            C+NV+ALNLNSLNYNANIASE+E++S N KGKE+S +D    DW  KF   +DELSS+D
Sbjct: 292 TCFNVKALNLNSLNYNANIASETEIRSVNAKGKEISALDRD--DWNGKFFPCDDELSSID 349

Query: 359 HSKELNVNANS-VNDEAASTKQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPSTNPDWD 417
           +SKEL V+A+  V+DE A+ KQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPS N DWD
Sbjct: 350 YSKELTVSASPLVDDEKANGKQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPS-NADWD 408

Query: 418 EEKKSTNEKIELDNSTPLDNLEDGHEPQLQELGFGK--LEKGFEKKESKWKKNRKKRHKK 475
           + K + + K+EL+NS+P D   D   PQ Q  G G    + G EKKES+ KK  KK+H+K
Sbjct: 409 DGKNNVHAKVELENSSPKDKDHDAIAPQSQVFGIGHNTTDNGVEKKESRGKKYHKKKHRK 468

Query: 476 MQEWWKEEHLDEISKKSSKLKKLETKWKKGFKIPHFDLARRFHFHRRNKFREQNQDDCDA 535
           MQEWWKEEHL E+SKK+SKLK L TKWKKG K+PHFDL RRF+  RR KF ++ ++ CD 
Sbjct: 469 MQEWWKEEHLAELSKKTSKLKNLHTKWKKGLKVPHFDLGRRFYLCRRKKFGQEGENKCDQ 528

Query: 536 NGEFSFRRGWRKKNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKAD 595
           NGEFSFRRGW+KK+  S+GSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCG+LMEKAD
Sbjct: 529 NGEFSFRRGWKKKSTRSIGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGFLMEKAD 588

Query: 596 IYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKE 655
           IYS GVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQ GNILELVDERLK+DYNKE
Sbjct: 589 IYSFGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQDGNILELVDERLKEDYNKE 648

Query: 656 QASLCINLALTCLQKTPELRPDIGETVRILKGEMDLPPVPFEFSPS-PSKLYGKSRQKQK 714
           QASLCINLAL CLQK PELRPDIG+ V+ILKGEM+LPP PFEFSPS PSKLY +SR+K K
Sbjct: 649 QASLCINLALICLQKIPELRPDIGDIVKILKGEMELPPFPFEFSPSPPSKLYSRSRRKPK 708

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358346449|ref|XP_003637280.1| Receptor-like protein kinase [Medicago truncatula] gi|355503215|gb|AES84418.1| Receptor-like protein kinase [Medicago truncatula]

 Score =  984 bits (2543), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 515/739 (69%), Positives = 600/739 (81%), Gaps = 34/739 (4%)

Query: 1   MPSRPLSPSSYNNLAKPSFVNKTRVLFLILTISSSVVIVFTFLYFLYHLWYNLVNRSRTI 60
           MPSR L+ ++ N   KP F      LF+ LTIS+SVVI F+ LYFLYHLW +LV+R++TI
Sbjct: 1   MPSRQLTSTTSNIFTKPKF------LFIALTISASVVIFFSILYFLYHLWLSLVHRAKTI 54

Query: 61  PFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL 120
           PFD+++PLKLQRF+YKELK ATN FD AN+IGKGGSGTVF G+ +DGK +AIKRLD+ SL
Sbjct: 55  PFDASSPLKLQRFSYKELKVATNVFDTANIIGKGGSGTVFKGVLKDGKFIAIKRLDSLSL 114

Query: 121 QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKW 180
           Q+EREFQNELQILGGLRSPFLVTLLGYC+E+NKR+LVYEYMPN SLQE LF D    L W
Sbjct: 115 QSEREFQNELQILGGLRSPFLVTLLGYCVEKNKRVLVYEYMPNTSLQESLFGDECFGLSW 174

Query: 181 SQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFG 240
            +RF IIMDVA+ALEFLH GCDPPVIHGDIKPSNVLLD++ RGK+SDFGLSRIKVEGEFG
Sbjct: 175 ERRFCIIMDVARALEFLHLGCDPPVIHGDIKPSNVLLDAEFRGKISDFGLSRIKVEGEFG 234

Query: 241 MDLFSQDLGKSQELWKSQELSGNLATATETPAISTPVDSAHEVDFALALQASSSSNNSR- 299
           +DLFSQDLGKSQ+LWKSQ+LSGNL    ETP I TPV+S  EVDFALALQAS+SS NSR 
Sbjct: 235 VDLFSQDLGKSQDLWKSQDLSGNL--TAETPVIGTPVESVSEVDFALALQASTSSKNSRS 292

Query: 300 CYNVRALNLNSLNYNANIASESEVKSGNGKGKEVSGVDLGAVD-----W-TSKFVAYEDE 353
           C NV+ALNLNSLNYNANI  ESE ++ N KGKE+S +D G        W T+KFV Y+DE
Sbjct: 293 CLNVKALNLNSLNYNANIVGESESRNVNAKGKEISSLDTGGGGGGDDCWNTNKFVPYDDE 352

Query: 354 LSSVDHSKELNVNANSVNDEAASTKQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPSTN 413
             S D+SK+    A  V++E  + KQWG+DWWWRQDGSGELCSKDYV EWIGSQICPS N
Sbjct: 353 FCSTDYSKD----AYLVDEEKENGKQWGEDWWWRQDGSGELCSKDYVKEWIGSQICPS-N 407

Query: 414 PDWDEEKKST-----NEKIELDNSTPLDNLEDGHEPQLQELGF--GKLEKGFEKKE-SKW 465
            DWD+   S       EK EL+NS+P+D   D +  QL ++        K  + KE    
Sbjct: 408 ADWDDGIGSAKINNIQEKSELENSSPIDKASDANGTQLLQVSVMENADNKVVDMKELKGK 467

Query: 466 KKNRKKRHKKMQEWWKEEHLDE-ISKKSSKLKKLETKWKKGFKIPHFDLARRFHFHRRNK 524
           K ++KK+++KMQEWWKEEH+ E   KKS+KLK L+TKWKKG K+PHF L RRF+  +R+K
Sbjct: 468 KNHKKKKNRKMQEWWKEEHIAELSKKKSNKLKSLQTKWKKGLKVPHFGLGRRFYLCQRSK 527

Query: 525 -FREQNQDDCDANGEFSFRRGWRKKNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPE 583
            + E+ Q++C+ NGEFSFRRGWRKK+  S+GSDMWSGDLFSRELSSTTSMRGTLCYVAPE
Sbjct: 528 NYGEEGQNECEQNGEFSFRRGWRKKSSRSIGSDMWSGDLFSRELSSTTSMRGTLCYVAPE 587

Query: 584 YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAG--NIL 641
           YGGCG+LMEKADIYS GVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAG  NIL
Sbjct: 588 YGGCGFLMEKADIYSFGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGGNNIL 647

Query: 642 ELVDERLKDD-YNKEQASLCINLALTCLQKTPELRPDIGETVRILKGEMDLPPVPFEFSP 700
           ELVDE+LK+D YNKEQASLCINLAL+CLQK PELRPDIG+ V+ILKGEM+LPP+PFEFSP
Sbjct: 648 ELVDEKLKEDNYNKEQASLCINLALSCLQKIPELRPDIGDIVKILKGEMELPPLPFEFSP 707

Query: 701 S-PSKLYGKSRQKQKPNAD 718
           S PS+LY +SR+KQK N +
Sbjct: 708 SPPSRLYSRSRRKQKGNGE 726

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449436189|ref|XP_004135876.1| PREDICTED: putative receptor-like protein kinase At1g80870-like [Cucumis sativus] gi|449509150|ref|XP_004163509.1| PREDICTED: putative receptor-like protein kinase At1g80870-like [Cucumis sativus]

 Score =  974 bits (2519), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 501/730 (68%), Positives = 601/730 (82%), Gaps = 22/730 (3%)

Query: 1   MPSRPLSPSSYNNLAKPSFVNKTRVLFLILTISSSVVIVFTFLYFLYHLWYNLVNRSRTI 60
           MPSRP + S  +++A  S +++T+V+FL LTIS+SVVI F+ LYFLYHL+++ V+R++TI
Sbjct: 1   MPSRPFASSPTSSVAGYSPLSRTKVVFLALTISASVVIFFSLLYFLYHLYHSFVHRAKTI 60

Query: 61  PFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL 120
           PFDS+APLKLQRF+Y+ELK ATN FD AN+IGKGGSGTVF GI RDGK +AIKRLD+ SL
Sbjct: 61  PFDSSAPLKLQRFSYRELKRATNRFDSANIIGKGGSGTVFKGILRDGKSIAIKRLDSVSL 120

Query: 121 QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKW 180
           +TEREFQNELQILGGLRSPFLVTLLGYC+E+NKR+LVYE+MPN+SLQE LFSDG   L W
Sbjct: 121 ETEREFQNELQILGGLRSPFLVTLLGYCVEKNKRVLVYEFMPNRSLQESLFSDGFGGLCW 180

Query: 181 SQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFG 240
            +RF+I++DVA+ALEFLH GCDPPVIHGDIKPSNVLLD D R K+SDFGLSRIK EGEFG
Sbjct: 181 ERRFDIVLDVARALEFLHLGCDPPVIHGDIKPSNVLLDMDQRAKISDFGLSRIKAEGEFG 240

Query: 241 MDLFSQDLGKSQELWKSQELSGNLATATETPAISTPVDSAHEVDFALALQA-SSSSNNSR 299
           +DLFSQ+LG+SQELWKSQ+ SG L  A ETPAI TPV+S  EVDFALALQA SSS N+  
Sbjct: 241 VDLFSQELGRSQELWKSQDYSGTL--ANETPAIGTPVESNTEVDFALALQASSSSKNSKT 298

Query: 300 CYNVRALNLNSLNYNANIASESEVKSGNGKGKEVSGVDLGAVDWTSKFVAYEDELSSVDH 359
            +NV+ +NLNSL+YNANI++E + K    KGKEVS +D+  VDW+++FV Y+     ++H
Sbjct: 299 SHNVKGMNLNSLSYNANISNEGDGK----KGKEVSSLDVNGVDWSNRFVPYD---CGIEH 351

Query: 360 SKELNVNAN-SVNDEAASTKQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPSTNPDWDE 418
           + +LN  A  SV+D   S KQWGKDWWWRQDGSGELCSKDYVMEWIGSQI P+ NPDWDE
Sbjct: 352 NNDLNSGAVLSVDDGGNSAKQWGKDWWWRQDGSGELCSKDYVMEWIGSQIYPTANPDWDE 411

Query: 419 EKKSTNEKIELDNSTPLDNLED-GHEPQLQELGFGKLEKGFEKKESKWKKNRKKRHKKMQ 477
           E K+T EK   + S PL+N++    + ++QELGF       E KESK  +N KK+ KKMQ
Sbjct: 412 ETKTTPEKANCNCSFPLENMDGVNGDSKVQELGFENPSNELEPKESK-TRNNKKKQKKMQ 470

Query: 478 EWWKEEHLDEISKKSS-KLKKLE----TKWKKGF-KIPHFDLARRFHFHRRN-KFREQNQ 530
           EWWKEE+  EIS+KS+ K K LE    +KW K   ++PHF L +RF+F RR  + R+Q+ 
Sbjct: 471 EWWKEENFAEISRKSNKKAKGLEASACSKWNKSLQQLPHFGLGKRFYFLRRTQRLRQQDP 530

Query: 531 DDCDANGEFSFRRGWRKKNKN-SMGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGY 589
           +  + + EFSFRRGW+KKN   S+GSDM SGDLFSRELSSTTSMRGTLCYVAPEYGGCG+
Sbjct: 531 NQTELDREFSFRRGWKKKNNTQSVGSDMCSGDLFSRELSSTTSMRGTLCYVAPEYGGCGF 590

Query: 590 LMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLK 649
           LMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQ+GN+LELVDERLK
Sbjct: 591 LMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQSGNVLELVDERLK 650

Query: 650 DDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKGEMDLPPVPFEFSPS-PSKLYGK 708
           D+YNKEQASLCINLAL CLQK PE+RP+IGE V+ILKGEM++P +PFEFSPS PSK + +
Sbjct: 651 DEYNKEQASLCINLALICLQKMPEMRPEIGEIVKILKGEMEIPQIPFEFSPSPPSKWFNR 710

Query: 709 SRQKQKPNAD 718
           SR+KQK NA+
Sbjct: 711 SRRKQKLNAE 720

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255543329|ref|XP_002512727.1| protein with unknown function [Ricinus communis] gi|223547738|gb|EEF49230.1| protein with unknown function [Ricinus communis]

 Score =  845 bits (2184), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 429/561 (76%), Positives = 475/561 (84%), Gaps = 32/561 (5%)

Query: 161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD 220
           MPNKSLQE+LF DG+L L W +RF II+DVAKALE LH GCDPPVIHGDIKPSNVLLD D
Sbjct: 1   MPNKSLQELLFGDGHLSLSWERRFSIILDVAKALELLHLGCDPPVIHGDIKPSNVLLDFD 60

Query: 221 CRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQELSGNLATATETPAISTPVDSA 280
            R K+SDFGLSRIKVEGEFG+DLFSQDLGKSQEL      SGNL +  ETPAI TPVDS 
Sbjct: 61  YRAKISDFGLSRIKVEGEFGVDLFSQDLGKSQEL------SGNLTS--ETPAIGTPVDSC 112

Query: 281 HEVDFALALQASSSSNNSR-CYNVRALNLNSLNYNANIASESEVKSGNGKGKEVSGVDLG 339
           +EVDFALALQASSSS NSR CYNVRALNLNSLNYNANIASES+ K+GNGKGKEVSGVD+G
Sbjct: 113 NEVDFALALQASSSSKNSRTCYNVRALNLNSLNYNANIASESDAKAGNGKGKEVSGVDIG 172

Query: 340 AVD-WTSKFVAYEDELSSVDHSKELNVNANSVNDEAASTKQWGKDWWWRQDGSGELCSKD 398
             D W  KFV Y+DE  S+DHSKELN   +S+ D++  TKQWGKDWWWRQDGSGELCSKD
Sbjct: 173 GGDDWNCKFVPYDDEPCSIDHSKELNCTGSSLVDDSTGTKQWGKDWWWRQDGSGELCSKD 232

Query: 399 YVMEWIGSQICPSTNPDWDEEKKSTNEKIELDNSTPLDNLEDGHEPQLQELGFGKLEKGF 458
           YVMEWIGSQICPSTNPDWDEEKK+T E+ EL ++                     +E  F
Sbjct: 233 YVMEWIGSQICPSTNPDWDEEKKNTPERRELQDA---------------------IESQF 271

Query: 459 EKKESKWKKNRKKRHKKMQEWWKEEHLDEISKKSSKLKKLETKWKKGFKIPHFDLARRFH 518
           +KKES+ +KNRK++++KMQEWWKEEHLDEI+KKSSKLK LETKWKK FK+PHF L+RRFH
Sbjct: 272 DKKESRIRKNRKRKNRKMQEWWKEEHLDEITKKSSKLKNLETKWKKKFKMPHFYLSRRFH 331

Query: 519 FHRRNKFREQNQDDCDANGEFSFRRGWRKKNKNSMGSDMWSGDLFSRELSSTTSMRGTLC 578
           F RR K  E NQ+ CD NGEFSFRRGW+KKN  S GSDMWSGDLFSRELSSTTSMRGTLC
Sbjct: 332 FQRRKKSGELNQNVCDRNGEFSFRRGWKKKNLCSAGSDMWSGDLFSRELSSTTSMRGTLC 391

Query: 579 YVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAG 638
           YVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAG
Sbjct: 392 YVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAG 451

Query: 639 NILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKGEMDLPPVPFEF 698
           NILELVDERLKDDY+KEQA+LCINLALTCLQK PELRPDIGE ++ILKG+ +LP +PFEF
Sbjct: 452 NILELVDERLKDDYSKEQATLCINLALTCLQKMPELRPDIGEILKILKGDTELPALPFEF 511

Query: 699 SPS-PSKLYGKSRQKQKPNAD 718
           SPS PSKL+ +SR++ K NA+
Sbjct: 512 SPSPPSKLFSRSRRRHKSNAE 532

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15220862|ref|NP_178202.1| protein kinase-like protein [Arabidopsis thaliana] gi|75336903|sp|Q9SAH3.1|Y1887_ARATH RecName: Full=Putative receptor-like protein kinase At1g80870 gi|6503299|gb|AAF14675.1|AC011713_23 Contains similarity to gb|U82481 KI domain interacting kinase 1 from Zea mays and contains PF|00069 Eukaryotic protein kinase domain. ESTs gb|H77140, gb|H76842 and gb|AI994303 come from this gene [Arabidopsis thaliana] gi|332198341|gb|AEE36462.1| protein kinase-like protein [Arabidopsis thaliana]

 Score =  791 bits (2044), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 451/740 (60%), Positives = 530/740 (71%), Gaps = 75/740 (10%)

Query: 1   MPSRPLSPSSYNNLAKPS-FVNKTRVLFLILTISSSVVIVFTFLYFLYHLWYNLVNRSRT 59
           MPSRP       N  +P  F N+T+ LFLILTISSS+VI F  LYF+YHLW +L+NRSRT
Sbjct: 1   MPSRP-------NPTRPKLFHNRTKTLFLILTISSSLVIFFAILYFIYHLWISLLNRSRT 53

Query: 60  IPFDSNA--PLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDT 117
           IPFD  A  PLKLQ FTYKELK ATNDFDE+NVIGKGGSGTVF GI RDGKL A+KRLD 
Sbjct: 54  IPFDVAAASPLKLQLFTYKELKLATNDFDESNVIGKGGSGTVFRGITRDGKLFAVKRLDN 113

Query: 118 FSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNL 176
            S+QTE EFQNELQILGGL+S FLVTLLGYC+E+N R L+YEYMPNKSLQE+LF+ DG+ 
Sbjct: 114 LSIQTETEFQNELQILGGLKSSFLVTLLGYCVEKNHRFLIYEYMPNKSLQELLFNEDGDS 173

Query: 177 VLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVE 236
            L W +RF II+DVAKALEF+HFGCDPPVIHGDIKPSNVLLDS+ R K+SDFGLSR+KVE
Sbjct: 174 CLNWERRFGIILDVAKALEFMHFGCDPPVIHGDIKPSNVLLDSEFRAKISDFGLSRVKVE 233

Query: 237 GEFGMDLFSQDLGKSQELWKSQELSGNLA-TATETPAISTPVDSAHEVDFALALQASSSS 295
           G +G+DLFSQ            ELSGN    +T   AI TP  + HEVDFALALQASSSS
Sbjct: 234 GGYGVDLFSQ------------ELSGNFGGESTPQTAIGTP--THHEVDFALALQASSSS 279

Query: 296 NNSRCY-NVRALNLNSLNYNANIASESEVKSGNGKGKEVSGVDLGAVDWTSKFVAYEDEL 354
            NSR   N++ ++LNS++   +         G  KGKEVS             ++ ED  
Sbjct: 280 KNSRTSRNIKEMSLNSMSLAMD---------GETKGKEVS---------NDVVLSCEDH- 320

Query: 355 SSVDHSKELNV-NANSVNDEAASTKQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPSTN 413
              D  KE+N+ + NSV D    +KQWG+DWWW+Q+GSGELCSKDYV EWIGSQI  + N
Sbjct: 321 -EFDQGKEMNLLSPNSVLDLGKGSKQWGRDWWWKQEGSGELCSKDYVREWIGSQI-DTAN 378

Query: 414 PDWDEEKKSTNEKIELDNST-PLDNLEDGHEPQLQELGFGKLEKGFEKKE-----SKWKK 467
           PDWD++KK      EL  ST  +D  E   E  L E  F  LE+ F K+E     +K  K
Sbjct: 379 PDWDDDKKVITTP-ELGVSTRTIDKAEHRDESGLNESRFDTLEEKFAKEEISERKNKRSK 437

Query: 468 NRKKRHKKMQEWWKEEHLDEISKKSSKLKKLETKWKKGFKIPHFDLARRFHFHRRNKFRE 527
           N+KK+H+ M+EWWKEE   E      K+  L  K+K   K PHF    R+ F ++ +   
Sbjct: 438 NKKKKHRNMEEWWKEEEHQEEMNNKKKIGVLRIKFKNHLKFPHF----RYCFRQKGENSV 493

Query: 528 QNQDDCDANGEFSFRRGWRKKNK-----------NSMGSDMWSGDLFSRELSSTTSMRGT 576
            +++  +A GEFSFRRGWR+K+             SMGS+MWSGDLFSRELSSTTSMRGT
Sbjct: 494 HDREG-EAAGEFSFRRGWRRKSNSSSKKKKKNNNGSMGSEMWSGDLFSRELSSTTSMRGT 552

Query: 577 LCYVAPEYGG-CGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLA 635
           LCY+APEYGG C YLMEK DIYS GVLILVIVSGRRPLHVLASPMKLEKANL+SWCR LA
Sbjct: 553 LCYIAPEYGGGCCYLMEKGDIYSFGVLILVIVSGRRPLHVLASPMKLEKANLVSWCRQLA 612

Query: 636 QAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKGEMDLPPVP 695
           Q+GN+LELVDE+LKD YNKE+A LCINLAL CLQK PELRPD+ E VRIL+GEMD+    
Sbjct: 613 QSGNVLELVDEKLKDGYNKEEAGLCINLALACLQKAPELRPDVSEVVRILRGEMDISSTA 672

Query: 696 FEFSPS-PSKLYGKSRQKQK 714
           FEFSPS P K+YG SR K++
Sbjct: 673 FEFSPSPPGKVYG-SRSKRR 691

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297842777|ref|XP_002889270.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297335111|gb|EFH65529.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  783 bits (2023), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 443/738 (60%), Positives = 529/738 (71%), Gaps = 65/738 (8%)

Query: 1   MPSRPLSPSSYNNLAKPSFVNKTRVLFLILTISSSVVIVFTFLYFLYHLWYNLVNRSRTI 60
           MPSRP      N +    F+N+T+ LFLILTISSS+VI F  LYF+YHLW +L+NRSRT 
Sbjct: 1   MPSRP------NPIRPKLFINRTKTLFLILTISSSLVIFFAILYFIYHLWISLLNRSRTN 54

Query: 61  PFDSNA--PLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTF 118
           PFD  A  PLKLQ FTYKELK ATNDFDE+NVIGKGGSGTVF GI R+GKL A+KRLD  
Sbjct: 55  PFDVAAASPLKLQLFTYKELKLATNDFDESNVIGKGGSGTVFRGITREGKLFAVKRLDNL 114

Query: 119 SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLV 177
           S+QTE EFQNELQILGGL+S FLVTLLGYC+E++ R L+YEYMPNKSLQE+LF+ DG+  
Sbjct: 115 SIQTETEFQNELQILGGLKSSFLVTLLGYCVEKHHRFLIYEYMPNKSLQELLFNEDGDSC 174

Query: 178 LKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           L W +RF I++DVAKALEF+HFGCDPPVIHGDIKPSNVLLDS+ R K+SDFGLSR+KVEG
Sbjct: 175 LHWERRFSILLDVAKALEFMHFGCDPPVIHGDIKPSNVLLDSEFRAKISDFGLSRVKVEG 234

Query: 238 EFGMDLFSQDLGKSQELWKSQELSGNLA-TATETPAISTPVDSAHEVDFALALQASSSSN 296
            +G+DLFSQ            ELSGN    +T   AI TP     EVDFALALQASSSS 
Sbjct: 235 GYGVDLFSQ------------ELSGNFGGESTPQTAIGTPTHP--EVDFALALQASSSSK 280

Query: 297 NSRCY-NVRALNLNSLNYNANIASESEVKSGNGKGKEVSGVDLGAVDWTSKFVAYEDELS 355
           NSR   NV+ +NLNS++    +A E E K     GKEVS       D     V    E  
Sbjct: 281 NSRTSRNVKGMNLNSMS----LAMEGETK-----GKEVSH---DGDDSKVNHVVLSCEDH 328

Query: 356 SVDHSKELNVNANSVNDEAASTKQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPSTNPD 415
             D   E+N++ NSV D    +KQWG+DWWW+Q+GSGELCSKDYV EWIGSQI  + NPD
Sbjct: 329 EFDQGNEMNLSPNSVLDLGKGSKQWGRDWWWKQEGSGELCSKDYVREWIGSQI-DTANPD 387

Query: 416 WDEEKKSTNEKIELDNST-PLDNLEDGHEPQLQELGFGKLEKGFEKKE----SKWKKNRK 470
           WD+EKK      EL  ST  +D  ED  E  L E  F  L + F K+E    +K K  +K
Sbjct: 388 WDDEKKVITTP-ELGVSTRTIDKAEDRDESGLNEYRFDTLGEKFAKEEINEKTKKKLKKK 446

Query: 471 KRHKKMQEWWKEE-HLDEISKKSSKLKKLETKWKKGFKIPHFDLARRFHFHRRNKFREQN 529
           K+H+ M+EWW+EE H DE++ K  K++ L  K+K   K PHF    R+ F ++ +    +
Sbjct: 447 KKHRNMEEWWREEEHQDEMNNKK-KIRILRIKFKNHLKFPHF----RYCFRQKGENSVHD 501

Query: 530 QDDCDANGEFSFRRGWRKKN----------KNSMGSDMWSGDLFSRELSSTT-SMRGTLC 578
           ++  +  GEFSFRR WR+++            SMG++MWSGDLF+RELSSTT SMRGTLC
Sbjct: 502 REG-EGAGEFSFRRAWRRESNSSSKKKKNYNRSMGNEMWSGDLFNRELSSTTTSMRGTLC 560

Query: 579 YVAPEYGG-CGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQA 637
           Y+APEYGG C YLMEK DIYS GVLILVI+SGRRPLHVLASPMKLEKANL+SWCR LAQ+
Sbjct: 561 YIAPEYGGGCCYLMEKGDIYSFGVLILVIISGRRPLHVLASPMKLEKANLVSWCRQLAQS 620

Query: 638 GNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKGEMDLPPVPFE 697
           GN+LELVDE+LKD YNKE+A LCINLAL CLQK PELRP + E VRIL+GEMD+    +E
Sbjct: 621 GNVLELVDEKLKDVYNKEEAGLCINLALACLQKAPELRPHVSEIVRILRGEMDISSTAYE 680

Query: 698 FSPS-PSKLYGKSRQKQK 714
           FSPS P+K YG SR K++
Sbjct: 681 FSPSPPAKFYG-SRSKRR 697

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224115844|ref|XP_002332071.1| predicted protein [Populus trichocarpa] gi|222831957|gb|EEE70434.1| predicted protein [Populus trichocarpa]

 Score =  661 bits (1705), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 343/457 (75%), Positives = 382/457 (83%), Gaps = 5/457 (1%)

Query: 267 ATETPAISTPVDSAHEVDFALALQASSSSNNSR-CYNVRALNLNSLNYNANIASESEVKS 325
            +ETPA  TPV+S HEVDFALALQASSSS N+R CYNV+ALNLNSLN NANI SES VK 
Sbjct: 2   TSETPANGTPVESCHEVDFALALQASSSSKNNRTCYNVKALNLNSLNDNANIVSESVVKV 61

Query: 326 GNGKGKEVSGVDLGAVDWTSKFVAYEDELSSVDHSKELNVNANSVNDEAASTKQWGKDWW 385
            NGKGKEVS VD+G  DW  KFV Y+D+  S DHSKELN N++SV D+ ASTKQWGKDWW
Sbjct: 62  RNGKGKEVSSVDIGWGDWNCKFVPYDDDFCSNDHSKELNCNSSSVVDDIASTKQWGKDWW 121

Query: 386 WRQDGSGELCSKDYVMEWIGSQICPSTNPDWDEEKKSTNEKIELDNSTPLDNLEDGHEP- 444
           WRQDGSGELCSKDYVMEWIGSQ CPS N DWD+EK+ST  + EL    PLD L+D +EP 
Sbjct: 122 WRQDGSGELCSKDYVMEWIGSQDCPSANLDWDDEKRSTPGRKELRRMVPLDKLDDANEPP 181

Query: 445 QLQELGFGKLEKGFEKKESKWKKNRKKRHKKMQEWWK-EEHLDEISKKSSKLKKLETKWK 503
           +L+E  F     GFEKKE + +KN +K+++KMQEWWK E+HLD I++K SKLK +ETK K
Sbjct: 182 RLKEFKFENHVSGFEKKEHEGRKNCRKKNRKMQEWWKDEQHLDGINQKGSKLKNIETKRK 241

Query: 504 KGFKIPHFDLARRFHFHRR-NKFREQNQDDCDANGEFSFRRGWRKKNKNSMGSDMWSGDL 562
            GF+IPHFDL RRF FHRR  K  EQNQ+D D NGEFSFRRGW+KKN  S GSDMWSGDL
Sbjct: 242 GGFRIPHFDLGRRFRFHRRREKMGEQNQNDTDQNGEFSFRRGWKKKNARSTGSDMWSGDL 301

Query: 563 FSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKL 622
           FSRELSSTTSMRGTLCYVAPE GGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKL
Sbjct: 302 FSRELSSTTSMRGTLCYVAPECGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKL 361

Query: 623 EKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETV 682
           EKANLISWCR LAQ GNILELVDER+KD+YNKEQASLCINLAL+CLQ+ PELRP IGE V
Sbjct: 362 EKANLISWCRQLAQTGNILELVDERVKDEYNKEQASLCINLALSCLQRMPELRPAIGEIV 421

Query: 683 RILKGEMDLPPVPFEFSPS-PSKLYGKSRQKQKPNAD 718
           +ILKGEMDLPP+PFEFS S PSKL  +SR+KQ  NA+
Sbjct: 422 KILKGEMDLPPLPFEFSSSPPSKLCSRSRRKQGSNAE 458

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147767779|emb|CAN78116.1| hypothetical protein VITISV_001341 [Vitis vinifera]

 Score =  510 bits (1313), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 275/370 (74%), Positives = 311/370 (84%), Gaps = 8/370 (2%)

Query: 356 SVDHSKELNVNANSV-NDEAASTKQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPSTNP 414
           S++HSKELN NA+SV +D +A +KQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPS NP
Sbjct: 22  SIEHSKELNGNASSVVDDVSAGSKQWGKDWWWRQDGSGELCSKDYVMEWIGSQICPSANP 81

Query: 415 DWDEEKK-STNEKIELDNSTPLDNLEDGHEPQLQELGFGKLEKGFEKKESK-WKKNRKKR 472
           DW+EEKK S +       ++ LD+     E QL E+G     KGFEK+E+K WK   KK+
Sbjct: 82  DWEEEKKCSPSPSPAKPQNSNLDSSIRLEESQLGEVGIENANKGFEKRETKGWKTRTKKK 141

Query: 473 HKKMQEWWKEEHLDEISKKSSKLKK---LETKWKKGFKIPHFDLARRFHFHRRN-KFREQ 528
           H+KMQEWWKEEHL EISKK +K+KK   LET+WKKGF++PH DL RRF   RR  KF +Q
Sbjct: 142 HRKMQEWWKEEHLAEISKKGAKMKKMKKLETRWKKGFRMPHLDLGRRFQLRRRRRKFGDQ 201

Query: 529 NQDDCDANGEFSFRRGWRKKNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCG 588
           N+++ D N EFSFRRGWRKKN  S GS+MWSGDLFSRELSSTTSMRGTLCYVAPEYGGCG
Sbjct: 202 NENEYDPNMEFSFRRGWRKKNTPSAGSEMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCG 261

Query: 589 YLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERL 648
           YLMEKADIYSLGVLILVIVSGRRPLHVL+SPMKLEKANLISWCR LAQAGNILELVDERL
Sbjct: 262 YLMEKADIYSLGVLILVIVSGRRPLHVLSSPMKLEKANLISWCRQLAQAGNILELVDERL 321

Query: 649 KDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKGEMDLPPVPFEFSPS-PSKLYG 707
           KD Y+K++ASLCINLALTCLQK PELRPD GE V+ILKGEMDLPP+PFEFSPS PSKL+ 
Sbjct: 322 KDGYSKDEASLCINLALTCLQKIPELRPDTGEIVKILKGEMDLPPLPFEFSPSPPSKLFS 381

Query: 708 KSRQKQKPNA 717
           +SR+K K +A
Sbjct: 382 RSRRKHKASA 391

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	718
TAIR|locus:2025742	692	AT1G80870 [Arabidopsis thalian	0.628	0.651	0.485	1.3e-202
TAIR|locus:2043629	683	AT2G45590 [Arabidopsis thalian	0.367	0.386	0.423	2.9e-91
TAIR|locus:2138014	651	AT4G25390 [Arabidopsis thalian	0.305	0.336	0.389	6.3e-71
TAIR|locus:2165301	654	AT5G51770 [Arabidopsis thalian	0.321	0.353	0.396	1.6e-68
TAIR|locus:2018209	509	PERK15 "proline-rich extensin-	0.240	0.339	0.421	7.5e-52
TAIR|locus:2091722	652	PERK1 "proline-rich extensin-l	0.224	0.246	0.478	2.8e-50
UNIPROTKB|Q9ARH1	647	Q9ARH1 "Receptor protein kinas	0.224	0.248	0.472	3.2e-50
TAIR|locus:2025396	472	AT1G01540 [Arabidopsis thalian	0.224	0.341	0.453	3.6e-50
TAIR|locus:2036818	389	AT1G61860 [Arabidopsis thalian	0.231	0.426	0.464	6.3e-50
TAIR|locus:2017923	390	AT1G16670 [Arabidopsis thalian	0.224	0.412	0.442	7.4e-50

TAIR|locus:2025742 AT1G80870 [Arabidopsis thaliana (taxid:3702)]

 Score = 999 (356.7 bits), Expect = 1.3e-202, Sum P(2) = 1.3e-202
 Identities = 245/505 (48%), Positives = 284/505 (56%)

Query:   232 RIKVEGEFGMDLFSQDLGKSQELWKSQELSGNLA-TATETPAISTPVDSAHEVDFALALQ 290
             R K+  +FG+     + G   +L+ SQELSGN    +T   AI TP    HEVDFALALQ
Sbjct:   219 RAKIS-DFGLSRVKVEGGYGVDLF-SQELSGNFGGESTPQTAIGTPTH--HEVDFALALQ 274

Query:   291 AXXXXXXXRCY-NVRXXXXXXXXXXXXXXSESEVKSGNGKGKEVSGVDLGAVDWTSKFVA 349
             A       R   N++              S S    G  KGKEVS  D+         ++
Sbjct:   275 ASSSSKNSRTSRNIKEMSLN---------SMSLAMDGETKGKEVSN-DV--------VLS 316

Query:   350 YEDELSSVDHSKELNV-NANSVNDEAASTKQWGKDWWWRQDGSGELCSKDYVMEWIGSQI 408
              ED     D  KE+N+ + NSV D    +KQWG+DWWW+Q+GSGELCSKDYV EWIGSQI
Sbjct:   317 CEDH--EFDQGKEMNLLSPNSVLDLGKGSKQWGRDWWWKQEGSGELCSKDYVREWIGSQI 374

Query:   409 CPSTNPDWDEEKKSTNEKIELDNST-PLDNLE----DG-HEPQLQXXXXXXXXXXXXXXX 462
               + NPDWD++KK      EL  ST  +D  E     G +E +                 
Sbjct:   375 -DTANPDWDDDKKVITTP-ELGVSTRTIDKAEHRDESGLNESRFDTLEEKFAKEEISERK 432

Query:   463 XXXXXXXXXXXXXXXXWWKEEHLDEIXXXXXXXXXXXXXXXXXXXIPHFDLAXXXXXXXX 522
                             WWKEE   E                     PHF           
Sbjct:   433 NKRSKNKKKKHRNMEEWWKEEEHQEEMNNKKKIGVLRIKFKNHLKFPHFRYCFRQKGENS 492

Query:   523 NKFREQNQDDCDANGEFSFRRGWR----------KKNKN-SMGSDMWSGDLFSRELSSTT 571
                RE      +A GEFSFRRGWR          KKN N SMGS+MWSGDLFSRELSSTT
Sbjct:   493 VHDREG-----EAAGEFSFRRGWRRKSNSSSKKKKKNNNGSMGSEMWSGDLFSRELSSTT 547

Query:   572 SMRGTLCYVAPEYGG-CGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISW 630
             SMRGTLCY+APEYGG C YLMEK DIYS GVLILVIVSGRRPLHVLASPMKLEKANL+SW
Sbjct:   548 SMRGTLCYIAPEYGGGCCYLMEKGDIYSFGVLILVIVSGRRPLHVLASPMKLEKANLVSW 607

Query:   631 CRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKGEMD 690
             CR LAQ+GN+LELVDE+LKD YNKE+A LCINLAL CLQK PELRPD+ E VRIL+GEMD
Sbjct:   608 CRQLAQSGNVLELVDEKLKDGYNKEEAGLCINLALACLQKAPELRPDVSEVVRILRGEMD 667

Query:   691 LXXXXXXXXXXX-XKLYGKSRQKQK 714
             +             K+YG SR K++
Sbjct:   668 ISSTAFEFSPSPPGKVYG-SRSKRR 691

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2043629 AT2G45590 [Arabidopsis thaliana (taxid:3702)]

 Score = 462 (167.7 bits), Expect = 2.9e-91, Sum P(3) = 2.9e-91
 Identities = 121/286 (42%), Positives = 167/286 (58%)

Query:     1 MPSRPLSPSSYNNLAKPSFVNKTRVLF--LILTISSSVVIVFTFLYFLYHLWYNLVNRSR 58
             MPSR LSP     L     V+     F  L L I+ S+ +    L  +  L Y  + R+R
Sbjct:     1 MPSR-LSPPDIPPLQPTPTVSDGHHRFQTLPLIIAGSLTLTGVLLILVTLLIYRRLYRNR 59

Query:    59 TIPFD----SNAPLKLQ--RFTYKELKNATNDFDEANVIGKGGSGTVFLG-IARDGKLLA 111
             T P D    S +P   Q  RF+Y +L+ ATN F E+  +G GG G+V+       G  LA
Sbjct:    60 TAPSDLISNSKSPQHYQCRRFSYSQLRRATNSFSESTHLGHGGFGSVYKADFPSGGDSLA 119

Query:   112 IKRLDTF--SLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKR--ILVYEYMPNKSL 166
             +K +DT   SLQ EREF NEL +   L  SP +V+LLG+  +R  R  ILVYE M N+SL
Sbjct:   120 VKVMDTSAGSLQGEREFHNELSLSSHLIGSPHVVSLLGFSSDRRGRKLILVYELMANRSL 179

Query:   167 QEMLFSDGNLV--LKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGK 224
             Q+ L  D   V  + W++RFEI  D+AK +EFLH  CDP +IHGDIKPSN+LLDSD + K
Sbjct:   180 QDALL-DRKCVELMDWNKRFEIATDIAKGIEFLHHCCDPIIIHGDIKPSNILLDSDFKAK 238

Query:   225 VSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQELSGNLATATET 270
             + DFGL+R+K E +F   +  ++  KS+++    E +G++   TE+
Sbjct:   239 IGDFGLARVKSE-DFDTRILIEEEDKSKDV---VEDNGSILEETES 280

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2138014 AT4G25390 [Arabidopsis thaliana (taxid:3702)]

 Score = 367 (134.2 bits), Expect = 6.3e-71, Sum P(4) = 6.3e-71
 Identities = 90/231 (38%), Positives = 137/231 (59%)

Query:    15 AKPS-FVNKTRVLFLILTISSSVVIVFTFLYFLYHLWYNLVNRSRTIPFDSNAPLKLQR- 72
             A PS   NKT  +F    ++ +    F+ L+    + +   +R R+ P   NA    +R 
Sbjct:    25 AAPSGHQNKTTRIFPPFVVAGAGA-GFS-LFITLSVCFCKFSRKRSSPPAENASSSPRRP 82

Query:    73 ----FTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQN 128
                 F+Y  L+ AT  F +AN +G+GG G VF G    G+ +A+K +D+ SLQ E EFQN
Sbjct:    83 SPREFSYSSLRRATGSFSQANRLGQGGFGVVFRGTISGGENVAVKVMDSGSLQGEGEFQN 142

Query:   129 ELQILGGLRSPFLVTLLGYCMERNKR--ILVYEYMPNKSLQE-MLFSDGNLVLKWSQRFE 185
             EL     L SP +V ++G+  +R +R  +LVY+ M N +LQ+ +L      ++ W++RF 
Sbjct:   143 ELFFAAKLDSPHVVPVIGFSHDRKRRRLLLVYKLMDNGNLQDALLHRRCPELMDWNRRFL 202

Query:   186 IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVE 236
             + +++A  ++ LH   +PPVIHGDIKPSNVLLDS    K++DFGL+R+K E
Sbjct:   203 VAVNIADGIKHLH-SLEPPVIHGDIKPSNVLLDSLFSAKIADFGLARLKAE 252

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009407 "toxin catabolic process" evidence=RCA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010583 "response to cyclopentenone" evidence=RCA

TAIR|locus:2165301 AT5G51770 [Arabidopsis thaliana (taxid:3702)]

 Score = 368 (134.6 bits), Expect = 1.6e-68, Sum P(4) = 1.6e-68
 Identities = 99/250 (39%), Positives = 138/250 (55%)

Query:     1 MPSRPL-SPSSYNNLAKPSFV-----NKTRVLFLILTISSSVVIVFTFLYFLYHLWYNLV 54
             MPSR L SP+  N+    S         TR+   +  +  S+ I  +  +  +    N  
Sbjct:     1 MPSRTLPSPAPVNSPFSSSVTPHHETTTTRIFPPLAAVGFSLFITLSICFCKF----NRK 56

Query:    55 NRS-RTIPFDSNAPLK--LQRFTYKELKNATNDFDEANVIGKGGSGTVFLGI---ARDGK 108
              RS   +   S  P K  L  F+Y  L+ AT  F   N +G+GG G+VF G    +  G 
Sbjct:    57 RRSPAAVASSSTPPQKQPLHEFSYSSLRKATASFSPENRLGQGGFGSVFRGTLSPSSGGG 116

Query:   109 LLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKR-ILVYEYMPNKSLQ 167
              +A+K +D+ SLQ EREFQNEL   G L SP +V+++G+   R  R ILVYE M   +LQ
Sbjct:   117 NVAVKVMDSGSLQGEREFQNELFFAGKLDSPHVVSVIGFSRRRRSRLILVYELMDIGNLQ 176

Query:   168 EMLFSDGNLVLK-WSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVS 226
             + L    +  L  W++RF + +D+AK +E LH   +P VIHGD+KPSNVLLD     K+S
Sbjct:   177 DALLHRRSPELMIWNRRFLVAIDIAKGIEHLH-SLNPCVIHGDLKPSNVLLDRFFSAKIS 235

Query:   227 DFGLSRIKVE 236
             DFGL+R+K E
Sbjct:   236 DFGLARLKSE 245

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

TAIR|locus:2018209 PERK15 "proline-rich extensin-like receptor kinase 15" [Arabidopsis thaliana (taxid:3702)]

 Score = 380 (138.8 bits), Expect = 7.5e-52, Sum P(2) = 7.5e-52
 Identities = 73/173 (42%), Positives = 114/173 (65%)

Query:    64 SNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTE 123
             S++ +    FTY++L  AT++F   N++G+GG G V  G+  DG L+AIK+L + S Q E
Sbjct:   122 SSSEIGQNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGE 181

Query:   124 REFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQR 183
             REFQ E+Q +  +    LV+LLGYC+   +R+LVYE++PNK+L+  L      V++WS+R
Sbjct:   182 REFQAEIQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKR 241

Query:   184 FEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVE 236
              +I +  AK L +LH  C+P  IH D+K +N+L+D     K++DFGL+R  ++
Sbjct:   242 MKIALGAAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLD 294

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 392 (143.0 bits), Expect = 2.8e-50, Sum P(2) = 2.8e-50
 Identities = 77/161 (47%), Positives = 108/161 (67%)

Query:    73 FTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQI 132
             FTY+EL  ATN F EAN++G+GG G V  GI   GK +A+K+L   S Q EREFQ E++I
Sbjct:   268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327

Query:   133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
             +  +    LV+L+GYCM   +R+LVYE++PN +L+  L   G   ++WS R +I +  AK
Sbjct:   328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSAK 387

Query:   193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
              L +LH  C+P +IH DIK SN+L+D     KV+DFGL++I
Sbjct:   388 GLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKI 428

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;ISS;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

GO:0052541 "plant-type cell wall cellulose metabolic process" evidence=RCA

GO:0052546 "cell wall pectin metabolic process" evidence=RCA

UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)]

 Score = 393 (143.4 bits), Expect = 3.2e-50, Sum P(2) = 3.2e-50
 Identities = 76/161 (47%), Positives = 109/161 (67%)

Query:    73 FTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQI 132
             FTY+EL  ATN F EAN++G+GG G V  G+   GK +A+K+L   S Q EREFQ E++I
Sbjct:   263 FTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSGQGEREFQAEVEI 322

Query:   133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
             +  +    LV+L+GYC+   KR+LVYE++PN +L+  L  +G   ++WS R +I +  AK
Sbjct:   323 ISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLHGEGRPTMEWSTRLKIALGSAK 382

Query:   193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
              L +LH  C+P +IH DIK SN+L+D     KV+DFGL++I
Sbjct:   383 GLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKI 423

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005887 "integral to plasma membrane" evidence=IDA

TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)]

 Score = 358 (131.1 bits), Expect = 3.6e-50, Sum P(2) = 3.6e-50
 Identities = 74/163 (45%), Positives = 108/163 (66%)

Query:    73 FTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQI 132
             +T +EL+ ATN   E NVIG+GG G V+ GI  DG  +A+K L     Q E+EF+ E+++
Sbjct:   142 YTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFKVEVEV 201

Query:   133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-GNLV-LKWSQRFEIIMDV 190
             +G +R   LV LLGYC+E   R+LVY+++ N +L++ +  D G++  L W  R  II+ +
Sbjct:   202 IGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMNIILGM 261

Query:   191 AKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             AK L +LH G +P V+H DIK SN+LLD     KVSDFGL+++
Sbjct:   262 AKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKL 304

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2036818 AT1G61860 [Arabidopsis thaliana (taxid:3702)]

 Score = 366 (133.9 bits), Expect = 6.3e-50, Sum P(2) = 6.3e-50
 Identities = 79/170 (46%), Positives = 109/170 (64%)

Query:    73 FTYKELKNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQ 131
             F +KEL  AT++F    +IG+GG G V+ G      +++A+KRLD   LQ  REF  E+ 
Sbjct:    73 FKFKELIAATDNFSMDCMIGEGGFGRVYKGFLTSLNQVVAVKRLDRNGLQGTREFFAEVM 132

Query:   132 ILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS--DGNLVLKWSQRFEIIMD 189
             +L   + P LV L+GYC+E  +R+LVYE+MPN SL++ LF   +G+  L W  R  I+  
Sbjct:   133 VLSLAQHPNLVNLIGYCVEDEQRVLVYEFMPNGSLEDHLFDLPEGSPSLDWFTRMRIVHG 192

Query:   190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI-KVEGE 238
              AK LE+LH   DPPVI+ D K SN+LL SD   K+SDFGL+R+   EG+
Sbjct:   193 AAKGLEYLHDYADPPVIYRDFKASNILLQSDFNSKLSDFGLARLGPTEGK 242

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)]

 Score = 345 (126.5 bits), Expect = 7.4e-50, Sum P(2) = 7.4e-50
 Identities = 73/165 (44%), Positives = 100/165 (60%)

Query:    73 FTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQI 132
             + Y+E++ AT+DF   N IG+GG G+V+ G  +DGKL AIK L   S Q  +EF  E+ +
Sbjct:    29 YKYREIRQATDDFSAENKIGEGGFGSVYKGCLKDGKLAAIKVLSAESRQGVKEFLTEINV 88

Query:   133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDG----NLVLKWSQRFEIIM 188
             +  ++   LV L G C+E N RILVY ++ N SL + L + G     +   WS R  I +
Sbjct:    89 ISEIQHENLVKLYGCCVEGNHRILVYNFLENNSLDKTLLAGGYTRSGIQFDWSSRANICV 148

Query:   189 DVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
              VAK L FLH    P +IH DIK SN+LLD     K+SDFGL+R+
Sbjct:   149 GVAKGLAFLHEEVRPHIIHRDIKASNILLDKYLSPKISDFGLARL 193

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9SAH3	Y1887_ARATH	2, ., 7, ., 1, 1, ., 1	0.6094	0.9261	0.9609	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	718
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	9e-34
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-30
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-28
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-27
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-26
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-25
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-25
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-19
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-19
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-18
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-18
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-16
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-15
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-15
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-15
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-15
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-14
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-14
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-14
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-14
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-14
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-14
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-14
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-13
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-13
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-13
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-13
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-13
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-12
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-12
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-11
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-11
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-11
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-11
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-11
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-11
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-11
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-11
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-11
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-10
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-10
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-10
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-10
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-09
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-09
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-09
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-09
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-09
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-09
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-09
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-08
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-08
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-08
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-08
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-08
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-08
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-08
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-08
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-08
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	9e-08
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-07
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-07
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-07
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-07
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-07
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-07
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-07
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-07
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-07
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-07
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-06
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-06
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-06
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-06
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-06
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-06
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-06
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-06
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-05
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-05
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-05
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-05
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-05
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-05
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-05
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-05
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-05
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-05
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-05
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-05
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-05
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-05
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-05
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-05
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	6e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-05
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-05
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-04
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-04
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-04
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-04
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-04
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-04
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-04
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-04
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-04
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-04
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-04
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-04
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-04
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-04
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-04
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	9e-04
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-04
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	0.001
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	0.001
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	0.001
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	0.001
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	0.001
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	0.001
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.001
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.002
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	0.002
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	0.002
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	0.002
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	0.002
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	0.002
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.002
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.003
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	0.003
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.003
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.003
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	0.004
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	0.004
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  128 bits (324), Expect = 9e-34
 Identities = 52/146 (35%), Positives = 80/146 (54%), Gaps = 7/146 (4%)

Query: 91  IGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTERE-FQNELQILGGLRSPFLVTLLGYC 148
           +G+GG GTV+L   +  GK +AIK +      +  E    E++IL  L  P +V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHG 208
            + N   LV EY    SL+++L  +    L   +   I++ + + LE+LH      +IH 
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLH---SNGIIHR 116

Query: 209 DIKPSNVLLDSDCRG-KVSDFGLSRI 233
           D+KP N+LLDSD    K++DFGLS++
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKL 142

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  120 bits (304), Expect = 1e-30
 Identities = 49/147 (33%), Positives = 78/147 (53%), Gaps = 7/147 (4%)

Query: 89  NVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTERE-FQNELQILGGLRSPFLVTLLG 146
             +G+G  G V+L   +  GKL+AIK +    ++ +RE    E++IL  L+ P +V L  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 147 YCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVI 206
              + +K  LV EY     L ++L   G L    ++    +  +  ALE+LH      ++
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF--YLRQILSALEYLH---SKGIV 119

Query: 207 HGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H D+KP N+LLD D   K++DFGL+R 
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQ 146

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  115 bits (289), Expect = 1e-28
 Identities = 45/148 (30%), Positives = 76/148 (51%), Gaps = 8/148 (5%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSL--QTEREFQNELQILGGLRSPFLVTLLG 146
            +G G  GTV+       GK++A+K L   S   + ++  + E++IL  L  P +V L+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 147 YCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVI 206
              +++   LV EY     L + L   G L     +  +I + + + LE+LH      +I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGGPL--SEDEAKKIALQILRGLEYLH---SNGII 120

Query: 207 HGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
           H D+KP N+LLD +   K++DFGL++  
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKL 148

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  111 bits (281), Expect = 1e-27
 Identities = 47/149 (31%), Positives = 69/149 (46%), Gaps = 9/149 (6%)

Query: 90  VIGKGGSGTVFLGIARDGKLL-----AIKRL-DTFSLQTEREFQNELQILGGLRSPFLVT 143
            +G+G  G V+ G  +          A+K L +  S Q   EF  E +I+  L  P +V 
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           LLG C E    ++V EYMP   L + L  +    L  S      + +A+ +E+L      
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SK 122

Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
             IH D+   N L+  +   K+SDFGLSR
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSR 151

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  109 bits (276), Expect = 6e-27
 Identities = 45/156 (28%), Positives = 68/156 (43%), Gaps = 15/156 (9%)

Query: 89  NVIGKGGSGTVFLGIARDGK----LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVT 143
             +G+G  G V+ G  +        +A+K L +  S +  ++F  E +++  L  P +V 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEML-------FSDGNLVLKWSQRFEIIMDVAKALEF 196
           LLG C E     LV EYM    L + L        S     L         + +AK +E+
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           L        +H D+   N L+  D   K+SDFGLSR
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSR 153

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  109 bits (275), Expect = 1e-26
 Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 10/149 (6%)

Query: 90  VIGKGGSGTVFLGIARDGKLL-----AIKRL-DTFSLQTEREFQNELQILGGLRSPFLVT 143
            +G+G  G V+ G  +          A+K L +  S +   EF  E  I+  L  P +V 
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           LLG C +     +V EYMP   L + L   G   L      ++ + +AK +E+L      
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLE---SK 121

Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
             +H D+   N L+  +   K+SDFGLSR
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSR 150

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  105 bits (264), Expect = 2e-25
 Identities = 46/149 (30%), Positives = 67/149 (44%), Gaps = 10/149 (6%)

Query: 90  VIGKGGSGTVFLGIARDGK-----LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVT 143
            +G+G  G V+ G  +         +A+K L +  S Q   EF  E +I+  L  P +V 
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           LLG C E     +V EYM    L   L  +    L  S      + +A+ +E+L      
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP-KLSLSDLLSFALQIARGMEYLE---SK 121

Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
             IH D+   N L+  +   K+SDFGLSR
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSR 150

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  104 bits (262), Expect = 6e-25
 Identities = 44/159 (27%), Positives = 84/159 (52%), Gaps = 18/159 (11%)

Query: 89  NVIGKGGSGTVFLGIARD-GKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
            ++G+G  G+V+L + +D G+L+A+K   L   S +     + E++IL  L+ P +V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 146 GYCMERNKR-ILVY-EYMPNKSLQEMLFSDG----NLVLKWSQRFEIIMDVAKALEFLHF 199
           G   +  K  + ++ EY+   SL  +L   G     ++ K+++       + + L +LH 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTR------QILEGLAYLH- 118

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
                ++H DIK +N+L+DSD   K++DFG ++   + E
Sbjct: 119 --SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  102 bits (257), Expect = 2e-24
 Identities = 53/149 (35%), Positives = 80/149 (53%), Gaps = 5/149 (3%)

Query: 84  DFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLV 142
            F+    IGKGG G V+     R GK +AIK +   S + + +  NE+QIL   + P +V
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
              G  +++++  +V E+    SL++ L    N  L  SQ   +  ++ K LE+LH    
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLH---S 116

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
             +IH DIK +N+LL SD   K+ DFGLS
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLS 145

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 12/156 (7%)

Query: 83  NDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPF 140
           +D +   V+G+G SG V+       GK+ A+K++      +  ++   EL+ L    SP+
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 141 LVTLLG-YCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFL 197
           +V   G +  E    I V EYM   SL ++L   G    K  +     I   + K L++L
Sbjct: 61  VVKCYGAFYKEGEISI-VLEYMDGGSLADLLKKVG----KIPEPVLAYIARQILKGLDYL 115

Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      +IH DIKPSN+L++S    K++DFG+S++
Sbjct: 116 HT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKV 149

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 53/150 (35%), Positives = 77/150 (51%), Gaps = 5/150 (3%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLV 142
            +      IGKG  G V LG  R G+ +A+K L   S    + F  E  ++  LR P LV
Sbjct: 6   KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLV 63

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
            LLG  ++ N   +V EYM   SL + L S G  V+  +Q+    +DV + +E+L    +
Sbjct: 64  QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---E 120

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
              +H D+   NVL+  D   KVSDFGL++
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 85.3 bits (212), Expect = 2e-18
 Identities = 51/155 (32%), Positives = 76/155 (49%), Gaps = 13/155 (8%)

Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRSPFLVTLLG 146
           +GKG  G V L   +D GKL A+K L    +   +E +    E  IL  +  PF+V L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 147 YCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLHFGCDPP 204
                 K  LV EY P   L   L  +G    + ++ +  EI++    ALE+LH      
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVL----ALEYLH-SLG-- 113

Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           +I+ D+KP N+LLD+D   K++DFGL++       
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS 148

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 83.7 bits (208), Expect = 7e-18
 Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 22/162 (13%)

Query: 84  DFDEANVIGKGGSGTVFLGIA-RDGKLLAIKRLDTFSL-QTEREF-QNELQILGGLRSPF 140
            ++    IGKG  G V+L     DGKL  +K +D  ++ + ERE   NE++IL  L  P 
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEML---------FSDGNLVLKWSQRFEIIMDVA 191
           ++       E+ K  +V EY     L + +         F +   +L W    ++ +   
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE-EQILDWF--VQLCL--- 114

Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            AL++LH      ++H DIKP N+ L S+   K+ DFG+S++
Sbjct: 115 -ALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 84.4 bits (207), Expect = 2e-17
 Identities = 54/149 (36%), Positives = 77/149 (51%), Gaps = 11/149 (7%)

Query: 90  VIGKGGSGTVFLGIARDGKLLAIKRLD---TFSLQTEREFQNELQILGGLRSP-FLVTLL 145
            +G+G  G V+L  ARD KL+A+K L        +    F  E+QIL  L  P  +V L 
Sbjct: 7   KLGEGSFGEVYL--ARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCDPP 204
            +  +     LV EY+   SL+++L   G    L  S+   I+  +  ALE+LH      
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121

Query: 205 VIHGDIKPSNVLLDSD-CRGKVSDFGLSR 232
           +IH DIKP N+LLD D    K+ DFGL++
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAK 150

Length = 384

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 80.7 bits (200), Expect = 2e-16
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 31/157 (19%)

Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRL-DTFSLQT--EREFQNE---LQILGGLRSPFLVT 143
           +GKG  G V+  I R   +++A+K++ D F   T  +R F+ E   LQ LG    P +V 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDH--PNIVK 71

Query: 144 LLG-YCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWS------QRFEIIMDVAKALE 195
           LL     E +K I LV+EYM          +D + V++ +      +R+ I+  + KAL+
Sbjct: 72  LLNVIKAENDKDIYLVFEYME---------TDLHAVIRANILEDVHKRY-IMYQLLKALK 121

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H G    VIH D+KPSN+LL+SDCR K++DFGL+R
Sbjct: 122 YIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 78.8 bits (194), Expect = 3e-16
 Identities = 52/154 (33%), Positives = 85/154 (55%), Gaps = 15/154 (9%)

Query: 87  EANVIGKGGSGTVFLGIARDGKLLAIKR--LDTFS-LQTEREF---QNELQILGGLRSPF 140
           +  V+GKG  GTV+ G+   G+L+A+K+  LDT + L  E+E+   Q E+ +L  L+   
Sbjct: 4   KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLH 198
           +V  LG C++ N   +  E++P  S+  +L   G L      ++  +I+  VA    +LH
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLH 119

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
             C   V+H DIK +NV+L  +   K+ DFG +R
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 42/150 (28%), Positives = 77/150 (51%), Gaps = 16/150 (10%)

Query: 89  NVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTE--REFQNELQILGGLRSPFLVTLL 145
           ++IG+G  G V+ G+    G  +AIK++    ++ E  +    E+ +L  L+ P +V  +
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDG----NLVLKWSQRFEIIMDVAKALEFLHFGC 201
           G     +   ++ EY  N SL++++   G    +LV  +      +  V + L +LH   
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY------VYQVLQGLAYLH--- 116

Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           +  VIH DIK +N+L   D   K++DFG++
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVA 146

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.3 bits (186), Expect = 5e-15
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 8/151 (5%)

Query: 83  NDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREF-QNELQILGGLRSPF 140
             F     IGKG  G V+  I  R  +++AIK +D    + E E  Q E+Q L   RSP+
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +    G  ++ +K  ++ EY    S  ++L       L  +    I+ +V   LE+LH  
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLGLEYLH-- 115

Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            +   IH DIK +N+LL  +   K++DFG+S
Sbjct: 116 -EEGKIHRDIKAANILLSEEGDVKLADFGVS 145

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 75.9 bits (187), Expect = 5e-15
 Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 14/154 (9%)

Query: 89  NVIGKGGSGTVFLG---IARD--GKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLV 142
             +G+G  G V L       D  G+ +A+K L+     Q   +F+ E++IL  L    +V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 143 TLLGYCMERNKRI--LVYEYMPNKSLQEML-FSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
              G C +   R   L+ EY+P+ SL++ L      + LK    F     + K +++L  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS--SQICKGMDYLG- 126

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
                 IH D+   N+L++S+   K+SDFGL+++
Sbjct: 127 --SQRYIHRDLAARNILVESEDLVKISDFGLAKV 158

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 75.7 bits (187), Expect = 6e-15
 Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 8/149 (5%)

Query: 85  FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           +     IG+G SG V+    R  GK +AIK++     Q +    NE+ I+   + P +V 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-LRKQNKELIINEILIMKDCKHPNIVD 79

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLV-LKWSQRFEIIMDVAKALEFLHFGCD 202
                +  ++  +V EYM   SL +++    N V +   Q   +  +V + LE+LH    
Sbjct: 80  YYDSYLVGDELWVVMEYMDGGSLTDII--TQNFVRMNEPQIAYVCREVLQGLEYLHSQ-- 135

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
             VIH DIK  N+LL  D   K++DFG +
Sbjct: 136 -NVIHRDIKSDNILLSKDGSVKLADFGFA 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 75.0 bits (185), Expect = 7e-15
 Identities = 52/154 (33%), Positives = 80/154 (51%), Gaps = 13/154 (8%)

Query: 91  IGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQN---ELQILGGLRSPFLVTLLG 146
           I KG  G VFL   +  G + AIK +    +  + +      E  IL   +SP++V L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 147 YCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH-FGCDPP 204
           Y  +  K + LV EY+P   L  +L + G+L    + R   I ++  ALE+LH  G    
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA-RI-YIAEIVLALEYLHSNGI--- 114

Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
            IH D+KP N+L+DS+   K++DFGLS++ +   
Sbjct: 115 -IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR 147

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 48/158 (30%), Positives = 73/158 (46%), Gaps = 17/158 (10%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQN----ELQILGGLR 137
           +D +    +G G SG V   + R  GK++A+K +    L+     Q     EL IL    
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI---RLEINEAIQKQILRELDILHKCN 57

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF---EIIMDVAKAL 194
           SP++V   G         +  EYM   SL ++L      V          +I + V K L
Sbjct: 58  SPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL----KEVQGRIPERILGKIAVAVLKGL 113

Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            +LH      +IH D+KPSN+L++S  + K+ DFG+S 
Sbjct: 114 TYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 45/150 (30%), Positives = 74/150 (49%), Gaps = 3/150 (2%)

Query: 84  DFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           +F     +G G  G V+ G+ ++   +AIK L +  L  +++FQ E+Q L  LR   L++
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           L   C       ++ E M   SL   L S    VL  +   ++   VA+ + +L    + 
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQ 123

Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             IH D+   N+L+  D   KV+DFGL+R+
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL 153

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 16/159 (10%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQ---NELQILGGL-R 137
           +DF    +IG+G   TV L   +   K  AIK LD   L  E++ +    E ++L  L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 138 SPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKAL 194
            P ++ L  Y  +  + +  V EY PN  L + +   G+L  K ++ +  EI++    AL
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL----AL 115

Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           E+LH      +IH D+KP N+LLD D   K++DFG +++
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKV 151

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 28/165 (16%)

Query: 90  VIGKGGSGTVFLGIARDGK------LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLV 142
            +G+G  G VFLG     +      L+A+K L +T S    ++F+ E ++L   +   +V
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDG---NLV---------LKWSQRFEIIMDV 190
              G C E +  I+V+EYM +  L + L S G     +         L  SQ  +I + +
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 191 AKALEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           A  + +L   HF      +H D+   N L+  D   K+ DFG+SR
Sbjct: 132 ASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 44/148 (29%), Positives = 75/148 (50%), Gaps = 8/148 (5%)

Query: 89  NVIGKGGSGTVFLGIARD-GKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           N IG G  G V+  +  D G+L+A+K  R+     +T +E  +E+++L  L+ P LV   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPV 205
           G  + R K  +  EY    +L+E+L     L     + + + +   + L +LH      +
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLH---SHGI 120

Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +H DIKP+N+ LD +   K+ DFG +  
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVK 148

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 72.8 bits (179), Expect = 4e-14
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 14/177 (7%)

Query: 89  NVIGKGGSGTVFLGI----ARDGKLLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVT 143
            VIG G  G V  G      +    +AIK L    S +   +F  E  I+G    P ++ 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEML-FSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           L G   +    +++ EYM N SL + L  +DG       Q   ++  +A  +++L    +
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT--VGQLVGMLRGIASGMKYL---SE 124

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQE 259
              +H D+   N+L++S+   KVSDFGLSR   + E     ++   GK    W + E
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE---ATYTTKGGKIPIRWTAPE 178

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 44/150 (29%), Positives = 74/150 (49%), Gaps = 7/150 (4%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
             FD    +G+G  G+V+  I ++ G+++AIK +        +E   E+ IL    SP++
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYI 60

Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           V   G   +     +V EY    S+ +++    N  L   +   I+    K LE+LH   
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLH--- 116

Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
               IH DIK  N+LL+ + + K++DFG+S
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVS 146

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 51/166 (30%), Positives = 83/166 (50%), Gaps = 23/166 (13%)

Query: 84  DFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRSP 139
           D++    IGKG  GTV       DGK+L  K +D +   TE+E Q   +E+ IL  L+ P
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEID-YGNMTEKEKQQLVSEVNILRELKHP 59

Query: 140 FLVTLLGYCMER-NKRI-LVYEY--------MPNKSLQEMLFSDGNLVLKWSQRFEIIMD 189
            +V      ++R N+ + +V EY        +  K  +E  + +   + +      I+  
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR------ILTQ 113

Query: 190 VAKALEFLHFGCDPP--VIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +  AL   H   DP   V+H D+KP+N+ LD++   K+ DFGL++I
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 6e-14
 Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 22/169 (13%)

Query: 78  LKNATNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGL 136
           L + T  F+   VIG+G  G V+     + G+L+AIK +D      E E + E  IL   
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKY 59

Query: 137 RS-PFLVTLLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFE---- 185
            + P + T  G  +++N         LV E     S+ +++      + K  +R +    
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV----KGLRKKGKRLKEEWI 115

Query: 186 --IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
             I+ +  + L +LH   +  VIH DIK  N+LL  +   K+ DFG+S 
Sbjct: 116 AYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 72.2 bits (177), Expect = 7e-14
 Identities = 46/157 (29%), Positives = 84/157 (53%), Gaps = 16/157 (10%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTERE---------FQNELQILGGLRSP 139
           +IG G  G+V+LG+ A  G+L+A+K+++  S+    +            E+ +L  L+  
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
            +V  LG  ++ +   +  EY+P  S+  +L + G       + F  +  + K L +LH 
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNF--VRQILKGLNYLH- 123

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVE 236
             +  +IH DIK +N+L+D+    K+SDFG+S+ K+E
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISK-KLE 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 51/171 (29%), Positives = 80/171 (46%), Gaps = 10/171 (5%)

Query: 91  IGKGGSGTVFLGIARDGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
           IGKG  G V+ G+ +    +A+K  R        +R+F  E +IL     P +V L+G C
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDL-KRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHG 208
           +++    +V E +P  SL   L    N  L   +  ++ +D A  +E+L        IH 
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117

Query: 209 DIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQE 259
           D+   N L+  +   K+SDFG+SR   E E G+   S  L +    W + E
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPE 165

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 45/149 (30%), Positives = 77/149 (51%), Gaps = 5/149 (3%)

Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  G V+LG   + + +AIK +   ++ +E +F  E Q++  L  P LV L G C E
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           R+   LV+E+M +  L + L +      +      + +DV + + +L       VIH D+
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGKFSQ-ETLLGMCLDVCEGMAYLESSN---VIHRDL 126

Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              N L+  +   KVSDFG++R  ++ ++
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQY 155

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 47/149 (31%), Positives = 72/149 (48%), Gaps = 5/149 (3%)

Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V LG  R    +AIK +   ++ +E +F  E +++  L  P LV L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    +V EYM N  L   L       L      ++  DV +A+E+L        IH D+
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126

Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              N L+  D   KVSDFGL+R  ++ ++
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQY 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 53/155 (34%), Positives = 76/155 (49%), Gaps = 13/155 (8%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDT---FSLQTEREFQNELQILGGLRS 138
            DF     +G+GG G VFL   +D G+++A+KR+     F L   R    E  IL   +S
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ-RFEIIMDVAKALEFL 197
            +LV LL    +     L  EY+P    + +L + G  VL     RF +      A++ L
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFE-AVDAL 117

Query: 198 H-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           H  G     IH D+KP N L+D+    K++DFGLS
Sbjct: 118 HELG----YIHRDLKPENFLIDASGHIKLTDFGLS 148

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 37/145 (25%), Positives = 68/145 (46%), Gaps = 8/145 (5%)

Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQN--ELQILGGLRSPFLVTLLGY 147
           IG+G  G V+       G+++AIK++               E+++L  L  P ++ LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
              +    LV+E+M     + +   D    L  S     +  + + L F H      ++H
Sbjct: 67  FRHKGDLYLVFEFMDTDLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILH 121

Query: 208 GDIKPSNVLLDSDCRGKVSDFGLSR 232
            D+KP N+L++++   K++DFGL+R
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 70.2 bits (173), Expect = 3e-13
 Identities = 44/155 (28%), Positives = 73/155 (47%), Gaps = 28/155 (18%)

Query: 91  IGKGGSGTVFLGIARD---GKLLAIK--RLDT----FSLQTEREFQNELQILGGLRSPFL 141
           +G+G  G V+   ARD   G+++A+K  RLD           RE    + +L  L+ P +
Sbjct: 7   LGEGTYGVVYK--ARDKKTGEIVALKKIRLDNEEEGIPSTALRE----ISLLKELKHPNI 60

Query: 142 VTLLGYCMERNKRILVYEYMPN--KSLQEMLFS--DGNLVLKWSQRFEIIMDVAKALEFL 197
           V LL       K  LV+EY     K   +        NL+      ++++    + L + 
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIM--YQLL----RGLAYC 114

Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      ++H D+KP N+L++ D   K++DFGL+R
Sbjct: 115 HSHR---ILHRDLKPQNILINRDGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 70.6 bits (174), Expect = 4e-13
 Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 28/165 (16%)

Query: 89  NVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQN---------ELQILGGLRS 138
             IG G  G V   +  R G+ +AIK++          F +         E+++L  LR 
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRH 58

Query: 139 PFLVTLL-----GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             ++ LL         + N   +V E M    L +++ S   L     Q F  +  + + 
Sbjct: 59  ENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYF--LYQILRG 115

Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
           L++LH      VIH D+KPSN+L++S+C  K+ DFGL+R     E
Sbjct: 116 LKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 69.2 bits (169), Expect = 5e-13
 Identities = 58/171 (33%), Positives = 81/171 (47%), Gaps = 15/171 (8%)

Query: 90  VIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
            IGKG  G V LG  R G  +A+K +   +  T + F  E  ++  LR   LV LLG  +
Sbjct: 13  TIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 150 ERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHG 208
           E    + +V EYM   SL + L S G  VL      +  +DV +A+E+L        +H 
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHR 126

Query: 209 DIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQE 259
           D+   NVL+  D   KVSDFGL++            +QD GK    W + E
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASS--------TQDTGKLPVKWTAPE 169

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 69.9 bits (172), Expect = 5e-13
 Identities = 55/162 (33%), Positives = 83/162 (51%), Gaps = 16/162 (9%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLD---TFSLQTEREFQNELQILGGLRS 138
           +DF+    +G G  G V L   +  GK  A+K L       L+      NE +IL  +R 
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF---EIIMDVAKALE 195
           PFLV L G   + +   LV EY+P   L   L   G      + RF   ++++    ALE
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA-RFYAAQVVL----ALE 115

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +++ D+KP N+LLDSD   K++DFG ++ +V+G
Sbjct: 116 YLH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAK-RVKG 153

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 69.5 bits (171), Expect = 7e-13
 Identities = 45/155 (29%), Positives = 79/155 (50%), Gaps = 26/155 (16%)

Query: 91  IGKGGSGTVFLGIA-RDGKLLAIKRLDTFSLQTERE-----FQNELQILGGLRSPFLVTL 144
           IG+G  G V+     + G+L+A+K++    ++ E+E        E+++L  LR P +V L
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63

Query: 145 LGYCMERNKR--ILVYEYMPN--KSL---QEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
                 + K    +V+EYM +    L    E+ F++  +     Q  E        L++L
Sbjct: 64  KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLE-------GLQYL 116

Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      ++H DIK SN+L+++D   K++DFGL+R
Sbjct: 117 H---SNGILHRDIKGSNILINNDGVLKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 7e-13
 Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 23/160 (14%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSL---QTEREFQNELQILGGL 136
           +DF+   VIG+G  G V+L   RD   G++ A+K L    +         + E  IL   
Sbjct: 1   DDFEVIKVIGRGAFGEVWL--VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA 58

Query: 137 RSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF---EIIMDVAK 192
            SP++V L  Y  +  + + LV EYMP   L  +L        + + RF   E+++    
Sbjct: 59  DSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA-RFYIAELVL---- 112

Query: 193 ALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL+ +H  G     IH DIKP N+L+D+D   K++DFGL 
Sbjct: 113 ALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLC 148

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 48/155 (30%), Positives = 70/155 (45%), Gaps = 19/155 (12%)

Query: 89  NVIGKGGSGTVFLGIARD-GKLLAIK---RLDTFSLQTEREFQNELQILGGLRSPFLVTL 144
            VIGKG  G V +   RD  K+ A+K   +       + R   NE +IL  L  PFLV L
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 145 LGYCMERNKRILVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
                +     LV + +    L     Q++ FS+         +F  I ++  ALE+LH 
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE------QVKF-WICEIVLALEYLH- 117

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
                +IH DIKP N+LLD      ++DF ++   
Sbjct: 118 --SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV 150

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 10/152 (6%)

Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V+ G+  +   +A+K L   ++  + +F  E QI+  LR P L+ L   C  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGCDPPVIH 207
                +V E M   SL E L       LK  Q  ++   VA  + +L   ++      IH
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY------IH 126

Query: 208 GDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
            D+   NVL+  +   KV+DFGL+R+  E  +
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIY 158

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 50/149 (33%), Positives = 71/149 (47%), Gaps = 5/149 (3%)

Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V  G  R    +AIK +   S+ +E EF  E +++  L    LV L G C +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    +V EYM N  L   L   G    + SQ  E+  DV + + +L        IH D+
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKR-FQPSQLLEMCKDVCEGMAYLE---SKQFIHRDL 126

Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              N L+D     KVSDFGLSR  ++ E+
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEY 155

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 67.6 bits (166), Expect = 3e-12
 Identities = 40/149 (26%), Positives = 80/149 (53%), Gaps = 11/149 (7%)

Query: 91  IGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQN-----ELQILGGLRSPFLVTL 144
           +G+G    V+    +  G+++AIK++     +  ++  N     E+++L  L+ P ++ L
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP 204
           L     ++   LV+E+M   +  E +  D ++VL  +     ++   + LE+LH      
Sbjct: 68  LDVFGHKSNINLVFEFME--TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNW 122

Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           ++H D+KP+N+L+ SD   K++DFGL+R 
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLARS 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 69.1 bits (169), Expect = 5e-12
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 17/166 (10%)

Query: 84  DFDEANVIGKGGSGTVFLGI-ARDGKLLAIK---RLDTFSLQTEREFQNELQILGGLRSP 139
           +F     I +G  G V+LG    + KL A+K   + D  +     + Q E   L   +SP
Sbjct: 5   EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSP 64

Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEML----FSDGNLVLKWSQRFEIIMDVAKALE 195
           F+V L       N   LV EY+    ++ +L    + D  + +K+      I +VA AL+
Sbjct: 65  FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY------ISEVALALD 118

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGM 241
           +LH      +IH D+KP N+L+ ++   K++DFGLS++ +  E  M
Sbjct: 119 YLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNM 161

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 66.7 bits (163), Expect = 6e-12
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 14/164 (8%)

Query: 84  DFDEANVIGKGGSGTVFL----GIARDGKLLAIKRLDTFSL----QTEREFQNELQILGG 135
           +F+   V+G G  G VFL    G    GKL A+K L   ++    +T    + E Q+L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 136 LR-SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
           +R  PFLVTL        K  L+ +Y+    L   L+   +      + +  I ++  AL
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVY--IAEIVLAL 118

Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
           + LH      +I+ DIK  N+LLDS+    ++DFGLS+  +  E
Sbjct: 119 DHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 65.8 bits (161), Expect = 7e-12
 Identities = 43/143 (30%), Positives = 68/143 (47%), Gaps = 4/143 (2%)

Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++G       +A+K L   ++  E  F  E QI+  LR   LV L   C E
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
                +V EYM   SL + L S     L+  Q  ++   +A+ + +L        IH D+
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDL 129

Query: 211 KPSNVLLDSDCRGKVSDFGLSRI 233
              N+L+  +   K++DFGL+R+
Sbjct: 130 AARNILVGENLVCKIADFGLARL 152

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 66.8 bits (163), Expect = 1e-11
 Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 29/161 (18%)

Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRL-----DTFSLQTEREFQNELQILGGLR 137
           + +  N IG G  GTV+  I R  G+L A+K +     DT   Q  RE    ++IL  + 
Sbjct: 75  ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICRE----IEILRDVN 130

Query: 138 SPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK---- 192
            P +V       + N  I ++ E+M   SL      +G  +    ++F  + DVA+    
Sbjct: 131 HPNVVKCHDM-FDHNGEIQVLLEFMDGGSL------EGTHI--ADEQF--LADVARQILS 179

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            + +LH      ++H DIKPSN+L++S    K++DFG+SRI
Sbjct: 180 GIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI 217

Length = 353

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 6/153 (3%)

Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQT--EREFQNELQILGGLRSPF 140
           DF+  N IGKG  G VF  + + D ++ A+K++D   +      E  +E ++L  L S +
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           ++      +++ K  +V EY  N  L ++L       L   Q +   + +   L  LH  
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH-- 118

Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               ++H DIK  N+ LD+    K+ D G++++
Sbjct: 119 -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL 150

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 46/157 (29%), Positives = 79/157 (50%), Gaps = 30/157 (19%)

Query: 91  IGKGGSGTVFLGIARD---GKLLAIKRL------DTFSLQTEREFQNELQILGGLRSPFL 141
           IG+G  G VF   A+D   G+ +A+K++           Q  RE    ++ L   + P++
Sbjct: 8   IGEGAHGIVFK--AKDRETGETVALKKVALRRLEGGIPNQALRE----IKALQACQHPYV 61

Query: 142 VTLL-----GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEF 196
           V LL     G        +LV EYMP+  L E+L  +    L  +Q    +  + K + +
Sbjct: 62  VKLLDVFPHGSGF-----VLVMEYMPS-DLSEVLRDEER-PLPEAQVKSYMRMLLKGVAY 114

Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +H      ++H D+KP+N+L+ +D   K++DFGL+R+
Sbjct: 115 MH---ANGIMHRDLKPANLLISADGVLKIADFGLARL 148

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 68.0 bits (166), Expect = 1e-11
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 17/157 (10%)

Query: 69  KLQRFTYKELKNATND-----FDEANVIGKGGSGTVFLG--IARDGKLLAIKRLDTFSLQ 121
           +LQ F  K  K+ T +       E NVI +G  G  + G  I    + +  +  D  S+ 
Sbjct: 671 ELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP 730

Query: 122 TEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWS 181
                 +E+  +G L+ P +V L+G C       L++EY+  K+L E+L +     L W 
Sbjct: 731 -----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWE 780

Query: 182 QRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD 218
           +R +I + +AKAL FLH  C P V+ G++ P  +++D
Sbjct: 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817

Length = 968

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 42/153 (27%), Positives = 79/153 (51%), Gaps = 21/153 (13%)

Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTE-----REFQNELQILGGLRSPFLVTL 144
           +G+G  G V+L    D G+ LA+K++       E        + E+Q+L  L+   +V  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 145 LGYCMERNKRILVY-EYMPNKSLQEMLFSDG----NLVLKWSQRFEIIMDVAKALEFLHF 199
            G C+  ++ + ++ EYMP  S+++ L + G     +  K++++      + + +E+LH 
Sbjct: 70  YG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ------ILEGVEYLH- 121

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                ++H DIK +N+L DS    K+ DFG S+
Sbjct: 122 --SNMIVHRDIKGANILRDSAGNVKLGDFGASK 152

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 51/160 (31%), Positives = 80/160 (50%), Gaps = 14/160 (8%)

Query: 76  KELKNATNDFDEANVIGKGGSGTVFLGIARDG-KLLAIKRLDTFSLQTERE---FQNELQ 131
            +L+    DFD   VIG+G  G V L   +   ++ A+K L  F +    +   F  E  
Sbjct: 36  TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 132 ILGGLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDV 190
           I+    S ++V L  Y  + +K + +V EYMP   L   L S+ ++  KW++ +    +V
Sbjct: 96  IMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFY--TAEV 151

Query: 191 AKALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
             AL+ +H  G     IH D+KP N+LLD     K++DFG
Sbjct: 152 VLALDAIHSMG----FIHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 50/180 (27%), Positives = 81/180 (45%), Gaps = 38/180 (21%)

Query: 91  IGKGGSGTVFLG------IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTL 144
           +G+G  G VFL         +D  L+A+K L   +L   ++FQ E ++L  L+   +V  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 145 LGYCMERNKRILVYEYMPNKSLQE---------MLFSDG-----NLVLKWSQRFEIIMDV 190
            G C + +  I+V+EYM +  L +         M+  DG        L  SQ   I   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 191 AKALEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQD 247
           A  + +L   HF      +H D+   N L+ ++   K+ DFG+SR         D++S D
Sbjct: 133 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSR---------DVYSTD 177

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 38/141 (26%), Positives = 63/141 (44%), Gaps = 22/141 (15%)

Query: 109 LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQ 167
            +AIK L +    + ++EF+ E +++  L+ P +V LLG C +     +++EY+ +  L 
Sbjct: 37  SVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLH 96

Query: 168 EMLFS--------------DGNLVLKWSQRFEIIMDVAKALEFL--HFGCDPPVIHGDIK 211
           E L                     L  S    I + +A  +E+L  H       +H D+ 
Sbjct: 97  EFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLA 151

Query: 212 PSNVLLDSDCRGKVSDFGLSR 232
             N L+      K+SDFGLSR
Sbjct: 152 ARNCLVGEGLTVKISDFGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 47/190 (24%), Positives = 73/190 (38%), Gaps = 39/190 (20%)

Query: 91  IGKGGSGTVFLGIA------RDGKLLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVT 143
           IG+G  G VF   A          ++A+K L +  S   + +FQ E  ++     P +V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEML-----------FSDGNLVLKWSQR--------- 183
           LLG C       L++EYM    L E L               +   K             
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 184 FEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDL 243
             I   VA  + +L    +   +H D+   N L+  +   K++DFGLSR         ++
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR---------NI 180

Query: 244 FSQDLGKSQE 253
           +S D  K+ E
Sbjct: 181 YSADYYKASE 190

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 44/158 (27%), Positives = 79/158 (50%), Gaps = 17/158 (10%)

Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRL-----DTFSLQTEREFQNELQILGGLRSPFLVTL 144
           +G G  G+V+ G+  D G   A+K +          +  ++ + E+ +L  L+ P +V  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLFSDGNL---VLKWSQRFEIIMDVAKALEFLHFGC 201
           LG   E +   +  E +P  SL ++L   G+    V++   R      +   LE+LH   
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH--- 119

Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           D   +H DIK +N+L+D++   K++DFG+++  VE  F
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF 157

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 55/168 (32%), Positives = 81/168 (48%), Gaps = 20/168 (11%)

Query: 83  NDFDEANVIGKGGSGTVFLG-IARDGKLL--AIKRLDTFSLQTE-REFQNELQILGGL-R 137
           ND    +VIG+G  G V    I +DG  +  AIKR+  ++ + + R+F  EL++L  L  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL--- 194
            P ++ LLG C  R    L  EY P+ +L + L    + VL+    F I    A  L   
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK--SRVLETDPAFAIANSTASTLSSQ 124

Query: 195 EFLHFGCD----------PPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LHF  D             IH D+   N+L+  +   K++DFGLSR
Sbjct: 125 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 52/157 (33%), Positives = 74/157 (47%), Gaps = 21/157 (13%)

Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRL-----DTFSLQTEREFQNELQILGG 135
           D++    IG G  G V+   ARD   G+L+AIK +     D F        Q E+ +L  
Sbjct: 4   DYELIQRIGSGTYGDVYK--ARDIATGELVAIKVIKLEPGDDFE-----IIQQEISMLKE 56

Query: 136 LRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALE 195
            R P +V   G  + R+K  +V EY    SLQ  ++      L   Q   +  +  K L 
Sbjct: 57  CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQ-DIYQVTRGPLSELQIAYVCRETLKGLA 115

Query: 196 FLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           +LH  G     IH DIK +N+LL  D   K++DFG+S
Sbjct: 116 YLHETG----KIHRDIKGANILLTEDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 41/158 (25%), Positives = 73/158 (46%), Gaps = 9/158 (5%)

Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQN---ELQILGGLR 137
             +F     IGKG    V+  I   DG+++A+K++  F +   +  Q+   E+ +L  L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEML--FSDGNLVLKWSQRFEIIMDVAKALE 195
            P ++  L   +E N+  +V E      L  M+  F     ++     ++  + +  ALE
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            +H      ++H DIKP+NV + +    K+ D GL R 
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRF 155

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 63.7 bits (155), Expect = 5e-11
 Identities = 46/148 (31%), Positives = 71/148 (47%), Gaps = 10/148 (6%)

Query: 91  IGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQN---ELQILGGLR-SPFLVTLL 145
           I KG  G+V+L   R  G   AIK L    +  + +  N   E  I+     SP++  L 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPV 205
                ++   LV EY+       ++ + G L   W++++  I +V   +E LH      +
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLH---QRGI 118

Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           IH DIKP N+L+D     K++DFGLSR 
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRN 146

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 6e-11
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 34/167 (20%)

Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLD-----TFSLQTERE------FQNE-- 129
            +   + IG+G  G V     +  G  +AIK++      TF  +T RE      F++E  
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65

Query: 130 LQILGGLRSPFLVTLLGYCMERNKRILVYEYMPN---KSLQEMLFSDGNLVLKWSQRFEI 186
           + IL  +R P   +        N   +V E M     K ++    S+ ++     Q F  
Sbjct: 66  IGILDIIRPPSFESF-------NDVYIVQELMETDLYKLIKTQHLSNDHI-----QYF-- 111

Query: 187 IMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +  + + L+++H   +  V+H D+KPSN+LL+++C  K+ DFGL+RI
Sbjct: 112 LYQILRGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARI 155

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 35/177 (19%)

Query: 91  IGKGGSGTVFLGIA------RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTL 144
           +G+G  G VFL         +D  L+A+K L   S    ++F  E ++L  L+   +V  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 145 LGYCMERNKRILVYEYMPNKSLQE---------MLFSDGN--LVLKWSQRFEIIMDVAKA 193
            G C+E +  I+V+EYM +  L +         +L ++GN    L  SQ   I   +A  
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 194 LEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQD 247
           + +L   HF      +H D+   N L+  +   K+ DFG+SR         D++S D
Sbjct: 133 MVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSR---------DVYSTD 174

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 63.6 bits (155), Expect = 7e-11
 Identities = 47/163 (28%), Positives = 78/163 (47%), Gaps = 29/163 (17%)

Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRL---DTFSLQTEREFQNELQILGGLR 137
           D +    +G G  G V L   RD       A+K +   +   L+ E+   NE ++L  + 
Sbjct: 2   DLERIKTVGTGTFGRVHL--VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59

Query: 138 SPFLVTLLGYCMERNKRIL--VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------D 189
            PF++ L  +  E ++R L  + EY+P   L    FS     L+ S RF          +
Sbjct: 60  HPFIIRL--FWTEHDQRFLYMLMEYVPGGEL----FS----YLRNSGRFSNSTGLFYASE 109

Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +  ALE+LH      +++ D+KP N+LLD +   K++DFG ++
Sbjct: 110 IVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK 149

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 62.8 bits (153), Expect = 8e-11
 Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 6/152 (3%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQTE-REFQNELQILGGLRSPF 140
           +D++   VIG G +  V+  I       +AIKR+D    QT   E + E+Q +     P 
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQE-MLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
           +V      +  ++  LV  Y+   SL + M  S     L  +    ++ +V K LE+LH 
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH- 119

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
                 IH DIK  N+LL  D   K++DFG+S
Sbjct: 120 --SNGQIHRDIKAGNILLGEDGSVKIADFGVS 149

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 53/163 (32%), Positives = 75/163 (46%), Gaps = 29/163 (17%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRL---DTFSLQTEREFQNELQILGGLRS 138
            DF    VIGKG  G V L   +D GK+ A+K L   + F        + E  +L    S
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWS------QRF---EIIMD 189
           P++V+L     +     L+ E++P   L  ML       +K+        RF   E ++ 
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML-------IKYDTFSEDVTRFYMAECVL- 112

Query: 190 VAKALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              A+E +H  G     IH DIKP N+L+D     K+SDFGLS
Sbjct: 113 ---AIEAVHKLG----FIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 51/166 (30%), Positives = 85/166 (51%), Gaps = 27/166 (16%)

Query: 85  FDEANVIGKGGSGTVFLGIARD---GKLLAIKRL------DTFSLQTEREFQNELQILGG 135
           ++E   IG+G  GTV+   ARD   G+ +A+K++      +   L T RE    + +L  
Sbjct: 1   YEELAEIGEGAYGTVYK--ARDLNTGRFVALKKVRVPLSEEGIPLSTLRE----IALLKQ 54

Query: 136 LRS---PFLVTLLGYCM-ERNKRI----LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEII 187
           L S   P +V LL  C   R  R     LV+E++ ++ L   L       L      +++
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLM 113

Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             + + ++FLH      ++H D+KP N+L+ SD + K++DFGL+RI
Sbjct: 114 RQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 27/158 (17%)

Query: 91  IGKGGSGTVFLGIAR-------DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           +GKG  G+V L   R        G+++A+K+L   + +  R+F+ E++IL  L+   +V 
Sbjct: 12  LGKGNFGSVEL--CRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 144 LLGYC--MERNKRILVYEYMPNKSLQEML------FSDGNLVLKWSQRFEIIMDVAKALE 195
             G C    R    LV EY+P  SL++ L           L+L  SQ       + K +E
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ-------ICKGME 122

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +L        +H D+   N+L++S+ R K+ DFGL+++
Sbjct: 123 YLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKV 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 8/149 (5%)

Query: 85  FDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTERE-FQNELQILGGLRSPFLV 142
           F +   IGKG  G VF GI  R  K++AIK +D    + E E  Q E+ +L    SP++ 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
              G  ++  K  ++ EY+   S  ++L       L  +Q   I+ ++ K L++LH    
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLH---S 119

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              IH DIK +NVLL      K++DFG++
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVA 148

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 6/149 (4%)

Query: 91  IGKGGSGTVFLGIAR-DGKLLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
           IG+G  G VF G  R D   +A+K   +T     + +F  E +IL     P +V L+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHG 208
            ++    +V E +        L ++G   LK  +  +++ + A  +E+L        IH 
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKH---CIHR 118

Query: 209 DIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           D+   N L+      K+SDFG+SR + +G
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDG 147

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 7/153 (4%)

Query: 85  FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREF--QNELQILGGLRSPFL 141
           +++  V+G+G  G V L   + D KL+ IK++    +  +     QNE Q+L  L  P +
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           +      +E    ++V EY P  +L E +    N +L         + +  AL  +H   
Sbjct: 62  IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH--- 118

Query: 202 DPPVIHGDIKPSNVLLDS-DCRGKVSDFGLSRI 233
              ++H D+K  N+LLD      K+ DFG+S+I
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKI 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 50/164 (30%), Positives = 69/164 (42%), Gaps = 28/164 (17%)

Query: 89  NVIGKGGSGTVFLG--IARDGKL----LAIKRL-DTFSLQTEREFQNELQILGGLRSPFL 141
             +G G  G V+ G    RDG      +A+K L ++ S Q E +F  E  I+       +
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGN-----LVLKWSQRFEIIMDVA---KA 193
           V L+G   ER  R ++ E M    L+  L  +         L          DVA   K 
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRG-----KVSDFGLSR 232
           LE  HF      IH DI   N LL   C+G     K++DFG++R
Sbjct: 132 LEENHF------IHRDIAARNCLL--TCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 48/150 (32%), Positives = 77/150 (51%), Gaps = 13/150 (8%)

Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREFQ-NELQILGGLRSP 139
             D    IG+G +G V   IA D   G+ +A+K++D    Q  RE   NE+ I+   + P
Sbjct: 20  YLDNFVKIGEGSTGIVC--IATDKSTGRQVAVKKMD-LRKQQRRELLFNEVVIMRDYQHP 76

Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
            +V +    +  ++  +V E++   +L +++    +  +   Q   + + V KAL FLH 
Sbjct: 77  NIVEMYSSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLAVLKALSFLH- 132

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
                VIH DIK  ++LL SD R K+SDFG
Sbjct: 133 --AQGVIHRDIKSDSILLTSDGRVKLSDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 41/147 (27%), Positives = 69/147 (46%), Gaps = 10/147 (6%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTE---REFQNELQILGGLRSPFLVTLL 145
           V+G+G  G V     +  G+++AIK+    S   E   +    E+++L  LR   +V L 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKE-SEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPV 205
                + +  LV+EY+    L+ +  S G L     +    I  + +A+ + H      +
Sbjct: 67  EAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRS--YIWQLLQAIAYCH---SHNI 121

Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           IH DIKP N+L+      K+ DFG +R
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 49/179 (27%), Positives = 76/179 (42%), Gaps = 37/179 (20%)

Query: 91  IGKGGSGTVFLGIA------RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTL 144
           +G+G  G VFL         +D  L+A+K L   S    ++FQ E ++L  L+   +V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLFS---DGNLV----------LKWSQRFEIIMDVA 191
            G C E    ++V+EYM +  L   L S   D  ++          L   Q   I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 192 KALEF---LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQD 247
             + +   LHF      +H D+   N L+      K+ DFG+SR         D++S D
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSR---------DIYSTD 176

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 61.0 bits (149), Expect = 4e-10
 Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 27/166 (16%)

Query: 75  YKELKNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQN--ELQ 131
           YK +K           +G G  G+V+L   ++ G+L+AIK++      +  E  N  E++
Sbjct: 1   YKVIKQ----------LGDGTFGSVYLARNKETGELVAIKKMKK-KFYSWEECMNLREVK 49

Query: 132 ILGGLRS-PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDV 190
            L  L   P +V L     E ++   V+EYM   +L +++          S    II  +
Sbjct: 50  SLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQI 108

Query: 191 AKALEFLH----FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            + L  +H    F       H D+KP N+L+      K++DFGL+R
Sbjct: 109 LQGLAHIHKHGFF-------HRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 60.3 bits (146), Expect = 5e-10
 Identities = 45/149 (30%), Positives = 71/149 (47%), Gaps = 5/149 (3%)

Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V LG  R    +AIK ++  ++ +E +F  E +++  L  P LV L G C +
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    +V E+M N  L   L       L       +  DV + +E+L        IH D+
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDL 126

Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              N L+ S    KVSDFG++R  ++ E+
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEY 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 60.6 bits (147), Expect = 6e-10
 Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 9/146 (6%)

Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRSPFLVTLLG 146
           +GKGG G V     +  GK+ A K+LD   L+  +  Q   NE +IL  + S F+V+L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 147 YCME-RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPV 205
           Y  E ++   LV   M    L+  +++ G      ++       +   LE LH      +
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRI 116

Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLS 231
           ++ D+KP NVLLD     ++SD GL+
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 60.7 bits (147), Expect = 7e-10
 Identities = 45/142 (31%), Positives = 74/142 (52%), Gaps = 9/142 (6%)

Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQ-NELQILGGLRSPFLVTLLGYC 148
           IG+G SGTV+  I    G+ +AIK+++    Q ++E   NE+ ++   + P +V  L   
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHG 208
           +  ++  +V EY+   SL +++       +   Q   +  +  +ALEFLH      VIH 
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLH---SNQVIHR 139

Query: 209 DIKPSNVLLDSDCRGKVSDFGL 230
           DIK  N+LL  D   K++DFG 
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 22/168 (13%)

Query: 84  DFDEANVIGKGGSGTVFLG-IARDGKLL--AIKRLDTFSLQTE-REFQNELQILGGL-RS 138
           D    +VIG+G  G V    I +DG  +  AIK L  F+ + + R+F  EL++L  L   
Sbjct: 3   DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNL--------------VLKWSQRF 184
           P ++ LLG C  R    +  EY P  +L + L     L               L   Q  
Sbjct: 63  PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122

Query: 185 EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +   DVA  +++L    +   IH D+   NVL+  +   K++DFGLSR
Sbjct: 123 QFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 60.8 bits (148), Expect = 9e-10
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 21/159 (13%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTERE----FQNELQILGGLR 137
           +DF+   VIG+G  G V L   +D G + A+K+L   S   E+E     + E  IL    
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRK-SEMLEKEQVAHVRAERDILAEAD 59

Query: 138 SPFLVTLLGYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALE 195
           +P++V L  Y   +++    L+ EY+P   +  +L        + ++ +  I +   A++
Sbjct: 60  NPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFY--IAETILAID 115

Query: 196 FLH---FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            +H   +      IH DIKP N+LLD+    K+SDFGL 
Sbjct: 116 SIHKLGY------IHRDIKPDNLLLDAKGHIKLSDFGLC 148

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 28/160 (17%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQ----------NELQILGGLRS 138
           +IGKG  G V+L +    G+++A+K+++  +    R             +E++ L  L  
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFE------IIMDVAK 192
             +V  LG+        +  EY+P  S+   L + G        RFE          V +
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG--------RFEEQLVRFFTEQVLE 119

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            L +LH      ++H D+K  N+L+D+D   K+SDFG+S+
Sbjct: 120 GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 11/149 (7%)

Query: 89  NVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           + +G G  G V+ G+  +    +A+K L   +++ E EF  E  ++  ++ P LV LLG 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70

Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGCDPP 204
           C       ++ E+M   +L + L       +       +   ++ A+E+L   +F     
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF----- 125

Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            IH D+   N L+  +   KV+DFGLSR+
Sbjct: 126 -IHRDLAARNCLVGENHLVKVADFGLSRL 153

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 11/153 (7%)

Query: 85  FDEANVIGKGGSGTVFLGIARD---GKLLAIK--RLDTFSLQTEREFQNELQILGGLRSP 139
           F +   IG+G  G V+   AR+   G+++A+K  RLDT +         E+ +L  L  P
Sbjct: 2   FQKVEKIGEGTYGVVYK--ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 59

Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
            +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F H 
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH- 117

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                V+H D+KP N+L++++   K++DFGL+R
Sbjct: 118 --SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 48/152 (31%), Positives = 81/152 (53%), Gaps = 15/152 (9%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRL--DTFSLQTERE---FQNELQILGGLRSPFLVT 143
           ++G+G  G V+L    D G+ LA+K++  D  S +T +E    + E+Q+L  LR   +V 
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 144 LLGYCM---ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
             G C+   E  K  +  EYMP  S+++ L + G L    ++R+     + + + +LH  
Sbjct: 69  YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRY--TRQILQGVSYLHSN 125

Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               ++H DIK +N+L DS    K+ DFG S+
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 55/187 (29%), Positives = 92/187 (49%), Gaps = 24/187 (12%)

Query: 84  DFDEANVIGKGGSGTVFLGI-ARDGKLL----AIKRL-DTFSLQTEREFQNELQILGGLR 137
           +     V+G G  GTV+ GI   +G+ +    AIK L +T   +   EF +E  I+  + 
Sbjct: 8   ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGN-----LVLKWSQRFEIIMDVAK 192
            P LV LLG C+    + LV + MP+  L + +    +     L+L W       + +AK
Sbjct: 68  HPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC------VQIAK 120

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQ 252
            + +L    +  ++H D+   NVL+ S    K++DFGL+R+ +EG+     ++ D GK  
Sbjct: 121 GMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGD--EKEYNADGGKMP 174

Query: 253 ELWKSQE 259
             W + E
Sbjct: 175 IKWMALE 181

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 44/149 (29%), Positives = 70/149 (46%), Gaps = 15/149 (10%)

Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLD---TFSLQTEREFQNELQILGGLRSPFLVTLLG 146
           +G GG G V L       +  A+K +          +    +E +IL     PF+V L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58

Query: 147 YCMERNKRILVY---EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           Y   ++K+  +Y   EY     L  +L   G    +++ RF  I  V  A E+LH   + 
Sbjct: 59  YRTFKDKK-YIYMLMEYCLGGELWTILRDRGLFD-EYTARF-YIACVVLAFEYLH---NR 112

Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            +I+ D+KP N+LLDS+   K+ DFG ++
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAK 141

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 10/158 (6%)

Query: 76  KELKNATNDFDEANVIGKGGSGTVFLGIARDG-KLLAIKRLDTFSLQTERE---FQNELQ 131
           ++L+    D+D   VIG+G  G V L   +   K+ A+K L  F +    +   F  E  
Sbjct: 36  RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 132 ILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVA 191
           I+    SP++V L     +     +V EYMP   L  ++ S+ ++  KW++ +    +V 
Sbjct: 96  IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM-SNYDVPEKWAKFY--TAEVV 152

Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
            AL+ +H      +IH D+KP N+LLD     K++DFG
Sbjct: 153 LALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 47/168 (27%), Positives = 72/168 (42%), Gaps = 22/168 (13%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQ--NELQILGGLRSPF 140
               E + +G+G  G+V     ++  ++   +  T     + + Q   EL+I    +SP+
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 141 LVTLLGYCM-ERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF------EIIMDVAK 192
           +V   G  + E +  I +  EY    SL     S    V K   R       +I   V K
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLD----SIYKKVKKRGGRIGEKVLGKIAESVLK 116

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFG 240
            L +LH      +IH DIKPSN+LL    + K+ DFG+S     GE  
Sbjct: 117 GLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELV 156

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 2e-09
 Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 21/159 (13%)

Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREFQN---ELQILGGLR 137
            F +  ++GKG  G VFL   R    GKL A+K LD   +    + +    E +IL  L 
Sbjct: 2   HFKKIKLLGKGDVGRVFL--VRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-GNLVLKWSQRF---EIIMDVAKA 193
            PFL TL           LV +Y P   L  +L    G  + +   RF   E+++    A
Sbjct: 60  HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL----A 115

Query: 194 LEFLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           LE+LH  G    +++ D+KP N+LL       +SDF LS
Sbjct: 116 LEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLS 150

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 43/151 (28%), Positives = 68/151 (45%), Gaps = 19/151 (12%)

Query: 91  IGKGGSGTVFLGIAR--DGKLL--AIKRL-DTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +G G  G+V  G+     GK +  A+K L        ++EF  E  ++  L  P +V L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNL----VLKWSQRFEIIMDVAKALEFLHFGC 201
           G C      +LV E  P   L + L     +    + + + +  + M     LE  HF  
Sbjct: 63  GVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGM---AYLESKHF-- 116

Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               +H D+   NVLL +  + K+SDFG+SR
Sbjct: 117 ----VHRDLAARNVLLVNRHQAKISDFGMSR 143

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 59.4 bits (143), Expect = 2e-09
 Identities = 47/143 (32%), Positives = 75/143 (52%), Gaps = 11/143 (7%)

Query: 91  IGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG+G SGTVF   A D   G+ +AIK+++      +    NE+ ++  L++P +V  L  
Sbjct: 27  IGQGASGTVF--TAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
            +  ++  +V EY+   SL +++       +  +Q   +  +  +ALEFLH      VIH
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHAN---QVIH 138

Query: 208 GDIKPSNVLLDSDCRGKVSDFGL 230
            DIK  NVLL  D   K++DFG 
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 21/155 (13%)

Query: 90  VIGKGGSGTVFLGI-ARDGK----LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVT 143
           V+G G  GTV+ GI   DG+     +AIK L +  S +  +E  +E  ++ G+ SP++  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLV-----LKWSQRFEIIMDVAKALEFLH 198
           LLG C+    + LV + MP   L + +  + + +     L W       + +AK + +L 
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWC------VQIAKGMSYLE 126

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
              +  ++H D+   NVL+ S    K++DFGL+R+
Sbjct: 127 ---EVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 49/161 (30%), Positives = 86/161 (53%), Gaps = 21/161 (13%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSL----QTEREFQNELQILGGLR 137
            DF+   +I  G  G V+L   ++ +   A+K+++  +L    Q ++ F  E  IL    
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAE 59

Query: 138 SPFLVTLLGYCMERNKRIL--VYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKA 193
           +PF+V++  +C    KR L  V EY+       +L + G L +  ++ +  E ++    A
Sbjct: 60  NPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL----A 113

Query: 194 LEFLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           LE+LH +G    ++H D+KP N+L+ S    K++DFGLS+I
Sbjct: 114 LEYLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 43/149 (28%), Positives = 75/149 (50%), Gaps = 11/149 (7%)

Query: 90  VIGKGGSGTVFLG----IARDGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSPFLVTL 144
           VIG G  G V  G      +    +AIK L + ++ +  R+F +E  I+G    P ++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 145 LGYCMERNKRILVYEYMPNKSLQEML-FSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
            G   +    +++ E+M N +L   L  +DG   +   Q   ++  +A  +++L    + 
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---SEM 125

Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
             +H D+   N+L++S+   KVSDFGLSR
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSR 154

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 40/156 (25%), Positives = 78/156 (50%), Gaps = 23/156 (14%)

Query: 90  VIGKGGSGTVFLGI----ARDGKL-LAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVT 143
           V+G G  GTV+ G+        K+ +AIK L +  S +  +E  +E  ++  +  P +V 
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 144 LLGYCMERNKRI-LVYEYMPNKSLQEMLFS-----DGNLVLKWSQRFEIIMDVAKALEFL 197
           LLG C+  + ++ L+ + MP   L + + +         +L W  +      +AK + +L
Sbjct: 74  LLGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL 125

Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               +  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 126 E---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 51/165 (30%), Positives = 76/165 (46%), Gaps = 31/165 (18%)

Query: 90  VIGKGGSGTVFLGIARDG----KLLAIKRL----------DTFSLQTEREFQNELQILGG 135
           V+GKGG G VF      G    K+ A+K L          DT   + ER       IL  
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAER------NILEA 56

Query: 136 LRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF---EIIMDVAK 192
           ++ PF+V L+       K  L+ EY+    L   L  +G + ++ +  F   EI +    
Sbjct: 57  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG-IFMEDTACFYLSEISL---- 111

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           ALE LH      +I+ D+KP N+LLD+    K++DFGL +  +  
Sbjct: 112 ALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 15/156 (9%)

Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQN---ELQILGGLRSP 139
           DF+    +G G  G V +   +  G+  AIK L    +   ++ Q+   E  IL  L  P
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDG---NLVLKWSQRFEIIMDVAKALEF 196
           F+V ++    + N+   + E++    L   L   G   N V K+    E+++    A E+
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA-ELVL----AFEY 133

Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           LH   D  +I+ D+KP N+LLD+    KV+DFG ++
Sbjct: 134 LH-SKD--IIYRDLKPENLLLDNKGHVKVTDFGFAK 166

Length = 329

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 46/152 (30%), Positives = 82/152 (53%), Gaps = 14/152 (9%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRL-DTFS-LQTEREFQNELQILGGLRSPFLVTLLG 146
           VIGKG  G V   I    G+ +AIK++ D F  +        E+++L  LR P +V +  
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 147 YCMERNKR-----ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
             +  ++R      +V+E M    L +++ ++ +L  +  Q F  +  + +AL+++H   
Sbjct: 67  IMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFF--LYQLLRALKYIH--- 120

Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
              V H D+KP N+L ++DC+ K+ DFGL+R+
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARV 152

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 57.8 bits (139), Expect = 4e-09
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 8/149 (5%)

Query: 85  FDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTERE-FQNELQILGGLRSPFLV 142
           F +   IGKG  G VF GI  R  +++AIK +D    + E E  Q E+ +L    SP++ 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
              G  ++  K  ++ EY+   S  ++L +         Q   ++ ++ K L++LH    
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLH---S 119

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              IH DIK +NVLL      K++DFG++
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVA 148

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 57.6 bits (139), Expect = 5e-09
 Identities = 49/150 (32%), Positives = 76/150 (50%), Gaps = 11/150 (7%)

Query: 90  VIGKGGSGTVFLG-IARDGK---LLAIKRLDT-FSLQTEREFQNELQILGGLRSPFLVTL 144
           VIG G  G V  G +   GK    +AIK L   ++ +  R+F +E  I+G    P ++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
            G   +    ++V EYM N SL   L   DG   +   Q   ++  +A  +++L    D 
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV--IQLVGMLRGIASGMKYL---SDM 125

Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             +H D+   N+L++S+   KVSDFGLSR+
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRV 155

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 34/159 (21%)

Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ------NELQILGGLRSPFLVT 143
           IG+G  G VF    R+ G+++AIK+     +++E +         E+++L  L+ P LV 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF----VESEDDPVIKKIALREIRMLKQLKHPNLVN 64

Query: 144 LLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGN-------LVLKWSQRFEIIMDVAKALE 195
           L+     R +++ LV+EY  +  L E+   + N       L+ K      II    +A+ 
Sbjct: 65  LI-EVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKK------IIWQTLQAVN 114

Query: 196 FLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           F H   C    IH D+KP N+L+    + K+ DFG +RI
Sbjct: 115 FCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARI 149

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 57.4 bits (138), Expect = 6e-09
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 8/149 (5%)

Query: 85  FDEANVIGKGGSGTVFLGIA-RDGKLLAIKRLDTFSLQTERE-FQNELQILGGLRSPFLV 142
           F +   IGKG  G V+ GI  R  +++AIK +D    + E E  Q E+ +L    SP++ 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
              G  ++  K  ++ EY+   S  ++L       L+ +    I+ ++ K L++LH    
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLH---S 119

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              IH DIK +NVLL      K++DFG++
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVA 148

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 57.0 bits (137), Expect = 7e-09
 Identities = 45/151 (29%), Positives = 78/151 (51%), Gaps = 13/151 (8%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRL--DTFSLQTERE---FQNELQILGGLRSPFLVT 143
           ++G+G  G V+L    D G+ LA+K++  D  S +T +E    + E+Q+L  L    +V 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 144 LLGYCMERNKRIL--VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
             G   +  +R L    E+MP  S+++ L S G L    ++++       + LE + +  
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKY-----TRQILEGVSYLH 123

Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
              ++H DIK +N+L DS    K+ DFG S+
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 57.2 bits (138), Expect = 7e-09
 Identities = 40/149 (26%), Positives = 74/149 (49%), Gaps = 5/149 (3%)

Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++G       +AIK L   S+  E  F  E  ++  L+ P LV L    + 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYA-VVT 71

Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    ++ EYM N SL + L +   + L  ++  ++   +A+ + F+        IH D+
Sbjct: 72  QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128

Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+      K++DFGL+R+  + E+
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNEY 157

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 57.0 bits (137), Expect = 8e-09
 Identities = 45/151 (29%), Positives = 80/151 (52%), Gaps = 13/151 (8%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRL--DTFSLQTERE---FQNELQILGGLRSPFLVT 143
           ++G+G  G V+L    D G+ LA K++  D  S +T +E    + E+Q+L  L+   +V 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 144 LLGYCMERNKRILV--YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
             G   +R ++ L    EYMP  S+++ L + G L    ++++     + + + +LH   
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY--TRQILEGMSYLHSNM 126

Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
              ++H DIK +N+L DS    K+ DFG S+
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 56.9 bits (137), Expect = 8e-09
 Identities = 49/158 (31%), Positives = 74/158 (46%), Gaps = 7/158 (4%)

Query: 85  FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQT---EREFQNELQILGGLRSPF 140
           F +  V+GKGG G V     R  GK+ A KRL+   ++    E    NE QIL  + S F
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V L      ++   LV   M    L+  +++ GN   +  +      ++   LE LH  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119

Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
                ++ D+KP N+LLD     ++SD GL+    EGE
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 7/148 (4%)

Query: 90  VIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +IG+G  G V  G    G+ +A+K +      T + F  E  ++  L    LV LLG  +
Sbjct: 13  IIGEGEFGAVLQG-EYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             N   +V E M   +L   L + G  ++   Q  +  +DVA+ +E+L       ++H D
Sbjct: 70  H-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRD 125

Query: 210 IKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +   N+L+  D   KVSDFGL+R+   G
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMG 153

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 51/180 (28%), Positives = 76/180 (42%), Gaps = 36/180 (20%)

Query: 89  NVIGKGGSGTVFLGIARD------GKL-LAIKRLDTFSLQTER-EFQNELQILGGLRSPF 140
           N +G G  G V+ G A D      G + +A+K L   +   E+ EF  E  ++     P 
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEML-----FSDGNLVLKWSQRFEIIMDVAKA-- 193
           +V LLG C+    + ++ E M    L   L        G  +L   +  +I +DVAK   
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 194 -LEFLHFGCDPPVIHGDIKPSNVLL---DSDCRG--KVSDFGLSRIKVEGEFGMDLFSQD 247
            LE +HF      IH D+   N L+     D     K+ DFGL+R         D++  D
Sbjct: 121 YLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLAR---------DIYKSD 165

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 44/159 (27%), Positives = 82/159 (51%), Gaps = 20/159 (12%)

Query: 84  DFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTERE-----FQNELQILGGLR 137
           D+ +   IG+G  G V+ G  +  G+++A+K++    L++E E        E+ +L  L+
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI---RLESEEEGVPSTAIREISLLKELQ 57

Query: 138 SPFLVTLLGYCMERNKRILVYEY--MPNKSLQEMLFSDGNL--VLKWSQRFEIIMDVAKA 193
            P +V L    M+ ++  L++E+  M  K   + L     +   L  S  ++I+    + 
Sbjct: 58  HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QG 113

Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + F H      V+H D+KP N+L+D+    K++DFGL+R
Sbjct: 114 ILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 47/159 (29%), Positives = 71/159 (44%), Gaps = 23/159 (14%)

Query: 92  GKGGSGTVFLGIARDGKLLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           GK   G ++L      +L+AIK L D  + Q   EFQ E  ++  L  P +V LLG   +
Sbjct: 19  GKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ 78

Query: 151 RNKRILVYEYMPNKSLQEMLF-----------SDGNLVLKWS----QRFEIIMDVAKALE 195
                +++EY+    L E L            SD +  +K S        I + +A  +E
Sbjct: 79  EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGME 138

Query: 196 FL--HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +L  HF      +H D+   N+L+      K+SD GLSR
Sbjct: 139 YLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 40/142 (28%), Positives = 64/142 (45%), Gaps = 5/142 (3%)

Query: 91  IGKGGSGTVFLGIARDGKLL-AIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G V+    ++  L  A K +   S +   +F  E+ IL   + P +V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             NK  ++ E+    +L  ++       L   Q   +   + +AL FLH      VIH D
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLH---SHKVIHRD 128

Query: 210 IKPSNVLLDSDCRGKVSDFGLS 231
           +K  N+LL  D   K++DFG+S
Sbjct: 129 LKAGNILLTLDGDVKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 10/158 (6%)

Query: 76  KELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTERE---FQNELQ 131
           ++L+    D++   VIG+G  G V L   +   K+ A+K L  F +    +   F  E  
Sbjct: 36  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 132 ILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVA 191
           I+    SP++V L     +     +V EYMP   L   L S+ ++  KW++ +    +V 
Sbjct: 96  IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFY--TAEVV 152

Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
            AL+ +H       IH D+KP N+LLD     K++DFG
Sbjct: 153 LALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 55/162 (33%), Positives = 79/162 (48%), Gaps = 22/162 (13%)

Query: 84  DFDEANVIGKGGSGTVFL----GIARDGKLLAIKRLDTFSL----QTEREFQNELQILGG 135
           +F+   V+G G  G VFL         GKL A+K L   +L    +T    + E  +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 136 LR-SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF---EIIMDVA 191
           +R SPFLVTL        K  L+ +Y+    +   L+   N   +   RF   EII+   
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS-EDEVRFYSGEIIL--- 116

Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            ALE LH  G    +++ DIK  N+LLDS+    ++DFGLS+
Sbjct: 117 -ALEHLHKLG----IVYRDIKLENILLDSEGHVVLTDFGLSK 153

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 20/159 (12%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQN--------ELQIL 133
             ++   ++G+G  G V     ++ G+++AIK+        E E           E+++L
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKF------LESEDDKMVKKIAMREIRML 54

Query: 134 GGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             LR   LV L+     + +  LV+E++ +  L ++      L     +++  +  + + 
Sbjct: 55  KQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKY--LFQILRG 112

Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +EF H      +IH DIKP N+L+      K+ DFG +R
Sbjct: 113 IEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 51/200 (25%), Positives = 93/200 (46%), Gaps = 49/200 (24%)

Query: 84  DFDEANVIGKGGSGTVFLGIAR--DGKLLAIKRLDTFSL-QTEREFQ-NELQILGGLRSP 139
           DF     +GKG  G+V+  + R  D +  A+K +D  S+ Q ERE   NE++IL  +  P
Sbjct: 1   DFKVLKKLGKGSYGSVYK-VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHP 59

Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQR------------FEII 187
            +++     ++ NK  +V EY P           G+L    S+R            + I 
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAP----------FGDLSKAISKRKKKRKLIPEQEIWRIF 109

Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQD 247
           + + + L+ LH   +  ++H D+K +N+LL ++   K+ D G+S++            ++
Sbjct: 110 IQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKV----------LKKN 156

Query: 248 LGKSQ---------ELWKSQ 258
           + K+Q         E+WK +
Sbjct: 157 MAKTQIGTPHYMAPEVWKGR 176

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 50/163 (30%), Positives = 77/163 (47%), Gaps = 22/163 (13%)

Query: 89  NVIGKGGSGTVFLG-IARDGKLL--AIKRLDTFSLQTE-REFQNELQILGGL-RSPFLVT 143
           +VIG+G  G V    I +DG  +  AIKR+  ++ + + R+F  EL++L  L   P ++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNL--------------VLKWSQRFEIIMD 189
           LLG C  R    L  EY P+ +L + L     L               L   Q      D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           VA+ +++L        IH D+   N+L+  +   K++DFGLSR
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 13/152 (8%)

Query: 84  DFDEANVIGKGGSGTVFLGI-ARDGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPF 140
           D     ++G G  GTV+        ++LA+K   LD  +++ +++  +EL+IL    SP+
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPY 60

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           ++   G     N+  +  E+M   SL ++       VL       I + V K L +L   
Sbjct: 61  IIGFYGAFFVENRISICTEFMDGGSL-DVYRKIPEHVLG-----RIAVAVVKGLTYL--- 111

Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               ++H D+KPSN+L+++  + K+ DFG+S 
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVST 143

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 9/149 (6%)

Query: 90  VIGKGGSGTVFLGI----ARDGKLLAIKRLDTFSLQTER-EFQNELQILGGLRSPFLVTL 144
           VIG G  G VF GI     R    +AIK L     + +R +F +E  I+G      ++ L
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP 204
            G   +    +++ EYM N +L + L  D +      Q   ++  +A  +++L    D  
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYL-RDHDGEFSSYQLVGMLRGIAAGMKYL---SDMN 127

Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            +H D+   N+L++S+   KVSDFGLSR+
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRV 156

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 8/157 (5%)

Query: 77  ELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ--TEREFQNELQILG 134
           ELK+  +DF++ + +G G  G VF    +   L+  ++L    ++     +   ELQ+L 
Sbjct: 1   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58

Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
              SP++V   G      +  +  E+M   SL ++L   G +  +   +  I   V K L
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGL 116

Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            +L       ++H D+KPSN+L++S    K+ DFG+S
Sbjct: 117 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 43/143 (30%), Positives = 70/143 (48%), Gaps = 7/143 (4%)

Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G V+    ++ G L A K ++T S +   ++  E++IL     P++V LLG   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 150 ERNKRILVYEYMPNKSLQE-MLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHG 208
              K  ++ E+ P  ++   ML  D  L        +I +   + LE L +     +IH 
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGL-----TEPQIQVICRQMLEALQYLHSMKIIHR 134

Query: 209 DIKPSNVLLDSDCRGKVSDFGLS 231
           D+K  NVLL  D   K++DFG+S
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 54.8 bits (133), Expect = 4e-08
 Identities = 38/132 (28%), Positives = 57/132 (43%), Gaps = 36/132 (27%)

Query: 560 GDL-FSRELSST----TSMRGTLCYVAPE------YGGCGYLMEKADIYSLGVLILVIVS 608
           GD   S+ LSST     ++ GT  Y++PE      Y        K+DI+SLG ++  + +
Sbjct: 145 GDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYN------YKSDIWSLGCVLYELCT 198

Query: 609 GRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCL 668
            + P          E  NL+     LA    IL+     +   Y+ E  +L      + L
Sbjct: 199 LKHPF---------EGENLLE----LAL--KILKGQYPPIPSQYSSELRNLV----SSLL 239

Query: 669 QKTPELRPDIGE 680
           QK PE RP I +
Sbjct: 240 QKDPEERPSIAQ 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 21/157 (13%)

Query: 91  IGKGGSGTVFLGIARD---GKLLAIKRL------DTFSLQTEREFQNELQILGGLRSPFL 141
           IG G  GTV+   ARD   G  +A+K +      D   L T RE    L+ L     P +
Sbjct: 8   IGVGAYGTVYK--ARDPHSGHFVALKSVRVQTNEDGLPLSTVREVA-LLKRLEAFDHPNI 64

Query: 142 VTLLGYCM-----ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEF 196
           V L+  C         K  LV+E++ ++ L+  L       L      +++    + L+F
Sbjct: 65  VRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           LH  C   ++H D+KP N+L+ S  + K++DFGL+RI
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 9/146 (6%)

Query: 91  IGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           +G+G   TV+ G  R  G+++A+K   LD     T      E+ ++  L+   +V L   
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDA-EEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNL-VLKWSQRFEIIMDVAKALEFLHFGCDPPVI 206
               NK +LV+EYM +K L++ + + G    L  +        + K + F H   +  V+
Sbjct: 67  IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVL 122

Query: 207 HGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H D+KP N+L++     K++DFGL+R
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 53/169 (31%), Positives = 78/169 (46%), Gaps = 24/169 (14%)

Query: 84  DFDEANVIGKGGSGTVFL----GIARDGKLLAIKRLDTFSL----QTEREFQNELQILGG 135
           +F+   V+G G  G VFL         GKL A+K L   ++    +T    + E Q+L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 136 LR-SPFLVTLLGYCMERNKRILVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEIIMD 189
           +R SPFLVTL        K  L+ +Y+    L     Q   F +  + +          +
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQI-------YSGE 113

Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
           +  ALE LH      +I+ DIK  N+LLDS+    ++DFGLS+   E E
Sbjct: 114 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 54.7 bits (131), Expect = 6e-08
 Identities = 40/141 (28%), Positives = 72/141 (51%), Gaps = 7/141 (4%)

Query: 91  IGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           IG+G +G V +   +  GK +A+K++D    Q      NE+ I+       +V +    +
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             ++  +V E++   +L +++    +  +   Q   + + V +AL +LH   +  VIH D
Sbjct: 90  VGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRD 143

Query: 210 IKPSNVLLDSDCRGKVSDFGL 230
           IK  ++LL SD R K+SDFG 
Sbjct: 144 IKSDSILLTSDGRIKLSDFGF 164

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 54.3 bits (130), Expect = 7e-08
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 7/141 (4%)

Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           IG+G SGTV+  +    G+ +AI++++      +    NE+ ++   ++P +V  L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             ++  +V EY+   SL +++       +   Q   +  +  +ALEFLH      VIH D
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRD 141

Query: 210 IKPSNVLLDSDCRGKVSDFGL 230
           IK  N+LL  D   K++DFG 
Sbjct: 142 IKSDNILLGMDGSVKLTDFGF 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 5/149 (3%)

Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L     E
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM   SL + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 73  EPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 128

Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+  +   KV+DFGL+R+  + E+
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEY 157

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 53.8 bits (129), Expect = 8e-08
 Identities = 35/153 (22%), Positives = 70/153 (45%), Gaps = 7/153 (4%)

Query: 85  FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLD--TFSLQTEREFQNELQILGGLRSPFL 141
           ++    IG+G  G ++L  A+ D +   IK +D     ++ +   + E+ +L  ++ P +
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           VT      E  +  +V EY     L + +     ++    Q     + ++  L+ +H   
Sbjct: 62  VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH--- 118

Query: 202 DPPVIHGDIKPSNVLLDSDCR-GKVSDFGLSRI 233
           D  ++H DIK  N+ L  +    K+ DFG++R 
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 5/149 (3%)

Query: 90  VIGKGGSGTVFLGIARDGKLLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
           ++GKG  G VF G  +D   +A+K   +    + + +F +E +IL     P +V L+G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHG 208
            +R    +V E +P       L    +  LK  Q  +  +D A  + +L        IH 
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYLE---SKNCIHR 117

Query: 209 DIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           D+   N L+  +   K+SDFG+SR + +G
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDG 146

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 54.4 bits (131), Expect = 8e-08
 Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 17/160 (10%)

Query: 82  TNDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRL-DTFS--LQTEREFQNELQILGG 135
           TN + +   +G G  G V    ARD   G+ +AIK++   FS  +  +R ++ EL++L  
Sbjct: 9   TNRYVDLQPVGMGAFGLVC--SARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKH 65

Query: 136 LRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
           LR   +++L    +   + I  V E +    L  +L S   L  ++ Q F  +  + + L
Sbjct: 66  LRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYF--LYQILRGL 121

Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
           +++H      V+H D+KPSN+L++ +C  K+ DFGL+RI+
Sbjct: 122 KYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ 158

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 54.2 bits (130), Expect = 9e-08
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 15/150 (10%)

Query: 91  IGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQ----NELQILGGLRSPFLVTLL 145
           +G+G   TV+ GI+R +G+L+A+K     S++TE         E  +L GL+   +V L 
Sbjct: 13  LGEGSYATVYKGISRINGQLVALK---VISMKTEEGVPFTAIREASLLKGLKHANIVLLH 69

Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM-DVAKALEFLHFGCDPP 204
                +     V+EYM     Q M+   G L         + M  + + L ++H      
Sbjct: 70  DIIHTKETLTFVFEYMHTDLAQYMIQHPGGL---HPYNVRLFMFQLLRGLAYIH---GQH 123

Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
           ++H D+KP N+L+      K++DFGL+R K
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAK 153

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 54.0 bits (129), Expect = 9e-08
 Identities = 43/142 (30%), Positives = 74/142 (52%), Gaps = 9/142 (6%)

Query: 91  IGKGGSGTVF--LGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
           IG+G SGTV+  + IA  G+ +AIK+++      +    NE+ ++   ++P +V  L   
Sbjct: 27  IGQGASGTVYTAIDIA-TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHG 208
           +  ++  +V EY+   SL +++       +   Q   +  +  +AL+FLH      VIH 
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLH---SNQVIHR 139

Query: 209 DIKPSNVLLDSDCRGKVSDFGL 230
           DIK  N+LL  D   K++DFG 
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 54.3 bits (131), Expect = 9e-08
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 13/150 (8%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRL-DTFS-LQTEREFQNELQILGGLRSPFLVTLLG 146
            IG G  G V   I  R GK +AIK++   F      +    EL+IL   +   ++ +  
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71

Query: 147 YCMERNKRI----LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
                        +V + M +  L  ++ SD  L  +  + F  +  + + L+++H    
Sbjct: 72  ILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYF--LYQLLRGLKYIHSAN- 127

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
             VIH D+KPSN+L++ DC  ++ DFG++R
Sbjct: 128 --VIHRDLKPSNLLVNEDCELRIGDFGMAR 155

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 35/157 (22%), Positives = 66/157 (42%), Gaps = 18/157 (11%)

Query: 91  IGKGGSGTVFLGIARD------GKLLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVT 143
           +G+G  G V+ G+A+          +AIK + +  S++   EF NE  ++       +V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 144 LLGYCMERNKRILVYEYMPNKSLQ--------EMLFSDGNLVLKWSQRFEIIMDVAKALE 195
           LLG        ++V E M    L+        E   + G       +  ++  ++A  + 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +L        +H D+   N ++  D   K+ DFG++R
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 7/141 (4%)

Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           IG+G +G V +   +  GKL+A+K++D    Q      NE+ I+   +   +V +    +
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             ++  +V E++   +L +++    +  +   Q   + + V KAL  LH      VIH D
Sbjct: 88  VGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRD 141

Query: 210 IKPSNVLLDSDCRGKVSDFGL 230
           IK  ++LL  D R K+SDFG 
Sbjct: 142 IKSDSILLTHDGRVKLSDFGF 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 22/158 (13%)

Query: 84  DFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQN----ELQILGGLRSP 139
           DF++   +G G  G V   + R   L+  ++L    L+ +   +N    EL++L    SP
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGLIMARKL--IHLEIKPAIRNQIIRELKVLHECNSP 59

Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF------EIIMDVAKA 193
           ++V   G      +  +  E+M   SL        + VLK + R       +I + V + 
Sbjct: 60  YIVGFYGAFYSDGEISICMEHMDGGSL--------DQVLKKAGRIPENILGKISIAVLRG 111

Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           L +L       ++H D+KPSN+L++S    K+ DFG+S
Sbjct: 112 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 147

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 4/103 (3%)

Query: 129 ELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM 188
           ELQI+   RSP++V+  G  +  N   +  E+M   SL  +    G + ++   +  I +
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAV 110

Query: 189 DVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            V + L +L+      ++H DIKPSN+L++S  + K+ DFG+S
Sbjct: 111 AVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 52/160 (32%), Positives = 75/160 (46%), Gaps = 22/160 (13%)

Query: 90  VIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQ-----ILGGLRSPFLVT 143
           VIGKG  G V L   + DG   A+K L   ++  ++E QN +      +L  L+ PFLV 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVG 60

Query: 144 LLGYCMERNKRILVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           L        K   V +Y+    L     +E  F +         RF    +VA A+ +LH
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPR------ARF-YAAEVASAIGYLH 113

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
                 +I+ D+KP N+LLDS     ++DFGL +  VE E
Sbjct: 114 ---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE 150

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 46/151 (30%), Positives = 72/151 (47%), Gaps = 9/151 (5%)

Query: 84  DFDEANVIGKGGSGTVFLGIARD-GKLLAIKRL---DTFSLQTEREFQNELQILGGLRSP 139
           DF+   VIG+G  G V L   +D G + A+K L   D    +     + E  IL    S 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
           ++V +     ++    L+ E++P   +  +L     L  + +Q +  I +   A++ +H 
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY--IAETVLAIDSIH- 118

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL 230
                 IH DIKP N+LLDS    K+SDFGL
Sbjct: 119 --QLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 54.9 bits (132), Expect = 1e-07
 Identities = 39/133 (29%), Positives = 65/133 (48%), Gaps = 14/133 (10%)

Query: 107 GKLLAIKRLDTFSLQTERE---FQNELQILGGLRSPFLVTLL--GYCMERNKRILVYEYM 161
           G  +AIK L T + + E +   F+ E  +   L  P +V LL  G          V+EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61

Query: 162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL---D 218
           P ++L+E+L +DG   L   +   +++ V  AL   H   +  ++H D+KP N+++    
Sbjct: 62  PGRTLREVLAADG--ALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116

Query: 219 SDCRGKVSDFGLS 231
                KV DFG+ 
Sbjct: 117 VRPHAKVLDFGIG 129

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 5/149 (3%)

Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E QI+  LR   LV L     E
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V E+M   SL + L       LK  Q  ++   +A  + ++        IH D+
Sbjct: 73  EPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDL 128

Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+  +   K++DFGL+R+  + E+
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEY 157

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 53.5 bits (129), Expect = 2e-07
 Identities = 44/156 (28%), Positives = 68/156 (43%), Gaps = 29/156 (18%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRL---------DTFSLQTEREFQNELQILGGLRSP 139
           V+G+G  G V L   +  G+L AIK L         +  SL  E+      +     R P
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRI---FETANSERHP 62

Query: 140 FLVTLLGYCMERNKRI-LVYEYMPNKSL----QEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
           FLV L   C +    +  V EY     L       +FS+   V   +        V   L
Sbjct: 63  FLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC-------VVLGL 114

Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL 230
           ++LH   +  +++ D+K  N+LLD++   K++DFGL
Sbjct: 115 QYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 9/152 (5%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRL---DTFSLQTEREFQNELQILGGLRS 138
           +DF+   VIG+G  G V L   +D G + A+K L   D    +     + E  IL     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
            ++V +     ++    L+ E++P   +  +L     L  + +Q +  I +   A++ +H
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFY--IAETVLAIDAIH 118

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL 230
                  IH DIKP N+LLD+    K+SDFGL
Sbjct: 119 ---QLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 45/148 (30%), Positives = 69/148 (46%), Gaps = 10/148 (6%)

Query: 91  IGKGGSGTVFLGIARDGKLLA---IKRL-DTFSLQTEREFQNELQILGGLRSPFLVTLLG 146
           IG G  G V LG A  G   A   +K L  + +   +  F  E+Q    L  P ++  LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 147 YCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQR---FEIIMDVAKALEFLHFGCDP 203
            C+E    +LV E+ P   L+  L S+  +V + +Q+     +  +VA  L +LH     
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119

Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
             IH D+   N  L +D   K+ D+GL+
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 41/145 (28%), Positives = 70/145 (48%), Gaps = 20/145 (13%)

Query: 109 LLAIKRLDTFSLQTER-EFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQ 167
           L+A+K L     +T R +F  E++I+  L++P ++ LLG C+  +   ++ EYM N  L 
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105

Query: 168 EML--------FSDGNLVLKWSQRFEIIMDVA-----KALEFLHFGCDPPVIHGDIKPSN 214
           + L        F+  N +   S    + M V      K L  L+F      +H D+   N
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF------VHRDLATRN 159

Query: 215 VLLDSDCRGKVSDFGLSRIKVEGEF 239
            L+ +    K++DFG+SR    G++
Sbjct: 160 CLVGNHYTIKIADFGMSRNLYSGDY 184

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 9/146 (6%)

Query: 91  IGKGGSGTVF-LGIARDGKLLAIKRLDTFSLQT---EREFQNELQILGGLRSPFLVTLLG 146
           +GKGG G V  + +   GK+ A K+LD   L+    E+    E +IL  + SPF+V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59

Query: 147 YCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPV 205
           Y  E    + LV   M    L+  +++ G   L+  +       +   +  LH      +
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDI 116

Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLS 231
           ++ D+KP NVLLD     ++SD GL+
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 36/147 (24%), Positives = 66/147 (44%), Gaps = 6/147 (4%)

Query: 90  VIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTE--REFQNELQILGGLRSPFLVTLLG 146
           V+GKG  G   L     D  L+  K ++   L  +  R+  NE+ IL  L+ P ++    
Sbjct: 7   VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 147 YCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVI 206
           + M+ N  ++  EY    +L + +      + +       +  +  A+ ++H      ++
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123

Query: 207 HGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H DIK  N+ L      K+ DFG+S+I
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKI 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 22/158 (13%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTERE---FQNELQILGGLRS 138
            DFD  +++G+G  G V +   +  G + A+K +    L  +     F+ E  IL    S
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMD-------VA 191
           P++  L     +++   LV EY P   L  +L            R+E   D       +A
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL-----------NRYEDQFDEDMAQFYLA 109

Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
           + +  +H       +H DIKP NVL+D     K++DFG
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG 147

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 23/161 (14%)

Query: 90  VIGKGGSGTVFLG---IARD-GKLLAIKRLDTFSLQTEREFQ--NELQILGGLRSPFLVT 143
           V+G+G  G VFL       D G+L A+K L   +L+     +   E  IL  +  PF+V 
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 144 LLGYCMERNKRILVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           L        K  L+ +++    L     +E++F++ ++          + ++A AL+ LH
Sbjct: 63  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-------YLAELALALDHLH 115

Query: 199 -FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
             G    +I+ D+KP N+LLD +   K++DFGLS+  ++ E
Sbjct: 116 SLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 43/149 (28%), Positives = 68/149 (45%), Gaps = 5/149 (3%)

Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++G       +A+K L   ++  E  F  E QI+  LR   LV L     E
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM   SL + L       LK     ++   VA  + ++        IH D+
Sbjct: 73  EPIYI-VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 128

Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+      K++DFGL+R+  + E+
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEY 157

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 40/150 (26%), Positives = 76/150 (50%), Gaps = 17/150 (11%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIK--RLDTFSLQTEREFQNELQILGGLR---SPFLVT 143
           +IG+G  G V+ G     G+++A+K   LDT       + Q E+ +L  LR    P +  
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS-DIQREVALLSQLRQSQPPNITK 66

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFE--IIMDVAKALEFLHFGC 201
             G  ++  +  ++ EY    S++ ++ +        ++++   II +V  AL+++H   
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIH--- 118

Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              VIH DIK +N+L+ +    K+ DFG++
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVA 148

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 44/162 (27%), Positives = 81/162 (50%), Gaps = 23/162 (14%)

Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRL-DTF-----SLQTEREFQNELQILGGLRSPFLVT 143
           IG+G  G V      +  + +AIK++ + F     + +T RE    +++L  L    ++ 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLRE----IKLLRHLDHENVIA 68

Query: 144 LLGYCMERNKRI-----LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           +       ++       +VYE M +  L +++ S   L     Q F  +  + + L+++H
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYF--LYQLLRGLKYIH 125

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVE-GEF 239
                 V+H D+KPSN+LL+++C  K+ DFGL+R   E G+F
Sbjct: 126 ---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF 164

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 50/158 (31%), Positives = 78/158 (49%), Gaps = 12/158 (7%)

Query: 89  NVIGKGGSGTVFLG--IARDGKLL--AIKRLDTFS-LQTEREFQNELQILGGLRSPFLVT 143
            VIGKG  G V+ G  I  DG+ +  A+K L+  + L+   +F  E  I+     P +++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 144 LLGYCMERNKRILV-YEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGC 201
           LLG C+      LV   YM +  L+  + S+  N  +K    F   + VAK +E+L    
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG--LQVAKGMEYL---A 115

Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
               +H D+   N +LD     KV+DFGL+R   + E+
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 9/159 (5%)

Query: 85  FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQT---EREFQNELQILGGLRSPF 140
           F +  V+GKGG G V     R  GK+ A K+L+   ++    E    NE QIL  + S F
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 141 LVTLLGYCME-RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
           +V+L  Y  E ++   LV   M    L+  ++  G    +  +      ++   LE LH 
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH- 119

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
                +++ D+KP N+LLD     ++SD GL+    EG+
Sbjct: 120 --QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 42/170 (24%), Positives = 68/170 (40%), Gaps = 23/170 (13%)

Query: 87  EANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFSLQT-EREFQNELQILGGLRSP 139
           E   +G+G  G VFL  A+         L+ +K L     +  + EF+ EL +   L   
Sbjct: 9   EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHK 68

Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLV-------LKWSQRFEIIMDVAK 192
            +V LLG C E     ++ EY     L++ L +  +         L   Q+  +   +A 
Sbjct: 69  NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128

Query: 193 ALEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
            ++ L    F      +H D+   N L+ S    KVS   LS+     E+
Sbjct: 129 GMDHLSNARF------VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY 172

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 14/157 (8%)

Query: 90  VIGKGGSGTVFL---GIARD--GKLLAIKRLDT-FSLQTEREFQNELQILGGLRSPFLVT 143
           V+G+G  G V L     A D  G+++A+K L      Q    ++ E+ IL  L    +V 
Sbjct: 11  VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 144 LLGYCMERNKRI--LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
             G C E+  +   L+ EY+P  SL++ L       L  +Q       + + + +LH   
Sbjct: 71  YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLH--- 124

Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
               IH D+   NVLLD+D   K+ DFGL++   EG 
Sbjct: 125 SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 20/159 (12%)

Query: 90  VIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQ----ILGGLRSPFLVTL 144
           VIGKG  G V L   + DGK  A+K L   ++  ++E ++ +     +L  ++ PFLV L
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 145 LGYCMERNKRILVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
                  +K   V +Y+    L     +E  F +         RF    ++A AL +LH 
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPR------ARF-YAAEIASALGYLH- 113

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
                +I+ D+KP N+LLDS     ++DFGL +  +E  
Sbjct: 114 --SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS 150

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 16/159 (10%)

Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQI 132
           +N   DF+    IG G  G V+   AR+   G+L AIK      L+   +F   Q E+ +
Sbjct: 5   RNPQEDFELIQRIGSGTYGDVYK--ARNVNTGELAAIK---VIKLEPGEDFAVVQQEIIM 59

Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           +   +   +V   G  + R+K  +  E+    SLQ++    G L    SQ   +  +  +
Sbjct: 60  MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPL--SESQIAYVSRETLQ 117

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            L +LH       +H DIK +N+LL  +   K++DFG+S
Sbjct: 118 GLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVS 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 36/149 (24%), Positives = 70/149 (46%), Gaps = 4/149 (2%)

Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++G   +   +A+K L   ++  +  F  E  ++  L+   LV L     +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-AFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
                ++ EYM   SL + L SD    +   +  +    +A+ + ++        IH D+
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 129

Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +NVL+      K++DFGL+R+  + E+
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEY 158

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 52.0 bits (125), Expect = 6e-07
 Identities = 51/170 (30%), Positives = 71/170 (41%), Gaps = 49/170 (28%)

Query: 90  VIGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLG 146
            IG G  G V    A D      +AIK+L        R FQN        R   L+ L+ 
Sbjct: 23  PIGSGAQGIVCA--AYDTVTGQNVAIKKL-------SRPFQNVTHAKRAYRELVLMKLVN 73

Query: 147 YCMERNKRI--LVYEYMPNKSLQE-------MLFSDGNLVLKWSQRFEII-MDVAK---- 192
           +     K I  L+  + P KSL+E       M   D NL        ++I MD+      
Sbjct: 74  H-----KNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLC-------QVIQMDLDHERMS 121

Query: 193 --------ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
                    ++ LH      +IH D+KPSN+++ SDC  K+ DFGL+R  
Sbjct: 122 YLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 51.2 bits (123), Expect = 6e-07
 Identities = 42/147 (28%), Positives = 64/147 (43%), Gaps = 9/147 (6%)

Query: 91  IGKGGSGTVFLG--IARDGKLL--AIKRLDTFSLQ-TEREFQNELQILGGLRSPFLVTLL 145
           +G G  G V  G      GK++  A+K L +  L     +F  E  I+  L    L+ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPV 205
           G  +  +  ++V E  P  SL + L  D       S   +  + +A  + +L        
Sbjct: 63  GVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRF 118

Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           IH D+   N+LL SD + K+ DFGL R
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMR 145

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 51.0 bits (122), Expect = 7e-07
 Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 17/159 (10%)

Query: 84  DFDEAN---VIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQILGGLRSP 139
           ++DE     V+GKG  G V+       ++ +AIK +     +  +    E+ +   L+  
Sbjct: 6   EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65

Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKW----SQRFEIIMDVAKALE 195
            +V  LG   E     +  E +P  SL  +L S      KW         II    + LE
Sbjct: 66  NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRS------KWGPLKDNEQTIIFYTKQILE 119

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRG--KVSDFGLSR 232
            L +  D  ++H DIK  NVL+++   G  K+SDFG S+
Sbjct: 120 GLKYLHDNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSK 157

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 50.6 bits (121), Expect = 8e-07
 Identities = 53/237 (22%), Positives = 102/237 (43%), Gaps = 64/237 (27%)

Query: 90  VIGKGGSGTVFLGIARD---GKLLAIKRL----DTFSLQTE--REFQNELQILGGLRSPF 140
            +G G   + +   ARD   G L+A+K++    +T S Q E     + E++++  L  P 
Sbjct: 7   QLGTGAFSSCYQ--ARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDG----NLVLKWSQRFEIIMDVAKALEF 196
           ++ +LG   E +   L  E+M   S+  +L   G     +++ +         + + L +
Sbjct: 65  IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY------TEQLLRGLSY 118

Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGL-----SRIKVEGEFGMDLF------ 244
           LH   +  +IH D+K +N+L+DS  +  +++DFG      ++    GEF   L       
Sbjct: 119 LH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175

Query: 245 ------SQDLGKSQELWK----------------SQELSGNL------ATATETPAI 273
                  +  G+S ++W                 +++ S +L      A+AT  P+I
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI 232

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 26/160 (16%)

Query: 91  IGKGGSGTVFLGIARD----GKLLAIKRLDTFSLQTEREFQ-----NELQILGGLRS--- 138
           IG+G  G VF   ARD    G+ +A+KR+    +QT  E        E+ +L  L +   
Sbjct: 9   IGEGAYGKVFK--ARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFEH 63

Query: 139 PFLVTLLGYCM-----ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
           P +V L   C         K  LV+E++ ++ L   L       +      +++  + + 
Sbjct: 64  PNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122

Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           L+FLH      V+H D+KP N+L+ S  + K++DFGL+RI
Sbjct: 123 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 50.8 bits (122), Expect = 1e-06
 Identities = 49/177 (27%), Positives = 75/177 (42%), Gaps = 57/177 (32%)

Query: 83  NDFDEANVIGKGGSGTVF-LGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLR---- 137
           ND +    IG G  G V+ +   + G ++A+K++     +T  + +N+ +IL  L     
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQM----RRTGNKEENK-RILMDLDVVLK 69

Query: 138 ---SPFLVTLLGY---------CMER--------NKRILVYEYMPNKSLQEMLFSDGNLV 177
               P++V   GY         CME          KRI     +P   L +M  +     
Sbjct: 70  SHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILGKMTVA----- 122

Query: 178 LKWSQRFEIIMDVAKALEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
                       + KAL +L   H      VIH D+KPSN+LLD+    K+ DFG+S
Sbjct: 123 ------------IVKALHYLKEKH-----GVIHRDVKPSNILLDASGNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 49/158 (31%), Positives = 79/158 (50%), Gaps = 8/158 (5%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRL-DTFSLQTEREFQ-NELQILGGLRSP 139
           N F+   V+G+G  G V     ++ K ++AIK+  D+   +  +E    EL++L  L+  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
            +V L      R K  LV+EY+  K++ E+L    N V     R   I  + KA+ + H 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYV-EKNMLELLEEMPNGVPPEKVR-SYIYQLIKAIHWCH- 117

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
                ++H DIKP N+L+  +   K+ DFG +R   EG
Sbjct: 118 --KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 48/167 (28%), Positives = 78/167 (46%), Gaps = 34/167 (20%)

Query: 83  NDFDEANVIGKGGSGTVF-LGIARDGKLLAIKRLD-TFSLQTEREFQNELQILGGLRS-- 138
           +D +    +G+G  G V  +     G ++A+KR+  T + Q ++    +L I   +RS  
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDI--SMRSVD 58

Query: 139 -PFLVTLLG---------YCMERNKRIL--VYE--YMPNKSLQEMLFSDGNLVLKWSQRF 184
            P+ VT  G          CME     L   Y+  Y    ++ E +              
Sbjct: 59  CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILG------------ 106

Query: 185 EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           +I + + KALE+LH      VIH D+KPSNVL++ + + K+ DFG+S
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS 151

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 50/159 (31%), Positives = 76/159 (47%), Gaps = 9/159 (5%)

Query: 85  FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQT---EREFQNELQILGGLRSPF 140
           F    V+GKGG G V     R  GK+ A K+L+   ++    E    NE QIL  + S F
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 141 LVTLLGYCME-RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
           +V+L  Y  E ++   LV   M    L+  +++ GN      +      ++   LE LH 
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH- 119

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
                +++ D+KP N+LLD     ++SD GL+    EGE
Sbjct: 120 --RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 45/151 (29%), Positives = 77/151 (50%), Gaps = 17/151 (11%)

Query: 91  IGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTERE-----FQNELQILGGLRSPFLV 142
           IG+G  G V+   ARD   G+++A+K++    L+TE E        E+ +L  L  P +V
Sbjct: 7   IGEGTYGVVYK--ARDKLTGEIVALKKI---RLETEDEGVPSTAIREISLLKELNHPNIV 61

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
            LL      NK  LV+E++ +  L++ + S     L        +  + + + + H    
Sbjct: 62  RLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---S 117

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             V+H D+KP N+L+D +   K++DFGL+R 
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 9/159 (5%)

Query: 85  FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQT---EREFQNELQILGGLRSPF 140
           F    V+GKGG G V     R  GK+ A K+L+   ++    E    NE +IL  + S F
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 141 LVTLLGYCME-RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
           +V+L  Y  E ++   LV   M    L+  +++ GN      +      ++   LE L  
Sbjct: 62  VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ- 119

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
                +++ D+KP N+LLD     ++SD GL+    EGE
Sbjct: 120 --RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 38/148 (25%), Positives = 66/148 (44%), Gaps = 27/148 (18%)

Query: 109 LLAIKRLDTFSLQTER-EFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQ 167
           L+A+K L   + +  R +F  E++I+  L+ P ++ LL  C+  +   ++ EYM N  L 
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 168 EML----------------FSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIK 211
           + L                 S   L+   +Q    I    K L  L+F      +H D+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQ----IASGMKYLSSLNF------VHRDLA 157

Query: 212 PSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
             N L+  +   K++DFG+SR    G++
Sbjct: 158 TRNCLVGKNYTIKIADFGMSRNLYSGDY 185

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 51/156 (32%), Positives = 75/156 (48%), Gaps = 27/156 (17%)

Query: 90  VIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQNEL---QILGGLRSPFLVTLL 145
           ++GKG  G V L      GK  A+K L    +  + E  + L   ++L   R PFL T L
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL-TAL 60

Query: 146 GYCMERNKRI-LVYEYMPNKSL-----QEMLFSDGNLVLKWSQRF---EIIMDVAKALEF 196
            Y  + + R+  V EY     L     +E +FS+         RF   EI+     AL +
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR------ARFYGAEIVS----ALGY 110

Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           LH  CD  V++ D+K  N++LD D   K++DFGL +
Sbjct: 111 LH-SCD--VVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 43/149 (28%), Positives = 69/149 (46%), Gaps = 12/149 (8%)

Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREF------QNELQILGGLRSPFLVT 143
           IGKG  G V+    +D  ++ A+K L    +  ++E       +N L       SPF+V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           L       +   LV +YM    L   L  +G      ++ +  I ++  ALE LH     
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFY--IAELVLALEHLH---KY 115

Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            +++ D+KP N+LLD+     + DFGLS+
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSK 144

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 28/157 (17%)

Query: 90  VIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS-PFLVTL 144
           V+GKG  G V L  +   G+L A+K L    +  + + +    E +IL   R+ PFL T 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL-TQ 60

Query: 145 LGYCMERNKRIL-VYEYMPNKSLQEMLFSDGNLV--LKWSQRFE------IIMDVAKALE 195
           L  C +   R+  V E++          + G+L+  ++ S+RF+         ++  AL 
Sbjct: 61  LYCCFQTPDRLFFVMEFV----------NGGDLMFHIQKSRRFDEARARFYAAEITSALM 110

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           FLH   D  +I+ D+K  NVLLD +   K++DFG+ +
Sbjct: 111 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 44/155 (28%), Positives = 80/155 (51%), Gaps = 16/155 (10%)

Query: 85  FDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTERE-----FQNELQILGGLRS 138
           +++   IG+G  GTVF    R+  +++A+KR+    L  + E        E+ +L  L+ 
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELKH 58

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLVLKWSQRFEIIMDVAKALEFL 197
             +V L        K  LV+EY  ++ L++   S +G++  +  + F  +  + K L F 
Sbjct: 59  KNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSF--MFQLLKGLAFC 115

Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H D+KP N+L++ +   K++DFGL+R
Sbjct: 116 H---SHNVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.0 bits (120), Expect = 2e-06
 Identities = 40/153 (26%), Positives = 69/153 (45%), Gaps = 22/153 (14%)

Query: 90  VIGKG--GSGTVFLGIARD-GKLLAIKRLDTFSLQTER--EFQNELQILGGLRSPFLVTL 144
           +IGK       V L   +    L+A+K+++  S   E     Q E+     L+ P ++  
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 145 LGYCMERNKRILVYEYMPNKSLQEML---FSDG--NLVLKWSQRFEIIMDVAKALEFLH- 198
           +   +  ++  +V   M   S +++L   F +G   L + +     I+ DV  AL+++H 
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-----ILKDVLNALDYIHS 119

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            G     IH  +K S++LL  D  GKV   GL 
Sbjct: 120 KGF----IHRSVKASHILLSGD--GKVVLSGLR 146

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 21/169 (12%)

Query: 76  KELKNATNDFDEANVIGKGGSGTVF-LGIARDGKLLAIKRLDTFSLQTEREFQNELQILG 134
           + L + T+ ++    IGKG  G V+ +   +DG L A+K LD  S   + E + E  IL 
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQ 73

Query: 135 GLRS-PFLVTLLGYCMERNKRI-----LVYEYMPNKSLQEMLFSDGNLVLKWSQRFE--- 185
            L + P +V   G   + +K +     LV E     S+ E++      +L   QR +   
Sbjct: 74  SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG----LLICGQRLDEAM 129

Query: 186 ---IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              I+      L+ LH   +  +IH D+K +N+LL ++   K+ DFG+S
Sbjct: 130 ISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 40/161 (24%), Positives = 79/161 (49%), Gaps = 21/161 (13%)

Query: 84  DFDEANVIGKGGSGTVFLGI-ARDGKLL----AIKRL-DTFSLQTEREFQNELQILGGLR 137
           +F +  V+G G  GTV+ G+   +G+ +    AIK L +  S +  +E  +E  ++  + 
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVAK 192
           +P +  LLG C+    + L+ + MP   L + +           +L W       + +AK
Sbjct: 68  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIAK 120

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            + +L    +  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 121 GMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 49.1 bits (118), Expect = 3e-06
 Identities = 30/123 (24%), Positives = 48/123 (39%), Gaps = 23/123 (18%)

Query: 563 FSRELSS---TTSMRGTLCYVAPE-YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLAS 618
            +R+L      T+  GT  Y+APE   G GY  +  DI+SLGV++  +++G+ P      
Sbjct: 143 LARQLDPGEKLTTFVGTPEYMAPEVLLGKGY-GKAVDIWSLGVILYELLTGKPPFPGDDQ 201

Query: 619 PMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQAS-LCINLALTCLQKTPELRPD 677
            ++L K                  +   +      +   S    +L    L K PE R  
Sbjct: 202 LLELFKK-----------------IGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLT 244

Query: 678 IGE 680
             E
Sbjct: 245 AEE 247

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 39/132 (29%), Positives = 64/132 (48%), Gaps = 18/132 (13%)

Query: 556 DMWSGDLFSRELSSTTSMRGTLCYVAPE-YGGCGYLMEKADIYSLGVLILVIVSGRRPLH 614
           D+  G  FS + ++  S+ GT  Y++PE     GY   K+DI+SLG L+         + 
Sbjct: 149 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF-KSDIWSLGCLLY-------EMA 200

Query: 615 VLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPEL 674
            L SP   +K NL S C+ + +  +   L  +     Y++E   L ++    C+   PE 
Sbjct: 201 ALQSPFYGDKMNLYSLCKKIEK-CDYPPLPADH----YSEELRDL-VSR---CINPDPEK 251

Query: 675 RPDIGETVRILK 686
           RPDI   +++ K
Sbjct: 252 RPDISYVLQVAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 48/167 (28%), Positives = 72/167 (43%), Gaps = 37/167 (22%)

Query: 85  FDEANVIGKGGSGTV------FLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRS 138
           + +   IG G  G V       LGI      +A+K+L        R FQN+       R 
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGIN-----VAVKKL-------SRPFQNQTHAKRAYRE 70

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFE 185
              + LL     +N   L+  + P KSL+E       M   D NL       L   +   
Sbjct: 71  ---LVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSY 127

Query: 186 IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++  +   ++ LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 128 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 38/149 (25%), Positives = 72/149 (48%), Gaps = 21/149 (14%)

Query: 109 LLAIKRLDTFSLQTER-EFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQ 167
           L+A+K L   + +  R +F  E++IL  L+ P ++ LLG C++ +   ++ EYM N  L 
Sbjct: 48  LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 168 EMLFS--------DGN---------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           + L S        +GN           + +S    + + +A  +++L        +H D+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164

Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              N L+  +   K++DFG+SR    G++
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDY 193

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 9/146 (6%)

Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTER-EFQNELQILGGLRSPFLVTLLG 146
           +G G  G V  G+ +  K    +AIK L   + ++ R E   E +I+  L +P++V ++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 147 YCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVI 206
            C E    +LV E      L + L    + +   S   E++  V+  +++L        +
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFLSGKKDEITV-SNVVELMHQVSMGMKYLE---GKNFV 117

Query: 207 HGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H D+   NVLL +    K+SDFGLS+
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSK 143

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 43/163 (26%), Positives = 77/163 (47%), Gaps = 20/163 (12%)

Query: 77  ELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ--TEREFQNELQILG 134
           ELK+  +DF+  + +G G  G V     +   L+  ++L    ++     +   ELQ+L 
Sbjct: 1   ELKD--DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58

Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF------EIIM 188
              SP++V   G      +  +  E+M   SL +        VLK ++R       ++ +
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ--------VLKEAKRIPEEILGKVSI 110

Query: 189 DVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            V + L +L       ++H D+KPSN+L++S    K+ DFG+S
Sbjct: 111 AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS 151

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)

Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 74

Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 75  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 134

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 135 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 168

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 20/153 (13%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQ----ILGGLRSPFLVTL 144
           VIGKG  G V L     DGK  A+K L    +   +E ++ +     +L  ++ PFLV L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 145 LGYCMERNKRILVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
                   K   V +++    L     +E  F +         RF    ++A AL +LH 
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPR------ARF-YAAEIASALGYLH- 113

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                +++ D+KP N+LLDS     ++DFGL +
Sbjct: 114 --SINIVYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 40/159 (25%), Positives = 69/159 (43%), Gaps = 19/159 (11%)

Query: 90  VIGKGGSGTVFLGI--ARDGKLL--AIK--RLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           ++G+G  G+V  G     DG  L  A+K  +LD  +     EF +E   +     P ++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 144 LLGYCMERNKR------ILVYEYMPNKSLQEMLFS----DGNLVLKWSQRFEIIMDVAKA 193
           L+G C E +        +++  +M +  L   L           L      + ++D+A  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +E+L    +   IH D+   N +L  D    V+DFGLS+
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 49.1 bits (117), Expect = 3e-06
 Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 9/147 (6%)

Query: 91  IGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQN---ELQILGGLRSPFLVTLLG 146
           +GKGG G V     R  GKL A K+L+   L+  + ++    E +IL  + S F+V+L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 147 YCMERNKRILVYEYMPNKSLQEMLFS--DGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP 204
               +    LV   M    L+  +++  + N      +       +   LE LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117

Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           +I+ D+KP NVLLD+D   ++SD GL+
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 10/152 (6%)

Query: 90  VIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQ----ILGGLRSPFLVTL 144
           VIGKG  G V L   + + K  A+K L   ++  ++E ++ +     +L  ++ PFLV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP 204
                  +K   V +Y+    L   L  +    L+   RF    ++A AL +LH      
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARF-YAAEIASALGYLH---SLN 116

Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVE 236
           +++ D+KP N+LLDS     ++DFGL +  +E
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 148

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 48.0 bits (115), Expect = 4e-06
 Identities = 20/53 (37%), Positives = 31/53 (58%), Gaps = 1/53 (1%)

Query: 555 SDMWSGDLFSRELSSTTSMRGTLCYVAPE-YGGCGYLMEKADIYSLGVLILVI 606
           +D     L + + S   ++ GT  Y+APE   G GY  EK+DI+SLGV++  +
Sbjct: 135 ADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 8/156 (5%)

Query: 90  VIGKGGSGTVFLGIAR-DGKLLAIKRLD--TFSLQTEREFQNELQILGGLRSPFLVTLL- 145
           V+GKG  G V L   R DGK   IK+L+    S +  +  + E Q+L  L+ P +V    
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPV 205
            +  E     +V  +     L   L      +L  +Q  E  + +A AL++LH   +  +
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHI 123

Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGM 241
           +H D+K  NV L      KV D G++R+ +E +  M
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARV-LENQCDM 158

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 21/161 (13%)

Query: 82  TNDFDEANVIGKGGSGTVFLGI-ARDGKLL----AIKRL-DTFSLQTEREFQNELQILGG 135
             +  +  ++G G  GTV  GI   +G  +    AIK + D    QT +E  + +  +G 
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65

Query: 136 LRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-----DGNLVLKWSQRFEIIMDV 190
           L   ++V LLG C   + + LV +  P  SL + +       D   +L W       + +
Sbjct: 66  LDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC------VQI 118

Query: 191 AKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AK + +L       ++H ++   N+LL SD   +++DFG++
Sbjct: 119 AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVA 156

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 48.9 bits (117), Expect = 4e-06
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 48/173 (27%)

Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRL------DTFSLQTEREFQNELQILG 134
           +F++ N IG+G  G V+   ARD   G+++A+K++      D   + + RE    + +L 
Sbjct: 8   EFEKLNRIGEGTYGIVYR--ARDTTSGEIVALKKVRMDNERDGIPISSLRE----ITLLL 61

Query: 135 GLRSPFLVTLL---------------GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLK 179
            LR P +V L                 YC +    +L  + MP        FS+      
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPTP------FSE------ 107

Query: 180 WSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            SQ   +++ + + L++LH      +IH D+K SN+LL      K++DFGL+R
Sbjct: 108 -SQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 48.9 bits (116), Expect = 4e-06
 Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 13/157 (8%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQ----NELQILGGLR 137
           + +++   +G+G   TV+ G ++ +GKL+A+K      LQ E         E  +L GL+
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALK---VIRLQEEEGTPFTAIREASLLKGLK 61

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
              +V L      +    LV+EY+     Q M    G L  +  + F  +  + + L ++
Sbjct: 62  HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLF--LFQLLRGLSYI 119

Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
           H      ++H D+KP N+L+      K++DFGL+R K
Sbjct: 120 H---QRYILHRDLKPQNLLISDTGELKLADFGLARAK 153

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 49.0 bits (117), Expect = 4e-06
 Identities = 44/150 (29%), Positives = 65/150 (43%), Gaps = 10/150 (6%)

Query: 88  ANVIGKGGSGTVFLGIARDGKLL--AIKRLDTFSLQTERE-FQNELQILGGLRSPF-LVT 143
           A   GK    T + G+++   ++  A+K L   +  +ERE   +EL+I+  L +   +V 
Sbjct: 45  AGAFGKVVEATAY-GLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVN 103

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF-GCD 202
           LLG C      +++ EY     L   L       L           VAK + FL    C 
Sbjct: 104 LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC- 162

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
              IH D+   NVLL      K+ DFGL+R
Sbjct: 163 ---IHRDLAARNVLLTHGKIVKICDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 49.0 bits (117), Expect = 5e-06
 Identities = 53/171 (30%), Positives = 72/171 (42%), Gaps = 32/171 (18%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRL---------DTFSLQTEREFQNELQILG-GLRS 138
           V+GKG  G V L   +   +  AIK L         D      ER      ++L      
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVER------RVLALAWEH 55

Query: 139 PFLVTLLGYCMERNKRIL--VYEYMPNKSLQEMLFSDGNLVLKWSQRF---EIIMDVAKA 193
           PFL  L  +C  + K  L  V EY+    L   + S G      + RF   EII      
Sbjct: 56  PFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARA-RFYAAEIIC----G 108

Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLF 244
           L+FLH      +I+ D+K  NVLLD D   K++DFG+ +  + GE     F
Sbjct: 109 LQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF 156

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 42/132 (31%), Positives = 62/132 (46%), Gaps = 18/132 (13%)

Query: 556 DMWSGDLFSRELSSTTSMRGTLCYVAPE-YGGCGYLMEKADIYSLGVLILVIVSGRRPLH 614
           D+  G  FS + ++  S+ GT  Y++PE     GY   K+DI+SLG L+         + 
Sbjct: 149 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF-KSDIWSLGCLLY-------EMA 200

Query: 615 VLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPEL 674
            L SP   +K NL S C+ + Q  +   L  E   +   +E  S+CI          P+ 
Sbjct: 201 ALQSPFYGDKMNLFSLCQKIEQC-DYPPLPTEHYSEKL-RELVSMCIY-------PDPDQ 251

Query: 675 RPDIGETVRILK 686
           RPDIG   +I K
Sbjct: 252 RPDIGYVHQIAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.2 bits (114), Expect = 9e-06
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 31/158 (19%)

Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 25  IGSGAQGIVC--AAYDAVLDRNVAIKKL-------SRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P KSL+E       M   D NL       L   +   ++  +   +
Sbjct: 76  ---KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132

Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 133 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 42/153 (27%), Positives = 67/153 (43%), Gaps = 20/153 (13%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRL---------DTFSLQTEREFQNELQILGGLRSP 139
           V+GKG  G V L   +   +L A+K L         D     TE+     L + G  + P
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRV---LALAG--KHP 56

Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
           FL  L      +++   V EY+    L   +   G       +      ++   L+FLH 
Sbjct: 57  FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLH- 113

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
             +  +I+ D+K  NVLLDS+   K++DFG+ +
Sbjct: 114 --ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 31/158 (19%)

Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 32  IGSGAQGIVC--AAYDAILERNVAIKKL-------SRPFQNQTHAKRAYRELVLMKCVNH 82

Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P KSL+E       M   D NL       L   +   ++  +   +
Sbjct: 83  ---KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139

Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 47.8 bits (113), Expect = 1e-05
 Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 19/164 (11%)

Query: 90  VIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNEL---QILGGLRSPFLVTLL 145
           ++GKG  G V L   +  GK  A+K L    +  + E  + L   ++L   R PFL +L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 146 GYCMERNKRILVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
                +++   V EY+    L     +E +FS+         RF    ++  AL++LH G
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDR------TRF-YGAEIVSALDYLHSG 114

Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLF 244
               +++ D+K  N++LD D   K++DFGL +  +     M  F
Sbjct: 115 ---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF 155

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 26/157 (16%)

Query: 90  VIGKGGSGT---VFLGIA-RDGKLLAIKRL-DTFSLQTEREFQNELQILGGLRS-PFLVT 143
           ++GK G GT   V    + + GK  AIK +   F    +     E+Q L  L   P ++ 
Sbjct: 3   ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 144 LLGYCMER-NKRI-LVYEYMPNKSLQEML------FSDGNLVLKWSQRFEIIMDVAKALE 195
           L+    +R   R+ LV+E M + +L E++        +   V  +      +  + K+L+
Sbjct: 63  LIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPE-KRVKSY------MYQLLKSLD 114

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            +H      + H DIKP N+L+  D   K++DFG  R
Sbjct: 115 HMH-RNG--IFHRDIKPENILIKDDI-LKLADFGSCR 147

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 38/169 (22%), Positives = 77/169 (45%), Gaps = 18/169 (10%)

Query: 74  TYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKL--LAIKRLDTFSLQTEREFQ---N 128
             ++ K    DF+    +G G  G V L   ++     +AIKR +   +  +++     +
Sbjct: 21  PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS 80

Query: 129 ELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD----GNLVLKWSQRF 184
           E +IL  +  PF V L G   + +   LV E++        L  +     ++   ++ + 
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140

Query: 185 EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            +I +  ++L          +++ D+KP N+LLD D   K++DFG +++
Sbjct: 141 VLIFEYLQSLN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180

Length = 340

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 11/143 (7%)

Query: 91  IGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG+G +G V   IAR+   G+ +A+K +D    Q      NE+ I+   +   +V +   
Sbjct: 29  IGEGSTGIVC--IAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86

Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
            +   +  ++ E++   +L +++       L   Q   +   V +AL +LH      VIH
Sbjct: 87  YLVGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLH---SQGVIH 140

Query: 208 GDIKPSNVLLDSDCRGKVSDFGL 230
            DIK  ++LL  D R K+SDFG 
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGF 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 16/123 (13%)

Query: 556 DMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHV 615
           D+  G  FS + ++  S+ GT  Y++PE         K+DI+SLG L+  + +       
Sbjct: 149 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA------- 201

Query: 616 LASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELR 675
           L SP   +K NL S C+ + Q           L  D+  E+    +N+   C+   PE R
Sbjct: 202 LQSPFYGDKMNLYSLCKKIEQCDY------PPLPSDHYSEELRQLVNM---CINPDPEKR 252

Query: 676 PDI 678
           PDI
Sbjct: 253 PDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 39/137 (28%), Positives = 61/137 (44%), Gaps = 19/137 (13%)

Query: 109 LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQ 167
           L+A+K L    S     +F  E++IL  L  P +  LLG C       ++ EYM N  L 
Sbjct: 48  LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107

Query: 168 EML-----FSDGNLVLKWSQRFEIIMDVA-------KALEFLHFGCDPPVIHGDIKPSNV 215
           + L      + G      S  F  ++ +A       + LE L+F      +H D+   N 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF------VHRDLATRNC 161

Query: 216 LLDSDCRGKVSDFGLSR 232
           L+  +   K++DFG+SR
Sbjct: 162 LVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 21/72 (29%), Positives = 41/72 (56%), Gaps = 9/72 (12%)

Query: 167 QEMLFSDGNLVLKWSQRFE------IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD 220
           +E++ +D + +++  Q          I  +   L+++H      V+H D+KP N+L+++D
Sbjct: 85  EELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNAD 141

Query: 221 CRGKVSDFGLSR 232
           C  K+ DFGL+R
Sbjct: 142 CELKICDFGLAR 153

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 19/164 (11%)

Query: 90  VIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQN---ELQILGGLRSPFLVTLL 145
           ++GKG  G V L   +  G+  A+K L    +  + E  +   E ++L   R PFL  L 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 146 GYCMERNKRILVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
                 ++   V EY     L     +E +F++         RF    ++  ALE+LH  
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER------ARF-YGAEIVSALEYLH-- 112

Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLF 244
               V++ DIK  N++LD D   K++DFGL +  +     M  F
Sbjct: 113 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 49/175 (28%), Positives = 77/175 (44%), Gaps = 42/175 (24%)

Query: 75  YKELKNATNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQIL 133
           Y++LK           +G G  GTV   +  R G  +AIK+L        R FQ+EL   
Sbjct: 17  YRDLKQ----------VGSGAYGTVCSALDRRTGAKVAIKKL-------YRPFQSELFAK 59

Query: 134 GGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKW------------- 180
              R    + LL +    N   L+  + P+ SL    F D  LV+ +             
Sbjct: 60  RAYRE---LRLLKHMKHENVIGLLDVFTPDLSLDR--FHDFYLVMPFMGTDLGKLMKHEK 114

Query: 181 --SQRFE-IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               R + ++  + K L+++H      +IH D+KP N+ ++ DC  K+ DFGL+R
Sbjct: 115 LSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 46.9 bits (112), Expect = 2e-05
 Identities = 42/171 (24%), Positives = 71/171 (41%), Gaps = 52/171 (30%)

Query: 89  NVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQN---------ELQILGGLRS 138
           + +G G  G V           +AIK+L        R FQ+         EL++L  +  
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDH 73

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLV-----------LKWSQRFE-- 185
             ++ LL              + P  SL++  F D  LV           +K  Q+    
Sbjct: 74  ENVIGLLDV------------FTPASSLED--FQDVYLVTHLMGADLNNIVK-CQKLSDD 118

Query: 186 ----IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               ++  + + L+++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 119 HIQFLVYQILRGLKYIH-SAG--IIHRDLKPSNIAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 38/140 (27%), Positives = 72/140 (51%), Gaps = 10/140 (7%)

Query: 105 RDGKLLAIKRLDTFSLQTE-REFQNELQILGGLRSPFLVTLLGYCMERNKR--ILVYEYM 161
             G+ +A+K L   S      + + E++IL  L    +V   G C E       L+ E++
Sbjct: 31  NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90

Query: 162 PNKSLQEMLFSDGNLV-LKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD 220
           P+ SL+E L  + N + LK   ++ +   + K +++L        +H D+   NVL++S+
Sbjct: 91  PSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYLG---SRQYVHRDLAARNVLVESE 145

Query: 221 CRGKVSDFGLSR-IKVEGEF 239
            + K+ DFGL++ I+ + E+
Sbjct: 146 HQVKIGDFGLTKAIETDKEY 165

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 44/150 (29%), Positives = 66/150 (44%), Gaps = 9/150 (6%)

Query: 85  FDEANVIGKGGSGTVFLGIARD-GKLLAIKRL---DTFSLQTEREFQNELQILGGLRSPF 140
           F +   IG G  G V L    D   L A+K L   D          + E  IL    + +
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V L     +++    V +Y+P   +  +L   G      + RF  I ++  A+E +H  
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-RF-YIAELTCAIESVH-- 118

Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGL 230
                IH DIKP N+L+D D   K++DFGL
Sbjct: 119 -KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 9/155 (5%)

Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQN---ELQILGGLRSP 139
           +F     IG+G    V+      D K +A+K++  F +   +  Q+   E+ +L  L  P
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEML--FSDGNLVLKWSQRFEIIMDVAKALEFL 197
            ++  L   +E N+  +V E      L +M+  F     ++     ++  + +  A+E +
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H DIKP+NV + +    K+ D GL R
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGR 154

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 46.4 bits (111), Expect = 3e-05
 Identities = 48/167 (28%), Positives = 86/167 (51%), Gaps = 36/167 (21%)

Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRL------DTFSLQTEREFQNELQILG 134
           ++++ N I +G  G V+   ARD   G+++A+K+L      + F + + RE      IL 
Sbjct: 6   EYEKLNRIEEGTYGVVYR--ARDKKTGEIVALKKLKMEKEKEGFPITSLREIN----ILL 59

Query: 135 GLRSPFLVTL----LGYCMERNKRILVYEYMPN--KSLQEML---FSDGNLVLKWSQRFE 185
            L+ P +VT+    +G  +  +K  +V EY+ +  KSL E +   F         S+   
Sbjct: 60  KLQHPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETMKQPFLQ-------SEVKC 110

Query: 186 IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +++ +   +  LH   D  ++H D+K SN+LL++    K+ DFGL+R
Sbjct: 111 LMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 7/143 (4%)

Query: 91  IGKGGSGTVFLGIARDGKLLAI-KRLDTFSLQTEREFQNELQILGGLRSPFLVTLL-GYC 148
           +G G  G V+    ++  +LA  K +DT S +   ++  E+ IL     P +V LL  + 
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHG 208
            E N  IL+ E+    ++  ++  +    L   Q   +     +AL +LH   +  +IH 
Sbjct: 73  YENNLWILI-EFCAGGAVDAVML-ELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHR 127

Query: 209 DIKPSNVLLDSDCRGKVSDFGLS 231
           D+K  N+L   D   K++DFG+S
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 43/193 (22%), Positives = 87/193 (45%), Gaps = 26/193 (13%)

Query: 89  NVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQN--------------ELQIL 133
             +G+G  G V        GK++AIK++    +  +                   EL+I+
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 134 GGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             ++   ++ L+   +E +   LV + M    L++++  D  + L  SQ   I++ +   
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV--DRKIRLTESQVKCILLQILNG 131

Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQE 253
           L  LH       +H D+ P+N+ ++S    K++DFGL+R      +G   +S  L K + 
Sbjct: 132 LNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR-----RYGYPPYSDTLSKDET 183

Query: 254 LWKSQELSGNLAT 266
           + + +E++  + T
Sbjct: 184 MQRREEMTSKVVT 196

Length = 335

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 50/190 (26%), Positives = 80/190 (42%), Gaps = 19/190 (10%)

Query: 77  ELKNATNDFDEANVIGKGGSGTVFLGI----ARDGKLLAIKRL-DTFSLQTEREFQNELQ 131
           EL N +   +   ++G G  G +  G     ++    +AI  L    S +  R F  E  
Sbjct: 1   ELDNKSIKIER--ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL 58

Query: 132 ILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLVLKWSQRFEIIMDV 190
            LG      +V L G     N  ++V EYM N +L   L   +G LV    Q   ++  +
Sbjct: 59  TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVA--GQLMGMLPGL 116

Query: 191 AKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG-LSRIKVEGEFGMDLFSQDLG 249
           A  +++L    +   +H  +    VL++SD   K+S F  L   K E      +++   G
Sbjct: 117 ASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA-----IYTTMSG 168

Query: 250 KSQELWKSQE 259
           KS  LW + E
Sbjct: 169 KSPVLWAAPE 178

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 46.1 bits (110), Expect = 4e-05
 Identities = 42/169 (24%), Positives = 80/169 (47%), Gaps = 29/169 (17%)

Query: 85  FDEANVIGKGGSGTVFLGIA---RDGKLLAIKRLDTFSLQTEREFQN---ELQILGGLRS 138
           ++    IG+G  G V+       +DGK  AIK+      Q     Q+   E+ +L  L+ 
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 139 PFLVTLLGYCMERNKRI--LVYEYMPNKSLQEMLFSDGNLVLKW---SQRFEIIMDVAKA 193
             +V+L+   +E   +   L+++Y  +   Q         ++K+   ++R  I   + K+
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQ---------IIKFHRQAKRVSIPPSMVKS 112

Query: 194 LEF-----LHFGCDPPVIHGDIKPSNVLL--DSDCRG--KVSDFGLSRI 233
           L +     +H+     V+H D+KP+N+L+  +   RG  K+ D GL+R+
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 54/172 (31%), Positives = 84/172 (48%), Gaps = 28/172 (16%)

Query: 85  FDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTERE-FQ----NELQILGGL 136
           FD    IG+G  G V+   ARD   G+L+A+K++    L  E+E F      E++IL  L
Sbjct: 9   FDIIGQIGEGTYGQVYK--ARDKDTGELVALKKV---RLDNEKEGFPITAIREIKILRQL 63

Query: 137 RSPFLVTL----------LGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEI 186
               +V L          L +  ++    LV+EYM +  L  +L S   LV       + 
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLES--GLVHFSEDHIKS 120

Query: 187 IMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
            M   + LE L++      +H DIK SN+LL++  + K++DFGL+R+    E
Sbjct: 121 FMK--QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 46.3 bits (110), Expect = 4e-05
 Identities = 18/42 (42%), Positives = 30/42 (71%), Gaps = 3/42 (7%)

Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           + L++LH      ++H DIKP N+L++S+C  K+ DFGL+R+
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARV 152

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 45.7 bits (108), Expect = 4e-05
 Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 18/157 (11%)

Query: 91  IGKGGSGTVFLGIARD---GKL---LAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVT 143
           +G+G  G V+ G ARD   G+    +A+K + ++ SL+   EF NE  ++ G     +V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFS--------DGNLVLKWSQRFEIIMDVAKALE 195
           LLG   +    ++V E M +  L+  L S         G       +  ++  ++A  + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +L+       +H D+   N ++  D   K+ DFG++R
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 38/146 (26%), Positives = 69/146 (47%), Gaps = 6/146 (4%)

Query: 91  IGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQT-ER-EFQNELQILGGLRSPFLVTLLGY 147
           IG+G  G   L  ++ DGK   IK ++   +   ER E + E+ +L  ++ P +V     
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67

Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
             E     +V +Y     L + + +   ++    Q  +  + +  AL+ +H   D  ++H
Sbjct: 68  FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILH 124

Query: 208 GDIKPSNVLLDSDCRGKVSDFGLSRI 233
            DIK  N+ L  D   K+ DFG++R+
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARV 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 45.5 bits (108), Expect = 4e-05
 Identities = 32/116 (27%), Positives = 53/116 (45%), Gaps = 14/116 (12%)

Query: 125 EFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLV-LKWSQR 183
            F     ++  L    LV L G C+ R++ I+V EY+    L   L  + N V L W  +
Sbjct: 47  AFFETASLMSQLSHKHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--K 103

Query: 184 FEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL--DSDCRG-----KVSDFGLSR 232
            ++   +A AL +L    D  ++HG++   N+L+       G     K+SD G+  
Sbjct: 104 LDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 45.3 bits (108), Expect = 5e-05
 Identities = 34/115 (29%), Positives = 49/115 (42%), Gaps = 16/115 (13%)

Query: 568 SSTTSMRGTLCYVAPE--YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKA 625
           SS T+  GT  Y+APE   GG GY   K D++SLGV++  +++G+ P        +L+  
Sbjct: 153 SSLTTFVGTPWYMAPEVLLGGNGYG-PKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211

Query: 626 NLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGE 680
             I                DE      ++E      +L   CL K P  RP   E
Sbjct: 212 RRILGPPL---------EFDEPKWSSGSEE----AKDLIKKCLNKDPSKRPTAEE 253

Length = 260

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 38/148 (25%), Positives = 66/148 (44%), Gaps = 9/148 (6%)

Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQN---ELQILGGLRSPFLVTLLG 146
           IG+G    V+      DG  +A+K++  F L   +   +   E+ +L  L  P ++    
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 147 YCMERNKRILVYEYMPNKSLQEML--FSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP 204
             +E N+  +V E      L  M+  F     ++     ++  + +  ALE +H      
Sbjct: 70  SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRR 126

Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           V+H DIKP+NV + +    K+ D GL R
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGR 154

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 45.5 bits (107), Expect = 5e-05
 Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 12/162 (7%)

Query: 78  LKNATNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGL 136
           L++    F+   ++G G  G V+ G   + G+L AIK +D  +   E E + E+ +L   
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKY 59

Query: 137 -RSPFLVTLLGYCMERN------KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMD 189
                + T  G  +++N      +  LV E+    S+ +++ +     LK      I  +
Sbjct: 60  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 119

Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           + + L  LH      VIH DIK  NVLL  +   K+ DFG+S
Sbjct: 120 ILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 43/150 (28%), Positives = 75/150 (50%), Gaps = 15/150 (10%)

Query: 91  IGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQ----NELQILGGLRSPFLVTLL 145
           +G+G   TVF G ++    L+A+K +    L+ E         E+ +L  L+   +VTL 
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKNLKHANIVTLH 69

Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM-DVAKALEFLHFGCDPP 204
                     LV+EY+ +  L++ L + GNL+       +I M  + + L + H      
Sbjct: 70  DIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSM--HNVKIFMFQLLRGLSYCH---KRK 123

Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
           ++H D+KP N+L++     K++DFGL+R K
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAK 153

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 47/152 (30%), Positives = 71/152 (46%), Gaps = 18/152 (11%)

Query: 90  VIGKGGSGTVF-LGIARDGKLLAIKRLDTFSL---QTEREFQNE---LQILGGLRSPFLV 142
           +IG+GG G V+    A  GK+ A+K LD   +   Q E    NE   L ++     PF+V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF---EIIMDVAKALEFLHF 199
            +       +K   + + M    L   L   G    K   RF   EII+     LE +H 
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEK-EMRFYATEIIL----GLEHMH- 114

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
             +  V++ D+KP+N+LLD     ++SD GL+
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 45.8 bits (109), Expect = 5e-05
 Identities = 43/168 (25%), Positives = 84/168 (50%), Gaps = 24/168 (14%)

Query: 81  ATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRL------DTFSLQTEREFQNELQIL 133
              D++    +G+G  G V+       G+++A+K++      D F +   RE    ++IL
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALRE----IKIL 61

Query: 134 GGLRSPFLVTLLGYCMERNKRI--------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFE 185
             L+ P +V L+   +ER  +         +V  YM +  L  +L  + ++ L  SQ   
Sbjct: 62  KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLL-ENPSVKLTESQIKC 119

Query: 186 IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            ++ + + + +LH   +  ++H DIK +N+L+D+    K++DFGL+R 
Sbjct: 120 YMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARP 164

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 45.2 bits (107), Expect = 5e-05
 Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 9/146 (6%)

Query: 91  IGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           +GKG  G+V+  + R  G  +A+K  RL+        +   EL IL    SP++V   G 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGA 67

Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLV--LKWSQRFEIIMDVAKALEFLHFGCDPPV 205
                   +  EYM   SL + L++ G     +       I   V K L+FL    +  +
Sbjct: 68  FFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNI 124

Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLS 231
           IH D+KP+NVL++ + + K+ DFG+S
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 45.7 bits (108), Expect = 6e-05
 Identities = 44/158 (27%), Positives = 70/158 (44%), Gaps = 31/158 (19%)

Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V   I  R G+ +AIK+L        R FQ+E+      R    +TLL +  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKL-------SRPFQSEIFAKRAYRE---LTLLKHMQ 72

Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---------RFE------IIMDVAKAL 194
             N   L+  +    S  E  F D  LV+ + Q                  ++  +   L
Sbjct: 73  HENVIGLLDVFTSAVSGDE--FQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130

Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +++H      +IH D+KP N+ ++ DC  K+ DFGL+R
Sbjct: 131 KYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 44.5 bits (106), Expect = 6e-05
 Identities = 42/190 (22%), Positives = 87/190 (45%), Gaps = 44/190 (23%)

Query: 90  VIGKGGSGTVFLGI---------ARDGKLLAIKRLDTFSLQTEREFQNELQIL-----GG 135
           +I KG    ++LG           R  K      LD   ++ ER  +NE ++L      G
Sbjct: 1   LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDE-RIRRERT-RNEARLLSRARKAG 58

Query: 136 LRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALE 195
           + +P +     Y ++ + + +V EY+  K L++++    +         E++ ++ + + 
Sbjct: 59  VNTPVV-----YDVDPDNKTIVMEYIEGKPLKDVIEEGND---------ELLREIGRLVG 104

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI--KVEGEFGMDLF-------SQ 246
            LH      ++HGD+  SN+++  D +  + DFGL +   ++E +  +DL        S 
Sbjct: 105 KLH---KAGIVHGDLTTSNIIVRDD-KLYLIDFGLGKYSDEIE-DKAVDLHVLKRSLEST 159

Query: 247 DLGKSQELWK 256
              K++EL++
Sbjct: 160 HPDKAEELFE 169

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 45.4 bits (107), Expect = 6e-05
 Identities = 41/149 (27%), Positives = 74/149 (49%), Gaps = 13/149 (8%)

Query: 91  IGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQ----NELQILGGLRSPFLVTLL 145
           +G+G   TV+ G ++    L+A+K +    L+ E         E+ +L  L+   +VTL 
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPV 205
                     LV+EY+ +K L++ L   GN +   + +   +  + + L + H      V
Sbjct: 71  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKL-FLFQLLRGLNYCH---RRKV 125

Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
           +H D+KP N+L++     K++DFGL+R K
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAK 154

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 44.9 bits (106), Expect = 7e-05
 Identities = 45/156 (28%), Positives = 68/156 (43%), Gaps = 10/156 (6%)

Query: 91  IGKGGSGTVFLGIARDG---KLLAIKRLD-TFSLQTEREFQNELQILGGLRSPFLVTLLG 146
           IG G  G V LG    G     + +K L  + S+Q + +F  E Q    L+   L+  LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 147 YCMERNKRILVYEYMPNKSLQEMLFS---DGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
            C E    +LV E+ P   L+  L S      +    +    +  ++A  L  LH     
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119

Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
             IH D+   N LL +D   K+ D+GLS  K + ++
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 37/138 (26%), Positives = 59/138 (42%), Gaps = 18/138 (13%)

Query: 110 LAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQE 168
           +AIK L D        EF++E  +   L+ P +V LLG   +     +++ Y  +  L E
Sbjct: 38  VAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE 97

Query: 169 MLF----------SDGNLVLKWSQR----FEIIMDVAKALEFLHFGCDPPVIHGDIKPSN 214
            L           +D +  +K +        I+  +A  +EFL       V+H D+   N
Sbjct: 98  FLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRN 154

Query: 215 VLLDSDCRGKVSDFGLSR 232
           VL+      K+SD GL R
Sbjct: 155 VLVFDKLNVKISDLGLFR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 44.6 bits (105), Expect = 8e-05
 Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 11/147 (7%)

Query: 91  IGKGGSGTV---FLGIARDGKLLAIKRL--DTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +G G  GTV      + +  K +A+K L  D      + E   E  ++  L +P++V ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPV 205
           G C E    +LV E      L + L  + ++  K     E++  V+  +++L    +   
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEK--NITELVHQVSMGMKYLE---ETNF 116

Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +H D+   NVLL +    K+SDFGLS+
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSK 143

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 44.7 bits (105), Expect = 9e-05
 Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 9/153 (5%)

Query: 85  FDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQN---ELQILGGLRSPF 140
           F +   IG G  G V+     R+ +++AIK++     Q+  ++Q+   E++ L  LR P 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
            +   G  +  +   LV EY    S  ++L     +  K  Q  EI      AL+ L + 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLG-SASDLL----EVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               +IH D+K  N+LL      K+ DFG + I
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 44.7 bits (106), Expect = 9e-05
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 29/165 (17%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTE-REFQNELQILGGLRS-- 138
            D  +   IG+G  GTV   + +  G ++A+KR+ +   + E +    +L ++  +RS  
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MRSSD 61

Query: 139 -PFLVTLLG---------YCMERNKRIL--VYEYMPNKSLQEMLFSDGNLVLKWSQRFEI 186
            P++V   G          CME     L   Y+Y+       +      ++ K      I
Sbjct: 62  CPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVI---PEEILGK------I 112

Query: 187 IMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            +   KAL +L    +  +IH D+KPSN+LLD +   K+ DFG+S
Sbjct: 113 AVATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 41/150 (27%), Positives = 66/150 (44%), Gaps = 9/150 (6%)

Query: 85  FDEANVIGKGGSGTVFLGIARD-GKLLAIKRL---DTFSLQTEREFQNELQILGGLRSPF 140
           F +   +G G  G V L    D   L A+K L   D          + E  IL    + +
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V L     +++    V +Y+P   +  +L   G      ++ +  I ++  A+E +H  
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFY--IAELTCAVESVH-- 118

Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGL 230
                IH DIKP N+L+D D   K++DFGL
Sbjct: 119 -KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 43.3 bits (103), Expect = 2e-04
 Identities = 29/112 (25%), Positives = 49/112 (43%), Gaps = 17/112 (15%)

Query: 569 STTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLI 628
            T S+RGT  ++APE          ADI+SLG  ++ + +G+ P   L +PM    A L 
Sbjct: 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM----AALY 214

Query: 629 SWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGE 680
                +  +G   E+ +   ++           +    CL++ P+ RP   E
Sbjct: 215 ----KIGSSGEPPEIPEHLSEE---------AKDFLRKCLRRDPKKRPTADE 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 43.6 bits (101), Expect = 2e-04
 Identities = 21/114 (18%), Positives = 38/114 (33%), Gaps = 10/114 (8%)

Query: 570 TTSMRGTLCYVAPEY---GGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKAN 626
            ++  GT  Y+APE        Y    +DI+SLG+ +  +++G  P     +     +  
Sbjct: 165 PSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL 224

Query: 627 LISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGE 680
            I               +   L     +  +    +L    L K P+ R     
Sbjct: 225 KIILE-------LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271

Length = 384

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 41/149 (27%), Positives = 75/149 (50%), Gaps = 13/149 (8%)

Query: 91  IGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQ----NELQILGGLRSPFLVTLL 145
           +G+G   TVF G ++    L+A+K +    L+ E         E+ +L  L+   +VTL 
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPV 205
                     LV+EY+ +K L++ +   GN++   + +   +  + + L + H      V
Sbjct: 71  DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKI-FLYQILRGLAYCH---RRKV 125

Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
           +H D+KP N+L++     K++DFGL+R K
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAK 154

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 38/172 (22%), Positives = 68/172 (39%), Gaps = 32/172 (18%)

Query: 90  VIGKGGSGTVFLGIARDGK------LLAIKRLDTFSLQTE-REFQNELQILGGLRSPFLV 142
            +G+G  G V    A   K       +A+K L   +  +E R+  +E  +L  +  P ++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEML----------------------FSDGNLVLKW 180
            L G C +    +L+ EY    SL+  L                       +     L  
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 181 SQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                    +++ +++L    +  ++H D+   NVL+    + K+SDFGLSR
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 41/167 (24%), Positives = 82/167 (49%), Gaps = 28/167 (16%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRL------DTFSLQTEREFQNELQIL 133
           + +++   IG+G  G VF   AR     +++A+K++      + F +   RE    ++IL
Sbjct: 12  SKYEKLAKIGQGTFGEVFK--ARHKKTKQIVALKKVLMENEKEGFPITALRE----IKIL 65

Query: 134 GGLRSPFLVTLLGYC-----MERNKR---ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFE 185
             L+   +V L+  C          +    LV+E+  +  L  +L S+ N+    S+  +
Sbjct: 66  QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL-SNKNVKFTLSEIKK 123

Query: 186 IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++  +   L ++H      ++H D+K +N+L+  D   K++DFGL+R
Sbjct: 124 VMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 22/154 (14%)

Query: 90  VIGKGGSGTVF-LGIARDGKLLAIKRLDTFSL---QTEREFQNE---LQILGGLRSPFLV 142
           +IG+GG G V+    A  GK+ A+K LD   +   Q E    NE   L ++     PF+V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 143 TLLGYCMERNKRILVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            +       +K   + + M    L     Q  +FS+  +    +   EII+     LE +
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAA---EIIL----GLEHM 113

Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           H   +  V++ D+KP+N+LLD     ++SD GL+
Sbjct: 114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 40/150 (26%), Positives = 66/150 (44%), Gaps = 9/150 (6%)

Query: 85  FDEANVIGKGGSGTVFLGIARD-GKLLAIKRL---DTFSLQTEREFQNELQILGGLRSPF 140
           F +   +G G  G V L    D   L A+K L   D  +       + E  IL    + +
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V L     +++    V +Y+P   +  +L          ++ +  I ++  A+E +H  
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFY--IAELTLAIESVH-- 118

Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGL 230
                IH DIKP N+L+D D   K++DFGL
Sbjct: 119 -KMGFIHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 20/161 (12%)

Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRL-----DTFSLQTEREFQNEL 130
           +N  +D++    +G G  G V+   AR+   G+L A+K +     D FSL      Q E+
Sbjct: 5   RNPQHDYELIQRVGSGTYGDVYK--ARNLHTGELAAVKIIKLEPGDDFSL-----IQQEI 57

Query: 131 QILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDV 190
            ++   +   +V   G  + R K  +  EY    SLQ++    G L     Q   +  + 
Sbjct: 58  FMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPL--SELQIAYVCRET 115

Query: 191 AKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            + L +LH       +H DIK +N+LL  +   K++DFG++
Sbjct: 116 LQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 24/161 (14%)

Query: 84  DFDEANVIGKGGSGTVFLGIARDG--KLLAIKRL---------DTFSLQTEREFQNELQI 132
           DF+   V+GKG  G V L   R G  +L AIK L         D      E+      ++
Sbjct: 1   DFNFLMVLGKGSFGKVMLA-ERKGTDELYAIKILKKDVIIQDDDVECTMVEK------RV 53

Query: 133 LGGLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVA 191
           L     P  +T L  C +   R+  V EY+    L   +   G    K         ++A
Sbjct: 54  LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKF--KEPHAVFYAAEIA 111

Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
             L FLH      +I+ D+K  NV+LD++   K++DFG+ +
Sbjct: 112 IGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 12/162 (7%)

Query: 78  LKNATNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGL 136
           L++    F+   V+G G  G V+ G   + G+L AIK +D  +   E E + E+ +L   
Sbjct: 11  LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKY 69

Query: 137 -RSPFLVTLLGYCMER------NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMD 189
                + T  G  +++      ++  LV E+    S+ +++ +     LK      I  +
Sbjct: 70  SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICRE 129

Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           + + L  LH      VIH DIK  NVLL  +   K+ DFG+S
Sbjct: 130 ILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 168

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 20/165 (12%)

Query: 90  VIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNEL---QILGGLRSPFLVTLL 145
           ++GKG  G V L   +  G+  A+K L    +  + E  + L   ++L   R PFL T L
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL-TAL 60

Query: 146 GYCMERNKRI-LVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
            Y  + + R+  V EY     L     +E +FS+         RF    ++  AL++LH 
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR------ARF-YGAEIVSALDYLH- 112

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLF 244
             +  V++ D+K  N++LD D   K++DFGL +  ++    M  F
Sbjct: 113 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 156

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 42.5 bits (100), Expect = 4e-04
 Identities = 19/48 (39%), Positives = 29/48 (60%), Gaps = 4/48 (8%)

Query: 568 SSTTSMRGTLCYVAPEY---GGCGYLMEKADIYSLGVLILVIVSGRRP 612
               SM+G++ ++APE       GY   K DI+SLG ++L + +GRRP
Sbjct: 165 DQNMSMQGSVFWMAPEVIHSYSQGY-SAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 33/117 (28%), Positives = 50/117 (42%), Gaps = 30/117 (25%)

Query: 568 SSTTSMRGTLCYVAPE------YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMK 621
           S  TS+ GT+ Y  PE      YG      EKAD+++ G ++  + + + P +       
Sbjct: 168 SKLTSVVGTILYSCPEIVKNEPYG------EKADVWAFGCILYQMCTLQPPFY------- 214

Query: 622 LEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDI 678
               N++S       A  I+E V E L +    E  +  I    +CL    E RPDI
Sbjct: 215 --STNMLSL------ATKIVEAVYEPLPEGMYSEDVTDVIT---SCLTPDAEARPDI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 43.1 bits (101), Expect = 4e-04
 Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 10/154 (6%)

Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQN---ELQILGGLRSP 139
           DF+   V+GKG  G V L   +   +L AIK L    +  + + +    E ++L     P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 140 FLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
             +T L  C +   R+  V EY+    L   +   G    K  Q      +++  L FLH
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKF--KEPQAVFYAAEISVGLFFLH 118

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                 +I+ D+K  NV+LDS+   K++DFG+ +
Sbjct: 119 ---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 42.8 bits (101), Expect = 4e-04
 Identities = 41/153 (26%), Positives = 75/153 (49%), Gaps = 19/153 (12%)

Query: 90  VIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQ----NELQILGGLRSPFLVTL 144
            +G+G   TV+ G ++  G+L+A+K +    L+ E         E  +L  L+   +VTL
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEI---RLEHEEGAPFTAIREASLLKDLKHANIVTL 68

Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQR---FEIIMDVAKALEFLHFGC 201
                 +    LV+EY+ +  L++ +   G  +   + R   F+++    + L + H   
Sbjct: 69  HDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLL----RGLAYCH--- 120

Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
              V+H D+KP N+L+      K++DFGL+R K
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLARAK 153

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 42.6 bits (100), Expect = 5e-04
 Identities = 42/154 (27%), Positives = 69/154 (44%), Gaps = 10/154 (6%)

Query: 90  VIGKGGSGTVFLG-IARDGKLLAIKRL--DTFSLQTEREFQN-ELQILG-GLRSPFLVTL 144
           V+GKG  G V L  +   G+  A+K L  D   +  + E    E ++L     +PFL  L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP 204
                 +     V E++    L   +   G   L  +  +    ++   L+FLH      
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYA--AEIVCGLQFLH---SKG 116

Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
           +I+ D+K  NV+LD D   K++DFG+ +  V G+
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD 150

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 42.4 bits (99), Expect = 5e-04
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 14/153 (9%)

Query: 84  DFDEANVIGKGGSGTV-FLGIARDGKLLAIKRLDTFSLQTERE---FQNELQILGGLRSP 139
           DF+   VIG+G  G V  + +    K+ A+K L+ + +    E   F+ E  +L    + 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF---EIIMDVAKALEF 196
           ++ TL     + N   LV +Y     L  +L    + + +   RF   E+++ +  ++  
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DSVHQ 120

Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
           LH+      +H DIKP N+L+D +   +++DFG
Sbjct: 121 LHY------VHRDIKPDNILMDMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 42.3 bits (99), Expect = 6e-04
 Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 9/147 (6%)

Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQN---ELQILGGLRSPFLVTLLG 146
           IG G  G V+    +   +++A+K++     QT  ++Q+   E++ L  L+ P  +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 147 YCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVI 206
             ++ +   LV EY    S  ++L     +  K  Q  EI      AL+ L +     +I
Sbjct: 89  CYLKEHTAWLVMEYCLG-SASDLL----EVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143

Query: 207 HGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H DIK  N+LL    + K++DFG +  
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASK 170

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 42.4 bits (99), Expect = 6e-04
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 9/153 (5%)

Query: 85  FDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQN---ELQILGGLRSPF 140
           F +   IG G  G V+     R  +++AIK++     Q+  ++Q+   E++ L  ++ P 
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
            +   G  +  +   LV EY    S  ++L     +  K  Q  EI      AL+ L + 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLG-SASDLL----EVHKKPLQEVEIAAITHGALQGLAYL 141

Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               +IH DIK  N+LL    + K++DFG + I
Sbjct: 142 HSHNMIHRDIKAGNILLTEPGQVKLADFGSASI 174

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 41.8 bits (98), Expect = 6e-04
 Identities = 47/159 (29%), Positives = 73/159 (45%), Gaps = 24/159 (15%)

Query: 91  IGKGGSGTVFLGIARD----GKL----LAIKRLDTFSLQTEREFQNELQILGGLRSPFLV 142
           +G+G    +F GI R+    G+L    + +K LD         F     ++  L    LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLV-LKWSQRFEIIMDVAKALEF-LHFG 200
              G C+  ++ I+V EY+   SL   L  + NL+ + W       ++VAK L + LHF 
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWALHFL 116

Query: 201 CDPPVIHGDIKPSNVLL---DSDCRG-----KVSDFGLS 231
            D  + HG++   NVLL   +    G     K+SD G+S
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 48/158 (30%), Positives = 74/158 (46%), Gaps = 18/158 (11%)

Query: 90  VIGKGGSGTVFLG-IARDGKLLAIKRL--DTFSLQTEREFQN-ELQILG-GLRSPFLVTL 144
           ++GKG  G VFL  +    +  AIK L  D   +  + E    E ++L      PFL  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 145 LGYCMERNKRIL--VYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLHFG 200
             YC  + K  L  V EY+    L   + S     L  +  +  EII      L+FLH  
Sbjct: 62  --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC----GLQFLH-- 113

Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
               +++ D+K  N+LLD+D   K++DFG+ +  + G+
Sbjct: 114 -SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD 150

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 41.7 bits (98), Expect = 8e-04
 Identities = 43/157 (27%), Positives = 77/157 (49%), Gaps = 20/157 (12%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTERE---FQNELQIL--GGL 136
           +DF+   VIG+G  G V +   ++ G++ A+K L+ + +    E   F+ E  +L  G  
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 137 RSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF---EIIMDVAK 192
           R    +T L Y  +    + LV +Y     L  +L    + + +   RF   E+++ +  
Sbjct: 61  R---WITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI-D 116

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
           ++  L +      +H DIKP NVLLD +   +++DFG
Sbjct: 117 SVHQLGY------VHRDIKPDNVLLDKNGHIRLADFG 147

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 41.5 bits (97), Expect = 9e-04
 Identities = 35/149 (23%), Positives = 69/149 (46%), Gaps = 5/149 (3%)

Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++        +A+K +   S+  E  F  E  ++  L+   LV L    + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKL-HAVVT 71

Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    ++ E+M   SL + L SD        +  +    +A+ + F+        IH D+
Sbjct: 72  KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDL 128

Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+ +    K++DFGL+R+  + E+
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEY 157

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 41.6 bits (98), Expect = 9e-04
 Identities = 46/155 (29%), Positives = 67/155 (43%), Gaps = 24/155 (15%)

Query: 90  VIGKGGSGTVFLGIARDGK----LLAIKRLDTFSLQTERE-FQNELQILGGLRSPFLVTL 144
            IG+G  G V+ G+    +     +A+K     +  + RE F  E  I+     P +V L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 145 LGYCMERNKRILVYEYMPNKSLQEML------FSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           +G   E N   +V E  P   L+  L          +L+L   Q       ++ AL +L 
Sbjct: 73  IGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQ-------LSTALAYLE 124

Query: 199 FGCDPPVIHGDIKPSNVLLDS-DCRGKVSDFGLSR 232
                  +H DI   NVL+ S DC  K+ DFGLSR
Sbjct: 125 ---SKRFVHRDIAARNVLVSSPDCV-KLGDFGLSR 155

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 41.4 bits (98), Expect = 0.001
 Identities = 31/117 (26%), Positives = 45/117 (38%), Gaps = 31/117 (26%)

Query: 569 STTSMRGTLCYVAPE------YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKL 622
           +  +M GT  ++APE      Y        KADI+SLG+  + +  G+ P   L  PMK 
Sbjct: 153 ARNTMVGTPYWMAPEVINGKPYDY------KADIWSLGITAIELAEGKPPYSEL-PPMKA 205

Query: 623 EKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCI-NLALTCLQKTPELRPDI 678
                            + ++         N E+ S    +    CLQK PE RP  
Sbjct: 206 -----------------LFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTA 245

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 41.8 bits (98), Expect = 0.001
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 24/155 (15%)

Query: 90  VIGKGGSGTVFLGIARDGK--LLAIKRLDTFSLQTEREFQ---NELQILG-GLRSPFLVT 143
           V+GKG  G V L     G   + AIK L    +  + +      E +IL    + PFL  
Sbjct: 2   VLGKGSFGKVMLA-ELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFE------IIMDVAKALEFL 197
           L      +++   V EY+    L   +F      ++ S++F+         +V  AL FL
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDL---MFQ-----IQRSRKFDEPRSRFYAAEVTLALMFL 112

Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      VI+ D+K  N+LLD++   K++DFG+ +
Sbjct: 113 H---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 41.7 bits (98), Expect = 0.001
 Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 29/162 (17%)

Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTL----- 144
           +G G +G VF  +  D  K +A+K++     Q+ +    E++I+  L    +V +     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 145 ---------LGYCMERNKRILVYEYMPN---KSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
                    +G   E N   +V EYM       L++   S+ +  L   Q       + +
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ-------LLR 125

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDS-DCRGKVSDFGLSRI 233
            L+++H      V+H D+KP+NV +++ D   K+ DFGL+RI
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 41.7 bits (98), Expect = 0.001
 Identities = 43/160 (26%), Positives = 68/160 (42%), Gaps = 33/160 (20%)

Query: 91  IGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREFQN---ELQILGGLRSPFLVTL 144
           IG G  G V+   ARD    +++AIK++     Q+  ++Q+   E++ L  LR P  +  
Sbjct: 23  IGHGSFGAVYF--ARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 145 LGYCMERNKRILVYEY----------MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
            G  +  +   LV EY          +  K LQE+  +             I     + L
Sbjct: 81  KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIA------------AICHGALQGL 128

Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
            +LH       IH DIK  N+LL      K++DFG + + 
Sbjct: 129 AYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLV 165

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 18/157 (11%)

Query: 91  IGKGGSGTVFLGIARD------GKLLAIKRLDTFSLQTER-EFQNELQILGGLRSPFLVT 143
           +G+G  G V+ GIA+          +AIK ++  +   ER EF NE  ++       +V 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFS-----DGNLVLK---WSQRFEIIMDVAKALE 195
           LLG   +    +++ E M    L+  L S     + N V       +  ++  ++A  + 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +L+       +H D+   N ++  D   K+ DFG++R
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 41.6 bits (97), Expect = 0.001
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 36/161 (22%)

Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDT--FSLQTEREFQNELQILGGLRSPFLVTLL 145
           +G G  G+V    A D +L   +A+K+L     SL   R    EL++L  ++   ++ LL
Sbjct: 23  VGSGAYGSV--CSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 146 GYCMERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVA 191
                         + P  S++          ++ +D N ++K  +  +     +I  + 
Sbjct: 81  DV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128

Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + L+++H      +IH D+KPSNV ++ DC  ++ DFGL+R
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.8 bits (99), Expect = 0.001
 Identities = 49/189 (25%), Positives = 83/189 (43%), Gaps = 42/189 (22%)

Query: 89  NVIGKGGSGTVFLGIA---------RDGKLLAIKRLDTFSLQTEREFQNELQIL-----G 134
           ++IGKG    +  G           R  K      LD   L+TER  + E ++L      
Sbjct: 339 HLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDE-RLRTERT-RAEARLLSEARRA 396

Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
           G+ +P +     Y ++  ++ +V EY+  K L+++L  +GN         E++  V + +
Sbjct: 397 GVPTPVI-----YDVDPEEKTIVMEYIGGKDLKDVL--EGNP--------ELVRKVGEIV 441

Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE-FGMDL--FSQDLG-- 249
             LH      ++HGD+  SN ++  D R  + DFGL +     E   +DL    Q L   
Sbjct: 442 AKLH---KAGIVHGDLTTSNFIVRDD-RLYLIDFGLGKYSDLIEDKAVDLHVLKQSLEST 497

Query: 250 --KSQELWK 256
               +ELW+
Sbjct: 498 HYDFEELWE 506

Length = 535

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 41.4 bits (97), Expect = 0.002
 Identities = 28/110 (25%), Positives = 54/110 (49%), Gaps = 6/110 (5%)

Query: 579 YVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAG 638
           YVAPE      + EK+DIY  G++++ +++G+ P    A        +++ W R+     
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSP----ADAEFGVHGSIVEWARYCYSDC 899

Query: 639 NILELVDERLKDD--YNKEQASLCINLALTCLQKTPELRPDIGETVRILK 686
           ++   +D  ++ D   N+ +    +NLAL C    P  RP   + ++ L+
Sbjct: 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 40.4 bits (95), Expect = 0.002
 Identities = 31/111 (27%), Positives = 44/111 (39%), Gaps = 17/111 (15%)

Query: 575 GTLCYVAPE--YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCR 632
           GT C++APE      GY   KADI+S G+  + + +G  P      PMK+    L     
Sbjct: 168 GTPCWMAPEVMEQVHGY-DFKADIWSFGITAIELATGAAPYSKY-PPMKVLMLTL----- 220

Query: 633 HLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVR 683
                 +   L        Y+K        +   CLQK P  RP   E ++
Sbjct: 221 ----QNDPPSLETGADYKKYSKSFR----KMISLCLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 22/53 (41%), Positives = 29/53 (54%), Gaps = 4/53 (7%)

Query: 570 TTSMRGTLCYVAPE---YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASP 619
           T +  GTL Y+APE    G  GY    ADI+SLG  I+ + +G+ P   L  P
Sbjct: 166 TETFTGTLQYMAPEVIDKGPRGY-GAPADIWSLGCTIVEMATGKPPFIELGEP 217

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 42/168 (25%), Positives = 77/168 (45%), Gaps = 27/168 (16%)

Query: 91  IGKGGSGTVFLGIARDG--KLLAIKRLDTFSL---QTERE-------FQNELQILG-GLR 137
           +G G  G V+    ++    LLA+K ++  +    + +RE         +E+ I+   LR
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWS-QRFE------IIMDV 190
            P +V      +E ++  +V + +    L E   S     LK   QRF       I + +
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNS-----LKEKKQRFTEERIWNIFVQM 122

Query: 191 AKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
             AL +LH   +  ++H D+ P+N++L  D +  ++DFGL++ K    
Sbjct: 123 VLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES 168

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 46/178 (25%), Positives = 79/178 (44%), Gaps = 21/178 (11%)

Query: 67  PLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTERE 125
           PL  +   +    + ++ ++    IGKG  G VF  + + +G   A+K LD      + E
Sbjct: 2   PLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEE 60

Query: 126 FQNELQILGGLRS-PFLVTLLGYCMERNKRI-----LVYEYMPNKSLQEMLFSDGNLVLK 179
            + E  IL  L   P +V   G   +++ +      LV E     S+ +++       LK
Sbjct: 61  IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG----FLK 116

Query: 180 WSQRFE------IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
             +R E      I+ +    L+ LH       IH D+K +N+LL ++   K+ DFG+S
Sbjct: 117 RGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 12/155 (7%)

Query: 84  DFDEANVIGKGGSGTVFLGIARDG--KLLAIKRLDTFSLQTEREFQN---ELQILGGLRS 138
           DF+   V+GKG  G V L   R G  +L AIK L    +  + + +    E ++L     
Sbjct: 1   DFNFLMVLGKGSFGKVMLA-ERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK 59

Query: 139 PFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
           P  +T L  C +   R+  V EY+    L   +   G    K         ++A  L FL
Sbjct: 60  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRF--KEPHAVFYAAEIAIGLFFL 117

Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      +I+ D+K  NV+LDS+   K++DFG+ +
Sbjct: 118 H---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 14/154 (9%)

Query: 83  NDFDEANVIGKGGSGTV-FLGIARDGKLLAIKRLDTFSLQTERE---FQNELQILGGLRS 138
           +DF+   VIG+G  G V  + +    ++ A+K L+ + +    E   F+ E  +L     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF---EIIMDVAKALE 195
            ++ TL     + N   LV +Y     L  +L    + + +   RF   E+++ +  ++ 
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI-HSIH 119

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
            LH+      +H DIKP NVLLD +   +++DFG
Sbjct: 120 QLHY------VHRDIKPDNVLLDMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.9 bits (93), Expect = 0.003
 Identities = 17/45 (37%), Positives = 30/45 (66%), Gaps = 3/45 (6%)

Query: 186 IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL 230
           I+ D+   LE++H   +  + HGDIKP N+++D + RG + D+G+
Sbjct: 131 IMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGI 172

Length = 294

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 39.9 bits (93), Expect = 0.003
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 9/158 (5%)

Query: 91  IGKGGSGTVFLGIARDG-KLLAIKRLDTFSLQTEREFQNEL---QILGGLRSPFLVTLLG 146
           IGKG  G V     RD  ++ A+K +    + +  E  + L    +L  +  PF+V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 147 YCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVI 206
                 K  LV  ++    L   L  +G   L  ++ +    ++  ALE LH      VI
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFY--TAELLCALENLH---KFNVI 115

Query: 207 HGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLF 244
           + D+KP N+LLD      + DFGL ++ ++ +   + F
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF 153

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 39.2 bits (92), Expect = 0.003
 Identities = 43/188 (22%), Positives = 77/188 (40%), Gaps = 41/188 (21%)

Query: 90  VIGKGGSGTVFLGIARDG---------KLLAIKRLDTFSLQTEREFQNELQILG-----G 135
           +I +G    ++L               K      LD   L+ ER  + E +IL      G
Sbjct: 3   LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDE-KLRRERT-RREARILAKAREAG 60

Query: 136 LRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALE 195
           +  P +     Y ++ +  ++V EY+  + L++ L            R +++ +V + + 
Sbjct: 61  VPVPIV-----YDVDPDNGLIVMEYIEGELLKDAL---------EEARPDLLREVGRLVG 106

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE-FGMDL--FSQDLG--- 249
            LH      ++HGD+  SN++L    R    DFGL     E E   +DL    + L    
Sbjct: 107 KLH---KAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFSDEVEDKAVDLHVLERALESTH 162

Query: 250 -KSQELWK 256
            K++EL+ 
Sbjct: 163 EKAEELFA 170

Length = 204

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 39.1 bits (92), Expect = 0.003
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 23/127 (18%)

Query: 122 TEREFQNELQIL-GGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKW 180
           T RE +   +    G+  P +     Y ++    I+V EY+  + L++++ S+G      
Sbjct: 46  TRREARIMSRARKAGVNVPAV-----YFVDPENFIIVMEYIEGEPLKDLINSNGME---- 96

Query: 181 SQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVS--DFGLSRIK--VE 236
               E+  ++ + +  LH      +IHGD+  SN++L S   GK+   DFGL+     +E
Sbjct: 97  --ELELSREIGRLVGKLHSA---GIIHGDLTTSNMIL-SG--GKIYLIDFGLAEFSKDLE 148

Query: 237 GEFGMDL 243
            +  +DL
Sbjct: 149 -DRAVDL 154

Length = 211

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 39.8 bits (93), Expect = 0.004
 Identities = 50/163 (30%), Positives = 82/163 (50%), Gaps = 33/163 (20%)

Query: 91  IGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTERE-----FQNELQILGGL-RSPFL 141
           IG+G  G V+   ARD   GKL+A+K+     L+ + E        E+ +L  L  S ++
Sbjct: 9   IGEGTYGKVYK--ARDKNTGKLVALKKT---RLEMDEEGIPPTALREISLLQMLSESIYI 63

Query: 142 VTLLG--YCMERNKRI---LVYEYMPNKSLQEMLFSDGN-----LVLKWSQRFEIIMDVA 191
           V LL   +  E+N +    LV+EY+ +  L++ + S+G      L  K  + F  +  + 
Sbjct: 64  VRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF--MYQLL 120

Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG--KVSDFGLSR 232
           K +   H      V+H D+KP N+L+D   +G  K++D GL R
Sbjct: 121 KGVAHCH---KHGVMHRDLKPQNLLVDKQ-KGLLKIADLGLGR 159

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 39.2 bits (91), Expect = 0.004
 Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 18/164 (10%)

Query: 91  IGKGGSGTVFLG-IARDGKLL--AIKRLD-TFSLQTERE-FQNELQILGGLRSPFLVTLL 145
           +G+G  G+V  G + +D  +L  A+K +      ++E E F +E   +     P ++ L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 146 GYCMERNKR------ILVYEYMPNKSLQEMLF----SDGNLVLKWSQRFEIIMDVAKALE 195
           G C++  +       +++  +M +  L   L      D    L      + + D+A  +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           +L        IH D+   N +L+ +    V+DFGLS+    G++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY 167

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 39.5 bits (92), Expect = 0.004
 Identities = 42/173 (24%), Positives = 73/173 (42%), Gaps = 23/173 (13%)

Query: 85  FDEANVIGKGGSGTV---FLGIARD-GKLLAIKRL--DTFSLQTEREFQNELQILGGLRS 138
           F    ++GKG  G+V    L       + +A+K L  D FS     EF  E   +     
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 139 PFLVTLLGYCMERNKR------ILVYEYMPNKSLQEMLFSDG------NLVLKWSQRFEI 186
           P ++ L+G  +    +      +++  +M +  L   L           L L+   RF  
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF-- 118

Query: 187 IMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           ++D+A  +E+L        IH D+   N +L+ +    V+DFGLS+    G++
Sbjct: 119 MIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY 168

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	718
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.85
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.8
PRK10345	210	hypothetical protein; Provisional	99.78
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.76
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.75
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.75
PRK12274	218	serine/threonine protein kinase; Provisional	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.73
smart00090	237	RIO RIO-like kinase.	99.72
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.72
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.71
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.71
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.71
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.67
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.67
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.66
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.62
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.62
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.61
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.57
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.44
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.41
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.27
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.25
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.23
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.17
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.08
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.07
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.05
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.04
KOG3087	229	consensus Serine/threonine protein kinase [General	98.88
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.85
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.77
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.67
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.41
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.36
KOG1243	690	consensus Protein kinase [General function predict	98.33
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.33
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.29
PRK09902	216	hypothetical protein; Provisional	98.28
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.18
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.16
PF01636	239	APH: Phosphotransferase enzyme family This family	98.16
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.05
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.97
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.96
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.84
PLN02876	822	acyl-CoA dehydrogenase	97.8
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.73
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.71
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.62
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.6
COG4248	637	Uncharacterized protein with protein kinase and he	97.52
PRK10593	297	hypothetical protein; Provisional	97.5
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.48
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.38
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.34
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.28
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.27
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.26
PRK05231	319	homoserine kinase; Provisional	97.12
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.85
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.75
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.55
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.39
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.23
PLN02236	344	choline kinase	95.78
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.66
KOG1187	361	consensus Serine/threonine protein kinase [Signal	95.65
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	95.56
PLN02756	418	S-methyl-5-thioribose kinase	95.52
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.47
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.1
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.42
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	94.37
KOG2270	520	consensus Serine/threonine protein kinase involved	94.34
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	94.13
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	93.95
PRK11768	325	serine/threonine protein kinase; Provisional	93.07
PRK12396	409	5-methylribose kinase; Reviewed	93.02
PRK06148	1013	hypothetical protein; Provisional	92.86
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	92.57
COG2334	331	Putative homoserine kinase type II (protein kinase	92.42
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	91.95
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	91.76
KOG1236	565	consensus Predicted unusual protein kinase [Genera	90.31
PTZ00384	383	choline kinase; Provisional	88.69

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-54  Score=469.95  Aligned_cols=290  Identities=45%  Similarity=0.827  Sum_probs=255.8

Q ss_pred             ccccccHHHHHHHhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEE
Q 005033           69 KLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC  148 (718)
Q Consensus        69 ~l~~~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~  148 (718)
                      ....|++.++..+|++|...+.||+|+||.||+|...+|..||||++.....+...+|.+|+.+|.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56779999999999999999999999999999999999999999988765433145699999999999999999999999


Q ss_pred             eeCC-eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEee
Q 005033          149 MERN-KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSD  227 (718)
Q Consensus       149 ~~~~-~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsD  227 (718)
                      .+.+ +.+||+|||++|+|.++|+......++|..+++|+.++|+||+|||+.+.+.||||||||+|||||+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9998 599999999999999999876543789999999999999999999998888999999999999999999999999


Q ss_pred             ccCceeeec-CccccccccccccchhhhhhhhhhccccccCCCCCCCCCCCCcchhhhHHHHhhhccCCCCcccchhhhh
Q 005033          228 FGLSRIKVE-GEFGMDLFSQDLGKSQELWKSQELSGNLATATETPAISTPVDSAHEVDFALALQASSSSNNSRCYNVRAL  306 (718)
Q Consensus       228 FGLAr~~~~-~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (718)
                      ||||+.... ..                                                                    
T Consensus       221 FGLa~~~~~~~~--------------------------------------------------------------------  232 (361)
T KOG1187|consen  221 FGLAKLGPEGDT--------------------------------------------------------------------  232 (361)
T ss_pred             ccCcccCCcccc--------------------------------------------------------------------
Confidence            999965311 00                                                                    


Q ss_pred             cccccccccccccccccccCCCCCccccccccCccccccccccccccccccccccccccccCcccchhhcccccCCcccc
Q 005033          307 NLNSLNYNANIASESEVKSGNGKGKEVSGVDLGAVDWTSKFVAYEDELSSVDHSKELNVNANSVNDEAASTKQWGKDWWW  386 (718)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (718)
                                                                                                      
T Consensus       233 --------------------------------------------------------------------------------  232 (361)
T KOG1187|consen  233 --------------------------------------------------------------------------------  232 (361)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             cccCCCccccchhhhhhcccccCCCCCCCchhhhhcccccccccCCCCCCCCCCCCCchhhhhcccccccchhhhhhhhh
Q 005033          387 RQDGSGELCSKDYVMEWIGSQICPSTNPDWDEEKKSTNEKIELDNSTPLDNLEDGHEPQLQELGFGKLEKGFEKKESKWK  466 (718)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (718)
                                                                                                      
T Consensus       233 --------------------------------------------------------------------------------  232 (361)
T KOG1187|consen  233 --------------------------------------------------------------------------------  232 (361)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhhhhhhHHhhhhhhHHHhhhhhhhhhhhhhccCCccccccchhhhcccccccccccccccCCCCCccccccccc
Q 005033          467 KNRKKRHKKMQEWWKEEHLDEISKKSSKLKKLETKWKKGFKIPHFDLARRFHFHRRNKFREQNQDDCDANGEFSFRRGWR  546 (718)
Q Consensus       467 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~  546 (718)
                                                                                                      
T Consensus       233 --------------------------------------------------------------------------------  232 (361)
T KOG1187|consen  233 --------------------------------------------------------------------------------  232 (361)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             ccCCCCCCCCCccCccccccccccccc-ccCccccCccccCCCCCcccccccchhhhHHHhhhCCCCCcccCCchhhhhh
Q 005033          547 KKNKNSMGSDMWSGDLFSRELSSTTSM-RGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKA  625 (718)
Q Consensus       547 ~~~~~~~~~d~~~~~~~~~~~~~~~~~-~Gt~~Y~APE~~~~~~~~~k~Dv~S~Gv~l~elltG~~p~~~~~~~~~~~~~  625 (718)
                                            ...+. .||.+|+|||++..+.+++|+|||||||+|+||+||++|.+...   ...+.
T Consensus       233 ----------------------~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~---~~~~~  287 (361)
T KOG1187|consen  233 ----------------------SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR---PRGEL  287 (361)
T ss_pred             ----------------------ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC---Ccccc
Confidence                                  00111 79999999999999999999999999999999999999987432   12345


Q ss_pred             hHHHHHHHHHHcCCcccccccccc-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCC
Q 005033          626 NLISWCRHLAQAGNILELVDERLK-DDYNK-EQASLCINLALTCLQKTPELRPDIGETVRILKGEMDL  691 (718)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~-~~~~~~~~l~~~cl~~~P~~Rps~~ev~~~l~~~~~~  691 (718)
                      ++++|++..+..+.+.+++|+.+. ..++. ++...+..++.+|++.+|..||+|.||+++|+.....
T Consensus       288 ~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  288 SLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             cHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            699999999999999999999998 77775 7888999999999999999999999999999664433

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-46  Score=404.29  Aligned_cols=146  Identities=34%  Similarity=0.583  Sum_probs=129.9

Q ss_pred             cccceecccCceEEEEEEEcCCcEEEEEEcccCCh--hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC-eEEEEEeccC
Q 005033           86 DEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL--QTEREFQNELQILGGLRSPFLVTLLGYCMERN-KRILVYEYMP  162 (718)
Q Consensus        86 ~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-~~~LVmEy~~  162 (718)
                      ...+.||+|+||+||+|.++....||||++.....  ...+.|.+|+.+|.+++|||||+++|+|.+.. ..+||||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            34456999999999999998555599999965332  22568999999999999999999999999988 7999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCCCEEECCCC-CEEEeeccCceee
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP-VIHGDIKPSNVLLDSDC-RGKVSDFGLSRIK  234 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~g-IVHRDLKP~NILLd~~~-~vKLsDFGLAr~~  234 (718)
                      +|+|.+++.......+++..++.++.|||+||.|||   +.+ ||||||||+|||++.++ ++||+|||+++..
T Consensus       124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK  194 (362)
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence            999999998854457999999999999999999999   777 99999999999999998 9999999999874

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=391.38  Aligned_cols=147  Identities=32%  Similarity=0.502  Sum_probs=132.2

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEccc-CChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC-eEEEEEec
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSPFLVTLLGYCMERN-KRILVYEY  160 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~-~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-~~~LVmEy  160 (718)
                      +++..+.||+|+.|+||++.++ +++.+|+|.+.. ......+++.+|+++++.++||+||.+||+|...+ .++|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3445678999999999999998 689999999943 33455678999999999999999999999999999 49999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |.+|+|.+++...+  .+++...-.|+.+|++||.|||+  +++||||||||+|||++..|++||||||.++.+
T Consensus       160 MDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~l  229 (364)
T KOG0581|consen  160 MDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGIL  229 (364)
T ss_pred             cCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence            99999999998765  57889999999999999999993  389999999999999999999999999998764

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-45  Score=408.36  Aligned_cols=147  Identities=24%  Similarity=0.408  Sum_probs=136.3

Q ss_pred             cCccccceecccCceEEEEEEE-cCCcEEEEEEcccC---ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIA-RDGKLLAIKRLDTF---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~-~~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ..|...++||+|||+.||.+++ .+|+.||+|++.+.   .....+.+.+||+|.+.|+|||||+++++|++.+++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4689999999999999999998 68999999999652   3345667899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+|.+++|.++++..+  .+++.+++.++.||+.||.|||   +.+|||||||..|++|++++++||+|||||..+
T Consensus        98 ELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l  168 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQL  168 (592)
T ss_pred             EecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeee
Confidence            9999999999998554  7899999999999999999999   999999999999999999999999999999876

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-45  Score=388.05  Aligned_cols=148  Identities=30%  Similarity=0.469  Sum_probs=135.9

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      .++|...+.||+|+||+||+|+++ ++..||||.+...  .....+.+..|+.+|+.++|||||+|++++..++.+||||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            468889999999999999999987 5899999999765  4455667889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC------CCEEEeeccCce
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD------CRGKVSDFGLSR  232 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~------~~vKLsDFGLAr  232 (718)
                      |||.||||.+||+..+  .+++..+..++.|||.||++||   +++||||||||+||||+..      -.+||+|||+||
T Consensus        89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            9999999999999886  6899999999999999999999   9999999999999999765      458999999999


Q ss_pred             ee
Q 005033          233 IK  234 (718)
Q Consensus       233 ~~  234 (718)
                      .+
T Consensus       164 ~L  165 (429)
T KOG0595|consen  164 FL  165 (429)
T ss_pred             hC
Confidence            86

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-45  Score=391.66  Aligned_cols=147  Identities=29%  Similarity=0.505  Sum_probs=129.5

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChh-------hHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQ-------TEREFQNELQILGGLRSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~-------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~  154 (718)
                      +.|.+.+.||+|+||.|-+|..+ +|+.||||+++.....       ......+|++||++|+|||||+++++|......
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            45778899999999999999876 6999999999653211       123357999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC---CCEEEeeccCc
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD---CRGKVSDFGLS  231 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~---~~vKLsDFGLA  231 (718)
                      ||||||+.||+|.+++-.++  .+.+..-..++.|++.|+.|||   ++||+||||||+|||+..+   ..+||+|||+|
T Consensus       252 YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             EEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            99999999999999998776  4666677889999999999999   9999999999999999766   67999999999


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      +..
T Consensus       327 K~~  329 (475)
T KOG0615|consen  327 KVS  329 (475)
T ss_pred             hcc
Confidence            975

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=387.80  Aligned_cols=150  Identities=31%  Similarity=0.486  Sum_probs=136.7

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      ..+..++.||+|.||.||+|.++....||+|.+.... ...+.|.+|+++|++|+|+|||+++|+|..+..+|||||||+
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            3455678999999999999999988899999997653 345689999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceeeec
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVE  236 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~~~  236 (718)
                      .|+|.++|+......+...+.+.++.|||.||+||+   ++++|||||.++||||+++..+||+||||||...+
T Consensus       285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD  355 (468)
T ss_pred             cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCC
Confidence            999999999866667888999999999999999999   99999999999999999999999999999996533

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-44  Score=367.97  Aligned_cols=151  Identities=27%  Similarity=0.442  Sum_probs=131.5

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhCCCCCcceeEEE-EEeeCCe-EEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT--FSLQTEREFQNELQILGGLRSPFLVTLLG-YCMERNK-RILV  157 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~--~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g-~~~~~~~-~~LV  157 (718)
                      .+|++.++||+|+||+||++... +|..||.|.++-  .+.+..+.+..|+.+|++|+|||||++++ .|.+++. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            46888999999999999999875 799999999863  23455678999999999999999999999 5666665 8999


Q ss_pred             EeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          158 YEYMPNKSLQEMLFSD--GNLVLKWSQRFEIIMDVAKALEFLHFGCDPP--VIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~--~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~g--IVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||||.+|||.+.|+..  ....+++..++.++.|++.||.++|... +.  |+||||||.||+|+.+|.+||+||||++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999999653  3457899999999999999999999311 44  99999999999999999999999999998


Q ss_pred             e
Q 005033          234 K  234 (718)
Q Consensus       234 ~  234 (718)
                      +
T Consensus       178 l  178 (375)
T KOG0591|consen  178 L  178 (375)
T ss_pred             h
Confidence            6

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-43  Score=371.47  Aligned_cols=147  Identities=32%  Similarity=0.494  Sum_probs=135.3

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++|++.++||+|+||.||+++.+ +++.+|+|++++...   ...+...+|..||.+++||+||+++..|++...+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            468999999999999999999887 599999999976432   3345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +||+.||.|..+|.+.+  .+++..+..++.+|+.||.|||   +.+||||||||+|||||.+|.++|+|||||+.
T Consensus       104 ld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~  174 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKE  174 (357)
T ss_pred             EeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchh
Confidence            99999999999998776  5788889999999999999999   99999999999999999999999999999985

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-42  Score=375.16  Aligned_cols=151  Identities=32%  Similarity=0.459  Sum_probs=136.9

Q ss_pred             HHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCe
Q 005033           79 KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGL-RSPFLVTLLGYCMERNK  153 (718)
Q Consensus        79 ~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~  153 (718)
                      .....+|...+.||+|+|++|++|+.. +++.||||++.+.-   ....+.+.+|-.+|.+| .||.|++|+..|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            344578999999999999999999987 69999999996532   23335577899999999 89999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +|+|+||+++|+|.++|+..+  .+++...+.++.+|+.||+|||   ++|||||||||+|||||.+|+++|+|||.|+.
T Consensus       149 LYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeecccccc
Confidence            999999999999999999886  6888889999999999999999   99999999999999999999999999999998


Q ss_pred             e
Q 005033          234 K  234 (718)
Q Consensus       234 ~  234 (718)
                      +
T Consensus       224 l  224 (604)
T KOG0592|consen  224 L  224 (604)
T ss_pred             C
Confidence            7

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-41  Score=363.69  Aligned_cols=151  Identities=26%  Similarity=0.382  Sum_probs=129.1

Q ss_pred             HhcCccccceecccCceEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCC
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFS-LQTEREFQNELQILGGL-RSPFLVTLLGYCMERN  152 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~  152 (718)
                      ..++|++.+.||+|+||.||+|.+.      ++..||||++.... ......+.+|+.++..+ +||||++++++|...+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            4568999999999999999999742      35789999986532 23346789999999999 8999999999987654


Q ss_pred             -eEEEEEeccCCCCHHHHHhhCCC--------------------------------------------------------
Q 005033          153 -KRILVYEYMPNKSLQEMLFSDGN--------------------------------------------------------  175 (718)
Q Consensus       153 -~~~LVmEy~~gGsL~~~L~~~~~--------------------------------------------------------  175 (718)
                       ..++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             58999999999999999975321                                                        


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          176 ----LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       176 ----~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                          ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~  224 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDI  224 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeeccccccc
Confidence                24677888999999999999999   899999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-41  Score=369.05  Aligned_cols=150  Identities=30%  Similarity=0.472  Sum_probs=134.2

Q ss_pred             HHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC----Ch-hhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCC
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF----SL-QTEREFQNELQILGGLR-SPFLVTLLGYCMERN  152 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~----~~-~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~  152 (718)
                      ...+.|.+.+.||+|+||.|++|... ++..||||++...    .. ...+.+.+|+.+++.++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34578999999999999999999876 6899999977553    11 23455678999999998 999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC-CCEEEeeccCc
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD-CRGKVSDFGLS  231 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~-~~vKLsDFGLA  231 (718)
                      .+|+|||||.||+|.+++...+  .+.+..+..++.|++.|++|||   +++|+||||||+|||++.+ +++||+|||++
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            9999999999999999998854  5788999999999999999999   9999999999999999999 99999999999


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      ...
T Consensus       169 ~~~  171 (370)
T KOG0583|consen  169 AIS  171 (370)
T ss_pred             ccc
Confidence            864

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=9.4e-42  Score=390.67  Aligned_cols=151  Identities=33%  Similarity=0.511  Sum_probs=135.2

Q ss_pred             HhcCccccceecccCceEEEEEEEc------CCcEEEEEEcccCChh-hHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFSLQ-TEREFQNELQILGGLRSPFLVTLLGYCMERNK  153 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~  153 (718)
                      .+.+....+.||+|+||.||+|...      +...||||.++..... ..++|++|+++|..|+|||||+|+|+|..++.
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            3455667789999999999999864      3568999999875544 77899999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhCCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC
Q 005033          154 RILVYEYMPNKSLQEMLFSDGN------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC  221 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~  221 (718)
                      .|+|+|||..|||.+||.....            ..++..+.+.|+.|||.||.||-   ++.+|||||..+|+||.++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccce
Confidence            9999999999999999975421            23888999999999999999999   99999999999999999999


Q ss_pred             CEEEeeccCceee
Q 005033          222 RGKVSDFGLSRIK  234 (718)
Q Consensus       222 ~vKLsDFGLAr~~  234 (718)
                      .|||+||||+|..
T Consensus       641 ~VKIsDfGLsRdi  653 (774)
T KOG1026|consen  641 VVKISDFGLSRDI  653 (774)
T ss_pred             EEEecccccchhh
Confidence            9999999999976

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=360.88  Aligned_cols=148  Identities=28%  Similarity=0.533  Sum_probs=132.5

Q ss_pred             cCccccceecccCceEEEEEEEcC-CcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC--eEEEEEe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERN--KRILVYE  159 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~-g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~--~~~LVmE  159 (718)
                      .++...+.||+|+||+||++...+ |...|||.+........+.+.+|+.+|.+++|||||+++|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            457778899999999999999874 8999999986643333567899999999999999999999854444  6899999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC-CCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS-DCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~-~~~vKLsDFGLAr~~  234 (718)
                      |+++|+|.+++...+. .+++..+..+++||+.||.|||   +++||||||||+|||++. ++.+||+|||+++..
T Consensus        97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence            9999999999998876 7999999999999999999999   999999999999999999 799999999999864

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.1e-40  Score=363.45  Aligned_cols=150  Identities=31%  Similarity=0.439  Sum_probs=137.5

Q ss_pred             HHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEE
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~  155 (718)
                      ...++|+++..||+|+||.||+|+-+ +|..+|+|++++..   ......++.|..+|....+|+||+||..|++..++|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            45679999999999999999999987 69999999997643   234456889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||||++|||+..+|...+  .|++..+..++.+++.|+.-||   ..|+|||||||+|+|||..|++||+|||||..+
T Consensus       218 LiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchh
Confidence            9999999999999998876  6888899999999999999999   999999999999999999999999999999654

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.4e-41  Score=372.30  Aligned_cols=146  Identities=31%  Similarity=0.474  Sum_probs=134.4

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ++|.+.+.||+|+||+||+|+.+ +.+.||+|.+.+..  ....+.+.+|++|++.|+|||||.++++|+...++|+|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888899999999999999987 68999999996532  3445679999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||.| +|..+|...+  .+++..+..|+.|++.||.|||   +.+|+|||+||.|||++..|.+|+||||+|+..
T Consensus        82 ~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAM  150 (808)
T ss_pred             hhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhc
Confidence            9965 9999998876  5889999999999999999999   999999999999999999999999999999975

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.6e-40  Score=346.15  Aligned_cols=147  Identities=29%  Similarity=0.378  Sum_probs=131.0

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .|+..+.||+|+||.||+|... +|+.||||.+....   ......+.+|+.++..++|+||+++++++...+..|+|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3778899999999999999875 68999999986432   2233467899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+++|+|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||++..
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~  151 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQ  151 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence            999999998887654446889999999999999999999   99999999999999999999999999998875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.2e-39  Score=390.94  Aligned_cols=145  Identities=30%  Similarity=0.605  Sum_probs=123.7

Q ss_pred             ccHHHHHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC
Q 005033           73 FTYKELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMER  151 (718)
Q Consensus        73 ~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~  151 (718)
                      ++++++.   ..|...+.||+|+||.||+|... ++..||||++......    ...|++++++++|||||+++|+|...
T Consensus       683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~  755 (968)
T PLN00113        683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE  755 (968)
T ss_pred             hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence            4444443   45778889999999999999985 7899999998653321    23468899999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccC
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL  230 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGL  230 (718)
                      +..|+||||+++|+|.++++     .++|..+..|+.||+.||+|||+.+.++|+||||||+||+++.++.+++. ||.
T Consensus       756 ~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~  828 (968)
T PLN00113        756 KGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL  828 (968)
T ss_pred             CCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence            99999999999999999995     37899999999999999999997778899999999999999988887765 443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-40  Score=353.75  Aligned_cols=151  Identities=28%  Similarity=0.382  Sum_probs=138.5

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChh-hHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQ-TEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ..++|++...||.|.-++||+|+.. .+..||||+++-.... ....+.+|+..|+.++||||+.++..|..+..+|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            4468999999999999999999876 6899999999754332 3578999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      .||.+|++.++++..-...+++..+..|++++++||.|||   .+|-||||||+.||||+.+|.+||+|||.+..+
T Consensus       104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence            9999999999999877778999999999999999999999   999999999999999999999999999987654

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.2e-40  Score=345.68  Aligned_cols=140  Identities=19%  Similarity=0.328  Sum_probs=123.5

Q ss_pred             cceecccCceEEEEEEEcCCcEEEEEEcccCChhh---HHHHHHHHHHHhCCCCCcceeEEEEEee----CCeEEEEEec
Q 005033           88 ANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQT---EREFQNELQILGGLRSPFLVTLLGYCME----RNKRILVYEY  160 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~~LVmEy  160 (718)
                      ...||+|++|.||+|.+ +|+.||||.+.......   .+.|.+|+.+|.+++|||||+++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999988 58899999997543222   4678899999999999999999999977    3568999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD-PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~-~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +++|+|.+++....  .+++.....++.|++.||.|||   . .+++||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~  172 (283)
T PHA02988        104 CTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKI  172 (283)
T ss_pred             CCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhh
Confidence            99999999998654  5788899999999999999999   6 4889999999999999999999999998875

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.3e-39  Score=341.22  Aligned_cols=150  Identities=26%  Similarity=0.456  Sum_probs=130.3

Q ss_pred             hcCccccceecccCceEEEEEEEcC-----------------CcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCccee
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARD-----------------GKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVT  143 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~-----------------g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~  143 (718)
                      .++|.+.+.||+|+||.||+|.+.+                 +..||||.+.... ......|.+|+.+|.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578889999999999999997532                 3479999986542 334567999999999999999999


Q ss_pred             EEEEEeeCCeEEEEEeccCCCCHHHHHhhCC-----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 005033          144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDG-----------------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVI  206 (718)
Q Consensus       144 L~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~-----------------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIV  206 (718)
                      +++++...+..|+||||+++|+|.+++....                 ...+++..+..++.||+.||.|||   +.+|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            9999999999999999999999999986532                 124677888999999999999999   89999


Q ss_pred             ecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          207 HGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       207 HRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||||||+|||++.++.+||+|||+++..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~  188 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNL  188 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceec
Confidence            9999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8e-40  Score=349.52  Aligned_cols=140  Identities=29%  Similarity=0.361  Sum_probs=125.8

Q ss_pred             ceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCC
Q 005033           89 NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNK  164 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gG  164 (718)
                      +.||+|+||.||+|... +|+.||||++....   ......+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999886 68999999986432   223456789999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          165 SLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       165 sL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~  144 (323)
T cd05571          81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE  144 (323)
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcc
Confidence            9999997654  5788999999999999999999   99999999999999999999999999998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-39  Score=349.39  Aligned_cols=146  Identities=27%  Similarity=0.438  Sum_probs=131.9

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|.+.+.||+|+||.||+|... +++.||||++....   ......+.+|+.++.+++||||+++++++...+..|+||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57889999999999999999987 58999999986432   233456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||+.+|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  167 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK  167 (329)
T ss_pred             cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence            9999999999998764  5778888899999999999999   99999999999999999999999999998875

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-40  Score=345.65  Aligned_cols=146  Identities=27%  Similarity=0.466  Sum_probs=131.5

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||.||+|... +++.||||++....   ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47889999999999999999987 68999999985422   233456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||+++|+|.+++...+  .+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~  150 (291)
T cd05612          81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKK  150 (291)
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence            9999999999997664  5788888999999999999999   99999999999999999999999999998764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=347.89  Aligned_cols=146  Identities=33%  Similarity=0.504  Sum_probs=132.0

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||.||+|.+. +++.||||++....   ......+.+|+.++..++||||+++++++...+..||||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47899999999999999999987 58999999986432   233456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||+++|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~  150 (333)
T cd05600          81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKG  150 (333)
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence            9999999999997654  5788899999999999999999   99999999999999999999999999998865

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.3e-39  Score=346.16  Aligned_cols=140  Identities=28%  Similarity=0.387  Sum_probs=125.9

Q ss_pred             ceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCC
Q 005033           89 NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNK  164 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gG  164 (718)
                      +.||+|+||.||++... +++.||||++....   ......+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999986 68999999986432   233457889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          165 SLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       165 sL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +|..++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~  144 (328)
T cd05593          81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKE  144 (328)
T ss_pred             CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCcc
Confidence            9999987654  5788999999999999999999   99999999999999999999999999998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=346.58  Aligned_cols=138  Identities=30%  Similarity=0.376  Sum_probs=124.7

Q ss_pred             ecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCCH
Q 005033           91 IGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSL  166 (718)
Q Consensus        91 LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL  166 (718)
                      ||+|+||.||+|... +++.||||++...   .......+.+|+.++..++||||+++++++...+..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999987 5889999998642   223445688999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          167 QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       167 ~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.++|+|||+++.
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~  142 (312)
T cd05585          81 FHHLQREG--RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKL  142 (312)
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence            99997654  5788899999999999999999   99999999999999999999999999999874

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.3e-39  Score=356.34  Aligned_cols=151  Identities=28%  Similarity=0.395  Sum_probs=131.0

Q ss_pred             HhcCccccceecccCceEEEEEEE------cCCcEEEEEEcccCC-hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCC
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIA------RDGKLLAIKRLDTFS-LQTEREFQNELQILGGL-RSPFLVTLLGYCMERN  152 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~------~~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~  152 (718)
                      ..++|++.+.||+|+||.||+|..      .++..||||++.... ......+.+|+.+|..+ +||||++++++|...+
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            345788999999999999999974      236689999986432 33446788999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhCC----------------------------------------------------------
Q 005033          153 KRILVYEYMPNKSLQEMLFSDG----------------------------------------------------------  174 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~----------------------------------------------------------  174 (718)
                      ..++|||||++|+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999996532                                                          


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          175 ---------------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       175 ---------------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                                     ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~  264 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI  264 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceec
Confidence                           124678889999999999999999   899999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=359.86  Aligned_cols=149  Identities=25%  Similarity=0.412  Sum_probs=133.6

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhH-HHHHHHHHHHhCCC-CCcceeEEEEEeeCC-eEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTE-REFQNELQILGGLR-SPFLVTLLGYCMERN-KRIL  156 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~-~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~-~~~L  156 (718)
                      ..++|.+++.||.|.||.||+|+.. +|..||||+++....... -.=+||+..|++|+ |||||+|.+++.+.+ .+|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            4568999999999999999999976 689999999975432222 23478999999998 999999999999888 9999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||||| ..+|+++++.+ +..+++..++.|+.||++||+|+|   .+|+.|||+||+|||+.....+||+||||||..
T Consensus        88 VfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccc
Confidence            99999 67999999888 558999999999999999999999   999999999999999999999999999999975

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-40  Score=362.09  Aligned_cols=146  Identities=28%  Similarity=0.449  Sum_probs=134.9

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      ..|.....||+|+.|.||.+... +++.||||++........+-+++|+.+|+..+|+|||++++.|...+.+|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            45777889999999999999876 68899999998766666677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +||+|.+.+...   .+++.++..|+++++.||+|||   .++|+|||||.+|||++.+|.+||+|||++..+
T Consensus       353 ~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi  419 (550)
T KOG0578|consen  353 EGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQI  419 (550)
T ss_pred             CCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecc
Confidence            999999999765   5899999999999999999999   999999999999999999999999999998764

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.5e-39  Score=334.60  Aligned_cols=147  Identities=24%  Similarity=0.326  Sum_probs=131.0

Q ss_pred             cCccccceecccCceEEEEEEEc----CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR----DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~----~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ++|++.+.||+|+||.||+|.+.    .+..||+|.++... ......|.+|+.++.+++||||+++++++..++..|+|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            56888999999999999999864    36789999987643 33446789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |||+++|+|.+++..... .+++..++.++.||+.||+|||   +.+++||||||+|||++.++.++++|||++..
T Consensus        85 ~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          85 TEYMSNGALDSFLRKHEG-QLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEeCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            999999999999976533 5789999999999999999999   99999999999999999999999999997653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.3e-40  Score=340.11  Aligned_cols=147  Identities=26%  Similarity=0.398  Sum_probs=129.4

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      +.|+....+|+|+||+||+|+.+ +|+.||||++...  +....+-.++|+.+|++|+|+|+|.|+.+|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45778889999999999999988 5999999998543  23334567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+. ++.+-|....+ .++...+..++.|++.|+.|+|   +++||||||||+||||+.+|.+||||||+|+.+
T Consensus        82 ~~dh-TvL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L  151 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPN-GVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTL  151 (396)
T ss_pred             ecch-HHHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhh
Confidence            9965 55555555543 6788899999999999999999   999999999999999999999999999999986

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.7e-39  Score=334.18  Aligned_cols=147  Identities=27%  Similarity=0.385  Sum_probs=128.7

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ++|++.+.||+|+||.||+|.+. +++.||||++....  ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47899999999999999999987 58899999986432  2334568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |++++.|..+....  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  150 (287)
T cd07848          81 YVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNL  150 (287)
T ss_pred             cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence            99887776554332  25788899999999999999999   999999999999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.6e-39  Score=334.56  Aligned_cols=149  Identities=28%  Similarity=0.502  Sum_probs=130.7

Q ss_pred             cCccccceecccCceEEEEEEEcC------CcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARD------GKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~------g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~  155 (718)
                      ++|++.+.||+|+||.||+|....      ...||+|.+.... ......|.+|+.++..++||||+++++++......|
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999998753      2579999986433 334567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC
Q 005033          156 LVYEYMPNKSLQEMLFSDGN--------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC  221 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~--------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~  221 (718)
                      ++|||+++|+|.+++.....              ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            99999999999999976421              35788889999999999999999   89999999999999999999


Q ss_pred             CEEEeeccCceee
Q 005033          222 RGKVSDFGLSRIK  234 (718)
Q Consensus       222 ~vKLsDFGLAr~~  234 (718)
                      .++|+|||+++..
T Consensus       162 ~~~L~dfg~~~~~  174 (283)
T cd05048         162 TVKISDFGLSRDI  174 (283)
T ss_pred             cEEECCCcceeec
Confidence            9999999998753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.2e-39  Score=345.15  Aligned_cols=140  Identities=29%  Similarity=0.376  Sum_probs=125.4

Q ss_pred             ceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCC
Q 005033           89 NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNK  164 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gG  164 (718)
                      +.||+|+||.||++... +|..||+|++....   ......+.+|+.+++.++||||++++++|...+..||||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            36999999999999986 68999999986432   233456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          165 SLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       165 sL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +|..++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~  144 (323)
T cd05595          81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE  144 (323)
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhcc
Confidence            9999887654  5788999999999999999999   89999999999999999999999999998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.3e-39  Score=343.25  Aligned_cols=147  Identities=26%  Similarity=0.398  Sum_probs=132.2

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .++|++.+.||+|+||.||++.+. ++..||+|.+... .......+.+|+++|+.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999987 5889999998653 23345679999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP-PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~-gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+++|+|.+++....  .+++..+..++.|++.||.|||   +. +|+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  153 (331)
T cd06649          84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (331)
T ss_pred             cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence            999999999997654  5788899999999999999999   54 699999999999999999999999998864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.6e-39  Score=355.69  Aligned_cols=151  Identities=26%  Similarity=0.396  Sum_probs=130.5

Q ss_pred             HhcCccccceecccCceEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCC
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFS-LQTEREFQNELQILGGL-RSPFLVTLLGYCMERN  152 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~  152 (718)
                      ..++|++.+.||+|+||.||+|...      ++..||||++.... ......+.+|+.+++.+ +|+|||+++++|...+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            3457899999999999999998753      24589999996532 33445688999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhCC----------------------------------------------------------
Q 005033          153 KRILVYEYMPNKSLQEMLFSDG----------------------------------------------------------  174 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~----------------------------------------------------------  174 (718)
                      ..|+|||||++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999986421                                                          


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          175 ----------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       175 ----------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                                ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~  262 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDI  262 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeec
Confidence                      124678888999999999999999   899999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.3e-39  Score=330.06  Aligned_cols=149  Identities=23%  Similarity=0.402  Sum_probs=134.8

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      .++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            35789999999999999999998888899999986533 23567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++|+|.+++.......+++..++.++.|++.||.|||   ..+++||||||+||+++.++.++|+|||+++..
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  153 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVI  153 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceec
Confidence            9999999997655456888899999999999999999   899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=365.78  Aligned_cols=148  Identities=29%  Similarity=0.436  Sum_probs=130.8

Q ss_pred             HHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeE
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~  154 (718)
                      ...++|..+++||+|+||+|+++..+ +++.+|||++++..   ....+....|..|+... +||.+++|+.+|+...++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34578999999999999999999987 58899999997643   23455677888887766 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+||||+.|||+..+++..   .+++..+..|+..|+.||.|||   +++||+||||.+|||||.+|.+||+||||++.
T Consensus       445 ~fvmey~~Ggdm~~~~~~~---~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIHTD---VFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEecCCCcEEEEEecc---cccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccc
Confidence            9999999999965555433   6899999999999999999999   99999999999999999999999999999985

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6e-39  Score=328.57  Aligned_cols=147  Identities=30%  Similarity=0.442  Sum_probs=132.0

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      ++|++.+.||+|+||.||++...++..+|+|.+.... .....|.+|+.+++.++||||+++++++...+..|+||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4688889999999999999998888899999886432 234578999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +|+|.+++..... .+++..+..++.|++.||.|||   .++|+||||||+||+++.++.+||+|||+++..
T Consensus        83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~  150 (256)
T cd05114          83 NGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV  150 (256)
T ss_pred             CCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCcccc
Confidence            9999999975432 5788999999999999999999   899999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.6e-39  Score=334.17  Aligned_cols=147  Identities=29%  Similarity=0.465  Sum_probs=124.0

Q ss_pred             cCccccceecccCceEEEEEEEc--CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCC---CCCcceeEEEEEee-----
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR--DGKLLAIKRLDTFS--LQTEREFQNELQILGGL---RSPFLVTLLGYCME-----  150 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~--~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~-----  150 (718)
                      ++|++.+.||+|+||.||+|.+.  +++.||||.+....  ......+.+|+.+++.+   +||||++++++|..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999874  46889999886432  22234566777777665   69999999999853     


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccC
Q 005033          151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL  230 (718)
Q Consensus       151 ~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGL  230 (718)
                      ....++||||+. ++|.+++.......+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999995 79999997765556889999999999999999999   89999999999999999999999999999


Q ss_pred             cee
Q 005033          231 SRI  233 (718)
Q Consensus       231 Ar~  233 (718)
                      ++.
T Consensus       157 ~~~  159 (290)
T cd07862         157 ARI  159 (290)
T ss_pred             eEe
Confidence            875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-39  Score=362.37  Aligned_cols=147  Identities=26%  Similarity=0.428  Sum_probs=133.9

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      +-|++.+.||.|+-|.|.+|++. +|+.+|||++....   ......+.+||.||+-|.||||+++|++++...++|||.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45788899999999999999876 79999999996642   223456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++|.|++++...+  .+++.++..++.||+.|+.|+|   ..+|+||||||+|+|||..+++||+|||+|.+.
T Consensus        92 Eyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe  162 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLE  162 (786)
T ss_pred             EecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecc
Confidence            9999999999998887  5788899999999999999999   999999999999999999999999999999874

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-39  Score=328.29  Aligned_cols=150  Identities=29%  Similarity=0.429  Sum_probs=135.8

Q ss_pred             HhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ..++|++.+.||+|+||.||+|.+.+++.||||.+.... ...+.|.+|+.++++++|+||+++++++...+..|+||||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            346788999999999999999998878899999986543 2356789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++++|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||+++..
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  153 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVI  153 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence            99999999997765446899999999999999999999   899999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.4e-39  Score=341.57  Aligned_cols=140  Identities=28%  Similarity=0.371  Sum_probs=125.0

Q ss_pred             ceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCC
Q 005033           89 NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNK  164 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gG  164 (718)
                      +.||+|+||.||++... +|+.||+|++....   ......+.+|+.++..++||||+++++++...+..||||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999876 68999999986432   233456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          165 SLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD-PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       165 sL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~-~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +|..++....  .+++..+..++.||+.||.|||   + .+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~  145 (325)
T cd05594          81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE  145 (325)
T ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCee
Confidence            9999987654  5788999999999999999999   6 7999999999999999999999999999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.7e-39  Score=348.47  Aligned_cols=147  Identities=25%  Similarity=0.377  Sum_probs=131.0

Q ss_pred             hcCccccceecccCceEEEEEEEcC--CcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARD--GKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~--g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      .++|++.+.||+|+||.||+|.+..  +..||||++....   ......+.+|+.++..++||||+++++++...+..|+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3578999999999999999998653  3689999985421   2334568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||||+++|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       109 v~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            999999999999998764  5788899999999999999999   99999999999999999999999999998875

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=334.47  Aligned_cols=147  Identities=31%  Similarity=0.506  Sum_probs=134.8

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|+.++.||.|+||.|.+++.+ +|..+|+|+++...   ..+.+...+|..+|+.+.||++++|++.|.+.+.+||||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46888899999999999999987 68999999997643   234456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||++||.|..+|++.+  .+++..++.++.||+.||+|||   ..+|++|||||+|||||.+|.+||+|||+|+.+
T Consensus       124 eyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v  194 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV  194 (355)
T ss_pred             eccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence            9999999999999876  5788899999999999999999   999999999999999999999999999999874

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-40  Score=370.15  Aligned_cols=163  Identities=29%  Similarity=0.465  Sum_probs=144.9

Q ss_pred             cccccHHHHHHHhcCc---------cccceecccCceEEEEEEEcC----CcEEEEEEcccCC-hhhHHHHHHHHHHHhC
Q 005033           70 LQRFTYKELKNATNDF---------DEANVIGKGGSGTVFLGIARD----GKLLAIKRLDTFS-LQTEREFQNELQILGG  135 (718)
Q Consensus        70 l~~~s~~el~~at~~f---------~~~~~LG~G~FG~Vykg~~~~----g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~  135 (718)
                      ...+||++-..+...|         .+.++||.|.||.||+|+++-    ...||||.++... .....+|+.|+.||.+
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ  686 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ  686 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence            3567888766555444         467899999999999999872    4689999998754 4556789999999999


Q ss_pred             CCCCcceeEEEEEeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCE
Q 005033          136 LRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNV  215 (718)
Q Consensus       136 L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NI  215 (718)
                      +.||||++|.|+.......+||+|||++|+|..||+.+.. .+.+.+...++++||.||.||-   +++.|||||..+||
T Consensus       687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNI  762 (996)
T KOG0196|consen  687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNI  762 (996)
T ss_pred             CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhhe
Confidence            9999999999999999999999999999999999998765 4888899999999999999999   99999999999999


Q ss_pred             EECCCCCEEEeeccCceeeec
Q 005033          216 LLDSDCRGKVSDFGLSRIKVE  236 (718)
Q Consensus       216 LLd~~~~vKLsDFGLAr~~~~  236 (718)
                      |++.+..+||+||||+|.+.+
T Consensus       763 LVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  763 LVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             eeccceEEEeccccceeeccc
Confidence            999999999999999998743

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-40  Score=359.01  Aligned_cols=144  Identities=26%  Similarity=0.466  Sum_probs=125.8

Q ss_pred             ccccHHHHHHHhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEee
Q 005033           71 QRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME  150 (718)
Q Consensus        71 ~~~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~  150 (718)
                      ..+.|++|.       .++-||+|+.|.||+|+++ ++.||||+++...       ..+|+.|++|+|+||+.|.|+|..
T Consensus       119 WeiPFe~Is-------ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq  183 (904)
T KOG4721|consen  119 WEIPFEEIS-------ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ  183 (904)
T ss_pred             ccCCHHHhh-------hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC
Confidence            345555554       3567999999999999987 6889999875422       357888999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccC
Q 005033          151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL  230 (718)
Q Consensus       151 ~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGL  230 (718)
                      ...+|||||||..|-|++.|+...  .+.....+.+..+||.||.|||   .+.|||||||.-||||..+..+||+|||.
T Consensus       184 sPcyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGT  258 (904)
T KOG4721|consen  184 SPCYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGT  258 (904)
T ss_pred             CceeEEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccc
Confidence            999999999999999999998765  5677788899999999999999   99999999999999999999999999998


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      ++..
T Consensus       259 S~e~  262 (904)
T KOG4721|consen  259 SKEL  262 (904)
T ss_pred             hHhh
Confidence            7753

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.3e-39  Score=330.47  Aligned_cols=151  Identities=30%  Similarity=0.464  Sum_probs=138.4

Q ss_pred             HhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +..+|++.+.||.|+||.||+|...++..+|+|.+..........+.+|+.+++.++|+||+++++++......++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            45678999999999999999999988999999999776555567799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++|+|.+++.......+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~  154 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLI  154 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhc
Confidence            99999999998765556899999999999999999999   899999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=8.1e-39  Score=345.84  Aligned_cols=143  Identities=29%  Similarity=0.460  Sum_probs=125.7

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ++|+..+.||+|+||.||+|.+. +++.||||++.... ......+.+|+++++.++|+||+++++++...+..|+||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45667789999999999999986 68999999985432 33456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +.+|+|....      ...+..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       154 ~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~  218 (353)
T PLN00034        154 MDGGSLEGTH------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL  218 (353)
T ss_pred             CCCCcccccc------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence            9999986532      3456777889999999999999   899999999999999999999999999998764

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9e-39  Score=330.56  Aligned_cols=149  Identities=30%  Similarity=0.506  Sum_probs=132.1

Q ss_pred             cCccccceecccCceEEEEEEEcC------CcEEEEEEcccCChh-hHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARD------GKLLAIKRLDTFSLQ-TEREFQNELQILGGLRSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~------g~~VAVK~i~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~  155 (718)
                      ++|.+.+.||+|+||.||+|...+      +..||||.+...... ....|.+|+++|..++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            568888999999999999998642      478999998764433 4578999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCE
Q 005033          156 LVYEYMPNKSLQEMLFSDGN------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG  223 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~v  223 (718)
                      +||||+++|+|.+++...+.            ..+++..+..++.|++.||.|||   ..+++||||||+|||++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            99999999999999976431            34788889999999999999999   8999999999999999999999


Q ss_pred             EEeeccCceee
Q 005033          224 KVSDFGLSRIK  234 (718)
Q Consensus       224 KLsDFGLAr~~  234 (718)
                      +|+|||+++..
T Consensus       162 kl~d~g~~~~~  172 (280)
T cd05049         162 KIGDFGMSRDV  172 (280)
T ss_pred             EECCcccceec
Confidence            99999988753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.3e-38  Score=333.78  Aligned_cols=146  Identities=25%  Similarity=0.433  Sum_probs=129.6

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..|+||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            57899999999999999999886 68999999986432 22334678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ++ |+|.+++...+. .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        85 ~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~  152 (288)
T cd07871          85 LD-SDLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARA  152 (288)
T ss_pred             CC-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceee
Confidence            96 599999876543 5788899999999999999999   99999999999999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.1e-38  Score=328.44  Aligned_cols=148  Identities=26%  Similarity=0.418  Sum_probs=133.6

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      .+|.+.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++..++|+||+++++++...+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45788899999999999999976 58899999986543 34567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++++|.+++.......+++..++.++.|++.||.|||   ..+++||||||+|||++.++.+||+|||++...
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~  154 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  154 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccc
Confidence            9999999997765556899999999999999999999   899999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-38  Score=340.57  Aligned_cols=140  Identities=32%  Similarity=0.495  Sum_probs=124.1

Q ss_pred             ceecccCceEEEEEEEc----CCcEEEEEEcccCC----hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           89 NVIGKGGSGTVFLGIAR----DGKLLAIKRLDTFS----LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~----~g~~VAVK~i~~~~----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +.||+|+||.||++...    +++.||||++....    ......+.+|+.+|+.++||||++++++|..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            57999999999999863    57899999986422    12234578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +++|+|.+++...+  .+.+..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  149 (323)
T cd05584          82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKE  149 (323)
T ss_pred             CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence            99999999997664  4677888889999999999999   89999999999999999999999999999864

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.4e-38  Score=333.67  Aligned_cols=147  Identities=25%  Similarity=0.440  Sum_probs=130.0

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh-hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL-QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++......|+|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999987 689999999864322 223457889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+ .++|.+++..... .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~~-~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  152 (303)
T cd07869          84 YV-HTDLCQYMDKHPG-GLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARA  152 (303)
T ss_pred             CC-CcCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCccee
Confidence            99 5789888876532 5788889999999999999999   99999999999999999999999999998875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.7e-38  Score=339.07  Aligned_cols=143  Identities=29%  Similarity=0.438  Sum_probs=124.6

Q ss_pred             ccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHH---hCCCCCcceeEEEEEeeCCeEEEE
Q 005033           85 FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQIL---GGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL---~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      |++.+.||+|+||.||+|.+. +++.||||++....   ......+.+|+.++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            667899999999999999886 68999999986432   22234566666554   577899999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |||+++|+|..++...   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05589          81 MEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE  150 (324)
T ss_pred             EcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence            9999999999888653   5889999999999999999999   99999999999999999999999999998764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-38  Score=359.59  Aligned_cols=148  Identities=18%  Similarity=0.227  Sum_probs=131.7

Q ss_pred             CccccceecccCceEEEEEEEc-C-CcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-D-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~-g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      .|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+|+.++|||||+++++|...+..||||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4889999999999999999875 3 6789999876555555567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSD--GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~--~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++|+|.++|...  ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            999999988643  2335788899999999999999999   899999999999999999999999999998864

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=343.60  Aligned_cols=147  Identities=30%  Similarity=0.454  Sum_probs=133.2

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||.||+|... +++.||||++....   ......+.+|+.+|..++||||+++++++..++..||||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999987 58999999986432   233456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.++|+|||+++..
T Consensus        81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  151 (364)
T cd05599          81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL  151 (364)
T ss_pred             CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence            9999999999997654  5888999999999999999999   999999999999999999999999999999865

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.4e-38  Score=336.60  Aligned_cols=140  Identities=31%  Similarity=0.458  Sum_probs=121.5

Q ss_pred             ceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHH-HHhCCCCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQ-ILGGLRSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~-iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||.||+|... +|+.||||++....   ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999986 68999999986432   122334555555 56789999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+|..++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~  145 (323)
T cd05575          81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (323)
T ss_pred             CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence            99999997654  5788889999999999999999   89999999999999999999999999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=332.01  Aligned_cols=147  Identities=31%  Similarity=0.398  Sum_probs=131.1

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      +|++.+.||+|+||.||++... +++.||||.+.....   .....+.+|+.+++.++|+||+++++++..++..|+|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999976 689999999864321   223457889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+++|+|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+||++++++.++|+|||+++.
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVE  151 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence            999999999987655456899999999999999999999   89999999999999999999999999998865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.2e-38  Score=336.93  Aligned_cols=147  Identities=28%  Similarity=0.438  Sum_probs=131.8

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .++|++.+.||+|+||.||++.+. ++..+|+|.+... .......+.+|+++++.++|+||++++++|...+..|+|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999987 5889999988653 23344678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD-PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~-~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+++|+|.+++...+  .+++..+..++.|++.||.|||   . .+|+||||||+|||++.++.+||+|||++..
T Consensus        84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  153 (333)
T cd06650          84 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (333)
T ss_pred             cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence            999999999997654  4788888999999999999999   5 4799999999999999999999999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-39  Score=349.67  Aligned_cols=148  Identities=30%  Similarity=0.448  Sum_probs=131.9

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC--CeEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMER--NKRIL  156 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~L  156 (718)
                      .+.|+.+..||+|.||.||+|++. +|+.||+|++....  ........+||.||++|+||||++|.+.....  ..+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            356888899999999999999976 79999999986433  34456678999999999999999999998876  68999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+|||+ -||.-++...+ ..+++.++..++.|++.||.|+|   .++|+|||||.+|||||.+|.+||+|||||++.
T Consensus       196 VFeYMd-hDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  196 VFEYMD-HDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEeccc-chhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeec
Confidence            999995 59998887653 46899999999999999999999   999999999999999999999999999999985

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.1e-38  Score=337.21  Aligned_cols=140  Identities=30%  Similarity=0.431  Sum_probs=124.7

Q ss_pred             ceecccCceEEEEEEEc----CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           89 NVIGKGGSGTVFLGIAR----DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~----~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      +.||+|+||.||++...    +|+.||||++....  ......+.+|+++|.+++||||+++++++...+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            57999999999998752    58899999986532  2233457789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  147 (318)
T cd05582          82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE  147 (318)
T ss_pred             CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence            999999997654  5789999999999999999999   89999999999999999999999999998865

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.9e-38  Score=328.97  Aligned_cols=151  Identities=23%  Similarity=0.400  Sum_probs=131.3

Q ss_pred             HhcCccccceecccCceEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNK  153 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~  153 (718)
                      .+++|++.+.||+|+||.||+|.+.      .+..||||.+.... ......|.+|+.+++.++|+||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999998764      25689999986432 2344578999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhCCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEE
Q 005033          154 RILVYEYMPNKSLQEMLFSDGN--------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKV  225 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~--------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKL  225 (718)
                      .++||||+++|+|.+++.....        ..+++..++.++.|++.||.|||   +.+++||||||+|||++.++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            9999999999999999975321        23577888999999999999999   899999999999999999999999


Q ss_pred             eeccCceee
Q 005033          226 SDFGLSRIK  234 (718)
Q Consensus       226 sDFGLAr~~  234 (718)
                      +|||+++..
T Consensus       161 ~dfg~~~~~  169 (277)
T cd05062         161 GDFGMTRDI  169 (277)
T ss_pred             CCCCCcccc
Confidence            999998754

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.3e-38  Score=335.47  Aligned_cols=140  Identities=29%  Similarity=0.387  Sum_probs=121.8

Q ss_pred             ceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhC-CCCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGG-LRSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~-L~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||.||+|... +++.||||++....   ......+..|..++.. .+||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999986 58899999986422   2233455667777765 4899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~  145 (316)
T cd05592          81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE  145 (316)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence            99999997654  5788889999999999999999   89999999999999999999999999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4e-38  Score=336.31  Aligned_cols=148  Identities=27%  Similarity=0.377  Sum_probs=132.9

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|.+.+.||+|+||.||++... +|+.||||++....   ......+.+|+.++..++|+||+++++++...+..||||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47889999999999999999986 68999999986532   223456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++|+|.+++..... .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~  152 (330)
T cd05601          81 EYQPGGDLLSLLNRYED-QFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARL  152 (330)
T ss_pred             CCCCCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence            99999999999977532 5888999999999999999999   999999999999999999999999999998764

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.9e-38  Score=330.83  Aligned_cols=149  Identities=30%  Similarity=0.499  Sum_probs=132.7

Q ss_pred             cCccccceecccCceEEEEEEEc------CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      .+|.+.+.||+|+||.||+|...      ++..+|+|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46788899999999999999753      356799999877666666789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC
Q 005033          157 VYEYMPNKSLQEMLFSDGN--------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR  222 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~--------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~  222 (718)
                      ||||+++++|.+++.....              ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            9999999999999976431              24788999999999999999999   999999999999999999999


Q ss_pred             EEEeeccCceee
Q 005033          223 GKVSDFGLSRIK  234 (718)
Q Consensus       223 vKLsDFGLAr~~  234 (718)
                      ++|+|||++...
T Consensus       162 ~~l~dfg~a~~~  173 (291)
T cd05094         162 VKIGDFGMSRDV  173 (291)
T ss_pred             EEECCCCccccc
Confidence            999999988753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-39  Score=342.73  Aligned_cols=147  Identities=33%  Similarity=0.494  Sum_probs=133.4

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|.+.+.||+|+||.||+|... +++.||||++....   ......+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47889999999999999999987 68999999986432   133456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++|+|.+++....  .+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  151 (350)
T cd05573          81 EYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKM  151 (350)
T ss_pred             cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence            9999999999998763  5788899999999999999999   899999999999999999999999999999865

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3e-38  Score=328.59  Aligned_cols=149  Identities=27%  Similarity=0.446  Sum_probs=130.4

Q ss_pred             cCccccceecccCceEEEEEEEc-----CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-----DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-----~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      .+|++.+.||+|+||.||+|...     ++..||+|.+.... ......|.+|+.+++.++||||+++++++......|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            46788899999999999999852     46789999996433 3344678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC
Q 005033          157 VYEYMPNKSLQEMLFSDG---------------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC  221 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~---------------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~  221 (718)
                      ||||+++|+|.+++....               ...+++..++.++.|++.||.|||   +++|+||||||+|||++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999999985332               124788889999999999999999   89999999999999999999


Q ss_pred             CEEEeeccCceee
Q 005033          222 RGKVSDFGLSRIK  234 (718)
Q Consensus       222 ~vKLsDFGLAr~~  234 (718)
                      .+||+|||+++..
T Consensus       162 ~~kl~dfg~~~~~  174 (283)
T cd05090         162 HVKISDLGLSREI  174 (283)
T ss_pred             cEEeccccccccc
Confidence            9999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.1e-38  Score=336.51  Aligned_cols=145  Identities=32%  Similarity=0.421  Sum_probs=128.5

Q ss_pred             CccccceecccCceEEEEEEEc----CCcEEEEEEcccCC----hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR----DGKLLAIKRLDTFS----LQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~----~g~~VAVK~i~~~~----~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~  154 (718)
                      +|++.+.||+|+||.||++...    +++.||+|++....    ......+..|+.++..+ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5788999999999999998763    58899999986421    22335678899999999 589999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+||||+++|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999997654  5788899999999999999999   89999999999999999999999999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.2e-38  Score=345.75  Aligned_cols=139  Identities=22%  Similarity=0.310  Sum_probs=126.5

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      ++|++.+.||+|+||.||+|.+. +++.||||...      ...+.+|+.+|+.++|||||+++++|......|+|||++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            57999999999999999999986 68999999653      235789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                       +++|..++....  .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus       166 -~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~  231 (391)
T PHA03212        166 -KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACF  231 (391)
T ss_pred             -CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence             579999887654  5788899999999999999999   89999999999999999999999999999864

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.2e-38  Score=338.25  Aligned_cols=145  Identities=29%  Similarity=0.366  Sum_probs=127.8

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCCCCC-cceeEEEEEeeCCeEEEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGLRSP-FLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~Hp-NIV~L~g~~~~~~~~~LVm  158 (718)
                      +|++.+.||+|+||.||+|... +++.||||++...   .......+..|+.++..+.|+ +|+.+++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5888999999999999999987 5789999998642   123345688899999999764 6889999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||+++|+|.+++....  .+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05587          81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE  150 (324)
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence            9999999999997654  5788899999999999999999   89999999999999999999999999998864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.9e-38  Score=334.62  Aligned_cols=145  Identities=28%  Similarity=0.533  Sum_probs=126.6

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC-----eEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERN-----KRI  155 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~~  155 (718)
                      +|++.+.||+|+||.||+|... +++.||||++...  .......+.+|+.+++.++||||+++++++....     ..|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788899999999999999976 6899999998642  2233456889999999999999999999886432     479


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +||||| +++|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            999999 579999987654  5788999999999999999999   899999999999999999999999999998753

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.8e-38  Score=345.67  Aligned_cols=146  Identities=27%  Similarity=0.355  Sum_probs=131.8

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .|..++.||+|+||+||+|... +++.||||++....   ......+.+|+.++..++|+||+++++++.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999876 58899999996532   2334578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+++|+|.+++....  .+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            999999999997654  5788888899999999999999   899999999999999999999999999998764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.4e-38  Score=337.82  Aligned_cols=145  Identities=30%  Similarity=0.375  Sum_probs=127.5

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      +|.+.+.||+|+||.||+|... +++.||||.+....   ......+..|..++..+ +|++|+.+++++...+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5788999999999999999887 57899999986432   22334567788888777 5899999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||+++|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~  150 (323)
T cd05616          81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence            9999999999997654  5788899999999999999999   89999999999999999999999999998874

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.8e-38  Score=329.95  Aligned_cols=141  Identities=31%  Similarity=0.383  Sum_probs=124.0

Q ss_pred             ecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCCH
Q 005033           91 IGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSL  166 (718)
Q Consensus        91 LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL  166 (718)
                      ||+|+||+||++.+. +++.||||.+.....   .....+..|+.+++.++|+||+++++++...+..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999886 689999999864322   2235678899999999999999999999999999999999999999


Q ss_pred             HHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          167 QEMLFSD--GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       167 ~~~L~~~--~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      .+++...  ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.++|+|||++...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  147 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL  147 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceec
Confidence            9888542  2346889999999999999999999   899999999999999999999999999988653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=350.19  Aligned_cols=147  Identities=29%  Similarity=0.433  Sum_probs=131.8

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ..|.....||+|+||.||+|.+. +++.||+|++.... ......++.|+.+|.+++++||.++|+.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            35667789999999999999986 68999999997543 33456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |.||++.+.|+...  .+++..+..|+++++.||.|||   ..+.+|||||+.|||+..+|.+||+|||++..+
T Consensus        93 ~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql  161 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQL  161 (467)
T ss_pred             hcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeee
Confidence            99999999998664  4477778889999999999999   899999999999999999999999999998765

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.4e-38  Score=336.09  Aligned_cols=147  Identities=25%  Similarity=0.503  Sum_probs=128.9

Q ss_pred             cCccccceecccCceEEEEEEEc-CCc----EEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGK----LLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~----~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      .+|++.+.||+|+||.||+|.+. ++.    .||||.+.... ....+.|.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            57899999999999999999864 333    48999986532 34556799999999999999999999999765 5789


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+||+++|+|.+++..... .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        86 v~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccc
Confidence            9999999999999986543 5788889999999999999999   899999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.1e-38  Score=319.14  Aligned_cols=148  Identities=28%  Similarity=0.463  Sum_probs=133.6

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +|+..+.||+|+||.||+|... +++.||+|.+...  .......+.+|+.+++.++||||+++++++...+..|+||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            5778899999999999999986 6899999998542  344566799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++++|.+++.......+++..+..++.|++.||.|||   ..+|+||||||+||+++.++.++|+|||+++..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~  151 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL  151 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceec
Confidence            99999999998764457889999999999999999999   899999999999999999999999999988754

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.6e-38  Score=347.02  Aligned_cols=149  Identities=29%  Similarity=0.367  Sum_probs=132.0

Q ss_pred             HHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEE
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~  155 (718)
                      ...++|++.+.||+|+||.||++... +++.||||++....   ......+.+|+.+++.++||||+++++++..++..|
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34568999999999999999999986 58899999986421   223345788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +||||+++|+|.+++...   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       120 lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            999999999999999754   4677888889999999999999   899999999999999999999999999998753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.5e-38  Score=337.34  Aligned_cols=140  Identities=29%  Similarity=0.367  Sum_probs=123.7

Q ss_pred             ceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||.||+|... +++.||||++....   ......+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999986 58899999986432   23345677899998865 899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+|..++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~  145 (321)
T cd05591          81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKE  145 (321)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeeccccee
Confidence            99999987654  5788889999999999999999   99999999999999999999999999998864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.1e-38  Score=324.61  Aligned_cols=147  Identities=34%  Similarity=0.447  Sum_probs=132.2

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      ++|.+.+.||+|+||.||+|...++..+|||.+.... .....|.+|+.++.+++||||+++++++......|+||||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4678889999999999999988777789999986533 234678999999999999999999999999989999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +|+|.+++..... .+++..++.++.||+.||.|||   +.+++|+||||+||+++.++.+||+|||+++..
T Consensus        83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~  150 (256)
T cd05113          83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV  150 (256)
T ss_pred             CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceec
Confidence            9999999976543 6889999999999999999999   899999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.3e-38  Score=322.97  Aligned_cols=148  Identities=26%  Similarity=0.425  Sum_probs=131.6

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      .++|++.+.||+|+||.||+|...++..||+|.+..... ....|.+|+.++++++|+||+++++++. ....|+||||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            357889999999999999999988888899999865332 3457999999999999999999999885 45689999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++++|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+||++++++.++|+|||++...
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~  152 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLI  152 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence            9999999998755456889999999999999999999   899999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.8e-38  Score=336.10  Aligned_cols=140  Identities=26%  Similarity=0.352  Sum_probs=124.2

Q ss_pred             ceecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||.||++... +++.||+|++...   .......+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999986 5889999998653   223345678899988776 899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+|..++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~  145 (329)
T cd05618          81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  145 (329)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence            99999887654  5788999999999999999999   89999999999999999999999999998864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.6e-38  Score=335.31  Aligned_cols=140  Identities=26%  Similarity=0.387  Sum_probs=122.7

Q ss_pred             ceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhC-CCCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGG-LRSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~-L~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||.||+|.+. +|+.||||.+....   ......+..|..++.. ++||||+++++++...+..|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999987 58899999986432   1233456778888875 4899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+|..++....  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.++|+|||+++.
T Consensus        81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05620          81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE  145 (316)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence            99999997654  5788899999999999999999   99999999999999999999999999998864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6e-38  Score=336.21  Aligned_cols=140  Identities=25%  Similarity=0.345  Sum_probs=125.0

Q ss_pred             ceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||.||+|... +++.||||++....   ......+..|+.++..+ +||||++++++|...+..||||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999986 58899999996532   22345688899999988 799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  145 (329)
T cd05588          81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE  145 (329)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccc
Confidence            99999987654  5889999999999999999999   99999999999999999999999999998864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.2e-38  Score=343.66  Aligned_cols=147  Identities=27%  Similarity=0.381  Sum_probs=131.8

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++++.||+|+||.||++... +++.||||++....   ......+.+|+.+|..++|+||+++++.+..++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            37899999999999999999986 58999999986432   123456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||++|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|...
T Consensus        81 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~  151 (376)
T cd05598          81 DYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (376)
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence            9999999999997654  5788888899999999999999   999999999999999999999999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.5e-38  Score=337.95  Aligned_cols=140  Identities=29%  Similarity=0.388  Sum_probs=123.9

Q ss_pred             ceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||.||+|... +++.||||++....   ......+..|+.++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999986 58899999986421   23345677888888876 699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~  145 (320)
T cd05590          81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE  145 (320)
T ss_pred             chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence            99999987654  5788899999999999999999   99999999999999999999999999998864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.7e-38  Score=329.06  Aligned_cols=152  Identities=24%  Similarity=0.384  Sum_probs=132.7

Q ss_pred             HHhcCccccceecccCceEEEEEEEcC------CcEEEEEEcccC-ChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeC
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIARD------GKLLAIKRLDTF-SLQTEREFQNELQILGGL-RSPFLVTLLGYCMER  151 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~~------g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~  151 (718)
                      ...++|++.+.||+|+||.||++....      ...+|+|.+... .......+.+|+.++.++ +|+||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            345678899999999999999998642      368999998653 233446788999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDG--------------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL  217 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~--------------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL  217 (718)
                      +..+++|||+++|+|.+++....              ...+++..++.++.|++.||.|||   +.+|+||||||+|||+
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEE
Confidence            99999999999999999996531              235788999999999999999999   8999999999999999


Q ss_pred             CCCCCEEEeeccCceee
Q 005033          218 DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       218 d~~~~vKLsDFGLAr~~  234 (718)
                      +.++.+||+|||+++..
T Consensus       166 ~~~~~~kL~Dfg~~~~~  182 (293)
T cd05053         166 TEDHVMKIADFGLARDI  182 (293)
T ss_pred             cCCCeEEeCcccccccc
Confidence            99999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.4e-38  Score=340.98  Aligned_cols=147  Identities=29%  Similarity=0.420  Sum_probs=132.8

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||+||+|... +++.||||++....   ......+.+|+.++..++|+||+++++++.+....||||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999876 58999999986432   223356788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||++|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            9999999999997654  5788999999999999999999   999999999999999999999999999999865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.3e-38  Score=329.04  Aligned_cols=149  Identities=30%  Similarity=0.497  Sum_probs=133.0

Q ss_pred             cCccccceecccCceEEEEEEEc------CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      .+|.+.+.||+|+||.||++...      ++..+|+|.+..........+.+|++++.+++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            57888999999999999999752      356799999876655566789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEE
Q 005033          157 VYEYMPNKSLQEMLFSDG-----------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKV  225 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~-----------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKL  225 (718)
                      ||||+++++|.+++...+           ...+++..++.++.|++.||.|||   ..+++||||||+|||++.++.++|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence            999999999999997543           124899999999999999999999   899999999999999999999999


Q ss_pred             eeccCceee
Q 005033          226 SDFGLSRIK  234 (718)
Q Consensus       226 sDFGLAr~~  234 (718)
                      +|||+++..
T Consensus       162 ~dfg~~~~~  170 (288)
T cd05093         162 GDFGMSRDV  170 (288)
T ss_pred             ccCCccccc
Confidence            999988753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.9e-38  Score=348.66  Aligned_cols=151  Identities=26%  Similarity=0.363  Sum_probs=130.6

Q ss_pred             HhcCccccceecccCceEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCC
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFS-LQTEREFQNELQILGGLR-SPFLVTLLGYCMERN  152 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~  152 (718)
                      ..++|.+.+.||+|+||.||+|.+.      .+..||||++.... ....+.|.+|+.+|..+. |||||+++++|...+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            4578899999999999999999863      13479999996532 334567999999999996 999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhCC----------------------------------------------------------
Q 005033          153 KRILVYEYMPNKSLQEMLFSDG----------------------------------------------------------  174 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~----------------------------------------------------------  174 (718)
                      ..|||||||++|+|.++|....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999999986531                                                          


Q ss_pred             ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEC
Q 005033          175 ------------------------------------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD  218 (718)
Q Consensus       175 ------------------------------------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd  218 (718)
                                                          ...+++..++.++.||+.||.|||   ..+|+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence                                                123677888899999999999999   89999999999999999


Q ss_pred             CCCCEEEeeccCceee
Q 005033          219 SDCRGKVSDFGLSRIK  234 (718)
Q Consensus       219 ~~~~vKLsDFGLAr~~  234 (718)
                      .++.+||+|||+++..
T Consensus       272 ~~~~~kL~DfGla~~~  287 (400)
T cd05105         272 QGKIVKICDFGLARDI  287 (400)
T ss_pred             CCCEEEEEeCCcceec
Confidence            9999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.9e-38  Score=328.39  Aligned_cols=141  Identities=29%  Similarity=0.394  Sum_probs=124.9

Q ss_pred             ecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCCH
Q 005033           91 IGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSL  166 (718)
Q Consensus        91 LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL  166 (718)
                      ||+|+||.||++... +|+.||+|.+....   ......+..|++++.+++||||+++++++..+...|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999876 58999999985422   12234566799999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          167 QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       167 ~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      .+++.......+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.++|+|||++...
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~  145 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL  145 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeec
Confidence            99987665556889999999999999999999   899999999999999999999999999988653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-38  Score=322.08  Aligned_cols=148  Identities=29%  Similarity=0.412  Sum_probs=132.7

Q ss_pred             cCccccceecccCceEEEEEEEcC----CcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARD----GKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~----g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ++|++.+.||+|+||.||+|....    ...||||.+.... ......|.+|+.++..++|+||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            578899999999999999998752    4589999986533 33456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++++|.+++..... .+++..++.++.|++.||.|||   +++|+||||||+|||++.++.++|+|||+++..
T Consensus        84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          84 TEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            999999999999976543 6789999999999999999999   899999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.1e-38  Score=319.91  Aligned_cols=141  Identities=29%  Similarity=0.474  Sum_probs=126.6

Q ss_pred             ceecccCceEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCCH
Q 005033           89 NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSL  166 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL  166 (718)
                      +.||+|+||.||+|.+. +++.||+|.+... .......|.+|+++++.++||||++++++|......|+||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36899999999999986 6899999987543 234456799999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          167 QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       167 ~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .+++.... ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  143 (252)
T cd05084          81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSRE  143 (252)
T ss_pred             HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcc
Confidence            99997653 25788999999999999999999   99999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.4e-38  Score=344.87  Aligned_cols=150  Identities=29%  Similarity=0.391  Sum_probs=133.3

Q ss_pred             HHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeE
Q 005033           79 KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        79 ~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~  154 (718)
                      ....++|++.+.||+|+||.||++... +++.||+|++...   .......+.+|+.+++.++||||+++++++..++..
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            344578999999999999999999987 5889999998542   122345688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+|||||++|+|.+++...   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            9999999999999999754   4788889999999999999999   999999999999999999999999999998763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=354.88  Aligned_cols=151  Identities=29%  Similarity=0.457  Sum_probs=134.7

Q ss_pred             HHHhcCccccceecccCceEEEEEEEcC--C--cE-EEEEEccc---CChhhHHHHHHHHHHHhCCCCCcceeEEEEEee
Q 005033           79 KNATNDFDEANVIGKGGSGTVFLGIARD--G--KL-LAIKRLDT---FSLQTEREFQNELQILGGLRSPFLVTLLGYCME  150 (718)
Q Consensus        79 ~~at~~f~~~~~LG~G~FG~Vykg~~~~--g--~~-VAVK~i~~---~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~  150 (718)
                      ....++-.+.+.||+|+||.||+|.+..  +  .. ||||....   .......+|.+|+++|++++|||||++||++..
T Consensus       153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~  232 (474)
T KOG0194|consen  153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL  232 (474)
T ss_pred             EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            3344555667899999999999999863  2  23 89999874   335567889999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccC
Q 005033          151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL  230 (718)
Q Consensus       151 ~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGL  230 (718)
                      ...+|||||+|.||+|.++|+..+. .++..+.+.++.+.|.||+|||   .+++|||||..+|+|++.++.+||+||||
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccc
Confidence            9999999999999999999998865 6889999999999999999999   99999999999999999999999999999


Q ss_pred             cee
Q 005033          231 SRI  233 (718)
Q Consensus       231 Ar~  233 (718)
                      ++.
T Consensus       309 s~~  311 (474)
T KOG0194|consen  309 SRA  311 (474)
T ss_pred             ccC
Confidence            876

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=352.23  Aligned_cols=155  Identities=25%  Similarity=0.434  Sum_probs=137.3

Q ss_pred             ccHHHHHHHhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEee
Q 005033           73 FTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCME  150 (718)
Q Consensus        73 ~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~  150 (718)
                      .+.+++....+.+.+...||+|+||+||+|.+.  ..||||+++...  ....+.|.+|+.++++-+|.||+=+.|||..
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            444566666667788899999999999999986  469999997543  4456789999999999999999999999998


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccC
Q 005033          151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL  230 (718)
Q Consensus       151 ~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGL  230 (718)
                      ++. .||+.+|+|.+|+.+|+... ..++....+.|++||++||.|||   .++|||||||..||++.++++|||+||||
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccc
Confidence            887 99999999999999998664 36888899999999999999999   99999999999999999999999999999


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      +...
T Consensus       535 atvk  538 (678)
T KOG0193|consen  535 ATVK  538 (678)
T ss_pred             eeee
Confidence            9763

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.6e-38  Score=322.83  Aligned_cols=148  Identities=26%  Similarity=0.405  Sum_probs=130.7

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      .++|.+.+.||+|+||.||+|.+.++..||+|++.... .....|.+|+.+++.++|+||+++++++. ....|+||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            35689999999999999999998777789999987533 23457899999999999999999999875 45689999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++|+|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||+++..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~  152 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI  152 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeec
Confidence            9999999998654446788999999999999999999   899999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-38  Score=322.11  Aligned_cols=147  Identities=32%  Similarity=0.443  Sum_probs=131.7

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      .+|++.+.||+|+||.||+|.+.++..+|+|.+.... .....|.+|+.+++.++|+||+++++++...+..|+||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            3577889999999999999998877889999986432 234568899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++|.+++..... .+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        83 ~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~  150 (256)
T cd05059          83 NGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV  150 (256)
T ss_pred             CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceec
Confidence            9999999976543 6789999999999999999999   899999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.2e-38  Score=335.50  Aligned_cols=140  Identities=30%  Similarity=0.432  Sum_probs=121.8

Q ss_pred             ceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHH-HHhCCCCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQ-ILGGLRSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~-iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||.||+|... +|+.||||++....   ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            36999999999999876 68999999986421   223345566655 46789999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+|..++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~  145 (325)
T cd05604          81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKE  145 (325)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence            99999987654  5788999999999999999999   89999999999999999999999999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.2e-37  Score=320.00  Aligned_cols=149  Identities=25%  Similarity=0.415  Sum_probs=131.7

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||.||+|... +++.||||.+...   .......+.+|+.+++.++||||+++++++...+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999976 6899999987542   2344457899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSD--GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~--~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++|+|.+++...  ....++...+..++.||+.||.|||   +.+|+||||||+|||++.++.++|+|||++...
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~  156 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence            999999999988542  2235788889999999999999999   899999999999999999999999999988753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4e-38  Score=343.90  Aligned_cols=146  Identities=27%  Similarity=0.372  Sum_probs=131.4

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .|..++.||+|+||.||+|... +++.||||++....   ......+.+|+.+++.++|+|||++++++.+.+..|||||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999986 58899999986432   2334578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||++|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            999999999997654  5788888999999999999999   899999999999999999999999999998753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.7e-38  Score=320.74  Aligned_cols=148  Identities=26%  Similarity=0.448  Sum_probs=132.5

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      .++|++.+.||+|+||.||+|...+++.||+|.+..... ....|.+|+.++++++|+||+++++++. .+..|+||||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            467889999999999999999988899999999875432 3457899999999999999999999874 45789999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      .+++|.+++.......+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++...
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLI  152 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence            9999999997765557889999999999999999999   899999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.4e-38  Score=324.82  Aligned_cols=143  Identities=31%  Similarity=0.476  Sum_probs=125.9

Q ss_pred             cccceecccCceEEEEEEE-----cCCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC--CeEEEE
Q 005033           86 DEANVIGKGGSGTVFLGIA-----RDGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMER--NKRILV  157 (718)
Q Consensus        86 ~~~~~LG~G~FG~Vykg~~-----~~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LV  157 (718)
                      +..+.||+|+||+||++..     .++..||+|.+.... ......|.+|+++|+.++||||+++++++...  ...|+|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            7889999999999988753     257899999986543 23456788999999999999999999998654  468999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++|+|.+++...   .+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||+++..
T Consensus        87 ~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          87 MEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             ecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            9999999999999764   4899999999999999999999   899999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-38  Score=340.70  Aligned_cols=147  Identities=31%  Similarity=0.414  Sum_probs=132.0

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|.+.+.||+|+||.||++... +++.||||++....   ......+.+|++++..++||||+++++++.+.+..||||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47889999999999999999876 68999999985422   233456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++|+|.+++....  .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          81 EFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            9999999999997654  5788888899999999999999   999999999999999999999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.5e-38  Score=326.17  Aligned_cols=147  Identities=27%  Similarity=0.452  Sum_probs=126.1

Q ss_pred             cCccccceecccCceEEEEEEEc-CCc----EEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGK----LLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~----~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      ++|++.+.||+|+||.||+|.+. +++    .||+|.+.... .....++..|+.+++.+.||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46788899999999999999875 344    47888875432 2334578889999999999999999998854 45789


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++||+++|+|.+++..... .+++..++.++.||+.||.|||   +.+++||||||+|||++.++.+||+|||+++..
T Consensus        86 i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            9999999999999976543 5889999999999999999999   899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-38  Score=337.15  Aligned_cols=149  Identities=32%  Similarity=0.363  Sum_probs=136.8

Q ss_pred             cCccccceecccCceEEEEEEEcC-CcEEEEEEcccCChh---hHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQ---TEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~-g~~VAVK~i~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      +.|++++.||.|.-|+||++.+++ +..+|+|++.+....   ...+.+.|-+||+.+.||.++.||..|+.+...||||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            457788999999999999999984 689999999765433   3356778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+||+|..+++++....+++..++.++.+|+.||+|||   -.|||.|||||+||||.++|++.|+||.|+...
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            9999999999999888889999999999999999999999   999999999999999999999999999999764

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.6e-38  Score=332.52  Aligned_cols=140  Identities=31%  Similarity=0.445  Sum_probs=121.1

Q ss_pred             ceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHH-HHhCCCCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQ-ILGGLRSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~-iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||.||+|... +++.||||++....   ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999986 58899999986432   122344555654 67889999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+|..++....  .+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  145 (321)
T cd05603          81 GELFFHLQRER--CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (321)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence            99999887653  5778888899999999999999   89999999999999999999999999998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.9e-38  Score=325.28  Aligned_cols=151  Identities=28%  Similarity=0.407  Sum_probs=131.6

Q ss_pred             HhcCccccceecccCceEEEEEEEcC------CcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIARD------GKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNK  153 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~~------g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~  153 (718)
                      .+++|.+.+.||+|+||.||+|.+..      +..||+|.+.... ......|.+|+.+++.++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            34678999999999999999998753      5689999886433 3345679999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC---CEEE
Q 005033          154 RILVYEYMPNKSLQEMLFSDGN-----LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC---RGKV  225 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~-----~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~---~vKL  225 (718)
                      .++||||+++++|.+++.....     ..+++..++.++.||+.||.|||   ..+++||||||+|||++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence            9999999999999999976532     25889999999999999999999   89999999999999998765   5999


Q ss_pred             eeccCceee
Q 005033          226 SDFGLSRIK  234 (718)
Q Consensus       226 sDFGLAr~~  234 (718)
                      +|||+++..
T Consensus       161 ~dfg~~~~~  169 (277)
T cd05036         161 ADFGMARDI  169 (277)
T ss_pred             ccCcccccc
Confidence            999998764

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.4e-37  Score=331.90  Aligned_cols=140  Identities=26%  Similarity=0.375  Sum_probs=122.7

Q ss_pred             ceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhC-CCCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGG-LRSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~-L~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||.||+|.+. +++.||||++....   ......+..|..++.. ++||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999987 57899999986532   1233456778888876 4999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05619          81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKE  145 (316)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence            99999997653  5788889999999999999999   89999999999999999999999999998864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.1e-38  Score=326.41  Aligned_cols=148  Identities=26%  Similarity=0.388  Sum_probs=128.7

Q ss_pred             CccccceecccCceEEEEEEEc------CCcEEEEEEcccCCh-hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFSL-QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      +|.+.+.||+|+||.||+|...      .+..||||++..... .....|.+|+.++..++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4677889999999999999864      257899999975432 234568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC
Q 005033          157 VYEYMPNKSLQEMLFSDG--------------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR  222 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~--------------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~  222 (718)
                      ++||+.+++|.+++....              ...+++..+..++.|++.||.|||   +++|+||||||+|||+++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence            999999999999985321              124788888999999999999999   899999999999999999999


Q ss_pred             EEEeeccCceee
Q 005033          223 GKVSDFGLSRIK  234 (718)
Q Consensus       223 vKLsDFGLAr~~  234 (718)
                      +||+|||+++..
T Consensus       163 ~kl~Dfg~~~~~  174 (283)
T cd05091         163 VKISDLGLFREV  174 (283)
T ss_pred             eEeccccccccc
Confidence            999999998754

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-38  Score=349.43  Aligned_cols=149  Identities=23%  Similarity=0.432  Sum_probs=136.3

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe-EEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNK-RILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~-~~LVm  158 (718)
                      ++|..++.+|+|+||.+++++++ ++..+++|.+....  ....+....|+.++++++|||||.+.+.|..++. .||||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57889999999999999999887 57899999986432  3344578899999999999999999999999888 99999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +||+||+|.+.|.......+++..+..++.|++.|+.|||   +..|+|||||+.||+++.++.+||+|||+|+.+
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l  156 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL  156 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhc
Confidence            9999999999998887778999999999999999999999   999999999999999999999999999999986

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.8e-37  Score=316.21  Aligned_cols=149  Identities=26%  Similarity=0.458  Sum_probs=133.0

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++..   .......+.+|++++++++|+||+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999987 7999999988532   2233567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSD--GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~--~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++|+|.+++...  ....+++..+..++.|++.||.|||   +.+|+||||+|+||+++.++.++|+|||+++..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence            999999999998653  2345788999999999999999999   899999999999999999999999999988753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-37  Score=318.75  Aligned_cols=147  Identities=24%  Similarity=0.428  Sum_probs=126.6

Q ss_pred             ccccceecccCceEEEEEEEcC----CcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe-----
Q 005033           85 FDEANVIGKGGSGTVFLGIARD----GKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNK-----  153 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~~----g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~-----  153 (718)
                      |++.+.||+|+||.||+|....    +..||||.+...  .......+.+|+.+++.++|+||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998752    468999998643  23345678999999999999999999999876554     


Q ss_pred             -EEEEEeccCCCCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeec
Q 005033          154 -RILVYEYMPNKSLQEMLFSD----GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDF  228 (718)
Q Consensus       154 -~~LVmEy~~gGsL~~~L~~~----~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDF  228 (718)
                       .++||||+++|+|..++...    ....+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             79999999999999998543    2235788999999999999999999   899999999999999999999999999


Q ss_pred             cCceee
Q 005033          229 GLSRIK  234 (718)
Q Consensus       229 GLAr~~  234 (718)
                      |+++..
T Consensus       158 g~~~~~  163 (273)
T cd05035         158 GLSKKI  163 (273)
T ss_pred             cceeec
Confidence            998764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.9e-38  Score=322.60  Aligned_cols=151  Identities=28%  Similarity=0.420  Sum_probs=132.7

Q ss_pred             HHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeC------
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCMER------  151 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~------  151 (718)
                      .+++.|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +|+||++++++|...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45678999999999999999999876 58899999986533 3345788999999998 799999999998753      


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCc
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS  231 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLA  231 (718)
                      ...|+||||+.+|+|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            46899999999999999998755556889999999999999999999   899999999999999999999999999998


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      +..
T Consensus       159 ~~~  161 (272)
T cd06637         159 AQL  161 (272)
T ss_pred             eec
Confidence            753

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.8e-37  Score=319.10  Aligned_cols=148  Identities=25%  Similarity=0.354  Sum_probs=133.5

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      .++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++..++||||+++++++...+..|+||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            357999999999999999999975 6889999998654444455688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++++|.+++....  .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||+++..
T Consensus        88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~  156 (267)
T cd06646          88 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKI  156 (267)
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceee
Confidence            99999999987654  5788899999999999999999   899999999999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=322.01  Aligned_cols=150  Identities=23%  Similarity=0.386  Sum_probs=131.6

Q ss_pred             hcCccccceecccCceEEEEEEEcC------CcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARD------GKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~------g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~  154 (718)
                      .++|.+.+.||+|+||.||+|....      +..||+|.+.... ......+.+|+.++..++|+||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4678899999999999999998752      4689999986542 34456789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEe
Q 005033          155 ILVYEYMPNKSLQEMLFSDGN--------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVS  226 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~--------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLs  226 (718)
                      |+||||+++|+|.+++.....        ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            999999999999999975321        23678889999999999999999   8999999999999999999999999


Q ss_pred             eccCceee
Q 005033          227 DFGLSRIK  234 (718)
Q Consensus       227 DFGLAr~~  234 (718)
                      |||+++..
T Consensus       162 dfg~~~~~  169 (277)
T cd05032         162 DFGMTRDI  169 (277)
T ss_pred             Ccccchhh
Confidence            99998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.3e-37  Score=334.95  Aligned_cols=145  Identities=26%  Similarity=0.428  Sum_probs=125.2

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC-----
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERN-----  152 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----  152 (718)
                      ..++|++.+.||+|+||.||++.+. +|..||||.+...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3578999999999999999999886 5899999998542  2334567889999999999999999999986543     


Q ss_pred             -eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCc
Q 005033          153 -KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS  231 (718)
Q Consensus       153 -~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLA  231 (718)
                       ..|+||||+. ++|.+.+..    .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        99 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence             4799999995 577777643    3678888899999999999999   999999999999999999999999999988


Q ss_pred             ee
Q 005033          232 RI  233 (718)
Q Consensus       232 r~  233 (718)
                      +.
T Consensus       171 ~~  172 (359)
T cd07876         171 RT  172 (359)
T ss_pred             cc
Confidence            64

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.4e-38  Score=355.98  Aligned_cols=153  Identities=26%  Similarity=0.320  Sum_probs=132.0

Q ss_pred             HHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC---
Q 005033           79 KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERN---  152 (718)
Q Consensus        79 ~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~---  152 (718)
                      ....++|.+.+.||+|+||+||+|... +|+.||||++...  .......+.+|+.++..++|+||++++..+....   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            344579999999999999999999876 6899999998643  3344567889999999999999999988775432   


Q ss_pred             -----eEEEEEeccCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEE
Q 005033          153 -----KRILVYEYMPNKSLQEMLFSDG--NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKV  225 (718)
Q Consensus       153 -----~~~LVmEy~~gGsL~~~L~~~~--~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKL  225 (718)
                           ..++||||+++|+|.+++....  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEE
Confidence                 3689999999999999997532  246888899999999999999999   999999999999999999999999


Q ss_pred             eeccCceee
Q 005033          226 SDFGLSRIK  234 (718)
Q Consensus       226 sDFGLAr~~  234 (718)
                      +|||+++..
T Consensus       185 ~DFGls~~~  193 (496)
T PTZ00283        185 GDFGFSKMY  193 (496)
T ss_pred             EecccCeec
Confidence            999999864

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-38  Score=328.56  Aligned_cols=145  Identities=42%  Similarity=0.645  Sum_probs=127.3

Q ss_pred             ccceecccCceEEEEEEEc-----CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           87 EANVIGKGGSGTVFLGIAR-----DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        87 ~~~~LG~G~FG~Vykg~~~-----~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +.+.||.|+||.||+|.+.     .+..|+||.++.. .......|.+|++++++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999987     2578999999653 334467899999999999999999999999988889999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++|+|.++|.......+++..+..|+.||+.||.|||   +.+|+|+||+++|||++.++.+||+|||+++..
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~  153 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPI  153 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence            99999999999875557899999999999999999999   889999999999999999999999999998764

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.1e-37  Score=316.57  Aligned_cols=148  Identities=20%  Similarity=0.333  Sum_probs=132.6

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      +|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++|+||+++++++...+..|+||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            5788899999999999999986 6889999988542 2344567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++|+|.+++.......+++..++.++.||+.||.|||   ..+|+|+||||+||+++.++.++|+|||+++..
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  150 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL  150 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceee
Confidence            9999999987654446788999999999999999999   999999999999999999999999999988753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.6e-37  Score=322.66  Aligned_cols=150  Identities=27%  Similarity=0.423  Sum_probs=132.0

Q ss_pred             hcCccccceecccCceEEEEEEEcC-----------------CcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCccee
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARD-----------------GKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVT  143 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~-----------------g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~  143 (718)
                      .++|++.+.||+|+||.||+|....                 +..||+|.+.... ......|.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4678999999999999999987642                 2468999986543 344567999999999999999999


Q ss_pred             EEEEEeeCCeEEEEEeccCCCCHHHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 005033          144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDG---------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSN  214 (718)
Q Consensus       144 L~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~---------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~N  214 (718)
                      +++++..++..++||||+++++|.+++....         ...+++..++.++.|++.||.|||   +.+|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999997653         125789999999999999999999   8999999999999


Q ss_pred             EEECCCCCEEEeeccCceee
Q 005033          215 VLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       215 ILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+++.++.++|+|||+++..
T Consensus       161 ili~~~~~~~l~dfg~~~~~  180 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNL  180 (296)
T ss_pred             eeecCCCceEEccccceeec
Confidence            99999999999999988753

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.9e-37  Score=318.64  Aligned_cols=147  Identities=27%  Similarity=0.403  Sum_probs=130.2

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      ++|.+...||+|+||.||+|.+..+..+|+|.+.... .....+.+|+.+++.++|+||+++++++. .+..|+||||+.
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4688889999999999999998877789999886533 23457899999999999999999999875 456899999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +|+|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+||++++++.++|+|||+++..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~  152 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLI  152 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence            999999998755456789999999999999999999   899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.9e-37  Score=319.18  Aligned_cols=149  Identities=30%  Similarity=0.472  Sum_probs=131.8

Q ss_pred             hcCccccceecccCceEEEEEEEc-CC---cEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DG---KLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g---~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      .++|+..+.||+|+||.||+|... ++   ..+|||.+... .....+.+..|+.++..++|+||+++++++...+..|+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            357888899999999999999875 33   37999998654 23445678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||||+++++|.+++.... ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++...
T Consensus        84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence            999999999999997653 35788999999999999999999   899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=7.7e-38  Score=333.54  Aligned_cols=140  Identities=28%  Similarity=0.400  Sum_probs=124.4

Q ss_pred             ceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||.||+|.+. +++.||||++....   ......+.+|+.++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999987 58899999986432   23345677899999887 799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+|..++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  145 (318)
T cd05570          81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE  145 (318)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCee
Confidence            99999987664  5789999999999999999999   99999999999999999999999999998864

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.3e-38  Score=337.48  Aligned_cols=150  Identities=27%  Similarity=0.379  Sum_probs=128.1

Q ss_pred             hcCccccceecccCceEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeC-C
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFS-LQTEREFQNELQILGGL-RSPFLVTLLGYCMER-N  152 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~-~  152 (718)
                      .++|++.+.||+|+||.||+|...      +++.||+|++.... ....+.+..|+.++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            457899999999999999999643      35789999986532 23345688899999999 899999999988654 5


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCC---------------------------------------------------------
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGN---------------------------------------------------------  175 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~---------------------------------------------------------  175 (718)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            68999999999999999864321                                                         


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          176 --LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       176 --~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                        ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.++|+|||+++.+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~  223 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDI  223 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhc
Confidence              25788899999999999999999   899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.4e-37  Score=323.52  Aligned_cols=147  Identities=28%  Similarity=0.439  Sum_probs=123.6

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCC---CCCcceeEEEEEee-----CC
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGL---RSPFLVTLLGYCME-----RN  152 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~-----~~  152 (718)
                      +|++.+.||+|+||.||+|.+. +++.||+|.+....  ......+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999987 68999999886422  11223456777777655   79999999999864     24


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                      ..++||||+. ++|.+++.......+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            5799999996 69999987655446899999999999999999999   8999999999999999999999999999887


Q ss_pred             ee
Q 005033          233 IK  234 (718)
Q Consensus       233 ~~  234 (718)
                      ..
T Consensus       157 ~~  158 (288)
T cd07863         157 IY  158 (288)
T ss_pred             cc
Confidence            53

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-37  Score=317.09  Aligned_cols=148  Identities=36%  Similarity=0.563  Sum_probs=134.4

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      .++|++.+.||.|+||.||+|... |+.||||.+..... ..+.+.+|+.+++.++|+||+++++++...+..|+||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            357888999999999999999875 78999999976543 5667999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++++|.+++.......+++..+..++.|++.||.|||   ..+|+||||||+||+++.++.++|+|||+++..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~  152 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEA  152 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccc
Confidence            9999999998765446899999999999999999999   999999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=8.8e-38  Score=333.72  Aligned_cols=140  Identities=30%  Similarity=0.438  Sum_probs=120.2

Q ss_pred             ceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHH-HHhCCCCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQ-ILGGLRSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~-iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||.||+|.+. +++.||+|++....   ......+..|.. +++.++|+||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999987 57899999986422   122234444544 56889999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+|.+++....  .+.+..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~  145 (325)
T cd05602          81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKE  145 (325)
T ss_pred             CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence            99999997654  4677888889999999999999   99999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-38  Score=370.85  Aligned_cols=149  Identities=30%  Similarity=0.508  Sum_probs=134.0

Q ss_pred             cCccccceecccCceEEEEEEEcC--Cc----EEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARD--GK----LLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~--g~----~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~  155 (718)
                      .+.+..+.||+|+||.||.|...+  |.    .||||.+... +.+...+|.+|..+|+.++|||||+++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            445667899999999999999863  43    5999999764 4566788999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccC
Q 005033          156 LVYEYMPNKSLQEMLFSDG-----NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL  230 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~-----~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGL  230 (718)
                      |++|||++|||..||+...     ...+.....+.++.|||+|+.||+   ++++|||||..+|+||+....+||+||||
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999998762     246888999999999999999999   99999999999999999999999999999


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      |+.+
T Consensus       849 ArDi  852 (1025)
T KOG1095|consen  849 ARDI  852 (1025)
T ss_pred             hHhh
Confidence            9965

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.5e-37  Score=326.87  Aligned_cols=148  Identities=34%  Similarity=0.542  Sum_probs=128.9

Q ss_pred             cCccccceecccCceEEEEEEEcC-C--cEEEEEEcccC-ChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARD-G--KLLAIKRLDTF-SLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~-g--~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ++|++.+.||+|+||.||+|...+ +  ..+|+|.+... .....+.|.+|+.++.++ +||||+++++++...+..|+|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578899999999999999998763 3  35788888643 334456789999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCE
Q 005033          158 YEYMPNKSLQEMLFSDGN--------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG  223 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~--------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~v  223 (718)
                      |||+++|+|.+++.....              ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            999999999999975421              24788899999999999999999   8999999999999999999999


Q ss_pred             EEeeccCcee
Q 005033          224 KVSDFGLSRI  233 (718)
Q Consensus       224 KLsDFGLAr~  233 (718)
                      ||+|||++..
T Consensus       159 kl~dfg~~~~  168 (297)
T cd05089         159 KIADFGLSRG  168 (297)
T ss_pred             EECCcCCCcc
Confidence            9999998753

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-37  Score=323.95  Aligned_cols=149  Identities=30%  Similarity=0.464  Sum_probs=132.7

Q ss_pred             cCccccceecccCceEEEEEEEc------CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      .+|.....||+|+||.||++...      ++..+|+|.+..........|.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46778899999999999999642      356899999877666666789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCE
Q 005033          157 VYEYMPNKSLQEMLFSDGN-------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG  223 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~-------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~v  223 (718)
                      ||||+++|+|.+++.....             ..+++..++.++.||+.||.|||   +.+|+||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            9999999999999976532             24788999999999999999999   9999999999999999999999


Q ss_pred             EEeeccCceee
Q 005033          224 KVSDFGLSRIK  234 (718)
Q Consensus       224 KLsDFGLAr~~  234 (718)
                      +|+|||+++..
T Consensus       162 kL~dfg~~~~~  172 (280)
T cd05092         162 KIGDFGMSRDI  172 (280)
T ss_pred             EECCCCceeEc
Confidence            99999998753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.2e-37  Score=317.07  Aligned_cols=145  Identities=36%  Similarity=0.523  Sum_probs=129.1

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEe-eCCeEEEEEecc
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM-ERNKRILVYEYM  161 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~-~~~~~~LVmEy~  161 (718)
                      .+|++.+.||+|+||.||++... |..||+|.+....  ..+.|.+|+.++++++|+||+++++++. ..+..|+||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            47888999999999999999765 7889999986532  3457899999999999999999999765 456789999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ++++|.+++.......+++..++.++.||+.||.|||   ..+|+||||||+||+++.++.+||+|||+++.
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  151 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  151 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCcccee
Confidence            9999999998766556889999999999999999999   89999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.7e-37  Score=337.76  Aligned_cols=154  Identities=29%  Similarity=0.389  Sum_probs=136.0

Q ss_pred             HHHHHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEee
Q 005033           75 YKELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCME  150 (718)
Q Consensus        75 ~~el~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~  150 (718)
                      +.++....++|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|+.++..++||||+++++++..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4455566789999999999999999999987 58899999985421   2234557899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccC
Q 005033          151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL  230 (718)
Q Consensus       151 ~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGL  230 (718)
                      ++..|+||||+++|+|.+++...   .++...+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            99999999999999999999754   4788888899999999999999   99999999999999999999999999999


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      ++..
T Consensus       189 a~~~  192 (371)
T cd05622         189 CMKM  192 (371)
T ss_pred             eeEc
Confidence            8764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-38  Score=359.76  Aligned_cols=152  Identities=26%  Similarity=0.398  Sum_probs=133.6

Q ss_pred             HhcCccccceecccCceEEEEEEEcCC-cEEEEEEcccCChhhHHHHHHHHHHHhCCC-CCcceeEEEE-Eee---C---
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIARDG-KLLAIKRLDTFSLQTEREFQNELQILGGLR-SPFLVTLLGY-CME---R---  151 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~~g-~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~-~~~---~---  151 (718)
                      ...++++.+.|.+|||+.||++.+..+ ..||+|++-..+....+.+.+||++|+.|. |+|||.+++. ...   .   
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            344567889999999999999999865 999999997777888889999999999996 9999999993 221   1   


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCc
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS  231 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLA  231 (718)
                      -+++|.||||.||.|-+++..+....|++.++++|+.|+++|+++|| .+.++|||||||.+||||+.++..||||||.|
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            25689999999999999998766567999999999999999999999 34788999999999999999999999999987


Q ss_pred             ee
Q 005033          232 RI  233 (718)
Q Consensus       232 r~  233 (718)
                      .-
T Consensus       194 tt  195 (738)
T KOG1989|consen  194 TT  195 (738)
T ss_pred             cc
Confidence            54

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-37  Score=325.35  Aligned_cols=149  Identities=25%  Similarity=0.438  Sum_probs=129.6

Q ss_pred             cCccccceecccCceEEEEEEEcC---------------CcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARD---------------GKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLG  146 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~---------------g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g  146 (718)
                      ++|++.+.||+|+||.||+|....               ...||||.+... .......|.+|++++++++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578899999999999999987642               235899998653 2334567999999999999999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCHHHHHhhCCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEE
Q 005033          147 YCMERNKRILVYEYMPNKSLQEMLFSDGN----------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVL  216 (718)
Q Consensus       147 ~~~~~~~~~LVmEy~~gGsL~~~L~~~~~----------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NIL  216 (718)
                      ++...+..++||||+++++|.+++.....          ..+++..++.++.|++.||.|||   +.+++||||||+|||
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            99999999999999999999999965321          24678889999999999999999   899999999999999


Q ss_pred             ECCCCCEEEeeccCceee
Q 005033          217 LDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       217 Ld~~~~vKLsDFGLAr~~  234 (718)
                      ++.++.+||+|||+++..
T Consensus       162 l~~~~~~kl~dfg~~~~~  179 (295)
T cd05097         162 VGNHYTIKIADFGMSRNL  179 (295)
T ss_pred             EcCCCcEEeccccccccc
Confidence            999999999999988753

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3e-37  Score=314.02  Aligned_cols=141  Identities=30%  Similarity=0.476  Sum_probs=126.8

Q ss_pred             ceecccCceEEEEEEEcCCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCCHH
Q 005033           89 NVIGKGGSGTVFLGIARDGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQ  167 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL~  167 (718)
                      +.||+|+||.||+|...++..||+|.+.... ......|.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3689999999999998888999999986543 233456899999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          168 EMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       168 ~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +++..... .+++..++.++.|++.||.|||   ..+++||||||+||+++.++.++|+|||++..
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~  142 (250)
T cd05085          81 SFLRKKKD-ELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQ  142 (250)
T ss_pred             HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCcccee
Confidence            99876532 5788999999999999999999   89999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.3e-37  Score=332.69  Aligned_cols=145  Identities=30%  Similarity=0.368  Sum_probs=127.4

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCCeEEEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLR-SPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      +|+..+.||+|+||.||+|... +|+.||||++....   ......+..|+.++..+. |++|+++++++...+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4777899999999999999976 68999999986432   223456788999998885 577889999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||+++|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~  150 (323)
T cd05615          81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccc
Confidence            9999999999997654  5888999999999999999999   89999999999999999999999999998864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.8e-37  Score=317.22  Aligned_cols=149  Identities=25%  Similarity=0.411  Sum_probs=131.7

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||.||++... ++..||||.+...   .......+.+|+.+++.++|+||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888899999999999999975 7899999987542   2233467899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSD--GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~--~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++++|.+++...  ....+++..+..++.||+.||.|||   +.+++|+||||+||+++.++.++|+|||++...
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence            999999999998642  2235789999999999999999999   999999999999999999999999999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2e-37  Score=324.04  Aligned_cols=151  Identities=24%  Similarity=0.404  Sum_probs=130.4

Q ss_pred             HhcCccccceecccCceEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNK  153 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~  153 (718)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.+.... ......+.+|+.+++.++|+||+++++++...+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999754      24589999886432 2334568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEE
Q 005033          154 RILVYEYMPNKSLQEMLFSDG--------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKV  225 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~--------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKL  225 (718)
                      .|+||||+++|+|.+++....        .....+..+..++.|++.||.|||   +++|+||||||+|||++.++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999997532        123466778899999999999999   999999999999999999999999


Q ss_pred             eeccCceee
Q 005033          226 SDFGLSRIK  234 (718)
Q Consensus       226 sDFGLAr~~  234 (718)
                      +|||+++..
T Consensus       161 ~Dfg~~~~~  169 (288)
T cd05061         161 GDFGMTRDI  169 (288)
T ss_pred             CcCCccccc
Confidence            999998753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2e-37  Score=327.67  Aligned_cols=151  Identities=27%  Similarity=0.365  Sum_probs=132.6

Q ss_pred             HhcCccccceecccCceEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCC
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFS-LQTEREFQNELQILGGL-RSPFLVTLLGYCMERN  152 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~  152 (718)
                      ..++|.+.+.||+|+||.||++...      .+..||||++.... ......+.+|+.+++++ +|+||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            3457899999999999999999752      35589999986543 33346789999999999 7999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                      ..|+||||+++|+|.+++.......+++.++..++.||+.||.|||   +.+|+|+||||+|||++.++.++|+|||+++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999997654445899999999999999999999   8999999999999999999999999999887


Q ss_pred             ee
Q 005033          233 IK  234 (718)
Q Consensus       233 ~~  234 (718)
                      ..
T Consensus       190 ~~  191 (302)
T cd05055         190 DI  191 (302)
T ss_pred             cc
Confidence            53

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.9e-37  Score=324.81  Aligned_cols=146  Identities=30%  Similarity=0.400  Sum_probs=130.1

Q ss_pred             ccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           85 FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      |+..+.||+|+||.||++... +++.||||.+....   ......+.+|+.++..++|+||+.+++.+...+..|+||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677889999999999999987 68999999985432   22234578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +++++|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++..
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVH  151 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceee
Confidence            99999999997655556888999999999999999999   89999999999999999999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.8e-37  Score=324.34  Aligned_cols=148  Identities=24%  Similarity=0.410  Sum_probs=128.7

Q ss_pred             CccccceecccCceEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      +|++.+.||+|+||.||+|...      ....+|+|.+.... ......+.+|+.+++.++||||+++++.|...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999864      23579999886543 3345678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 005033          157 VYEYMPNKSLQEMLFSDG----------------------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSN  214 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~----------------------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~N  214 (718)
                      ||||+.+|+|.+++....                      ...+++..++.++.|++.||.|||   +.+|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999986431                      124788899999999999999999   8999999999999


Q ss_pred             EEECCCCCEEEeeccCceee
Q 005033          215 VLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       215 ILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++++.+||+|||+++..
T Consensus       158 ill~~~~~~kl~dfg~~~~~  177 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDV  177 (290)
T ss_pred             EEEcCCCcEEeccccccccc
Confidence            99999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.1e-37  Score=317.75  Aligned_cols=139  Identities=27%  Similarity=0.456  Sum_probs=122.4

Q ss_pred             eecccCceEEEEEEEc---CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCC
Q 005033           90 VIGKGGSGTVFLGIAR---DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNK  164 (718)
Q Consensus        90 ~LG~G~FG~Vykg~~~---~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gG  164 (718)
                      .||+|+||.||+|.+.   ++..+|||++....  ....+.+.+|+.+++.+.|+||+++++++. ....++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999753   57899999986432  334567999999999999999999999885 45679999999999


Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          165 SLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       165 sL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +|.+++....  .+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~  145 (257)
T cd05116          81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  145 (257)
T ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCcccccc
Confidence            9999997654  5788999999999999999999   899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.9e-37  Score=333.35  Aligned_cols=145  Identities=26%  Similarity=0.411  Sum_probs=125.5

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC------
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMER------  151 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------  151 (718)
                      ..++|++.+.||+|+||.||++.+. .++.||||.+...  .......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999876 5889999998643  233446788999999999999999999998644      


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCc
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS  231 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLA  231 (718)
                      ...|+||||+. ++|.+.+..    .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          95 QDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             ceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence            35799999995 578777753    3778888999999999999999   999999999999999999999999999998


Q ss_pred             ee
Q 005033          232 RI  233 (718)
Q Consensus       232 r~  233 (718)
                      +.
T Consensus       167 ~~  168 (355)
T cd07874         167 RT  168 (355)
T ss_pred             cc
Confidence            75

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.9e-37  Score=327.65  Aligned_cols=149  Identities=34%  Similarity=0.556  Sum_probs=129.5

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCc--EEEEEEcccC-ChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGK--LLAIKRLDTF-SLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~--~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~L  156 (718)
                      .++|++.+.||+|+||.||+|.+. ++.  .+|+|.+... .......|.+|++++.++ +|+||+++++++...+..|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357888999999999999999975 344  4688877543 234456788999999999 89999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC
Q 005033          157 VYEYMPNKSLQEMLFSDG--------------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR  222 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~--------------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~  222 (718)
                      ||||+++|+|.+++....              ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999997543              125788899999999999999999   999999999999999999999


Q ss_pred             EEEeeccCcee
Q 005033          223 GKVSDFGLSRI  233 (718)
Q Consensus       223 vKLsDFGLAr~  233 (718)
                      +||+|||+++.
T Consensus       163 ~kl~dfg~~~~  173 (303)
T cd05088         163 AKIADFGLSRG  173 (303)
T ss_pred             EEeCccccCcc
Confidence            99999998753

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.9e-37  Score=316.51  Aligned_cols=153  Identities=26%  Similarity=0.321  Sum_probs=133.6

Q ss_pred             HHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           78 LKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        78 l~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      +..+++++.....||+|+||.||+|.+. ++..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3455667777789999999999999976 578899999876655666789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC-CCCEEEeeccCcee
Q 005033          157 VYEYMPNKSLQEMLFSDGN-LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS-DCRGKVSDFGLSRI  233 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~-~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~-~~~vKLsDFGLAr~  233 (718)
                      |+||+++++|.+++..... ...++..+..++.||+.||.|||   +.+|+||||||+||+++. ++.++|+|||++..
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            9999999999999976432 12277888889999999999999   899999999999999976 67999999998865

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.6e-37  Score=324.46  Aligned_cols=145  Identities=28%  Similarity=0.464  Sum_probs=132.3

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      .+|++.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.+.|+||+++++++..+...|+||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888999999999999999875 68899999987655555667899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ++++|.+++...   .+++.++..++.|++.||.|||   ..+|+||||||+|||++.++.++|+|||++..
T Consensus       100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~  165 (296)
T cd06654         100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  165 (296)
T ss_pred             CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchh
Confidence            999999998654   4788899999999999999999   89999999999999999999999999998765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.2e-37  Score=329.39  Aligned_cols=140  Identities=27%  Similarity=0.362  Sum_probs=124.8

Q ss_pred             ceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||.||+|... +++.||||++....   ......+.+|+.++.++ +||||+.+++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999986 57899999996532   22345688999999888 699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+|..++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~  145 (327)
T cd05617          81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE  145 (327)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEecccccee
Confidence            99999887654  5889999999999999999999   89999999999999999999999999998864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.7e-37  Score=335.18  Aligned_cols=145  Identities=28%  Similarity=0.475  Sum_probs=128.3

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC-----eEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERN-----KRI  155 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~~  155 (718)
                      +|++.+.||+|+||.||++.+. +|+.||||.+...  .....+.+.+|+.+++.++|+||+++++++...+     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            5788999999999999999975 6899999998642  2234467889999999999999999999998776     789


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +||||+. ++|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999995 78988886554  5788999999999999999999   899999999999999999999999999998753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-37  Score=313.51  Aligned_cols=147  Identities=27%  Similarity=0.431  Sum_probs=131.2

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-----hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-----LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+....     ......+.+|+.++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57899999999999999999875 68999999885422     1223568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||||+++++|.+++....  .+++..+..++.|++.||.|||   +.+|+||||+|+||+++.++.++|+|||+++..
T Consensus        82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            999999999999997654  5788888999999999999999   899999999999999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.3e-37  Score=320.98  Aligned_cols=142  Identities=27%  Similarity=0.448  Sum_probs=127.0

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+... .......+.+|+.++.+++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36788899999999999999875 6889999998643 234456799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +++++|..+.      .+++..+..++.|++.||.|||   +.+|+|+||||+|||++.++.++|+|||++..
T Consensus        81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~  144 (279)
T cd06619          81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQ  144 (279)
T ss_pred             CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCccee
Confidence            9999997653      3677888899999999999999   99999999999999999999999999998865

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.6e-37  Score=314.11  Aligned_cols=147  Identities=26%  Similarity=0.481  Sum_probs=132.3

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChh--hHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQ--TEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .+|...+.||+|.||.||+|++. +|+.||||++......  .....++||..|+.++|+||+.|+++|...+.+-||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46777889999999999999986 7999999999654322  23467899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      || ..||...|+... ..+....+..++.++++||+|||   .+.|+||||||.|+||+.+|.+||+|||||+..
T Consensus        82 fm-~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f  151 (318)
T KOG0659|consen   82 FM-PTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFF  151 (318)
T ss_pred             ec-cccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhcc
Confidence            99 569999997764 47888999999999999999999   999999999999999999999999999999985

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.6e-37  Score=319.37  Aligned_cols=148  Identities=28%  Similarity=0.492  Sum_probs=131.4

Q ss_pred             cCccccceecccCceEEEEEEEc-----CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC--CeEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-----DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMER--NKRI  155 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-----~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~  155 (718)
                      .+|++.+.||+|+||.||+|...     ++..||||.+........+.|.+|++++..++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            57888999999999999999743     5789999999776666667899999999999999999999987543  4689


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +||||+++|+|.+++..... .+++..+..++.|++.||.|||   ..+|+||||||+|||++.++.++|+|||+++..
T Consensus        84 lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRE-RLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCc-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            99999999999999976532 5788999999999999999999   899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=329.89  Aligned_cols=144  Identities=28%  Similarity=0.468  Sum_probs=128.7

Q ss_pred             CccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhC--CCCCcceeEEEEEeeCC----eEEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGG--LRSPFLVTLLGYCMERN----KRILV  157 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~--L~HpNIV~L~g~~~~~~----~~~LV  157 (718)
                      ..++..+||+|.||.||+|.+. ++.||||++..   +..+.|++|-+|.+.  ++|+||++++++-....    .++||
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            4456678999999999999986 59999998854   566789999888764  58999999999987666    78999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCeEecCCCCCCEEECCCCCEEEeeccCc
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG------CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS  231 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~------~~~gIVHRDLKP~NILLd~~~~vKLsDFGLA  231 (718)
                      +||.+.|+|.+||..+   .++|....+|+..+++||+|||+.      ..++|+|||||++||||..|+++.|+|||||
T Consensus       287 t~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             eeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            9999999999999987   789999999999999999999964      3678999999999999999999999999999


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      ..+
T Consensus       364 l~~  366 (534)
T KOG3653|consen  364 LRL  366 (534)
T ss_pred             EEe
Confidence            986

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-38  Score=336.13  Aligned_cols=147  Identities=26%  Similarity=0.471  Sum_probs=134.6

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      .+|++.+.||+|.||.|-++... .|+.||||.|++...   ++.-.+.+||+||+.|+||||+.+|.+|+..+.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            46888899999999999999874 799999999976543   34456789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||..+|.|++|+...+  .+++.++..+++||+.|+.|+|   .++++|||||.+|||+|.++++||+||||+-..
T Consensus       133 EYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  133 EYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             EecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhh
Confidence            9999999999998876  6899999999999999999999   999999999999999999999999999998653

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=340.20  Aligned_cols=152  Identities=27%  Similarity=0.436  Sum_probs=136.1

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcccCCh-hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL-QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      +...+.+.||+|.||.|.+|....+..||||+++.... ....+|.+|+++|.+|+|||||+|+|+|..++.+|+|+|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            34556789999999999999998889999999987543 44588999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceeeecC
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG  237 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~  237 (718)
                      ++|+|.+||..+....+.-...+.|+.||+.||+||.   +.++|||||.++|||++.++++||+|||++|.+..+
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccC
Confidence            9999999998885544455667789999999999999   999999999999999999999999999999976433

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-38  Score=319.74  Aligned_cols=149  Identities=32%  Similarity=0.453  Sum_probs=135.1

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++|++.+.||+|-||.||+|+.+ ++-.||+|++.+..   .+...++.+|++|-+.|+||||+++|++|.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            367899999999999999999987 57899999996533   23346789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +||.++|+|...|.......+++.....++.|+|.||.|+|   .++||||||||+|+|++..+.+||+|||-+-.
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVH  173 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence            99999999999999766667888899999999999999999   99999999999999999999999999997654

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.2e-37  Score=337.50  Aligned_cols=147  Identities=28%  Similarity=0.430  Sum_probs=132.5

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|+..+.||+|+||.||++... +++.||||++....   ......+.+|+.++..++|+||+++++++...+..||||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999986 58999999986422   223456888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++|+|.+++....  .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||+++..
T Consensus        81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            9999999999997654  5788899999999999999999   999999999999999999999999999999865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4e-37  Score=316.93  Aligned_cols=147  Identities=22%  Similarity=0.417  Sum_probs=124.0

Q ss_pred             ccccceecccCceEEEEEEEcC-Cc--EEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC------Ce
Q 005033           85 FDEANVIGKGGSGTVFLGIARD-GK--LLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMER------NK  153 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~~-g~--~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~~  153 (718)
                      |.+.+.||+|+||.||+|.... +.  .||||.+...  .......|.+|+.+++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3466889999999999999864 33  6899988643  234456789999999999999999999987542      24


Q ss_pred             EEEEEeccCCCCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeecc
Q 005033          154 RILVYEYMPNKSLQEMLFSD----GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG  229 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~----~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFG  229 (718)
                      .++||||+++|+|.+++...    ....+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999987432    1235789999999999999999999   8999999999999999999999999999


Q ss_pred             Cceee
Q 005033          230 LSRIK  234 (718)
Q Consensus       230 LAr~~  234 (718)
                      +++..
T Consensus       158 ~~~~~  162 (272)
T cd05075         158 LSKKI  162 (272)
T ss_pred             ccccc
Confidence            98764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.4e-37  Score=324.74  Aligned_cols=151  Identities=23%  Similarity=0.390  Sum_probs=131.0

Q ss_pred             HhcCccccceecccCceEEEEEEEc--------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCC-CCCcceeEEEEEee
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR--------DGKLLAIKRLDTFS-LQTEREFQNELQILGGL-RSPFLVTLLGYCME  150 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~--------~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~  150 (718)
                      ..++|.+.+.||+|+||.||+|...        ++..||+|.+.... ......+.+|+.++..+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3467888999999999999999742        24579999986432 34456789999999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEE
Q 005033          151 RNKRILVYEYMPNKSLQEMLFSDGN--------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVL  216 (718)
Q Consensus       151 ~~~~~LVmEy~~gGsL~~~L~~~~~--------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NIL  216 (718)
                      ....|+||||+++|+|.+++.....              ..+++..++.++.||+.||.|||   +++|+||||||+|||
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEE
Confidence            9999999999999999999976421              24678888999999999999999   899999999999999


Q ss_pred             ECCCCCEEEeeccCceee
Q 005033          217 LDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       217 Ld~~~~vKLsDFGLAr~~  234 (718)
                      ++.++.+||+|||+++..
T Consensus       170 i~~~~~~kl~D~g~~~~~  187 (304)
T cd05101         170 VTENNVMKIADFGLARDV  187 (304)
T ss_pred             EcCCCcEEECCCccceec
Confidence            999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.6e-37  Score=314.63  Aligned_cols=148  Identities=22%  Similarity=0.377  Sum_probs=132.5

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      .++|++.+.||+|+||.||++....+..+|+|.+.... .....|.+|+.+++.++|+||+++++++.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            46789999999999999999998778889999886532 345678999999999999999999999887 7789999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++|+|.+++.......+++..++.++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++...
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  152 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVI  152 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeec
Confidence            9999999998765556788899999999999999999   889999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-37  Score=314.98  Aligned_cols=150  Identities=28%  Similarity=0.446  Sum_probs=135.7

Q ss_pred             HhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ..++|.+.+.||+|+||.||++...+++.||||.+.... .....+.+|+.+++.++|+||+++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            346889999999999999999998878899999987533 3346789999999999999999999999998999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++++|.+++.......+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++..
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~  153 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLI  153 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceec
Confidence            99999999998765456899999999999999999999   899999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5e-37  Score=316.67  Aligned_cols=148  Identities=28%  Similarity=0.455  Sum_probs=131.5

Q ss_pred             cCccccceecccCceEEEEEEEcC-C---cEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARD-G---KLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~-g---~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ++|++.+.||+|+||.||+|.... +   ..||||.+... .......|..|+.+++.++||||+++++++..+...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457888999999999999998763 3   36999998654 344456899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++|+|.+++..... .+++..++.++.|++.||.|||   +.+++||||||+||+++.++.++|+|||+++..
T Consensus        84 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          84 TEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             EecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence            999999999999976543 5788999999999999999999   899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-38  Score=337.81  Aligned_cols=151  Identities=36%  Similarity=0.450  Sum_probs=128.0

Q ss_pred             HHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChh--------------hHHHHHHHHHHHhCCCCCccee
Q 005033           79 KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQ--------------TEREFQNELQILGGLRSPFLVT  143 (718)
Q Consensus        79 ~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~--------------~~~~f~~Ei~iL~~L~HpNIV~  143 (718)
                      ....+.|.+...||+|.||.|-+|+.. +++.||||++.+....              ..+.+.+||.||++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            344578999999999999999999987 6999999999542111              1246889999999999999999


Q ss_pred             EEEEEeeC--CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC
Q 005033          144 LLGYCMER--NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC  221 (718)
Q Consensus       144 L~g~~~~~--~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~  221 (718)
                      |+.+.-+.  +.+|||+|||..|.+...=..  ...+.+.+++.|+++++.||+|||   .++||||||||+|+||+++|
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d--~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPD--KPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCCC--cccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCC
Confidence            99998664  578999999998887543211  123888999999999999999999   99999999999999999999


Q ss_pred             CEEEeeccCceee
Q 005033          222 RGKVSDFGLSRIK  234 (718)
Q Consensus       222 ~vKLsDFGLAr~~  234 (718)
                      ++||+|||.+-..
T Consensus       248 ~VKIsDFGVs~~~  260 (576)
T KOG0585|consen  248 TVKISDFGVSNEF  260 (576)
T ss_pred             cEEeeccceeeec
Confidence            9999999988764

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=327.02  Aligned_cols=148  Identities=26%  Similarity=0.352  Sum_probs=131.7

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||.||++... +++.||||++...   .....+.|.+|+.++..++|+||+++++++..++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999986 5899999998642   1223456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++|+|.+++..... .+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++...
T Consensus        81 e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  152 (331)
T cd05597          81 DYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL  152 (331)
T ss_pred             ecCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence            99999999999976432 5788899999999999999999   999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.2e-37  Score=323.25  Aligned_cols=141  Identities=22%  Similarity=0.416  Sum_probs=118.8

Q ss_pred             cceecccCceEEEEEEEc---CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEee--CCeEEEEEeccC
Q 005033           88 ANVIGKGGSGTVFLGIAR---DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME--RNKRILVYEYMP  162 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~---~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LVmEy~~  162 (718)
                      ...||+|+||.||+|...   +++.||+|.+....  ....+.+|+.+|+.++||||+++++++..  ....|+||||+ 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence            468999999999999865   46789999986532  23457889999999999999999999854  45689999999 


Q ss_pred             CCCHHHHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE----CCCCCEEEeeccCc
Q 005033          163 NKSLQEMLFSDG-------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL----DSDCRGKVSDFGLS  231 (718)
Q Consensus       163 gGsL~~~L~~~~-------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL----d~~~~vKLsDFGLA  231 (718)
                      +++|.+++....       ...+++..+..++.||+.||.|||   +.+|+||||||+|||+    +.++.+||+|||++
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            569988875431       235788899999999999999999   8999999999999999    45678999999998


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      +..
T Consensus       160 ~~~  162 (317)
T cd07868         160 RLF  162 (317)
T ss_pred             ecc
Confidence            764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3e-37  Score=325.97  Aligned_cols=150  Identities=24%  Similarity=0.378  Sum_probs=130.9

Q ss_pred             hcCccccceecccCceEEEEEEEc--------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeC
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR--------DGKLLAIKRLDTF-SLQTEREFQNELQILGGL-RSPFLVTLLGYCMER  151 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~--------~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~  151 (718)
                      .++|.+.+.||+|+||.||++...        ++..+|+|.+... .......+.+|+.++..+ +|+||++++++|...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            357899999999999999999753        2357999998753 233456788999999999 799999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDGN--------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL  217 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~~--------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL  217 (718)
                      +..|+||||+++|+|.+++.....              ..+++..++.++.|++.||+|||   +.+++||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence            999999999999999999976431              24788899999999999999999   8999999999999999


Q ss_pred             CCCCCEEEeeccCceee
Q 005033          218 DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       218 d~~~~vKLsDFGLAr~~  234 (718)
                      +.++.+||+|||+++..
T Consensus       174 ~~~~~~kL~dfg~a~~~  190 (307)
T cd05098         174 TEDNVMKIADFGLARDI  190 (307)
T ss_pred             cCCCcEEECCCcccccc
Confidence            99999999999988753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7.4e-37  Score=311.87  Aligned_cols=148  Identities=28%  Similarity=0.392  Sum_probs=130.2

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEee-CCeEEEEEe
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCME-RNKRILVYE  159 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~~~LVmE  159 (718)
                      +|++.+.||+|+||.||++... +++.||+|.+....  ....+.+.+|+.++++++|+||+++++.+.. ....|+|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4888999999999999999976 57899999986432  2344578899999999999999999998864 446899999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+++++|.+++.......+++.++..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++...
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEe
Confidence            999999999998754446899999999999999999999   899999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.5e-37  Score=345.94  Aligned_cols=146  Identities=24%  Similarity=0.364  Sum_probs=121.6

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC--------
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMER--------  151 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--------  151 (718)
                      ...+|++.+.||+|+||.||+|... +++.||||++....    ....+|+.+|+.++|||||++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3467999999999999999999986 58999999885422    2345799999999999999999887532        


Q ss_pred             CeEEEEEeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC-CEEEeec
Q 005033          152 NKRILVYEYMPNKSLQEMLFSD--GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC-RGKVSDF  228 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~--~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~-~vKLsDF  228 (718)
                      ...++||||++ ++|.+++...  ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence            24679999996 5787777532  2346888999999999999999999   89999999999999998665 7999999


Q ss_pred             cCceee
Q 005033          229 GLSRIK  234 (718)
Q Consensus       229 GLAr~~  234 (718)
                      |+|+..
T Consensus       216 Gla~~~  221 (440)
T PTZ00036        216 GSAKNL  221 (440)
T ss_pred             ccchhc
Confidence            998753

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8.7e-37  Score=331.00  Aligned_cols=145  Identities=25%  Similarity=0.400  Sum_probs=125.6

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC------
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMER------  151 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------  151 (718)
                      ..++|++.+.||+|+||.||++.+. .++.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999976 5889999998643  233446788999999999999999999988643      


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCc
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS  231 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLA  231 (718)
                      ...|+||||+. ++|.+++..    .+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            35799999995 588887753    3678888999999999999999   899999999999999999999999999998


Q ss_pred             ee
Q 005033          232 RI  233 (718)
Q Consensus       232 r~  233 (718)
                      +.
T Consensus       174 ~~  175 (364)
T cd07875         174 RT  175 (364)
T ss_pred             cc
Confidence            75

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.8e-37  Score=321.45  Aligned_cols=146  Identities=32%  Similarity=0.392  Sum_probs=130.3

Q ss_pred             ccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           85 FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      |+..+.||+|+||+||++.+. +++.||+|.+....   ......+.+|+.+|+.++|+||+.+++++..++..|+||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999886 68899999986432   12234578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +++++|.+++...+...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++..
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~  151 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVK  151 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCccee
Confidence            99999999987655556899999999999999999999   99999999999999999999999999998865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=8.4e-37  Score=311.77  Aligned_cols=148  Identities=24%  Similarity=0.391  Sum_probs=133.2

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +|+..+.||.|+||.||.+... +++.+++|.+...  .......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5788999999999999998876 5889999987543  344456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++|+|.+++.......+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||++...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~  151 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL  151 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence            99999999998764456889999999999999999999   899999999999999999999999999988753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.7e-37  Score=318.33  Aligned_cols=148  Identities=30%  Similarity=0.540  Sum_probs=128.7

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCc----EEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGK----LLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~----~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~  155 (718)
                      .++|+..+.||+|+||+||+|.+. ++.    .||||.+... .......+.+|+.++..++|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            357888999999999999999864 444    4899998653 33445678999999999999999999999975 4578


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++|||+++|+|.+++..... .+++..++.++.||+.||.|||   +.+|+||||||+|||+++++.+||+|||+++..
T Consensus        85 l~~~~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKD-RIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence            99999999999999976532 5788999999999999999999   999999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.1e-36  Score=322.47  Aligned_cols=146  Identities=27%  Similarity=0.432  Sum_probs=130.7

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ++|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++.+++||||++++++|..++..|+||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46889999999999999999876 5889999988653 233445688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD-PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~-~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +++++|.+++....  .+++..+..++.||+.||.|||   + .+++||||||+|||++.++.++|+|||++..
T Consensus        81 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  149 (308)
T cd06615          81 MDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  149 (308)
T ss_pred             cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCccc
Confidence            99999999997664  5788889999999999999999   6 5899999999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.9e-37  Score=324.05  Aligned_cols=146  Identities=26%  Similarity=0.438  Sum_probs=129.1

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57899999999999999999986 58899999986432 22234678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ++ ++|.+++...+. .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  153 (309)
T cd07872          86 LD-KDLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA  153 (309)
T ss_pred             CC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcccccee
Confidence            96 589988876543 5788889999999999999999   89999999999999999999999999998875

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.9e-37  Score=316.20  Aligned_cols=148  Identities=30%  Similarity=0.443  Sum_probs=131.3

Q ss_pred             cCccccceecccCceEEEEEEEc-C---CcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-D---GKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~---g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .+|++.+.||+|+||.||+|... +   +..+|+|.+.... ......|.+|+.++.+++||||+++++++..++..|+|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            47888999999999999999874 2   3479999986532 33456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++++|.+++..... .+++..++.++.|++.||.|||   +.+++||||||+|||++.++.++|+|||+++..
T Consensus        84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          84 TEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            999999999999976543 5788999999999999999999   999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=8.9e-37  Score=321.65  Aligned_cols=146  Identities=29%  Similarity=0.463  Sum_probs=133.2

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ..+|++.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++|+||+++++++..++..|+||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            367899999999999999999975 6899999998765545556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +++++|.+++...   .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||++..
T Consensus        98 ~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~  164 (297)
T cd06656          98 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  164 (297)
T ss_pred             cCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceE
Confidence            9999999999654   4788899999999999999999   89999999999999999999999999998865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.4e-37  Score=319.95  Aligned_cols=150  Identities=29%  Similarity=0.473  Sum_probs=132.0

Q ss_pred             hcCccccceecccCceEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~  154 (718)
                      .++|++.+.||+|+||.||++...      ++..||+|.+.... ......|.+|+.+++.++||||+++++++..+...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            468999999999999999999864      46789999986532 34456799999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 005033          155 ILVYEYMPNKSLQEMLFSDG--------------------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSN  214 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~--------------------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~N  214 (718)
                      |+||||+++|+|.+++....                    ...+++..++.++.|++.||.|||   ..+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999997432                    124678888999999999999999   8999999999999


Q ss_pred             EEECCCCCEEEeeccCceee
Q 005033          215 VLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       215 ILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||++.++.++|+|||+++..
T Consensus       161 il~~~~~~~~l~dfg~~~~~  180 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNI  180 (288)
T ss_pred             eEecCCCceEECccccceec
Confidence            99999999999999988753

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.3e-37  Score=318.28  Aligned_cols=151  Identities=25%  Similarity=0.361  Sum_probs=132.3

Q ss_pred             HhcCccccceecccCceEEEEEEEcC-----CcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEee-CCe
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIARD-----GKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCME-RNK  153 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~~-----g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~  153 (718)
                      ..++|++.+.||+|+||.||+|.+..     +..||+|++... .......+.+|+.+++.++|+||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34678899999999999999999865     688999998653 33445678999999999999999999998876 467


Q ss_pred             EEEEEeccCCCCHHHHHhhCCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGN------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSD  227 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsD  227 (718)
                      .++++||+++|+|.+++.....      ..+++..++.++.||+.||.|||   +.+++||||||+||+++.++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence            8999999999999999976422      35889999999999999999999   89999999999999999999999999


Q ss_pred             ccCceee
Q 005033          228 FGLSRIK  234 (718)
Q Consensus       228 FGLAr~~  234 (718)
                      ||+++..
T Consensus       161 ~g~~~~~  167 (280)
T cd05043         161 NALSRDL  167 (280)
T ss_pred             CCCcccc
Confidence            9998754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9.7e-37  Score=317.07  Aligned_cols=145  Identities=26%  Similarity=0.391  Sum_probs=131.4

Q ss_pred             ccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           85 FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      |++.+.||+|+||.||+|... ++..+|+|.+..........+.+|+++++.++|+||+++++++...+..|+||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            577889999999999999987 4788999998766556667899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ++|..++.... ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||++..
T Consensus        87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  152 (282)
T cd06643          87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAK  152 (282)
T ss_pred             CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccc
Confidence            99999886533 26889999999999999999999   89999999999999999999999999998864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.1e-37  Score=344.43  Aligned_cols=139  Identities=21%  Similarity=0.380  Sum_probs=113.2

Q ss_pred             HHHHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCC------CCcceeEEEEE
Q 005033           76 KELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLR------SPFLVTLLGYC  148 (718)
Q Consensus        76 ~el~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~------HpNIV~L~g~~  148 (718)
                      +++...+++|++.+.||+|+||.||+|.+. +++.||||+++... .....+..|+.++..++      |.+|+.++++|
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            344556788999999999999999999886 58899999986432 22344566777766654      45689999988


Q ss_pred             eeC-CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEECCCC
Q 005033          149 MER-NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD-PPVIHGDIKPSNVLLDSDC  221 (718)
Q Consensus       149 ~~~-~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~-~gIVHRDLKP~NILLd~~~  221 (718)
                      ... .+.|+|||++ +++|.+++...+  .+++..+..|+.||+.||.|||   . .+||||||||+|||++.++
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~  269 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSD  269 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCC
Confidence            764 5789999998 889999987654  5888999999999999999999   6 5999999999999997665

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.1e-36  Score=313.42  Aligned_cols=148  Identities=28%  Similarity=0.382  Sum_probs=133.5

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++...+..|+||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            357888899999999999999876 5889999998765444456688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++++|.+++...+  .+++..+..++.|++.||.|||   ..+|+||||||+||+++.++.++|+|||++...
T Consensus        88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd06645          88 CGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQI  156 (267)
T ss_pred             cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence            99999999997664  5788999999999999999999   899999999999999999999999999988653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.8e-37  Score=341.02  Aligned_cols=152  Identities=25%  Similarity=0.372  Sum_probs=130.7

Q ss_pred             HHhcCccccceecccCceEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeC
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFS-LQTEREFQNELQILGGLR-SPFLVTLLGYCMER  151 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~  151 (718)
                      ...++|.+.+.||+|+||.||+|.+.      .+..||||++.... ....+.+.+|+.+|..+. |||||+++++|...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            34457888899999999999999864      24689999997532 233457889999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCCC--------------------------------------------------------
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDGN--------------------------------------------------------  175 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~~--------------------------------------------------------  175 (718)
                      +..|+|||||++|+|.++++....                                                        
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            999999999999999999965321                                                        


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCE
Q 005033          176 ----------------------------------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNV  215 (718)
Q Consensus       176 ----------------------------------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NI  215 (718)
                                                              ..+++..++.++.||+.||.|||   ..+|+||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceE
Confidence                                                    23677788899999999999999   89999999999999


Q ss_pred             EECCCCCEEEeeccCceee
Q 005033          216 LLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       216 LLd~~~~vKLsDFGLAr~~  234 (718)
                      |++.++.+||+|||+++..
T Consensus       271 Ll~~~~~~kL~DfGla~~~  289 (401)
T cd05107         271 LICEGKLVKICDFGLARDI  289 (401)
T ss_pred             EEeCCCEEEEEecCcceec
Confidence            9999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-37  Score=316.03  Aligned_cols=141  Identities=34%  Similarity=0.582  Sum_probs=123.1

Q ss_pred             ceecccCceEEEEEEEcC-Cc--EEEEEEcccC-ChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIARD-GK--LLAIKRLDTF-SLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~-g~--~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||.||+|.+.+ +.  .+|+|.+... .......+.+|++++.++ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999863 43  5789988643 234456789999999999 899999999999999999999999999


Q ss_pred             CCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeecc
Q 005033          164 KSLQEMLFSDG--------------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG  229 (718)
Q Consensus       164 GsL~~~L~~~~--------------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFG  229 (718)
                      |+|.+++....              ...+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999997542              124788899999999999999999   8999999999999999999999999999


Q ss_pred             Cce
Q 005033          230 LSR  232 (718)
Q Consensus       230 LAr  232 (718)
                      ++.
T Consensus       158 l~~  160 (270)
T cd05047         158 LSR  160 (270)
T ss_pred             Ccc
Confidence            875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=314.92  Aligned_cols=146  Identities=31%  Similarity=0.449  Sum_probs=132.5

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ++|++.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++++++..+...|+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999986 58899999986532 33446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++++|.+++...   .+++..+..++.|++.||.|||   ..+++||||+|+||+++.++.++|+|||+++..
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  148 (274)
T cd06609          81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQL  148 (274)
T ss_pred             eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceee
Confidence            9999999999765   6789999999999999999999   899999999999999999999999999998764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.5e-36  Score=325.67  Aligned_cols=148  Identities=26%  Similarity=0.341  Sum_probs=131.5

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|.+.+.||+|+||.||++... +++.||||++....   ......+.+|+.++..++|+||+++++++...+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999987 58899999986421   223345788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++|+|.+++..... .+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus        81 Ey~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~  152 (331)
T cd05624          81 DYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM  152 (331)
T ss_pred             eCCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence            99999999999976432 5788889999999999999999   999999999999999999999999999998753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.9e-37  Score=327.29  Aligned_cols=147  Identities=26%  Similarity=0.424  Sum_probs=127.7

Q ss_pred             HHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC-----
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMER-----  151 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----  151 (718)
                      ...++|++.+.||+|+||.||+|.+. +++.||||.+....  ......+.+|+.+|+.++|+||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            45578999999999999999999876 68899999986432  22345678999999999999999999988543     


Q ss_pred             -CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccC
Q 005033          152 -NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL  230 (718)
Q Consensus       152 -~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGL  230 (718)
                       ...|++||++ +++|.+++...   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcc
Confidence             3579999998 88999888643   5888999999999999999999   99999999999999999999999999998


Q ss_pred             cee
Q 005033          231 SRI  233 (718)
Q Consensus       231 Ar~  233 (718)
                      ++.
T Consensus       165 ~~~  167 (343)
T cd07878         165 ARQ  167 (343)
T ss_pred             cee
Confidence            875

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-36  Score=311.27  Aligned_cols=140  Identities=29%  Similarity=0.447  Sum_probs=123.3

Q ss_pred             ceecccCceEEEEEEEcC----CcEEEEEEcccCCh-hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIARD----GKLLAIKRLDTFSL-QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~----g~~VAVK~i~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||.||+|.+..    +..||+|.+..... .....+.+|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999998642    36899999875433 34567999999999999999999999876 4568999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+|.+++....  .+++..+..++.|++.||.|||   ..+++||||||+|||++.++.+||+|||+++..
T Consensus        80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~  145 (257)
T cd05060          80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL  145 (257)
T ss_pred             CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEecccccccee
Confidence            99999998765  5788999999999999999999   889999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=8.8e-37  Score=311.62  Aligned_cols=147  Identities=31%  Similarity=0.502  Sum_probs=131.5

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      .+|++.+.||+|+||.||++.+.++..+|+|.+.... .....|.+|++++++++||||+++++++......|+||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            4678889999999999999998778899999886533 234578999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++|.+++..... .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||+++..
T Consensus        83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  150 (256)
T cd05112          83 HGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV  150 (256)
T ss_pred             CCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeec
Confidence            9999999976543 5788899999999999999999   899999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.6e-37  Score=317.20  Aligned_cols=159  Identities=25%  Similarity=0.387  Sum_probs=136.0

Q ss_pred             cccHHHHHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEEe
Q 005033           72 RFTYKELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCM  149 (718)
Q Consensus        72 ~~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~  149 (718)
                      .+.++.+..++++|++.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++..+ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638           7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             eEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            3556677778899999999999999999999886 58899999876432 2335688899999999 6999999999884


Q ss_pred             -----eCCeEEEEEeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC
Q 005033          150 -----ERNKRILVYEYMPNKSLQEMLFSD--GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR  222 (718)
Q Consensus       150 -----~~~~~~LVmEy~~gGsL~~~L~~~--~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~  222 (718)
                           .++..|+||||+++++|.+++...  ....+++..+..++.|++.||.|||   ..+|+||||||+||+++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~  162 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCC
Confidence                 345689999999999999988642  2235788889999999999999999   899999999999999999999


Q ss_pred             EEEeeccCceee
Q 005033          223 GKVSDFGLSRIK  234 (718)
Q Consensus       223 vKLsDFGLAr~~  234 (718)
                      ++|+|||+++..
T Consensus       163 ~kl~dfg~~~~~  174 (286)
T cd06638         163 VKLVDFGVSAQL  174 (286)
T ss_pred             EEEccCCceeec
Confidence            999999998753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=8e-37  Score=312.54  Aligned_cols=144  Identities=30%  Similarity=0.498  Sum_probs=128.1

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      ++|++.+.||+|+||.||++.. +++.||+|.+....  ....+.+|+.++..++||||+++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4688899999999999999875 57889999986532  345789999999999999999999998764 4799999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +++|.+++.......+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||+++.
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~  149 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARV  149 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCcccee
Confidence            999999998765556888999999999999999999   89999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.2e-36  Score=313.41  Aligned_cols=140  Identities=28%  Similarity=0.439  Sum_probs=122.1

Q ss_pred             eecccCceEEEEEEEc---CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCC
Q 005033           90 VIGKGGSGTVFLGIAR---DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKS  165 (718)
Q Consensus        90 ~LG~G~FG~Vykg~~~---~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGs  165 (718)
                      .||+|+||.||+|.+.   ++..||+|++.... ....+.|.+|+.++++++|+||+++++++. ....++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999865   35679999986543 233467999999999999999999999885 457899999999999


Q ss_pred             HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          166 LQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       166 L~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |.+++.... ..+++..++.++.||+.||.|||   ..+++||||||+|||++.++.+||+|||+++..
T Consensus        81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  145 (257)
T cd05115          81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL  145 (257)
T ss_pred             HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccc
Confidence            999997543 26889999999999999999999   899999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-36  Score=307.84  Aligned_cols=143  Identities=30%  Similarity=0.492  Sum_probs=128.5

Q ss_pred             ceecccCceEEEEEEEcC----CcEEEEEEcccCChh-hHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIARD----GKLLAIKRLDTFSLQ-TEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~----g~~VAVK~i~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||.||+|....    +..||+|.+...... ....+.+|+.++..++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            369999999999999864    789999999764433 357889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          164 KSLQEMLFSDG-------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       164 GsL~~~L~~~~-------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++|.+++....       ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++...
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccc
Confidence            99999998752       236899999999999999999999   899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.9e-37  Score=321.63  Aligned_cols=148  Identities=26%  Similarity=0.376  Sum_probs=129.1

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh--hhHHHHHHHHHHHhCCCCCcceeEEEEEeeC--CeEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL--QTEREFQNELQILGGLRSPFLVTLLGYCMER--NKRIL  156 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~L  156 (718)
                      .++|+..+.|++|+||.||+|+++ +++.||+|+++....  ...-.-++||.+|.+++|||||.+-.+....  +.+||
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            356888999999999999999987 689999999965321  1122458999999999999999999887654  57999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||||+ .||..++..-. ..+...++..++.|+++||+|||   .+.|+|||||++|+|++..|.+||+||||||..
T Consensus       155 VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  155 VMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhh
Confidence            999995 69999998765 36888899999999999999999   999999999999999999999999999999964

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.5e-36  Score=313.61  Aligned_cols=142  Identities=30%  Similarity=0.387  Sum_probs=122.9

Q ss_pred             ceecccCceEEEEEEEcC---CcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCC
Q 005033           89 NVIGKGGSGTVFLGIARD---GKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNK  164 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~---g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gG  164 (718)
                      +.||+|+||.||+|...+   +..+|+|.+.... ......|.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998653   4679999886533 234457899999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          165 SLQEMLFSDG---NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       165 sL~~~L~~~~---~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +|.+++....   ....++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||+++.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~  149 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN  149 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCcccccc
Confidence            9999997532   224567778889999999999999   89999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.1e-36  Score=324.35  Aligned_cols=148  Identities=25%  Similarity=0.345  Sum_probs=130.9

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||.||++... +++.||+|++....   ......+..|+.++..++|+||+++++++...+..|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47889999999999999999987 47899999985421   122345888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++|+|.+++..... .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus        81 ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~  152 (332)
T cd05623          81 DYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL  152 (332)
T ss_pred             eccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheec
Confidence            99999999999976432 5788889999999999999999   999999999999999999999999999998653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=334.15  Aligned_cols=148  Identities=28%  Similarity=0.423  Sum_probs=133.0

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChh---hHHHHHHHHHHHhCCC-CCcceeEEEEEeeCCeEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQ---TEREFQNELQILGGLR-SPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~---~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~  155 (718)
                      ....|++.+.||+|.||.||+|+.+ +|+.+|+|.+.+....   ....+.+|+.+|+++. |||||.++++|+.....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3457888899999999999999988 4999999999664432   3457899999999998 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC----CCEEEeeccCc
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD----CRGKVSDFGLS  231 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~----~~vKLsDFGLA  231 (718)
                      +|||+|.||.|.+.|...   .+++..+..++.||+.|+.|||   +.+|+||||||+|+|+...    +.+|++|||+|
T Consensus       113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            999999999999999876   3899999999999999999999   9999999999999999543    47999999999


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      ...
T Consensus       187 ~~~  189 (382)
T KOG0032|consen  187 KFI  189 (382)
T ss_pred             eEc
Confidence            874

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.7e-37  Score=317.47  Aligned_cols=145  Identities=30%  Similarity=0.464  Sum_probs=129.3

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      .|+..+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.+++.++|+||+++++++...+..|+||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4667788999999999999876 57899999986432 334467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++++|.+++...   .+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++...
T Consensus        85 ~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06642          85 GGGSALDLLKPG---PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQL  151 (277)
T ss_pred             CCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccc
Confidence            999999998643   5788899999999999999999   899999999999999999999999999988653

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.5e-36  Score=309.91  Aligned_cols=148  Identities=25%  Similarity=0.439  Sum_probs=132.6

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +|++.+.||+|+||.||++... +|+.||+|.+...  .......+.+|+.++++++|+||+++++++...+..|+||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788999999999999999876 6889999998642  233456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++++|.+++.......+++..++.++.|++.||.|||   +.+++|+||+|+|||++.++.++|+|||++...
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~  151 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL  151 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence            99999999997655446788999999999999999999   899999999999999999999999999988753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-36  Score=328.69  Aligned_cols=142  Identities=18%  Similarity=0.261  Sum_probs=126.6

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ...+|.+.+.||+|+||.||+|... ++..||+|.....      ....|+.++++++|+||+++++++...+..|+|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3467999999999999999999987 5789999975432      23569999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+ .++|.+++..... .+++..++.|+.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++.
T Consensus       138 ~~-~~~l~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  206 (357)
T PHA03209        138 HY-SSDLYTYLTKRSR-PLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF  206 (357)
T ss_pred             cc-CCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccc
Confidence            99 5799998876433 6889999999999999999999   89999999999999999999999999998864

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1e-36  Score=323.25  Aligned_cols=150  Identities=24%  Similarity=0.381  Sum_probs=130.4

Q ss_pred             hcCccccceecccCceEEEEEEEc--------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeC
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR--------DGKLLAIKRLDTF-SLQTEREFQNELQILGGL-RSPFLVTLLGYCMER  151 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~--------~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~  151 (718)
                      .++|.+.+.||+|+||.||++...        ....||+|.+... .......+.+|+.++..+ +||||++++++|...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            457888999999999999999752        2457999998643 233456788999999999 699999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDG--------------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL  217 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~--------------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL  217 (718)
                      +..|+||||+++|+|.+++....              ...+++..++.++.||+.||.|||   +.+|+||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence            99999999999999999997642              124788899999999999999999   8999999999999999


Q ss_pred             CCCCCEEEeeccCceee
Q 005033          218 DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       218 d~~~~vKLsDFGLAr~~  234 (718)
                      +.++.+||+|||+++..
T Consensus       168 ~~~~~~kL~Dfg~~~~~  184 (314)
T cd05099         168 TEDNVMKIADFGLARGV  184 (314)
T ss_pred             cCCCcEEEccccccccc
Confidence            99999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.8e-36  Score=315.57  Aligned_cols=147  Identities=29%  Similarity=0.432  Sum_probs=134.0

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      +.|++.+.||.|+||.||+|... ++..||+|.+..........+.+|+.+++.++|+||+++++++..++..|+||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56889999999999999999986 58999999997766666778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ++++|..++..... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++..
T Consensus        92 ~~~~l~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  159 (292)
T cd06644          92 PGGAVDAIMLELDR-GLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK  159 (292)
T ss_pred             CCCcHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCcccee
Confidence            99999988765432 5788999999999999999999   89999999999999999999999999998764

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.9e-36  Score=317.91  Aligned_cols=150  Identities=25%  Similarity=0.444  Sum_probs=130.3

Q ss_pred             hcCccccceecccCceEEEEEEEc-----------------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCccee
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-----------------DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVT  143 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-----------------~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~  143 (718)
                      .++|++.+.||+|+||.||++...                 ++..||+|.+... .......|.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            357899999999999999998542                 2447999998653 3344567999999999999999999


Q ss_pred             EEEEEeeCCeEEEEEeccCCCCHHHHHhhCCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 005033          144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGN---------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSN  214 (718)
Q Consensus       144 L~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~---------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~N  214 (718)
                      +++++...+..|+||||+++|+|.+++.....         ..+++..+..++.||+.||.|||   +.+|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence            99999999999999999999999999976431         23677889999999999999999   8999999999999


Q ss_pred             EEECCCCCEEEeeccCceee
Q 005033          215 VLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       215 ILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||++.++.++|+|||+++..
T Consensus       161 ili~~~~~~~l~dfg~~~~~  180 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNL  180 (296)
T ss_pred             EEEcCCCCEEeccCcccccc
Confidence            99999999999999998753

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-37  Score=328.75  Aligned_cols=138  Identities=30%  Similarity=0.382  Sum_probs=120.0

Q ss_pred             ecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHHHhCC---CCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           91 IGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNELQILGGL---RSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        91 LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      ||+|+||.||+|... +++.||||++.....   .....+..|..++..+   .||||+++++++...+..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999986 589999999854221   2223455677777655   699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.++|+|||+++.
T Consensus        81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~  145 (330)
T cd05586          81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKA  145 (330)
T ss_pred             ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence            99999987654  5788999999999999999999   89999999999999999999999999998864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.5e-36  Score=307.36  Aligned_cols=142  Identities=29%  Similarity=0.388  Sum_probs=127.2

Q ss_pred             ceecccCceEEEEEEEcC--C--cEEEEEEcccCCh-hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIARD--G--KLLAIKRLDTFSL-QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~--g--~~VAVK~i~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||.||+|.+.+  +  ..||||.+..... ...+.|.+|+.++++++|+||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999998753  3  3699999977555 556789999999999999999999999988 889999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+|.+++.......+++..+..++.|++.||.|||   ..+++||||||+||+++.++.+||+|||+++..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~  147 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRAL  147 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccc
Confidence            99999998764346889999999999999999999   999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-36  Score=307.67  Aligned_cols=142  Identities=30%  Similarity=0.501  Sum_probs=127.9

Q ss_pred             ceecccCceEEEEEEEcCCcEEEEEEcccCChh-hHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCCHH
Q 005033           89 NVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ-TEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQ  167 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL~  167 (718)
                      +.||+|+||.||++.+.+++.||+|.+...... ....|.+|+.++++++|+||+++++++......++||||+.+++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            368999999999999877999999998654333 4567999999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          168 EMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       168 ~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++..... .+++..++.++.+++.||.|||   +++++||||||+|||++.++.++|+|||++...
T Consensus        81 ~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~  143 (251)
T cd05041          81 TFLRKKKN-RLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREE  143 (251)
T ss_pred             HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccc
Confidence            99976533 5788889999999999999999   899999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2e-36  Score=310.91  Aligned_cols=146  Identities=29%  Similarity=0.522  Sum_probs=129.3

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh---------hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---------QTEREFQNELQILGGLRSPFLVTLLGYCMERNK  153 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~  153 (718)
                      +|.+...||+|+||.||+|... +++.||+|.+.....         .....+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3667889999999999999875 588999998854321         122568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .++||||+++++|.+++...+  .+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||+++.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            999999999999999997764  5788888999999999999999   89999999999999999999999999999876


Q ss_pred             e
Q 005033          234 K  234 (718)
Q Consensus       234 ~  234 (718)
                      .
T Consensus       156 ~  156 (267)
T cd06628         156 L  156 (267)
T ss_pred             c
Confidence            4

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6.7e-37  Score=329.95  Aligned_cols=150  Identities=28%  Similarity=0.387  Sum_probs=127.7

Q ss_pred             hcCccccceecccCceEEEEEEE------cCCcEEEEEEcccCC-hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeC-C
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIA------RDGKLLAIKRLDTFS-LQTEREFQNELQILGGL-RSPFLVTLLGYCMER-N  152 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~------~~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~-~  152 (718)
                      .++|++.+.||+|+||.||+|.+      .+++.||||++.... ......+.+|+.+|.++ +|+||++++++|... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46799999999999999999974      247899999996533 23345788999999999 789999999988654 4


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCC---------------------------------------------------------
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGN---------------------------------------------------------  175 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~---------------------------------------------------------  175 (718)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67999999999999999865321                                                         


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          176 --------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       176 --------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                              ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~  229 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDI  229 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEeccccccc
Confidence                    13677888899999999999999   999999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.5e-36  Score=312.55  Aligned_cols=146  Identities=29%  Similarity=0.460  Sum_probs=131.0

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ..|+..+.||.|+||.||+|.+. ++..||||.+.... ......+.+|+.+++.+.|+||+++++++..++..|+||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45778889999999999999986 58899999986432 34456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++|+|.+++...   .+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++...
T Consensus        84 ~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~  151 (277)
T cd06640          84 LGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQL  151 (277)
T ss_pred             CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceec
Confidence            9999999998754   4788889999999999999999   899999999999999999999999999988753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2e-36  Score=308.02  Aligned_cols=147  Identities=29%  Similarity=0.469  Sum_probs=133.6

Q ss_pred             hcCccccceecccCceEEEEEEEcC-CcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~-g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      .++|+..+.||+|+||.||+|.... ++.||+|.+.....  ...+.+|+.+++.++|+||+++++++......|+++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3678999999999999999999874 88999999865432  66899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++++|.+++.... ..+++..+..++.|++.||.|||   ..+|+||||+|+||+++.++.++|+|||++...
T Consensus        80 ~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~  149 (256)
T cd06612          80 CGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL  149 (256)
T ss_pred             CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhc
Confidence            99999999997644 36889999999999999999999   899999999999999999999999999988753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.8e-36  Score=311.41  Aligned_cols=146  Identities=29%  Similarity=0.503  Sum_probs=130.3

Q ss_pred             CccccceecccCceEEEEEEEcCCcEEEEEEcccCC------hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFS------LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~------~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      +|...+.||.|+||.||+|...+++.+|||.+....      ......+.+|+++++.++|+||+++++++...+..|+|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999998889999999885422      12235688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||   +.+|+|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            99999999999997654  4688888999999999999999   899999999999999999999999999988753

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4e-37  Score=316.31  Aligned_cols=139  Identities=30%  Similarity=0.443  Sum_probs=119.0

Q ss_pred             ceecccCceEEEEEEEcC--------CcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           89 NVIGKGGSGTVFLGIARD--------GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~--------g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +.||+|+||.||+|....        ...||+|.+........+.+..|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            368999999999998742        235888888655445556789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCE--------EEeeccCc
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG--------KVSDFGLS  231 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~v--------KLsDFGLA  231 (718)
                      +++|+|.+++...+. .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++..        +++|||++
T Consensus        81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999976543 5788899999999999999999   9999999999999999887765        55555544

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.7e-36  Score=319.69  Aligned_cols=145  Identities=32%  Similarity=0.500  Sum_probs=132.6

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      .+|++.+.||.|+||.||+|... +++.||||.+..........+.+|+.+++.++|+||+++++++...+..|+|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46899999999999999999875 68999999986655455667899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ++++|.+++...   .+++.++..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++..
T Consensus        99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~  164 (296)
T cd06655          99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ  164 (296)
T ss_pred             CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchh
Confidence            999999998654   5789999999999999999999   99999999999999999999999999998765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.7e-36  Score=314.89  Aligned_cols=157  Identities=29%  Similarity=0.410  Sum_probs=137.1

Q ss_pred             ccHHHHHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEEee
Q 005033           73 FTYKELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCME  150 (718)
Q Consensus        73 ~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~  150 (718)
                      .++.++..+.+.|++.+.||+|+||.||+|.+. +++.||+|.+.... .....+..|+.++.++ +|+||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            466677778899999999999999999999986 58899999886543 3345688899999998 79999999999853


Q ss_pred             ------CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEE
Q 005033          151 ------RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGK  224 (718)
Q Consensus       151 ------~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vK  224 (718)
                            ....|++|||+++|+|.+++.......+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence                  457899999999999999998755556788888999999999999999   89999999999999999999999


Q ss_pred             EeeccCcee
Q 005033          225 VSDFGLSRI  233 (718)
Q Consensus       225 LsDFGLAr~  233 (718)
                      |+|||++..
T Consensus       162 l~dfg~~~~  170 (282)
T cd06636         162 LVDFGVSAQ  170 (282)
T ss_pred             EeeCcchhh
Confidence            999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-37  Score=341.57  Aligned_cols=142  Identities=30%  Similarity=0.371  Sum_probs=126.7

Q ss_pred             eecccCceEEEEEEEcC-CcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCCHHH
Q 005033           90 VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQE  168 (718)
Q Consensus        90 ~LG~G~FG~Vykg~~~~-g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL~~  168 (718)
                      +||+|.||+||-|++.+ ...+|||-+........+-+..||.+.++|+|.|||+++|.|..++..-|.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            69999999999999874 67899999987666677778999999999999999999999999999999999999999999


Q ss_pred             HHhhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC-CCCEEEeeccCceee
Q 005033          169 MLFSDGN-LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS-DCRGKVSDFGLSRIK  234 (718)
Q Consensus       169 ~L~~~~~-~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~-~~~vKLsDFGLAr~~  234 (718)
                      +|+..-+ ..-.+..+-.+..||+.||.|||   ++.|||||||-+||||+. .|.+||+|||.++.+
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL  726 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL  726 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhh
Confidence            9987643 22266777789999999999999   999999999999999975 789999999988764

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.2e-36  Score=309.75  Aligned_cols=142  Identities=30%  Similarity=0.482  Sum_probs=121.6

Q ss_pred             ceecccCceEEEEEEEc----CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEe-eCCeEEEEEeccC
Q 005033           89 NVIGKGGSGTVFLGIAR----DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCM-ERNKRILVYEYMP  162 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~----~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~-~~~~~~LVmEy~~  162 (718)
                      +.||+|+||.||+|...    .+..||||.+... .......+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            36899999999999864    2457999998543 3344567889999999999999999999876 4556899999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +|+|.+++..... .+.+..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~  148 (262)
T cd05058          81 HGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDI  148 (262)
T ss_pred             CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccc
Confidence            9999999976533 4567778889999999999999   899999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.6e-36  Score=321.23  Aligned_cols=143  Identities=21%  Similarity=0.259  Sum_probs=126.3

Q ss_pred             ccceeccc--CceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           87 EANVIGKG--GSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        87 ~~~~LG~G--~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      +.++||+|  +|++||++..+ +|+.||||++....  ......+.+|+.+++.++||||++++++|..++..|+||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  78999999886 68999999986532  233456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                      ++|+|.+++.......+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.++++|||.+.
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~  149 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNL  149 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhh
Confidence            9999999997654445889999999999999999999   8999999999999999999999999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-36  Score=316.62  Aligned_cols=139  Identities=22%  Similarity=0.335  Sum_probs=118.9

Q ss_pred             eecccCceEEEEEEEcC-------------------------CcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeE
Q 005033           90 VIGKGGSGTVFLGIARD-------------------------GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTL  144 (718)
Q Consensus        90 ~LG~G~FG~Vykg~~~~-------------------------g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L  144 (718)
                      .||+|+||.||+|....                         ...||+|.+..........|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         23589999865444445678999999999999999999


Q ss_pred             EEEEeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC---
Q 005033          145 LGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC---  221 (718)
Q Consensus       145 ~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~---  221 (718)
                      +++|......|+||||+++|+|..++..... .+++..++.++.||+.||.|||   +.+|+||||||+|||++..+   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG-RVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCccc
Confidence            9999999999999999999999999876433 5788899999999999999999   89999999999999997643   


Q ss_pred             ----CEEEeeccCce
Q 005033          222 ----RGKVSDFGLSR  232 (718)
Q Consensus       222 ----~vKLsDFGLAr  232 (718)
                          .+|++|||++.
T Consensus       158 ~~~~~~kl~d~g~~~  172 (274)
T cd05076         158 GTSPFIKLSDPGVSF  172 (274)
T ss_pred             CccceeeecCCcccc
Confidence                37888888664

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=315.25  Aligned_cols=148  Identities=27%  Similarity=0.376  Sum_probs=135.2

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      .++|++.+.||.|+||.||++... ++..||+|.+........+.|.+|+.++++++|+||+++++++..+...|+||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467899999999999999999986 6899999998766556667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +++++|.+++..... .+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++..
T Consensus        84 ~~~~~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~  152 (280)
T cd06611          84 CDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAK  152 (280)
T ss_pred             cCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchh
Confidence            999999999876543 5888999999999999999999   89999999999999999999999999998764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-36  Score=324.65  Aligned_cols=149  Identities=24%  Similarity=0.383  Sum_probs=129.5

Q ss_pred             cCccccceecccCceEEEEEEEcC--------CcEEEEEEcccCC-hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCC
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARD--------GKLLAIKRLDTFS-LQTEREFQNELQILGGL-RSPFLVTLLGYCMERN  152 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~--------g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~  152 (718)
                      .+|.+.+.||+|+||.||+|....        +..||+|.+.... ......+.+|+.++.++ +|+||++++++|...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            468899999999999999997531        2379999886432 33456789999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEC
Q 005033          153 KRILVYEYMPNKSLQEMLFSDG--------------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD  218 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~--------------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd  218 (718)
                      ..|++|||+++|+|.+++....              ...+++..++.++.||+.||.|||   .++|+||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence            9999999999999999997532              124778889999999999999999   89999999999999999


Q ss_pred             CCCCEEEeeccCceee
Q 005033          219 SDCRGKVSDFGLSRIK  234 (718)
Q Consensus       219 ~~~~vKLsDFGLAr~~  234 (718)
                      .++.+||+|||+++..
T Consensus       169 ~~~~~kL~Dfg~~~~~  184 (334)
T cd05100         169 EDNVMKIADFGLARDV  184 (334)
T ss_pred             CCCcEEECCcccceec
Confidence            9999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-36  Score=316.59  Aligned_cols=147  Identities=28%  Similarity=0.455  Sum_probs=129.3

Q ss_pred             CccccceecccCceEEEEEEEc-----CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC--CeEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-----DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMER--NKRI  155 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-----~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~  155 (718)
                      .|++.+.||+|+||.||++...     ++..||+|.+.... ......+.+|+.+++.++|+||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            4688899999999999999742     47899999986543 33446799999999999999999999999775  5689


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +||||+++++|.+++..... .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.++|+|||+++..
T Consensus        85 lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence            99999999999999976533 5789999999999999999999   999999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-36  Score=306.40  Aligned_cols=148  Identities=31%  Similarity=0.410  Sum_probs=134.2

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      .++|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+.++++++||||+++++++...+..|++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            367899999999999999999886 5789999998765555667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +++++|.+++.... ..+++..+..++.|++.||.|||   ..+|+|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~  150 (262)
T cd06613          82 CGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQ  150 (262)
T ss_pred             CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchh
Confidence            99999999987652 25788999999999999999999   89999999999999999999999999998765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.2e-36  Score=313.48  Aligned_cols=146  Identities=27%  Similarity=0.458  Sum_probs=129.2

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +|++.+.||+|+||.||+|... +++.||||.+....  ......+.+|+.++..++||||+++++++..++..|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5788899999999999999986 68999999985432  22345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGN-LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~-~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ++ ++|.+++..... ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.++|+|||++..
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  150 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARA  150 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceee
Confidence            96 799998865432 46889999999999999999999   89999999999999999999999999998865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.6e-36  Score=311.99  Aligned_cols=143  Identities=30%  Similarity=0.472  Sum_probs=123.9

Q ss_pred             ceecccCceEEEEEEEcC-------CcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           89 NVIGKGGSGTVFLGIARD-------GKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~-------g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +.||+|+||.||+|...+       +..+|||.+.... ......|.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998752       3579999885432 23456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC-----CEEEeeccC
Q 005033          161 MPNKSLQEMLFSDG-----NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC-----RGKVSDFGL  230 (718)
Q Consensus       161 ~~gGsL~~~L~~~~-----~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~-----~vKLsDFGL  230 (718)
                      +++++|.+++....     ...+++..++.++.|++.||.|||   +.+++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999997532     234788999999999999999999   89999999999999999877     899999999


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      ++..
T Consensus       158 ~~~~  161 (269)
T cd05044         158 ARDI  161 (269)
T ss_pred             cccc
Confidence            8754

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-36  Score=315.53  Aligned_cols=147  Identities=28%  Similarity=0.414  Sum_probs=130.7

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ++|++.+.||+|+||+||++... +++.||+|++.... ......+.+|++++..++||||+++++++...+..|+||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            57888899999999999999876 58899999875432 34456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +++++|.+++...+  .+++..+..++.+++.||.|||+  ..+|+||||||+||+++.++.++|+|||++..
T Consensus        85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~  153 (284)
T cd06620          85 MDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGE  153 (284)
T ss_pred             CCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence            99999999987654  57889999999999999999992  25899999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.8e-36  Score=312.00  Aligned_cols=141  Identities=23%  Similarity=0.404  Sum_probs=120.8

Q ss_pred             ceecccCceEEEEEEEcC-------------CcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEE
Q 005033           89 NVIGKGGSGTVFLGIARD-------------GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~-------------g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~  155 (718)
                      +.||+|+||.||+|...+             ...||+|.+..........|..|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998532             2368999886654455567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC-------EEEeec
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR-------GKVSDF  228 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~-------vKLsDF  228 (718)
                      +||||+++|+|..++..... .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.       ++++||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEecccCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            99999999999999875433 5788899999999999999999   999999999999999987654       788888


Q ss_pred             cCcee
Q 005033          229 GLSRI  233 (718)
Q Consensus       229 GLAr~  233 (718)
                      |++..
T Consensus       157 g~~~~  161 (262)
T cd05077         157 GIPIT  161 (262)
T ss_pred             CCCcc
Confidence            87653

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.2e-36  Score=305.64  Aligned_cols=148  Identities=29%  Similarity=0.462  Sum_probs=131.1

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +|+..+.||+|+||.||++... +++.+|||.+...  .......+.+|+.+++.++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4788899999999999999876 6889999998643  233456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC-CEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC-RGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~-~vKLsDFGLAr~~  234 (718)
                      +++++|.+++.......+++..+..++.|++.||.|||   +.+|+||||+|+||+++.++ .++|+|||++...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999999998765556889999999999999999999   89999999999999998654 5899999988753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.3e-36  Score=316.96  Aligned_cols=141  Identities=23%  Similarity=0.419  Sum_probs=118.3

Q ss_pred             cceecccCceEEEEEEEc---CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEee--CCeEEEEEeccC
Q 005033           88 ANVIGKGGSGTVFLGIAR---DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME--RNKRILVYEYMP  162 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~---~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LVmEy~~  162 (718)
                      ...||+|+||.||+|...   ++..||+|.+....  ....+.+|+.+++.++||||+++++++..  +...|+||||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            357999999999999875   35789999986532  23457899999999999999999999854  567899999995


Q ss_pred             CCCHHHHHhhC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE----CCCCCEEEeeccCc
Q 005033          163 NKSLQEMLFSD-------GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL----DSDCRGKVSDFGLS  231 (718)
Q Consensus       163 gGsL~~~L~~~-------~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL----d~~~~vKLsDFGLA  231 (718)
                       ++|.+++...       ....+++..+..++.||+.||.|||   +.+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             6888887532       1235788889999999999999999   8999999999999999    56679999999999


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      +..
T Consensus       160 ~~~  162 (317)
T cd07867         160 RLF  162 (317)
T ss_pred             ecc
Confidence            864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.1e-36  Score=313.45  Aligned_cols=149  Identities=28%  Similarity=0.410  Sum_probs=131.3

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ++|++.+.||+|+||.||++... ++..||+|.+... .......+.+|+.++.+++|+||+++++++...+..|+||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36888999999999999999987 6899999988643 233446789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~-~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+  ..+|+||||||+||+++.++.++|+|||++..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  152 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN  152 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence            99999999987642 2357899999999999999999992  25899999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.9e-36  Score=315.47  Aligned_cols=146  Identities=26%  Similarity=0.436  Sum_probs=129.4

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++++++...+..|+||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57889999999999999999886 58899999986432 22334678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +. ++|.+++..... .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.++|+|||++..
T Consensus        86 ~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  153 (301)
T cd07873          86 LD-KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA  153 (301)
T ss_pred             cc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence            96 699998876533 5788899999999999999999   99999999999999999999999999998865

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4e-36  Score=310.05  Aligned_cols=147  Identities=28%  Similarity=0.397  Sum_probs=129.0

Q ss_pred             cCccccceecccCceEEEEEEEcC----CcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARD----GKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~----g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ++|.+.+.||+|+||.||+|.+.+    ...||||...... ....+.+.+|+.+++.++||||+++++++.. ...|+|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            467888999999999999998753    3479999886544 4455689999999999999999999999875 557899


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++|+|.+++..... .+++..++.++.|++.||.|||   +.+++||||||+|||++.++.++|+|||+++..
T Consensus        85 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          85 MELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeec
Confidence            999999999999976543 5789999999999999999999   899999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.5e-36  Score=355.88  Aligned_cols=149  Identities=24%  Similarity=0.386  Sum_probs=131.6

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||.||+|.+. +|+.||||++....   ....+.|.+|+.+++.++||||+++++++...+..|+||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999986 58999999986432   233467999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeecc
Q 005033          159 EYMPNKSLQEMLFSDG---------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG  229 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~---------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFG  229 (718)
                      ||++||+|.+++....         ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999986421         123556778899999999999999   8999999999999999999999999999


Q ss_pred             Cceee
Q 005033          230 LSRIK  234 (718)
Q Consensus       230 LAr~~  234 (718)
                      +++..
T Consensus       159 LAk~i  163 (932)
T PRK13184        159 AAIFK  163 (932)
T ss_pred             cceec
Confidence            99875

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.9e-36  Score=306.97  Aligned_cols=144  Identities=34%  Similarity=0.540  Sum_probs=128.6

Q ss_pred             ccccceecccCceEEEEEEEcC-CcEEEEEEcccCChhhH--HHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           85 FDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTE--REFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~~-g~~VAVK~i~~~~~~~~--~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      |++.+.||+|+||+||++.... ++.||+|.+........  ....+|+.++.+++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5678999999999999999874 67999999976543333  23456999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .+++|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.++|+|||++..
T Consensus        81 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~  147 (260)
T PF00069_consen   81 PGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVK  147 (260)
T ss_dssp             TTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred             ccccccccccccc--cccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence            9999999998333  5789999999999999999999   89999999999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5e-36  Score=305.04  Aligned_cols=151  Identities=28%  Similarity=0.426  Sum_probs=129.9

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEee--CCeEEEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCME--RNKRILVY  158 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LVm  158 (718)
                      +|++.+.||.|+||.||++... +++.||+|.+...  .....+.+..|+.+++.++|+||+++++++..  ....|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999876 6889999998642  33445678899999999999999999998864  45679999


Q ss_pred             eccCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDG--NLVLKWSQRFEIIMDVAKALEFLHFGC--DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~--~~~l~~~~~~~Ia~qIa~gL~yLH~~~--~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++++|.+++....  ...+++..++.++.||+.||.|||..+  ..+|+|+||+|+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            9999999999997531  236888999999999999999999554  678999999999999999999999999988753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.9e-36  Score=309.98  Aligned_cols=141  Identities=29%  Similarity=0.406  Sum_probs=122.2

Q ss_pred             eecccCceEEEEEEEcC---CcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCC
Q 005033           90 VIGKGGSGTVFLGIARD---GKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKS  165 (718)
Q Consensus        90 ~LG~G~FG~Vykg~~~~---g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGs  165 (718)
                      .||+|+||.||+|...+   ...+|+|.+.... ......|.+|+.+++.++|+||+++++++......|+||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997643   4578899875432 3344678899999999999999999999999999999999999999


Q ss_pred             HHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          166 LQEMLFSDGN---LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       166 L~~~L~~~~~---~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |.+++.....   ...++.....++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  149 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALE  149 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccc
Confidence            9999976532   23467778899999999999999   89999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.6e-36  Score=310.78  Aligned_cols=148  Identities=27%  Similarity=0.435  Sum_probs=131.4

Q ss_pred             cCccccceecccCceEEEEEEEc------CCcEEEEEEcccCChh-hHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFSLQ-TEREFQNELQILGGLRSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~  155 (718)
                      ++|+....||+|+||.||+|..+      +...||+|.+...... ....+.+|+.++++++|+||+++++++...+..|
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57889999999999999999864      2468999988654433 4567999999999999999999999999989999


Q ss_pred             EEEeccCCCCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeec
Q 005033          156 LVYEYMPNKSLQEMLFSDGN-------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDF  228 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~-------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDF  228 (718)
                      +||||+++|+|.+++.....       ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999976541       25889999999999999999999   899999999999999999999999999


Q ss_pred             cCcee
Q 005033          229 GLSRI  233 (718)
Q Consensus       229 GLAr~  233 (718)
                      |+++.
T Consensus       162 ~~~~~  166 (275)
T cd05046         162 SLSKD  166 (275)
T ss_pred             ccccc
Confidence            98764

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-36  Score=330.70  Aligned_cols=142  Identities=21%  Similarity=0.298  Sum_probs=126.1

Q ss_pred             hcCccccceecccCceEEEEEEEc---CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR---DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~---~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ..+|.+.+.||+|+||.||+|...   .+..||||.+...     ..+.+|+.+|+.++|||||++++++......|+||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999764   3678999988542     23568999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+ +++|.+++....  .+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.++|+|||+++..
T Consensus       166 e~~-~~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        166 PKY-KCDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             hhc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            999 579999985443  6889999999999999999999   899999999999999999999999999998753

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=8.4e-36  Score=307.46  Aligned_cols=147  Identities=27%  Similarity=0.418  Sum_probs=128.8

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-----hhhHHHHHHHHHHHhCCCCCcceeEEEEEee--CCeE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-----LQTEREFQNELQILGGLRSPFLVTLLGYCME--RNKR  154 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~  154 (718)
                      .+|+..+.||+|+||.||++... ++..||+|.+....     ......+.+|+.+++.++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47889999999999999999886 58999999885321     2234568899999999999999999999875  3578


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++|||+++++|.+++....  .+++.....++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||+++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            99999999999999997654  4788888999999999999999   899999999999999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-36  Score=310.89  Aligned_cols=147  Identities=25%  Similarity=0.493  Sum_probs=129.9

Q ss_pred             cCccccceecccCceEEEEEEEcC-Cc----EEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARD-GK----LLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~-g~----~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      .+|++.+.||+|+||.||+|.... |.    .||+|.+.... ......+.+|+.++..++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            568888999999999999998752 33    68999886543 3345678999999999999999999999987 78899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||||+++|+|.+++..... .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        86 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            9999999999999977543 4889999999999999999999   899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9e-36  Score=306.62  Aligned_cols=147  Identities=26%  Similarity=0.390  Sum_probs=128.5

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC-----ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC--CeE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF-----SLQTEREFQNELQILGGLRSPFLVTLLGYCMER--NKR  154 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~-----~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~  154 (718)
                      .+|++.+.||+|+||.||+|... ++..||||.+...     .......+.+|+.++.+++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47889999999999999999886 5899999987532     122345788999999999999999999998764  467


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++||||+++++|.+++....  .+++.....++.|++.||.|||   +.+|+|+||||+|||++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            89999999999999997654  4678888999999999999999   899999999999999999999999999988753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.1e-36  Score=303.27  Aligned_cols=147  Identities=30%  Similarity=0.471  Sum_probs=131.2

Q ss_pred             ccccceecccCceEEEEEEEcC-----CcEEEEEEcccCChh-hHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           85 FDEANVIGKGGSGTVFLGIARD-----GKLLAIKRLDTFSLQ-TEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~~-----g~~VAVK~i~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      |++.+.||.|+||.||++....     +..||+|.+...... ....+..|+.++..++|+||+++++++...+..|++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999999864     388999999654433 5668999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++++|.+++.......+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||+++..
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~  153 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDL  153 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceec
Confidence            9999999999997654323899999999999999999999   899999999999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=314.73  Aligned_cols=149  Identities=32%  Similarity=0.443  Sum_probs=134.1

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||.||+|... +++.||||.+.....   ...+.+..|++++..++|+||+++++++......|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999987 489999999865432   24457889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+.+++|.+++.......+++..+..++.||+.||.|||   ..+++||||||+||+++.++.++|+|||++...
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  153 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQS  153 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence            9999999999998654456899999999999999999999   899999999999999999999999999998764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-36  Score=307.33  Aligned_cols=151  Identities=31%  Similarity=0.444  Sum_probs=132.8

Q ss_pred             HHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCC-----
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCMERN-----  152 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~-----  152 (718)
                      .++++|++.+.||+|+||.||+|... +++.+|+|.+..... ....+.+|+.+++++ .|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            45689999999999999999999986 578999999865433 346789999999999 7999999999997654     


Q ss_pred             -eEEEEEeccCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeecc
Q 005033          153 -KRILVYEYMPNKSLQEMLFSDG--NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG  229 (718)
Q Consensus       153 -~~~LVmEy~~gGsL~~~L~~~~--~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFG  229 (718)
                       ..|+||||+++++|.+++....  ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999999986533  346888999999999999999999   9999999999999999999999999999


Q ss_pred             Cceee
Q 005033          230 LSRIK  234 (718)
Q Consensus       230 LAr~~  234 (718)
                      ++...
T Consensus       159 ~~~~~  163 (275)
T cd06608         159 VSAQL  163 (275)
T ss_pred             cceec
Confidence            88753

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=8.3e-36  Score=307.13  Aligned_cols=147  Identities=23%  Similarity=0.438  Sum_probs=126.5

Q ss_pred             CccccceecccCceEEEEEEEcC--CcEEEEEEcccC----------ChhhHHHHHHHHHHHhC-CCCCcceeEEEEEee
Q 005033           84 DFDEANVIGKGGSGTVFLGIARD--GKLLAIKRLDTF----------SLQTEREFQNELQILGG-LRSPFLVTLLGYCME  150 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~~--g~~VAVK~i~~~----------~~~~~~~f~~Ei~iL~~-L~HpNIV~L~g~~~~  150 (718)
                      +|++.+.||+|+||.||+|.+..  ++.+|||.+...          .......+.+|+.++.+ ++|+||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999864  788999987432          22234567889988865 799999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEECCCCCEEEee
Q 005033          151 RNKRILVYEYMPNKSLQEMLFSD--GNLVLKWSQRFEIIMDVAKALEFLHFGCD-PPVIHGDIKPSNVLLDSDCRGKVSD  227 (718)
Q Consensus       151 ~~~~~LVmEy~~gGsL~~~L~~~--~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~-~gIVHRDLKP~NILLd~~~~vKLsD  227 (718)
                      .+..|+||||+++++|.+++...  ....+++..++.++.|++.||.|||   . .+++||||+|+|||++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999988542  2236888899999999999999999   5 6899999999999999999999999


Q ss_pred             ccCcee
Q 005033          228 FGLSRI  233 (718)
Q Consensus       228 FGLAr~  233 (718)
                      ||++..
T Consensus       158 fg~~~~  163 (269)
T cd08528         158 FGLAKQ  163 (269)
T ss_pred             ccceee
Confidence            999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.4e-36  Score=309.47  Aligned_cols=148  Identities=26%  Similarity=0.443  Sum_probs=131.0

Q ss_pred             cCccccceecccCceEEEEEEEc-----CCcEEEEEEcccCChh-hHHHHHHHHHHHhCCCCCcceeEEEEEee--CCeE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-----DGKLLAIKRLDTFSLQ-TEREFQNELQILGGLRSPFLVTLLGYCME--RNKR  154 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-----~g~~VAVK~i~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~  154 (718)
                      .+|+..+.||+|+||.||++...     ++..||||.+...... ....|.+|+.+++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35777899999999999999864     3689999999754432 45689999999999999999999999987  5578


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++||||+++++|.+++..... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++...
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            999999999999999976543 5888999999999999999999   899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.5e-36  Score=312.16  Aligned_cols=147  Identities=25%  Similarity=0.442  Sum_probs=130.4

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....  ....+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999987 58999999885422  2234568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+++++|..+.....  .+++..+..++.||+.||.|||   +.+|+||||+|+||+++.++.++|+|||++...
T Consensus        81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~  150 (286)
T cd07846          81 FVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL  150 (286)
T ss_pred             cCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence            999999988776543  4789999999999999999999   899999999999999999999999999988753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-35  Score=302.88  Aligned_cols=139  Identities=24%  Similarity=0.402  Sum_probs=121.7

Q ss_pred             ceecccCceEEEEEEEcC-C----------cEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           89 NVIGKGGSGTVFLGIARD-G----------KLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~-g----------~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      +.||+|+||.||+|.+.+ +          ..|++|.+...... ...|.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            368999999999999864 3          25788877554322 6789999999999999999999999988 778999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC-------CEEEeeccC
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC-------RGKVSDFGL  230 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~-------~vKLsDFGL  230 (718)
                      |||+++|+|.+++..... .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++       .+||+|||+
T Consensus        79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            999999999999987643 5788899999999999999999   89999999999999999887       799999998


Q ss_pred             cee
Q 005033          231 SRI  233 (718)
Q Consensus       231 Ar~  233 (718)
                      +..
T Consensus       155 a~~  157 (259)
T cd05037         155 PIT  157 (259)
T ss_pred             ccc
Confidence            865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=9e-36  Score=308.62  Aligned_cols=147  Identities=29%  Similarity=0.451  Sum_probs=130.4

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ++|+..+.||+|+||.||+|.+. +|+.||+|++....  ....+.+.+|+.+++.++|+||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999987 58999999885422  2234568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+++++|..++....  .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.++|+|||++...
T Consensus        81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (286)
T cd07847          81 YCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARIL  150 (286)
T ss_pred             ccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceec
Confidence            999988888776543  5789999999999999999999   899999999999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.6e-36  Score=311.74  Aligned_cols=158  Identities=29%  Similarity=0.417  Sum_probs=135.8

Q ss_pred             ccHHHHHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEEee
Q 005033           73 FTYKELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCME  150 (718)
Q Consensus        73 ~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~  150 (718)
                      +++.++..++++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +||||+++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            455667778899999999999999999999986 68899999986532 2345678899999998 89999999999875


Q ss_pred             C-----CeEEEEEeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCE
Q 005033          151 R-----NKRILVYEYMPNKSLQEMLFSD--GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG  223 (718)
Q Consensus       151 ~-----~~~~LVmEy~~gGsL~~~L~~~--~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~v  223 (718)
                      .     +..|+||||+++|+|.+++...  ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence            4     3589999999999999988642  2235788999999999999999999   8999999999999999999999


Q ss_pred             EEeeccCceee
Q 005033          224 KVSDFGLSRIK  234 (718)
Q Consensus       224 KLsDFGLAr~~  234 (718)
                      ||+|||+++..
T Consensus       168 kl~dfg~~~~~  178 (291)
T cd06639         168 KLVDFGVSAQL  178 (291)
T ss_pred             EEeecccchhc
Confidence            99999988753

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-35  Score=334.85  Aligned_cols=140  Identities=22%  Similarity=0.251  Sum_probs=126.1

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      +|.+.+.||+|+||.||+|.+. .++.||||....      ..+.+|+.+|++|+|+|||++++++...+..|||||++ 
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-  242 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-  242 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-
Confidence            6899999999999999999987 488999996422      24678999999999999999999999999999999999 


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      .++|.+++..... .+++..++.|+.||+.||.|||   +.+|+||||||+||||+.++.+||+|||+++..
T Consensus       243 ~~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~  310 (461)
T PHA03211        243 RSDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFA  310 (461)
T ss_pred             CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceec
Confidence            5799998876433 6899999999999999999999   899999999999999999999999999998764

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.2e-36  Score=302.97  Aligned_cols=146  Identities=27%  Similarity=0.482  Sum_probs=130.8

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-----hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-----LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      +|+..+.||+|+||.||+|... ++..||+|.+....     ....+.+.+|+.+++.++|+||+++++++......|+|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677789999999999999987 78999999885432     23446789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++++|.+++....  .+++..+..++.||+.||.|||   ..+|+|+||+|+||+++.++.+||+|||++...
T Consensus        81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~  152 (258)
T cd06632          81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV  152 (258)
T ss_pred             EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence            99999999999997654  4788899999999999999999   899999999999999999999999999988753

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.1e-35  Score=313.63  Aligned_cols=146  Identities=27%  Similarity=0.436  Sum_probs=131.5

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||.||++... +++.||||.+....   ......+.+|+.+++.++||||+++++.+..++..|+||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47889999999999999999987 57899999986543   223456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||+++++|.+++...+  .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||+++.
T Consensus        81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            9999999999997654  5788889999999999999999   89999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.1e-35  Score=304.34  Aligned_cols=141  Identities=24%  Similarity=0.342  Sum_probs=120.8

Q ss_pred             eecccCceEEEEEEEcCC---cEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCC
Q 005033           90 VIGKGGSGTVFLGIARDG---KLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKS  165 (718)
Q Consensus        90 ~LG~G~FG~Vykg~~~~g---~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGs  165 (718)
                      .||+|+||.||+|...++   ..+++|.+.... ......|.+|+.+++.++||||++++++|......|+||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999976543   356677765432 3445689999999999999999999999999999999999999999


Q ss_pred             HHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          166 LQEMLFSDGN--LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       166 L~~~L~~~~~--~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |.+++.....  ...++..+..++.||+.||.|||   +.+|+||||||+|||++.++.++|+|||++..
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~  148 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS  148 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccc
Confidence            9999976422  24566777889999999999999   89999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.7e-36  Score=316.54  Aligned_cols=143  Identities=29%  Similarity=0.451  Sum_probs=128.1

Q ss_pred             ccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           85 FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      |.....||+|+||.||++... ++..||||.+..........+.+|+.+++.++|+||+++++.+..++..|+||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            344467999999999999876 5889999998765555566789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ++|.+++...   .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.++|+|||++..
T Consensus       104 ~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~  167 (292)
T cd06658         104 GALTDIVTHT---RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQ  167 (292)
T ss_pred             CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence            9999988543   4788899999999999999999   89999999999999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.2e-35  Score=301.70  Aligned_cols=149  Identities=30%  Similarity=0.417  Sum_probs=133.4

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ++|++.+.||.|+||+||+|... ++..+|+|++.... ......+.+|+.+++.++|+||+++++.+...+..|+||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47889999999999999999875 58899999986432 23556789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGN-LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~-~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++++|.+++..... ..+++..+..++.|++.||.|||   +.+|+||||+|+||++++++.++|+|||++...
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            999999999976432 36789999999999999999999   999999999999999999999999999988764

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.3e-35  Score=307.31  Aligned_cols=147  Identities=29%  Similarity=0.463  Sum_probs=125.8

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHH-HhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQI-LGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~i-L~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ++|++.+.||+|+||.||++.+. +|+.||||++.... ......+..|+.+ ++.++||||+++++++...+..|+|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47889999999999999999987 69999999986532 2233456667665 566799999999999999999999999


Q ss_pred             ccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          160 YMPNKSLQEMLFSD--GNLVLKWSQRFEIIMDVAKALEFLHFGCDP-PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       160 y~~gGsL~~~L~~~--~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~-gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |++ |+|.+++...  ....+++..+..++.||+.||.|||   ++ +++||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~  153 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGY  153 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence            995 7898888653  2246899999999999999999999   76 999999999999999999999999998865

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.9e-35  Score=307.91  Aligned_cols=146  Identities=26%  Similarity=0.471  Sum_probs=130.4

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCChh-----hHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQ-----TEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~-----~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      +|+..+.||+|+||.||+|... +++.||||.+......     ....+..|+++++.++|+||+++++++...+..|+|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999999986 6899999998654322     234577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+ +|+|.+++.... ..+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.++|+|||+++..
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~  152 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF  152 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence            9999 999999997654 36889999999999999999999   899999999999999999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.1e-35  Score=308.67  Aligned_cols=146  Identities=26%  Similarity=0.460  Sum_probs=130.2

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +|+..+.||.|+||.||+|... +++.||||.+....  ......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            5788999999999999999886 68999999886432  22335788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +. ++|.+++.......+++..+..++.|++.||+|||   ..+++||||+|+||+++.++.+||+|||+++.
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~  149 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARA  149 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhh
Confidence            95 78999987655557899999999999999999999   89999999999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2e-35  Score=303.19  Aligned_cols=146  Identities=23%  Similarity=0.439  Sum_probs=129.3

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC------hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS------LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~------~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      +|+..+.||+|+||.||++... +++.||+|.+....      ......+.+|+.++++++|+||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4778899999999999999874 68999999986422      1234678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC-CEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC-RGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~-~vKLsDFGLAr~~  234 (718)
                      ||||+++++|.+++....  .+++..+..++.||+.||.|||   +.+++||||+|+||+++.++ .++|+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999997654  5788899999999999999999   89999999999999998776 5999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.5e-35  Score=306.05  Aligned_cols=145  Identities=32%  Similarity=0.482  Sum_probs=129.6

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      -|+..+.||+|+||.||+|... ++..||||.+.... ......+.+|+.++.+++||||+++++++..++..|+||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4677889999999999999875 68899999875432 233467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++++|.+++...   .+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++...
T Consensus        85 ~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06641          85 GGGSALDLLEPG---PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL  151 (277)
T ss_pred             CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceec
Confidence            999999998653   5788999999999999999999   899999999999999999999999999988653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6.6e-36  Score=315.55  Aligned_cols=148  Identities=30%  Similarity=0.526  Sum_probs=127.1

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCc----EEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGK----LLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~----~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~  155 (718)
                      .++|+..+.||+|+||.||+|.+. +|.    .||+|.+.... ......+.+|+.+++.++||||++++++|... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356788899999999999999875 343    57999886533 23344688999999999999999999998754 467


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++||+++|+|.+++..... .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccc
Confidence            99999999999999976543 5788899999999999999999   899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6e-36  Score=310.56  Aligned_cols=145  Identities=28%  Similarity=0.422  Sum_probs=127.7

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +|++.+.||+|+||.||+|... +|+.||+|.+....  ......+.+|+.+++.++|+||+++++++.+.+..|+|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999986 68999999986432  22234678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +. ++|.+++..... .+++..+..++.||+.||.|||   ..+|+||||||+||+++.++.++|+|||+++.
T Consensus        81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~  148 (284)
T cd07839          81 CD-QDLKKYFDSCNG-DIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARA  148 (284)
T ss_pred             CC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhc
Confidence            95 688888865432 5889999999999999999999   89999999999999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-36  Score=316.27  Aligned_cols=149  Identities=30%  Similarity=0.462  Sum_probs=131.1

Q ss_pred             HHhcCccccceecccCceEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhCCCCCcceeEEEEEee-----C
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT--FSLQTEREFQNELQILGGLRSPFLVTLLGYCME-----R  151 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~--~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-----~  151 (718)
                      .....|..++.||+|+||.|+.+.+. +|+.||||++..  ......++-.+|+.+|+.++|+||+.+++.+..     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            34456777889999999999999987 699999999963  233445678899999999999999999999865     3


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCc
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS  231 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLA  231 (718)
                      +.+|+|+|+| +.||.+.|+...  .++...+..++.||++||.|+|   +.+|+||||||+|+|++.+..+||+|||||
T Consensus        99 ~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccce
Confidence            4689999999 789999998774  4788888999999999999999   999999999999999999999999999999


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      |..
T Consensus       173 R~~  175 (359)
T KOG0660|consen  173 RYL  175 (359)
T ss_pred             eec
Confidence            975

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2e-35  Score=331.26  Aligned_cols=146  Identities=32%  Similarity=0.439  Sum_probs=131.0

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCC-C-----CcceeEEEEEeeCCeEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLR-S-----PFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-H-----pNIV~L~g~~~~~~~~~L  156 (718)
                      +|.+.+.||+|+||.|.+|.+. +++.||||+++... ....+-..|+.+|..|+ |     -|+|+++++|...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            7889999999999999999987 69999999997643 33445678999999987 4     489999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC--CEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC--RGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~--~vKLsDFGLAr~~  234 (718)
                      |+|.+ .-+|+++|+.+.-..++...++.++.||+.||.+||   ..+|||+||||+||||.+-+  .+||+|||.|...
T Consensus       266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            99999 779999999988778999999999999999999999   99999999999999997644  6999999998864

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.1e-35  Score=307.80  Aligned_cols=146  Identities=35%  Similarity=0.513  Sum_probs=131.7

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||.||++... +++.||+|.+....   ......+.+|++++++++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47889999999999999999986 58999999986422   233456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||+++++|.+++....  .++...+..++.||+.||.|||   +.+|+||||+|+|||++.++.+||+|||+++.
T Consensus        81 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~  150 (290)
T cd05580          81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR  150 (290)
T ss_pred             ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence            9999999999997764  5788899999999999999999   89999999999999999999999999998765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.4e-35  Score=304.22  Aligned_cols=145  Identities=27%  Similarity=0.467  Sum_probs=128.3

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh----------hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL----------QTEREFQNELQILGGLRSPFLVTLLGYCMERN  152 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~----------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~  152 (718)
                      +|.+.+.||+|+||.||+|... +|+.||||.+.....          ...+.+.+|+.+++.++|+||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677889999999999999876 689999998753111          11246788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                      ..++||||+++++|.+++...+  .+++..+..++.||+.||.|||   +.+++||||+|+||+++.++.++|+|||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            9999999999999999997764  5788889999999999999999   8999999999999999999999999999886


Q ss_pred             e
Q 005033          233 I  233 (718)
Q Consensus       233 ~  233 (718)
                      .
T Consensus       157 ~  157 (272)
T cd06629         157 K  157 (272)
T ss_pred             c
Confidence            5

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.4e-35  Score=304.33  Aligned_cols=146  Identities=28%  Similarity=0.443  Sum_probs=131.5

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +|++.+.||+|+||.||+|.+. +|+.||||++....  ......+.+|+.++++++|+||+++++++..+...|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999986 68999999986533  23346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      + +++|.+++.... ..+++..+..++.||+.||.|||   +.+|+|+||||+||+++.++.++|+|||++...
T Consensus        81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~  149 (286)
T cd07832          81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLF  149 (286)
T ss_pred             c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence            9 999999987654 36889999999999999999999   899999999999999999999999999988753

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.5e-35  Score=299.75  Aligned_cols=147  Identities=31%  Similarity=0.529  Sum_probs=133.9

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh-hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL-QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.++..++|+||+++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46888999999999999999987 499999999866443 4457799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD-PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~-~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++++|.+++....  .+++..+..++.|++.||.|||   . .+++||||+|+||+++.++.++|+|||++...
T Consensus        81 ~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~  150 (264)
T cd06623          81 MDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL  150 (264)
T ss_pred             cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceec
Confidence            99999999997653  6788999999999999999999   8 99999999999999999999999999988754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-35  Score=304.57  Aligned_cols=145  Identities=26%  Similarity=0.440  Sum_probs=129.8

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCC---CCcceeEEEEEeeCCeEEEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF-SLQTEREFQNELQILGGLR---SPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      .|+..+.||+|+||.||+|.+. +++.||||.+... .......+.+|+.+++.++   ||||+++++++......|+||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4777889999999999999975 6899999998643 2334567889999999986   999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++++|.+++...   .+++..+..++.|++.||.|||   ..+|+||||+|+||+++.++.++|+|||++...
T Consensus        82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06917          82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL  151 (277)
T ss_pred             ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence            999999999998654   5788999999999999999999   899999999999999999999999999988764

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.8e-35  Score=309.97  Aligned_cols=147  Identities=27%  Similarity=0.388  Sum_probs=129.1

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ...|+..+.||+|+||.||+|... +++.||+|.+...   .......+.+|+.+++.++||||++++++|...+..|+|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356888899999999999999886 6899999988532   223345788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |||+. |+|.+++..... .+++..+..++.|++.||.|||   ..+|+||||+|+||+++.++.++|+|||++..
T Consensus        94 ~e~~~-g~l~~~~~~~~~-~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~  164 (307)
T cd06607          94 MEYCL-GSASDILEVHKK-PLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASL  164 (307)
T ss_pred             HHhhC-CCHHHHHHHccc-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCccee
Confidence            99995 688887765433 5889999999999999999999   89999999999999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-36  Score=302.96  Aligned_cols=153  Identities=24%  Similarity=0.326  Sum_probs=133.8

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC-----eE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERN-----KR  154 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~  154 (718)
                      ..++|.+.+.||+|||+-||++..- ++..+|+|++.....++.+..++|++..++++||||++++++...+.     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            4468999999999999999999854 68999999998777777888999999999999999999998875443     48


Q ss_pred             EEEEeccCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          155 ILVYEYMPNKSLQEMLFSDG--NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~--~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                      ||++.|...|+|.+.+....  +..+++.+.+.|+.+|++||.+||.. .++.+||||||.|||+.+.+.++|.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            99999999999999986542  34689999999999999999999932 3459999999999999999999999999877


Q ss_pred             ee
Q 005033          233 IK  234 (718)
Q Consensus       233 ~~  234 (718)
                      ..
T Consensus       178 ~a  179 (302)
T KOG2345|consen  178 QA  179 (302)
T ss_pred             cc
Confidence            53

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.2e-35  Score=309.29  Aligned_cols=145  Identities=30%  Similarity=0.466  Sum_probs=131.9

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      ++|.+.+.||+|+||.||++... ++..||+|.+..........+.+|+.+++.++||||+++++++...+..|+|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            67889999999999999999875 68899999986544445567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ++++|.+++...   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++..
T Consensus        99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~  164 (293)
T cd06647          99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  164 (293)
T ss_pred             CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceec
Confidence            999999999754   4678899999999999999999   99999999999999999999999999998765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.4e-36  Score=317.45  Aligned_cols=149  Identities=26%  Similarity=0.403  Sum_probs=130.4

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh--hhHHHHHHHHHHHhCCCCCc-ceeEEEEEeeCC-----
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL--QTEREFQNELQILGGLRSPF-LVTLLGYCMERN-----  152 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~--~~~~~f~~Ei~iL~~L~HpN-IV~L~g~~~~~~-----  152 (718)
                      ...|..++.||+|+||+||+|+.. +|+.||+|++.....  .......+|+.+|+.|+|+| ||+|++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            345667778999999999999987 689999999965432  23345789999999999999 999999998877     


Q ss_pred             -eEEEEEeccCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeecc
Q 005033          153 -KRILVYEYMPNKSLQEMLFSDGN--LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG  229 (718)
Q Consensus       153 -~~~LVmEy~~gGsL~~~L~~~~~--~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFG  229 (718)
                       ..+||+||+ .-+|..++.....  ..++...+..++.||+.||+|||   +++|+||||||+||||+.+|.+||+|||
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence             789999999 6799999987653  35777889999999999999999   9999999999999999999999999999


Q ss_pred             Cceee
Q 005033          230 LSRIK  234 (718)
Q Consensus       230 LAr~~  234 (718)
                      +|+..
T Consensus       166 lAra~  170 (323)
T KOG0594|consen  166 LARAF  170 (323)
T ss_pred             hHHHh
Confidence            99853

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.8e-35  Score=305.10  Aligned_cols=148  Identities=26%  Similarity=0.440  Sum_probs=128.8

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.++|+||+++++++..++..|+||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999876 68899999986432 222346788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||+ .++|.+++..... .+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.++|+|||+++.
T Consensus        83 e~~-~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~  152 (291)
T cd07870          83 EYM-HTDLAQYMIQHPG-GLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARA  152 (291)
T ss_pred             ecc-cCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccc
Confidence            999 4788887765432 4677888899999999999999   88999999999999999999999999998865

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.6e-35  Score=301.78  Aligned_cols=147  Identities=31%  Similarity=0.450  Sum_probs=132.1

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ++|+..+.||+|+||.||++.+. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36778889999999999999987 58999999986543 34456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD-PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~-~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +++++|.+++.... ..+++..+..++.|++.||.|||   + .+++||||||+||+++.++.++|+|||++..
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~  150 (265)
T cd06605          81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ  150 (265)
T ss_pred             cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchh
Confidence            99999999997653 36788899999999999999999   7 8999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=306.62  Aligned_cols=147  Identities=27%  Similarity=0.431  Sum_probs=129.1

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ++|++.+.||+|+||.||+|.+. +++.||||.+...  .......+.+|+++++.++|+||+++++++..++..|+|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999987 5889999988642  22334678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |++++.|..++....  .+++..+..++.||+.||.|||   ..+++||||+|+||+++.++.+||+|||++...
T Consensus        81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~  150 (288)
T cd07833          81 YVERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARAL  150 (288)
T ss_pred             cCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence            998877766655433  4788999999999999999999   899999999999999999999999999988764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-35  Score=305.04  Aligned_cols=146  Identities=25%  Similarity=0.437  Sum_probs=129.6

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh-hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL-QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ++|++.+.||+|+||.||+|... +++.||||.+..... .....+.+|+++++.++|+||+++++++...+..|+||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67899999999999999999987 689999999864321 2234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +. ++|.+++..... .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        85 ~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  152 (291)
T cd07844          85 LD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARA  152 (291)
T ss_pred             CC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccc
Confidence            96 599999876543 6788999999999999999999   89999999999999999999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.6e-35  Score=303.63  Aligned_cols=147  Identities=24%  Similarity=0.403  Sum_probs=124.5

Q ss_pred             ccccceecccCceEEEEEEEc----CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC------
Q 005033           85 FDEANVIGKGGSGTVFLGIAR----DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERN------  152 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~----~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------  152 (718)
                      |.+.+.||+|+||.||+|...    +++.||||++...  .....+.+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999864    3689999988643  2344567899999999999999999999986542      


Q ss_pred             eEEEEEeccCCCCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeec
Q 005033          153 KRILVYEYMPNKSLQEMLFSDG----NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDF  228 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~----~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDF  228 (718)
                      ..++++||+.+|+|.+++....    ...+++.....++.||+.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            2478999999999998875321    235788889999999999999999   899999999999999999999999999


Q ss_pred             cCceee
Q 005033          229 GLSRIK  234 (718)
Q Consensus       229 GLAr~~  234 (718)
                      |+++..
T Consensus       158 g~~~~~  163 (273)
T cd05074         158 GLSKKI  163 (273)
T ss_pred             cccccc
Confidence            988753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.9e-34  Score=338.57  Aligned_cols=149  Identities=31%  Similarity=0.492  Sum_probs=134.2

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|.+.+.||+|+||.||+|.+. +++.||||++....   ......+..|+.++..++|+||+++++++...+..||||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            67999999999999999999987 68999999986432   233467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceeeec
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVE  236 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~~~  236 (718)
                      ||+.+++|.+++...+  .+++..++.|+.||+.||.|||   ..+||||||||+||||+.++.+||+|||+++....
T Consensus        84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~  156 (669)
T cd05610          84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN  156 (669)
T ss_pred             eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence            9999999999997654  5788889999999999999999   88999999999999999999999999999997643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.1e-35  Score=304.21  Aligned_cols=148  Identities=28%  Similarity=0.394  Sum_probs=128.6

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC--CeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMER--NKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LVm  158 (718)
                      ++|...+.||.|++|.||+|.+. +++.+|+|.+.... ......+.+|+++++.++||||++++++|...  +..|+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888899999999999999986 58899999986432 23456789999999999999999999998654  4689999


Q ss_pred             eccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSD--GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~--~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||+++++|.+++...  ....++...+..++.||+.||.|||   ..+++|+||+|+||+++.++.++|+|||++..
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~  154 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGE  154 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccc
Confidence            999999999987542  2235788889999999999999999   89999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=334.05  Aligned_cols=160  Identities=24%  Similarity=0.376  Sum_probs=142.7

Q ss_pred             HHHHHHHhcCccccceecccCceEEEEEEEcC-CcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe
Q 005033           75 YKELKNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNK  153 (718)
Q Consensus        75 ~~el~~at~~f~~~~~LG~G~FG~Vykg~~~~-g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~  153 (718)
                      ++++..-..+....+.||-|.||.||.|.++. .-.||||.++... ....+|+.|+.+|+.++|||+|+|+|+|.....
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            35555555667778899999999999999974 6789999997643 456799999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .|||+|||.+|+|.+||+...+..++.-..+.++.||..||.||.   .+++|||||..+|+|+.++..+||+||||+++
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence            999999999999999999887767777788899999999999999   99999999999999999999999999999999


Q ss_pred             eecCc
Q 005033          234 KVEGE  238 (718)
Q Consensus       234 ~~~~~  238 (718)
                      +..+.
T Consensus       415 MtgDT  419 (1157)
T KOG4278|consen  415 MTGDT  419 (1157)
T ss_pred             hcCCc
Confidence            74433

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=331.35  Aligned_cols=146  Identities=27%  Similarity=0.387  Sum_probs=129.2

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      -|...+.||.|+||.||.+++. +.+.||||++.-..   ....+.++.|+..|.+++|||+|.+-|||......|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            4667788999999999999986 68899999996433   2334678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      || -|+-.++|.-..+ ++.+-.+..|+.+.+.||+|||   +.+.||||||..|||+++.|.|||+|||.|.+.
T Consensus       107 YC-lGSAsDlleVhkK-plqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIM  176 (948)
T ss_pred             HH-hccHHHHHHHHhc-cchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhc
Confidence            99 6788888876654 6788888999999999999999   999999999999999999999999999987653

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.8e-36  Score=320.77  Aligned_cols=143  Identities=30%  Similarity=0.440  Sum_probs=119.8

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC-----eEEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERN-----KRILV  157 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~~LV  157 (718)
                      .|...+++|+|+||.||+|... +++.||||++-...    +.-.+|+++|+.+.|||||+|.-+|....     ...||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4667889999999999999987 57999999874422    12347999999999999999998886532     23589


Q ss_pred             EeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC-CCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSD--GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD-CRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~--~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~-~~vKLsDFGLAr~~  234 (718)
                      ||||+ .+|.++++..  .+..++.-.+.-++.||.+||.|||   ..+|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            99995 6999999752  2235666777889999999999999   8999999999999999976 89999999999986

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.9e-35  Score=310.43  Aligned_cols=143  Identities=27%  Similarity=0.397  Sum_probs=127.9

Q ss_pred             ccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           85 FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      |.....||+|+||.||++... +++.||||.+..........+.+|+.++..++||||+++++++..++..|+||||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            344557999999999999876 6899999998654444556788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ++|..++...   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++..
T Consensus       103 ~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~  166 (297)
T cd06659         103 GALTDIVSQT---RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ  166 (297)
T ss_pred             CCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhh
Confidence            9999988653   5788999999999999999999   89999999999999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5e-35  Score=299.08  Aligned_cols=146  Identities=29%  Similarity=0.470  Sum_probs=132.0

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh--hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL--QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +|++.+.||+|+||.||+|... +++.||+|.+.....  ...+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4788899999999999999876 689999999865433  3567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++++|.+++....  .+++..+..++.|++.||.|||   +.+|+|+||+|+||+++.++.+||+|||++...
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~  149 (264)
T cd06626          81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL  149 (264)
T ss_pred             CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccccccccc
Confidence            99999999997653  4678888999999999999999   899999999999999999999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.5e-35  Score=350.99  Aligned_cols=141  Identities=18%  Similarity=0.283  Sum_probs=118.0

Q ss_pred             HHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEee--CCe
Q 005033           79 KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCME--RNK  153 (718)
Q Consensus        79 ~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~  153 (718)
                      ....++|.+++.||+|+||+||+|.+. ++..||+|.+...  .......|..|+.+|..|+|||||+++++|..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            345578999999999999999999987 5789999988643  23345678999999999999999999998865  356


Q ss_pred             EEEEEeccCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCeEecCCCCCCEEECC
Q 005033          154 RILVYEYMPNKSLQEMLFSDG--NLVLKWSQRFEIIMDVAKALEFLHFGC----DPPVIHGDIKPSNVLLDS  219 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~--~~~l~~~~~~~Ia~qIa~gL~yLH~~~----~~gIVHRDLKP~NILLd~  219 (718)
                      +||||||+++|+|.++|....  ...+++..++.|+.||+.||.|||...    ..+||||||||+||||+.
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s  160 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST  160 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence            899999999999999997532  235899999999999999999999321    145999999999999964

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.1e-35  Score=307.58  Aligned_cols=147  Identities=27%  Similarity=0.439  Sum_probs=123.5

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCCeEEEEEec
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLR-SPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +|...+.||+|+||.||++... +++.||||.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            5566778999999999999986 58999999986432 234567899999999996 99999999999999999999999


Q ss_pred             cCCCCHHHHH---hhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEML---FSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L---~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +. ++|.++.   .......+++..+..++.|++.||+|||+  ..+|+||||||+|||++.++.++|+|||+++.
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  157 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ  157 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence            84 5665543   32333468889999999999999999992  35999999999999999999999999998865

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=312.97  Aligned_cols=149  Identities=26%  Similarity=0.378  Sum_probs=130.0

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT--FSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~--~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++.|++-+.||+|.|+.||++... +|+.+|+|+++.  .+....+.+.+|+.|.+.|+|||||+|++.+...+..|||
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            3567888899999999999999876 699999999854  3344567889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC---CCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD---CRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~---~~vKLsDFGLAr~~  234 (718)
                      +|+|.|++|..-|-..  ..+++..+-.+++||+.+|.|+|   .++|||||+||+|+|+...   --+||+|||+|..+
T Consensus        89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999998766443  36788888899999999999999   9999999999999999543   35899999999875

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.7e-35  Score=301.28  Aligned_cols=148  Identities=24%  Similarity=0.459  Sum_probs=130.7

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +|++.+.||+|+||.||+|... +|..||+|.+....  ......+.+|+.+++.++|+||+++++.+...+..|+|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999987 58899999985431  23445788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC-EEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR-GKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~-vKLsDFGLAr~~  234 (718)
                      +++++|.+++.......+++..+..++.|++.||.|||   ..+++|+||||+||+++.++. ++|+|||++...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999999997765556789999999999999999999   899999999999999998864 699999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.8e-35  Score=306.73  Aligned_cols=147  Identities=26%  Similarity=0.394  Sum_probs=129.2

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh--hhHHHHHHHHHHHhCCCCCcceeEEEEEeeC--CeEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL--QTEREFQNELQILGGLRSPFLVTLLGYCMER--NKRILV  157 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LV  157 (718)
                      ++|++.+.||+|+||.||+|... +++.+|||.+.....  .....+.+|+.++.+++||||+++++++...  +..|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888999999999999999987 588999999864322  2234577899999999999999999999887  889999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+. ++|.+++..... .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.++|+|||+++..
T Consensus        85 ~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             ehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            99996 599999876543 6899999999999999999999   899999999999999999999999999988753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=325.53  Aligned_cols=150  Identities=32%  Similarity=0.429  Sum_probs=137.0

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .+.|..-++||+||||.||-|+.+ +|+.+|.|.+.+...   +.....++|-.||.+++.+.||.|-.+|+..+.+|||
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            356888899999999999999877 699999999865332   3344578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |..|.||||.-+|...++..+++..++.++.+|+.||++||   +.+||.|||||+|||+|+.|+++|+|+|||..+
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEec
Confidence            99999999999999988889999999999999999999999   999999999999999999999999999999865

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=322.59  Aligned_cols=149  Identities=23%  Similarity=0.308  Sum_probs=132.0

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhh--HHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQT--EREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      .+=|.+.+.||+|.|++|-++++- +|..||||++.+.....  ...+..|+..|+-++|||||+||.+.-....+|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            345788899999999999999876 79999999997654333  346889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEC-CCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD-SDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd-~~~~vKLsDFGLAr~~  234 (718)
                      |+-.+|+|++||..+.. .+.+..+..++.||+.|+.|+|   ...+|||||||+||.+- .-|-+||+|||++-..
T Consensus        97 ELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            99999999999987754 6888999999999999999999   99999999999999885 4578999999987543

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.2e-34  Score=291.34  Aligned_cols=147  Identities=35%  Similarity=0.492  Sum_probs=133.7

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      +|...+.||+|+||.||++... ++..+++|++..........+.+|+.+++.++|+||+++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999987 688999999976554566789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++|.+++.... ..+++..+..++.|++.||.|||   ..+++||||+|+||+++.++.++|+|||++...
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~  148 (253)
T cd05122          81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL  148 (253)
T ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccccccc
Confidence            999999997653 36889999999999999999999   899999999999999999999999999987653

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.3e-34  Score=312.82  Aligned_cols=146  Identities=27%  Similarity=0.447  Sum_probs=126.5

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC------
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMER------  151 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------  151 (718)
                      ..++|+..+.||+|+||.||+|... +++.||||.+...  .......+.+|+.+++.++|+||++++++|...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999986 6899999998542  233445678899999999999999999998644      


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCc
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS  231 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLA  231 (718)
                      ...|+||||+ .++|.+.+...    ++...+..++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~-~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEecc-CCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            3579999999 56898888643    788888999999999999999   899999999999999999999999999998


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      +..
T Consensus       166 ~~~  168 (353)
T cd07850         166 RTA  168 (353)
T ss_pred             eeC
Confidence            753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=6.5e-35  Score=305.39  Aligned_cols=144  Identities=30%  Similarity=0.466  Sum_probs=129.4

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      .|...+.||+|+||.||++... +++.+|+|.+........+.+.+|+.+++.++|+||+++++++...+..|+|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3555679999999999999875 688999999865544555678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +++|.+++...   .+++..+..++.|++.||.|||   +.+|+||||+|+||+++.++.++|+|||++..
T Consensus       100 ~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~  164 (285)
T cd06648         100 GGALTDIVTHT---RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQ  164 (285)
T ss_pred             CCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchh
Confidence            99999999763   5788899999999999999999   89999999999999999999999999997754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-35  Score=306.99  Aligned_cols=147  Identities=23%  Similarity=0.406  Sum_probs=126.7

Q ss_pred             CccccceecccCceEEEEEEEcC---CcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC--CeEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMER--NKRI  155 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~~---g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~  155 (718)
                      .|++.+.||+|+||.||+|....   ++.||||.+....   ......+.+|+.++..++||||+++++++...  ...|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47788999999999999999854   7899999987532   23345678899999999999999999999988  7899


Q ss_pred             EEEeccCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC----CCCEEEeec
Q 005033          156 LVYEYMPNKSLQEMLFSDG---NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS----DCRGKVSDF  228 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~---~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~----~~~vKLsDF  228 (718)
                      +||||++ ++|.+++....   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            9999995 57877775332   235788899999999999999999   899999999999999999    899999999


Q ss_pred             cCceee
Q 005033          229 GLSRIK  234 (718)
Q Consensus       229 GLAr~~  234 (718)
                      |+++..
T Consensus       157 g~~~~~  162 (316)
T cd07842         157 GLARLF  162 (316)
T ss_pred             cccccc
Confidence            998764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=5.9e-35  Score=305.14  Aligned_cols=139  Identities=29%  Similarity=0.390  Sum_probs=117.9

Q ss_pred             eecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHH---HhCCCCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           90 VIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNELQI---LGGLRSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        90 ~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei~i---L~~L~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      .||+|+||.||++... +++.||||.+.....   .....+.+|..+   +...+|+||+.+++++...+..|+||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999986 589999998854321   122334455443   344579999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +|+|.+++...+  .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||++..
T Consensus        81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~  146 (279)
T cd05633          81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD  146 (279)
T ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence            999999997654  5899999999999999999999   89999999999999999999999999998864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.3e-34  Score=307.87  Aligned_cols=145  Identities=26%  Similarity=0.398  Sum_probs=127.0

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .|...+.||+|+||.||++... ++..||+|.+...   .......+.+|+.+++.++|+|++++++++......|+|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3677889999999999999976 6889999998642   22334578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+. |+|.+++..... .+++..+..++.||+.||.|||   ..+|+||||+|+||+++.++.++|+|||++..
T Consensus       106 ~~~-g~l~~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~  174 (317)
T cd06635         106 YCL-GSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASI  174 (317)
T ss_pred             CCC-CCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccc
Confidence            995 688888765433 5889999999999999999999   89999999999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-35  Score=322.79  Aligned_cols=146  Identities=25%  Similarity=0.405  Sum_probs=129.4

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcc--cCChhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCCeEEEEEe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLD--TFSLQTEREFQNELQILGGLR-SPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~--~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ..|++++.||+||.+.||++...+.+.||+|++.  ..+.+....|.+|+.+|.+|+ |.+||+|++|-..++.+|||||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            3588899999999999999998888899998874  345566788999999999994 8999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |= ..||..+|.........| .++.+..||+.|+.++|   ..||||.||||.|+|+ -.|.+||+|||+|..+
T Consensus       441 ~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  441 CG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLL-VKGRLKLIDFGIANAI  509 (677)
T ss_pred             cc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEE-EeeeEEeeeechhccc
Confidence            87 679999998877654445 67789999999999999   9999999999999998 5689999999999876

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.7e-35  Score=301.53  Aligned_cols=145  Identities=32%  Similarity=0.433  Sum_probs=131.5

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      +|++.+.||.|+||.||+|.+. ++..||+|.+....   ....+.+.+|++++++++||||+++++++..+...|+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5788999999999999999987 58999999986432   2345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+.+++|.+++....  .+++..+..++.||+.||.|||   ..+++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~  149 (258)
T cd05578          81 LLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATK  149 (258)
T ss_pred             CCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccc
Confidence            999999999997663  6788899999999999999999   89999999999999999999999999998765

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.8e-36  Score=305.64  Aligned_cols=150  Identities=27%  Similarity=0.452  Sum_probs=131.6

Q ss_pred             HHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--------hhhHHHHHHHHHHHhCC-CCCcceeEEEEEe
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--------LQTEREFQNELQILGGL-RSPFLVTLLGYCM  149 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--------~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~  149 (718)
                      ...+.|...+.||.|..++|.+|..+ +|..+|+|++....        ....+.-.+|+.||+++ .||+|+.+.++|+
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            34456778889999999999998876 68899999985321        11234567899999998 6999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeecc
Q 005033          150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG  229 (718)
Q Consensus       150 ~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFG  229 (718)
                      .+...++|+|.|+.|.|.++|.+.-  .+++.....|++|+..|+.|||   ..+||||||||+|||++++.++||+|||
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccc
Confidence            9999999999999999999997653  6899999999999999999999   9999999999999999999999999999


Q ss_pred             Cceee
Q 005033          230 LSRIK  234 (718)
Q Consensus       230 LAr~~  234 (718)
                      +|..+
T Consensus       169 Fa~~l  173 (411)
T KOG0599|consen  169 FACQL  173 (411)
T ss_pred             eeecc
Confidence            99875

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=9e-35  Score=301.30  Aligned_cols=146  Identities=29%  Similarity=0.477  Sum_probs=129.4

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh-hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL-QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      +|+..+.||.|++|.||+|... +|..||||.+..... .....+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999986 589999999865332 23456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          162 PNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       162 ~gGsL~~~L~~~~-~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      + ++|.+++.... ...+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.++|+|||+++.
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~  149 (284)
T cd07836          81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARA  149 (284)
T ss_pred             C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhh
Confidence            7 58999887654 235899999999999999999999   89999999999999999999999999998864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.6e-34  Score=291.59  Aligned_cols=146  Identities=27%  Similarity=0.481  Sum_probs=132.7

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh--hhHHHHHHHHHHHhCCCCCcceeEEEEEeeC--CeEEEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL--QTEREFQNELQILGGLRSPFLVTLLGYCMER--NKRILVY  158 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LVm  158 (718)
                      +|+..+.||+|++|.||+|... ++..|++|.+.....  .....+.+|+.++++++|+||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999987 689999999865432  4467889999999999999999999999988  8899999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~  151 (260)
T cd06606          81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRL  151 (260)
T ss_pred             EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence            9999999999998765  6889999999999999999999   899999999999999999999999999988764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.3e-34  Score=302.98  Aligned_cols=147  Identities=22%  Similarity=0.399  Sum_probs=128.1

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ++|++.+.||+|+||.||+|... +|+.||||.+....  ......+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57889999999999999999986 68999999885432  2234568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC-CCCEEEeeccCcee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS-DCRGKVSDFGLSRI  233 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~-~~~vKLsDFGLAr~  233 (718)
                      |++ ++|.+++.......+++..+..++.||+.||.|||   +++|+||||+|+||+++. ++.+||+|||++..
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~  152 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARA  152 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence            995 68988887655545678888899999999999999   899999999999999985 55799999999865

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.5e-34  Score=301.64  Aligned_cols=147  Identities=28%  Similarity=0.424  Sum_probs=126.2

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCCe-----
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLR-SPFLVTLLGYCMERNK-----  153 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~-----  153 (718)
                      ++|++.+.||+|+||.||+|.+. +++.||||.+....  ......+.+|+.+++.+. |+||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999986 68999999875432  122356888999999995 6999999999987665     


Q ss_pred             EEEEEeccCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC-CCCEEEeecc
Q 005033          154 RILVYEYMPNKSLQEMLFSDG---NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS-DCRGKVSDFG  229 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~---~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~-~~~vKLsDFG  229 (718)
                      .|+||||++ ++|.+++....   ...+++..+..++.||+.||.|||   ..+|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            899999997 48999886542   235789999999999999999999   899999999999999998 8899999999


Q ss_pred             Ccee
Q 005033          230 LSRI  233 (718)
Q Consensus       230 LAr~  233 (718)
                      +++.
T Consensus       157 ~~~~  160 (295)
T cd07837         157 LGRA  160 (295)
T ss_pred             ccee
Confidence            8875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.6e-34  Score=298.63  Aligned_cols=144  Identities=27%  Similarity=0.372  Sum_probs=123.7

Q ss_pred             ccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeC--CeEEEEEe
Q 005033           85 FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLR-SPFLVTLLGYCMER--NKRILVYE  159 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~--~~~~LVmE  159 (718)
                      |++.+.||+|+||.||+|... +++.||+|.+.... ........+|+.++.++. |+||+++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999976 68999999986532 222234567999999885 99999999999987  88999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+. |+|.+++.... ..+++..+..++.||+.||.|||   ..+|+||||+|+||+++. +.+||+|||+++..
T Consensus        81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~  149 (282)
T cd07831          81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGI  149 (282)
T ss_pred             cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccccccc
Confidence            995 68888887643 26899999999999999999999   899999999999999999 99999999988753

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=309.97  Aligned_cols=146  Identities=27%  Similarity=0.477  Sum_probs=127.0

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC-----CeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMER-----NKR  154 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~~  154 (718)
                      .++|++.+.||+|+||.||+|.+. +|+.||||.+.... ......+.+|+.+++.++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999876 68999999986432 23345688899999999999999999987654     357


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+|+||+. ++|.+++...   .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||+++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            99999995 6898888654   5888999999999999999999   899999999999999999999999999998753

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.2e-34  Score=301.98  Aligned_cols=149  Identities=29%  Similarity=0.445  Sum_probs=134.8

Q ss_pred             HHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ..++.|+..+.||+|+||.||+|.+. ++..||+|.+..... ....+.+|+++++.++|+||+++++++...+..|+|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            34567888899999999999999987 688999999875443 4567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||+++++|.+++.... ..+++..+..++.|++.||.|||   ..+|+|+||+|+||+++.++.++|+|||++..
T Consensus        95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~  165 (286)
T cd06614          95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQ  165 (286)
T ss_pred             eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhh
Confidence            9999999999998764 36889999999999999999999   89999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=299.32  Aligned_cols=145  Identities=26%  Similarity=0.446  Sum_probs=129.2

Q ss_pred             ccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           85 FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      |++.+.||.|++|.||+|.+. +|..||||++....  ......+.+|+++++.++|+||+++++++...+..|+||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999986 69999999986432  223356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                       +++|.+++.......+++..+..++.|++.||.|||   .++++||||+|+||+++.++.++|+|||+++.
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~  148 (283)
T cd07835          81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARA  148 (283)
T ss_pred             -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccc
Confidence             579999997765446899999999999999999999   89999999999999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.6e-34  Score=302.78  Aligned_cols=146  Identities=20%  Similarity=0.292  Sum_probs=113.3

Q ss_pred             cCccccceecccCceEEEEEEEcC----CcEEEEEEcccCChhh--H---------HHHHHHHHHHhCCCCCcceeEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARD----GKLLAIKRLDTFSLQT--E---------REFQNELQILGGLRSPFLVTLLGY  147 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~----g~~VAVK~i~~~~~~~--~---------~~f~~Ei~iL~~L~HpNIV~L~g~  147 (718)
                      ++|++.+.||+|+||.||+|...+    +..+|+|.........  .         .....+...+..+.|+||++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            579999999999999999999764    4566777543221111  0         112334455677899999999998


Q ss_pred             EeeCC----eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCE
Q 005033          148 CMERN----KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG  223 (718)
Q Consensus       148 ~~~~~----~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~v  223 (718)
                      +....    ..++++|++ ..++.+.+....  ..++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+
T Consensus        92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeEecCCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcE
Confidence            76543    447889988 457777775442  3567788899999999999999   8999999999999999999999


Q ss_pred             EEeeccCceee
Q 005033          224 KVSDFGLSRIK  234 (718)
Q Consensus       224 KLsDFGLAr~~  234 (718)
                      +|+|||+|+..
T Consensus       166 ~l~DFGla~~~  176 (294)
T PHA02882        166 YIIDYGIASHF  176 (294)
T ss_pred             EEEEcCCceee
Confidence            99999999865

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.5e-34  Score=292.58  Aligned_cols=148  Identities=29%  Similarity=0.492  Sum_probs=133.2

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh--hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL--QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +|++.+.||+|+||.||++.+. ++..||+|++.....  .....+.+|+++++.++|+|++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788899999999999999986 588999999865432  4556789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDG--NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~--~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++++|.+++....  ...+++..+..++.+++.||.|||   ..+++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~  153 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL  153 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeec
Confidence            99999999997653  246899999999999999999999   889999999999999999999999999988753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1e-34  Score=301.60  Aligned_cols=140  Identities=30%  Similarity=0.403  Sum_probs=125.1

Q ss_pred             ecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCCH
Q 005033           91 IGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSL  166 (718)
Q Consensus        91 LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL  166 (718)
                      ||+|+||+||+|... +|+.||+|.+....   ......+.+|+++++.++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999876 68999999986432   22344578899999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          167 QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       167 ~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .+++.......+++..+..++.|++.||.|||   ..+++||||+|+||+++.++.++|+|||++..
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~  144 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVE  144 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhh
Confidence            99998766556889999999999999999999   89999999999999999999999999998765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-36  Score=331.05  Aligned_cols=148  Identities=27%  Similarity=0.430  Sum_probs=133.7

Q ss_pred             hcCccccceecccCceEEEEEEEcC-CcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~-g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      .+-|.++..||.|+||.||++..+. +-..|.|+|..........|+-||+||..+.||+||+|++.|...+.++|+.||
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            3456778889999999999999874 566778998877777788999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |.||-...++-.-+. .+.+.++..++.|++.||.|||   +++|||||||..|||++.+|.++|+|||.+..
T Consensus       111 C~GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAK  179 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAK  179 (1187)
T ss_pred             cCCchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeeccccccc
Confidence            999999988866554 7899999999999999999999   99999999999999999999999999998754

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-35  Score=324.22  Aligned_cols=148  Identities=28%  Similarity=0.465  Sum_probs=131.0

Q ss_pred             ccccceecccCceEEEEEEEcC---C--cEEEEEEccc-CChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           85 FDEANVIGKGGSGTVFLGIARD---G--KLLAIKRLDT-FSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~~---g--~~VAVK~i~~-~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ..+.++||.|.||.||+|.+.+   |  -.||||..+. ......+.|+.|.-+|++++|||||+|+|+|.+ ...||||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence            3456789999999999999753   2  3689999876 445567789999999999999999999999975 4789999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceeeecC
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG  237 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~  237 (718)
                      |+++-|.|.+||+.+.. .++......++.||+.||+|||   +..+|||||..+|||+...-.+||+||||+|.+.++
T Consensus       470 EL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             ecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            99999999999988765 6888888999999999999999   999999999999999999999999999999987444

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-34  Score=297.14  Aligned_cols=146  Identities=29%  Similarity=0.464  Sum_probs=124.9

Q ss_pred             ccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCC---CCCcceeEEEEEeeCCe-----
Q 005033           85 FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGL---RSPFLVTLLGYCMERNK-----  153 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~~~~-----  153 (718)
                      |++.+.||+|+||.||+|... +++.||||.+....  ......+.+|+.++.++   .|+||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999987 48999999986422  22234566788777655   69999999999988776     


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .+++|||+. ++|.+++.......+++..++.++.||+.||.|||   +.+++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999995 58999987755446899999999999999999999   89999999999999999999999999998865


Q ss_pred             e
Q 005033          234 K  234 (718)
Q Consensus       234 ~  234 (718)
                      .
T Consensus       157 ~  157 (287)
T cd07838         157 Y  157 (287)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.5e-34  Score=293.71  Aligned_cols=148  Identities=26%  Similarity=0.450  Sum_probs=130.8

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +|++.+.||+|+||.||++... +++.+|+|.+...  .......+.+|+.+++.++|+||+++++++......|+||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999876 6889999998643  233455788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDG--NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~--~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++++|.+++....  ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~  153 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL  153 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhh
Confidence            99999999986621  235788899999999999999999   999999999999999999999999999988753

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.2e-34  Score=301.93  Aligned_cols=148  Identities=28%  Similarity=0.428  Sum_probs=127.9

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh--hhHHHHHHHHHHHhCCCCCcceeEEEEEeeC--CeEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL--QTEREFQNELQILGGLRSPFLVTLLGYCMER--NKRIL  156 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~L  156 (718)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|.+.....  .....+.+|+.++++++|+||+++++++...  +..|+
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            468999999999999999999986 589999999854321  1223567899999999999999999999765  56899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||||+. ++|.+++.... ..+++..+..++.||+.||.|||   ..+++||||||+||+++.++.+||+|||++...
T Consensus        86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            999995 68998887643 36889999999999999999999   899999999999999999999999999988753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-35  Score=324.61  Aligned_cols=149  Identities=28%  Similarity=0.417  Sum_probs=135.2

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh--hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL--QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      -...|.+...||+|.|+.|.++++. ++..||||.+.+...  ...+.+.+|+++|..|+|||||+++.+......+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            4568899999999999999999987 699999999976443  3335589999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+.+|.++++|..++.  +.+..+..++.|+..|++|||   .+.|||||||++||||+.+.++||+|||++..+
T Consensus       134 ~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             EEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceee
Confidence            999999999999998874  455788889999999999999   999999999999999999999999999999875

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-34  Score=329.15  Aligned_cols=151  Identities=19%  Similarity=0.292  Sum_probs=120.2

Q ss_pred             HHhcCccccceecccCceEEEEEEEcC--CcEEEEEEcc-----------------cCChhhHHHHHHHHHHHhCCCCCc
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIARD--GKLLAIKRLD-----------------TFSLQTEREFQNELQILGGLRSPF  140 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~~--g~~VAVK~i~-----------------~~~~~~~~~f~~Ei~iL~~L~HpN  140 (718)
                      ...++|++++.||+|+||.||+|..+.  +..+++|.+.                 .........+.+|+.+|..++|+|
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            345789999999999999999987642  2222222110                 011223456889999999999999


Q ss_pred             ceeEEEEEeeCCeEEEEEeccCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 005033          141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDG---NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL  217 (718)
Q Consensus       141 IV~L~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~---~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL  217 (718)
                      ||++++++...+..|+|+|++ +++|.+++....   ........+..|+.||+.||.|||   +++||||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence            999999999999999999999 578888875432   112234567789999999999999   8999999999999999


Q ss_pred             CCCCCEEEeeccCceee
Q 005033          218 DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       218 d~~~~vKLsDFGLAr~~  234 (718)
                      +.++.+||+|||+++..
T Consensus       301 ~~~~~vkL~DFGla~~~  317 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPF  317 (501)
T ss_pred             CCCCCEEEEeCCCceec
Confidence            99999999999998764

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.6e-34  Score=305.13  Aligned_cols=141  Identities=21%  Similarity=0.240  Sum_probs=124.2

Q ss_pred             ceeccc--CceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKG--GSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G--~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      ..||+|  +||+||++.+. +|+.||||++...  .....+.+.+|+.+++.++||||++++++|..++..|+||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  99999999986 6999999998643  233346788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                      |+|.+++.......+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.++++|||.+.
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~  149 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLY  149 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHh
Confidence            99999998765556888999999999999999999   8999999999999999999999999997654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.7e-34  Score=301.45  Aligned_cols=143  Identities=20%  Similarity=0.179  Sum_probs=122.1

Q ss_pred             cceecccCceEEEEEEEcCCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCC
Q 005033           88 ANVIGKGGSGTVFLGIARDGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKS  165 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGs  165 (718)
                      .+.+|.|+++.||++.. +++.||||++...  .......+.+|+.+++.++|+||+++++++...+..|++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            33445555555555544 6899999998653  34455679999999999999999999999999999999999999999


Q ss_pred             HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          166 LQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       166 L~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |.+++.......+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||.+...
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~  151 (314)
T cd08216          86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM  151 (314)
T ss_pred             HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceee
Confidence            999998754446888899999999999999999   899999999999999999999999999988754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.4e-34  Score=295.18  Aligned_cols=139  Identities=28%  Similarity=0.391  Sum_probs=125.0

Q ss_pred             ecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCCH
Q 005033           91 IGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSL  166 (718)
Q Consensus        91 LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL  166 (718)
                      ||.|+||.||+|... +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++.+++..|+||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999987 48999999986432   23346789999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          167 QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       167 ~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      .+++....  .+++..+..++.||+.||.|||   +.+++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~  143 (262)
T cd05572          81 WTILRDRG--LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL  143 (262)
T ss_pred             HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCccccc
Confidence            99997654  4788899999999999999999   899999999999999999999999999988753

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-34  Score=289.31  Aligned_cols=146  Identities=27%  Similarity=0.487  Sum_probs=132.6

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh--hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL--QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +|++.+.||+|+||.||++... +++.||+|.+.....  .....+.+|++++.+++|+||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999876 588999999976543  4556799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++++|.+++....  .+++..+..++.|++.||.|||   +.+|+||||+|+||+++.++.++|+|||++...
T Consensus        81 ~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  149 (254)
T cd06627          81 AENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKL  149 (254)
T ss_pred             CCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceec
Confidence            99999999997663  5889999999999999999999   899999999999999999999999999998764

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.1e-34  Score=299.55  Aligned_cols=148  Identities=24%  Similarity=0.399  Sum_probs=126.9

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC------
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERN------  152 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------  152 (718)
                      .++|++.+.||+|+||.||+|... +++.||||.+....  ......+.+|+.++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457999999999999999999986 68999999885422  222345678999999999999999999987654      


Q ss_pred             --eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccC
Q 005033          153 --KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL  230 (718)
Q Consensus       153 --~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGL  230 (718)
                        ..|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||   +.+++|+||||+||+++.++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence              4599999995 68988886543 35789999999999999999999   88999999999999999999999999999


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      +...
T Consensus       166 ~~~~  169 (310)
T cd07865         166 ARAF  169 (310)
T ss_pred             cccc
Confidence            8764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-34  Score=293.61  Aligned_cols=147  Identities=27%  Similarity=0.429  Sum_probs=129.0

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC-----ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC--CeE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF-----SLQTEREFQNELQILGGLRSPFLVTLLGYCMER--NKR  154 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~-----~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~  154 (718)
                      .+|++.+.||+|+||.||+|.+. ++..||+|.+...     .......+.+|++++++++|+||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47889999999999999999976 5899999987431     123345788999999999999999999998764  468


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++||||+++++|.+++....  .+++..+..++.||+.||.|||   +.+++||||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            89999999999999997654  4788889999999999999999   899999999999999999999999999988753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.7e-34  Score=298.65  Aligned_cols=139  Identities=29%  Similarity=0.395  Sum_probs=117.8

Q ss_pred             eecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHH---HHHhCCCCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           90 VIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNEL---QILGGLRSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        90 ~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei---~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      .||+|+||.||++... +++.||+|.+.....   .....+..|.   .+++...||||+.+++++...+..|+||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999875 588999999864321   1122234443   34555689999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +|+|.+++...+  .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++..
T Consensus        81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~  146 (278)
T cd05606          81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD  146 (278)
T ss_pred             CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence            999999987654  5899999999999999999999   89999999999999999999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-34  Score=293.86  Aligned_cols=140  Identities=31%  Similarity=0.425  Sum_probs=119.9

Q ss_pred             ceecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHHH-hCCCCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNELQIL-GGLRSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei~iL-~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||.||+|... +++.||||.+.....   .....+..|..++ ...+|+||+++++++...+..|+||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999886 589999999865332   1223345555544 456899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ++|.+++....  .+++..+..++.||+.||.|||   +.+++||||+|+||+++.++.++|+|||+++.
T Consensus        82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  146 (260)
T cd05611          82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN  146 (260)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeeccccee
Confidence            99999997654  5788889999999999999999   89999999999999999999999999998764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.4e-34  Score=294.46  Aligned_cols=139  Identities=35%  Similarity=0.546  Sum_probs=126.0

Q ss_pred             ecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCCH
Q 005033           91 IGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSL  166 (718)
Q Consensus        91 LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL  166 (718)
                      ||.|+||.||++... +|+.||+|.+.....   .....+.+|+.++.+++|+||+++++.+......|+||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999987 499999999865433   3456788999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          167 QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       167 ~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      .+++...+  .+++..+..++.||+.||.|||   ..+++||||+|+||+++.++.++|+|||++...
T Consensus        81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~  143 (265)
T cd05579          81 ASLLENVG--SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVG  143 (265)
T ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhc
Confidence            99998755  5788999999999999999999   899999999999999999999999999988753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-34  Score=295.27  Aligned_cols=145  Identities=29%  Similarity=0.447  Sum_probs=128.4

Q ss_pred             ccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC--CeEEEEEe
Q 005033           85 FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMER--NKRILVYE  159 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LVmE  159 (718)
                      |++.+.||+|+||.||+|... +++.+|+|.+....  ......+.+|+.+++.++|+||+++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999987 48899999997542  33345688999999999999999999999888  88999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |++ ++|.+++.... ..+++..++.++.||+.||.|||   ..+++|+||+|+||++++++.++|+|||++...
T Consensus        81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~  150 (287)
T cd07840          81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPY  150 (287)
T ss_pred             ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeec
Confidence            996 59999887653 36889999999999999999999   899999999999999999999999999988754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-34  Score=296.10  Aligned_cols=146  Identities=27%  Similarity=0.409  Sum_probs=128.2

Q ss_pred             ccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh-hhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCCeEEEEEecc
Q 005033           85 FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL-QTEREFQNELQILGGLR-SPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~-~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      |++.+.||+|+||.||+|... +++.||||++..... .......+|+..+.+++ |+||+++++++..++..|+||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999986 488999999864322 22334567999999999 999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                       +|+|.+++.......+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++...
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~  149 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREI  149 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceec
Confidence             899999997765446899999999999999999999   899999999999999999999999999988653

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=8.8e-34  Score=303.73  Aligned_cols=147  Identities=33%  Similarity=0.550  Sum_probs=127.6

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeC--CeE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGL-RSPFLVTLLGYCMER--NKR  154 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~--~~~  154 (718)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++...  .......+.+|+.++.++ +|+||++++++|...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4568899999999999999999986 5889999988532  223345677899999999 999999999998654  368


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+||||+. ++|.+++...   .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            99999996 6999998764   5788888999999999999999   899999999999999999999999999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.5e-33  Score=292.70  Aligned_cols=149  Identities=25%  Similarity=0.330  Sum_probs=123.5

Q ss_pred             HHHHHHHhcCcccccee--cccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEEee
Q 005033           75 YKELKNATNDFDEANVI--GKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCME  150 (718)
Q Consensus        75 ~~el~~at~~f~~~~~L--G~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~  150 (718)
                      ..++....++|.+.+.+  |+|+||.||++... ++..+|+|.+........     |+.+...+ +|+||++++++|..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence            34445555677777776  99999999999876 688999998864321111     22222212 79999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC-CEEEeecc
Q 005033          151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC-RGKVSDFG  229 (718)
Q Consensus       151 ~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~-~vKLsDFG  229 (718)
                      .+..|+||||+++|+|.+++....  .+++..+..++.||+.||.|||   +.+++||||||+||+++.++ .++|+|||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            999999999999999999997764  6899999999999999999999   89999999999999999998 99999999


Q ss_pred             Ccee
Q 005033          230 LSRI  233 (718)
Q Consensus       230 LAr~  233 (718)
                      +++.
T Consensus       156 ~~~~  159 (267)
T PHA03390        156 LCKI  159 (267)
T ss_pred             ccee
Confidence            8764

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=309.90  Aligned_cols=146  Identities=29%  Similarity=0.475  Sum_probs=134.0

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      +-|.++..||+|+||.||++.++ +|+.+|||.+...  .+.+++..|+.||.++..++||++||.|.....+|+|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            44778899999999999999887 6999999998664  45678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ..|+..++++.+.+ ++.+.++..+++..++||+|||   ...-||||||..|||++.+|.+||+|||.|..+
T Consensus       111 GAGSiSDI~R~R~K-~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQL  179 (502)
T KOG0574|consen  111 GAGSISDIMRARRK-PLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQL  179 (502)
T ss_pred             CCCcHHHHHHHhcC-CccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchh
Confidence            99999999987654 7899999999999999999999   888999999999999999999999999998764

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=6.8e-34  Score=301.26  Aligned_cols=146  Identities=26%  Similarity=0.399  Sum_probs=127.1

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ..|+..+.||+|+||.||+|... ++..||||.+...   .......+.+|+.+++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            44777889999999999999986 5889999988532   2233456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||+. |+|.+++..... .+++..+..++.|++.||.|||   ..+++||||+|+|||++.++.++|+|||++..
T Consensus        95 e~~~-~~l~~~~~~~~~-~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  164 (308)
T cd06634          95 EYCL-GSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (308)
T ss_pred             EccC-CCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCccccee
Confidence            9995 688888765433 5788899999999999999999   89999999999999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.3e-33  Score=294.78  Aligned_cols=146  Identities=34%  Similarity=0.428  Sum_probs=128.7

Q ss_pred             CccccceecccCceEEEEEEEc----CCcEEEEEEcccCCh----hhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR----DGKLLAIKRLDTFSL----QTEREFQNELQILGGL-RSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~----~g~~VAVK~i~~~~~----~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~  154 (718)
                      +|++.+.||+|+||.||++...    +|..||+|++.....    ...+.+.+|+.++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4788899999999999999863    688999999864321    2335678899999999 589999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+||||+++++|.+++....  .+++..+..++.|++.||.|||   +.+++||||+|+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            99999999999999997654  5778888889999999999999   899999999999999999999999999988753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-33  Score=303.42  Aligned_cols=147  Identities=25%  Similarity=0.447  Sum_probs=127.6

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC-----Ce
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMER-----NK  153 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~  153 (718)
                      .++|.+.+.||+|+||.||+|... ++..||||.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457899999999999999999876 6899999998642  223345678899999999999999999988654     35


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .|+||||+ +++|.+++...+  .+++..+..++.||+.||.|||   +.+++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELM-DTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCC-CCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            79999999 579999987654  5888999999999999999999   89999999999999999999999999998875


Q ss_pred             e
Q 005033          234 K  234 (718)
Q Consensus       234 ~  234 (718)
                      .
T Consensus       158 ~  158 (337)
T cd07858         158 T  158 (337)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-33  Score=303.87  Aligned_cols=144  Identities=26%  Similarity=0.425  Sum_probs=123.5

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC------
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERN------  152 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------  152 (718)
                      .++|...+.||+|+||.||+|... +|+.||||++....  ......+.+|+.+++.++|+||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            378999999999999999999976 68999999986421  222356889999999999999999999987543      


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                      ..|+|+||+. .+|..++.    ..+++..+..++.|++.||.|||   ..+|+||||||+|||++.++.++|+|||+++
T Consensus        94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            4699999995 58877653    24788899999999999999999   8999999999999999999999999999876


Q ss_pred             e
Q 005033          233 I  233 (718)
Q Consensus       233 ~  233 (718)
                      .
T Consensus       166 ~  166 (342)
T cd07879         166 H  166 (342)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.1e-34  Score=304.44  Aligned_cols=147  Identities=26%  Similarity=0.437  Sum_probs=128.2

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEee----CCeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCME----RNKR  154 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~  154 (718)
                      .++|++.+.||+|+||.||+|... +|..||+|++....  ......+.+|+.+|+.++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368999999999999999999976 58999999986532  2334567889999999999999999998763    3568


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+||||+ +|+|.+++....  .+++..+..++.||+.||.|||   ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        84 ~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLM-ESDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehh-hhhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            9999999 579999987554  4889999999999999999999   899999999999999999999999999998764

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=291.78  Aligned_cols=145  Identities=26%  Similarity=0.433  Sum_probs=128.1

Q ss_pred             ccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh--hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           85 FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL--QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      |++.+.||+|++|.||+|... +++.+|+|.+.....  .....+.+|+.++++++|+||+++++++..++..++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999886 688999999865322  24467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      + ++|.+++.... ..+++..+..++.||+.||.|||   ..+|+|+||||+||+++.++.++|+|||++...
T Consensus        81 ~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~  148 (283)
T cd05118          81 D-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSF  148 (283)
T ss_pred             C-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence            6 59988887643 36888999999999999999999   899999999999999999999999999988753

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-33  Score=303.80  Aligned_cols=155  Identities=25%  Similarity=0.424  Sum_probs=133.4

Q ss_pred             cccHHHHHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEE
Q 005033           72 RFTYKELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYC  148 (718)
Q Consensus        72 ~~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~  148 (718)
                      .....++...+++|.+.+.||+|+||.||+|... +++.||||++...  .......+.+|+.++.+++|+||+++++++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877           6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            3455677788899999999999999999999875 6899999998643  223345688999999999999999999988


Q ss_pred             eeC------CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC
Q 005033          149 MER------NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR  222 (718)
Q Consensus       149 ~~~------~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~  222 (718)
                      ...      ...|++++++ +++|.+++...   .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCC
Confidence            643      3478899988 88999888654   4788999999999999999999   899999999999999999999


Q ss_pred             EEEeeccCcee
Q 005033          223 GKVSDFGLSRI  233 (718)
Q Consensus       223 vKLsDFGLAr~  233 (718)
                      +||+|||+++.
T Consensus       159 ~kl~dfg~~~~  169 (345)
T cd07877         159 LKILDFGLARH  169 (345)
T ss_pred             EEEeccccccc
Confidence            99999998764

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.5e-33  Score=295.88  Aligned_cols=147  Identities=27%  Similarity=0.460  Sum_probs=126.0

Q ss_pred             hcCccccceecccCceEEEEEEEcC-CcEEEEEEcccCC-hhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCCeEEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFS-LQTEREFQNELQILGGLR-SPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~-g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      .++|++.+.||+|+||.||+|.+.+ ++.||||.+.... ......+..|+.++.... |+||++++++|......|+||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3678889999999999999999874 8999999986532 233456777887777665 999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD-PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~-~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||+ +++|.+++..... .+++..+..++.||+.||.|||   . .+|+||||+|+||+++.++.+||+|||++..
T Consensus        94 e~~-~~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          94 ELM-STCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             ecc-CcCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence            998 5688887765433 6888999999999999999999   6 5999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.6e-33  Score=302.23  Aligned_cols=150  Identities=27%  Similarity=0.437  Sum_probs=129.8

Q ss_pred             HHHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEee-CC
Q 005033           77 ELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCME-RN  152 (718)
Q Consensus        77 el~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~  152 (718)
                      ++..++++|++.+.||.|+||.||++... +++.||||++...  .....+.+.+|+.++..++||||++++++|.. ..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            44557889999999999999999999876 6899999987532  22334668899999999999999999999876 56


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                      ..|+||||+ +++|.+++...   .+++..+..++.|++.||.|||   +.+|+||||+|+|||++.++.++|+|||++.
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            789999999 67999888643   4677888889999999999999   8999999999999999999999999999876


Q ss_pred             e
Q 005033          233 I  233 (718)
Q Consensus       233 ~  233 (718)
                      .
T Consensus       157 ~  157 (328)
T cd07856         157 I  157 (328)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.1e-33  Score=295.91  Aligned_cols=140  Identities=29%  Similarity=0.440  Sum_probs=126.5

Q ss_pred             cceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCCH
Q 005033           88 ANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSL  166 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL  166 (718)
                      ...||+|+||.||++... +++.||||.+..........+.+|+.+++.++|+||+++++++...+..|+||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            357999999999999886 6899999998655545566789999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          167 QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       167 ~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .+++...   .+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++..
T Consensus       105 ~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~  165 (292)
T cd06657         105 TDIVTHT---RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ  165 (292)
T ss_pred             HHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEccccccee
Confidence            9988543   4788899999999999999999   89999999999999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.1e-33  Score=298.52  Aligned_cols=143  Identities=25%  Similarity=0.402  Sum_probs=125.1

Q ss_pred             ccccceecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           85 FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      |...+.||+|+||.||+|... ++..||+|.+...   .......+.+|+++++.++|+||+++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            556678999999999999876 6889999998642   223345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                      +. |+|.+++..... .+++..+..++.||+.||.|||   ..+|+||||+|+||+++.++.++|+|||++.
T Consensus       103 ~~-~~l~~~l~~~~~-~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~  169 (313)
T cd06633         103 CL-GSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSAS  169 (313)
T ss_pred             CC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCc
Confidence            94 688888865433 5888999999999999999999   8999999999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.7e-35  Score=325.43  Aligned_cols=145  Identities=21%  Similarity=0.377  Sum_probs=124.4

Q ss_pred             ccceecccCceEEEEEEEc-CCcEEEEEEcc--c--CChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe--EEEEEe
Q 005033           87 EANVIGKGGSGTVFLGIAR-DGKLLAIKRLD--T--FSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNK--RILVYE  159 (718)
Q Consensus        87 ~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~--~--~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~--~~LVmE  159 (718)
                      ...+||+|+|-+||+|.+. +|..||--.++  .  ......++|..|+++|+.|+|+|||++|.++.+...  +-+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            3467999999999999986 58888843332  1  223445789999999999999999999999988765  678999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC-CCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD-CRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~-~~vKLsDFGLAr~~  234 (718)
                      ++..|+|..|+++.+  .++...+..|++||++||.|||+. .++|||||||.+||+|+.+ |.|||+|+|||..+
T Consensus       124 L~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~  196 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL  196 (632)
T ss_pred             cccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence            999999999999887  467789999999999999999954 7899999999999999764 89999999999874

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.9e-33  Score=294.33  Aligned_cols=150  Identities=27%  Similarity=0.406  Sum_probs=129.7

Q ss_pred             HHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC----
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERN----  152 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~----  152 (718)
                      ...++|++.+.||+|+||.||+|... +|+.||||.+....  ......+.+|+.+++.++||||+++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34578999999999999999999987 58899999986432  223356788999999999999999999987654    


Q ss_pred             ------eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEe
Q 005033          153 ------KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVS  226 (718)
Q Consensus       153 ------~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLs  226 (718)
                            ..|+|+||+++ +|..++.... ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeC
Confidence                  78999999965 7888776542 36889999999999999999999   8999999999999999999999999


Q ss_pred             eccCceee
Q 005033          227 DFGLSRIK  234 (718)
Q Consensus       227 DFGLAr~~  234 (718)
                      |||++...
T Consensus       159 dfg~~~~~  166 (302)
T cd07864         159 DFGLARLY  166 (302)
T ss_pred             cccccccc
Confidence            99988764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.4e-33  Score=295.61  Aligned_cols=148  Identities=27%  Similarity=0.440  Sum_probs=126.5

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh--hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC------
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL--QTEREFQNELQILGGLRSPFLVTLLGYCMERN------  152 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------  152 (718)
                      .++|++.+.||+|+||.||+|... +++.||||++.....  .....+.+|+++++.++|+||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999986 589999998854321  12345788999999999999999999875433      


Q ss_pred             --eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccC
Q 005033          153 --KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL  230 (718)
Q Consensus       153 --~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGL  230 (718)
                        ..|+||||+. ++|...+.... ..+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.++|+|||+
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence              4699999995 57888776543 36899999999999999999999   89999999999999999999999999999


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      ++..
T Consensus       162 ~~~~  165 (311)
T cd07866         162 ARPY  165 (311)
T ss_pred             chhc
Confidence            8764

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.6e-33  Score=293.79  Aligned_cols=146  Identities=34%  Similarity=0.454  Sum_probs=127.8

Q ss_pred             CccccceecccCceEEEEEEEc----CCcEEEEEEcccCC----hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR----DGKLLAIKRLDTFS----LQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~----~g~~VAVK~i~~~~----~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~  154 (718)
                      +|++.+.||+|+||.||++...    ++..||||.+....    ......+.+|+.++.++ +|+||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999998753    47889999986422    22335688999999999 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+||||+++|+|.+++....  .+++..+..++.|++.||.|||   ..+++||||+|+||+++.++.++|+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            99999999999999987653  5788889999999999999999   899999999999999999999999999988653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-33  Score=303.98  Aligned_cols=148  Identities=26%  Similarity=0.435  Sum_probs=128.5

Q ss_pred             HHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC---
Q 005033           79 KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERN---  152 (718)
Q Consensus        79 ~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~---  152 (718)
                      ....++|++.+.||+|+||.||++... ++..||||++...  .......+.+|+.+|+.++|+||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            345678999999999999999999876 6899999998542  2223456889999999999999999999987654   


Q ss_pred             ---eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeecc
Q 005033          153 ---KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG  229 (718)
Q Consensus       153 ---~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFG  229 (718)
                         ..|+||||+ +++|.+++...   .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.++|+|||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence               458999999 78999888643   5788999999999999999999   8999999999999999999999999999


Q ss_pred             Ccee
Q 005033          230 LSRI  233 (718)
Q Consensus       230 LAr~  233 (718)
                      ++..
T Consensus       164 ~~~~  167 (343)
T cd07880         164 LARQ  167 (343)
T ss_pred             cccc
Confidence            8764

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.2e-33  Score=291.00  Aligned_cols=147  Identities=31%  Similarity=0.450  Sum_probs=133.0

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCCeEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGLR-SPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ++|.+.+.||+|+||.||++... +++.||+|++...   .......+.+|+.++.+++ |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47889999999999999999986 6899999998642   2233467889999999998 99999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++++|.+++...+  .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~  152 (280)
T cd05581          81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVL  152 (280)
T ss_pred             EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence            99999999999998764  5899999999999999999999   899999999999999999999999999998865

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-35  Score=345.23  Aligned_cols=148  Identities=30%  Similarity=0.433  Sum_probs=130.3

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      +-+++-...||.|.||.||-|... +|...|+|-+....  ......+.+|+.++..++|||+|++||+-.+.+..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            345677789999999999999875 69999999875432  233456789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||.+|+|.+++...+  .+++.....+..|++.|++|||   +.|||||||||.||+++.+|.+|++|||.|..+
T Consensus      1314 EyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEe
Confidence            9999999999997664  4667777788999999999999   999999999999999999999999999999875

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=321.76  Aligned_cols=149  Identities=30%  Similarity=0.427  Sum_probs=132.5

Q ss_pred             CccccceecccCceEEEEEEEcC--C--cEEEEEEcccCChh-hHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIARD--G--KLLAIKRLDTFSLQ-TEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~~--g--~~VAVK~i~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ...+.++||+|+||+|++|.+..  |  ..||||++...... ....|++|+.+|.+|+|+|+|+|||+..+ ..+.+||
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            34456789999999999999873  3  47999999765544 56789999999999999999999999987 6789999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceeeec
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVE  236 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~~~  236 (718)
                      |+++.|+|.+.|+......+.......++.|||.||.||.   .+++|||||..+|+|+.....+||+||||.|.+..
T Consensus       190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            9999999999998855557788889999999999999999   99999999999999999999999999999998743

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.3e-33  Score=289.46  Aligned_cols=147  Identities=24%  Similarity=0.359  Sum_probs=123.3

Q ss_pred             CccccceecccCceEEEEEEEcC-CcEEEEEEcccC-----ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTF-----SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~~-g~~VAVK~i~~~-----~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      +|.+.+.||+|+||.||++.... +..+++|.++..     .......+..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999998763 445556655321     222334577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSD--GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~--~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++++|.+++...  ....+++..++.++.|++.||.|||   +.+++|+||+|+||+++. +.++|+|||+++..
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeec
Confidence            9999999999988642  2246889999999999999999999   899999999999999975 56999999988753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.7e-34  Score=334.67  Aligned_cols=151  Identities=27%  Similarity=0.448  Sum_probs=126.6

Q ss_pred             HHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEee-------
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCME-------  150 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-------  150 (718)
                      .-..+|+....||+||||.||+++.+ +|+.||||+|.... ......+.+|+.+|++|+|||||+++..+.+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34568899999999999999999988 89999999996543 3334568899999999999999999864320       


Q ss_pred             -----------------------------------------------------------------------C--------
Q 005033          151 -----------------------------------------------------------------------R--------  151 (718)
Q Consensus       151 -----------------------------------------------------------------------~--------  151 (718)
                                                                                             +        
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                   0        


Q ss_pred             ---------------------------------CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 005033          152 ---------------------------------NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH  198 (718)
Q Consensus       152 ---------------------------------~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH  198 (718)
                                                       ..+||-||||+...|.++++.+.... .....++++++|+.||+|+|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence                                             12478999999988888887764211 35677899999999999999


Q ss_pred             cCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       199 ~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                         +++||||||||.||+++++..+||+|||+|...
T Consensus       715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~  747 (1351)
T KOG1035|consen  715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDL  747 (1351)
T ss_pred             ---hCceeeccCCcceeEEcCCCCeeecccccchhh
Confidence               999999999999999999999999999999864

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.2e-33  Score=297.23  Aligned_cols=146  Identities=25%  Similarity=0.377  Sum_probs=126.7

Q ss_pred             cCcc-ccceecccCceEEEEEEEc-CCcEEEEEEcccCChhh--------------HHHHHHHHHHHhCCCCCcceeEEE
Q 005033           83 NDFD-EANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQT--------------EREFQNELQILGGLRSPFLVTLLG  146 (718)
Q Consensus        83 ~~f~-~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~--------------~~~f~~Ei~iL~~L~HpNIV~L~g  146 (718)
                      ++|. +.+.||.|+||.||+|.+. +++.||||.+.......              ...+.+|+.+++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4565 4577999999999999976 68999999885432111              124778999999999999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEe
Q 005033          147 YCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVS  226 (718)
Q Consensus       147 ~~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLs  226 (718)
                      ++...+..|+||||+. |+|.+++....  .+++.....++.|++.||.|||   ..+|+||||+|+||+++.++.++|+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEEC
Confidence            9999999999999995 79999997643  5788899999999999999999   8999999999999999999999999


Q ss_pred             eccCceee
Q 005033          227 DFGLSRIK  234 (718)
Q Consensus       227 DFGLAr~~  234 (718)
                      |||+++..
T Consensus       162 dfg~~~~~  169 (335)
T PTZ00024        162 DFGLARRY  169 (335)
T ss_pred             Cccceeec
Confidence            99998764

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.1e-33  Score=300.15  Aligned_cols=145  Identities=26%  Similarity=0.421  Sum_probs=126.1

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC----------
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMER----------  151 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~----------  151 (718)
                      .+|.+.+.||.|+||.||+|... +|+.||+|.+........+.+.+|+++++.++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            67999999999999999999986 5899999998665555567788999999999999999999876543          


Q ss_pred             ----CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC-CCCEEEe
Q 005033          152 ----NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS-DCRGKVS  226 (718)
Q Consensus       152 ----~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~-~~~vKLs  226 (718)
                          ...|+||||++ ++|.+++...   .+++..+..++.||+.||.|||   +.+|+||||||+||+++. ++.++|+
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence                35799999996 6999888643   5788999999999999999999   899999999999999974 5678999


Q ss_pred             eccCceee
Q 005033          227 DFGLSRIK  234 (718)
Q Consensus       227 DFGLAr~~  234 (718)
                      |||+++..
T Consensus       158 dfg~~~~~  165 (342)
T cd07854         158 DFGLARIV  165 (342)
T ss_pred             Ccccceec
Confidence            99988753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.9e-33  Score=294.94  Aligned_cols=145  Identities=29%  Similarity=0.485  Sum_probs=129.3

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC-----eEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERN-----KRI  155 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~~  155 (718)
                      +|++.+.||+|+||.||+|... +++.||||.+....  ....+.+.+|+.+++.++|+||+++++++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788899999999999999986 48999999986533  334567899999999999999999999998775     789


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +||||++ ++|.+++....  .+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999996 68999987654  6889999999999999999999   899999999999999999999999999998864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-33  Score=286.00  Aligned_cols=145  Identities=26%  Similarity=0.434  Sum_probs=128.8

Q ss_pred             ccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           85 FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      |+..+.||+|+||.||+|... +++.||+|.+....  ......+..|+.+++.++|+||+++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            556788999999999999987 48999999987542  233456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      + ++|.+++.... ..+++..+..++.|++.||.|||   ..+|+||||+|+||+++.++.++|+|||+++..
T Consensus        81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~  148 (282)
T cd07829          81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAF  148 (282)
T ss_pred             C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCccccc
Confidence            6 69999998753 25889999999999999999999   899999999999999999999999999988753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-33  Score=301.69  Aligned_cols=147  Identities=25%  Similarity=0.438  Sum_probs=128.6

Q ss_pred             HHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe---
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNK---  153 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~---  153 (718)
                      ...++|++.+.||+|+||.||+|... +++.||||++...  .......+.+|+.+++.++|+||+++++++.....   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999999986 5889999998642  22334567889999999999999999998876554   


Q ss_pred             ---EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccC
Q 005033          154 ---RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL  230 (718)
Q Consensus       154 ---~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGL  230 (718)
                         .|+|+||+ +++|.+++...   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||+
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccc
Confidence               89999999 78999998753   5889999999999999999999   89999999999999999999999999998


Q ss_pred             cee
Q 005033          231 SRI  233 (718)
Q Consensus       231 Ar~  233 (718)
                      +..
T Consensus       165 ~~~  167 (343)
T cd07851         165 ARH  167 (343)
T ss_pred             ccc
Confidence            864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-34  Score=329.78  Aligned_cols=156  Identities=31%  Similarity=0.356  Sum_probs=140.3

Q ss_pred             cHHHHHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 005033           74 TYKELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCM  149 (718)
Q Consensus        74 s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~  149 (718)
                      ...+++...++|.++++||+|+||.|.+++.+ +++.||+|+++++.   .....-|..|-.+|..-+.+.||.|+.+|.
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ  145 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ  145 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence            34567777889999999999999999999987 58999999997632   223356889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeecc
Q 005033          150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG  229 (718)
Q Consensus       150 ~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFG  229 (718)
                      +..++|+|||||+||||-.++....  .+++..+..++..|+.||.-||   +.|+|||||||+|||||..|++||+|||
T Consensus       146 D~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  146 DERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             CccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccch
Confidence            9999999999999999999998876  5788888899999999999999   9999999999999999999999999999


Q ss_pred             Cceee
Q 005033          230 LSRIK  234 (718)
Q Consensus       230 LAr~~  234 (718)
                      .+-.+
T Consensus       221 sClkm  225 (1317)
T KOG0612|consen  221 SCLKM  225 (1317)
T ss_pred             hHHhc
Confidence            87654

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.1e-32  Score=292.88  Aligned_cols=145  Identities=25%  Similarity=0.386  Sum_probs=123.7

Q ss_pred             CccccceecccCceEEEEEEEc-C--CcEEEEEEcccC--ChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeC----Ce
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-D--GKLLAIKRLDTF--SLQTEREFQNELQILGGL-RSPFLVTLLGYCMER----NK  153 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~--g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~----~~  153 (718)
                      +|++.+.||+|+||.||++... +  +..||||.+...  .....+.+.+|+.++.++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999986 3  779999998642  222345688899999999 599999999976433    45


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .|+++||+ +++|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.++|+|||+++.
T Consensus        81 ~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELM-EADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEecc-cCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            78999999 479999986543  5788999999999999999999   89999999999999999999999999999876


Q ss_pred             e
Q 005033          234 K  234 (718)
Q Consensus       234 ~  234 (718)
                      .
T Consensus       155 ~  155 (332)
T cd07857         155 F  155 (332)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=317.36  Aligned_cols=147  Identities=31%  Similarity=0.510  Sum_probs=126.6

Q ss_pred             ccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC------eEEE
Q 005033           85 FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERN------KRIL  156 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------~~~L  156 (718)
                      +...+.||+|+||.||+|+.+ +|+.||||.++... ....+..-+|+++|++|+|+|||++++.-....      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            445678999999999999966 79999999997643 344567889999999999999999999865543      5689


Q ss_pred             EEeccCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEC--CCC--CEEEeeccCc
Q 005033          157 VYEYMPNKSLQEMLFSDGN-LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD--SDC--RGKVSDFGLS  231 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~-~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd--~~~--~vKLsDFGLA  231 (718)
                      |||||.||||...|.+..+ ..+++.+.+.++.+++.||.|||   +++||||||||.||++-  .+|  .-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999987654 57999999999999999999999   99999999999999993  334  3699999999


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      |-+
T Consensus       172 rel  174 (732)
T KOG4250|consen  172 REL  174 (732)
T ss_pred             ccC
Confidence            875

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=317.94  Aligned_cols=144  Identities=29%  Similarity=0.463  Sum_probs=128.2

Q ss_pred             cccceecccCceEEEEEEEc-C----CcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           86 DEANVIGKGGSGTVFLGIAR-D----GKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        86 ~~~~~LG~G~FG~Vykg~~~-~----g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ...++||+|+||+||+|.+- .    ..+||||++.... .+...+|+.|+-+|.++.|||+++|+|+|.... +.||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            45678999999999999874 2    4589999986543 445678999999999999999999999998776 889999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+.|+|.+|++.++. .+-....+.|..|||+||.|||   .+++|||||..+|||+..-..+||.|||+|+.+
T Consensus       778 ~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             hcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence            9999999999988754 5667788999999999999999   999999999999999999999999999999986

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=305.39  Aligned_cols=143  Identities=32%  Similarity=0.476  Sum_probs=127.6

Q ss_pred             cceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCC
Q 005033           88 ANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNK  164 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gG  164 (718)
                      .+.||+|.||+||-|.++ +|+.||||+|.+.  .......+.+|+.||.+++||.||.|.-.|+..+.+++|||-+ +|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            478999999999999886 7999999999753  3455678999999999999999999999999999999999999 77


Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC---CCEEEeeccCceee
Q 005033          165 SLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD---CRGKVSDFGLSRIK  234 (718)
Q Consensus       165 sL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~---~~vKLsDFGLAr~~  234 (718)
                      |..+.|-......+++.....++.||+.||.|||   .++|+|+||||+|||+.+.   -.+||||||+||+.
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI  717 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARII  717 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeec
Confidence            8877776655557898888899999999999999   8999999999999999654   36999999999986

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.1e-33  Score=281.59  Aligned_cols=130  Identities=20%  Similarity=0.192  Sum_probs=114.6

Q ss_pred             cCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCCHHHHHhh
Q 005033           94 GGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS  172 (718)
Q Consensus        94 G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL~~~L~~  172 (718)
                      |.||.||++.+. +++.||+|.+....     .+.+|...+....||||+++++++...+..|+||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999986 68999999986532     234455556667799999999999999999999999999999999976


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          173 DGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       173 ~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ..  .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++++|||++..
T Consensus        79 ~~--~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~  134 (237)
T cd05576          79 FL--NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSE  134 (237)
T ss_pred             hc--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhc
Confidence            54  4788999999999999999999   89999999999999999999999999997654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-32  Score=295.94  Aligned_cols=147  Identities=25%  Similarity=0.401  Sum_probs=128.5

Q ss_pred             HhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhC--CCCCcceeEEEEEeeCC----eE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGG--LRSPFLVTLLGYCMERN----KR  154 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~--L~HpNIV~L~g~~~~~~----~~  154 (718)
                      ......+.+.||+|.||.||+|.++ |+.||||++..   .++..+.+|.+|...  |+|+||+.+++.-..++    .+
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            3356678899999999999999997 89999999865   345678899988875  59999999998865543    57


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeEecCCCCCCEEECCCCCEEEeecc
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF-----GCDPPVIHGDIKPSNVLLDSDCRGKVSDFG  229 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~-----~~~~gIVHRDLKP~NILLd~~~~vKLsDFG  229 (718)
                      |||++|.+.|||++||.+.   .++....++++..+|.||+|||.     ...+.|.|||||+.|||+..++.+.|+|+|
T Consensus       285 wLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            9999999999999999875   68889999999999999999993     347889999999999999999999999999


Q ss_pred             Cceee
Q 005033          230 LSRIK  234 (718)
Q Consensus       230 LAr~~  234 (718)
                      ||-..
T Consensus       362 LAv~h  366 (513)
T KOG2052|consen  362 LAVRH  366 (513)
T ss_pred             eeEEe
Confidence            99764

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=279.14  Aligned_cols=139  Identities=34%  Similarity=0.477  Sum_probs=125.4

Q ss_pred             ecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCCH
Q 005033           91 IGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSL  166 (718)
Q Consensus        91 LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL  166 (718)
                      ||+|+||.||++... +++.+|+|.+.....   .....+..|+.+++.++|+||+++++.+..++..|+||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999987 589999999865332   2445789999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          167 QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       167 ~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      .+++....  .+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  143 (250)
T cd05123          81 FSHLSKEG--RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKEL  143 (250)
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceec
Confidence            99997664  5788999999999999999999   899999999999999999999999999988763

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-34  Score=295.71  Aligned_cols=147  Identities=31%  Similarity=0.403  Sum_probs=131.4

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChh---hHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQ---TEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++|...++||+|.||.|-+|+.+ +++.+|||++++.-.-   ....-+.|-.+|...+||.+..|-..|+..+.+|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            468899999999999999999987 6999999999764322   233456789999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |||+.||.|.-+|.+..  .+++.....+...|+.||.|||   +.+||.||||.+|.|+|.+|.+||+||||++.
T Consensus       247 MeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE  317 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKE  317 (516)
T ss_pred             EEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchh
Confidence            99999999998887654  6788888899999999999999   89999999999999999999999999999974

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-32  Score=317.47  Aligned_cols=153  Identities=25%  Similarity=0.424  Sum_probs=132.6

Q ss_pred             HHHhcCccccceecccCceEEEEEEEc----C----CcEEEEEEcccCC-hhhHHHHHHHHHHHhCC-CCCcceeEEEEE
Q 005033           79 KNATNDFDEANVIGKGGSGTVFLGIAR----D----GKLLAIKRLDTFS-LQTEREFQNELQILGGL-RSPFLVTLLGYC  148 (718)
Q Consensus        79 ~~at~~f~~~~~LG~G~FG~Vykg~~~----~----g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~  148 (718)
                      ....++..+.+.||+|.||.|++|...    .    ...||||.+.... ....+.+..|+++|+.+ +|+||+.++|+|
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            334455566679999999999999754    1    4579999997533 34567899999999998 699999999999


Q ss_pred             eeCCeEEEEEeccCCCCHHHHHhhCC------------C--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 005033          149 MERNKRILVYEYMPNKSLQEMLFSDG------------N--LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSN  214 (718)
Q Consensus       149 ~~~~~~~LVmEy~~gGsL~~~L~~~~------------~--~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~N  214 (718)
                      ...+..++|+||+..|+|.++|+..+            .  ..++....+.++.|||.||+||+   +.++|||||..+|
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRN  448 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARN  448 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhh
Confidence            99999999999999999999998765            0  13788899999999999999999   9999999999999


Q ss_pred             EEECCCCCEEEeeccCceee
Q 005033          215 VLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       215 ILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+..+..+||+|||||+..
T Consensus       449 VLi~~~~~~kIaDFGlar~~  468 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDH  468 (609)
T ss_pred             EEecCCCEEEEccccceecc
Confidence            99999999999999999964

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-32  Score=279.27  Aligned_cols=147  Identities=25%  Similarity=0.412  Sum_probs=124.5

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCCeEEEEEec
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLR-SPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +.+.+..||.|+-|.|++++.+ +|..+|||.+.... ....++++..+.++...+ +|.||+.+|||..+...++.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            3455678999999999999987 58999999997644 344567888888877665 89999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      | ...+..+++.-.. ++++..+-.+...++.||.||.+  .++|||||+||+|||+|+.|++|+||||++-.+
T Consensus       173 M-s~C~ekLlkrik~-piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrl  242 (391)
T KOG0983|consen  173 M-STCAEKLLKRIKG-PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRL  242 (391)
T ss_pred             H-HHHHHHHHHHhcC-CchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeeccccccee
Confidence            9 4566666655433 58888888899999999999995  679999999999999999999999999998775

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-32  Score=281.47  Aligned_cols=146  Identities=23%  Similarity=0.387  Sum_probs=125.4

Q ss_pred             HHhcCcccc-ceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEEee----CC
Q 005033           80 NATNDFDEA-NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCME----RN  152 (718)
Q Consensus        80 ~at~~f~~~-~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~----~~  152 (718)
                      ..+++|++. ++||-|-.|.|..|..+ +|+.+|+|++...     ....+|+++.-.. .|||||+++++|..    ..
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            356777654 67999999999999887 6999999988542     2456788876555 69999999999864    34


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC---CCCEEEeecc
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFG  229 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~---~~~vKLsDFG  229 (718)
                      .+.+|||.|+||.|.+.+..++...+++.++-.|+.||+.|+.|||   +.+|.||||||+|+|...   +-.+||+|||
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccc
Confidence            5678999999999999999998888999999999999999999999   999999999999999965   4469999999


Q ss_pred             Ccee
Q 005033          230 LSRI  233 (718)
Q Consensus       230 LAr~  233 (718)
                      +|+.
T Consensus       210 FAK~  213 (400)
T KOG0604|consen  210 FAKE  213 (400)
T ss_pred             cccc
Confidence            9986

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.8e-32  Score=279.84  Aligned_cols=150  Identities=23%  Similarity=0.376  Sum_probs=132.4

Q ss_pred             cHHHHHHHhcCccccceecccCceEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeC
Q 005033           74 TYKELKNATNDFDEANVIGKGGSGTVFLGIA-RDGKLLAIKRLDTFSLQTEREFQNELQILGGLR-SPFLVTLLGYCMER  151 (718)
Q Consensus        74 s~~el~~at~~f~~~~~LG~G~FG~Vykg~~-~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~  151 (718)
                      +++++-.-|+     +.||+|+|+.|--|.. .+|..+|||++.+.......++.+|++++.+.+ |+||++|+++|+++
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            3555555553     5799999999998875 479999999998877788889999999999984 99999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC---CEEEeec
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC---RGKVSDF  228 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~---~vKLsDF  228 (718)
                      ...|||||-|.||+|..+|..+.  .+++.++.+++.+|+.||.|||   .+||.||||||+|||-.+..   -+|||||
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDf  223 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDF  223 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecc
Confidence            99999999999999999998765  6889999999999999999999   99999999999999996654   4899999


Q ss_pred             cCcee
Q 005033          229 GLSRI  233 (718)
Q Consensus       229 GLAr~  233 (718)
                      .|..-
T Consensus       224 DLgSg  228 (463)
T KOG0607|consen  224 DLGSG  228 (463)
T ss_pred             ccccc
Confidence            88654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-32  Score=304.67  Aligned_cols=143  Identities=22%  Similarity=0.282  Sum_probs=122.2

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ++.|.....+|.|+|+.|-.|.+. +++..|||++....    ....+|+.++... +||||+++++.+.++.+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            567888888999999999999876 68899999996642    2345677666555 79999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE-CCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL-DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL-d~~~~vKLsDFGLAr~~  234 (718)
                      ++.||-|.+.+.....   ....+..|+.+|+.|+.|||   ++|||||||||+|||+ +..++++|+|||.++..
T Consensus       397 ~l~g~ell~ri~~~~~---~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~  466 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPE---FCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL  466 (612)
T ss_pred             hccccHHHHHHHhcch---hHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence            9999998888876542   22677789999999999999   8999999999999999 68999999999988754

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=9.5e-32  Score=297.40  Aligned_cols=147  Identities=27%  Similarity=0.379  Sum_probs=131.1

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChh---hHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQ---TEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      .-|..++.||-|+||.|.++... +...||+|.+++.+.-   ....+..|..||..-.++.||+||..|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            34778899999999999998765 4778999999765432   2345778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||++|||+-.+|-+.+  .+++..++.++.++..|+++.|   .+|+|||||||+|||||.+|.+||+||||+.-+
T Consensus       709 dYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             eccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccc
Confidence            9999999999997765  6888889999999999999999   999999999999999999999999999998754

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=5.1e-31  Score=303.92  Aligned_cols=147  Identities=18%  Similarity=0.241  Sum_probs=106.6

Q ss_pred             HhcCccccceecccCceEEEEEEEc-C----CcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEE------Ee
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-D----GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY------CM  149 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~----g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~------~~  149 (718)
                      ..++|++.+.||+|+||.||+|.+. +    +..||||++.....  .+.+..|  .+....+.+++.++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            5678999999999999999999986 4    68999998864321  1111221  1122222222222211      24


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhCCCC------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 005033          150 ERNKRILVYEYMPNKSLQEMLFSDGNL------------------VLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIK  211 (718)
Q Consensus       150 ~~~~~~LVmEy~~gGsL~~~L~~~~~~------------------~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLK  211 (718)
                      .....+|||||+.+++|.+++......                  ......+..++.||+.||.|||   +.+|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            566789999999999999998754210                  0112335578999999999999   8999999999


Q ss_pred             CCCEEECC-CCCEEEeeccCceee
Q 005033          212 PSNVLLDS-DCRGKVSDFGLSRIK  234 (718)
Q Consensus       212 P~NILLd~-~~~vKLsDFGLAr~~  234 (718)
                      |+|||++. ++.+||+|||+|+..
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l  306 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADL  306 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccc
Confidence            99999986 589999999999754

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-31  Score=303.00  Aligned_cols=157  Identities=30%  Similarity=0.424  Sum_probs=137.6

Q ss_pred             cHHHHHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEEee-
Q 005033           74 TYKELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCME-  150 (718)
Q Consensus        74 s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~-  150 (718)
                      .++.+...++-|.+...||.|.+|.||+++.. +++.+|||++.... ....++..|.++|+.+ .|||++.++|+|.. 
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            34445566778999999999999999999876 68899999886543 3445678889999887 69999999999864 


Q ss_pred             ----CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEe
Q 005033          151 ----RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVS  226 (718)
Q Consensus       151 ----~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLs  226 (718)
                          ++.+|||||||.+|+..++++......+.|..+..|++.++.||.|||   .+.++|||||-.|||++.++.+||.
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEe
Confidence                468999999999999999998776678999999999999999999999   9999999999999999999999999


Q ss_pred             eccCceee
Q 005033          227 DFGLSRIK  234 (718)
Q Consensus       227 DFGLAr~~  234 (718)
                      |||++..+
T Consensus       166 DFGvSaQl  173 (953)
T KOG0587|consen  166 DFGVSAQL  173 (953)
T ss_pred             eeeeeeee
Confidence            99998875

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=7.5e-32  Score=279.67  Aligned_cols=149  Identities=25%  Similarity=0.421  Sum_probs=127.2

Q ss_pred             hcCccccceecccCceEEEEEEEcC-----CcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEee-CCe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARD-----GKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCME-RNK  153 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~-----g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~  153 (718)
                      ...|+.+..||+|.||.||++...+     ...+|||.++...  ........+|+.+++.|+||||+.|..+|.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            3578899999999999999996542     3379999996542  1223457899999999999999999999987 778


Q ss_pred             EEEEEeccCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC----CCEEEe
Q 005033          154 RILVYEYMPNKSLQEMLFSDG---NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD----CRGKVS  226 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~---~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~----~~vKLs  226 (718)
                      ++|++||.+ -||.++|+-+.   ...++...+..|+.||+.|+.|||   ++-|+||||||.|||+..+    |.+||+
T Consensus       103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence            999999995 59999996543   246888889999999999999999   9999999999999999877    899999


Q ss_pred             eccCceee
Q 005033          227 DFGLSRIK  234 (718)
Q Consensus       227 DFGLAr~~  234 (718)
                      |||++|..
T Consensus       179 DlGlaR~~  186 (438)
T KOG0666|consen  179 DLGLARLF  186 (438)
T ss_pred             cccHHHHh
Confidence            99999985

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-32  Score=290.67  Aligned_cols=147  Identities=30%  Similarity=0.396  Sum_probs=126.0

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~L  156 (718)
                      ..+|..+.+||+|+||.|.++..+ +.+.+|||++++.-.   .+.+--..|-.+|.-. +-|.+++|+.+|+.-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            347888999999999999999877 478999999975321   1222334566777665 56899999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||||+.||+|--.|+..++  +.+..++.++.+||-||-|||   +++||.||||.+|||++.+|.+||+|||+++.
T Consensus       428 VMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             EEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccc
Confidence            9999999999999987764  667788899999999999999   99999999999999999999999999999874

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=7.5e-31  Score=261.22  Aligned_cols=135  Identities=34%  Similarity=0.518  Sum_probs=122.2

Q ss_pred             CceEEEEEEEc-CCcEEEEEEcccCChhh-HHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCCHHHHHhh
Q 005033           95 GSGTVFLGIAR-DGKLLAIKRLDTFSLQT-EREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS  172 (718)
Q Consensus        95 ~FG~Vykg~~~-~g~~VAVK~i~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL~~~L~~  172 (718)
                      +||.||+|... +++.+|+|++....... ...+.+|+.++++++|+||+++++++......++++||+.+++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 48999999997654433 67899999999999999999999999999999999999999999999976


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          173 DGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       173 ~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ...  +++..+..++.+++.+|.|||   ..+++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~~~--~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~  137 (244)
T smart00220       81 RGR--LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQL  137 (244)
T ss_pred             ccC--CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeee
Confidence            543  788999999999999999999   889999999999999999999999999988764

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=285.26  Aligned_cols=139  Identities=22%  Similarity=0.321  Sum_probs=119.7

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCC--C----cceeEEEEEeeCCe
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRS--P----FLVTLLGYCMERNK  153 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~H--p----NIV~L~g~~~~~~~  153 (718)
                      .+++|.+...+|+|.||.|..|.+. .+..||||+++.-. ...+...-|+++|.++.+  |    -+|.+.++|.-.++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            3688999999999999999999886 47899999996532 334456779999999942  2    37888999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEE
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGK  224 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vK  224 (718)
                      .|||+|.+ |-|+.++|..++-.+++...+..|+.|++.+++|||   +.+++|-||||+|||+-+.-..+
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEE
Confidence            99999999 789999999988888999999999999999999999   99999999999999986554333

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=285.07  Aligned_cols=154  Identities=27%  Similarity=0.404  Sum_probs=129.4

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC---Ch----hhHHHHHHHHHHHhCCCCCcceeEEEEEe-eCC
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SL----QTEREFQNELQILGGLRSPFLVTLLGYCM-ERN  152 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~----~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~-~~~  152 (718)
                      .++|-++++||+|||+.||++.+- ..+.||||+-...   ..    ...+...+|..|.+.|.||.||++|++|. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            356778899999999999999876 4788999976321   11    11234568999999999999999999996 456


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEC---CCCCEEEeecc
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD---SDCRGKVSDFG  229 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd---~~~~vKLsDFG  229 (718)
                      ..|-|+|||+|.+|.-||+.+.  .+++.++..|+.||+.||.||.+. ..+|||=||||.|||+-   ..|.+||+|||
T Consensus       542 sFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            7899999999999999998875  688999999999999999999954 78999999999999994   45789999999


Q ss_pred             CceeeecCc
Q 005033          230 LSRIKVEGE  238 (718)
Q Consensus       230 LAr~~~~~~  238 (718)
                      |++++.+++
T Consensus       619 LSKIMdddS  627 (775)
T KOG1151|consen  619 LSKIMDDDS  627 (775)
T ss_pred             hhhhccCCc
Confidence            999975443

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-31  Score=279.84  Aligned_cols=157  Identities=25%  Similarity=0.293  Sum_probs=132.7

Q ss_pred             HHHHHHHhcCccccceecccCceEEEEEEEc------CCcEEEEEEccc-CChhhHHHHHHHHHHHhCCCCCcceeEEEE
Q 005033           75 YKELKNATNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSPFLVTLLGY  147 (718)
Q Consensus        75 ~~el~~at~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~-~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~  147 (718)
                      ..++.....+++...++-+|.||.||+|.++      +.+.|-+|.++. .+.-+...|+.|..++..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            4566666778888899999999999999664      345677887754 344456779999999999999999999999


Q ss_pred             EeeC-CeEEEEEeccCCCCHHHHHhhC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC
Q 005033          148 CMER-NKRILVYEYMPNKSLQEMLFSD------GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD  220 (718)
Q Consensus       148 ~~~~-~~~~LVmEy~~gGsL~~~L~~~------~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~  220 (718)
                      +... ...+.++.++.-|+|..||...      ....++-.+.+.++.|++.|++|||   +.+|||.||..+|++|++.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhh
Confidence            8765 4678999999999999999722      2245777788899999999999999   9999999999999999999


Q ss_pred             CCEEEeeccCceee
Q 005033          221 CRGKVSDFGLSRIK  234 (718)
Q Consensus       221 ~~vKLsDFGLAr~~  234 (718)
                      ..+||+|=.|+|.+
T Consensus       433 LqVkltDsaLSRDL  446 (563)
T KOG1024|consen  433 LQVKLTDSALSRDL  446 (563)
T ss_pred             eeEEeccchhcccc
Confidence            99999999999875

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=4.7e-32  Score=276.51  Aligned_cols=146  Identities=27%  Similarity=0.386  Sum_probs=122.0

Q ss_pred             cccceecccCceEEEEEEEc-CCcEEEEEEcccCCh-hhHHHHHHHHHHHhC-CCCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           86 DEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL-QTEREFQNELQILGG-LRSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        86 ~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~-~~~~~f~~Ei~iL~~-L~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      +....||.|+||+|++-.++ .|+..|||+|+.... ...++++.|.++..+ -+.||||++||.+..++..|+.||+| 
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-  145 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-  145 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence            34567999999999998877 699999999976543 556788999887554 47899999999999999999999999 


Q ss_pred             CCCHHHHHh---hCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          163 NKSLQEMLF---SDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       163 gGsL~~~L~---~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      .-||..+.+   .-.+..+++...-.|..-.+.||.||-+  ...|||||+||+|||++..|.+||||||++-.+
T Consensus       146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence            567765542   3334467888777888889999999985  678999999999999999999999999988654

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.7e-32  Score=294.67  Aligned_cols=147  Identities=27%  Similarity=0.323  Sum_probs=130.3

Q ss_pred             cCccccceecccCceEEEEEEEcCCc-EEEEEEcccC---ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTF---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~-~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      .+++.+..||-||||.|=++...+.. .+|+|++++.   .....+.+..|-.||..++.|.||+||-.|.+...+|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45566788999999999998877533 4899988642   3445567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |-|-||.|...|+..+  .++......++..++.|++|||   +++||.|||||+|+|++.+|.+||.|||+|+.+
T Consensus       500 EaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki  570 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI  570 (732)
T ss_pred             HhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHh
Confidence            9999999999998877  5777788889999999999999   999999999999999999999999999999875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3e-29  Score=272.60  Aligned_cols=134  Identities=25%  Similarity=0.351  Sum_probs=115.8

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCC-----C---CcceeEEEEEee---
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLR-----S---PFLVTLLGYCME---  150 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-----H---pNIV~L~g~~~~---  150 (718)
                      ++|.+.++||-|.|++||+|.+. +.+.||+|+.+.. ....+..+.||++|++++     |   .+||+|++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            67899999999999999999987 5789999998653 234456788999999884     3   369999999975   


Q ss_pred             -CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC
Q 005033          151 -RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD  220 (718)
Q Consensus       151 -~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~  220 (718)
                       +.++|+|+|++ |-+|..+|.......++...+..|++||+.||.|||.  ..+|||-||||+|||+...
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeeecc
Confidence             45899999999 8899999988877789999999999999999999996  4599999999999999543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=3e-29  Score=284.63  Aligned_cols=150  Identities=23%  Similarity=0.372  Sum_probs=119.0

Q ss_pred             HhcCccccceecccCceEEEEEEE-----------------cCCcEEEEEEcccCChhhHHHH--------------HHH
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIA-----------------RDGKLLAIKRLDTFSLQTEREF--------------QNE  129 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~-----------------~~g~~VAVK~i~~~~~~~~~~f--------------~~E  129 (718)
                      ..++|++.++||+|+||.||+|..                 ..++.||||++........++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999964                 2356899999865433333333              346


Q ss_pred             HHHHhCCCCCcc-----eeEEEEEee--------CCeEEEEEeccCCCCHHHHHhhCCC---------------------
Q 005033          130 LQILGGLRSPFL-----VTLLGYCME--------RNKRILVYEYMPNKSLQEMLFSDGN---------------------  175 (718)
Q Consensus       130 i~iL~~L~HpNI-----V~L~g~~~~--------~~~~~LVmEy~~gGsL~~~L~~~~~---------------------  175 (718)
                      +.++.+++|.++     ++++++|..        .+..+|||||+++|+|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            667777766554     677787753        3568999999999999999874311                     


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          176 -LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       176 -~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                       ..+++..+..++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++.
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~  358 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVD  358 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccc
Confidence             12456778889999999999999   89999999999999999999999999999865

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=9e-30  Score=247.51  Aligned_cols=146  Identities=27%  Similarity=0.413  Sum_probs=129.7

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +|...+.||+|.||+||+++.. +++.||+|+++-.  ........++|+.+|+.++|.|||+++++...+...-||+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4566778999999999999976 5899999998542  333446789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      | ..+|..+..+-.. .++......++.|+++||.|+|   +++++||||||.|.||+.+|++|++|||+|+..
T Consensus        83 c-dqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglaraf  151 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAF  151 (292)
T ss_pred             h-hHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhc
Confidence            9 6799998876543 6788889999999999999999   999999999999999999999999999999864

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=9.9e-30  Score=290.03  Aligned_cols=142  Identities=31%  Similarity=0.469  Sum_probs=115.7

Q ss_pred             ccccceecccCceE-EEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           85 FDEANVIGKGGSGT-VFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        85 f~~~~~LG~G~FG~-Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      |...+.+|.|+-|+ ||+|... |+.||||++-.   ....-..+||..|+.- .|||||++|+.-.++...||+.|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            34456789999885 6899885 78999998843   2233457899999887 6999999999999999999999999 


Q ss_pred             CCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC---C--CCEEEeeccCceee
Q 005033          163 NKSLQEMLFSDGN--LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS---D--CRGKVSDFGLSRIK  234 (718)
Q Consensus       163 gGsL~~~L~~~~~--~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~---~--~~vKLsDFGLAr~~  234 (718)
                      ..+|.+++.....  ....-...+.++.|++.||+|||   +.+||||||||.||||..   +  .+++|+|||+++.+
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            7899999987411  11111344678899999999999   899999999999999976   3  46899999999986

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.4e-30  Score=266.31  Aligned_cols=146  Identities=27%  Similarity=0.364  Sum_probs=127.9

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ++|.+.++||+|+|+.|.++.+. +.+.+|+|++++.-   ..+....+.|-.+..+. +||.+|.|+.+|.....+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            57999999999999999999886 68899999986532   23334567777777665 799999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .||++||+|--++++..  .+++..+..+...|+.||.|||   +.|||.||||.+|+|+|..|.+||+|+|+++.
T Consensus       330 ieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke  400 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE  400 (593)
T ss_pred             EEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhc
Confidence            99999999987776654  5788899999999999999999   99999999999999999999999999999874

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=6e-27  Score=226.15  Aligned_cols=140  Identities=36%  Similarity=0.591  Sum_probs=125.5

Q ss_pred             ecccCceEEEEEEEcC-CcEEEEEEcccCChh-hHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCCHHH
Q 005033           91 IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQ-TEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQE  168 (718)
Q Consensus        91 LG~G~FG~Vykg~~~~-g~~VAVK~i~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL~~  168 (718)
                      ||+|++|.||++.... ++.++||++...... ....+.+|+.+++.+.|++|+++++++......+++|||+.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999874 899999998764332 34679999999999999999999999999999999999999999999


Q ss_pred             HHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC-CCCEEEeeccCceee
Q 005033          169 MLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS-DCRGKVSDFGLSRIK  234 (718)
Q Consensus       169 ~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~-~~~vKLsDFGLAr~~  234 (718)
                      ++.... ..+++..+..++.+++.+|.|||   ..+++|+||+|.||+++. ++.++|+|||.+...
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~  143 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL  143 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence            997653 25788999999999999999999   889999999999999999 899999999988764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=2.7e-28  Score=241.75  Aligned_cols=154  Identities=28%  Similarity=0.405  Sum_probs=128.2

Q ss_pred             HHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeE
Q 005033           78 LKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF-SLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        78 l~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~  154 (718)
                      +....++...+..||+|+||.|-+-++. +|...|+|++... ..+..+..++|+.+..+. .+|.+|.+||.+.+....
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            3344455666778999999999887775 7999999999653 345556788999886654 799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          155 ILVYEYMPNKSLQEMLFSD--GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~--~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                      ++.||.| .-||..+-+.-  ....+++..+-+|+..|+.||.|||+  ...+||||+||+||||+.+|++||||||++-
T Consensus       121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            9999999 56887765431  22367888888999999999999995  6799999999999999999999999999998


Q ss_pred             ee
Q 005033          233 IK  234 (718)
Q Consensus       233 ~~  234 (718)
                      .+
T Consensus       198 ~L  199 (282)
T KOG0984|consen  198 YL  199 (282)
T ss_pred             ee
Confidence            76

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=2.2e-28  Score=292.43  Aligned_cols=94  Identities=14%  Similarity=0.205  Sum_probs=80.2

Q ss_pred             CCCC-CcceeEEEEE-------eeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 005033          135 GLRS-PFLVTLLGYC-------MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVI  206 (718)
Q Consensus       135 ~L~H-pNIV~L~g~~-------~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIV  206 (718)
                      .++| +||++++++|       .....++++|||+ +++|.++|.... ..+++..++.++.||+.||.|||   +++|+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAH---SQGIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            4456 6888888887       2334567889988 779999997543 35899999999999999999999   99999


Q ss_pred             ecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          207 HGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       207 HRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||||||+||||+..+.+|++|||++..
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~  129 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSD  129 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCc
Confidence            999999999999999999999998875

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=3.2e-29  Score=254.09  Aligned_cols=146  Identities=26%  Similarity=0.425  Sum_probs=122.5

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhCCCCCcceeEEEEEee--------CC
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT--FSLQTEREFQNELQILGGLRSPFLVTLLGYCME--------RN  152 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~--~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--------~~  152 (718)
                      .|.....||+|.||.||+++.+ +|+.||+|++-.  ........-++|+.+|..|+|+|++.++..|..        ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            4556678999999999999887 478899887622  222223456899999999999999999988753        23


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                      ..||||.+|+ .+|.-+|... ...++...+..++.++..||.|+|   +..|+|||+|+.|+||+.+|.+||+|||+++
T Consensus        98 t~ylVf~~ce-hDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   98 TFYLVFDFCE-HDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             eeeeeHHHhh-hhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            4799999994 5999888654 346888899999999999999999   9999999999999999999999999999998


Q ss_pred             ee
Q 005033          233 IK  234 (718)
Q Consensus       233 ~~  234 (718)
                      .+
T Consensus       173 ~f  174 (376)
T KOG0669|consen  173 AF  174 (376)
T ss_pred             ce
Confidence            75

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.5e-29  Score=253.97  Aligned_cols=144  Identities=27%  Similarity=0.469  Sum_probs=123.1

Q ss_pred             ccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC-----eEEE
Q 005033           85 FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERN-----KRIL  156 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~~L  156 (718)
                      .+..+.||-|+||.||-+++. +|+.||+|++....  ....+.+.+|+.+|..++|.|++..++...-.+     ++|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            345678999999999999886 79999999885432  233467899999999999999999998876543     4688


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++|+| ..||..+|-+..  .++...+.-++.||++||.|||   +.+|+||||||.|.|++.+..+||||||||+..
T Consensus       135 ~TELm-QSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHH-HhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEeccccccccc
Confidence            99999 679998887654  5666778888999999999999   999999999999999999999999999999974

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-27  Score=248.94  Aligned_cols=142  Identities=27%  Similarity=0.454  Sum_probs=119.3

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC------e
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERN------K  153 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------~  153 (718)
                      .+|...+.+|.|.- .|..+.+. .++.||+|.+...  .....++..+|..++..++|+||++++.+|.-..      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46777788898887 56666554 5899999987432  1233456789999999999999999999997543      5


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .|+||||| .++|.+.+..    .++...+..|+.|++.|+.|||   +.+|+||||||+||++..+..+||.|||+|+.
T Consensus        96 ~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence            69999999 7899999873    4677788899999999999999   99999999999999999999999999999985

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=3.4e-26  Score=226.71  Aligned_cols=146  Identities=32%  Similarity=0.524  Sum_probs=131.3

Q ss_pred             ccccceecccCceEEEEEEEcC-CcEEEEEEcccCChh-hHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           85 FDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQ-TEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~~-g~~VAVK~i~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      |.+.+.||+|++|.||++.... ++.+|+|.+...... ....+.+|++.+..++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5667899999999999999875 899999999765444 56789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++|.+++..... .+++.....++.+++.+|.|||   ..+++|+||+|.||+++.++.++|+|||++...
T Consensus        81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~  148 (225)
T smart00221       81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFI  148 (225)
T ss_pred             CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence            9999999986542 1788899999999999999999   889999999999999999999999999988764

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.9e-27  Score=262.20  Aligned_cols=147  Identities=24%  Similarity=0.326  Sum_probs=127.1

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhh--------HHHHHHHHHHHhCCC---CCcceeEEEEEee
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQT--------EREFQNELQILGGLR---SPFLVTLLGYCME  150 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~--------~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~  150 (718)
                      .+|..++.+|+|+||.|++|.++ +...|+||.|.+...-.        .-.+-.||.||..|+   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35888999999999999999998 46689999986532211        112446999999997   9999999999999


Q ss_pred             CCeEEEEEecc-CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeecc
Q 005033          151 RNKRILVYEYM-PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG  229 (718)
Q Consensus       151 ~~~~~LVmEy~-~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFG  229 (718)
                      ++.+||+||-. ++-+|.++|..+.  .+++.++..|+.||+.|+++||   +.+|||||||-+||.++.+|.+||+|||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence            99999999975 4669999998765  5788899999999999999999   9999999999999999999999999999


Q ss_pred             Cceee
Q 005033          230 LSRIK  234 (718)
Q Consensus       230 LAr~~  234 (718)
                      .|...
T Consensus       716 saa~~  720 (772)
T KOG1152|consen  716 SAAYT  720 (772)
T ss_pred             chhhh
Confidence            77653

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=5.5e-27  Score=255.89  Aligned_cols=147  Identities=27%  Similarity=0.326  Sum_probs=128.2

Q ss_pred             cCccccceecccCceEEEEEEEcC-CcEEEEEEcccCChhhHHHHHHHHHHHhCCCC------CcceeEEEEEeeCCeEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRS------PFLVTLLGYCMERNKRI  155 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~-g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~H------pNIV~L~g~~~~~~~~~  155 (718)
                      .+|.+....|+|-|++|.+|.+.. |+.||||+|.... ...+.=+.|++||++|+.      .|+++|+-.|...+++|
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC  510 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC  510 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence            578888899999999999999874 8899999997643 334455789999999963      58999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC-CEEEeeccCcee
Q 005033          156 LVYEYMPNKSLQEMLFSDGN-LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC-RGKVSDFGLSRI  233 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~-~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~-~vKLsDFGLAr~  233 (718)
                      ||+|-+ ..+|.++|+..+. ..|....+..++.|+..||.+|-   ..+|+|.||||.|||+++.. .+||||||.|..
T Consensus       511 lVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~  586 (752)
T KOG0670|consen  511 LVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSASF  586 (752)
T ss_pred             EEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccccc
Confidence            999998 7899999988763 56788889999999999999999   88999999999999998764 689999998877


Q ss_pred             e
Q 005033          234 K  234 (718)
Q Consensus       234 ~  234 (718)
                      .
T Consensus       587 ~  587 (752)
T KOG0670|consen  587 A  587 (752)
T ss_pred             c
Confidence            5

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=2.1e-27  Score=265.38  Aligned_cols=148  Identities=28%  Similarity=0.429  Sum_probs=136.1

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ..++|.++..+|.|.||.||++++. +++..|||+++-.......-.+.|+-+++..+|||||.++|.+......+++||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            4578999999999999999999987 699999999987666667778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||.+|+|++.-+..+  .+++.++..+++..++||.|||   +.+-+|||||-.|||+++.|.+|++|||.+..
T Consensus        93 ycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaq  161 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQ  161 (829)
T ss_pred             ecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhh
Confidence            999999999877665  6888899999999999999999   99999999999999999999999999998754

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=3.6e-26  Score=245.84  Aligned_cols=146  Identities=27%  Similarity=0.430  Sum_probs=127.8

Q ss_pred             HHHHhcCccccceecccCceEEEEEEEcC----CcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCC
Q 005033           78 LKNATNDFDEANVIGKGGSGTVFLGIARD----GKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCMERN  152 (718)
Q Consensus        78 l~~at~~f~~~~~LG~G~FG~Vykg~~~~----g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~  152 (718)
                      +....+.|..++.||+|.|++||++.+..    .+.||+|.+...+  ....+.+|+++|..+ .+.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            44556788999999999999999998653    6799999986643  345689999999999 5899999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC-CCEEEeeccCc
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD-CRGKVSDFGLS  231 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~-~~vKLsDFGLA  231 (718)
                      ..++||||++.-...+++..     ++...+..++..++.||.|+|   .+|||||||||+|+|.+.. +.-.|.|||||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhH
Confidence            99999999999999999863     567888899999999999999   9999999999999999754 56889999999


Q ss_pred             ee
Q 005033          232 RI  233 (718)
Q Consensus       232 r~  233 (718)
                      ..
T Consensus       181 ~~  182 (418)
T KOG1167|consen  181 QR  182 (418)
T ss_pred             HH
Confidence            85

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.92  E-value=1.5e-25  Score=225.01  Aligned_cols=143  Identities=27%  Similarity=0.501  Sum_probs=123.9

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCC--eEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLR-SPFLVTLLGYCMERN--KRIL  156 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~--~~~L  156 (718)
                      ..++|++.+.+|+|-|+.||.|..- +++.++||+++.   -..+.+.+|+.||..|. ||||++|++...+..  ...|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            3468999999999999999999854 678899999865   34457899999999997 999999999997764  4689


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC-CEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC-RGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~-~vKLsDFGLAr~~  234 (718)
                      |+||+.+.+...+..     .++...+..++.+++.||.|+|   ++||+|||+||.|++||... .++|+|+|||.+.
T Consensus       113 iFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             HhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhc
Confidence            999999988877653     4566778889999999999999   99999999999999998754 6999999999875

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=1.6e-24  Score=210.26  Aligned_cols=102  Identities=21%  Similarity=0.219  Sum_probs=70.7

Q ss_pred             ccCccccCccccCCCCCcccccccchhhhHHHhhhCCCCCcccCCchhhhhhhHHHHHHHHHHcCCccccccccccCCCC
Q 005033          574 RGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYN  653 (718)
Q Consensus       574 ~Gt~~Y~APE~~~~~~~~~k~Dv~S~Gv~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  653 (718)
                      .||+.|||||++.++.++.++|||||||++|||+||+.||.....        +...........  ... ++. ....+
T Consensus        65 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--------~~~~~~~~~~~~--~~~-~~~-~~~~~  132 (176)
T smart00750       65 RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--------LSAILEILLNGM--PAD-DPR-DRSNL  132 (176)
T ss_pred             CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--------hcHHHHHHHHHh--ccC-Ccc-ccccH
Confidence            478999999999999999999999999999999999999963211        111111111110  000 000 00111


Q ss_pred             HHHHH--HHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 005033          654 KEQAS--LCINLALTCLQKTPELRPDIGETVRILKG  687 (718)
Q Consensus       654 ~~~~~--~~~~l~~~cl~~~P~~Rps~~ev~~~l~~  687 (718)
                      .....  .+.+++.+||+.+|++|||+.|+++.+..
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            22233  68999999999999999999999998764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.7e-23  Score=214.65  Aligned_cols=145  Identities=21%  Similarity=0.335  Sum_probs=122.3

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEE-EeeCCeEEEEEe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGY-CMERNKRILVYE  159 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~-~~~~~~~~LVmE  159 (718)
                      +.|.+.+.||+|.||.+-++.++ +.+.+++|.+... ....++|.+|..---.| .|.||+.-|++ |+..+..++++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            57889999999999999999988 5788999988653 34457899998876566 58899988764 667778889999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEC--CCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD--SDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd--~~~~vKLsDFGLAr~~  234 (718)
                      |++.|||.+-+...   .+-+.....++.|+++||.|||   +.++||||||.+||||-  +..++||||||+.+..
T Consensus       103 ~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  103 FAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             cCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            99999999888654   4677788899999999999999   99999999999999993  3457999999988763

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.89  E-value=1.2e-21  Score=197.58  Aligned_cols=145  Identities=36%  Similarity=0.540  Sum_probs=126.0

Q ss_pred             ccccceecccCceEEEEEEEcCCcEEEEEEcccCChh---hHHHHHHHHHHHhCCCCC-cceeEEEEEeeCCeEEEEEec
Q 005033           85 FDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ---TEREFQNELQILGGLRSP-FLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~---~~~~f~~Ei~iL~~L~Hp-NIV~L~g~~~~~~~~~LVmEy  160 (718)
                      |.+...||.|+||.||++...  ..+|+|.+......   ....|.+|+.++..+.|+ +|+++++++......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667789999999999999987  88999998653322   367799999999999988 799999999877788999999


Q ss_pred             cCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC-CEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGN-LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC-RGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~-~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~-~vKLsDFGLAr~~  234 (718)
                      +.+++|.+++..... ..+.......++.|++.++.|+|   ..+++|||+||+||+++..+ .++++|||+++..
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~  152 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL  152 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence            999999977765532 15778889999999999999999   89999999999999999988 7999999998753

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=4.8e-21  Score=209.79  Aligned_cols=141  Identities=24%  Similarity=0.231  Sum_probs=115.2

Q ss_pred             HHHhcCccccceecccCceEEEEEEEc--CCcEEEEEEcccC-----ChhhHHHHHHHHHHHhCCCCCccee-EEEEEee
Q 005033           79 KNATNDFDEANVIGKGGSGTVFLGIAR--DGKLLAIKRLDTF-----SLQTEREFQNELQILGGLRSPFLVT-LLGYCME  150 (718)
Q Consensus        79 ~~at~~f~~~~~LG~G~FG~Vykg~~~--~g~~VAVK~i~~~-----~~~~~~~f~~Ei~iL~~L~HpNIV~-L~g~~~~  150 (718)
                      ....++|.+.+.||+|+||+||+|.+.  +++.||||++...     .......|.+|+++|..++|+||+. ++++   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            345578999999999999999999875  5778899987532     1223566999999999999999985 4432   


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCCEEECCCCCEEEeecc
Q 005033          151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI-KPSNVLLDSDCRGKVSDFG  229 (718)
Q Consensus       151 ~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDL-KP~NILLd~~~~vKLsDFG  229 (718)
                       +..||||||++|++|... ...     .   ...++.|++.||.|||   +.+|+|||| ||+|||++.++.+||+|||
T Consensus        91 -~~~~LVmE~~~G~~L~~~-~~~-----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLA-RPH-----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             -CCcEEEEEccCCCCHHHh-Ccc-----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence             467999999999999732 111     1   1357889999999999   999999999 9999999999999999999


Q ss_pred             Cceeee
Q 005033          230 LSRIKV  235 (718)
Q Consensus       230 LAr~~~  235 (718)
                      +|+...
T Consensus       158 lA~~~~  163 (365)
T PRK09188        158 LASVFR  163 (365)
T ss_pred             cceecc
Confidence            999863

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=2.1e-20  Score=201.30  Aligned_cols=146  Identities=25%  Similarity=0.305  Sum_probs=124.0

Q ss_pred             CccccceecccCceEEEEEEEcCC--cEEEEEEcccCChhhHHHHHHHHHHHhCCCC----CcceeEEEEE-eeCCeEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIARDG--KLLAIKRLDTFSLQTEREFQNELQILGGLRS----PFLVTLLGYC-MERNKRIL  156 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~~g--~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~H----pNIV~L~g~~-~~~~~~~L  156 (718)
                      +|.+.+.||+|+||.||+|.....  ..+|+|............+..|+.++..+..    .++..+++.. ......|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999998753  5789988755332222267788888888863    6899999998 47778999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC-----CCEEEeeccCc
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD-----CRGKVSDFGLS  231 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~-----~~vKLsDFGLA  231 (718)
                      ||+.+ |.+|.++........++...++.|+.|++.+|.+||   +.|++||||||+|+++...     ..+.|.|||+|
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999 999999887666557899999999999999999999   9999999999999999865     46899999999


Q ss_pred             ee
Q 005033          232 RI  233 (718)
Q Consensus       232 r~  233 (718)
                      +.
T Consensus       175 r~  176 (322)
T KOG1164|consen  175 RR  176 (322)
T ss_pred             cc
Confidence            84

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=1.2e-20  Score=189.05  Aligned_cols=139  Identities=22%  Similarity=0.256  Sum_probs=107.9

Q ss_pred             cceecccCceEEEEEEEcCCcEEEEEEcccCChh--h-------H-----------------HHHHHHHHHHhCCCCCcc
Q 005033           88 ANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ--T-------E-----------------REFQNELQILGGLRSPFL  141 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~--~-------~-----------------~~f~~Ei~iL~~L~HpNI  141 (718)
                      ...||+|+||.||+|...+|+.||||+++.....  .       .                 .....|+.+|..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999888999999998643211  0       0                 122349999999987776


Q ss_pred             eeEEEEEeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCCCCCEEECCC
Q 005033          142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL-HFGCDPPVIHGDIKPSNVLLDSD  220 (718)
Q Consensus       142 V~L~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yL-H~~~~~gIVHRDLKP~NILLd~~  220 (718)
                      .....+...  ..+|||||+++++|...+....  .++...+..++.|++.+|.|| |   ..+|+||||||+|||++ +
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~--~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDA--PLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhcC--CCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-C
Confidence            433322222  2389999998887765533332  578888999999999999999 6   78999999999999998 4


Q ss_pred             CCEEEeeccCceee
Q 005033          221 CRGKVSDFGLSRIK  234 (718)
Q Consensus       221 ~~vKLsDFGLAr~~  234 (718)
                      +.++|+|||+|...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            78999999999865

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=3.9e-21  Score=222.71  Aligned_cols=143  Identities=24%  Similarity=0.335  Sum_probs=111.4

Q ss_pred             cccceecccCceEEEEEEEc-CCcEEEEEEcc----c-CChhh-HHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           86 DEANVIGKGGSGTVFLGIAR-DGKLLAIKRLD----T-FSLQT-EREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        86 ~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~----~-~~~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      .....+|.|++|.|+..... ....++.|...    . ..... ...+..|..+-..++|+|++..+..+.+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            35678999999988877654 23334444322    1 11111 122667888888999999988887777776666669


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||++ ||..++...+  .+....+..++.|++.|+.|||   ..||.|||||++|+++..+|.+||+|||.+...
T Consensus       401 E~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf  470 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVF  470 (601)
T ss_pred             hcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceee
Confidence            99999 9999998763  3566778889999999999999   999999999999999999999999999988764

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=9.8e-20  Score=181.66  Aligned_cols=140  Identities=21%  Similarity=0.219  Sum_probs=110.7

Q ss_pred             cceecccCceEEEEEEEcCCcEEEEEEcccCChh--------------------------hHHHHHHHHHHHhCCCCCcc
Q 005033           88 ANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ--------------------------TEREFQNELQILGGLRSPFL  141 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~--------------------------~~~~f~~Ei~iL~~L~HpNI  141 (718)
                      ...||+|+||.||+|.+.+|+.||||+++.....                          ....+.+|...+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999888999999998653210                          01224578999999999987


Q ss_pred             eeEEEEEeeCCeEEEEEeccCCCCHHHH-HhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEECC
Q 005033          142 VTLLGYCMERNKRILVYEYMPNKSLQEM-LFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD-PPVIHGDIKPSNVLLDS  219 (718)
Q Consensus       142 V~L~g~~~~~~~~~LVmEy~~gGsL~~~-L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~-~gIVHRDLKP~NILLd~  219 (718)
                      .....+...  ..||||||++|+++... +...   .++......++.|++.+|.+||   . .+|+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~---~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV---PLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhhc---cCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-
Confidence            544443333  24899999988865443 4322   4677888899999999999999   7 8999999999999998 


Q ss_pred             CCCEEEeeccCceeeec
Q 005033          220 DCRGKVSDFGLSRIKVE  236 (718)
Q Consensus       220 ~~~vKLsDFGLAr~~~~  236 (718)
                      ++.++|+|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            88999999999988643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1.6e-20  Score=192.67  Aligned_cols=138  Identities=24%  Similarity=0.439  Sum_probs=115.6

Q ss_pred             ccceecccCceEEEEEEEcCCcEEEEEEccc--CChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCC
Q 005033           87 EANVIGKGGSGTVFLGIARDGKLLAIKRLDT--FSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNK  164 (718)
Q Consensus        87 ~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~--~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gG  164 (718)
                      +..+|.+...|..|+|++. |..+++|++..  ......+.|..|.-.|+-+.||||+.++|.|....+..++..||+.|
T Consensus       194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            4456888999999999997 45566676643  33344568999999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEe
Q 005033          165 SLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVS  226 (718)
Q Consensus       165 sL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLs  226 (718)
                      +|+..|+.......+..++++++.+|++|++|||+- ++-|.---|.+..++||++.+++|+
T Consensus       273 slynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee
Confidence            999999998888888999999999999999999942 3334444688999999999887764

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=2.1e-18  Score=175.79  Aligned_cols=137  Identities=19%  Similarity=0.254  Sum_probs=107.8

Q ss_pred             cccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCC-----CCCcceeEEEEEeeCC---eEE-
Q 005033           86 DEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGL-----RSPFLVTLLGYCMERN---KRI-  155 (718)
Q Consensus        86 ~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-----~HpNIV~L~g~~~~~~---~~~-  155 (718)
                      .....||+|+||.||.  +. ++.. +||++........+.+.+|+.+++.+     .||||++++|++.++.   ..+ 
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            4467899999999996  44 3444 79988665444567799999999999     5799999999998873   434 


Q ss_pred             EEEec--cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEecCCCCCCEEECC----CCCEEEee-
Q 005033          156 LVYEY--MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL-EFLHFGCDPPVIHGDIKPSNVLLDS----DCRGKVSD-  227 (718)
Q Consensus       156 LVmEy--~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL-~yLH~~~~~gIVHRDLKP~NILLd~----~~~vKLsD-  227 (718)
                      +||||  +.+|+|.+++...   .+++.  ..++.|++.++ .|||   +++|+||||||+|||++.    +..++|+| 
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            78999  5579999999664   24444  35678888888 8999   999999999999999974    34799999 


Q ss_pred             ccCcee
Q 005033          228 FGLSRI  233 (718)
Q Consensus       228 FGLAr~  233 (718)
                      ||....
T Consensus       154 ~G~~~~  159 (210)
T PRK10345        154 IGESTF  159 (210)
T ss_pred             CCCcce
Confidence            554444

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.76  E-value=1e-18  Score=177.22  Aligned_cols=146  Identities=23%  Similarity=0.349  Sum_probs=122.9

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCC-CcceeEEEEEeeCCeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRS-PFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~H-pNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .+.|.+++.||+|+||.+|.|..- +|..||||.=....  ....+..|..+...|+| ..|..+..+..+..+-.||||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            368999999999999999999865 69999999754322  22356788899888875 678888888888899999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC---CCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD---CRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~---~~vKLsDFGLAr~~  234 (718)
                      ++ |.+|.++..-.. ..++...++-++-|++.-++|+|   .+++|||||||+|+|+.-+   ..+.++|||||+..
T Consensus        92 LL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             cc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            99 899999875443 25788889999999999999999   8999999999999999654   45789999999875

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.75  E-value=2.3e-19  Score=209.98  Aligned_cols=142  Identities=22%  Similarity=0.254  Sum_probs=115.1

Q ss_pred             CccccceecccCceEEEEEEEcCCcEEEEEEcccCC-hhhHHHHHH---HHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           84 DFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFS-LQTEREFQN---ELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~-~~~~~~f~~---Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      +|...+.||++.|=.|.+|+++.|. |+||++-+.. .-..+.|.+   |++ ....+|||++.+.-+-......|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5677789999999999999998777 8899884432 233344443   444 455689999998887777777899999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |. ..+|++.|..+.  -+...+..-|+.|++.||.-+|   ..+|+|+|||.+||||+.-.-+.|+||..-+.
T Consensus       102 yv-khnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen  102 YV-KHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HH-hhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCC
Confidence            99 669999997653  4666777889999999999999   99999999999999999999999999975443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.75  E-value=2e-19  Score=202.24  Aligned_cols=140  Identities=30%  Similarity=0.368  Sum_probs=116.4

Q ss_pred             eecccCceEEEEEEE----cCCcEEEEEEcccCChhh--HHHHHHHHHHHhCCC-CCcceeEEEEEeeCCeEEEEEeccC
Q 005033           90 VIGKGGSGTVFLGIA----RDGKLLAIKRLDTFSLQT--EREFQNELQILGGLR-SPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        90 ~LG~G~FG~Vykg~~----~~g~~VAVK~i~~~~~~~--~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      .+|+|+||.|+++.-    ..|..+|+|.+.......  ......|..++..++ ||.+|+++..++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999997642    347889999886532211  124456788888887 9999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+|...+....  .+.+.....+...++.|++++|   ..+|+|||+|++||+++.+|.+++.|||+++..
T Consensus        81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~  147 (612)
T KOG0603|consen   81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEA  147 (612)
T ss_pred             cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHh
Confidence            999998886654  4566666778888999999999   999999999999999999999999999998763

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=3.7e-17  Score=166.20  Aligned_cols=132  Identities=20%  Similarity=0.185  Sum_probs=105.8

Q ss_pred             cccceecccCceEEEEEEEcCCcEEEEEEcccCChh----hHHHHHHHHHHHhCCC-CCcceeEEEEEeeCCeEEEEEec
Q 005033           86 DEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ----TEREFQNELQILGGLR-SPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        86 ~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~----~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      .+...|++|+||+||.+.. .+..++.+.+.....-    ....|.+|+++|.+|. |++|++++++    +..|++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3567899999999997765 6788887777543221    1225789999999995 5889999886    446999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI-KPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDL-KP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +.|.+|.+.+..         ....++.|++.+|.++|   ..||+|||| ||+|||++.++.++|+|||+|...
T Consensus        80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             ecCccHHhhhhh---------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence            999999765421         11357789999999999   999999999 799999999999999999999753

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=1.8e-17  Score=166.13  Aligned_cols=135  Identities=24%  Similarity=0.398  Sum_probs=114.2

Q ss_pred             ceecccCceEEEEEEEcCCcEEEEEEcccCCh--------hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           89 NVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL--------QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~--------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      +.||+|++|.||+|.. .|..|+||.......        .....+.+|+.++..+.|++|+....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 577899997643221        1124578899999999999988777777777888999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++|++|.+++....     . .+..++.+++.+|.+||   ..+++|||++|.|||++ ++.++|+|||+++..
T Consensus        81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            99999999986532     1 67789999999999999   99999999999999999 789999999998863

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.73  E-value=1.7e-17  Score=174.72  Aligned_cols=144  Identities=23%  Similarity=0.329  Sum_probs=120.7

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEEEecc
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      +|.+.+.||+|+||+++.|..- +++.||||.=...+  ...++..|....+.| ..++|...|-+...+.+-.||||++
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            6899999999999999999854 79999999653322  122455666666666 4689999998888888899999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC-----CEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC-----RGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~-----~vKLsDFGLAr~~  234 (718)
                       |.+|.++..-.++ .++...++.++.|++.-++|+|   ++.+|.|||||+|+||..-+     .+.|+|||+|+..
T Consensus       107 -GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  107 -GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             -CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence             9999999876654 6888999999999999999999   99999999999999996543     5889999999975

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=2e-17  Score=171.55  Aligned_cols=141  Identities=21%  Similarity=0.253  Sum_probs=110.6

Q ss_pred             CccccceecccCceEEEEEE--EcCCcEEEEEEcccCChh------------------------hHHHHHHHHHHHhCCC
Q 005033           84 DFDEANVIGKGGSGTVFLGI--ARDGKLLAIKRLDTFSLQ------------------------TEREFQNELQILGGLR  137 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~--~~~g~~VAVK~i~~~~~~------------------------~~~~f~~Ei~iL~~L~  137 (718)
                      .|++.+.||+|+||.||+|.  ..+|+.||||++......                        ....+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47888999999999999998  457999999998643210                        1123568999999997


Q ss_pred             CCc--ceeEEEEEeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCCC
Q 005033          138 SPF--LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP-VIHGDIKPSN  214 (718)
Q Consensus       138 HpN--IV~L~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~g-IVHRDLKP~N  214 (718)
                      +.+  +.+++++    ...+|||||+++++|........  .+.......++.||+.+|.|||   ..+ |+||||||+|
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhh
Confidence            533  3444443    23589999999888876653322  3455567789999999999999   889 9999999999


Q ss_pred             EEECCCCCEEEeeccCceee
Q 005033          215 VLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       215 ILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+++ ++.++|+|||++...
T Consensus       180 Ili~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEEE-CCCEEEEEChhhhcc
Confidence            9999 889999999999865

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.72  E-value=7e-17  Score=185.69  Aligned_cols=141  Identities=23%  Similarity=0.352  Sum_probs=114.3

Q ss_pred             HHHhcCccccceecccCceEEEEEEEcCCcEEEEEEc-cc-CCh------hhHHHHHHHHHHHhCCCCCcceeEEEEEee
Q 005033           79 KNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRL-DT-FSL------QTEREFQNELQILGGLRSPFLVTLLGYCME  150 (718)
Q Consensus        79 ~~at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i-~~-~~~------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~  150 (718)
                      ......|...+.||+|+||.||+|.+.... +++|+. .. ...      .....+.+|+.++..++|++|+....++..
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~  407 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD  407 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence            333445667899999999999999876443 444432 11 111      123568899999999999999988888887


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccC
Q 005033          151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL  230 (718)
Q Consensus       151 ~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGL  230 (718)
                      ....++||||+++++|.+++.          ....++.+++.+|.|||   +.+|+||||||+|||+ .++.++|+|||+
T Consensus       408 ~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGl  473 (535)
T PRK09605        408 PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGL  473 (535)
T ss_pred             CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcc
Confidence            778899999999999999885          34578999999999999   9999999999999999 678999999999


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      ++..
T Consensus       474 a~~~  477 (535)
T PRK09605        474 GKYS  477 (535)
T ss_pred             cccC
Confidence            9874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=5.2e-17  Score=161.53  Aligned_cols=131  Identities=25%  Similarity=0.434  Sum_probs=107.5

Q ss_pred             eecccCceEEEEEEEcCCcEEEEEEcccCCh--------hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           90 VIGKGGSGTVFLGIARDGKLLAIKRLDTFSL--------QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        90 ~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~--------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      .||+|+||.||+|.. +|..|++|.......        .....+.+|+.++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 578899998643211        11256788999999999887665555566667789999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +|++|.+++.....         .++.+++.+|.+||   ..+++|||++|.|||++ ++.++++|||+++..
T Consensus        80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGND---------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcHH---------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999998754321         68899999999999   99999999999999999 889999999998874

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.71  E-value=6.9e-17  Score=161.62  Aligned_cols=144  Identities=21%  Similarity=0.233  Sum_probs=112.0

Q ss_pred             HHHHHhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCCh----------------------hhHHHHHHHHHHHh
Q 005033           77 ELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL----------------------QTEREFQNELQILG  134 (718)
Q Consensus        77 el~~at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~----------------------~~~~~f~~Ei~iL~  134 (718)
                      ++...-.-|.+.+.||+|+||.||++...+|+.||||++.....                      .....+..|+.++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            34443334778899999999999999988899999998753210                      01123677899999


Q ss_pred             CCCCCc--ceeEEEEEeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 005033          135 GLRSPF--LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKP  212 (718)
Q Consensus       135 ~L~HpN--IV~L~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP  212 (718)
                      .+.|++  ++..++.    ...++||||++|++|..+...        .....++.+++.++.++|   ..+|+||||||
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p  153 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY---KHGIIHGDLSE  153 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCc
Confidence            888774  4444442    345899999999999776431        234568899999999999   89999999999


Q ss_pred             CCEEECCCCCEEEeeccCceeee
Q 005033          213 SNVLLDSDCRGKVSDFGLSRIKV  235 (718)
Q Consensus       213 ~NILLd~~~~vKLsDFGLAr~~~  235 (718)
                      +||+++.++.++|+|||++....
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.71  E-value=4.5e-17  Score=182.74  Aligned_cols=98  Identities=32%  Similarity=0.566  Sum_probs=88.8

Q ss_pred             HhCCCCCcceeEEEEEeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-EecCCC
Q 005033          133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPV-IHGDIK  211 (718)
Q Consensus       133 L~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gI-VHRDLK  211 (718)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+... ...+++.-...++++|+.||.|||   ..+| .|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeec
Confidence            45789999999999999999999999999999999999874 346888888999999999999999   4444 999999


Q ss_pred             CCCEEECCCCCEEEeeccCceee
Q 005033          212 PSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       212 P~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +.|++++....+||+|||+....
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~   99 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLL   99 (484)
T ss_pred             cccceeeeeEEEEechhhhcccc
Confidence            99999999999999999998764

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.71  E-value=4.9e-17  Score=167.69  Aligned_cols=139  Identities=18%  Similarity=0.231  Sum_probs=114.6

Q ss_pred             HhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhH---HH------HHHHHHHHhCCCCCcceeEEEEEeeC
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTE---RE------FQNELQILGGLRSPFLVTLLGYCMER  151 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~---~~------f~~Ei~iL~~L~HpNIV~L~g~~~~~  151 (718)
                      ..++|+..++||.|+||.||+... ++..+|||.+........   ..      +.+|+..+.++.|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            457899999999999999999655 577899999964332222   22      67899999999999999999886643


Q ss_pred             --------CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCE
Q 005033          152 --------NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG  223 (718)
Q Consensus       152 --------~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~v  223 (718)
                              +..+|||||++|.+|.++..      ++.    ....+++.+|..||   ..+++|||+||+||+++.++ +
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-E
Confidence                    35799999999999988742      222    24569999999999   99999999999999999988 9


Q ss_pred             EEeeccCceee
Q 005033          224 KVSDFGLSRIK  234 (718)
Q Consensus       224 KLsDFGLAr~~  234 (718)
                      +|+|||..+..
T Consensus       174 ~liDfg~~~~~  184 (232)
T PRK10359        174 RIIDLSGKRCT  184 (232)
T ss_pred             EEEECCCcccc
Confidence            99999988765

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.67  E-value=3.6e-17  Score=191.78  Aligned_cols=112  Identities=32%  Similarity=0.529  Sum_probs=82.3

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ...+|..++.|..|+||.||.++++ +.+.+|+| +++...     +.+-  ++.....|.+|                 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee-----------------
Confidence            3468999999999999999999887 47788884 433211     1111  33333344443                 


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                          ||-...++.-+..+.          +++.+++|||   +.+|+|||+||+|.||+.-|.+|++|||+++..
T Consensus       136 ----gDc~tllk~~g~lPv----------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  136 ----GDCATLLKNIGPLPV----------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             ----chhhhhcccCCCCcc----------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhh
Confidence                566666665543332          2378999999   999999999999999999999999999999864

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.67  E-value=1.8e-16  Score=170.01  Aligned_cols=90  Identities=27%  Similarity=0.407  Sum_probs=74.1

Q ss_pred             CCCcceeEEEEEee---------------------------CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHH
Q 005033          137 RSPFLVTLLGYCME---------------------------RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMD  189 (718)
Q Consensus       137 ~HpNIV~L~g~~~~---------------------------~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~q  189 (718)
                      +|||||+++++|.+                           +..+|+||.-. ..+|.+++..+.   .+.....-|+.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence            59999999998864                           22468999888 569999998763   455566778999


Q ss_pred             HHHHHHHHhcCCCCCeEecCCCCCCEEE--CCCC--CEEEeeccCcee
Q 005033          190 VAKALEFLHFGCDPPVIHGDIKPSNVLL--DSDC--RGKVSDFGLSRI  233 (718)
Q Consensus       190 Ia~gL~yLH~~~~~gIVHRDLKP~NILL--d~~~--~vKLsDFGLAr~  233 (718)
                      ++.|+.|||   .++|.|||+|++||||  ++++  .+.|+|||++-.
T Consensus       350 lLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA  394 (598)
T KOG4158|consen  350 LLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLA  394 (598)
T ss_pred             HHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeee
Confidence            999999999   9999999999999999  4444  478999998754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.66  E-value=3.6e-16  Score=165.79  Aligned_cols=145  Identities=26%  Similarity=0.341  Sum_probs=93.1

Q ss_pred             ccccceecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCCCC-----------CcceeEEE---
Q 005033           85 FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGLRS-----------PFLVTLLG---  146 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~H-----------pNIV~L~g---  146 (718)
                      +.....||.|+|+.||.+++. +|+.+|||+....   .....+.+.+|.-....+.+           ..++.+--   
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            345678999999999999997 5999999987432   22334566666544444322           11221111   


Q ss_pred             -----EEeeCC--------eEEEEEeccCCCCHHHHHhh---CCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 005033          147 -----YCMERN--------KRILVYEYMPNKSLQEMLFS---DGN--LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHG  208 (718)
Q Consensus       147 -----~~~~~~--------~~~LVmEy~~gGsL~~~L~~---~~~--~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHR  208 (718)
                           ++....        ..+++|+-+ .+||.+++..   ...  ..+....++.+..|+++.+++||   ..|+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence                 111111        236788877 6799888642   211  23444556677899999999999   9999999


Q ss_pred             CCCCCCEEECCCCCEEEeeccCcee
Q 005033          209 DIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       209 DLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||+|+|++++.+|.+.|+||+....
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r  194 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVR  194 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEE
T ss_pred             ccceeeEEEcCCCCEEEcChHHHee
Confidence            9999999999999999999975543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=1.7e-15  Score=140.08  Aligned_cols=136  Identities=20%  Similarity=0.206  Sum_probs=114.1

Q ss_pred             ccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCC--CcceeEEEEEeeCCeEEEEEeccCCC
Q 005033           87 EANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRS--PFLVTLLGYCMERNKRILVYEYMPNK  164 (718)
Q Consensus        87 ~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~~~~~LVmEy~~gG  164 (718)
                      +.+.||+|.++.||++...+ ..++||.......  ...+.+|+.++..++|  .+++++++++...+..+++|||+.++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999864 7899999865432  4578899999999976  58999999988888899999999888


Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          165 SLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       165 sL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      .+..+         +......++.+++.+|.+||.....+++|+|++|+|||++..+.++++|||+++..
T Consensus        79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            77644         34556678899999999999433357999999999999999899999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.62  E-value=1.5e-15  Score=149.34  Aligned_cols=135  Identities=21%  Similarity=0.299  Sum_probs=97.7

Q ss_pred             cceecccCceEEEEEEEcCCcEEEEEEcccCChh--hHHH----------------------HHHHHHHHhCCCCCc--c
Q 005033           88 ANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ--TERE----------------------FQNELQILGGLRSPF--L  141 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~--~~~~----------------------f~~Ei~iL~~L~HpN--I  141 (718)
                      .+.||+|+||.||+|...+++.||||++......  ....                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999988643211  1111                      134566666654432  4


Q ss_pred             eeEEEEEeeCCeEEEEEeccCCCCHHH-HHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEECC
Q 005033          142 VTLLGYCMERNKRILVYEYMPNKSLQE-MLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD-PPVIHGDIKPSNVLLDS  219 (718)
Q Consensus       142 V~L~g~~~~~~~~~LVmEy~~gGsL~~-~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~-~gIVHRDLKP~NILLd~  219 (718)
                      .+.+++    ...++||||++++++.. .+....   .. .....++.+++.++.++|   . .+|+||||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-
Confidence            444443    24589999999854321 111110   11 456788999999999999   7 9999999999999999 


Q ss_pred             CCCEEEeeccCceee
Q 005033          220 DCRGKVSDFGLSRIK  234 (718)
Q Consensus       220 ~~~vKLsDFGLAr~~  234 (718)
                      ++.++|+|||.+...
T Consensus       150 ~~~~~liDfg~a~~~  164 (187)
T cd05119         150 DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCcEEEEECcccccc
Confidence            899999999999765

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=2.2e-15  Score=179.70  Aligned_cols=146  Identities=29%  Similarity=0.392  Sum_probs=113.4

Q ss_pred             HhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCC---CCcceeEEEEEeeCCeEEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLR---SPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .-..|.+.+.||+|+||+||+|...+|+.||+|+=.....-   +|.-=.+++.+|+   -+-|..+..++...+..+||
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            34568889999999999999999989999999986542211   1222223444444   13345555556667788999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC-------CCCEEEeeccC
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS-------DCRGKVSDFGL  230 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~-------~~~vKLsDFGL  230 (718)
                      +||.+.|+|.+++...  ..+++...+.++.|++.-+++||   ..+|||+||||+|+||..       ...++|+|||.
T Consensus       773 ~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  773 SEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             eeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            9999999999999744  47899999999999999999999   999999999999999942       34589999997


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      +-.+
T Consensus       848 siDm  851 (974)
T KOG1166|consen  848 SIDM  851 (974)
T ss_pred             ceee
Confidence            7543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.61  E-value=1.3e-16  Score=176.97  Aligned_cols=76  Identities=26%  Similarity=0.403  Sum_probs=66.3

Q ss_pred             eEEEEEeccCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCc
Q 005033          153 KRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS  231 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~-~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLA  231 (718)
                      ..||.|++|.-.+|.++|.... ....++.....++.|++.|+.|      ++.+|||+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            4789999999999999997443 3456777888999999999998      58999999999999999999999999998


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      ...
T Consensus       404 ts~  406 (516)
T KOG1033|consen  404 TSQ  406 (516)
T ss_pred             eec
Confidence            754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.57  E-value=2.4e-14  Score=148.69  Aligned_cols=136  Identities=21%  Similarity=0.273  Sum_probs=106.4

Q ss_pred             cceec-ccCceEEEEEEEcCCcEEEEEEcccCC-------------hhhHHHHHHHHHHHhCCCCCcc--eeEEEEEeeC
Q 005033           88 ANVIG-KGGSGTVFLGIARDGKLLAIKRLDTFS-------------LQTEREFQNELQILGGLRSPFL--VTLLGYCMER  151 (718)
Q Consensus        88 ~~~LG-~G~FG~Vykg~~~~g~~VAVK~i~~~~-------------~~~~~~f~~Ei~iL~~L~HpNI--V~L~g~~~~~  151 (718)
                      ...|| .||.|+||.+... +..++||++....             ......+.+|+.++..|.|++|  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35688 8999999998775 7788999874311             1223467889999999998775  6777765433


Q ss_pred             C----eEEEEEeccCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEe
Q 005033          152 N----KRILVYEYMPN-KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVS  226 (718)
Q Consensus       152 ~----~~~LVmEy~~g-GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLs  226 (718)
                      .    ..++||||++| .+|.+++...   .++..    .+.+|+.+|.+||   ..||+||||||.|||++.++.++|+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEE
Confidence            2    23599999997 6999988653   34433    3678999999999   9999999999999999999999999


Q ss_pred             eccCceee
Q 005033          227 DFGLSRIK  234 (718)
Q Consensus       227 DFGLAr~~  234 (718)
                      |||.++..
T Consensus       185 Dfg~~~~~  192 (239)
T PRK01723        185 DFDRGELR  192 (239)
T ss_pred             ECCCcccC
Confidence            99999874

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.44  E-value=1.6e-14  Score=167.96  Aligned_cols=150  Identities=24%  Similarity=0.282  Sum_probs=119.7

Q ss_pred             hcCccccceecccCceEEEEEEEc--CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCCeEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR--DGKLLAIKRLDTFS--LQTEREFQNELQILGGLR-SPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~--~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~L  156 (718)
                      ...|.+.+.||+|+|+.|-.....  ....+|+|.+....  .........|..+-..+. |.|++++++.....+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            345777888999999999887764  35567777775433  222233445777777776 9999999999999999999


Q ss_pred             EEeccCCCCHHHHH-hhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC-CEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEML-FSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC-RGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L-~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~-~vKLsDFGLAr~~  234 (718)
                      +++|..++++.+.+ .... ...+....-.++.|+..++.|+|.  ..++.||||||+|.+++..+ ..+++|||+|...
T Consensus        99 ~~~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             ccCcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            99999999999988 4332 134445566789999999999994  57899999999999999999 9999999998764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.41  E-value=8.1e-13  Score=148.73  Aligned_cols=141  Identities=20%  Similarity=0.216  Sum_probs=99.8

Q ss_pred             cceecccCceEEEEEEEcCCcEEEEEEcccCChhhH----------------------------------------HHHH
Q 005033           88 ANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTE----------------------------------------REFQ  127 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~----------------------------------------~~f~  127 (718)
                      .+.||.|++|.||+|++.+|+.||||+.+..-....                                        -.|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999999999999999854311100                                        0244


Q ss_pred             HHHHHHhCC----CCCcceeEEEEEe-eCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHH-HHHHHhcCC
Q 005033          128 NELQILGGL----RSPFLVTLLGYCM-ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK-ALEFLHFGC  201 (718)
Q Consensus       128 ~Ei~iL~~L----~HpNIV~L~g~~~-~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~-gL~yLH~~~  201 (718)
                      +|+..+.++    +|.+-+.+-.++. .....+|||||++|++|.++...... ..+   ...++.+++. .+..+|   
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~---  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVL---  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHH---
Confidence            555555544    2333333333332 23456999999999999988753211 122   2345666655 467888   


Q ss_pred             CCCeEecCCCCCCEEECCCCCEEEeeccCceeee
Q 005033          202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKV  235 (718)
Q Consensus       202 ~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~~  235 (718)
                      ..|++|+|++|.||+++.++.++++|||++..+.
T Consensus       275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            8899999999999999999999999999998864

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.27  E-value=1.3e-11  Score=119.09  Aligned_cols=129  Identities=19%  Similarity=0.175  Sum_probs=96.3

Q ss_pred             cceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcc-eeEEEEEeeCCeEEEEEeccCCCCH
Q 005033           88 ANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFL-VTLLGYCMERNKRILVYEYMPNKSL  166 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LVmEy~~gGsL  166 (718)
                      ++.|+.|.++.||++... +..|++|....... ....+..|+.++..+.+.++ .+++.+.  ....++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            457899999999999875 77899998754321 12346789999988865554 4455543  2345899999999888


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          167 QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP-----VIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       167 ~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~g-----IVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      .+..      .    ....++.+++.+|+.||   ..+     ++|+|++|.||+++ ++.++++|||.+...
T Consensus        79 ~~~~------~----~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          79 LTED------F----SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             cccc------c----cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence            6430      0    11245678999999999   555     59999999999998 678999999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.25  E-value=8.1e-12  Score=143.31  Aligned_cols=143  Identities=19%  Similarity=0.259  Sum_probs=93.8

Q ss_pred             cCccccceecccCceEEEEEEEcC-CcEEEEEEcccCChh----------------------------------hHH---
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQ----------------------------------TER---  124 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~-g~~VAVK~i~~~~~~----------------------------------~~~---  124 (718)
                      .+|+. +.||+|++|.||+|++++ |+.||||+++..-..                                  ..+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35665 789999999999999987 999999998643110                                  001   


Q ss_pred             ---HHHHHHHHHhCCC----CCcceeEEEEEee-CCeEEEEEeccCCCCHHHHH--hhCCC--CCCCHHHHHHHHHHHHH
Q 005033          125 ---EFQNELQILGGLR----SPFLVTLLGYCME-RNKRILVYEYMPNKSLQEML--FSDGN--LVLKWSQRFEIIMDVAK  192 (718)
Q Consensus       125 ---~f~~Ei~iL~~L~----HpNIV~L~g~~~~-~~~~~LVmEy~~gGsL~~~L--~~~~~--~~l~~~~~~~Ia~qIa~  192 (718)
                         +|.+|+..+.+++    +.+.+.+-.++.+ ....+|||||+.|+.|.++-  ...+.  ..+....+..++.|   
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q---  275 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ---  275 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence               1344444444442    3444444444432 34568999999999998753  22221  01111112222223   


Q ss_pred             HHHHHhcCCCCCeEecCCCCCCEEECCCC----CEEEeeccCceeeec
Q 005033          193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDC----RGKVSDFGLSRIKVE  236 (718)
Q Consensus       193 gL~yLH~~~~~gIVHRDLKP~NILLd~~~----~vKLsDFGLAr~~~~  236 (718)
                          ++   ..|++|+|+||.||+++.++    .+++.|||+...+.+
T Consensus       276 ----if---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 ----VF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ----HH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                33   67999999999999999888    999999999988744

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.23  E-value=1.2e-11  Score=139.56  Aligned_cols=146  Identities=23%  Similarity=0.250  Sum_probs=118.3

Q ss_pred             Cccccceecc--cCceEEEEEEE--c-CCcEEEEEEccc--CChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEE
Q 005033           84 DFDEANVIGK--GGSGTVFLGIA--R-DGKLLAIKRLDT--FSLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        84 ~f~~~~~LG~--G~FG~Vykg~~--~-~g~~VAVK~i~~--~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~  155 (718)
                      .|.....+|.  |.+|.||.+..  . ++..+|+|.-+.  ........=.+|+.....+ .|+|.++.+..+...+..|
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4566788999  99999999877  3 588999997432  2122223335566666666 4999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeEecCCCCCCEEECCC-CCEEEeeccC
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK----ALEFLHFGCDPPVIHGDIKPSNVLLDSD-CRGKVSDFGL  230 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~----gL~yLH~~~~~gIVHRDLKP~NILLd~~-~~vKLsDFGL  230 (718)
                      +-+|+| +.+|..+...... .++......+..+...    ||.++|   ..+|+|-|+||.||++..+ ..++++|||+
T Consensus       195 iqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence            999999 6899998876543 3666777788888888    999999   9999999999999999999 8899999999


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      ...+
T Consensus       270 v~~i  273 (524)
T KOG0601|consen  270 VSKI  273 (524)
T ss_pred             eEEc
Confidence            8775

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.17  E-value=2e-11  Score=129.27  Aligned_cols=94  Identities=27%  Similarity=0.445  Sum_probs=78.1

Q ss_pred             HHhCCCCCcceeEEEEEeeCC-----eEEEEEeccCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 005033          132 ILGGLRSPFLVTLLGYCMERN-----KRILVYEYMPNKSLQEMLFSDG--NLVLKWSQRFEIIMDVAKALEFLHFGCDPP  204 (718)
Q Consensus       132 iL~~L~HpNIV~L~g~~~~~~-----~~~LVmEy~~gGsL~~~L~~~~--~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~g  204 (718)
                      -|-++-|.|||+++.|+.+..     ...++.|||..|+|.++|++..  ...+......+++-||+.||.||| .|.++
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCCc
Confidence            355667999999999986543     4688999999999999997643  234666677789999999999999 45899


Q ss_pred             eEecCCCCCCEEECCCCCEEEe
Q 005033          205 VIHGDIKPSNVLLDSDCRGKVS  226 (718)
Q Consensus       205 IVHRDLKP~NILLd~~~~vKLs  226 (718)
                      |+|+++..+-|++..+|-+||.
T Consensus       199 iihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             cccCCcchhheeecCCceEEec
Confidence            9999999999999998888763

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.08  E-value=7.2e-10  Score=110.86  Aligned_cols=143  Identities=23%  Similarity=0.335  Sum_probs=109.7

Q ss_pred             ceecccCceEEEEEEEcCCcEEEEEEcccCCh-hhHHHHHHHHHHHhCCCC--CcceeEEEEEeeC---CeEEEEEeccC
Q 005033           89 NVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL-QTEREFQNELQILGGLRS--PFLVTLLGYCMER---NKRILVYEYMP  162 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~-~~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~---~~~~LVmEy~~  162 (718)
                      +.|+.|.++.||++...+|..+++|....... .....+.+|++++..+.+  .++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999887778999998754322 134568899999999876  4467777777654   25689999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG------------------------------------------  200 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~------------------------------------------  200 (718)
                      |.+|.+.+..   ..++......++.+++.+|.+||..                                          
T Consensus        84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            9988775532   1356667777888888888888831                                          


Q ss_pred             -----------CCCCeEecCCCCCCEEECC--CCCEEEeeccCceee
Q 005033          201 -----------CDPPVIHGDIKPSNVLLDS--DCRGKVSDFGLSRIK  234 (718)
Q Consensus       201 -----------~~~gIVHRDLKP~NILLd~--~~~vKLsDFGLAr~~  234 (718)
                                 ....++|+|+.|.|||++.  ++.+.|+||+.+..-
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                       1256799999999999998  567899999988763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.07  E-value=1.8e-10  Score=130.33  Aligned_cols=150  Identities=21%  Similarity=0.208  Sum_probs=118.6

Q ss_pred             HHHhcCccccceecccCceEEEEEEEc--CCcEEEEEEcccCChhhHHH--HHHHHHHHhCC-CCCcceeEEEEEeeCCe
Q 005033           79 KNATNDFDEANVIGKGGSGTVFLGIAR--DGKLLAIKRLDTFSLQTERE--FQNELQILGGL-RSPFLVTLLGYCMERNK  153 (718)
Q Consensus        79 ~~at~~f~~~~~LG~G~FG~Vykg~~~--~g~~VAVK~i~~~~~~~~~~--f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~  153 (718)
                      ..-+.+|..+..||.|.|+.|+.+..+  ++..|++|.+.........+  -..|+-+...+ .|.++++++..+.....
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            344568899999999999999998754  57899999875533222221  23455555555 58899999888888888


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC-CCEEEeeccCce
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD-CRGKVSDFGLSR  232 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~-~~vKLsDFGLAr  232 (718)
                      .|+-.|||.++++...+...  ..++...++.+..|++.++.++|   ++.++|+|+||+||++..+ +..++.|||++.
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             ccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccc
Confidence            89999999999988766322  35677788899999999999999   9999999999999999876 778888888765


Q ss_pred             e
Q 005033          233 I  233 (718)
Q Consensus       233 ~  233 (718)
                      .
T Consensus       416 ~  416 (524)
T KOG0601|consen  416 R  416 (524)
T ss_pred             c
Confidence            3

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.05  E-value=1.9e-09  Score=109.19  Aligned_cols=135  Identities=18%  Similarity=0.186  Sum_probs=97.5

Q ss_pred             ceecccCceEEEEEEEcC-------CcEEEEEEcccCC----------------------hhhHHHH----HHHHHHHhC
Q 005033           89 NVIGKGGSGTVFLGIARD-------GKLLAIKRLDTFS----------------------LQTEREF----QNELQILGG  135 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~-------g~~VAVK~i~~~~----------------------~~~~~~f----~~Ei~iL~~  135 (718)
                      ..||.|--+.||.|...+       +..+|||+.+...                      ....+.+    .+|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998653       4799999763210                      0112223    379999988


Q ss_pred             CCC--CcceeEEEEEeeCCeEEEEEeccCCCCHHH-HHhhCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCC
Q 005033          136 LRS--PFLVTLLGYCMERNKRILVYEYMPNKSLQE-MLFSDGNLVLKWSQRFEIIMDVAKALEFL-HFGCDPPVIHGDIK  211 (718)
Q Consensus       136 L~H--pNIV~L~g~~~~~~~~~LVmEy~~gGsL~~-~L~~~~~~~l~~~~~~~Ia~qIa~gL~yL-H~~~~~gIVHRDLK  211 (718)
                      +..  -++...+++    ...+|||||+.+..+.. .++..   .++......+..+++.+|.+| |   ..+|||+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            853  456666654    45689999996654422 23221   344455667789999999999 7   8899999999


Q ss_pred             CCCEEECCCCCEEEeeccCceee
Q 005033          212 PSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       212 P~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +.|||++ ++.+.|+|||.+-..
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeC
Confidence            9999996 467999999988765

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.04  E-value=5.7e-11  Score=140.55  Aligned_cols=148  Identities=22%  Similarity=0.263  Sum_probs=107.2

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      ..+.|.+.+-+-+|+|+.++.+.-. .|...++|......   ....+....+-.++-..+||.++...-.+......+|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4466777788889999999977544 35445555432211   1122233344444444566777766666666778899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |++|+.+++|...|+..+  +.+..-....+..+..+++|||   ...++|||++|.|+|+..++..+++|||+...
T Consensus       882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccc
Confidence            999999999999998765  3444445566777889999999   77799999999999999999999999996554

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.88  E-value=1.5e-08  Score=100.87  Aligned_cols=144  Identities=22%  Similarity=0.283  Sum_probs=106.6

Q ss_pred             ccceecccCceEEEEEEEcCCcEEEEEEc-ccC-------ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           87 EANVIGKGGSGTVFLGIARDGKLLAIKRL-DTF-------SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        87 ~~~~LG~G~FG~Vykg~~~~g~~VAVK~i-~~~-------~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ....|-+|+-+.|+++.+. |+.+.||.- .+.       ..-..++..+|+.+|.++.--.|.--.=++.+...-+|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4568889999999999875 777777743 111       1112356788999998876545444444566677778999


Q ss_pred             eccCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC---CEEEeeccCceee
Q 005033          159 EYMPN-KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC---RGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~g-GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~---~vKLsDFGLAr~~  234 (718)
                      ||++| .++.+++...............++..|-..+.-||   ..+|||+||..+||++..++   .+.++||||+...
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            99966 48889987664433333333678899999999999   99999999999999997665   3589999998764

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.85  E-value=2.3e-08  Score=99.70  Aligned_cols=132  Identities=22%  Similarity=0.363  Sum_probs=97.8

Q ss_pred             ceecccCceEEEEEEEcCCcEEEEEEc-ccC-Ch------hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           89 NVIGKGGSGTVFLGIARDGKLLAIKRL-DTF-SL------QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~g~~VAVK~i-~~~-~~------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ..+++|+-+.+|.+.+. |..+.+|.= .+. ..      -....-.+|+.++.+++--.|.--.=+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999998664 444666642 211 11      1123567899999888654444444455567778899999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++|..|.+++...         ...++..|-.-+.-||   ..+|||+||.++||++..+. +.++||||+...
T Consensus        81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA---------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc---------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            9999999898655         1346677777788899   99999999999999997765 999999999874

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.77  E-value=1.4e-07  Score=99.96  Aligned_cols=140  Identities=16%  Similarity=0.058  Sum_probs=98.5

Q ss_pred             eecccCceEEEEEEEcCCcEEEEEEcccCChh-hH----------HHHHHHHHHHhCCCCC--cceeEEEEEee-----C
Q 005033           90 VIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ-TE----------REFQNELQILGGLRSP--FLVTLLGYCME-----R  151 (718)
Q Consensus        90 ~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~-~~----------~~f~~Ei~iL~~L~Hp--NIV~L~g~~~~-----~  151 (718)
                      .+-+.....|++... +|+.|.||+....... ..          ..+.+|...+..|..-  .++..+++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            344444445667655 5788999976433211 01          1477888888777432  33444555443     2


Q ss_pred             CeEEEEEeccCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC-------CCCE
Q 005033          152 NKRILVYEYMPNK-SLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS-------DCRG  223 (718)
Q Consensus       152 ~~~~LVmEy~~gG-sL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~-------~~~v  223 (718)
                      ...+||||++++. +|.+++........+......++.+++..+.-||   ..||+|+||+++|||++.       ++.+
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceE
Confidence            3578999999876 8999986432223455667789999999999999   999999999999999975       4679


Q ss_pred             EEeeccCcee
Q 005033          224 KVSDFGLSRI  233 (718)
Q Consensus       224 KLsDFGLAr~  233 (718)
                      .|+||+.++.
T Consensus       185 ~LIDl~r~~~  194 (268)
T PRK15123        185 SVIDLHRAQI  194 (268)
T ss_pred             EEEECCcccc
Confidence            9999998865

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.67  E-value=8e-08  Score=96.72  Aligned_cols=125  Identities=23%  Similarity=0.328  Sum_probs=82.0

Q ss_pred             EEEEEEEcCCcEEEEEEcccCCh--------------------------hhHHHHHHHHHHHhCCCCC--cceeEEEEEe
Q 005033           98 TVFLGIARDGKLLAIKRLDTFSL--------------------------QTEREFQNELQILGGLRSP--FLVTLLGYCM  149 (718)
Q Consensus        98 ~Vykg~~~~g~~VAVK~i~~~~~--------------------------~~~~~f~~Ei~iL~~L~Hp--NIV~L~g~~~  149 (718)
                      .||.|...+|..+|||+......                          .......+|...|.++..-  ++.+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999998899999998632100                          0113467899999999765  566666543 


Q ss_pred             eCCeEEEEEeccC--CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeEecCCCCCCEEECCCCCEEEe
Q 005033          150 ERNKRILVYEYMP--NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEF-LHFGCDPPVIHGDIKPSNVLLDSDCRGKVS  226 (718)
Q Consensus       150 ~~~~~~LVmEy~~--gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~y-LH~~~~~gIVHRDLKP~NILLd~~~~vKLs  226 (718)
                         ..+|||||++  |..+..+....    ++......++.+++..+.. +|   ..+|+|+||.+.|||++++ .+.|+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEE
Confidence               3479999997  55555443322    1122344567777775555 57   8899999999999999887 99999


Q ss_pred             eccCceee
Q 005033          227 DFGLSRIK  234 (718)
Q Consensus       227 DFGLAr~~  234 (718)
                      |||.+...
T Consensus       149 Df~qav~~  156 (188)
T PF01163_consen  149 DFGQAVDS  156 (188)
T ss_dssp             -GTTEEET
T ss_pred             ecCcceec
Confidence            99988764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.41  E-value=2e-06  Score=87.35  Aligned_cols=106  Identities=30%  Similarity=0.416  Sum_probs=82.8

Q ss_pred             HHHHHHHHHHhCCCC--CcceeEEEEEeeCC----eEEEEEeccCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHH
Q 005033          124 REFQNELQILGGLRS--PFLVTLLGYCMERN----KRILVYEYMPNK-SLQEMLFSDGNLVLKWSQRFEIIMDVAKALEF  196 (718)
Q Consensus       124 ~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~~----~~~LVmEy~~gG-sL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~y  196 (718)
                      ....+|...+..|..  -.+...+++.....    ..+||+|++++. +|.+++.....  .+......++.+++..+.-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence            457778887777643  33455566655422    458999999874 89999976432  4555677899999999999


Q ss_pred             HhcCCCCCeEecCCCCCCEEECCCC---CEEEeeccCceee
Q 005033          197 LHFGCDPPVIHGDIKPSNVLLDSDC---RGKVSDFGLSRIK  234 (718)
Q Consensus       197 LH~~~~~gIVHRDLKP~NILLd~~~---~vKLsDFGLAr~~  234 (718)
                      ||   ..||+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99   99999999999999999887   8999999988764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.36  E-value=2e-06  Score=96.64  Aligned_cols=138  Identities=20%  Similarity=0.276  Sum_probs=110.1

Q ss_pred             ceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEe----eCCeEEEEEeccCC-CCHHHH
Q 005033           96 SGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM----ERNKRILVYEYMPN-KSLQEM  169 (718)
Q Consensus        96 FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~----~~~~~~LVmEy~~g-GsL~~~  169 (718)
                      -.+.|++... +|..|++|+++....+.....-.-+++++++.|.|||++..+|.    .+..+++|++|.++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            4567888865 79999999995443333333345578899999999999999886    34578999999875 588887


Q ss_pred             HhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceeeec
Q 005033          170 LFSDG-------------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVE  236 (718)
Q Consensus       170 L~~~~-------------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~~~  236 (718)
                      -....             +...++..++.++.|+..||.++|   +.|+.-+-|-+.+||++.+.+++|+..|....+.+
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            64321             234677899999999999999999   88999999999999999999999998888777643

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.33  E-value=2e-06  Score=99.09  Aligned_cols=120  Identities=20%  Similarity=0.250  Sum_probs=98.4

Q ss_pred             CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHH
Q 005033          106 DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFE  185 (718)
Q Consensus       106 ~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~  185 (718)
                      ++.+|.|...............+-++.|+.++||||++++..+...+..|||+|-+  .-|..++...+     ......
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~~~v~~  108 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----KEEVCL  108 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----HHHHHH
Confidence            57778887776544433345677888999999999999999999999999999998  36777776553     344555


Q ss_pred             HHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          186 IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       186 Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      -+.||+.||.|||+  +.+++|++|.-+.|+++..|..||++|-++...
T Consensus       109 Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~  155 (690)
T KOG1243|consen  109 GLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKA  155 (690)
T ss_pred             HHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence            68899999999985  568999999999999999999999999887553

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.33  E-value=1.9e-06  Score=98.89  Aligned_cols=143  Identities=17%  Similarity=0.186  Sum_probs=92.9

Q ss_pred             ceecccCceEEEEEEEcCCcEEEEEEcccCChhh------------------------------HH----------HHHH
Q 005033           89 NVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQT------------------------------ER----------EFQN  128 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~------------------------------~~----------~f~~  128 (718)
                      ..|+.++-|.||+|++++|+.||||+.+..-...                              ..          .+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6789999999999999999999999885421110                              00          1344


Q ss_pred             HHHHHhCCC----CCcceeEEEEEe-eCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 005033          129 ELQILGGLR----SPFLVTLLGYCM-ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP  203 (718)
Q Consensus       129 Ei~iL~~L~----HpNIV~L~g~~~-~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~  203 (718)
                      |..-+.+++    +..=+.+=.+|. -.+...|+|||+.|-.+.++..... ...+...+.....++.-  ..+-   ..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~--~q~~---~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFL--RQLL---RD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHH--HHHH---hc
Confidence            555554442    222233333333 2456789999999999988843222 13443332222222221  1222   45


Q ss_pred             CeEecCCCCCCEEECCCCCEEEeeccCceeeecC
Q 005033          204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG  237 (718)
Q Consensus       204 gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~  237 (718)
                      |++|.|..|.||+++.+|.+.+.|||+...+.+.
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            8999999999999999999999999998876443

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.29  E-value=3.1e-06  Score=89.19  Aligned_cols=135  Identities=20%  Similarity=0.248  Sum_probs=94.2

Q ss_pred             ccccceecccCceEEEEEEEcCCcEEEEEEcccCCh----------------------hhHHHHHHHHHHHhCCCCC--c
Q 005033           85 FDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL----------------------QTEREFQNELQILGGLRSP--F  140 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~----------------------~~~~~f~~Ei~iL~~L~Hp--N  140 (718)
                      ..+...||-|--+.||.|....|..+|||.-+....                      -......+|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            356689999999999999999999999996422111                      0122456899999988644  5


Q ss_pred             ceeEEEEEeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC
Q 005033          141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD  220 (718)
Q Consensus       141 IV~L~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~  220 (718)
                      |.+-+++    +...+||||++|--|...-       ++....-.++..|+.-+.-+-   ..||||+|+.+=|||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~d  238 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecC
Confidence            5555543    4568999999886665432       112222234444444444444   5789999999999999999


Q ss_pred             CCEEEeeccCcee
Q 005033          221 CRGKVSDFGLSRI  233 (718)
Q Consensus       221 ~~vKLsDFGLAr~  233 (718)
                      |.+.++||=-+..
T Consensus       239 g~~~vIDwPQ~v~  251 (304)
T COG0478         239 GDIVVIDWPQAVP  251 (304)
T ss_pred             CCEEEEeCccccc
Confidence            9999999964443

>PRK09902 hypothetical protein; Provisional

Probab=98.28  E-value=1.2e-05  Score=82.43  Aligned_cols=140  Identities=17%  Similarity=0.144  Sum_probs=103.4

Q ss_pred             ecccCceEEEEEEEcCCcEEEEEEcccCC------hhhHHHHHHHHHHHhCCCCC--cceeEEEEEee--C--CeEEEEE
Q 005033           91 IGKGGSGTVFLGIARDGKLLAIKRLDTFS------LQTEREFQNELQILGGLRSP--FLVTLLGYCME--R--NKRILVY  158 (718)
Q Consensus        91 LG~G~FG~Vykg~~~~g~~VAVK~i~~~~------~~~~~~f~~Ei~iL~~L~Hp--NIV~L~g~~~~--~--~~~~LVm  158 (718)
                      -|+||-+.|+.-... |..+=+|+-....      +.....|.+|+..|..|..-  .+.+...+...  +  -..+||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            367899999987665 4578888764211      23567899999999988542  24444422212  1  1358999


Q ss_pred             eccCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC--EEEeeccCceee
Q 005033          159 EYMPN-KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR--GKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~g-GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~--vKLsDFGLAr~~  234 (718)
                      |-+.| -+|.+++....-...+......++.+|+..+.-||   ..++.|+|+-+.|||++.++.  ++++||--++..
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~  180 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR  180 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence            97743 59999986654334566777889999999999999   999999999999999986666  999999877653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.18  E-value=2.3e-05  Score=81.02  Aligned_cols=139  Identities=16%  Similarity=0.164  Sum_probs=85.3

Q ss_pred             ceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCc--ceeEEEEEeeCCeEEEEEeccCCCC-
Q 005033           89 NVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPF--LVTLLGYCMERNKRILVYEYMPNKS-  165 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~L~g~~~~~~~~~LVmEy~~gGs-  165 (718)
                      ..||.|..+.||+.   .|..+++|......  ......+|.+++..+..-.  +.+.+++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999984   24567788775432  2345688999998886433  4677888777778889999998863 


Q ss_pred             HHHHH---------------------hhCCCCCCCHHHHH-HHHH----------HHHH-HHHHHhc-CCCCCeEecCCC
Q 005033          166 LQEML---------------------FSDGNLVLKWSQRF-EIIM----------DVAK-ALEFLHF-GCDPPVIHGDIK  211 (718)
Q Consensus       166 L~~~L---------------------~~~~~~~l~~~~~~-~Ia~----------qIa~-gL~yLH~-~~~~gIVHRDLK  211 (718)
                      +...+                     +.-........... .+..          .+.. ...+|.. .....++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            22111                     11000011111100 0000          0011 1122220 124467899999


Q ss_pred             CCCEEECCCCCEEEeeccCcee
Q 005033          212 PSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       212 P~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |.||++++++ +.|+||+.+..
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcCc
Confidence            9999999888 99999998875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.16  E-value=1.5e-06  Score=100.46  Aligned_cols=95  Identities=22%  Similarity=0.243  Sum_probs=61.5

Q ss_pred             CccccCccccCCCCCcccccccchhhhHHHhhh-CCCCCcccCCchhhhhhhHHHHHHHHHHcCCccccccccccCCCCH
Q 005033          576 TLCYVAPEYGGCGYLMEKADIYSLGVLILVIVS-GRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNK  654 (718)
Q Consensus       576 t~~Y~APE~~~~~~~~~k~Dv~S~Gv~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  654 (718)
                      .+.|.|||++.+...+.++|+|||||++|-|.. |+.-+.......        ..        ......+..-.-.+..
T Consensus       172 ~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~--------~~--------~~~~~~~~~~~~~~s~  235 (700)
T KOG2137|consen  172 HLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL--------SY--------SFSRNLLNAGAFGYSN  235 (700)
T ss_pred             CcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcc--------hh--------hhhhcccccccccccc
Confidence            356999999999899999999999999999995 555443211110        00        0000011100111334


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 005033          655 EQASLCINLALTCLQKTPELRPDIGETVRILK  686 (718)
Q Consensus       655 ~~~~~~~~l~~~cl~~~P~~Rps~~ev~~~l~  686 (718)
                      ..+.++.+=+.+++..++..||++.++....-
T Consensus       236 ~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~f  267 (700)
T KOG2137|consen  236 NLPSELRESLKKLLNGDSAVRPTLDLLLSIPF  267 (700)
T ss_pred             cCcHHHHHHHHHHhcCCcccCcchhhhhcccc
Confidence            55566777778899999999999888876533

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.16  E-value=2.5e-05  Score=78.13  Aligned_cols=144  Identities=22%  Similarity=0.254  Sum_probs=86.0

Q ss_pred             cceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCC--cceeEEEEEee---CCeEEEEEeccC
Q 005033           88 ANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSP--FLVTLLGYCME---RNKRILVYEYMP  162 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~Hp--NIV~L~g~~~~---~~~~~LVmEy~~  162 (718)
                      ++.|+.|..+.||+....+ ..+++|.....  .....+.+|..++..+...  .+.+++.++..   ....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4678999999999999876 68999987553  4456778888888877433  35666765433   335799999999


Q ss_pred             CCCHHH----------------HH---hhC--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHh-
Q 005033          163 NKSLQE----------------ML---FSD--GNLVLKWSQ---------RFEI------------IMDVAK-ALEFLH-  198 (718)
Q Consensus       163 gGsL~~----------------~L---~~~--~~~~l~~~~---------~~~I------------a~qIa~-gL~yLH-  198 (718)
                      |..+..                .+   +..  .........         ....            ...+.. .+..++ 
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988877                11   111  000111110         0000            011122 222222 


Q ss_pred             ---cCCCCCeEecCCCCCCEEEC-CCCCEEEeeccCceee
Q 005033          199 ---FGCDPPVIHGDIKPSNVLLD-SDCRGKVSDFGLSRIK  234 (718)
Q Consensus       199 ---~~~~~gIVHRDLKP~NILLd-~~~~vKLsDFGLAr~~  234 (718)
                         ......++|+|+.|.|||++ .++.+.|+||+.+...
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~  198 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG  198 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence               11357799999999999999 5666689999988764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.05  E-value=1.7e-05  Score=91.18  Aligned_cols=138  Identities=17%  Similarity=0.195  Sum_probs=90.6

Q ss_pred             ceecccCceEEEEEEEcCCcEEEEEEcccCChhh-------------------------------------HHHHHHHHH
Q 005033           89 NVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQT-------------------------------------EREFQNELQ  131 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~-------------------------------------~~~f~~Ei~  131 (718)
                      +.||.-+.|.||+|+.++|+.||||+-+..-...                                     +-+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5799999999999999999999999875421110                                     002444544


Q ss_pred             HHhC----CCCCc------ceeEEEEEeeCCeEEEEEeccCCCCHHHH--HhhCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 005033          132 ILGG----LRSPF------LVTLLGYCMERNKRILVYEYMPNKSLQEM--LFSDGNLVLKWSQRFEIIMDVAKALEFLHF  199 (718)
Q Consensus       132 iL~~----L~HpN------IV~L~g~~~~~~~~~LVmEy~~gGsL~~~--L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~  199 (718)
                      -..+    +.|-+      |.+++-.+  .....|+||||+|.-+.+.  |.+.   .++...+..-+.++..-+-+   
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~~qIf---  318 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYLEQIF---  318 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHHHHHH---
Confidence            3332    33444      33333332  3457899999999877654  4444   34444444333333333333   


Q ss_pred             CCCCCeEecCCCCCCEEECC----CCCEEEeeccCceeeec
Q 005033          200 GCDPPVIHGDIKPSNVLLDS----DCRGKVSDFGLSRIKVE  236 (718)
Q Consensus       200 ~~~~gIVHRDLKP~NILLd~----~~~vKLsDFGLAr~~~~  236 (718)
                        ..|++|+|-.|.||++..    ++.+.+-|||+......
T Consensus       319 --~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  319 --KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             --hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence              458999999999999984    67899999999887643

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.97  E-value=7.4e-05  Score=77.09  Aligned_cols=139  Identities=18%  Similarity=0.175  Sum_probs=85.1

Q ss_pred             ecccCc-eEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCCeEEEEEeccCCCCHHH
Q 005033           91 IGKGGS-GTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLR-SPFLVTLLGYCMERNKRILVYEYMPNKSLQE  168 (718)
Q Consensus        91 LG~G~F-G~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmEy~~gGsL~~  168 (718)
                      |-.|.+ ..||+.... +..+.||+.....   ...+.+|++++..+. +--+.+++++....+..++|||+++|.+|..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            445555 788998764 4778888875432   234677888887773 3446677887777677899999999887764


Q ss_pred             HH-------------------hhCC--CCCCC--HHHHHHH-----------------------HHHHHHHHHHHh-cCC
Q 005033          169 ML-------------------FSDG--NLVLK--WSQRFEI-----------------------IMDVAKALEFLH-FGC  201 (718)
Q Consensus       169 ~L-------------------~~~~--~~~l~--~~~~~~I-----------------------a~qIa~gL~yLH-~~~  201 (718)
                      ..                   +.-.  .....  .......                       ..++...|.... ...
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            32                   1100  00111  0000000                       011111111100 011


Q ss_pred             CCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       202 ~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ...++|+|+.|.|||++.++...|+||+.+..
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            45699999999999999987788999998875

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.96  E-value=9.2e-05  Score=76.45  Aligned_cols=138  Identities=20%  Similarity=0.244  Sum_probs=90.1

Q ss_pred             HhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHH---------HHHHHHHhCCCC---CcceeEEEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREF---------QNELQILGGLRS---PFLVTLLGYC  148 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f---------~~Ei~iL~~L~H---pNIV~L~g~~  148 (718)
                      ..++|...+.+-......|.+-.. +|..+.+|..........+.|         .+++..+..++.   -..+.++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            346778778887777777776654 478899998754332222222         233333333322   2223333333


Q ss_pred             ee-----CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCE
Q 005033          149 ME-----RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG  223 (718)
Q Consensus       149 ~~-----~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~v  223 (718)
                      ..     ....+|+|||++|..|.++..      ++.    .+...|+.++.-||   ..|++|+|..|.|++++.++ +
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i  173 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-I  173 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-E
Confidence            22     234568999999988876642      222    24456778899999   99999999999999998655 9


Q ss_pred             EEeeccCcee
Q 005033          224 KVSDFGLSRI  233 (718)
Q Consensus       224 KLsDFGLAr~  233 (718)
                      +++||+..+.
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            9999987765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.84  E-value=0.00012  Score=76.51  Aligned_cols=156  Identities=18%  Similarity=0.241  Sum_probs=101.5

Q ss_pred             cccccHHHHHHHhcCcccccee---cccCceEEEEEEEcCCcEEEEEEcccCChhhH-----------------------
Q 005033           70 LQRFTYKELKNATNDFDEANVI---GKGGSGTVFLGIARDGKLLAIKRLDTFSLQTE-----------------------  123 (718)
Q Consensus        70 l~~~s~~el~~at~~f~~~~~L---G~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~-----------------------  123 (718)
                      +...|++.+....++..+....   .+|--+.||+|...++..+|||+.........                       
T Consensus        32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv  111 (268)
T COG1718          32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV  111 (268)
T ss_pred             hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence            4456777777777766665554   45666789999988899999998854221111                       


Q ss_pred             -HHHHHHHHHHhCCC--CCcceeEEEEEeeCCeEEEEEeccCCCCH-HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 005033          124 -REFQNELQILGGLR--SPFLVTLLGYCMERNKRILVYEYMPNKSL-QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF  199 (718)
Q Consensus       124 -~~f~~Ei~iL~~L~--HpNIV~L~g~~~~~~~~~LVmEy~~gGsL-~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~  199 (718)
                       .....|..-|.++.  +-.+.+-+++.    .-.|||||+....+ .=.|..   ..+.......+..++++.+.-|- 
T Consensus       112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~-  183 (268)
T COG1718         112 FAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLY-  183 (268)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHH-
Confidence             01234666666553  22333333332    34699999954311 111111   12233356677888888888877 


Q ss_pred             CCCCCeEecCCCCCCEEECCCCCEEEeeccCceeee
Q 005033          200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKV  235 (718)
Q Consensus       200 ~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~~  235 (718)
                       +..++||+||..=|||+. ++.+.|+|||-|....
T Consensus       184 -~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         184 -KEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             -HhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence             248999999999999999 8899999999887653

>PLN02876 acyl-CoA dehydrogenase

Probab=97.80  E-value=0.00025  Score=86.42  Aligned_cols=78  Identities=21%  Similarity=0.357  Sum_probs=57.1

Q ss_pred             cceecccCceEEEEEEEcCC---cEEEEEEcccCC-hhhHHHHHHHHHHHhCCC-CCcc--eeEEEEEeeC---CeEEEE
Q 005033           88 ANVIGKGGSGTVFLGIARDG---KLLAIKRLDTFS-LQTEREFQNELQILGGLR-SPFL--VTLLGYCMER---NKRILV  157 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~g---~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~-HpNI--V~L~g~~~~~---~~~~LV  157 (718)
                      .+.|+.|.+..+|+....++   ..+++|+..... ......+.+|+.+|+.+. |.+|  .+++.+|.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999877653   367777764322 123346889999999995 6654  7888888764   467999


Q ss_pred             EeccCCCC
Q 005033          158 YEYMPNKS  165 (718)
Q Consensus       158 mEy~~gGs  165 (718)
                      |||++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998764

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.73  E-value=0.00031  Score=71.66  Aligned_cols=137  Identities=28%  Similarity=0.438  Sum_probs=97.7

Q ss_pred             CCcccccccHHHHHHHhcCccccceecccCc-eEEEEEEEcCCcEEEEEEcccC---C--------h----------hhH
Q 005033           66 APLKLQRFTYKELKNATNDFDEANVIGKGGS-GTVFLGIARDGKLLAIKRLDTF---S--------L----------QTE  123 (718)
Q Consensus        66 ~~~~l~~~s~~el~~at~~f~~~~~LG~G~F-G~Vykg~~~~g~~VAVK~i~~~---~--------~----------~~~  123 (718)
                      ...++.+|+..     +.+++.++.||.|.- |.||++... |+.+|+|.....   .        .          ...
T Consensus        25 ~gPKL~~F~~h-----~~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~   98 (207)
T PF13095_consen   25 PGPKLEPFTHH-----GDDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYA   98 (207)
T ss_pred             CCCCcCCcCCC-----CCcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhc
Confidence            34456677762     278899999999999 999999875 779999993210   0        0          111


Q ss_pred             HHHHHHHHHHhCCC---CCcc--eeEEEEEeeC------------------CeEEEEEeccCCCCHHHHHhhCCCCCCCH
Q 005033          124 REFQNELQILGGLR---SPFL--VTLLGYCMER------------------NKRILVYEYMPNKSLQEMLFSDGNLVLKW  180 (718)
Q Consensus       124 ~~f~~Ei~iL~~L~---HpNI--V~L~g~~~~~------------------~~~~LVmEy~~gGsL~~~L~~~~~~~l~~  180 (718)
                      .-|..|.....+|+   +.++  |+++||..-.                  ....||.||++...           .+..
T Consensus        99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~  167 (207)
T PF13095_consen   99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI  167 (207)
T ss_pred             ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch
Confidence            34788988877774   4456  9999997322                  12368888886543           1121


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCc
Q 005033          181 SQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS  231 (718)
Q Consensus       181 ~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLA  231 (718)
                          .-+.+|.+-|..+|   ..+|+-+|+++.|..     .-+|+|||.+
T Consensus       168 ----~~~~~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  168 ----RDIPQMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ----hHHHHHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence                23567778888999   999999999999986     4589999864

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.71  E-value=0.00012  Score=73.88  Aligned_cols=103  Identities=29%  Similarity=0.323  Sum_probs=80.9

Q ss_pred             HHHHHHHhCCCC-CcceeEEEEEeeCCeEEEEEeccCCCCHHHHHhh-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 005033          127 QNELQILGGLRS-PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP  204 (718)
Q Consensus       127 ~~Ei~iL~~L~H-pNIV~L~g~~~~~~~~~LVmEy~~gGsL~~~L~~-~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~g  204 (718)
                      ..|.-+|..+++ +++.+++|+|-    .++|.||...+++...-.. ..-...+|..+.+|+.+++..+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            457888888876 69999999993    3679999987766422000 00014689999999999999999999765566


Q ss_pred             eEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       205 IVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +.-.|++++|+-+++++++|++|......
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            88899999999999999999999986654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.62  E-value=0.00098  Score=67.92  Aligned_cols=134  Identities=20%  Similarity=0.271  Sum_probs=91.4

Q ss_pred             ccceecccCceEEEEEEEcCCcEEEEEEcccCC----------------hhhHHHHHHHHHHHhCCC------CCcceeE
Q 005033           87 EANVIGKGGSGTVFLGIARDGKLLAIKRLDTFS----------------LQTEREFQNELQILGGLR------SPFLVTL  144 (718)
Q Consensus        87 ~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~----------------~~~~~~f~~Ei~iL~~L~------HpNIV~L  144 (718)
                      ....||+|+.-.||.  +.+.....||++....                ....+++.+|+.-...+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            346799999999997  4455667888876543                112345666666555544      7899999


Q ss_pred             EEEEeeCCeEEEEEeccCC------CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEC
Q 005033          145 LGYCMERNKRILVYEYMPN------KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD  218 (718)
Q Consensus       145 ~g~~~~~~~~~LVmEy~~g------GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd  218 (718)
                      +|+..++...-+|+|.+.+      .+|.+++...   .++. .....+.   .-..||-   ...|+.+||+|.||++.
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~---~f~~~l~---~~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALD---EFKRYLL---DHHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHH---HHHHHHH---HcCCeecCCCcccEEEE
Confidence            9999999989999998632      4688888654   3443 3333333   3345666   77899999999999995


Q ss_pred             CC--C--CEEEee-ccCce
Q 005033          219 SD--C--RGKVSD-FGLSR  232 (718)
Q Consensus       219 ~~--~--~vKLsD-FGLAr  232 (718)
                      ..  +  .+.|+| ||-..
T Consensus       153 ~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             ecCCCceEEEEEeCCCCcc
Confidence            43  2  466666 45433

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.60  E-value=1.2e-05  Score=92.31  Aligned_cols=135  Identities=16%  Similarity=0.066  Sum_probs=89.7

Q ss_pred             ccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCc-ceeEEEEEeeCCeEEEEEeccCC
Q 005033           85 FDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPF-LVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpN-IV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +...+-+++|+++.+++.+....+....+.+...     ....-++++|.+++||| .+..++-+..+...+++|+++.+
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            3444568899999999976543444445544322     34456889999999999 78888888888889999999987


Q ss_pred             C-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          164 K-SLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       164 G-sL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      | +-..... .....+...+...+.+.-+++|+|+|   +-.-+|||    ||+..+ +..+..||+....
T Consensus       319 ~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~  380 (829)
T KOG0576|consen  319 GRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQ  380 (829)
T ss_pred             CccccccCC-hhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcc
Confidence            7 2211110 01112333444556677788999999   55568888    777654 5567777765543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=97.52  E-value=0.00093  Score=74.19  Aligned_cols=134  Identities=14%  Similarity=0.204  Sum_probs=81.6

Q ss_pred             ccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEE------EeeCC-eEEEEE
Q 005033           87 EANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGY------CMERN-KRILVY  158 (718)
Q Consensus        87 ~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~------~~~~~-~~~LVm  158 (718)
                      ..+.||+|+-+.+|-.-.- +.. +.|+...-........   +..|... .||-+..-+.+      .-+.+ .+-+.|
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchh-hch-hheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            4577999999999953221 112 3455543222222221   2223333 45543321111      01122 255777


Q ss_pred             eccCCCC-HHHHHh----hCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeec
Q 005033          159 EYMPNKS-LQEMLF----SDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDF  228 (718)
Q Consensus       159 Ey~~gGs-L~~~L~----~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDF  228 (718)
                      ..+++.- ...++.    +..-....|...++.++.++.+.+-||   ..|-+-+|+.++|+|+.+++.+.|.|-
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcc
Confidence            7776642 222221    111245789999999999999999999   889999999999999999998888764

>PRK10593 hypothetical protein; Provisional

Probab=97.50  E-value=0.0013  Score=70.76  Aligned_cols=77  Identities=17%  Similarity=0.127  Sum_probs=56.2

Q ss_pred             ccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCC---CcceeEEEEEee---CCeEEEEEec
Q 005033           87 EANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRS---PFLVTLLGYCME---RNKRILVYEY  160 (718)
Q Consensus        87 ~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~H---pNIV~L~g~~~~---~~~~~LVmEy  160 (718)
                      ..+.||.|..+.||.....+++ +.+|..+..  .....|.+|...|+.|.-   -.+.+++++|..   .+..+||||+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            3567999999999998765554 666764321  123478899999988853   357888888754   3668999999


Q ss_pred             cCCCCH
Q 005033          161 MPNKSL  166 (718)
Q Consensus       161 ~~gGsL  166 (718)
                      ++++++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            988765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.48  E-value=0.0007  Score=69.79  Aligned_cols=73  Identities=15%  Similarity=0.179  Sum_probs=45.2

Q ss_pred             ceecccCce-EEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCC---cceeEEEEEeeC---CeEEEEEecc
Q 005033           89 NVIGKGGSG-TVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSP---FLVTLLGYCMER---NKRILVYEYM  161 (718)
Q Consensus        89 ~~LG~G~FG-~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~Hp---NIV~L~g~~~~~---~~~~LVmEy~  161 (718)
                      +.|+.|+.. .||+.    +..+.+|.....  .....+.+|.++|..+...   -+.++++.....   ...|++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            467777776 48875    235677765432  2234688899998777532   244444443332   2358999999


Q ss_pred             CCCCHH
Q 005033          162 PNKSLQ  167 (718)
Q Consensus       162 ~gGsL~  167 (718)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            887764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.38  E-value=0.00077  Score=67.45  Aligned_cols=130  Identities=22%  Similarity=0.299  Sum_probs=89.2

Q ss_pred             cccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcce-eEEEEEeeCCeEEEEEeccCCC
Q 005033           86 DEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLV-TLLGYCMERNKRILVYEYMPNK  164 (718)
Q Consensus        86 ~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV-~L~g~~~~~~~~~LVmEy~~gG  164 (718)
                      .+.+.||+|.+|.||+|.+. |..+|+|+-...  .....+..|+++|..+.-.++. +++.|.    ..++.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence            45678999999999999987 558899976543  3456789999999988876654 444443    234669999888


Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC-CCCEEECCCCCEEEeeccCceee
Q 005033          165 SLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIK-PSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       165 sL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLK-P~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      .|.+.-...     +-..    +..++..---|-   ..||-|..|. |..++|-.++.+-|+||.-|+..
T Consensus        98 ~L~~~~~~~-----~rk~----l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          98 PLGKLEIGG-----DRKH----LLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             chhhhhhcc-----cHHH----HHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            887765321     1122    233444433344   6778887774 55555555569999999988854

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.34  E-value=0.0019  Score=66.09  Aligned_cols=141  Identities=16%  Similarity=0.173  Sum_probs=81.0

Q ss_pred             cceecccCceEEEEEEEcC--CcEEEEEEcccCChhhHHHHHHHHHHHhCCCCC-cceeEEEEEeeCCeEEEEEeccCCC
Q 005033           88 ANVIGKGGSGTVFLGIARD--GKLLAIKRLDTFSLQTEREFQNELQILGGLRSP-FLVTLLGYCMERNKRILVYEYMPNK  164 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~--g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~Hp-NIV~L~g~~~~~~~~~LVmEy~~gG  164 (718)
                      ++.|..|-...+|+....+  +..|++|+....... .-...+|+.++..+... ...++++.+..    .+||||++|.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCCC
Confidence            3567778888999988764  678889976542211 11224688888877433 34455544321    3899999887


Q ss_pred             CHHHH--------------H---hhCCC-C--------CCC-HHHHHHHH-------------------------HHHHH
Q 005033          165 SLQEM--------------L---FSDGN-L--------VLK-WSQRFEII-------------------------MDVAK  192 (718)
Q Consensus       165 sL~~~--------------L---~~~~~-~--------~l~-~~~~~~Ia-------------------------~qIa~  192 (718)
                      ++...              +   +.... .        ... +..+..+.                         .+.+.
T Consensus        78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  157 (235)
T cd05157          78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS  157 (235)
T ss_pred             cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence            65321              1   11100 0        111 11111111                         11111


Q ss_pred             HHH-HHhc-CCCCCeEecCCCCCCEEECC-CCCEEEeeccCcee
Q 005033          193 ALE-FLHF-GCDPPVIHGDIKPSNVLLDS-DCRGKVSDFGLSRI  233 (718)
Q Consensus       193 gL~-yLH~-~~~~gIVHRDLKP~NILLd~-~~~vKLsDFGLAr~  233 (718)
                      .|. .+-. .....++|+|+.+.|||++. ++.+.|+||-.|..
T Consensus       158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            111 1111 12457999999999999998 57899999988775

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.28  E-value=0.0012  Score=68.84  Aligned_cols=138  Identities=14%  Similarity=0.086  Sum_probs=77.3

Q ss_pred             ecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcc-eeEEEEEeeCCeEEEEEeccCCCCHHHH
Q 005033           91 IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFL-VTLLGYCMERNKRILVYEYMPNKSLQEM  169 (718)
Q Consensus        91 LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LVmEy~~gGsL~~~  169 (718)
                      +..|-.+.+|+... ++..+++|..........-...+|..+++.+....+ .+++..+.    .++||||++|..+...
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            45677788998873 466788887543221111134678888888754333 34444432    3689999988665321


Q ss_pred             --------------H---hhCC--CCCCCHHH-HHHHHHHH---------HHHHHHHhc-----CCCCCeEecCCCCCCE
Q 005033          170 --------------L---FSDG--NLVLKWSQ-RFEIIMDV---------AKALEFLHF-----GCDPPVIHGDIKPSNV  215 (718)
Q Consensus       170 --------------L---~~~~--~~~l~~~~-~~~Ia~qI---------a~gL~yLH~-----~~~~gIVHRDLKP~NI  215 (718)
                                    +   +...  ...++... ...+..++         ...+..+-.     .....++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                          1   1111  11112111 11111111         111111110     1134689999999999


Q ss_pred             EECCCCCEEEeeccCceee
Q 005033          216 LLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       216 LLd~~~~vKLsDFGLAr~~  234 (718)
                      |++.++ +.|+||..|..-
T Consensus       159 l~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             EEeCCC-CEEEeccccCcC
Confidence            999877 789999988763

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.27  E-value=0.005  Score=69.16  Aligned_cols=76  Identities=21%  Similarity=0.243  Sum_probs=54.2

Q ss_pred             cceecccCceEEEEEEEcCC-cEEEEEEcccC------C-hhhHHHHHHHHHHHhCCC---CCcceeEEEEEeeCCeEEE
Q 005033           88 ANVIGKGGSGTVFLGIARDG-KLLAIKRLDTF------S-LQTEREFQNELQILGGLR---SPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~g-~~VAVK~i~~~------~-~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~L  156 (718)
                      .+.||.|.+..||++...+| +.|.||.-...      . ......+..|.+.|..+.   -.++.+++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            35799999999999998876 58999985321      0 123456777888887762   3457777777  3455789


Q ss_pred             EEeccCCCC
Q 005033          157 VYEYMPNKS  165 (718)
Q Consensus       157 VmEy~~gGs  165 (718)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999997643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.26  E-value=0.0011  Score=70.45  Aligned_cols=142  Identities=19%  Similarity=0.165  Sum_probs=83.8

Q ss_pred             cceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCC--cceeEEEE------EeeCCeEEEEEe
Q 005033           88 ANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSP--FLVTLLGY------CMERNKRILVYE  159 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~Hp--NIV~L~g~------~~~~~~~~LVmE  159 (718)
                      .+.|..|....+|+.... +..+++|+...   ........|+.++..+.+.  .+.+++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            456777877899998654 44688898754   2234456677777776432  24444432      223456789999


Q ss_pred             ccCCCCHHH----HH----------hhC----CC-----CCCCHHHHH----------HHHHHHHHHHHHHhc----CCC
Q 005033          160 YMPNKSLQE----ML----------FSD----GN-----LVLKWSQRF----------EIIMDVAKALEFLHF----GCD  202 (718)
Q Consensus       160 y~~gGsL~~----~L----------~~~----~~-----~~l~~~~~~----------~Ia~qIa~gL~yLH~----~~~  202 (718)
                      |++|..+..    ..          +..    ..     ....|....          .....+..++.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            998876532    11          100    00     011111110          011112333444431    124


Q ss_pred             CCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       203 ~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .+++|+|+.|.|||++.++.+.|.||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            5799999999999999887788999998765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.12  E-value=0.013  Score=63.01  Aligned_cols=157  Identities=20%  Similarity=0.243  Sum_probs=82.2

Q ss_pred             ccHHHHHHHhcCccc-----cceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCC--CcceeEE
Q 005033           73 FTYKELKNATNDFDE-----ANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRS--PFLVTLL  145 (718)
Q Consensus        73 ~s~~el~~at~~f~~-----~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~H--pNIV~L~  145 (718)
                      ++..++......|.+     .+.|+.|....+|+....+| .+++|+......   .....|+.++..|..  -.+.+.+
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i   82 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPV   82 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcce
Confidence            344445444444533     34566777789999876555 688898752222   223334444444421  1133333


Q ss_pred             E------EEeeCCeEEEEEeccCCCCHH-----------HHH---hhCC-C--------CCCCH-HHHHH----------
Q 005033          146 G------YCMERNKRILVYEYMPNKSLQ-----------EML---FSDG-N--------LVLKW-SQRFE----------  185 (718)
Q Consensus       146 g------~~~~~~~~~LVmEy~~gGsL~-----------~~L---~~~~-~--------~~l~~-~~~~~----------  185 (718)
                      .      +....+..++++||++|..+.           +.|   +... .        ..+.| .....          
T Consensus        83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (319)
T PRK05231         83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ  162 (319)
T ss_pred             eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence            2      122355678999999886431           111   1100 0        01111 11111          


Q ss_pred             --HHHH-HHHHHHHHhc----CCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          186 --IIMD-VAKALEFLHF----GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       186 --Ia~q-Ia~gL~yLH~----~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                        .+.+ +...+..+..    ....++||+|+.|.|||++.+...-|+||+.+..
T Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence              1111 1111222221    1245899999999999998766668999998865

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.85  E-value=0.0061  Score=65.01  Aligned_cols=140  Identities=20%  Similarity=0.219  Sum_probs=81.7

Q ss_pred             ceecccCceEEEEEEEcC-------CcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCc-ceeEEEEEeeCCeEEEEEec
Q 005033           89 NVIGKGGSGTVFLGIARD-------GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPF-LVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~-------g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpN-IV~L~g~~~~~~~~~LVmEy  160 (718)
                      +.|..|-...||+....+       ++.+++|+..... .......+|..++..+.... ..++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            455666677899887654       5788899865432 22234567877777774322 3455655532    368999


Q ss_pred             cCCCCHHHH--------------H---hhCCCC-------CCC--HHHHHH--------------------------HHH
Q 005033          161 MPNKSLQEM--------------L---FSDGNL-------VLK--WSQRFE--------------------------IIM  188 (718)
Q Consensus       161 ~~gGsL~~~--------------L---~~~~~~-------~l~--~~~~~~--------------------------Ia~  188 (718)
                      ++|..+...              +   +.....       ..+  +.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            988766431              0   111000       000  101100                          011


Q ss_pred             HHHHHHHHHhc------CCCCCeEecCCCCCCEEECCC----CCEEEeeccCcee
Q 005033          189 DVAKALEFLHF------GCDPPVIHGDIKPSNVLLDSD----CRGKVSDFGLSRI  233 (718)
Q Consensus       189 qIa~gL~yLH~------~~~~gIVHRDLKP~NILLd~~----~~vKLsDFGLAr~  233 (718)
                      .+..-+.+|-.      .....++|+|+.+.|||++.+    +.+.++||..|..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            22222333331      235689999999999999885    8899999998875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.75  E-value=0.015  Score=62.39  Aligned_cols=143  Identities=20%  Similarity=0.235  Sum_probs=81.6

Q ss_pred             cceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCC--cceeEEEEE------eeCCeEEEEEe
Q 005033           88 ANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSP--FLVTLLGYC------MERNKRILVYE  159 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~Hp--NIV~L~g~~------~~~~~~~LVmE  159 (718)
                      ++.++.|.-..+|+....+| .+.+|+.....  .......|++++..|...  .+.+++...      ...+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45677777789999876545 57788765421  123445566666665321  234444321      22456789999


Q ss_pred             ccCCCCHH-----------HHH---hhC-CCC---------CCCHHHHH------------HHHHHHHHHHHHHhc----
Q 005033          160 YMPNKSLQ-----------EML---FSD-GNL---------VLKWSQRF------------EIIMDVAKALEFLHF----  199 (718)
Q Consensus       160 y~~gGsL~-----------~~L---~~~-~~~---------~l~~~~~~------------~Ia~qIa~gL~yLH~----  199 (718)
                      |++|..+.           ..+   +.. ...         .-.|....            .....+...++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            99875431           111   110 000         01111110            001123344555531    


Q ss_pred             CCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       200 ~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ....+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            2257899999999999999888778999998865

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.55  E-value=0.01  Score=73.05  Aligned_cols=71  Identities=23%  Similarity=0.232  Sum_probs=56.3

Q ss_pred             HHHHHHHHhCCCCCcceeEEEEEeeCCeE----EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 005033          126 FQNELQILGGLRSPFLVTLLGYCMERNKR----ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH  198 (718)
Q Consensus       126 f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~----~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH  198 (718)
                      ..-|+..+..+.|+|++.++.|-......    .+..|+|..-++...+..-+  ..+....+.+..++..||.|+|
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHH
Confidence            34567778889999999999987654332    34557888889988887665  5677788889999999999999

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.39  E-value=0.0047  Score=67.15  Aligned_cols=150  Identities=19%  Similarity=0.263  Sum_probs=98.6

Q ss_pred             CCcccccccHHHHHHHhc---CccccceecccCceEEEEEEEcCCcEEEEEEcccCCh--h-------------------
Q 005033           66 APLKLQRFTYKELKNATN---DFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL--Q-------------------  121 (718)
Q Consensus        66 ~~~~l~~~s~~el~~at~---~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~--~-------------------  121 (718)
                      ..+....+.|-.|....+   -+.+.+.||-|--+.||.+.+..|++.++|.-+....  .                   
T Consensus        72 YRLTy~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWly  151 (465)
T KOG2268|consen   72 YRLTYAGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLY  151 (465)
T ss_pred             eEeeeccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhh
Confidence            334444555555554443   3678899999999999999999999999985321100  0                   


Q ss_pred             -hHHHHHHHHHHHhCCC-CC-cceeEEEEEeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 005033          122 -TEREFQNELQILGGLR-SP-FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH  198 (718)
Q Consensus       122 -~~~~f~~Ei~iL~~L~-Hp-NIV~L~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH  198 (718)
                       ..-...+|...|+.|. |. -|.+.+++    +..|+|||++.|-.|.+.-+-.     +...+..-+..+   +--|-
T Consensus       152 LSRlaa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-----d~~~ly~~lm~~---Iv~la  219 (465)
T KOG2268|consen  152 LSRLAATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-----DPPTLYDDLMGL---IVRLA  219 (465)
T ss_pred             hHHHHHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC-----ChHHHHHHHHHH---HHHHH
Confidence             0112456888888774 22 23444433    4568999999888887654322     223333222222   33344


Q ss_pred             cCCCCCeEecCCCCCCEEECCCCCEEEeeccC
Q 005033          199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL  230 (718)
Q Consensus       199 ~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGL  230 (718)
                         .+|+||+|..-=||++++++.++++||--
T Consensus       220 ---~~GlIHgDFNEFNimv~dd~~i~vIDFPQ  248 (465)
T KOG2268|consen  220 ---NHGLIHGDFNEFNIMVKDDDKIVVIDFPQ  248 (465)
T ss_pred             ---HcCceecccchheeEEecCCCEEEeechH
Confidence               78999999999999999999999999953

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.23  E-value=0.034  Score=59.35  Aligned_cols=33  Identities=27%  Similarity=0.669  Sum_probs=27.3

Q ss_pred             CCCeEecCCCCCCEEECCCCC-EEEeeccCceee
Q 005033          202 DPPVIHGDIKPSNVLLDSDCR-GKVSDFGLSRIK  234 (718)
Q Consensus       202 ~~gIVHRDLKP~NILLd~~~~-vKLsDFGLAr~~  234 (718)
                      ...++|+|+.|.|||++.++. .-|.||+.+..-
T Consensus       184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CCeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            346899999999999987565 469999988764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=95.78  E-value=0.067  Score=58.90  Aligned_cols=140  Identities=14%  Similarity=0.156  Sum_probs=78.4

Q ss_pred             eecccCceEEEEEEEcC-----CcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcc-eeEEEEEeeCCeEEEEEeccCC
Q 005033           90 VIGKGGSGTVFLGIARD-----GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFL-VTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        90 ~LG~G~FG~Vykg~~~~-----g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      .|-.|-.-.+|++...+     +..|.+|+.......... -.+|..++..+..-++ .++++.+..+    .|+||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            44446777888886532     367888877543322211 2568888777754333 3556665332    58999977


Q ss_pred             CCHHHH-----------------HhhCC---CC-CCCHHHHHHHHHHH-----------------HHHHHH----Hhc-C
Q 005033          164 KSLQEM-----------------LFSDG---NL-VLKWSQRFEIIMDV-----------------AKALEF----LHF-G  200 (718)
Q Consensus       164 GsL~~~-----------------L~~~~---~~-~l~~~~~~~Ia~qI-----------------a~gL~y----LH~-~  200 (718)
                      .+|...                 ++...   .. ...+..+..+..++                 ...+..    +.. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            666421                 11111   00 11122222222111                 111111    121 2


Q ss_pred             CCCCeEecCCCCCCEEECC-CCCEEEeeccCceee
Q 005033          201 CDPPVIHGDIKPSNVLLDS-DCRGKVSDFGLSRIK  234 (718)
Q Consensus       201 ~~~gIVHRDLKP~NILLd~-~~~vKLsDFGLAr~~  234 (718)
                      ....++|+|+++.|||+++ ++.+.|+||..|...
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence            2457899999999999976 478999999988764

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.66  E-value=0.2  Score=53.37  Aligned_cols=31  Identities=29%  Similarity=0.264  Sum_probs=26.9

Q ss_pred             CCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       202 ~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ..+++|+|+.+.|||++. +.+.|+||+.+..
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            468999999999999987 6789999997654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=95.65  E-value=0.0013  Score=72.99  Aligned_cols=96  Identities=17%  Similarity=0.106  Sum_probs=67.9

Q ss_pred             CCCchhhhhcccccccchhhhhhhhhhhhhhhhhhhhhHHhhhhhhHHHhhhhhhhhhhhhhccCCccccccchhhhccc
Q 005033          441 GHEPQLQELGFGKLEKGFEKKESKWKKNRKKRHKKMQEWWKEEHLDEISKKSSKLKKLETKWKKGFKIPHFDLARRFHFH  520 (718)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (718)
                      .|.+.++.+||     |.+.++         .+-.++||-.+..|++........   .+.|..|++|+...+.....+|
T Consensus       129 ~H~Nlv~LlGy-----C~e~~~---------~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH  191 (361)
T KOG1187|consen  129 RHPNLVKLLGY-----CLEGGE---------HRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLH  191 (361)
T ss_pred             CCcCcccEEEE-----EecCCc---------eEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHc
Confidence            48999999999     444332         356799999999999887775543   5699999999877666666666


Q ss_pred             ccccccccccccCCCCCcccccccccccCCCCCCCCCccC
Q 005033          521 RRNKFREQNQDDCDANGEFSFRRGWRKKNKNSMGSDMWSG  560 (718)
Q Consensus       521 ~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~~~  560 (718)
                      ....++.+|-|++++|=       +.-.+++.+++|||++
T Consensus       192 ~~~~~~iiHrDiKssNI-------LLD~~~~aKlsDFGLa  224 (361)
T KOG1187|consen  192 EGCPPPIIHRDIKSSNI-------LLDEDFNAKLSDFGLA  224 (361)
T ss_pred             cCCCCCEecCCCCHHHe-------eECCCCCEEccCccCc
Confidence            66655555555555441       1122568999999985

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=95.56  E-value=0.1  Score=57.04  Aligned_cols=33  Identities=30%  Similarity=0.645  Sum_probs=29.7

Q ss_pred             CCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       202 ~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ...++|+|+.+.||+++..+-+=|.||+++..-
T Consensus       197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             CceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            457999999999999999888999999999864

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.52  E-value=0.14  Score=57.83  Aligned_cols=80  Identities=14%  Similarity=0.168  Sum_probs=52.4

Q ss_pred             cceecccCceEEEEEEEcCCcEEEEEEcccC----Ch---hhHHHHHHHHHHHhCCC---CCcceeEEEEEeeCCeEEEE
Q 005033           88 ANVIGKGGSGTVFLGIARDGKLLAIKRLDTF----SL---QTEREFQNELQILGGLR---SPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~----~~---~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .+.||.|....||+.... +..+.||+-...    ..   ....+-..|...|..+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            567899999999998864 557889976411    10   12233344566665543   357888888886  446789


Q ss_pred             EeccCC--CCHHHHH
Q 005033          158 YEYMPN--KSLQEML  170 (718)
Q Consensus       158 mEy~~g--GsL~~~L  170 (718)
                      |||+++  ..|.+.+
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            999976  3455443

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.47  E-value=0.15  Score=56.66  Aligned_cols=79  Identities=16%  Similarity=0.178  Sum_probs=49.5

Q ss_pred             eecccCceEEEEEEEcCC-cEEEEEEccc-------CChhhHHHHHHHHHHHhCCC--CC-cceeEEEEEeeCCeEEEEE
Q 005033           90 VIGKGGSGTVFLGIARDG-KLLAIKRLDT-------FSLQTEREFQNELQILGGLR--SP-FLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        90 ~LG~G~FG~Vykg~~~~g-~~VAVK~i~~-------~~~~~~~~f~~Ei~iL~~L~--Hp-NIV~L~g~~~~~~~~~LVm  158 (718)
                      .||.|....||++...+| +.|+||.-..       .-.-...+..-|.+.|....  -| .+.+++.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            579999999999998654 6899997521       11222344556777776553  24 45555443  455567999


Q ss_pred             eccCCC-CHHHHH
Q 005033          159 EYMPNK-SLQEML  170 (718)
Q Consensus       159 Ey~~gG-sL~~~L  170 (718)
                      |+++.. .|.+.|
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            998543 344444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.10  E-value=0.12  Score=55.70  Aligned_cols=139  Identities=19%  Similarity=0.234  Sum_probs=72.6

Q ss_pred             ccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCC---CCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           87 EANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLR---SPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        87 ~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      ..+.|+-|....+|+.. .+++.+.||+-..   .....|..|.+-|+.|.   --.+.+.+++....+..||||||++.
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            45678889999999977 5678899997652   23346778888777773   45577888888877788999999876


Q ss_pred             C--C------HHHH---Hhh-CC--C-----------------CCCCHHHHH-----HH--------------HHHHHHH
Q 005033          164 K--S------LQEM---LFS-DG--N-----------------LVLKWSQRF-----EI--------------IMDVAKA  193 (718)
Q Consensus       164 G--s------L~~~---L~~-~~--~-----------------~~l~~~~~~-----~I--------------a~qIa~g  193 (718)
                      +  +      |...   |+. ..  .                 -.-+|....     ..              +.++...
T Consensus        97 ~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~  176 (288)
T PF03881_consen   97 GSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVER  176 (288)
T ss_dssp             ----CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHH
Confidence            6  1      1111   122 10  0                 112333211     11              1112222


Q ss_pred             HHH-Hh-cCCCCCeEecCCCCCCEEECCCCCEEEeecc
Q 005033          194 LEF-LH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG  229 (718)
Q Consensus       194 L~y-LH-~~~~~gIVHRDLKP~NILLd~~~~vKLsDFG  229 (718)
                      +.. |+ ....+.++|+||-+.|++.+.+|.+.|.|=.
T Consensus       177 ~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa  214 (288)
T PF03881_consen  177 LPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA  214 (288)
T ss_dssp             HHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred             HHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence            221 22 1125679999999999999999989998754

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.42  E-value=0.15  Score=53.10  Aligned_cols=102  Identities=18%  Similarity=0.176  Sum_probs=66.4

Q ss_pred             EEEEEEcccCChh-hHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHH
Q 005033          109 LLAIKRLDTFSLQ-TEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEII  187 (718)
Q Consensus       109 ~VAVK~i~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia  187 (718)
                      ...+|++...... ...-|.++..++.+++  .|++|..-  ..-..-+++|+|-...           ..    ...++
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-----------i~----~~N~i  147 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-----------IN----FSNFI  147 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-----------cc----hhHHH
Confidence            3456666544433 3456788888888876  47777622  2224558899983110           01    11122


Q ss_pred             HHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccC
Q 005033          188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL  230 (718)
Q Consensus       188 ~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGL  230 (718)
                      ..=+.+|.-.|.+ ..+.+|+|..|+|||-|..|.+||.|=+.
T Consensus       148 ~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  148 TAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence            2224667777843 67899999999999999999999999764

The function of this family is unknown.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=94.37  E-value=0.75  Score=49.54  Aligned_cols=32  Identities=22%  Similarity=0.385  Sum_probs=29.1

Q ss_pred             CCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       202 ~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ..+++|+|+.+.|||++.++.+-|+||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45899999999999999999999999988775

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=94.34  E-value=0.23  Score=55.29  Aligned_cols=138  Identities=20%  Similarity=0.187  Sum_probs=88.7

Q ss_pred             ccceecccCceEEEEEEEcCCcEEEEEEcccC---------------------Ch----hhHH-HHHHHHHHHhCCCCCc
Q 005033           87 EANVIGKGGSGTVFLGIARDGKLLAIKRLDTF---------------------SL----QTER-EFQNELQILGGLRSPF  140 (718)
Q Consensus        87 ~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~---------------------~~----~~~~-~f~~Ei~iL~~L~HpN  140 (718)
                      +..+|..|--+.||.++..+|..+|||+.+..                     ..    ...+ ....|+.-|.+|+.-.
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            44678889999999999999999999987321                     00    0001 1234666677665433


Q ss_pred             ceeEEEEEeeCCeEEEEEeccCCCCHH--HHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEC
Q 005033          141 LVTLLGYCMERNKRILVYEYMPNKSLQ--EMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD  218 (718)
Q Consensus       141 IV~L~g~~~~~~~~~LVmEy~~gGsL~--~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd  218 (718)
                      |..---...  ....|||+|+. ++=.  -.|+.   ..++...+..+-.|++.-|.-|-.  ..++||.||.-=|+|+ 
T Consensus       228 IP~PePIlL--k~hVLVM~FlG-rdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Ly-  298 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLG-RDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLY-  298 (520)
T ss_pred             CCCCCceee--ecceEeeeecc-CCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheE-
Confidence            321110110  12369999994 3221  11221   245666677777888888877764  4589999999999998 


Q ss_pred             CCCCEEEeeccCcee
Q 005033          219 SDCRGKVSDFGLSRI  233 (718)
Q Consensus       219 ~~~~vKLsDFGLAr~  233 (718)
                      .+|.+.|+|-+-+--
T Consensus       299 hdG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  299 HDGKLYIIDVSQSVE  313 (520)
T ss_pred             ECCEEEEEEcccccc
Confidence            567899999886654

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=94.13  E-value=0.0068  Score=76.05  Aligned_cols=108  Identities=10%  Similarity=-0.033  Sum_probs=73.6

Q ss_pred             HHHHHHHHhCCCCCcceeEEEEEee--CCeEEEEEeccCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHhc--
Q 005033          126 FQNELQILGGLRSPFLVTLLGYCME--RNKRILVYEYMPNKSLQEMLFSDGN--LVLKWSQRFEIIMDVAKALEFLHF--  199 (718)
Q Consensus       126 f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LVmEy~~gGsL~~~L~~~~~--~~l~~~~~~~Ia~qIa~gL~yLH~--  199 (718)
                      ...|...++...|+++...+.-...  ....|.+++|+.+|++.+.|-+.-.  ..++..-+.....+.+.+..-+|.  
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            4455556667789988776554432  2356899999999999999865432  223322223233333555555552  


Q ss_pred             CCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       200 ~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ....-.+|++||+-|.+|..+..++++++|+.++
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKI 1389 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKI 1389 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccc
Confidence            2244578999999999999999999999999985

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=93.95  E-value=0.35  Score=52.89  Aligned_cols=141  Identities=13%  Similarity=0.183  Sum_probs=76.0

Q ss_pred             ceecccCceEEEEEEEcC----CcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcc-eeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIARD----GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFL-VTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~----g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.|..|=-..+|+....+    +..|.+++........ -.-.+|..++..+..-++ .++++++. .+   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            344446666788876543    2378888765432211 122467888877754444 45566653 22   58899877


Q ss_pred             CCHHH-------HH----------hhCC---CC-CCCHHHHHHHHHHH----------------------HHHHH----H
Q 005033          164 KSLQE-------ML----------FSDG---NL-VLKWSQRFEIIMDV----------------------AKALE----F  196 (718)
Q Consensus       164 GsL~~-------~L----------~~~~---~~-~l~~~~~~~Ia~qI----------------------a~gL~----y  196 (718)
                      ..|..       .+          +...   .. .--+..+..+..++                      ..-+.    +
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            65522       11          1111   00 11122222222111                      11111    1


Q ss_pred             Hhc-CCCCCeEecCCCCCCEEECC-CCCEEEeeccCceee
Q 005033          197 LHF-GCDPPVIHGDIKPSNVLLDS-DCRGKVSDFGLSRIK  234 (718)
Q Consensus       197 LH~-~~~~gIVHRDLKP~NILLd~-~~~vKLsDFGLAr~~  234 (718)
                      +.. ....-++|.|+.+.|||+++ ++.++++||..|...
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence            110 11234789999999999975 578999999988763

>PRK11768 serine/threonine protein kinase; Provisional

Probab=93.07  E-value=4.6  Score=44.01  Aligned_cols=71  Identities=13%  Similarity=0.091  Sum_probs=42.2

Q ss_pred             cCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCC--ccee---EEE--EEeeCCeEEEEEeccCCCC
Q 005033           94 GGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSP--FLVT---LLG--YCMERNKRILVYEYMPNKS  165 (718)
Q Consensus        94 G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~Hp--NIV~---L~g--~~~~~~~~~LVmEy~~gGs  165 (718)
                      +.-..||+....+|..+++|+.+... .....+..|++.+..|...  .++.   .-|  ....++..+.++++++|..
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            34567999888778889999875322 2334556676666555211  1222   111  1223456788999997764

>PRK12396 5-methylribose kinase; Reviewed

Probab=93.02  E-value=0.44  Score=53.76  Aligned_cols=81  Identities=16%  Similarity=0.174  Sum_probs=51.3

Q ss_pred             cceecccCceEEEEEEEcC-CcEEEEEEccc------CChhhHHHHHHHHHHHhCCC--CC-cceeEEEEEeeCCeEEEE
Q 005033           88 ANVIGKGGSGTVFLGIARD-GKLLAIKRLDT------FSLQTEREFQNELQILGGLR--SP-FLVTLLGYCMERNKRILV  157 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~-g~~VAVK~i~~------~~~~~~~~f~~Ei~iL~~L~--Hp-NIV~L~g~~~~~~~~~LV  157 (718)
                      .+.||.|.-..||++.+.+ +..|+||.-..      .-.-...+..-|.+.|+.+.  -| .+.+++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4678999999999999853 56899996521      11223345666777777553  24 45556544  44456789


Q ss_pred             EeccCCC-CHHHHH
Q 005033          158 YEYMPNK-SLQEML  170 (718)
Q Consensus       158 mEy~~gG-sL~~~L  170 (718)
                      ||+++.. .|.+.|
T Consensus       112 MEdL~~~~ilR~~L  125 (409)
T PRK12396        112 MEDLSDHTILRTAL  125 (409)
T ss_pred             HHhCcccHHHHHHH
Confidence            9998542 344443

>PRK06148 hypothetical protein; Provisional

Probab=92.86  E-value=0.92  Score=57.09  Aligned_cols=141  Identities=23%  Similarity=0.264  Sum_probs=77.4

Q ss_pred             ceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCC-------CCCcceeEE-E----EEee-CC--e
Q 005033           89 NVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGL-------RSPFLVTLL-G----YCME-RN--K  153 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-------~HpNIV~L~-g----~~~~-~~--~  153 (718)
                      +.|+ |..-.+|+....+|..+++|+.+.....  .....|..+|..|       .-|.+++-. |    .... .+  .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            4564 4567789888777889999998754322  2233344444333       233433321 1    1111 22  4


Q ss_pred             EEEEEeccCCCCHHHH-------H----------hh----CC----CCCCCHHH-----------------HHHHHHHHH
Q 005033          154 RILVYEYMPNKSLQEM-------L----------FS----DG----NLVLKWSQ-----------------RFEIIMDVA  191 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~-------L----------~~----~~----~~~l~~~~-----------------~~~Ia~qIa  191 (718)
                      .+-+++|++|..|.+.       +          +.    ..    ...+.|..                 ...++.++.
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            5778999998877651       1          00    00    01122211                 112222222


Q ss_pred             HHHH-----HHhcCCCCCeEecCCCCCCEEECCCC--CEE-EeeccCcee
Q 005033          192 KALE-----FLHFGCDPPVIHGDIKPSNVLLDSDC--RGK-VSDFGLSRI  233 (718)
Q Consensus       192 ~gL~-----yLH~~~~~gIVHRDLKP~NILLd~~~--~vK-LsDFGLAr~  233 (718)
                      ....     .+. .....+||.|+.+.|||++.++  .+. |+|||-+..
T Consensus       188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            2221     121 2356899999999999998875  454 999998764

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=92.57  E-value=0.32  Score=54.07  Aligned_cols=73  Identities=18%  Similarity=0.263  Sum_probs=56.4

Q ss_pred             CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCc
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS  231 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLA  231 (718)
                      ...|++|++. |++|.-.-      .-.+.+...++.+.+.-+.-+..  .-..=|||+.-.||||+ +|++.|+||-++
T Consensus       299 ~y~yl~~kdh-gt~is~ik------~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         299 LYLYLHFKDH-GTPISIIK------ADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             eEEEEEEecC-Cceeeeee------cccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeee
Confidence            3568888887 66664221      24677888888887776666652  55788999999999999 999999999999


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      |..
T Consensus       369 Rl~  371 (488)
T COG5072         369 RLS  371 (488)
T ss_pred             ecc
Confidence            964

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=92.42  E-value=0.8  Score=50.44  Aligned_cols=140  Identities=26%  Similarity=0.348  Sum_probs=79.4

Q ss_pred             eecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCC---Cc---ceeEEEE----EeeCCeEEEEEe
Q 005033           90 VIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRS---PF---LVTLLGY----CMERNKRILVYE  159 (718)
Q Consensus        90 ~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~H---pN---IV~L~g~----~~~~~~~~LVmE  159 (718)
                      .|.+ .-..||+....+|.. ++|+.+..  ....+..-|+..|..|.-   +-   |..+=|-    ...+...+-+++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            3444 456789988877776 88887664  233445556666655521   11   2222221    111236788999


Q ss_pred             ccCCCCHHH-----HH----------hh----CC-----C-CCCCHHH----H---------HHHHHHHHHHHHHHhcC-
Q 005033          160 YMPNKSLQE-----ML----------FS----DG-----N-LVLKWSQ----R---------FEIIMDVAKALEFLHFG-  200 (718)
Q Consensus       160 y~~gGsL~~-----~L----------~~----~~-----~-~~l~~~~----~---------~~Ia~qIa~gL~yLH~~-  200 (718)
                      |++|..+..     .+          +.    ..     . ....|..    .         .....++...+..+... 
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999887772     11          10    00     0 1222320    0         01233444444444421 


Q ss_pred             ---CCC-C--eEecCCCCCCEEECCCCC-EEEeeccCcee
Q 005033          201 ---CDP-P--VIHGDIKPSNVLLDSDCR-GKVSDFGLSRI  233 (718)
Q Consensus       201 ---~~~-g--IVHRDLKP~NILLd~~~~-vKLsDFGLAr~  233 (718)
                         ... +  +||+|+.|.||+++.+.. +.+.|||-+..
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence               122 3  999999999999998885 88999998765

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=91.95  E-value=0.069  Score=63.92  Aligned_cols=71  Identities=14%  Similarity=-0.069  Sum_probs=52.5

Q ss_pred             hcccccccccccccccCCCCCcccccccccccCCCCCCCCCccCcccccccccccccccCccccCccccCC-CCCccccc
Q 005033          517 FHFHRRNKFREQNQDDCDANGEFSFRRGWRKKNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGC-GYLMEKAD  595 (718)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~~~k~D  595 (718)
                      -++|++.++.+++++.                +..++++|||+++.............||+.|+|||.... ..-...++
T Consensus       124 gIiHrDLKP~NILl~~----------------~g~vkL~DFGls~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~s~  187 (669)
T cd05610         124 GIIHRDLKPDNMLISN----------------EGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYSRTPGQVLSL  187 (669)
T ss_pred             CEEeCCccHHHEEEcC----------------CCCEEEEeCCCCccccCCcccccccccCccccCccccccCCCCceeee
Confidence            4688888888877754                236889999999887765445567889999999995433 34446788


Q ss_pred             ccchhhhH
Q 005033          596 IYSLGVLI  603 (718)
Q Consensus       596 v~S~Gv~l  603 (718)
                      +||+|+-.
T Consensus       188 ~~s~g~~~  195 (669)
T cd05610         188 ISSLGFNT  195 (669)
T ss_pred             eeecCcCC
Confidence            89988654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=91.76  E-value=0.82  Score=48.51  Aligned_cols=33  Identities=30%  Similarity=0.374  Sum_probs=27.0

Q ss_pred             CCCeEecCCCCCCEEECCC--C---CEEEeeccCceee
Q 005033          202 DPPVIHGDIKPSNVLLDSD--C---RGKVSDFGLSRIK  234 (718)
Q Consensus       202 ~~gIVHRDLKP~NILLd~~--~---~vKLsDFGLAr~~  234 (718)
                      ..-++|+|+++.|||+..+  |   .+++.||-+++..
T Consensus       214 ~~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~g  251 (294)
T PF02958_consen  214 FNVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARYG  251 (294)
T ss_pred             ceEEEcCccCHHhEeEccccccccccceeeccccccCC
Confidence            3468999999999999665  3   5899999988763

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=90.31  E-value=0.77  Score=51.87  Aligned_cols=61  Identities=20%  Similarity=0.150  Sum_probs=42.5

Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS  219 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~  219 (718)
                      ..|+-+|+.|-++..++....   .++.....++.-.+.||.-+-.  --+++|.|+.|.||++.-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEe
Confidence            357778999999999997664   3444455555555556543331  457999999999999943

>PTZ00384 choline kinase; Provisional

Probab=88.69  E-value=2.5  Score=47.53  Aligned_cols=74  Identities=15%  Similarity=0.240  Sum_probs=42.9

Q ss_pred             ceecccCceEEEEEEEcCC--cE-----EEEEEcccCChhhHHHHHHHHHHHhCCCCCcc-eeEEEEEeeCCeEEEEEec
Q 005033           89 NVIGKGGSGTVFLGIARDG--KL-----LAIKRLDTFSLQTEREFQNELQILGGLRSPFL-VTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~g--~~-----VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LVmEy  160 (718)
                      +.|..|-...+|++...++  ..     |.+........... .-.+|+.+++.+...++ .++++.+..    ++|.||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            4555577888999876432  22     44443211111111 12468888888865444 455666642    599999


Q ss_pred             cCCCCHH
Q 005033          161 MPNKSLQ  167 (718)
Q Consensus       161 ~~gGsL~  167 (718)
                      ++|..|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9887664

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	718
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-28
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-14
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-28
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-14
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-26
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-09
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-26
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-09
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-22
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-22
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-22
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-14
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		8e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		9e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-08
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-08
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-08
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-08
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-08
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-08
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-08
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-08
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-08
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-08
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-08
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-08
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-08
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-08
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		7e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		7e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-08
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		7e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		8e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-08
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-08
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		9e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		9e-08
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-07
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-07
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-07
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-07
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-07
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-07
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-07
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-07
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-07
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-07
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-07
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-07
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-07
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-07
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-07
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-07
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-07
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-07
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-07
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-07
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-07
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-07
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-07
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-07
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-07
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-07
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-07
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-07
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		9e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		9e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		9e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-06
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-06
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-06
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-06
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-06
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-06
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-06
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-06
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-06
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-06
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-06
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-06
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-06
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-06
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-06
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-06
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-06
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-06
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-06
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-06
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-06
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-06
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-06
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-06
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-06
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-06
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-06
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-06
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-06
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-06
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-06
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-06
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-06
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-06
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-06
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-06
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-06
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-06
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-06
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-06
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-06
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-06
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-06
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-06
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-06
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-06
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		8e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-06
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		8e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		8e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-06
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-06
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		9e-06
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		9e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-05
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-05
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-05
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-05
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-05
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-05
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-05
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-05
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-05
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-05
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-05
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-05
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-05
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-05
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-05
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-05
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-05
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-05
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-05
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-05
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-05
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-05
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-05
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-05
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-05
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-05
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-05
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-05
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-05
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-05
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-05
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-05
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-05
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-05
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-05
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-05
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-05
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-05
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-05
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-05
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		9e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-04
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-04
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-04
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-04
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-04
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-04
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-04
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-04
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-04
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-04
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-04
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-04
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-04
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-04
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-04
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-04
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-04
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-04
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		5e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		6e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		6e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		6e-04
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		7e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		9e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  123 bits (308), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 64/168 (38%), Positives = 101/168 (60%), Gaps = 3/168 (1%)
Query: 69  KLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQT-EREFQ 127
           +L+RF+ +EL+ A+++F   N++G+GG G V+ G   DG L+A+KRL     Q  E +FQ
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 128 NELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS--DGNLVLKWSQRFE 185
            E++++       L+ L G+CM   +R+LVY YM N S+   L    +    L W +R  
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 186 IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           I +  A+ L +LH  CDP +IH D+K +N+LLD +    V DFGL+++
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 191

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 67/117 (57%), Gaps = 1/117 (0%)
Query: 572 SMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWC 631
           ++RGT+ ++APEY   G   EK D++  GV++L +++G+R    LA     +   L+ W 
Sbjct: 202 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD-LARLANDDDVMLLDWV 260
Query: 632 RHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKGE 688
           + L +   +  LVD  L+ +Y  E+    I +AL C Q +P  RP + E VR+L+G+
Sbjct: 261 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  122 bits (307), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 64/168 (38%), Positives = 101/168 (60%), Gaps = 3/168 (1%)
Query: 69  KLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQT-EREFQ 127
           +L+RF+ +EL+ A+++F   N++G+GG G V+ G   DG L+A+KRL     Q  E +FQ
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 128 NELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS--DGNLVLKWSQRFE 185
            E++++       L+ L G+CM   +R+LVY YM N S+   L    +    L W +R  
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 186 IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           I +  A+ L +LH  CDP +IH D+K +N+LLD +    V DFGL+++
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 66/117 (56%), Gaps = 1/117 (0%)
Query: 572 SMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWC 631
           ++RG + ++APEY   G   EK D++  GV++L +++G+R    LA     +   L+ W 
Sbjct: 194 AVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD-LARLANDDDVMLLDWV 252
Query: 632 RHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKGE 688
           + L +   +  LVD  L+ +Y  E+    I +AL C Q +P  RP + E VR+L+G+
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 69/181 (38%), Positives = 106/181 (58%), Gaps = 11/181 (6%)
Query: 54  VNRSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIK 113
           ++ S  +PF+S       R    +L+ ATN+FD   +IG G  G V+ G+ RDG  +A+K
Sbjct: 16  LSSSYLVPFES------YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK 69
Query: 114 RLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD 173
           R    S Q   EF+ E++ L   R P LV+L+G+C ERN+ IL+Y+YM N +L+  L+  
Sbjct: 70  RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129
Query: 174 G--NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
               + + W QR EI +  A+ L +LH      +IH D+K  N+LLD +   K++DFG+S
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGIS 186
Query: 232 R 232
           +
Sbjct: 187 K 187

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 54/110 (49%), Gaps = 3/110 (2%)
Query: 573 MRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCR 632
           ++GTL Y+ PEY   G L EK+D+YS GV++  ++  R     +   +  E  NL  W  
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS---AIVQSLPREMVNLAEWAV 257
Query: 633 HLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETV 682
                G + ++VD  L D    E      + A+ CL  + E RP +G+ +
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 69/181 (38%), Positives = 106/181 (58%), Gaps = 11/181 (6%)
Query: 54  VNRSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIK 113
           ++ S  +PF+S       R    +L+ ATN+FD   +IG G  G V+ G+ RDG  +A+K
Sbjct: 16  LSSSYLVPFES------YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK 69
Query: 114 RLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD 173
           R    S Q   EF+ E++ L   R P LV+L+G+C ERN+ IL+Y+YM N +L+  L+  
Sbjct: 70  RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129
Query: 174 G--NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
               + + W QR EI +  A+ L +LH      +IH D+K  N+LLD +   K++DFG+S
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGIS 186
Query: 232 R 232
           +
Sbjct: 187 K 187

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 54/110 (49%), Gaps = 3/110 (2%)
Query: 573 MRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLISWCR 632
           ++GTL Y+ PEY   G L EK+D+YS GV++  ++  R     +   +  E  NL  W  
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS---AIVQSLPREMVNLAEWAV 257
Query: 633 HLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETV 682
                G + ++VD  L D    E      + A+ CL  + E RP +G+ +
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 64/175 (36%), Positives = 96/175 (54%), Gaps = 15/175 (8%)
Query: 69  KLQRFTYKELKNATNDFDE------ANVIGKGGSGTVFLGIARDGKLLAIKRL----DTF 118
           +   F++ ELKN TN+FDE       N +G+GG G V+ G   +   +A+K+L    D  
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDIT 69
Query: 119 SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLV 177
           + + +++F  E++++   +   LV LLG+  + +   LVY YMPN SL + L   DG   
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 178 LKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           L W  R +I    A  + FLH   +   IH DIK +N+LLD     K+SDFGL+R
Sbjct: 130 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR 181

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 64/175 (36%), Positives = 96/175 (54%), Gaps = 15/175 (8%)
Query: 69  KLQRFTYKELKNATNDFDE------ANVIGKGGSGTVFLGIARDGKLLAIKRL----DTF 118
           +   F++ ELKN TN+FDE       N +G+GG G V+ G   +   +A+K+L    D  
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDIT 69
Query: 119 SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLV 177
           + + +++F  E++++   +   LV LLG+  + +   LVY YMPN SL + L   DG   
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 178 LKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           L W  R +I    A  + FLH   +   IH DIK +N+LLD     K+SDFGL+R
Sbjct: 130 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR 181

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 64/175 (36%), Positives = 96/175 (54%), Gaps = 15/175 (8%)
Query: 69  KLQRFTYKELKNATNDFDE------ANVIGKGGSGTVFLGIARDGKLLAIKRL----DTF 118
           +   F++ ELKN TN+FDE       N +G+GG G V+ G   +   +A+K+L    D  
Sbjct: 5   RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDIT 63
Query: 119 SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLV 177
           + + +++F  E++++   +   LV LLG+  + +   LVY YMPN SL + L   DG   
Sbjct: 64  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 123
Query: 178 LKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           L W  R +I    A  + FLH   +   IH DIK +N+LLD     K+SDFGL+R
Sbjct: 124 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR 175

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 63/175 (36%), Positives = 93/175 (53%), Gaps = 15/175 (8%)
Query: 69  KLQRFTYKELKNATNDFDE------ANVIGKGGSGTVFLGIARDGKLLAIKRL----DTF 118
           +   F++ ELKN TN+FDE       N  G+GG G V+ G   +   +A+K+L    D  
Sbjct: 2   RFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDIT 60
Query: 119 SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLV 177
           + + +++F  E+++    +   LV LLG+  + +   LVY Y PN SL + L   DG   
Sbjct: 61  TEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP 120
Query: 178 LKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           L W  R +I    A  + FLH   +   IH DIK +N+LLD     K+SDFGL+R
Sbjct: 121 LSWHXRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR 172

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 90/174 (51%), Gaps = 17/174 (9%)
Query: 81  ATNDFDEANVIGKGGSGTVFLG-IARDGKLLAIKRL-------DTFSLQTEREFQNELQI 132
           A N+ +    IGKGG G V  G + +D  ++AIK L       +T  ++  +EFQ E+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           +  L  P +V L  Y +  N   +V E++P   L   L    + + KWS +  +++D+A 
Sbjct: 77  MSNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPI-KWSVKLRLMLDIAL 133
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDS-----DCRGKVSDFGLSRIKVEGEFGM 241
            +E++    +PP++H D++  N+ L S         KV+DFGLS+  V    G+
Sbjct: 134 GIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL 186

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/154 (35%), Positives = 76/154 (49%), Gaps = 5/154 (3%)
Query: 84  DFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTER--EFQNELQILGGLRSPFL 141
           D +    IG G  GTV       G  +A+K L       ER  EF  E+ I+  LR P +
Sbjct: 38  DLNIKEKIGAGSFGTVHRA-EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNL-VLKWSQRFEIIMDVAKALEFLHFG 200
           V  +G   +     +V EY+   SL  +L   G    L   +R  +  DVAK + +LH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
            +PP++H D+K  N+L+D     KV DFGLSR+K
Sbjct: 156 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK 189

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 89/174 (51%), Gaps = 17/174 (9%)
Query: 81  ATNDFDEANVIGKGGSGTVFLG-IARDGKLLAIKRL-------DTFSLQTEREFQNELQI 132
           A N+ +    IGKGG G V  G + +D  ++AIK L       +T  ++  +EFQ E+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           +  L  P +V L  Y +  N   +V E++P   L   L    + + KWS +  +++D+A 
Sbjct: 77  MSNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPI-KWSVKLRLMLDIAL 133
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDS-----DCRGKVSDFGLSRIKVEGEFGM 241
            +E++    +PP++H D++  N+ L S         KV+DFG S+  V    G+
Sbjct: 134 GIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGL 186

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 89/174 (51%), Gaps = 17/174 (9%)
Query: 81  ATNDFDEANVIGKGGSGTVFLG-IARDGKLLAIKRL-------DTFSLQTEREFQNELQI 132
           A N+ +    IGKGG G V  G + +D  ++AIK L       +T  ++  +EFQ E+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           +  L  P +V L  Y +  N   +V E++P   L   L    + + KWS +  +++D+A 
Sbjct: 77  MSNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPI-KWSVKLRLMLDIAL 133
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDS-----DCRGKVSDFGLSRIKVEGEFGM 241
            +E++    +PP++H D++  N+ L S         KV+DF LS+  V    G+
Sbjct: 134 GIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGL 186

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 76/155 (49%), Gaps = 5/155 (3%)
Query: 84  DFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTER--EFQNELQILGGLRSPFL 141
           D +    IG G  GTV       G  +A+K L       ER  EF  E+ I+  LR P +
Sbjct: 38  DLNIKEKIGAGSFGTVHRA-EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNL-VLKWSQRFEIIMDVAKALEFLHFG 200
           V  +G   +     +V EY+   SL  +L   G    L   +R  +  DVAK + +LH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKV 235
            +PP++H ++K  N+L+D     KV DFGLSR+K 
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 78/156 (50%), Gaps = 17/156 (10%)
Query: 84  DFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGLRSP 139
           DFD    +GKG  G V+L   R  K +LA+K L    L+    E + + E++I   LR P
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 140 FLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALE 195
            ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A AL 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY------ITELANALS 126
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           + H      VIH DIKP N+LL S+   K++DFG S
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSNGELKIADFGWS 159

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 78/156 (50%), Gaps = 17/156 (10%)
Query: 84  DFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGLRSP 139
           DFD    +GKG  G V+L   R  K +LA+K L    L+    E + + E++I   LR P
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 140 FLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALE 195
            ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A AL 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY------ITELANALS 126
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           + H      VIH DIKP N+LL S+   K++DFG S
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSNGELKIADFGWS 159

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPN----KSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     K LQ++   D      +      I ++A 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY------ITELAN 124
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPN----KSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     K LQ++   D      +      I ++A 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY------ITELAN 124
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 136
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 137 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 172

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 79/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   ++ K +LA+K L    L+    E + + E++I   L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 120 ALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 145
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 146 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 124
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 121
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 157

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 145
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 146 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 120
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 124
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 120
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 120
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILG 134
           K   +DFD    +GKG  G V+L   +  K ++A+K L    L+    E + + E++I  
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
            LR P ++ +  Y  +R +  L+ E+ P   L + L   G    + S  F  + ++A AL
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF--MEELADAL 127
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            + H   +  VIH DIKP N+L+      K++DFG S
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS 161

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 124
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILG 134
           K   +DFD    +GKG  G V+L   +  K ++A+K L    L+    E + + E++I  
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
            LR P ++ +  Y  +R +  L+ E+ P   L + L   G    + S  F  + ++A AL
Sbjct: 71  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF--MEELADAL 128
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            + H   +  VIH DIKP N+L+      K++DFG S
Sbjct: 129 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS 162

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 118
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 119 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 154

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 81/168 (48%), Gaps = 20/168 (11%)
Query: 83  NDFDEANVIGKGGSGTVFLG-IARDGKLL--AIKRLDTFSLQTE-REFQNELQILGGL-R 137
           ND    +VIG+G  G V    I +DG  +  AIKR+  ++ + + R+F  EL++L  L  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL--- 194
            P ++ LLG C  R    L  EY P+ +L + L    + VL+    F I    A  L   
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK--SRVLETDPAFAIANSTASTLSSQ 142
Query: 195 EFLHFGCD----------PPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LHF  D             IH D+   N+L+  +   K++DFGLSR
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 81/168 (48%), Gaps = 20/168 (11%)
Query: 83  NDFDEANVIGKGGSGTVFLG-IARDGKLL--AIKRLDTFSLQTE-REFQNELQILGGL-R 137
           ND    +VIG+G  G V    I +DG  +  AIKR+  ++ + + R+F  EL++L  L  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL--- 194
            P ++ LLG C  R    L  EY P+ +L + L    + VL+    F I    A  L   
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK--SRVLETDPAFAIANSTASTLSSQ 132
Query: 195 EFLHFGCD----------PPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LHF  D             IH D+   N+L+  +   K++DFGLSR
Sbjct: 133 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 123
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 159

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 116
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K++DFG S
Sbjct: 117 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 152

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 121
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K+++FG S
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS 157

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQ---TEREFQNELQILGGL 136
           A  DF+    +GKG  G V+L   +  K +LA+K L    L+    E + + E++I   L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           R P ++ L GY  +  +  L+ EY P     + LQ++   D      +      I ++A 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL + H      VIH DIKP N+LL S    K+++FG S
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS 158

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 86/149 (57%), Gaps = 15/149 (10%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRL-DTF--SLQTEREFQNELQILGGLR-SPFLVTLL 145
           +GKG  G V+  I  R G+++A+K++ D F  S   +R F+ E+ IL  L     +V LL
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 146 GYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
                 N R   LV++YM    L  ++ ++   +L+   +  ++  + K +++LH G   
Sbjct: 76  NVLRADNDRDVYLVFDYMET-DLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG-- 129
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            ++H D+KPSN+LL+++C  KV+DFGLSR
Sbjct: 130 -LLHRDMKPSNILLNAECHVKVADFGLSR 157

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 81/168 (48%), Gaps = 20/168 (11%)
Query: 83  NDFDEANVIGKGGSGTVFLG-IARDGKLL--AIKRLDTFSLQTE-REFQNELQILGGL-R 137
           ND    +VIG+G  G V    I +DG  +  AIKR+  ++ + + R+F  EL++L  L  
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL--- 194
            P ++ LLG C  R    L  EY P+ +L + L    + VL+    F I    A  L   
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK--SRVLETDPAFAIANSTASTLSSQ 139
Query: 195 EFLHFGCD----------PPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LHF  D             IH ++   N+L+  +   K++DFGLSR
Sbjct: 140 QLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  G V LG   +   +AIK +   S+ +E +F  E +++  L  P LV L G C+E
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSM-SEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    LV+E+M +  L + L +   L         + +DV + + +L   C   VIH D+
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 149
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              N L+  +   KVSDFG++R  ++ ++
Sbjct: 150 AARNCLVGENQVIKVSDFGMTRFVLDDQY 178

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 81/172 (47%), Gaps = 15/172 (8%)
Query: 89  NVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
             IGKG  G V LG  R  K+ A+K +   +  T + F  E  ++  LR   LV LLG  
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKV-AVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 149 MERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
           +E    + +V EYM   SL + L S G  VL      +  +DV +A+E+L        +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 312
Query: 208 GDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQE 259
            D+   NVL+  D   KVSDFGL++            +QD GK    W + E
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASS--------TQDTGKLPVKWTAPE 356

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 86/183 (46%), Gaps = 15/183 (8%)
Query: 89  NVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
             IGKG  G V LG  R  K+ A+K +   +  T + F  E  ++  LR   LV LLG  
Sbjct: 18  QTIGKGEFGDVMLGDYRGNKV-AVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 149 MERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
           +E    + +V EYM   SL + L S G  VL      +  +DV +A+E+L        +H
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 131
Query: 208 GDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQELSGNLATA 267
            D+   NVL+  D   KVSDFGL++            +QD GK    W + E     A +
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTKEASS--------TQDTGKLPVKWTAPEALREAAFS 183
Query: 268 TET 270
           T++
Sbjct: 184 TKS 186

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  G V LG   +   +AIK +   ++ +E +F  E +++  L  P LV L G C+E
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    LV+E+M +  L + L +   L         + +DV + + +L   C   VIH D+
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHRDL 132
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              N L+  +   KVSDFG++R  ++ ++
Sbjct: 133 AARNCLVGENQVIKVSDFGMTRFVLDDQY 161

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  G V LG   +   +AIK +   ++ +E +F  E +++  L  P LV L G C+E
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    LV+E+M +  L + L +   L         + +DV + + +L   C   VIH D+
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 129
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              N L+  +   KVSDFG++R  ++ ++
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQY 158

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  G V LG   +   +AIK +   ++ +E +F  E +++  L  P LV L G C+E
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    LV+E+M +  L + L +   L         + +DV + + +L   C   VIH D+
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 127
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              N L+  +   KVSDFG++R  ++ ++
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQY 156

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 73/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V LG  +    +A+K +   S+ +E EF  E Q +  L  P LV   G C +
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
                +V EY+ N  L   L S G   L+ SQ  E+  DV + + FL        IH D+
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDL 130
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              N L+D D   KVSDFG++R  ++ ++
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQY 159

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 81/172 (47%), Gaps = 15/172 (8%)
Query: 89  NVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
             IGKG  G V LG  R  K+ A+K +   +  T + F  E  ++  LR   LV LLG  
Sbjct: 27  QTIGKGEFGDVMLGDYRGNKV-AVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 149 MERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
           +E    + +V EYM   SL + L S G  VL      +  +DV +A+E+L        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140
Query: 208 GDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQE 259
            D+   NVL+  D   KVSDFGL++            +QD GK    W + E
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASS--------TQDTGKLPVKWTAPE 184

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 81/172 (47%), Gaps = 15/172 (8%)
Query: 89  NVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
             IGKG  G V LG  R  K+ A+K +   +  T + F  E  ++  LR   LV LLG  
Sbjct: 12  QTIGKGEFGDVMLGDYRGNKV-AVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 149 MERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
           +E    + +V EYM   SL + L S G  VL      +  +DV +A+E+L        +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 125
Query: 208 GDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQE 259
            D+   NVL+  D   KVSDFGL++            +QD GK    W + E
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASS--------TQDTGKLPVKWTAPE 169

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 26/184 (14%)
Query: 76  KELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREF--------- 126
           KE     ND+     + +G    + L   +D K  A+K+ +   L+ +R+F         
Sbjct: 24  KEKDKYINDYRIIRTLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDKIS 82
Query: 127 --------QNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVL 178
                   +NELQI+  +++ + +T  G     ++  ++YEYM N S+  + F +   VL
Sbjct: 83  IKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI--LKFDEYFFVL 140
Query: 179 KWSQRFEIIMDVAKAL------EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
             +    I + V K +       F +   +  + H D+KPSN+L+D + R K+SDFG S 
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE 200
Query: 233 IKVE 236
             V+
Sbjct: 201 YMVD 204

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 75/149 (50%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  G V LG   +   +AIK +   ++ +E +F  E +++  L  P LV L G C+E
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    LV E+M +  L + L +   L         + +DV + + +L   C   VIH D+
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHRDL 130
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              N L+  +   KVSDFG++R  ++ ++
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQY 159

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 78/155 (50%), Gaps = 5/155 (3%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
           +D     V+GKG  G       R+ G+++ +K L  F  +T+R F  E++++  L  P +
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           +  +G   +  +   + EY+   +L+ ++ S  +    WSQR     D+A  + +LH   
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLH--- 125
Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVE 236
              +IH D+   N L+  +    V+DFGL+R+ V+
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  G V LG   +   +AIK +   ++ +E +F  E +++  L  P LV L G C+E
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    LV+E+M +  L + L +   L         + +DV + + +L    +  VIH D+
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLE---EASVIHRDL 129
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              N L+  +   KVSDFG++R  ++ ++
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQY 158

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 84/175 (48%), Gaps = 20/175 (11%)
Query: 74  TYKELKNATNDFD---EAN------VIGKGGSGTVFLGIAR-DGKL---LAIKRLDT-FS 119
           TY+E   A   F    EA+      +IG G SG V  G  R  G+    +AIK L   ++
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 120 LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLVL 178
            +  R+F +E  I+G    P ++ L G        ++V EYM N SL   L + DG   +
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 179 KWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
              Q   ++  V   + +L    D   +H D+   NVL+DS+   KVSDFGLSR+
Sbjct: 151 M--QLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 84/175 (48%), Gaps = 20/175 (11%)
Query: 74  TYKELKNATNDFD---EAN------VIGKGGSGTVFLGIAR-DGKL---LAIKRLDT-FS 119
           TY+E   A   F    EA+      +IG G SG V  G  R  G+    +AIK L   ++
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 120 LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLVL 178
            +  R+F +E  I+G    P ++ L G        ++V EYM N SL   L + DG   +
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 179 KWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
              Q   ++  V   + +L    D   +H D+   NVL+DS+   KVSDFGLSR+
Sbjct: 151 M--QLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 26/162 (16%)
Query: 91  IGKGGSGTVFLGIA------RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTL 144
           +G+G  G VFL         +D  L+A+K L   S    ++F  E ++L  L+   +V  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 145 LGYCMERNKRILVYEYMPNKSLQE---------MLFSDGN--LVLKWSQRFEIIMDVAKA 193
            G C+E +  I+V+EYM +  L +         +L ++GN    L  SQ   I   +A  
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 194 LEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + +L   HF      +H D+   N L+  +   K+ DFG+SR
Sbjct: 141 MVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSR 176

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 29/165 (17%)
Query: 91  IGKGGSGTVFLG------IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTL 144
           +G+G  G VFL         +D  L+A+K L   +L   ++FQ E ++L  L+   +V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLFSDGN----LV----------LKWSQRFEIIMDV 190
            G C + +  I+V+EYM +  L + L + G     LV          L  SQ   I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 191 AKALEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           A  + +L   HF      +H D+   N L+ ++   K+ DFG+SR
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSR 181

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 21/155 (13%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V L          G L+A+K+L       +R+FQ E+QIL  L S F+V   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 146 G--YCMERNKRILVYEYMPNKSLQEMLFS-----DGNLVLKWSQRFEIIMDVAKALEFLH 198
           G  Y   R    LV EY+P+  L++ L       D + +L +S +      + K +E+L 
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ------ICKGMEYLG 144
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
                  +H D+   N+L++S+   K++DFGL+++
Sbjct: 145 ---SRRCVHRDLAARNILVESEAHVKIADFGLAKL 176

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 21/155 (13%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V L          G L+A+K+L       +R+FQ E+QIL  L S F+V   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 146 G--YCMERNKRILVYEYMPNKSLQEMLFS-----DGNLVLKWSQRFEIIMDVAKALEFLH 198
           G  Y   R    LV EY+P+  L++ L       D + +L +S +      + K +E+L 
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ------ICKGMEYLG 131
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
                  +H D+   N+L++S+   K++DFGL+++
Sbjct: 132 ---SRRCVHRDLAARNILVESEAHVKIADFGLAKL 163

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 21/155 (13%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V L          G L+A+K+L       +R+FQ E+QIL  L S F+V   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 146 G--YCMERNKRILVYEYMPNKSLQEMLFS-----DGNLVLKWSQRFEIIMDVAKALEFLH 198
           G  Y   R    LV EY+P+  L++ L       D + +L +S +      + K +E+L 
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ------ICKGMEYLG 132
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
                  +H D+   N+L++S+   K++DFGL+++
Sbjct: 133 ---SRRCVHRDLAARNILVESEAHVKIADFGLAKL 164

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 6/152 (3%)
Query: 91  IGKGGSGTVFLGIAR-DGKLLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
           IG+G  G VF G  R D  L+A+K   +T     + +F  E +IL     P +V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHG 208
            ++    +V E +        L ++G   L+     +++ D A  +E+L   C    IH 
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESKC---CIHR 237
Query: 209 DIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFG 240
           D+   N L+      K+SDFG+SR + +G + 
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYA 269

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 80/155 (51%), Gaps = 21/155 (13%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V L          G L+A+K+L       +R+FQ E+QIL  L S F+V   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 146 G--YCMERNKRILVYEYMPNKSLQEMLFS-----DGNLVLKWSQRFEIIMDVAKALEFLH 198
           G  Y   R +  LV EY+P+  L++ L       D + +L +S +      + K +E+L 
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ------ICKGMEYLG 128
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
                  +H D+   N+L++S+   K++DFGL+++
Sbjct: 129 ---SRRCVHRDLAARNILVESEAHVKIADFGLAKL 160

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 29/207 (14%)
Query: 64  SNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGI-ARDGKLL----AIKRL-DT 117
             AP + Q    KE      +     V+G G  GTV+ GI   +G+ +    AIK L +T
Sbjct: 24  GTAPNQAQLRILKE-----TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET 78
Query: 118 FSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD---- 173
              +   EF +E  I+  +  P LV LLG C+    + LV + MP+  L E +       
Sbjct: 79  TGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNI 137
Query: 174 -GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
              L+L W       + +AK + +L    +  ++H D+   NVL+ S    K++DFGL+R
Sbjct: 138 GSQLLLNWC------VQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLAR 188
Query: 233 IKVEGEFGMDLFSQDLGKSQELWKSQE 259
           + +EG+     ++ D GK    W + E
Sbjct: 189 L-LEGD--EKEYNADGGKMPIKWMALE 212

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 72/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V  G  R    +AIK +   S+ +E EF  E +++  L    LV L G C +
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    ++ EYM N  L   L  +     +  Q  E+  DV +A+E+L        +H D+
Sbjct: 75  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 130
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              N L++     KVSDFGLSR  ++ E+
Sbjct: 131 AARNCLVNDQGVVKVSDFGLSRYVLDDEY 159

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 91  IGKGGSGTVFLGIAR-DGKLLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
           IG+G  G VF G  R D  L+A+K   +T     + +F  E +IL     P +V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHG 208
            ++    +V E +        L ++G   L+     +++ D A  +E+L   C    IH 
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESKC---CIHR 237
Query: 209 DIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           D+   N L+      K+SDFG+SR + +G
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADG 266

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 72/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V  G  R    +AIK +   S+ +E EF  E +++  L    LV L G C +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    ++ EYM N  L   L  +     +  Q  E+  DV +A+E+L        +H D+
Sbjct: 91  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 146
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              N L++     KVSDFGLSR  ++ E+
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEY 175

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 72/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V  G  R    +AIK +   S+ +E EF  E +++  L    LV L G C +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    ++ EYM N  L   L  +     +  Q  E+  DV +A+E+L        +H D+
Sbjct: 76  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 131
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              N L++     KVSDFGLSR  ++ E+
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYVLDDEY 160

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 72/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V  G  R    +AIK +   S+ +E EF  E +++  L    LV L G C +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    ++ EYM N  L   L  +     +  Q  E+  DV +A+E+L        +H D+
Sbjct: 76  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 131
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              N L++     KVSDFGLSR  ++ E+
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYVLDDEY 160

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 75/156 (48%), Gaps = 9/156 (5%)
Query: 88  ANVIGKGGSGTVFLGIAR-DGKLLAIK---RLDTFSLQTEREFQNELQILGGLRSPFLVT 143
            + +G G  G V +G     G  +A+K   R    SL    + + E+Q L   R P ++ 
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           L       +   +V EY+    L + +  +G L  K S+R  +   +   +++ H     
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRR--LFQQILSGVDYCHRHM-- 136
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
            V+H D+KP NVLLD+    K++DFGLS +  +GEF
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 72/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V  G  R    +AIK +   S+ +E EF  E +++  L    LV L G C +
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    ++ EYM N  L   L  +     +  Q  E+  DV +A+E+L        +H D+
Sbjct: 82  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 137
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              N L++     KVSDFGLSR  ++ E+
Sbjct: 138 AARNCLVNDQGVVKVSDFGLSRYVLDDEY 166

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 72/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V  G  R    +AIK +   S+ +E EF  E +++  L    LV L G C +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    ++ EYM N  L   L  +     +  Q  E+  DV +A+E+L        +H D+
Sbjct: 71  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 126
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              N L++     KVSDFGLSR  ++ E+
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVLDDEY 155

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 29/206 (14%)
Query: 65  NAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGI-ARDGKLL----AIKRL-DTF 118
            AP + Q    KE      +     V+G G  GTV+ GI   +G+ +    AIK L +T 
Sbjct: 2   TAPNQAQLRILKE-----TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT 56
Query: 119 SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD----- 173
             +   EF +E  I+  +  P LV LLG C+    + LV + MP+  L E +        
Sbjct: 57  GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIG 115
Query: 174 GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             L+L W       + +AK + +L    +  ++H D+   NVL+ S    K++DFGL+R+
Sbjct: 116 SQLLLNWC------VQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARL 166
Query: 234 KVEGEFGMDLFSQDLGKSQELWKSQE 259
            +EG+     ++ D GK    W + E
Sbjct: 167 -LEGD--EKEYNADGGKMPIKWMALE 189

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 93/170 (54%), Gaps = 32/170 (18%)
Query: 80  NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF-----SLQTEREFQNELQIL 133
           N ++DF   +++G+G  G V     +  G+++AIK+++ F     +L+T RE    ++IL
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE----IKIL 63
Query: 134 GGLRSPFLVTLLGYCMER-------NKRILVYEYMP---NKSLQEMLFSDGNLVLKWSQR 183
              +   ++T+    ++R       N+  ++ E M    ++ +   + SD ++     Q 
Sbjct: 64  KHFKHENIITIFN--IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI-----QY 116
Query: 184 FEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           F  I    +A++ LH G +  VIH D+KPSN+L++S+C  KV DFGL+RI
Sbjct: 117 F--IYQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARI 161

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 93/170 (54%), Gaps = 32/170 (18%)
Query: 80  NATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTF-----SLQTEREFQNELQIL 133
           N ++DF   +++G+G  G V     +  G+++AIK+++ F     +L+T RE    ++IL
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE----IKIL 63
Query: 134 GGLRSPFLVTLLGYCMER-------NKRILVYEYMP---NKSLQEMLFSDGNLVLKWSQR 183
              +   ++T+    ++R       N+  ++ E M    ++ +   + SD ++     Q 
Sbjct: 64  KHFKHENIITIFN--IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI-----QY 116
Query: 184 FEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           F  I    +A++ LH G +  VIH D+KPSN+L++S+C  KV DFGL+RI
Sbjct: 117 F--IYQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARI 161

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 93/170 (54%), Gaps = 32/170 (18%)
Query: 80  NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF-----SLQTEREFQNELQIL 133
           N ++DF   +++G+G  G V     +  G+++AIK+++ F     +L+T RE    ++IL
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE----IKIL 63
Query: 134 GGLRSPFLVTLLGYCMER-------NKRILVYEYMP---NKSLQEMLFSDGNLVLKWSQR 183
              +   ++T+    ++R       N+  ++ E M    ++ +   + SD ++     Q 
Sbjct: 64  KHFKHENIITIFN--IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI-----QY 116
Query: 184 FEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           F  I    +A++ LH G +  VIH D+KPSN+L++S+C  KV DFGL+RI
Sbjct: 117 F--IYQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARI 161

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 83/162 (51%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLGI-ARDGK----LLAIKRL-DTFSLQTEREFQNELQILGGL 136
            +  +  V+G G  GTV+ GI   DG+     +AIK L +  S +  +E  +E  ++ G+
Sbjct: 17  TELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 76
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-GNL----VLKWSQRFEIIMDVA 191
            SP++  LLG C+    + LV + MP   L + +  + G L    +L W       M +A
Sbjct: 77  GSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWC------MQIA 129
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ S    K++DFGL+R+
Sbjct: 130 KGMSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARL 168

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 5/152 (3%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
            D    + +G G  G V++G+ +   L +A+K L   +++ E EF  E  ++  ++ P L
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 90
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           V LLG C       +V EYMP  +L + L       +       +   ++ A+E+L    
Sbjct: 91  VQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE--- 147
Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               IH D+   N L+  +   KV+DFGLSR+
Sbjct: 148 KKNFIHRDLAARNCLVGENHVVKVADFGLSRL 179

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 90/191 (47%), Gaps = 25/191 (13%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIARDGKL---LAIKRL-------DTFSLQTEREFQNELQ 131
           ++ ++   ++G GG   V L  ARD +L   +A+K L        +F L+  RE QN   
Sbjct: 11  SDRYELGEILGFGGMSEVHL--ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA-- 66
Query: 132 ILGGLRSPFLVTLLGYCMERNKR----ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEII 187
               L  P +V +               +V EY+   +L++++ ++G +  K +   E+I
Sbjct: 67  --AALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA--IEVI 122
Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQD 247
            D  +AL F H      +IH D+KP+N+++ +    KV DFG++R   +    +   +  
Sbjct: 123 ADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 248 LGKSQELWKSQ 258
           +G +Q L   Q
Sbjct: 180 IGTAQYLSPEQ 190

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 71/148 (47%), Gaps = 5/148 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V  G  R    +AIK +   S+ +E EF  E +++  L    LV L G C +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    ++ EYM N  L   L  +     +  Q  E+  DV +A+E+L        +H D+
Sbjct: 91  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 146
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
              N L++     KVSDFGLSR  ++ E
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 78  LKNATNDFDEANVIGKGGSGTVFLGIARDG-KLLAIKRLDTFSLQTERE---FQNELQIL 133
           L+    D+D   VIG+G  G V L   +   K+ A+K L  F +    +   F  E  I+
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 134 GGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
               SP++V L     +     +V EYMP   L  ++ S+ ++  KW++ +    +V  A
Sbjct: 130 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM-SNYDVPEKWAKFY--TAEVVLA 186
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
           L+ +H      +IH D+KP N+LLD     K++DFG
Sbjct: 187 LDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFG 219

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 21/189 (11%)
Query: 82  TNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIK-------RLDTFSLQTEREFQNELQIL 133
           ++ ++   ++G GG   V L    RD + +A+K       R  +F L+  RE QN     
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA---- 66
Query: 134 GGLRSPFLVTLLGYCMERNKR----ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMD 189
             L  P +V +               +V EY+   +L++++ ++G +  K +   E+I D
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA--IEVIAD 124
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLG 249
             +AL F H      +IH D+KP+N+L+ +    KV DFG++R   +    +   +  +G
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIG 181
Query: 250 KSQELWKSQ 258
            +Q L   Q
Sbjct: 182 TAQYLSPEQ 190

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 76  KELKNATNDFDEANVIGKGGSGTVFLGIARDG-KLLAIKRLDTFSLQTERE---FQNELQ 131
           ++L+    D++   VIG+G  G V L   +   K+ A+K L  F +    +   F  E  
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 132 ILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVA 191
           I+    SP++V L     +     +V EYMP   L  ++ S+ ++  KW++ +    +V 
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFY--TAEVV 183
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
            AL+ +H       IH D+KP N+LLD     K++DFG
Sbjct: 184 LALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG 218

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 75/149 (50%), Gaps = 8/149 (5%)
Query: 85  FDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLD-TFSLQTEREFQNELQILGGLRSPFLV 142
           F +   IGKG  G VF GI  R  K++AIK +D   +     + Q E+ +L    SP++ 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
              G  ++  K  ++ EY+   S  ++L       L  +Q   I+ ++ K L++LH    
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLH---S 137
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              IH DIK +NVLL      K++DFG++
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVA 166

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 75/149 (50%), Gaps = 8/149 (5%)
Query: 85  FDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLD-TFSLQTEREFQNELQILGGLRSPFLV 142
           F +   IGKG  G VF GI  R  K++AIK +D   +     + Q E+ +L    SP++ 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
              G  ++  K  ++ EY+   S  ++L       L  +Q   I+ ++ K L++LH    
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLH---S 122
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              IH DIK +NVLL      K++DFG++
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVA 151

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 76  KELKNATNDFDEANVIGKGGSGTVFLGIARDG-KLLAIKRLDTFSLQTERE---FQNELQ 131
           ++L+    D++   VIG+G  G V L   +   K+ A+K L  F +    +   F  E  
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 132 ILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVA 191
           I+    SP++V L     +     +V EYMP   L  ++ S+ ++  KW++ +    +V 
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFY--TAEVV 178
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
            AL+ +H       IH D+KP N+LLD     K++DFG
Sbjct: 179 LALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG 213

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 75/149 (50%), Gaps = 8/149 (5%)
Query: 85  FDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLD-TFSLQTEREFQNELQILGGLRSPFLV 142
           F +   IGKG  G VF GI  R  K++AIK +D   +     + Q E+ +L    SP++ 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
              G  ++  K  ++ EY+   S  ++L       L  +Q   I+ ++ K L++LH    
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLH---S 122
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              IH DIK +NVLL      K++DFG++
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVA 151

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 86/175 (49%), Gaps = 20/175 (11%)
Query: 73  FTYKELKNATNDFDEA---------NVIGKGGSGTVFLG-IARDGK---LLAIKRLDT-F 118
           FT+++   A  +F +           VIG G  G V  G +   GK    +AIK L + +
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 119 SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLF-SDGNLV 177
           + +  R+F +E  I+G    P ++ L G   +    +++ E+M N SL   L  +DG   
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 178 LKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +   Q   ++  +A  +++L    D   +H D+   N+L++S+   KVSDFGLSR
Sbjct: 134 V--IQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSR 183

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 76  KELKNATNDFDEANVIGKGGSGTVFLGIARDG-KLLAIKRLDTFSLQTERE---FQNELQ 131
           ++L+    D++   VIG+G  G V L   +   K+ A+K L  F +    +   F  E  
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 132 ILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVA 191
           I+    SP++V L     +     +V EYMP   L  ++ S+ ++  KW++ +    +V 
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFY--TAEVV 183
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
            AL+ +H       IH D+KP N+LLD     K++DFG
Sbjct: 184 LALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG 218

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 77/149 (51%), Gaps = 9/149 (6%)
Query: 85  FDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLV 142
           FD    +G+G  G+V+  I ++ G+++AIK++   S LQ   E   E+ I+    SP +V
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ---EIIKEISIMQQCDSPHVV 87
Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
              G   +     +V EY    S+ +++    N  L   +   I+    K LE+LHF   
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDII-RLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              IH DIK  N+LL+++   K++DFG++
Sbjct: 147 ---IHRDIKAGNILLNTEGHAKLADFGVA 172

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 90/191 (47%), Gaps = 25/191 (13%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIARDGKL---LAIK-------RLDTFSLQTEREFQNELQ 131
           ++ ++   ++G GG   V L  ARD +L   +A+K       R  +F L+  RE QN   
Sbjct: 11  SDRYELGEILGFGGMSEVHL--ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA-- 66
Query: 132 ILGGLRSPFLVTLLGYCMERNKR----ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEII 187
               L  P +V +               +V EY+   +L++++ ++G +  K +   E+I
Sbjct: 67  --AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA--IEVI 122
Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQD 247
            D  +AL F H      +IH D+KP+N+++ +    KV DFG++R   +    +   +  
Sbjct: 123 ADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 248 LGKSQELWKSQ 258
           +G +Q L   Q
Sbjct: 180 IGTAQYLSPEQ 190

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 88/189 (46%), Gaps = 21/189 (11%)
Query: 82  TNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIK-------RLDTFSLQTEREFQNELQIL 133
           ++ ++   ++G GG   V L    RD + +A+K       R  +F L+  RE QN     
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA---- 66
Query: 134 GGLRSPFLVTLLGYCMERNKR----ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMD 189
             L  P +V +               +V EY+   +L++++ ++G +  K +   E+I D
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA--IEVIAD 124
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLG 249
             +AL F H      +IH D+KP+N+++ +    KV DFG++R   +    +   +  +G
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 250 KSQELWKSQ 258
            +Q L   Q
Sbjct: 182 TAQYLSPEQ 190

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 88/189 (46%), Gaps = 21/189 (11%)
Query: 82  TNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIK-------RLDTFSLQTEREFQNELQIL 133
           ++ ++   ++G GG   V L    RD + +A+K       R  +F L+  RE QN     
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA---- 66
Query: 134 GGLRSPFLVTLLGYCMERNKR----ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMD 189
             L  P +V +               +V EY+   +L++++ ++G +  K +   E+I D
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA--IEVIAD 124
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLG 249
             +AL F H      +IH D+KP+N+++ +    KV DFG++R   +    +   +  +G
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 250 KSQELWKSQ 258
            +Q L   Q
Sbjct: 182 TAQYLSPEQ 190

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 20/175 (11%)
Query: 74  TYKELKNATNDFDEA---------NVIGKGGSGTVFLG-IARDGKL---LAIKRLDT-FS 119
           TY++   A ++F +           VIG G  G V  G +   GK    +AIK L   ++
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 120 LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLF-SDGNLVL 178
            +  R+F  E  I+G    P ++ L G   +    ++V EYM N SL   L  +DG   +
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV 123
Query: 179 KWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
              Q   ++  ++  +++L    D   +H D+   N+L++S+   KVSDFGLSR+
Sbjct: 124 --IQLVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 173

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 75/149 (50%), Gaps = 8/149 (5%)
Query: 85  FDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLD-TFSLQTEREFQNELQILGGLRSPFLV 142
           F +   IGKG  G VF GI  R  K++AIK +D   +     + Q E+ +L    SP++ 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
              G  ++  K  ++ EY+   S  ++L       L  +Q   I+ ++ K L++LH    
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLH---S 142
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              IH DIK +NVLL      K++DFG++
Sbjct: 143 EKKIHRDIKAANVLLSEHGEVKLADFGVA 171

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 90/191 (47%), Gaps = 25/191 (13%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIARDGKL---LAIKRL-------DTFSLQTEREFQNELQ 131
           ++ ++   ++G GG   V L  ARD +L   +A+K L        +F L+  RE QN   
Sbjct: 28  SDRYELGEILGFGGMSEVHL--ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA-- 83
Query: 132 ILGGLRSPFLVTLLGYCMERNKR----ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEII 187
               L  P +V +               +V EY+   +L++++ ++G +  K +   E+I
Sbjct: 84  --AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA--IEVI 139
Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQD 247
            D  +AL F H      +IH D+KP+N+++ +    KV DFG++R   +    +   +  
Sbjct: 140 ADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 196
Query: 248 LGKSQELWKSQ 258
           +G +Q L   Q
Sbjct: 197 IGTAQYLSPEQ 207

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 13/184 (7%)
Query: 56  RSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLG-IARDGK---LLA 111
           R+   PF    P +  R   KE+  +    ++  VIG G  G V  G +   GK    +A
Sbjct: 4   RTFVDPFTFEDPNQAVREFAKEIDASCIKIEK--VIGVGEFGEVCSGRLKVPGKREICVA 61
Query: 112 IKRLDT-FSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEML 170
           IK L   ++ +  R+F +E  I+G    P ++ L G   +    +++ EYM N SL   L
Sbjct: 62  IKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL 121
Query: 171 F-SDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
             +DG   +   Q   ++  +   +++L    D   +H D+   N+L++S+   KVSDFG
Sbjct: 122 RKNDGRFTV--IQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFG 176
Query: 230 LSRI 233
           +SR+
Sbjct: 177 MSRV 180

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 85/168 (50%), Gaps = 10/168 (5%)
Query: 75  YKELKNATNDFDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQ-TEREFQNELQI 132
           +K+ ++  + +D  +V+G G    V L    R  KL+AIK +   +L+  E   +NE+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           L  ++ P +V L           L+ + +    L + +   G    + + R  +I  V  
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--LIFQVLD 127
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVL---LDSDCRGKVSDFGLSRIKVEG 237
           A+++LH   D  ++H D+KP N+L   LD D +  +SDFGLS+++  G
Sbjct: 128 AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 172

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 85/168 (50%), Gaps = 10/168 (5%)
Query: 75  YKELKNATNDFDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQ-TEREFQNELQI 132
           +K+ ++  + +D  +V+G G    V L    R  KL+AIK +   +L+  E   +NE+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           L  ++ P +V L           L+ + +    L + +   G    + + R  +I  V  
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--LIFQVLD 127
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVL---LDSDCRGKVSDFGLSRIKVEG 237
           A+++LH   D  ++H D+KP N+L   LD D +  +SDFGLS+++  G
Sbjct: 128 AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 172

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 85/168 (50%), Gaps = 10/168 (5%)
Query: 75  YKELKNATNDFDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQ-TEREFQNELQI 132
           +K+ ++  + +D  +V+G G    V L    R  KL+AIK +   +L+  E   +NE+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 69
Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           L  ++ P +V L           L+ + +    L + +   G    + + R  +I  V  
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--LIFQVLD 127
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVL---LDSDCRGKVSDFGLSRIKVEG 237
           A+++LH   D  ++H D+KP N+L   LD D +  +SDFGLS+++  G
Sbjct: 128 AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 172

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 83/184 (45%), Gaps = 13/184 (7%)
Query: 56  RSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLG----IARDGKLLA 111
           R+   P     P +      KEL       D+  V+G G  G V  G     ++    +A
Sbjct: 20  RTYVDPHTYEDPTQTVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVA 77
Query: 112 IKRLDT-FSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEML 170
           IK L   ++ +  R+F  E  I+G    P ++ L G   +    ++V EYM N SL   L
Sbjct: 78  IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Query: 171 FS-DGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
              D    +   Q   ++  +A  +++L    D   +H D+   N+L++S+   KVSDFG
Sbjct: 138 RKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFG 192
Query: 230 LSRI 233
           LSR+
Sbjct: 193 LSRV 196

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 83/184 (45%), Gaps = 13/184 (7%)
Query: 56  RSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLG----IARDGKLLA 111
           R+   P     P +      KEL       D+  V+G G  G V  G     ++    +A
Sbjct: 18  RTYVDPHTYEDPTQTVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVA 75
Query: 112 IKRLDT-FSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEML 170
           IK L   ++ +  R+F  E  I+G    P ++ L G   +    ++V EYM N SL   L
Sbjct: 76  IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 135
Query: 171 FS-DGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
              D    +   Q   ++  +A  +++L    D   +H D+   N+L++S+   KVSDFG
Sbjct: 136 RKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFG 190
Query: 230 LSRI 233
           LSR+
Sbjct: 191 LSRV 194

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 11/150 (7%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V +          G+++A+K+L   + +  R+F+ E++IL  L+   +V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 146 GYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           G C    +R   L+ EY+P  SL++ L +    +    +  +    + K +E+L      
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERI-DHIKLLQYTSQICKGMEYL---GTK 136
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             IH D+   N+L++++ R K+ DFGL+++
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKV 166

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 85/168 (50%), Gaps = 10/168 (5%)
Query: 75  YKELKNATNDFDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQ-TEREFQNELQI 132
           +K+ ++  + +D  +V+G G    V L    R  KL+AIK +   +L+  E   +NE+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           L  ++ P +V L           L+ + +    L + +   G    + + R  +I  V  
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--LIFQVLD 127
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVL---LDSDCRGKVSDFGLSRIKVEG 237
           A+++LH   D  ++H D+KP N+L   LD D +  +SDFGLS+++  G
Sbjct: 128 AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 172

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 83/184 (45%), Gaps = 13/184 (7%)
Query: 56  RSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLG----IARDGKLLA 111
           R+   P     P +      KEL       D+  V+G G  G V  G     ++    +A
Sbjct: 20  RTYVDPHTFEDPTQTVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVA 77
Query: 112 IKRLDT-FSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEML 170
           IK L   ++ +  R+F  E  I+G    P ++ L G   +    ++V EYM N SL   L
Sbjct: 78  IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Query: 171 FS-DGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
              D    +   Q   ++  +A  +++L    D   +H D+   N+L++S+   KVSDFG
Sbjct: 138 RKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFG 192
Query: 230 LSRI 233
           LSR+
Sbjct: 193 LSRV 196

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 37/179 (20%)
Query: 91  IGKGGSGTVFLGIA------RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTL 144
           +G+G  G VFL         +D  L+A+K L   S    ++FQ E ++L  L+   +V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLFS---DGNLV----------LKWSQRFEIIMDVA 191
            G C E    ++V+EYM +  L   L S   D  L+          L   Q   +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 192 KALEF---LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQD 247
             + +   LHF      +H D+   N L+      K+ DFG+SR         D++S D
Sbjct: 146 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSR---------DIYSTD 189

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 76  KELKNATNDFDEANVIGKGGSGTVFLG----IARDGKLLAIKRLDT-FSLQTEREFQNEL 130
           KEL       D+  V+G G  G V  G     ++    +AIK L   ++ +  R+F  E 
Sbjct: 11  KELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 131 QILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLVLKWSQRFEIIMD 189
            I+G    P ++ L G   +    ++V EYM N SL   L   D    +   Q   ++  
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRG 126
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +A  +++L    D   +H D+   N+L++S+   KVSDFGLSR+
Sbjct: 127 IASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRV 167

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 37/179 (20%)
Query: 91  IGKGGSGTVFLGIA------RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTL 144
           +G+G  G VFL         +D  L+A+K L   S    ++FQ E ++L  L+   +V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLFS---DGNLV----------LKWSQRFEIIMDVA 191
            G C E    ++V+EYM +  L   L S   D  L+          L   Q   +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 192 KALEF---LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQD 247
             + +   LHF      +H D+   N L+      K+ DFG+SR         D++S D
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSR---------DIYSTD 212

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 83/184 (45%), Gaps = 13/184 (7%)
Query: 56  RSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLG----IARDGKLLA 111
           R+   P     P +      KEL       D+  V+G G  G V  G     ++    +A
Sbjct: 20  RTFVDPHTYEDPTQTVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVA 77
Query: 112 IKRLDT-FSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEML 170
           IK L   ++ +  R+F  E  I+G    P ++ L G   +    ++V EYM N SL   L
Sbjct: 78  IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Query: 171 FS-DGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
              D    +   Q   ++  +A  +++L    D   +H D+   N+L++S+   KVSDFG
Sbjct: 138 RKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFG 192
Query: 230 LSRI 233
           LSR+
Sbjct: 193 LSRV 196

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 76  KELKNATNDFDEANVIGKGGSGTVFLG----IARDGKLLAIKRLDT-FSLQTEREFQNEL 130
           KEL       D+  V+G G  G V  G     ++    +AIK L   ++ +  R+F  E 
Sbjct: 28  KELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 85
Query: 131 QILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLVLKWSQRFEIIMD 189
            I+G    P ++ L G   +    ++V EYM N SL   L   D    +   Q   ++  
Sbjct: 86  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRG 143
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +A  +++L    D   +H D+   N+L++S+   KVSDFGLSR+
Sbjct: 144 IASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRV 184

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 76  KELKNATNDFDEANVIGKGGSGTVFLG----IARDGKLLAIKRLDT-FSLQTEREFQNEL 130
           KEL       D+  V+G G  G V  G     ++    +AIK L   ++ +  R+F  E 
Sbjct: 40  KELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 131 QILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLVLKWSQRFEIIMD 189
            I+G    P ++ L G   +    ++V EYM N SL   L   D    +   Q   ++  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRG 155
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +A  +++L    D   +H D+   N+L++S+   KVSDFGLSR+
Sbjct: 156 IASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRV 196

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 37/179 (20%)
Query: 91  IGKGGSGTVFLGIA------RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTL 144
           +G+G  G VFL         +D  L+A+K L   S    ++FQ E ++L  L+   +V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLFS---DGNLV----------LKWSQRFEIIMDVA 191
            G C E    ++V+EYM +  L   L S   D  L+          L   Q   +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 192 KALEF---LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQD 247
             + +   LHF      +H D+   N L+      K+ DFG+SR         D++S D
Sbjct: 140 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSR---------DIYSTD 183

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 76  KELKNATNDFDEANVIGKGGSGTVFLG----IARDGKLLAIKRLDT-FSLQTEREFQNEL 130
           KEL       D+  V+G G  G V  G     ++    +AIK L   ++ +  R+F  E 
Sbjct: 40  KELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 131 QILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLVLKWSQRFEIIMD 189
            I+G    P ++ L G   +    ++V EYM N SL   L   D    +   Q   ++  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRG 155
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +A  +++L    D   +H D+   N+L++S+   KVSDFGLSR+
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 196

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 78/158 (49%), Gaps = 19/158 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARDGK---LLAIKRLDTFSLQTERE-----FQNELQILG 134
           +DF+    +GKG  G V+L  AR+ K   ++A+K L  F  Q E+E      + E++I  
Sbjct: 23  DDFEIGRPLGKGKFGNVYL--AREKKSHFIVALKVL--FKSQIEKEGVEHQLRREIEIQA 78
Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMD-VAKA 193
            L  P ++ L  Y  +R +  L+ EY P   L + L           QR   IM+ +A A
Sbjct: 79  HLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFD---EQRTATIMEELADA 135
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           L + H      VIH DIKP N+LL      K++DFG S
Sbjct: 136 LMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWS 170

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 10/160 (6%)
Query: 84  DFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQ---TEREFQNELQILGGLRSP 139
           ++     +G+G  G V L      G+ +A+K ++   L     +   + E+  L  LR P
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
            ++ L      +++ I+V EY  N+    ++  D  +  + ++RF     +  A+E+ H 
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRF--FQQIISAVEYCH- 130
Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
                ++H D+KP N+LLD     K++DFGLS I  +G F
Sbjct: 131 --RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 168

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 10/160 (6%)
Query: 84  DFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQ---TEREFQNELQILGGLRSP 139
           ++     +G+G  G V L      G+ +A+K ++   L     +   + E+  L  LR P
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
            ++ L      +++ I+V EY  N+    ++  D  +  + ++RF     +  A+E+ H 
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRF--FQQIISAVEYCH- 129
Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
                ++H D+KP N+LLD     K++DFGLS I  +G F
Sbjct: 130 --RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 81/176 (46%), Gaps = 11/176 (6%)
Query: 90  VIGKGGSGTVFLG-IARDGK---LLAIKRLDT-FSLQTEREFQNELQILGGLRSPFLVTL 144
           VIG G  G V  G +   GK    +AIK L   ++ +  REF +E  I+G    P ++ L
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 145 LGYCMERNKRILVYEYMPNKSLQEML-FSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
            G        +++ E+M N +L   L  +DG   +   Q   ++  +A  + +L    + 
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRYL---AEM 135
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQE 259
             +H D+   N+L++S+   KVSDFGLSR   E        S   GK    W + E
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPE 191

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L     E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM   SL + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 251 EPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+  +   KV+DFGL+R+  + E+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEY 335

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L     E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM   SL + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 251 EPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+  +   KV+DFGL+R+  + E+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEY 335

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V +          G+++A+K+L   + +  R+F+ E++IL  L+   +V   
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 146 GYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           G C    +R   L+ EY+P  SL++ L      +    +  +    + K +E+L      
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL---GTK 132
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             IH D+   N+L++++ R K+ DFGL+++
Sbjct: 133 RYIHRDLATRNILVENENRVKIGDFGLTKV 162

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 11/149 (7%)
Query: 90  VIGKGGSGTVFLG-IARDGK---LLAIKRLDT-FSLQTEREFQNELQILGGLRSPFLVTL 144
           VIG G  G V  G +   GK    +AIK L   ++ +  REF +E  I+G    P ++ L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 145 LGYCMERNKRILVYEYMPNKSLQEML-FSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
            G        +++ E+M N +L   L  +DG   +   Q   ++  +A  + +L    + 
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRYL---AEM 137
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
             +H D+   N+L++S+   KVSDFGLSR
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSR 166

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 10/160 (6%)
Query: 84  DFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQ---TEREFQNELQILGGLRSP 139
           ++     +G+G  G V L      G+ +A+K ++   L     +   + E+  L  LR P
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
            ++ L      +++ I+V EY  N+    ++  D  +  + ++RF     +  A+E+ H 
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRF--FQQIISAVEYCH- 120
Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
                ++H D+KP N+LLD     K++DFGLS I  +G F
Sbjct: 121 --RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 158

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 79/163 (48%), Gaps = 8/163 (4%)
Query: 71  QRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ--TEREFQN 128
           Q+    ELK+  +DF++ + +G G  G VF    +   L+  ++L    ++     +   
Sbjct: 58  QKQKVGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 115
Query: 129 ELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM 188
           ELQ+L    SP++V   G      +  +  E+M   SL ++L   G +  +   +  I  
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA- 174
Query: 189 DVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            V K L +L       ++H D+KPSN+L++S    K+ DFG+S
Sbjct: 175 -VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 214

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V +          G+++A+K+L   + +  R+F+ E++IL  L+   +V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 146 GYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           G C    +R   L+ EY+P  SL++ L      +    +  +    + K +E+L      
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL---GTK 136
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             IH D+   N+L++++ R K+ DFGL+++
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKV 166

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V +          G+++A+K+L   + +  R+F+ E++IL  L+   +V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 146 GYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           G C    +R   L+ EY+P  SL++ L      +    +  +    + K +E+L      
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL---GTK 133
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             IH D+   N+L++++ R K+ DFGL+++
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKV 163

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V +          G+++A+K+L   + +  R+F+ E++IL  L+   +V   
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 146 GYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           G C    +R   L+ EY+P  SL++ L      +    +  +    + K +E+L      
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL---GTK 131
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             IH D+   N+L++++ R K+ DFGL+++
Sbjct: 132 RYIHRDLATRNILVENENRVKIGDFGLTKV 161

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V +          G+++A+K+L   + +  R+F+ E++IL  L+   +V   
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 146 GYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           G C    +R   L+ EY+P  SL++ L      +    +  +    + K +E+L      
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL---GTK 138
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             IH D+   N+L++++ R K+ DFGL+++
Sbjct: 139 RYIHRDLATRNILVENENRVKIGDFGLTKV 168

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V +          G+++A+K+L   + +  R+F+ E++IL  L+   +V   
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 146 GYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           G C    +R   L+ EY+P  SL++ L      +    +  +    + K +E+L      
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL---GTK 140
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             IH D+   N+L++++ R K+ DFGL+++
Sbjct: 141 RYIHRDLATRNILVENENRVKIGDFGLTKV 170

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 10/160 (6%)
Query: 84  DFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQ---TEREFQNELQILGGLRSP 139
           ++     +G+G  G V L      G+ +A+K ++   L     +   + E+  L  LR P
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
            ++ L      +++ I+V EY  N+    ++  D  +  + ++RF     +  A+E+ H 
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRF--FQQIISAVEYCH- 124
Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
                ++H D+KP N+LLD     K++DFGLS I  +G F
Sbjct: 125 --RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 162

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V +          G+++A+K+L   + +  R+F+ E++IL  L+   +V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 146 GYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           G C    +R   L+ EY+P  SL++ L      +    +  +    + K +E+L      
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL---GTK 133
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             IH D+   N+L++++ R K+ DFGL+++
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKV 163

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L     E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM   SL + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 334 EPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 389
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+  +   KV+DFGL+R+  + E+
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEY 418

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 76/150 (50%), Gaps = 11/150 (7%)
Query: 90  VIGKGGSGTVFLG-IARDGK---LLAIKRLDT-FSLQTEREFQNELQILGGLRSPFLVTL 144
           VIG G  G V  G +   GK    +AIK L   ++ +  R+F +E  I+G    P ++ L
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLF-SDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
            G   +    +++ EYM N SL   L  +DG   +   Q   ++  +   +++L    D 
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLS---DM 135
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             +H D+   N+L++S+   KVSDFG+SR+
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRV 165

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V +          G+++A+K+L   + +  R+F+ E++IL  L+   +V   
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 146 GYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           G C    +R   L+ EY+P  SL++ L      +    +  +    + K +E+L      
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL---GTK 164
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             IH D+   N+L++++ R K+ DFGL+++
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKV 194

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V +          G+++A+K+L   + +  R+F+ E++IL  L+   +V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 146 GYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           G C    +R   L+ E++P  SL+E L      +    +  +    + K +E+L      
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERI-DHIKLLQYTSQICKGMEYL---GTK 136
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             IH D+   N+L++++ R K+ DFGL+++
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKV 166

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V +          G+++A+K+L   + +  R+F+ E++IL  L+   +V   
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 146 GYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           G C    +R   L+ EY+P  SL++ L      +    +  +    + K +E+L      
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL---GTK 139
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             IH D+   N+L++++ R K+ DFGL+++
Sbjct: 140 RYIHRDLATRNILVENENRVKIGDFGLTKV 169

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 39/219 (17%)
Query: 82  TNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLR 137
            +DF+E  V+G+G  G V     A D +  AIK++      TE +     +E+ +L  L 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR----HTEEKLSTILSEVMLLASLN 60
Query: 138 SPFLVTLLGYCMERNKRI-------------LVYEYMPNKSLQEMLFSDGNLVLKWSQRF 184
             ++V      +ER   +             +  EY  N++L +++ S+ NL  +  + +
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSE-NLNQQRDEYW 119
Query: 185 EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLF 244
            +   + +AL ++H      +IH D+KP N+ +D     K+ DFGL++        +D+ 
Sbjct: 120 RLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK---NVHRSLDIL 173
Query: 245 SQDLGKSQELWKSQELSGNLATATETPAISTPVDSAHEV 283
             D         SQ L G  ++   T AI T +  A EV
Sbjct: 174 KLD---------SQNLPG--SSDNLTSAIGTAMYVATEV 201

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V +          G+++A+K+L   + +  R+F+ E++IL  L+   +V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 146 GYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           G C    +R   L+ EY+P  SL++ L      +    +  +    + K +E+L      
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL---GTK 133
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             IH D+   N+L++++ R K+ DFGL+++
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKV 163

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V +          G+++A+K+L   + +  R+F+ E++IL  L+   +V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 146 GYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           G C    +R   L+ EY+P  SL++ L      +    +  +    + K +E+L      
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL---GTK 151
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             IH D+   N+L++++ R K+ DFGL+++
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKV 181

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 76  KELKNATNDFDEANVIGKGGSGTVFLG----IARDGKLLAIKRLDT-FSLQTEREFQNEL 130
           KEL       D+  V+G G  G V  G     ++    +AIK L   ++ +  R+F  E 
Sbjct: 40  KELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 131 QILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLVLKWSQRFEIIMD 189
            I+G    P ++ L G   +    ++V EYM N SL   L   D    +   Q   ++  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRG 155
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +A  +++L    D   +H D+   N+L++S+   KVSDFGL+R+
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARV 196

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L     E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM   SL + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 251 EPIYI-VGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+  +   KV+DFGL+R+  + E+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEY 335

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V +          G+++A+K+L   + +  R+F+ E++IL  L+   +V   
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 146 GYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           G C    +R   L+ EY+P  SL++ L      +    +  +    + K +E+L      
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL---GTK 137
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             IH D+   N+L++++ R K+ DFGL+++
Sbjct: 138 RYIHRDLATRNILVENENRVKIGDFGLTKV 167

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 76/150 (50%), Gaps = 11/150 (7%)
Query: 90  VIGKGGSGTVFLG-IARDGK---LLAIKRLDT-FSLQTEREFQNELQILGGLRSPFLVTL 144
           VIG G  G V  G +   GK    +AIK L   ++ +  R+F +E  I+G    P ++ L
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLF-SDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
            G   +    +++ EYM N SL   L  +DG   +   Q   ++  +   +++L    D 
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLS---DM 129
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             +H D+   N+L++S+   KVSDFG+SR+
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRV 159

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 81/175 (46%), Gaps = 20/175 (11%)
Query: 74  TYKELKNATNDFDEA---------NVIGKGGSGTVFLG-IARDGK---LLAIKRLDT-FS 119
           TY++   A + F +           VIG G  G V  G +   GK    +AIK L   ++
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 120 LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLVL 178
            +  R+F  E  I+G    P +V L G        ++V E+M N +L   L   DG   +
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV 144
Query: 179 KWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
              Q   ++  +A  + +L    D   +H D+   N+L++S+   KVSDFGLSR+
Sbjct: 145 --IQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 194

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V +          G+++A+K+L   + +  R+F+ E++IL  L+   +V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 146 GYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           G C    +R   L+ EY+P  SL++ L      +    +  +    + K +E+L      
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL---GTK 151
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             IH D+   N+L++++ R K+ DFGL+++
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKV 181

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 9/156 (5%)
Query: 88  ANVIGKGGSGTVFLGIAR-DGKLLAIKRLD---TFSLQTEREFQNELQILGGLRSPFLVT 143
            + +G G  G V +G  +  G  +A+K L+     SL    + + E+Q L   R P ++ 
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           L           +V EY+    L + +   G +    ++R  +   +  A+++ H     
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR--LFQQILSAVDYCHRHM-- 131
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
            V+H D+KP NVLLD+    K++DFGLS +  +GEF
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 9/159 (5%)
Query: 88  ANVIGKGGSGTVFLGIAR-DGKLLAIKRLD---TFSLQTEREFQNELQILGGLRSPFLVT 143
            + +G G  G V +G  +  G  +A+K L+     SL    + + E+Q L   R P ++ 
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           L           +V EY+    L + +   G +    ++R  +   +  A+++ H     
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR--LFQQILSAVDYCHRHM-- 131
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMD 242
            V+H D+KP NVLLD+    K++DFGLS +  +GEF  D
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRD 169

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 11/149 (7%)
Query: 90  VIGKGGSGTVFLG-IARDGK---LLAIKRLDT-FSLQTEREFQNELQILGGLRSPFLVTL 144
           VIG G  G V  G +   GK    +AIK L + ++ +  R+F +E  I+G    P ++ L
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLF-SDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
            G   +    +++ E+M N SL   L  +DG   +   Q   ++  +A  +++L    D 
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---ADM 128
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
             +H  +   N+L++S+   KVSDFGLSR
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSR 157

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L     E
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM   SL + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 78  EPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 133
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+  +   KV+DFGL+R+  + E+
Sbjct: 134 RAANILVGENLVCKVADFGLARLIEDNEY 162

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I++ EYM   SL + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 85  EPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+  +   KV+DFGL+R+  + E+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEY 169

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 83/182 (45%), Gaps = 30/182 (16%)
Query: 68  LKLQRFTYKELKNATNDFDEANVIGKGGSGTVFL----GIARDGKLLAIKRLDTFSL--- 120
           L+    T    K    +F+   V+G G  G VFL         GKL A+K L   ++   
Sbjct: 39  LRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK 98
Query: 121 -QTEREFQNELQILGGLR-SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVL 178
            +T    + E Q+L  +R SPFLVTL        K  L+ +Y+          + G L  
Sbjct: 99  AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYI----------NGGELFT 148
Query: 179 KWSQR-----FEI---IMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL 230
             SQR      E+   + ++  ALE LH      +I+ DIK  N+LLDS+    ++DFGL
Sbjct: 149 HLSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL 205
Query: 231 SR 232
           S+
Sbjct: 206 SK 207

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 79/163 (48%), Gaps = 8/163 (4%)
Query: 71  QRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ--TEREFQN 128
           Q+    ELK+  +DF++ + +G G  G VF    +   L+  ++L    ++     +   
Sbjct: 23  QKQKVGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80
Query: 129 ELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM 188
           ELQ+L    SP++V   G      +  +  E+M   SL ++L   G +  +   +  I  
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA- 139
Query: 189 DVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            V K L +L       ++H D+KPSN+L++S    K+ DFG+S
Sbjct: 140 -VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 179

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 76  KELKNATNDFDEANVIGKGGSGTVFLG----IARDGKLLAIKRLDT-FSLQTEREFQNEL 130
           KEL       D+  V+G G  G V  G     ++    +AIK L   ++ +  R+F  E 
Sbjct: 40  KELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 131 QILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLVLKWSQRFEIIMD 189
            I+G    P ++ L G   +    ++V EYM N SL   L   D    +   Q   ++  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRG 155
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +A  +++L    D   +H D+   N+L++S+   KVSDFGL R+
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L     E
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM   SL + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 76  EPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 131
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+  +   KV+DFGL+R+  + E+
Sbjct: 132 RAANILVGENLVCKVADFGLARLIEDNEY 160

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 24/178 (13%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRL------DTFSLQTEREFQNELQ 131
           AT+ ++    IG G  GTV+   ARD   G  +A+K +      +   + T RE    L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYK--ARDPHSGHFVALKSVRVPNGEEGLPISTVREVAL-LR 58
Query: 132 ILGGLRSPFLVTLLGYCMERN-----KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEI 186
            L     P +V L+  C         K  LV+E++ ++ L+  L       L      ++
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDL 117
Query: 187 IMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLF 244
           +    + L+FLH  C   ++H D+KP N+L+ S    K++DFGL+RI     + M LF
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALF 169

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 21/167 (12%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRL------DTFSLQTEREFQNELQ 131
           AT+ ++    IG G  GTV+   ARD   G  +A+K +      +   + T RE    L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYK--ARDPHSGHFVALKSVRVPNGEEGLPISTVREVAL-LR 58
Query: 132 ILGGLRSPFLVTLLGYCMERN-----KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEI 186
            L     P +V L+  C         K  LV+E++ ++ L+  L       L      ++
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDL 117
Query: 187 IMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +    + L+FLH  C   ++H D+KP N+L+ S    K++DFGL+RI
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 21/167 (12%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRL------DTFSLQTEREFQNELQ 131
           AT+ ++    IG G  GTV+   ARD   G  +A+K +      +   + T RE    L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYK--ARDPHSGHFVALKSVRVPNGEEGLPISTVREVAL-LR 58
Query: 132 ILGGLRSPFLVTLLGYCMERN-----KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEI 186
            L     P +V L+  C         K  LV+E++ ++ L+  L       L      ++
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDL 117
Query: 187 IMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +    + L+FLH  C   ++H D+KP N+L+ S    K++DFGL+RI
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 85/171 (49%), Gaps = 21/171 (12%)
Query: 79  KNATNDFDEANVIGKGGSGTVFL--GIAR--DGKLLAIKRLDTFSLQTEREFQNELQ--I 132
           K   + F+   V+G+G  G VFL   + R   G L A+K L   +L+     + +++  I
Sbjct: 24  KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI 83
Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEII 187
           L  +  PF+V L        K  L+ +++    L     +E++F++ ++          +
Sbjct: 84  LADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-------YL 136
Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
            ++A  L+ LH      +I+ D+KP N+LLD +   K++DFGLS+  ++ E
Sbjct: 137 AELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHE 184

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 8/157 (5%)
Query: 77  ELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ--TEREFQNELQILG 134
           ELK+  +DF++ + +G G  G VF    +   L+  ++L    ++     +   ELQ+L 
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
              SP++V   G      +  +  E+M   SL ++L   G +  +   +  I   V K L
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGL 117
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            +L       ++H D+KPSN+L++S    K+ DFG+S
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 21/164 (12%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLD---TFSLQTEREFQNELQILG 134
           K +  DF     +G G  G V L  +R +G+  A+K L       L+      +E  +L 
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFE------IIM 188
            +  PF++ + G   +  +  ++ +Y+    L    FS    +L+ SQRF          
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL----FS----LLRKSQRFPNPVAKFYAA 113
Query: 189 DVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +V  ALE+LH      +I+ D+KP N+LLD +   K++DFG ++
Sbjct: 114 EVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK 154

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 79/163 (48%), Gaps = 8/163 (4%)
Query: 71  QRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ--TEREFQN 128
           Q+    ELK+  +DF++ + +G G  G VF    +   L+  ++L    ++     +   
Sbjct: 15  QKQKVGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 72
Query: 129 ELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM 188
           ELQ+L    SP++V   G      +  +  E+M   SL ++L   G +  +   +  I  
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI-- 130
Query: 189 DVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            V K L +L       ++H D+KPSN+L++S    K+ DFG+S
Sbjct: 131 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 171

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 7/141 (4%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           IG+G SGTV+  +    G+ +AI++++      +    NE+ ++   ++P +V  L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             ++  +V EY+   SL +++       +   Q   +  +  +ALEFLH      VIH D
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 210 IKPSNVLLDSDCRGKVSDFGL 230
           IK  N+LL  D   K++DFG 
Sbjct: 142 IKSDNILLGMDGSVKLTDFGF 162

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L     E
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM   SL + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 74  EPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 129
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+  +   KV+DFGL+R+  + E+
Sbjct: 130 RAANILVGENLVCKVADFGLARLIEDNEY 158

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 7/141 (4%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           IG+G SGTV+  +    G+ +AI++++      +    NE+ ++   ++P +V  L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             ++  +V EY+   SL +++       +   Q   +  +  +ALEFLH      VIH D
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 210 IKPSNVLLDSDCRGKVSDFGL 230
           IK  N+LL  D   K++DFG 
Sbjct: 142 IKSDNILLGMDGSVKLTDFGF 162

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM   SL + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 85  EPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+  +   KV+DFGL+R+  + E+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEY 169

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 7/141 (4%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           IG+G SGTV+  +    G+ +AI++++      +    NE+ ++   ++P +V  L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             ++  +V EY+   SL +++       +   Q   +  +  +ALEFLH      VIH D
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 210 IKPSNVLLDSDCRGKVSDFGL 230
           IK  N+LL  D   K++DFG 
Sbjct: 142 IKSDNILLGMDGSVKLTDFGF 162

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 5/160 (3%)
Query: 75  YKELKNATNDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQIL 133
           Y + +    D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 68
Query: 134 GGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             ++ P LV LLG C       ++ E+M   +L + L       +       +   ++ A
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 128
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +E+L        IH D+   N L+  +   KV+DFGLSR+
Sbjct: 129 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 165

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 8/157 (5%)
Query: 77  ELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ--TEREFQNELQILG 134
           ELK+  +DF++ + +G G  G VF    +   L+  ++L    ++     +   ELQ+L 
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
              SP++V   G      +  +  E+M   SL ++L   G +  +   +  I   V K L
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGL 117
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            +L       ++H D+KPSN+L++S    K+ DFG+S
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQN---ELQILG 134
           K   NDFD   ++GKG  G V L   +  G+  A+K L    +  + E  +   E ++L 
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 63
Query: 135 GLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             R PFL T L Y  + + R+  V EY     L   L S   +  +   RF    ++  A
Sbjct: 64  NTRHPFL-TALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARF-YGAEIVSA 120
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           LE+LH      V++ DIK  N++LD D   K++DFGL +
Sbjct: 121 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 156

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 7/141 (4%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           IG+G SGTV+  +    G+ +AI++++      +    NE+ ++   ++P +V  L   +
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             ++  +V EY+   SL +++       +   Q   +  +  +ALEFLH      VIH D
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRD 142
Query: 210 IKPSNVLLDSDCRGKVSDFGL 230
           IK  N+LL  D   K++DFG 
Sbjct: 143 IKSDNILLGMDGSVKLTDFGF 163

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQN---ELQILG 134
           K   NDFD   ++GKG  G V L   +  G+  A+K L    +  + E  +   E ++L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 135 GLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             R PFL T L Y  + + R+  V EY     L   L S   +  +   RF    ++  A
Sbjct: 61  NTRHPFL-TALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARF-YGAEIVSA 117
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           LE+LH      V++ DIK  N++LD D   K++DFGL +
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQN---ELQILG 134
           K   NDFD   ++GKG  G V L   +  G+  A+K L    +  + E  +   E ++L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 135 GLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             R PFL T L Y  + + R+  V EY     L   L S   +  +   RF    ++  A
Sbjct: 61  NTRHPFL-TALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARF-YGAEIVSA 117
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           LE+LH      V++ DIK  N++LD D   K++DFGL +
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 5/160 (3%)
Query: 75  YKELKNATNDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQIL 133
           Y + +    D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 63
Query: 134 GGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             ++ P LV LLG C       ++ E+M   +L + L       +       +   ++ A
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +E+L        IH D+   N L+  +   KV+DFGLSR+
Sbjct: 124 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM   SL + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 85  EPIYI-VCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+  +   KV+DFGL+R+  + E+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEY 169

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 5/160 (3%)
Query: 75  YKELKNATNDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQIL 133
           Y + +    D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++
Sbjct: 6   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 64
Query: 134 GGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             ++ P LV LLG C       ++ E+M   +L + L       +       +   ++ A
Sbjct: 65  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 124
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +E+L        IH D+   N L+  +   KV+DFGLSR+
Sbjct: 125 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 161

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 8/157 (5%)
Query: 77  ELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ--TEREFQNELQILG 134
           ELK+  +DF++ + +G G  G VF    +   L+  ++L    ++     +   ELQ+L 
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
              SP++V   G      +  +  E+M   SL ++L   G +  +   +  I   V K L
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGL 117
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            +L       ++H D+KPSN+L++S    K+ DFG+S
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 71/149 (47%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L     E
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM   SL + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 252 EPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 307
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+  +   KV+DFGL R+  + E+
Sbjct: 308 RAANILVGENLVCKVADFGLGRLIEDNEY 336

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 90/164 (54%), Gaps = 15/164 (9%)
Query: 77  ELKNATNDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREFQN----- 128
           ++K+    +++ + +G+G   TV+   ARD    +++AIK++        ++  N     
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVY--KARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61
Query: 129 ELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM 188
           E+++L  L  P ++ LL     ++   LV+++M  ++  E++  D +LVL  S     ++
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM--ETDLEVIIKDNSLVLTPSHIKAYML 119
Query: 189 DVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
              + LE+LH      ++H D+KP+N+LLD +   K++DFGL++
Sbjct: 120 MTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQN---ELQILG 134
           K   NDFD   ++GKG  G V L   +  G+  A+K L    +  + E  +   E ++L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 135 GLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             R PFL T L Y  + + R+  V EY     L   L S   +  +   RF    ++  A
Sbjct: 61  NTRHPFL-TALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARF-YGAEIVSA 117
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           LE+LH      V++ DIK  N++LD D   K++DFGL +
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 5/160 (3%)
Query: 75  YKELKNATNDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQIL 133
           Y + +    D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 68
Query: 134 GGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             ++ P LV LLG C       ++ E+M   +L + L       +       +   ++ A
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 128
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +E+L        IH D+   N L+  +   KV+DFGLSR+
Sbjct: 129 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 165

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 5/160 (3%)
Query: 75  YKELKNATNDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQIL 133
           Y + +    D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 63
Query: 134 GGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             ++ P LV LLG C       ++ E+M   +L + L       +       +   ++ A
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +E+L        IH D+   N L+  +   KV+DFGLSR+
Sbjct: 124 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 5/160 (3%)
Query: 75  YKELKNATNDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQIL 133
           Y + +    D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 63
Query: 134 GGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             ++ P LV LLG C       ++ E+M   +L + L       +       +   ++ A
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +E+L        IH D+   N L+  +   KV+DFGLSR+
Sbjct: 124 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 5/160 (3%)
Query: 75  YKELKNATNDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQIL 133
           Y + +    D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 68
Query: 134 GGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             ++ P LV LLG C       ++ E+M   +L + L       +       +   ++ A
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 128
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +E+L        IH D+   N L+  +   KV+DFGLSR+
Sbjct: 129 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 165

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 5/152 (3%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
            D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++  ++ P L
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 69
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           V LLG C       ++ E+M   +L + L       +       +   ++ A+E+L    
Sbjct: 70  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 126
Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               IH D+   N L+  +   KV+DFGLSR+
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 158

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 5/160 (3%)
Query: 75  YKELKNATNDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQIL 133
           Y + +    D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 67
Query: 134 GGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             ++ P LV LLG C       ++ E+M   +L + L       +       +   ++ A
Sbjct: 68  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 127
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +E+L        IH D+   N L+  +   KV+DFGLSR+
Sbjct: 128 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 164

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 5/152 (3%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
            D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++  ++ P L
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 76
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           V LLG C       ++ E+M   +L + L       +       +   ++ A+E+L    
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 133
Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               IH D+   N L+  +   KV+DFGLSR+
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 165

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQN---ELQILG 134
           K   NDFD   ++GKG  G V L   +  G+  A+K L    +  + E  +   E ++L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 135 GLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             R PFL T L Y  + + R+  V EY     L   L S   +  +   RF    ++  A
Sbjct: 61  NTRHPFL-TALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARF-YGAEIVSA 117
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           LE+LH      V++ DIK  N++LD D   K++DFGL +
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 8/157 (5%)
Query: 77  ELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ--TEREFQNELQILG 134
           ELK+  +DF++ + +G G  G VF    +   L+  ++L    ++     +   ELQ+L 
Sbjct: 5   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 62
Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
              SP++V   G      +  +  E+M   SL ++L   G +  +   +  I   V K L
Sbjct: 63  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGL 120
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            +L       ++H D+KPSN+L++S    K+ DFG+S
Sbjct: 121 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 155

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 5/143 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L     E
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM   SL + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 75  EPIXI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 130
Query: 211 KPSNVLLDSDCRGKVSDFGLSRI 233
           + +N+L+  +   KV+DFGL+R+
Sbjct: 131 RAANILVGENLVCKVADFGLARL 153

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 5/152 (3%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
            D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++  ++ P L
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 71
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           V LLG C       ++ E+M   +L + L       +       +   ++ A+E+L    
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 128
Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               IH D+   N L+  +   KV+DFGLSR+
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 5/152 (3%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
            D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++  ++ P L
Sbjct: 26  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 84
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           V LLG C       ++ E+M   +L + L       +       +   ++ A+E+L    
Sbjct: 85  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 141
Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               IH D+   N L+  +   KV+DFGLSR+
Sbjct: 142 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 173

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQN---ELQILG 134
           K   NDFD   ++GKG  G V L   +  G+  A+K L    +  + E  +   E ++L 
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 65
Query: 135 GLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             R PFL T L Y  + + R+  V EY     L   L S   +  +   RF    ++  A
Sbjct: 66  NTRHPFL-TALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARF-YGAEIVSA 122
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           LE+LH      V++ DIK  N++LD D   K++DFGL +
Sbjct: 123 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 158

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 5/152 (3%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
            D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++  ++ P L
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 73
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           V LLG C       ++ E+M   +L + L       +       +   ++ A+E+L    
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 130
Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               IH D+   N L+  +   KV+DFGLSR+
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 162

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 5/152 (3%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
            D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++  ++ P L
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 71
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           V LLG C       ++ E+M   +L + L       +       +   ++ A+E+L    
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 128
Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               IH D+   N L+  +   KV+DFGLSR+
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 5/152 (3%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
            D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++  ++ P L
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 73
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           V LLG C       ++ E+M   +L + L       +       +   ++ A+E+L    
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 130
Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               IH D+   N L+  +   KV+DFGLSR+
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 162

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 120 H---SHRVLHRDLKPENLLINTEGAIKLADFGLAR 151

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 5/152 (3%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
            D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++  ++ P L
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 72
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           V LLG C       ++ E+M   +L + L       +       +   ++ A+E+L    
Sbjct: 73  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 129
Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               IH D+   N L+  +   KV+DFGLSR+
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 161

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 5/152 (3%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
            D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++  ++ P L
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 71
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           V LLG C       ++ E+M   +L + L       +       +   ++ A+E+L    
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 128
Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               IH D+   N L+  +   KV+DFGLSR+
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQN---ELQILG 134
           K   NDFD   ++GKG  G V L   +  G+  A+K L    +  + E  +   E ++L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 135 GLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             R PFL T L Y  + + R+  V EY     L   L S   +  +   RF    ++  A
Sbjct: 61  NTRHPFL-TALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARF-YGAEIVSA 117
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           LE+LH      V++ DIK  N++LD D   K++DFGL +
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 5/143 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I++ EYM   SL + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 85  EPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 211 KPSNVLLDSDCRGKVSDFGLSRI 233
           + +N+L+  +   KV+DFGL+R+
Sbjct: 141 RAANILVGENLVCKVADFGLARL 163

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 5/152 (3%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
            D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++  ++ P L
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 73
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           V LLG C       ++ E+M   +L + L       +       +   ++ A+E+L    
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 130
Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               IH D+   N L+  +   KV+DFGLSR+
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 162

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L     E
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM   SL + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 82  EPIYI-VTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRDL 137
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+  +   KV+DFGL+R+  + E+
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEY 166

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 8/157 (5%)
Query: 77  ELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ--TEREFQNELQILG 134
           ELK+  +DF++ + +G G  G VF    +   L+  ++L    ++     +   ELQ+L 
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
              SP++V   G      +  +  E+M   SL ++L   G +  +   +  I   V K L
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGL 117
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            +L       ++H D+KPSN+L++S    K+ DFG+S
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 8/157 (5%)
Query: 77  ELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ--TEREFQNELQILG 134
           ELK+  +DF++ + +G G  G VF    +   L+  ++L    ++     +   ELQ+L 
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
              SP++V   G      +  +  E+M   SL ++L   G +  +   +  I   V K L
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGL 117
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            +L       ++H D+KPSN+L++S    K+ DFG+S
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 122 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 122 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 5/160 (3%)
Query: 75  YKELKNATNDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQIL 133
           Y + +    D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 68
Query: 134 GGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             ++ P LV LLG C       ++ E+M   +L + L       +       +   ++ A
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 128
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +E+L        IH D+   N L+  +   KV+DFGLSR+
Sbjct: 129 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 165

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 39/219 (17%)
Query: 82  TNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLR 137
            +DF+E  V+G+G  G V     A D +  AIK++      TE +     +E+ +L  L 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR----HTEEKLSTILSEVMLLASLN 60
Query: 138 SPFLVTLLGYCMERNKRI-------------LVYEYMPNKSLQEMLFSDGNLVLKWSQRF 184
             ++V      +ER   +             +  EY  N +L +++ S+ NL  +  + +
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYW 119
Query: 185 EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLF 244
            +   + +AL ++H      +IH D+KP N+ +D     K+ DFGL++        +D+ 
Sbjct: 120 RLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK---NVHRSLDIL 173
Query: 245 SQDLGKSQELWKSQELSGNLATATETPAISTPVDSAHEV 283
             D         SQ L G  ++   T AI T +  A EV
Sbjct: 174 KLD---------SQNLPG--SSDNLTSAIGTAMYVATEV 201

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPF 140
           +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L  P 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH-- 120
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               V+H D+KP N+L++++   K++DFGL+R
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPF 140
           +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L  P 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               V+H D+KP N+L++++   K++DFGL+R
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 121 H---SHRVLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 82/184 (44%), Gaps = 13/184 (7%)
Query: 56  RSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLG----IARDGKLLA 111
           R+   P     P +      KEL       D+  V+G G  G V  G     ++    +A
Sbjct: 20  RTYVDPHTYEDPTQTVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVA 77
Query: 112 IKRLDT-FSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEML 170
           IK L   ++ +  R+F  E  I+G    P ++ L G   +    ++V E M N SL   L
Sbjct: 78  IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 137
Query: 171 FS-DGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
              D    +   Q   ++  +A  +++L    D   +H D+   N+L++S+   KVSDFG
Sbjct: 138 RKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFG 192
Query: 230 LSRI 233
           LSR+
Sbjct: 193 LSRV 196

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPF 140
           +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L  P 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               V+H D+KP N+L++++   K++DFGL+R
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 5/152 (3%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
            D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++  ++ P L
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 69
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           V LLG C       ++ E+M   +L + L       +       +   ++ A+E+L    
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 126
Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               IH D+   N L+  +   KV+DFGLSR+
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 158

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 122 H---SHRVLHRDLKPENLLINTEGAIKLADFGLAR 153

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 91  IGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +GKG  G+V +          G+++A+K+L   + +  R+F+ E++IL  L+   +V   
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 146 GYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           G C    +R   L+ EY+P  SL++ L      +    +  +    + K +E+L      
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL---GTK 134
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             IH ++   N+L++++ R K+ DFGL+++
Sbjct: 135 RYIHRNLATRNILVENENRVKIGDFGLTKV 164

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPF 140
           +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L  P 
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F H  
Sbjct: 71  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 127
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               V+H D+KP N+L++++   K++DFGL+R
Sbjct: 128 -SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPF 140
           +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L  P 
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F H  
Sbjct: 68  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 124
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               V+H D+KP N+L++++   K++DFGL+R
Sbjct: 125 -SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPF 140
           +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L  P 
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F H  
Sbjct: 65  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 121
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               V+H D+KP N+L++++   K++DFGL+R
Sbjct: 122 -SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPF 140
           +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L  P 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               V+H D+KP N+L++++   K++DFGL+R
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPF 140
           +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L  P 
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F H  
Sbjct: 71  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 127
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               V+H D+KP N+L++++   K++DFGL+R
Sbjct: 128 -SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 72/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  +R   LV L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM   SL + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 85  EPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+  +   KV+DFGL+R+  + E+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEY 169

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPF 140
           +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L  P 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               V+H D+KP N+L++++   K++DFGL+R
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPF 140
           +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L  P 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               V+H D+KP N+L++++   K++DFGL+R
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 5/152 (3%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
            D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++  ++ P L
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 69
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           V LLG C       ++ E+M   +L + L       +       +   ++ A+E+L    
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 126
Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               IH D+   N L+  +   KV+DFGLSR+
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 158

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 124 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPF 140
           +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L  P 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               V+H D+KP N+L++++   K++DFGL+R
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 80/168 (47%), Gaps = 25/168 (14%)
Query: 82  TNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLR 137
            +DF+E  V+G+G  G V     A D +  AIK++      TE +     +E+ +L  L 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR----HTEEKLSTILSEVXLLASLN 60
Query: 138 SPFLVTLLGYCMERNKRI-------------LVYEYMPNKSLQEMLFSDGNLVLKWSQRF 184
             ++V      +ER   +             +  EY  N++L +++ S+ NL  +  + +
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSE-NLNQQRDEYW 119
Query: 185 EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            +   + +AL ++H      +IH ++KP N+ +D     K+ DFGL++
Sbjct: 120 RLFRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPF 140
           +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L  P 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               V+H D+KP N+L++++   K++DFGL+R
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 8/149 (5%)
Query: 85  FDEANVIGKGGSGTVFLGIARDGK-LLAIKRLD-TFSLQTEREFQNELQILGGLRSPFLV 142
           F + + IGKG  G V+ GI    K ++AIK +D   +     + Q E+ +L    SP++ 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
              G  ++  K  ++ EY+   S  ++L       L+ +    I+ ++ K L++LH    
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLH---S 134
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              IH DIK +NVLL      K++DFG++
Sbjct: 135 ERKIHRDIKAANVLLSEQGDVKLADFGVA 163

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 76  KELKNATNDFDEANVIGKGGSGTVFLG----IARDGKLLAIKRLDT-FSLQTEREFQNEL 130
           KEL       D+  V+G G  G V  G     ++    +AIK L   ++ +  R+F  E 
Sbjct: 40  KELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 131 QILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLVLKWSQRFEIIMD 189
            I+G    P ++ L G   +    ++V E M N SL   L   D    +   Q   ++  
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRG 155
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +A  +++L    D   +H D+   N+L++S+   KVSDFGLSR+
Sbjct: 156 IASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRV 196

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 13/158 (8%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 138 SPFLVTLLGYCMERNKRILVYEYMP---NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
            P +V LL      NK  LV+E++     K +     +   L L  S  F+++    + L
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 119
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            F H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 120 AFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLAR 154

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 13/158 (8%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 138 SPFLVTLLGYCMERNKRILVYEYMP---NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
            P +V LL      NK  LV+E++     K +     +   L L  S  F+++    + L
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 117
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            F H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 118 AFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 71/149 (47%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM   SL + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 85  EPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
             +N+L+  +   KV+DFGL+R+  + E+
Sbjct: 141 AAANILVGENLVCKVADFGLARLIEDNEY 169

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 76  KELKNATNDFDEANVIGKGGSGTVFLG----IARDGKLLAIKRLDT-FSLQTEREFQNEL 130
           KEL       D+  V+G G  G V  G     ++    +AIK L   ++ +  R+F  E 
Sbjct: 11  KELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 131 QILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLVLKWSQRFEIIMD 189
            I+G    P ++ L G   +    ++V E M N SL   L   D    +   Q   ++  
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRG 126
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +A  +++L    D   +H D+   N+L++S+   KVSDFGLSR+
Sbjct: 127 IASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRV 167

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 78/155 (50%), Gaps = 7/155 (4%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P +V LL      NK  LV+E++ ++ L+  + +     +        +  + + L F 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 24/170 (14%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDT---------FSLQTEREFQN 128
           AT+ ++    IG G  GTV+   ARD   G  +A+K +             + T RE   
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYK--ARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVA- 63
Query: 129 ELQILGGLRSPFLVTLLGYCMERN-----KRILVYEYMPNKSLQEMLFSDGNLVLKWSQR 183
            L+ L     P +V L+  C         K  LV+E++ ++ L+  L       L     
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETI 122
Query: 184 FEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            +++    + L+FLH  C   ++H D+KP N+L+ S    K++DFGL+RI
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 18/163 (11%)
Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTERE-FQNELQILGGLRSPF 140
            DF+    +G+GG G VF    + D    AIKR+   + +  RE    E++ L  L  P 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 141 LVTLLGYCMERN-------KRILVYEYMPNKSLQEMLFSD---GNLVLKWSQR---FEII 187
           +V      +E+N           VY Y+  +  ++    D   G   ++  +R     I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL 230
           + +A+A+EFLH      ++H D+KPSN+    D   KV DFGL
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 85/171 (49%), Gaps = 21/171 (12%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARDG----KLLAIKRLDTFSLQTEREFQNELQ--I 132
           K   + F+   V+G+G  G VFL     G    +L A+K L   +L+     + +++  I
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEII 187
           L  +  PF+V L        K  L+ +++    L     +E++F++ ++          +
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-------YL 132
Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
            ++A AL+ LH      +I+ D+KP N+LLD +   K++DFGLS+  ++ E
Sbjct: 133 AELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM    L + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 85  EPIYI-VMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+  +   KV+DFGL+R+  + E+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEY 169

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 85/171 (49%), Gaps = 21/171 (12%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARDG----KLLAIKRLDTFSLQTEREFQNELQ--I 132
           K   + F+   V+G+G  G VFL     G    +L A+K L   +L+     + +++  I
Sbjct: 21  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 80
Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEII 187
           L  +  PF+V L        K  L+ +++    L     +E++F++ ++          +
Sbjct: 81  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-------YL 133
Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
            ++A AL+ LH      +I+ D+KP N+LLD +   K++DFGLS+  ++ E
Sbjct: 134 AELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 181

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 25/162 (15%)
Query: 85  FDEANVIGKGGSGTVF----LGIARDGKLLAIKRL----------DTFSLQTEREFQNEL 130
           F+   V+GKGG G VF    +  A  GK+ A+K L          DT   + ER      
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER------ 72
Query: 131 QILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDV 190
            IL  ++ PF+V L+       K  L+ EY+    L   L  +G + ++ +  F  + ++
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACF-YLAEI 130
Query: 191 AKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + AL  LH      +I+ D+KP N++L+     K++DFGL +
Sbjct: 131 SMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 25/162 (15%)
Query: 85  FDEANVIGKGGSGTVF----LGIARDGKLLAIKRL----------DTFSLQTEREFQNEL 130
           F+   V+GKGG G VF    +  A  GK+ A+K L          DT   + ER      
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER------ 72
Query: 131 QILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDV 190
            IL  ++ PF+V L+       K  L+ EY+    L   L  +G + ++ +  F  + ++
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACF-YLAEI 130
Query: 191 AKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + AL  LH      +I+ D+KP N++L+     K++DFGL +
Sbjct: 131 SMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 5/143 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L     E
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM   SL + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 82  EPIYI-VTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRDL 137
Query: 211 KPSNVLLDSDCRGKVSDFGLSRI 233
           + +N+L+  +   KV+DFGL+R+
Sbjct: 138 RAANILVGENLVCKVADFGLARL 160

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 85/171 (49%), Gaps = 21/171 (12%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARDG----KLLAIKRLDTFSLQTEREFQNELQ--I 132
           K   + F+   V+G+G  G VFL     G    +L A+K L   +L+     + +++  I
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEII 187
           L  +  PF+V L        K  L+ +++    L     +E++F++ ++          +
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-------YL 132
Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
            ++A AL+ LH      +I+ D+KP N+LLD +   K++DFGLS+  ++ E
Sbjct: 133 AELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 77/157 (49%), Gaps = 10/157 (6%)
Query: 80  NATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRL--DTFSLQTEREFQNELQILGGL 136
            +   ++   ++G+G  G V     +D G+++AIK+          ++    E+++L  L
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEM-LFSDGNLVLKWSQRFEIIMDVAKALE 195
           R   LV LL  C ++ +  LV+E++ +  L ++ LF +G   L +    + +  +   + 
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIG 138
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           F H      +IH DIKP N+L+      K+ DFG +R
Sbjct: 139 FCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFAR 172

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 9/153 (5%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARDGK-LLAIKRLDTFSLQTEREFQN---ELQILGGLRS 138
           + F+    IGKG  G V +    D K + A+K ++        E +N   ELQI+ GL  
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           PFLV L     +     +V + +    L+  L    N+  K       I ++  AL++L 
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICELVMALDYLQ 132
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              +  +IH D+KP N+LLD      ++DF ++
Sbjct: 133 ---NQRIIHRDMKPDNILLDEHGHVHITDFNIA 162

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM    L + L  +    L+  Q  ++   +A  + ++        +H D+
Sbjct: 85  EPIYI-VTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+  +   KV+DFGL+R+  + E+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEY 169

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 78/155 (50%), Gaps = 7/155 (4%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P +V LL      NK  LV+E++ +  L++ + +     +        +  + + L F 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G +G V++G       +A+K L   S+  +  F  E  ++  L+   LV L     +
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I+  EYM N SL + L +   + L  ++  ++   +A+ + F+    +   IH D+
Sbjct: 80  EPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
           + +N+L+      K++DFGL+R+  + E
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDAE 163

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 78/155 (50%), Gaps = 7/155 (4%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLR 137
           +  +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P +V LL      NK  LV+E++ +  L++ + +     +        +  + + L F 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 122 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 5/152 (3%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
            D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++  ++ P L
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 278
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           V LLG C       ++ E+M   +L + L       +       +   ++ A+E+L    
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 335
Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               IH ++   N L+  +   KV+DFGLSR+
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRL 367

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 77/152 (50%), Gaps = 7/152 (4%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPF 140
           +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L  P 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V LL      NK  LV+E++ ++ L+  + +     +        +  + + L F H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               V+H D+KP N+L++++   K++DFGL+R
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 72/141 (51%), Gaps = 7/141 (4%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           IG+G SGTV+  +    G+ +AI++++      +    NE+ ++   ++P +V  L   +
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             ++  +V EY+   SL +++       +   Q   +  +  +ALEFLH      VIH +
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRN 142
Query: 210 IKPSNVLLDSDCRGKVSDFGL 230
           IK  N+LL  D   K++DFG 
Sbjct: 143 IKSDNILLGMDGSVKLTDFGF 163

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 73/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++G       +A+K L   S+  +  F  E  ++  L+   LV L     +
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I+  EYM N SL + L +   + L  ++  ++   +A+ + F+    +   IH D+
Sbjct: 90  EPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 145
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+      K++DFGL+R+  + E+
Sbjct: 146 RAANILVSDTLSCKIADFGLARLIEDNEY 174

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 73/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++G       +A+K L   S+  +  F  E  ++  L+   LV L     +
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I+  EYM N SL + L +   + L  ++  ++   +A+ + F+    +   IH D+
Sbjct: 85  EPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 140
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+      K++DFGL+R+  + E+
Sbjct: 141 RAANILVSDTLSCKIADFGLARLIEDNEY 169

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 73/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++G       +A+K L   S+  +  F  E  ++  L+   LV L     +
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I+  EYM N SL + L +   + L  ++  ++   +A+ + F+    +   IH D+
Sbjct: 86  EPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 141
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+      K++DFGL+R+  + E+
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEY 170

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 7/141 (4%)
Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           IG+G +G V +   R  GKL+A+K++D    Q      NE+ I+   +   +V +    +
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             ++  +V E++   +L +++    +  +   Q   + + V +AL  LH      VIH D
Sbjct: 219 VGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRD 272
Query: 210 IKPSNVLLDSDCRGKVSDFGL 230
           IK  ++LL  D R K+SDFG 
Sbjct: 273 IKSDSILLTHDGRVKLSDFGF 293

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 71/151 (47%), Gaps = 5/151 (3%)
Query: 84  DFDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQILGGLRSPFLV 142
           D    + +G G  G V+ G+ +   L +A+K L   +++ E EF  E  ++  ++ P LV
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 318
Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
            LLG C       ++ E+M   +L + L       +       +   ++ A+E+L     
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---K 375
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
              IH ++   N L+  +   KV+DFGLSR+
Sbjct: 376 KNFIHRNLAARNCLVGENHLVKVADFGLSRL 406

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 73/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++G       +A+K L   S+  +  F  E  ++  L+   LV L     +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I+  EYM N SL + L +   + L  ++  ++   +A+ + F+    +   IH D+
Sbjct: 80  EPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+      K++DFGL+R+  + E+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEY 164

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 74/150 (49%), Gaps = 17/150 (11%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTERE-----FQNELQILGGLRSPFLV 142
           +G GG  TV+L  A D  L   +AIK +  F    E+E     F+ E+     L    +V
Sbjct: 19  LGGGGMSTVYL--AEDTILNIKVAIKAI--FIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           +++    E +   LV EY+   +L E + S G L +  +  F       + L+ +    D
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINF-----TNQILDGIKHAHD 129
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
             ++H DIKP N+L+DS+   K+ DFG+++
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAK 159

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 32/190 (16%)
Query: 62  FDSNAPLKLQRFTYKELKNAT----NDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLD 116
           F SNA  +   F  +EL          +   + +G G  G+V      + G  +A+K+L 
Sbjct: 20  FQSNASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL- 78
Query: 117 TFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQE-------- 168
                  R FQ+   I+   R+   + LL +    N   L+  + P +SL+E        
Sbjct: 79  ------SRPFQS---IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 129
Query: 169 -MLFSDGNLVLKWSQRFE-----IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR 222
            ++ +D N ++K  +  +     +I  + + L+++H      +IH D+KPSN+ ++ DC 
Sbjct: 130 HLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCE 186
Query: 223 GKVSDFGLSR 232
            K+ DFGL+R
Sbjct: 187 LKILDFGLAR 196

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 7/141 (4%)
Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           IG+G +G V +   R  GKL+A+K++D    Q      NE+ I+   +   +V +    +
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             ++  +V E++   +L +++    +  +   Q   + + V +AL  LH      VIH D
Sbjct: 97  VGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRD 150
Query: 210 IKPSNVLLDSDCRGKVSDFGL 230
           IK  ++LL  D R K+SDFG 
Sbjct: 151 IKSDSILLTHDGRVKLSDFGF 171

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 7/141 (4%)
Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           IG+G +G V +   R  GKL+A+K++D    Q      NE+ I+   +   +V +    +
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             ++  +V E++   +L +++    +  +   Q   + + V +AL  LH      VIH D
Sbjct: 99  VGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRD 152
Query: 210 IKPSNVLLDSDCRGKVSDFGL 230
           IK  ++LL  D R K+SDFG 
Sbjct: 153 IKSDSILLTHDGRVKLSDFGF 173

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 76/151 (50%), Gaps = 12/151 (7%)
Query: 90  VIGKGGSGTVFLGIAR--DGKL---LAIKRLDTFSLQTER-EFQNELQILGGLRSPFLVT 143
           VIG G  G V+ G+ +   GK    +AIK L     + +R +F  E  I+G      ++ 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLF-SDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           L G   +    +++ EYM N +L + L   DG   +   Q   ++  +A  +++L    +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL--QLVGMLRGIAAGMKYL---AN 165
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
              +H D+   N+L++S+   KVSDFGLSR+
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 7/141 (4%)
Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           IG+G +G V +   R  GKL+A+K++D    Q      NE+ I+   +   +V +    +
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             ++  +V E++   +L +++    +  +   Q   + + V +AL  LH      VIH D
Sbjct: 88  VGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRD 141
Query: 210 IKPSNVLLDSDCRGKVSDFGL 230
           IK  ++LL  D R K+SDFG 
Sbjct: 142 IKSDSILLTHDGRVKLSDFGF 162

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 79/163 (48%), Gaps = 11/163 (6%)
Query: 76  KELKNATNDFDEANV------IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQN 128
           +E ++   D D   V      +G G  G V+    ++ G L A K ++T S +   ++  
Sbjct: 6   REYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV 65
Query: 129 ELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM 188
           E++IL     P++V LLG      K  ++ E+ P  ++  ++  + +  L   Q   +  
Sbjct: 66  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIML-ELDRGLTEPQIQVVCR 124
Query: 189 DVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            + +AL FLH      +IH D+K  NVL+  +   +++DFG+S
Sbjct: 125 QMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVS 164

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 73/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++G       +A+K L   S+  +  F  E  ++  L+   LV L     +
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I+  EYM N SL + L +   + L  ++  ++   +A+ + F+    +   IH D+
Sbjct: 75  EPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 130
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+      K++DFGL+R+  + E+
Sbjct: 131 RAANILVSDTLSCKIADFGLARLIEDNEY 159

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 7/141 (4%)
Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           IG+G +G V +   R  GKL+A+K++D    Q      NE+ I+   +   +V +    +
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             ++  +V E++   +L +++    +  +   Q   + + V +AL  LH      VIH D
Sbjct: 92  VGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRD 145
Query: 210 IKPSNVLLDSDCRGKVSDFGL 230
           IK  ++LL  D R K+SDFG 
Sbjct: 146 IKSDSILLTHDGRVKLSDFGF 166

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 77/152 (50%), Gaps = 7/152 (4%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPF 140
           +F +   IG+G  G V+    +  G+++A+   RLDT +         E+ +L  L  P 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               V+H D+KP N+L++++   K++DFGL+R
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 77/152 (50%), Gaps = 7/152 (4%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPF 140
           +F +   IG+G  G V+    +  G+++A+   RLDT +         E+ +L  L  P 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               V+H D+KP N+L++++   K++DFGL+R
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V   I  R G+ +AIK+L        R FQ+E+      R    + LL +  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRE---LLLLKHMQ 81
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---------RFE------IIMDVAKAL 194
             N   L+  + P  SL+   F D  LV+ + Q         +F       ++  + K L
Sbjct: 82  HENVIGLLDVFTPASSLRN--FYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGL 139
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +++H      V+H D+KP N+ ++ DC  K+ DFGL+R
Sbjct: 140 KYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    IG G  G V L      G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EYMP   +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     KV+DFG ++ +V+G
Sbjct: 156 YLH-SLD--LIYRDLKPENLLIDQQGYIKVADFGFAK-RVKG 193

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    IG G  G V L      G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EYMP   +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     KV+DFG ++ +V+G
Sbjct: 156 YLH-SLD--LIYRDLKPENLLIDQQGYIKVADFGFAK-RVKG 193

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 7/141 (4%)
Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           IG+G +G V +   R  GKL+A+K++D    Q      NE+ I+   +   +V +    +
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             ++  +V E++   +L +++    +  +   Q   + + V +AL  LH      VIH D
Sbjct: 142 VGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRD 195
Query: 210 IKPSNVLLDSDCRGKVSDFGL 230
           IK  ++LL  D R K+SDFG 
Sbjct: 196 IKSDSILLTHDGRVKLSDFGF 216

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 75/167 (44%), Gaps = 25/167 (14%)
Query: 84  DFDEAN---VIGKGGSGTVFLGIARDGKLLAIKRL----DTFSLQTEREFQNELQILGGL 136
           DF E     +IG GG G V+      G  +A+K      D    QT    + E ++   L
Sbjct: 5   DFAELTLEEIIGIGGFGKVYRAF-WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD---GNLVLKWSQRFEIIMDVAKA 193
           + P ++ L G C++     LV E+     L  +L       ++++ W+      + +A+ 
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWA------VQIARG 117
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRG--------KVSDFGLSR 232
           + +LH     P+IH D+K SN+L+              K++DFGL+R
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 70/151 (46%), Gaps = 8/151 (5%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLD--TFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
           +G G  G V++G   +   +A+K L   T S+Q    F  E  ++  L+   LV L    
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAVV 77
Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHG 208
                  ++ EYM   SL + L SD    +   +  +    +A+ + ++        IH 
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 134
Query: 209 DIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           D++ +NVL+      K++DFGL+R+  + E+
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEY 165

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 129
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 168

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 77/163 (47%), Gaps = 15/163 (9%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK-------RLDTFSLQTEREF-QNE 129
           K     +D  +VIG+G S  V   + R  G   A+K       RL    L+  RE  + E
Sbjct: 90  KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149
Query: 130 LQILGGLRS-PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM 188
             IL  +   P ++TL+      +   LV++ M    L + L     L  K ++   I+ 
Sbjct: 150 THILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR--SIMR 207
Query: 189 DVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            + +A+ FLH      ++H D+KP N+LLD + + ++SDFG S
Sbjct: 208 SLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFS 247

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 128
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 129 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 167

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 85  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 137
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 138 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 176

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 131
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 132 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 170

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 78/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 75
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K ++  +     +I  + + L+
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLK 135
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 136 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 130
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 131 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWC------VQIA 128
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 129 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 167

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 7/144 (4%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKR--LDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
           +G+G  G V+      G+++A+KR  LD            E+ +L  L  P +V+L+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHG 208
                  LV+E+M  K L+++L  +    L+ SQ    +  + + +   H      ++H 
Sbjct: 89  HSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHR 143
Query: 209 DIKPSNVLLDSDCRGKVSDFGLSR 232
           D+KP N+L++SD   K++DFGL+R
Sbjct: 144 DLKPQNLLINSDGALKLADFGLAR 167

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 70/143 (48%), Gaps = 5/143 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++G       +A+K L   S+  +  F  E  ++  L+   LV L     +
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I+  EYM N SL + L +   + L  ++  ++   +A+ + F+    +   IH D+
Sbjct: 88  EPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 143
Query: 211 KPSNVLLDSDCRGKVSDFGLSRI 233
           + +N+L+      K++DFGL+R+
Sbjct: 144 RAANILVSDTLSCKIADFGLARL 166

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 90  VIGKGGSGTVFLG--IARDGKLL--AIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTL 144
           VIG+G  G V+ G  +  DGK +  A+K L+  + +    +F  E  I+     P +++L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 145 LGYCME-RNKRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           LG C+      ++V  YM +  L+  + ++  N  +K    F   + VAK ++FL     
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKFL---AS 152
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +H D+   N +LD     KV+DFGL+R  ++ EF
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEF 189

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 70/143 (48%), Gaps = 5/143 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++G       +A+K L   S+  +  F  E  ++  L+   LV L     +
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I+  EYM N SL + L +   + L  ++  ++   +A+ + F+    +   IH D+
Sbjct: 86  EPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 141
Query: 211 KPSNVLLDSDCRGKVSDFGLSRI 233
           + +N+L+      K++DFGL+R+
Sbjct: 142 RAANILVSDTLSCKIADFGLARL 164

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 7/144 (4%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKR--LDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
           +G+G  G V+      G+++A+KR  LD            E+ +L  L  P +V+L+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHG 208
                  LV+E+M  K L+++L  +    L+ SQ    +  + + +   H      ++H 
Sbjct: 89  HSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHR 143
Query: 209 DIKPSNVLLDSDCRGKVSDFGLSR 232
           D+KP N+L++SD   K++DFGL+R
Sbjct: 144 DLKPQNLLINSDGALKLADFGLAR 167

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 85
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 146 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 69  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 121
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 122 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 81  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 133
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 134 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 172

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 70/143 (48%), Gaps = 5/143 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++G       +A+K L   S+  +  F  E  ++  L+   LV L     +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I+  EYM N SL + L +   + L  ++  ++   +A+ + F+    +   IH D+
Sbjct: 80  EPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 211 KPSNVLLDSDCRGKVSDFGLSRI 233
           + +N+L+      K++DFGL+R+
Sbjct: 136 RAANILVSDTLSCKIADFGLARL 158

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 129
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 168

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 70/143 (48%), Gaps = 5/143 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++G       +A+K L   S+  +  F  E  ++  L+   LV L     +
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I+  EYM N SL + L +   + L  ++  ++   +A+ + F+    +   IH D+
Sbjct: 81  EPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 136
Query: 211 KPSNVLLDSDCRGKVSDFGLSRI 233
           + +N+L+      K++DFGL+R+
Sbjct: 137 RAANILVSDTLSCKIADFGLARL 159

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 130
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 131 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 70/143 (48%), Gaps = 5/143 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++G       +A+K L   S+  +  F  E  ++  L+   LV L     +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I+  EYM N SL + L +   + L  ++  ++   +A+ + F+    +   IH D+
Sbjct: 80  EPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 211 KPSNVLLDSDCRGKVSDFGLSRI 233
           + +N+L+      K++DFGL+R+
Sbjct: 136 RAANILVSDTLSCKIADFGLARL 158

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 89
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 90  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 149
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 150 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 183

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 130
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 131 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 130
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 131 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 32/207 (15%)
Query: 53  LVNRSRTIPFDSNAPLKL-----QRFTYKEL---------KNATNDFDEANVIGKGGSGT 98
           LV + +  P ++N+ + L     + F + +L         K   +++  +  +G G  G 
Sbjct: 105 LVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGE 164
Query: 99  VFLGIARDG-KLLAIKRLDT--FSLQTERE------FQNELQILGGLRSPFLVTLLGYCM 149
           V L   R   K +AI+ +    F++ + RE       + E++IL  L  P ++ +  +  
Sbjct: 165 VKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-F 223
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
           +     +V E M    L + +   GN  LK +        +  A+++LH   +  +IH D
Sbjct: 224 DAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRD 278
Query: 210 IKPSNVLLDS---DCRGKVSDFGLSRI 233
           +KP NVLL S   DC  K++DFG S+I
Sbjct: 279 LKPENVLLSSQEEDCLIKITDFGHSKI 305

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 70/143 (48%), Gaps = 5/143 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++G       +A+K L   S+  +  F  E  ++  L+   LV L     +
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I+  EYM N SL + L +   + L  ++  ++   +A+ + F+    +   IH D+
Sbjct: 82  EPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 137
Query: 211 KPSNVLLDSDCRGKVSDFGLSRI 233
           + +N+L+      K++DFGL+R+
Sbjct: 138 RAANILVSDTLSCKIADFGLARL 160

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 20/169 (11%)
Query: 71  QRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ--TEREFQN 128
           Q+    ELK+  +DF+  + +G G  G V     R   L+  ++L    ++     +   
Sbjct: 6   QKAKVGELKD--DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIR 63
Query: 129 ELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF---- 184
           ELQ+L    SP++V   G      +  +  E+M   SL +        VLK ++R     
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ--------VLKEAKRIPEEI 115
Query: 185 --EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
             ++ + V + L +L       ++H D+KPSN+L++S    K+ DFG+S
Sbjct: 116 LGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS 162

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 134
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 135 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 173

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 70/143 (48%), Gaps = 5/143 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++G       +A+K L   S+  +  F  E  ++  L+   LV L     +
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I+  EYM N SL + L +   + L  ++  ++   +A+ + F+    +   IH D+
Sbjct: 89  EPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 144
Query: 211 KPSNVLLDSDCRGKVSDFGLSRI 233
           + +N+L+      K++DFGL+R+
Sbjct: 145 RAANILVSDTLSCKIADFGLARL 167

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 100 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 152
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 153 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 191

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 72/141 (51%), Gaps = 7/141 (4%)
Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           IG+G +G V +   +  GK +A+K++D    Q      NE+ I+       +V +    +
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             ++  +V E++   +L +++    +  +   Q   + + V +AL +LH   +  VIH D
Sbjct: 113 VGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRD 166
Query: 210 IKPSNVLLDSDCRGKVSDFGL 230
           IK  ++LL SD R K+SDFG 
Sbjct: 167 IKSDSILLTSDGRIKLSDFGF 187

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 72/142 (50%), Gaps = 5/142 (3%)
Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G V+    ++ G L A K ++T S +   ++  E++IL     P++V LLG   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
              K  ++ E+ P  ++  ++  + +  L   Q   +   + +AL FLH      +IH D
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIML-ELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRD 134
Query: 210 IKPSNVLLDSDCRGKVSDFGLS 231
           +K  NVL+  +   +++DFG+S
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVS 156

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +R    ELQI+  L    +V 
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 105
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVA 191
           L  +     ++       LV +Y+P     E ++       +  Q   +I        + 
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 160
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           ++L ++H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        
Sbjct: 161 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 216
Query: 250 KSQEL 254
           ++ EL
Sbjct: 217 RAPEL 221

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 18/167 (10%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARDG-KLLAIKRLDT--FSLQTERE------FQNE 129
           K   +++  +  +G G  G V L   R   K +AIK +    F++ + RE       + E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 130 LQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMD 189
           ++IL  L  P ++ +  +  +     +V E M    L + +   GN  LK +        
Sbjct: 66  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQ 122
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLSRI 233
           +  A+++LH   +  +IH D+KP NVLL S   DC  K++DFG S+I
Sbjct: 123 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 83/172 (48%), Gaps = 20/172 (11%)
Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNEL---QILGGLRS 138
           N+F+   ++GKG  G V L   +  G+  A+K L    +  + E  + L   ++L   R 
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 139 PFLVTLLGYCMERNKRI-LVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEIIMDVAK 192
           PFL T L Y  + + R+  V EY     L     +E +FS+         RF    ++  
Sbjct: 211 PFL-TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR------ARF-YGAEIVS 262
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLF 244
           AL++LH   +  V++ D+K  N++LD D   K++DFGL +  ++    M  F
Sbjct: 263 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 312

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 83/172 (48%), Gaps = 20/172 (11%)
Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNEL---QILGGLRS 138
           N+F+   ++GKG  G V L   +  G+  A+K L    +  + E  + L   ++L   R 
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 139 PFLVTLLGYCMERNKRI-LVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEIIMDVAK 192
           PFL T L Y  + + R+  V EY     L     +E +FS+         RF    ++  
Sbjct: 208 PFL-TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR------ARF-YGAEIVS 259
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLF 244
           AL++LH   +  V++ D+K  N++LD D   K++DFGL +  ++    M  F
Sbjct: 260 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 309

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 32/207 (15%)
Query: 53  LVNRSRTIPFDSNAPLKL-----QRFTYKEL---------KNATNDFDEANVIGKGGSGT 98
           LV + +  P ++N+ + L     + F + +L         K   +++  +  +G G  G 
Sbjct: 91  LVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGE 150
Query: 99  VFLGIARDG-KLLAIKRLDT--FSLQTERE------FQNELQILGGLRSPFLVTLLGYCM 149
           V L   R   K +AI+ +    F++ + RE       + E++IL  L  P ++ +  +  
Sbjct: 151 VKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-F 209
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
           +     +V E M    L + +   GN  LK +        +  A+++LH   +  +IH D
Sbjct: 210 DAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRD 264
Query: 210 IKPSNVLLDS---DCRGKVSDFGLSRI 233
           +KP NVLL S   DC  K++DFG S+I
Sbjct: 265 LKPENVLLSSQEEDCLIKITDFGHSKI 291

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 18/157 (11%)
Query: 85  FDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTERE------FQNELQILGGLR 137
           +++   IG+G  G VF    RD G+++AIK+     L++E +         E+++L  L+
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF----LESEDDPVIKKIALREIRMLKQLK 60
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P LV LL     + +  LV+EY  +  L E+      +     +   I     +A+ F 
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVK--SITWQTLQAVNFC 118
Query: 198 H-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H   C    IH D+KP N+L+      K+ DFG +R+
Sbjct: 119 HKHNC----IHRDVKPENILITKHSVIKLCDFGFARL 151

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 10/159 (6%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKLL-AIKRLDTFSLQTEREFQNELQ----ILGGLR 137
           +DF    VIGKG  G V L   +  ++  A+K L   ++  ++E ++ +     +L  ++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            PFLV L       +K   V +Y+    L   L  +    L+   RF    ++A AL +L
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARF-YAAEIASALGYL 155
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVE 236
           H      +++ D+KP N+LLDS     ++DFGL +  +E
Sbjct: 156 H---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 75
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 136 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 18/167 (10%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARDG-KLLAIKRLDT--FSLQTERE------FQNE 129
           K   +++  +  +G G  G V L   R   K +AIK +    F++ + RE       + E
Sbjct: 5   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 64
Query: 130 LQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMD 189
           ++IL  L  P ++ +  +  +     +V E M    L + +   GN  LK +        
Sbjct: 65  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQ 121
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLSRI 233
           +  A+++LH   +  +IH D+KP NVLL S   DC  K++DFG S+I
Sbjct: 122 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 165

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 18/167 (10%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARDG-KLLAIKRLDT--FSLQTERE------FQNE 129
           K   +++  +  +G G  G V L   R   K +AIK +    F++ + RE       + E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 130 LQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMD 189
           ++IL  L  P ++ +  +  +     +V E M    L + +   GN  LK +        
Sbjct: 66  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQ 122
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLSRI 233
           +  A+++LH   +  +IH D+KP NVLL S   DC  K++DFG S+I
Sbjct: 123 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +R    ELQI+  L    +V 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 111
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVA 191
           L  +     ++       LV +Y+P     E ++       +  Q   +I        + 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           ++L ++H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        
Sbjct: 167 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 222
Query: 250 KSQEL 254
           ++ EL
Sbjct: 223 RAPEL 227

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +R    ELQI+  L    +V 
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 115
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVA 191
           L  +     ++       LV +Y+P     E ++       +  Q   +I        + 
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 170
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           ++L ++H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        
Sbjct: 171 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 226
Query: 250 KSQEL 254
           ++ EL
Sbjct: 227 RAPEL 231

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 90  VIGKGGSGTVFLG--IARDGKLL--AIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTL 144
           VIG+G  G V+ G  +  DGK +  A+K L+  + +    +F  E  I+     P +++L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 145 LGYCME-RNKRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           LG C+      ++V  YM +  L+  + ++  N  +K    F   + VAK ++FL     
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKFL---AS 149
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +H D+   N +LD     KV+DFGL+R   + EF
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 186

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +R    ELQI+  L    +V 
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 82
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVA 191
           L  +     ++       LV +Y+P     E ++       +  Q   +I        + 
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 137
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           ++L ++H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        
Sbjct: 138 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 193
Query: 250 KSQEL 254
           ++ EL
Sbjct: 194 RAPEL 198

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 99
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 159
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 160 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 75
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 136 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 98
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 158
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 159 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 18/167 (10%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARDG-KLLAIKRLDT--FSLQTERE------FQNE 129
           K   +++  +  +G G  G V L   R   K +AIK +    F++ + RE       + E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 130 LQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMD 189
           ++IL  L  P ++ +  +  +     +V E M    L + +   GN  LK +        
Sbjct: 66  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQ 122
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLSRI 233
           +  A+++LH   +  +IH D+KP NVLL S   DC  K++DFG S+I
Sbjct: 123 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +R    ELQI+  L    +V 
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 113
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVA 191
           L  +     ++       LV +Y+P     E ++       +  Q   +I        + 
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 168
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           ++L ++H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        
Sbjct: 169 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 224
Query: 250 KSQEL 254
           ++ EL
Sbjct: 225 RAPEL 229

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 90  VIGKGGSGTVFLG--IARDGKLL--AIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTL 144
           VIG+G  G V+ G  +  DGK +  A+K L+  + +    +F  E  I+     P +++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 145 LGYCME-RNKRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           LG C+      ++V  YM +  L+  + ++  N  +K    F   + VAK ++FL     
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKFL---AS 151
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +H D+   N +LD     KV+DFGL+R   + EF
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 188

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +R    ELQI+  L    +V 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 111
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVA 191
           L  +     ++       LV +Y+P     E ++       +  Q   +I        + 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           ++L ++H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        
Sbjct: 167 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 222
Query: 250 KSQEL 254
           ++ EL
Sbjct: 223 RAPEL 227

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 90  VIGKGGSGTVFLG--IARDGKLL--AIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTL 144
           VIG+G  G V+ G  +  DGK +  A+K L+  + +    +F  E  I+     P +++L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 145 LGYCME-RNKRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           LG C+      ++V  YM +  L+  + ++  N  +K    F   + VAK ++FL     
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKFL---AS 156
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +H D+   N +LD     KV+DFGL+R   + EF
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 193

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 90  VIGKGGSGTVFLG--IARDGKLL--AIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTL 144
           VIG+G  G V+ G  +  DGK +  A+K L+  + +    +F  E  I+     P +++L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 145 LGYCME-RNKRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           LG C+      ++V  YM +  L+  + ++  N  +K    F   + VAK ++FL     
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKFL---AS 152
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +H D+   N +LD     KV+DFGL+R   + EF
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 189

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 18/167 (10%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARDG-KLLAIKRLDT--FSLQTERE------FQNE 129
           K   +++  +  +G G  G V L   R   K +AIK +    F++ + RE       + E
Sbjct: 12  KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 71
Query: 130 LQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMD 189
           ++IL  L  P ++ +  +  +     +V E M    L + +   GN  LK +        
Sbjct: 72  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQ 128
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLSRI 233
           +  A+++LH   +  +IH D+KP NVLL S   DC  K++DFG S+I
Sbjct: 129 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 172

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 8/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTV-FLGIARDGKLLAIKRL-DTFSLQTEREFQNELQI-LGGLRS 138
            +D +    +G+G  G V  +     G+++A+KR+  T + Q ++    +L I +  +  
Sbjct: 50  ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 109
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEML--FSDGNLVLKWSQRFEIIMDVAKALEF 196
           PF VT  G         +  E M + SL +      D    +      +I + + KALE 
Sbjct: 110 PFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 168
Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           LH      VIH D+KPSNVL+++  + K+ DFG+S
Sbjct: 169 LHSKLS--VIHRDVKPSNVLINALGQVKMCDFGIS 201

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +R    ELQI+  L    +V 
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 85
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVA 191
           L  +     ++       LV +Y+P     E ++       +  Q   +I        + 
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 140
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           ++L ++H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        
Sbjct: 141 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 196
Query: 250 KSQEL 254
           ++ EL
Sbjct: 197 RAPEL 201

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 80/173 (46%), Gaps = 25/173 (14%)
Query: 78  LKNATNDFDEANVIGKGGSGTVFLGIAR--DGKLLAIKRLDTFSLQTEREFQ---NELQI 132
           + +   D++    IG G  G     I R  DGK+L  K LD  S+ TE E Q   +E+ +
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRC-QKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNL 58
Query: 133 LGGLRSPFLVTLLGYCMERNKRIL--VYEY--------MPNKSLQEMLFSDGNLVLKWSQ 182
           L  L+ P +V      ++R    L  V EY        +  K  +E  + D   VL+   
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR--- 115
Query: 183 RFEIIMDVAKALEFLHFGCD--PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
              ++  +  AL+  H   D    V+H D+KP+NV LD     K+ DFGL+RI
Sbjct: 116 ---VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 99
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 159
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 160 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 81/157 (51%), Gaps = 12/157 (7%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARDG-KLLAIKRLDTF--SLQTEREFQNELQILGGLRSP 139
           ++++  ++IG+G  G V+L   ++  K +AIK+++     L   +    E+ IL  L+S 
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 140 FLVTLLGYCMERN----KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALE 195
           +++ L    +  +      + +   + +  L+++  +   + L       I+ ++    +
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTP--IFLTEQHVKTILYNLLLGEK 145
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           F+H   +  +IH D+KP+N LL+ DC  K+ DFGL+R
Sbjct: 146 FIH---ESGIIHRDLKPANCLLNQDCSVKICDFGLAR 179

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +R    ELQI+  L    +V 
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 90
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVA 191
           L  +     ++       LV +Y+P     E ++       +  Q   +I        + 
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 145
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           ++L ++H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        
Sbjct: 146 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 201
Query: 250 KSQEL 254
           ++ EL
Sbjct: 202 RAPEL 206

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQILGGLR 137
           DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  ++  L 
Sbjct: 38  DFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 95
Query: 138 SPFLVTLLGYCMERNKRILV-YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEF 196
            PF V L  +C + ++++     Y  N  L + +   G+   +   RF    ++  ALE+
Sbjct: 96  HPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVSALEY 152
Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           LH      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 153 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 186

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 78/167 (46%), Gaps = 25/167 (14%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR--DGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           D++    IG G  G     I R  DGK+L  K LD  S+ TE E Q   +E+ +L  L+ 
Sbjct: 7   DYEVLYTIGTGSYGRC-QKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKH 64
Query: 139 PFLVTLLGYCMERNKRIL--VYEY--------MPNKSLQEMLFSDGNLVLKWSQRFEIIM 188
           P +V      ++R    L  V EY        +  K  +E  + D   VL+      ++ 
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR------VMT 118
Query: 189 DVAKALEFLHFGCD--PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            +  AL+  H   D    V+H D+KP+NV LD     K+ DFGL+RI
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V   I  R G+ +AIK+L        R FQ+E+      R    + LL +  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRE---LLLLKHMQ 99
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---------RFE------IIMDVAKAL 194
             N   L+  + P  SL+   F D  LV+ + Q          F       ++  + K L
Sbjct: 100 HENVIGLLDVFTPASSLRN--FYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGL 157
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +++H      V+H D+KP N+ ++ DC  K+ DFGL+R
Sbjct: 158 KYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +R    ELQI+  L    +V 
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 96
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVA 191
           L  +     ++       LV +Y+P     E ++       +  Q   +I        + 
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 151
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           ++L ++H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        
Sbjct: 152 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 207
Query: 250 KSQEL 254
           ++ EL
Sbjct: 208 RAPEL 212

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +R    ELQI+  L    +V 
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 156
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVA 191
           L  +     ++       LV +Y+P     E ++       +  Q   +I        + 
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 211
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           ++L ++H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        
Sbjct: 212 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 267
Query: 250 KSQEL 254
           ++ EL
Sbjct: 268 RAPEL 272

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 80/173 (46%), Gaps = 25/173 (14%)
Query: 78  LKNATNDFDEANVIGKGGSGTVFLGIAR--DGKLLAIKRLDTFSLQTEREFQ---NELQI 132
           + +   D++    IG G  G     I R  DGK+L  K LD  S+ TE E Q   +E+ +
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRC-QKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNL 58
Query: 133 LGGLRSPFLVTLLGYCMERNKRIL--VYEY--------MPNKSLQEMLFSDGNLVLKWSQ 182
           L  L+ P +V      ++R    L  V EY        +  K  +E  + D   VL+   
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR--- 115
Query: 183 RFEIIMDVAKALEFLHFGCD--PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
              ++  +  AL+  H   D    V+H D+KP+NV LD     K+ DFGL+RI
Sbjct: 116 ---VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 83/180 (46%), Gaps = 18/180 (10%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +R    ELQI+  L    +V 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 77
Query: 144 LLGYCMERN-KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVAKALEF 196
           L  +      K+ +VY  +    + E ++       +  Q   +I        + ++L +
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 197 LH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLGKSQEL 254
           +H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        ++ EL
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 90  VIGKGGSGTVFLG--IARDGKLL--AIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTL 144
           VIG+G  G V+ G  +  DGK +  A+K L+  + +    +F  E  I+     P +++L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 145 LGYCME-RNKRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           LG C+      ++V  YM +  L+  + ++  N  +K    F   + VAK ++FL     
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKFL---AS 210
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +H D+   N +LD     KV+DFGL+R   + EF
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 86
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 147 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 90  VIGKGGSGTVFLG--IARDGKLL--AIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTL 144
           VIG+G  G V+ G  +  DGK +  A+K L+  + +    +F  E  I+     P +++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 145 LGYCME-RNKRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           LG C+      ++V  YM +  L+  + ++  N  +K    F   + VAK ++FL     
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKFL---AS 151
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +H D+   N +LD     KV+DFGL+R   + EF
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 188

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 73/161 (45%), Gaps = 13/161 (8%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQI 132
           K    DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  +
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDV 61
Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           +  L  PF V L     +  K      Y  N  L + +   G+   +   RF    ++  
Sbjct: 62  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVS 119
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           ALE+LH      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 120 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 157

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 73/161 (45%), Gaps = 13/161 (8%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQI 132
           K    DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  +
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDV 62
Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           +  L  PF V L     +  K      Y  N  L + +   G+   +   RF    ++  
Sbjct: 63  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVS 120
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           ALE+LH      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 121 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 158

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 73/161 (45%), Gaps = 13/161 (8%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQI 132
           K    DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  +
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDV 60
Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           +  L  PF V L     +  K      Y  N  L + +   G+   +   RF    ++  
Sbjct: 61  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVS 118
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           ALE+LH      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 119 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 156

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 85
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 146 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 84
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 145 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 73/161 (45%), Gaps = 13/161 (8%)
Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQI 132
           K    DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  +
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDV 63
Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           +  L  PF V L     +  K      Y  N  L + +   G+   +   RF    ++  
Sbjct: 64  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVS 121
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           ALE+LH      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 122 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 159

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +R    ELQI+  L    +V 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 89
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVA 191
           L  +     ++       LV +Y+P     E ++       +  Q   +I        + 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           ++L ++H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        
Sbjct: 145 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 200
Query: 250 KSQEL 254
           ++ EL
Sbjct: 201 RAPEL 205

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 78
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 79  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 138
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 139 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 172

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 74/149 (49%), Gaps = 8/149 (5%)
Query: 85  FDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLD-TFSLQTEREFQNELQILGGLRSPFLV 142
           F +   IGKG  G VF GI  R  +++AIK +D   +     + Q E+ +L    S ++ 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
              G  ++ +K  ++ EY+   S  ++L +         Q   ++ ++ K L++LH    
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLH---S 138
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              IH DIK +NVLL      K++DFG++
Sbjct: 139 EKKIHRDIKAANVLLSEQGDVKLADFGVA 167

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 86
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 147 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +R    ELQI+  L    +V 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 77
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVA 191
           L  +     ++       LV +Y+P     E ++       +  Q   +I        + 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           ++L ++H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        
Sbjct: 133 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 250 KSQEL 254
           ++ EL
Sbjct: 189 RAPEL 193

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 86
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 147 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 85
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 146 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 86
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 147 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +R    ELQI+  L    +V 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 77
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVA 191
           L  +     ++       LV +Y+P     E ++       +  Q   +I        + 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           ++L ++H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        
Sbjct: 133 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 188
Query: 250 KSQEL 254
           ++ EL
Sbjct: 189 RAPEL 193

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +R    ELQI+  L    +V 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 89
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVA 191
           L  +     ++       LV +Y+P     E ++       +  Q   +I        + 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           ++L ++H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        
Sbjct: 145 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 200
Query: 250 KSQEL 254
           ++ EL
Sbjct: 201 RAPEL 205

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +R    ELQI+  L    +V 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 77
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVA 191
           L  +     ++       LV +Y+P     E ++       +  Q   +I        + 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           ++L ++H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        
Sbjct: 133 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 188
Query: 250 KSQEL 254
           ++ EL
Sbjct: 189 RAPEL 193

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 22/171 (12%)
Query: 78  LKNATNDFDEANVIGKGGSGTVFLGIARD----GKLLAIKRL------DTFSLQTEREFQ 127
           L  A   ++    IG+G  G VF   ARD    G+ +A+KR+      +   L T RE  
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFK--ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 128 NELQILGGLRSPFLVTLLGYCM-----ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ 182
             L+ L     P +V L   C         K  LV+E++ ++ L   L       +    
Sbjct: 64  V-LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTET 121
Query: 183 RFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             +++  + + L+FLH      V+H D+KP N+L+ S  + K++DFGL+RI
Sbjct: 122 IKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 81
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 142 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 81
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 142 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    IG G  G V L      G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+P   +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     KV+DFG ++ +V+G
Sbjct: 156 YLH-SLD--LIYRDLKPENLLIDQQGYIKVADFGFAK-RVKG 193

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L      G   A+K LD   +   +E +   NE +IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY P   +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+++D     KV+DFGL++ +V+G
Sbjct: 156 YLH-SLD--LIYRDLKPENLMIDQQGYIKVTDFGLAK-RVKG 193

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 73/149 (48%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++G       +A+K L   S+  +  F  E  ++  L+   LV L     +
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I+  EYM N SL + L +   + L  ++  ++   +A+ + F+    +   IH ++
Sbjct: 76  EPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRNL 131
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+      K++DFGL+R+  + E+
Sbjct: 132 RAANILVSDTLSCKIADFGLARLIEDNEY 160

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 81
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 142 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +R    ELQI+  L    +V 
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 78
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVA 191
           L  +     ++       LV +Y+P     E ++       +  Q   +I        + 
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 133
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           ++L ++H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        
Sbjct: 134 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 189
Query: 250 KSQEL 254
           ++ EL
Sbjct: 190 RAPEL 194

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 91
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 151
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 152 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 90
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 150
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 151 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 184

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 91
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 151
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 152 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 70  IGSGAQGIV--CAAYDAVLDRNVAIKKL-------SRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P K+L+E       M   D NL       L   +   ++  +   +
Sbjct: 121 ---KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 177
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 178 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 20/160 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNEL---QILGGLRS 138
           N+F+   ++GKG  G V L   +  G+  A+K L    +  + E  + L   ++L   R 
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 139 PFLVTLLGYCMERNKRI-LVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEIIMDVAK 192
           PFL T L Y  + + R+  V EY     L     +E +FS+       ++       +  
Sbjct: 69  PFL-TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE-------IVS 120
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           AL++LH   +  V++ D+K  N++LD D   K++DFGL +
Sbjct: 121 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 158

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 9/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSP 139
             D+D    +G+G +G V L + R   + +A+K +D   ++      + E+ I   L   
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH- 198
            +V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 122
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            G    + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 123 IG----ITHRDIKPENLLLDERDNLKISDFGLATV 153

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 98
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 158
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 159 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 8/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTV-FLGIARDGKLLAIKRL-DTFSLQTEREFQNELQI-LGGLRS 138
            +D +    +G+G  G V  +     G+++A+KR+  T + Q ++    +L I +  +  
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEML--FSDGNLVLKWSQRFEIIMDVAKALEF 196
           PF VT  G         +  E M + SL +      D    +      +I + + KALE 
Sbjct: 66  PFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           LH      VIH D+KPSNVL+++  + K+ DFG+S
Sbjct: 125 LHSKLS--VIHRDVKPSNVLINALGQVKMCDFGIS 157

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 84
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 145 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 35/160 (21%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 32  IGSGAQGIV--CAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKW-----SQRFEIIMDVAK---------- 192
              +N   L+  + P KSL+E  F D  +V++      SQ  ++ +D  +          
Sbjct: 83  ---KNIIGLLNVFTPQKSLEE--FQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC 137
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            ++ LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 76
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 136
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 137 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 73/179 (40%), Gaps = 32/179 (17%)
Query: 83  NDFDEANVIGKGGSGTVFLGIA------RDGKLLAIKRL-DTFSLQTEREFQNELQILGG 135
           N+ +    IG+G  G VF   A          ++A+K L +  S   + +FQ E  ++  
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 136 LRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEML----------------------FSD 173
             +P +V LLG C       L++EYM    L E L                       S 
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 174 GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           G   L  +++  I   VA  + +L    +   +H D+   N L+  +   K++DFGLSR
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 76
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 136
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 137 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 22/171 (12%)
Query: 78  LKNATNDFDEANVIGKGGSGTVFLGIARD----GKLLAIKRL------DTFSLQTEREFQ 127
           L  A   ++    IG+G  G VF   ARD    G+ +A+KR+      +   L T RE  
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFK--ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 128 NELQILGGLRSPFLVTLLGYCM-----ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ 182
             L+ L     P +V L   C         K  LV+E++ ++ L   L       +    
Sbjct: 64  V-LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTET 121
Query: 183 RFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             +++  + + L+FLH      V+H D+KP N+L+ S  + K++DFGL+RI
Sbjct: 122 IKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 20/172 (11%)
Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNEL---QILGGLRS 138
           N+F+   ++GKG  G V L   +  G+  A+K L    +  + E  + L   ++L   R 
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 139 PFLVTLLGYCMERNKRI-LVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEIIMDVAK 192
           PFL T L Y  + + R+  V EY     L     +E +FS+       ++       +  
Sbjct: 68  PFL-TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE-------IVS 119
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLF 244
           AL++LH   +  V++ D+K  N++LD D   K++DFGL +  ++    M  F
Sbjct: 120 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF 169

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +R    ELQI+  L    +V 
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 81
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVA 191
           L  +     ++       LV +Y+P     E ++       +  Q   +I        + 
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 136
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           ++L ++H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        
Sbjct: 137 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 192
Query: 250 KSQEL 254
           ++ EL
Sbjct: 193 RAPEL 197

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 99
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 159
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 160 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 20/172 (11%)
Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNEL---QILGGLRS 138
           N+F+   ++GKG  G V L   +  G+  A+K L    +  + E  + L   ++L   R 
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 139 PFLVTLLGYCMERNKRI-LVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEIIMDVAK 192
           PFL T L Y  + + R+  V EY     L     +E +FS+       ++       +  
Sbjct: 70  PFL-TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE-------IVS 121
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLF 244
           AL++LH   +  V++ D+K  N++LD D   K++DFGL +  ++    M  F
Sbjct: 122 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF 171

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 75
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 136 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 77
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 78  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 137
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 138 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 171

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 68/144 (47%), Gaps = 5/144 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  GTV+ G       + +  +   + Q  + F+NE+ +L   R   ++  +GY   
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 78
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           + +  +V ++    SL   L +      +  +  +I    A+ +++LH      +IH D+
Sbjct: 79  KPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDL 134
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIK 234
           K +N+ L  D   K+ DFGL+ +K
Sbjct: 135 KSNNIFLHEDNTVKIGDFGLATVK 158

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 71/151 (47%), Gaps = 8/151 (5%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLD--TFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
           +G G  G V++G   +   +A+K L   T S+Q    F  E  ++  L+   LV L    
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAVV 76
Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHG 208
            +     ++ E+M   SL + L SD    +   +  +    +A+ + ++        IH 
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 133
Query: 209 DIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           D++ +NVL+      K++DFGL+R+  + E+
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEY 164

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+P   +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 156 YLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 102
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 103 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 162
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 163 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+P   +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 156 YLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQILGGLR 137
           DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  ++  L 
Sbjct: 30  DFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 87
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            PF V L     +  K      Y  N  L + +   G+   +   RF    ++  ALE+L
Sbjct: 88  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVSALEYL 145
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 146 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 178

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 22/171 (12%)
Query: 78  LKNATNDFDEANVIGKGGSGTVFLGIARD----GKLLAIKRL------DTFSLQTEREFQ 127
           L  A   ++    IG+G  G VF   ARD    G+ +A+KR+      +   L T RE  
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFK--ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 128 NELQILGGLRSPFLVTLLGYCM-----ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ 182
             L+ L     P +V L   C         K  LV+E++ ++ L   L       +    
Sbjct: 64  V-LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTET 121
Query: 183 RFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             +++  + + L+FLH      V+H D+KP N+L+ S  + K++DFGL+RI
Sbjct: 122 IKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQILGGLR 137
           DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  ++  L 
Sbjct: 30  DFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 87
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            PF V L     +  K      Y  N  L + +   G+   +   RF    ++  ALE+L
Sbjct: 88  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVSALEYL 145
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 146 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 178

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 70  IGSGAQGIV--CAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 120
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P K+L+E       M   D NL       L   +   ++  +   +
Sbjct: 121 ---KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 177
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 178 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSP 139
             D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH- 198
            +V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 122
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            G    + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 123 IG----ITHRDIKPENLLLDERDNLKISDFGLATV 153

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 32  IGSGAQGIV--CAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P KSL+E       M   D NL       L   +   ++  +   +
Sbjct: 83  ---KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQILGGLR 137
           DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  ++  L 
Sbjct: 31  DFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            PF V L     +  K      Y  N  L + +   G+   +   RF    ++  ALE+L
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVSALEYL 146
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 179

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 26  IGSGAQGIV--CAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 76
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P KSL+E       M   D NL       L   +   ++  +   +
Sbjct: 77  ---KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 134 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQILGGLR 137
           DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  ++  L 
Sbjct: 31  DFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            PF V L     +  K      Y  N  L + +   G+   +   RF    ++  ALE+L
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVSALEYL 146
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 179

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQILGGLR 137
           DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  ++  L 
Sbjct: 31  DFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            PF V L     +  K      Y  N  L + +   G+   +   RF    ++  ALE+L
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVSALEYL 146
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 179

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 32  IGSGAQGIV--CAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P KSL+E       M   D NL       L   +   ++  +   +
Sbjct: 83  ---KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 33  IGSGAQGIV--CAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 83
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P K+L+E       M   D NL       L   +   ++  +   +
Sbjct: 84  ---KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 141 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+P   +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 156 YLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQILGGLR 137
           DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  ++  L 
Sbjct: 15  DFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 72
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            PF V L     +  K      Y  N  L + +   G+   +   RF    ++  ALE+L
Sbjct: 73  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVSALEYL 130
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 131 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 163

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 32  IGSGAQGIV--CAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P K+L+E       M   D NL       L   +   ++  +   +
Sbjct: 83  ---KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSP 139
             D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH- 198
            +V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 123
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            G    + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 124 IG----ITHRDIKPENLLLDERDNLKISDFGLATV 154

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQILGGLR 137
           DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  ++  L 
Sbjct: 33  DFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 90
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            PF V L     +  K      Y  N  L + +   G+   +   RF    ++  ALE+L
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVSALEYL 148
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 181

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQILGGLR 137
           DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  ++  L 
Sbjct: 33  DFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 90
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            PF V L     +  K      Y  N  L + +   G+   +   RF    ++  ALE+L
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVSALEYL 148
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 181

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 32  IGSGAQGIV--CAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P KSL+E       M   D NL       L   +   ++  +   +
Sbjct: 83  ---KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 31  IGSGAQGIV--CAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 81
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P K+L+E       M   D NL       L   +   ++  +   +
Sbjct: 82  ---KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 138
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 139 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 173

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSP 139
             D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH- 198
            +V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 123
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            G    + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 124 IG----ITHRDIKPENLLLDERDNLKISDFGLATV 154

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQILGGLR 137
           DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  ++  L 
Sbjct: 33  DFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 90
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            PF V L     +  K      Y  N  L + +   G+   +   RF    ++  ALE+L
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVSALEYL 148
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 181

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQILGGLR 137
           DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  ++  L 
Sbjct: 34  DFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 91
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            PF V L     +  K      Y  N  L + +   G+   +   RF    ++  ALE+L
Sbjct: 92  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVSALEYL 149
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 150 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 182

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 32  IGSGAQGIV--CAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P K+L+E       M   D NL       L   +   ++  +   +
Sbjct: 83  ---KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQILGGLR 137
           DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  ++  L 
Sbjct: 34  DFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 91
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            PF V L     +  K      Y  N  L + +   G+   +   RF    ++  ALE+L
Sbjct: 92  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVSALEYL 149
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 150 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 182

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 66/143 (46%), Gaps = 5/143 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++G       +AIK L   ++  E  F  E QI+  L+   LV L     E
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE-SFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V EYM   SL + L       LK     ++   VA  + ++        IH D+
Sbjct: 76  EPIYI-VTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 131
Query: 211 KPSNVLLDSDCRGKVSDFGLSRI 233
           + +N+L+ +    K++DFGL+R+
Sbjct: 132 RSANILVGNGLICKIADFGLARL 154

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSP 139
             D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH- 198
            +V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 122
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            G    + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 123 IG----ITHRDIKPENLLLDERDNLKISDFGLATV 153

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQILGGLR 137
           DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  ++  L 
Sbjct: 33  DFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 90
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            PF V L     +  K      Y  N  L + +   G+   +   RF    ++  ALE+L
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVSALEYL 148
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 181

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQILGGLR 137
           DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  ++  L 
Sbjct: 33  DFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 90
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            PF V L     +  K      Y  N  L + +   G+   +   RF    ++  ALE+L
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVSALEYL 148
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 181

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 72  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 124
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           + + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 125 EGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 163

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 33  IGSGAQGIV--CAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 83
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P K+L+E       M   D NL       L   +   ++  +   +
Sbjct: 84  ---KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 141 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 37  IGSGAQGIV--CAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 87
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P KSL+E       M   D NL       L   +   ++  +   +
Sbjct: 88  ---KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 144
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 145 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 179

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 26  IGSGAQGIV--CAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 76
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P K+L+E       M   D NL       L   +   ++  +   +
Sbjct: 77  ---KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 134 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 32  IGSGAQGIV--CAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P KSL+E       M   D NL       L   +   ++  +   +
Sbjct: 83  ---KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 26  IGSGAQGIV--CAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 76
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P K+L+E       M   D NL       L   +   ++  +   +
Sbjct: 77  ---KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 134 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQILGGLR 137
           DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  ++  L 
Sbjct: 33  DFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 90
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            PF V L     +  K      Y  N  L + +   G+   +   RF    ++  ALE+L
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFD-ETCTRF-YTAEIVSALEYL 148
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 181

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQILGGLR 137
           DF    ++G+G   TV L  AR+    +  AIK L+   +  E +      E  ++  L 
Sbjct: 36  DFKFGKILGEGSFSTVVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 93
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            PF V L     +  K      Y  N  L + +   G+   +   RF    ++  ALE+L
Sbjct: 94  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVSALEYL 151
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 152 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 184

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 25  IGSGAQGIV--CAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 75
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P K+L+E       M   D NL       L   +   ++  +   +
Sbjct: 76  ---KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 133 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 9/153 (5%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSPFL 141
           D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L    +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH-FG 200
           V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH  G
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG 124
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 125 ----ITHRDIKPENLLLDERDNLKISDFGLATV 153

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 33  IGSGAQGIV--CAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 83
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P KSL+E       M   D NL       L   +   ++  +   +
Sbjct: 84  ---KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 141 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 32  IGSGAQGIV--CAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P KSL+E       M   D NL       L   +   ++  +   +
Sbjct: 83  ---KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 9/162 (5%)
Query: 80  NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRS 138
           N    F    V+G G    VFL   R  GKL A+K +       +   +NE+ +L  ++ 
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
             +VTL           LV + +    L + +   G    K +    +I  V  A+++LH
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL--VIQQVLSAVKYLH 123
Query: 199 FGCDPPVIHGDIKPSNVLL---DSDCRGKVSDFGLSRIKVEG 237
              +  ++H D+KP N+L    + + +  ++DFGLS+++  G
Sbjct: 124 ---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 69/144 (47%), Gaps = 5/144 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  GTV+ G       + I ++   + +  + F+NE+ +L   R   ++  +GY M 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY-MT 102
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           ++   +V ++    SL + L        +  Q  +I    A+ +++LH      +IH D+
Sbjct: 103 KDNLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDM 158
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIK 234
           K +N+ L      K+ DFGL+ +K
Sbjct: 159 KSNNIFLHEGLTVKIGDFGLATVK 182

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY P   +    FS    + ++S+   RF     +    E
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 156
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+++D     KV+DFG ++ +V+G
Sbjct: 157 YLH-SLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK-RVKG 194

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 78/148 (52%), Gaps = 15/148 (10%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTERE-----FQNELQILGGLRSPFLVTLL 145
           IG+G  G V+      G+  A+K++    L+ E E        E+ IL  L+   +V L 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 146 GYCMERNKRILVYEYMPNKSLQEML-FSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP 204
                + + +LV+E++ ++ L+++L   +G L    ++ F  ++ +   + + H   D  
Sbjct: 67  DVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSF--LLQLLNGIAYCH---DRR 120
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           V+H D+KP N+L++ +   K++DFGL+R
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+P   +    FS    + ++S+   RF     +    E
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 156
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 157 YLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 194

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+P   +    FS    + ++S+   RF     +    E
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 156
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 157 YLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 194

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 78/148 (52%), Gaps = 15/148 (10%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTERE-----FQNELQILGGLRSPFLVTLL 145
           IG+G  G V+      G+  A+K++    L+ E E        E+ IL  L+   +V L 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 146 GYCMERNKRILVYEYMPNKSLQEML-FSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP 204
                + + +LV+E++ ++ L+++L   +G L    ++ F  ++ +   + + H   D  
Sbjct: 67  DVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSF--LLQLLNGIAYCH---DRR 120
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           V+H D+KP N+L++ +   K++DFGL+R
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 34  IGSGAQGIV--CAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 84
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDVAKAL 194
              +N   L+  + P KSL+E       M   D NL       L   +   ++  +   +
Sbjct: 85  ---KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 141
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 142 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 176

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 78/148 (52%), Gaps = 15/148 (10%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTERE-----FQNELQILGGLRSPFLVTLL 145
           IG+G  G V+      G+  A+K++    L+ E E        E+ IL  L+   +V L 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 146 GYCMERNKRILVYEYMPNKSLQEML-FSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP 204
                + + +LV+E++ ++ L+++L   +G L    ++ F  ++ +   + + H   D  
Sbjct: 67  DVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSF--LLQLLNGIAYCH---DRR 120
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           V+H D+KP N+L++ +   K++DFGL+R
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 9/153 (5%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSPFL 141
           D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L    +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH-FG 200
           V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH  G
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG 125
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 126 ----ITHRDIKPENLLLDERDNLKISDFGLATV 154

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+P   +    FS    + ++S+   RF     +    E
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 156
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 157 YLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 194

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 131
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFG +++
Sbjct: 132 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKL 170

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 129
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFG +++
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKL 168

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+P   +    FS    + ++S+   RF     +    E
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 148
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 149 YLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 186

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 50/208 (24%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLV 142
           DF E  +IG GG G VF    R DGK   IKR+   + + ERE    ++ L  L    +V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIV 67
Query: 143 TLLGYCMERNKRILVYEYMPNKSLQ------------EMLFSDGNLVLKWSQR------- 183
              G C +       ++Y P  S +            +M F D   + +W ++       
Sbjct: 68  HYNG-CWDG------FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 184 ----FEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL--------S 231
                E+   + K ++++H      +I+ D+KPSN+ L    + K+ DFGL         
Sbjct: 121 KVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 232 RIKVEGEFGM----DLFSQDLGKSQELW 255
           R + +G         + SQD GK  +L+
Sbjct: 178 RXRSKGTLRYMSPEQISSQDYGKEVDLY 205

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ D+GL+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLAR 173

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+  G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 134
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 135 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 173

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 32/159 (20%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G V   +  R G  +AIK+L        R FQ+EL      R    + LL +  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKL-------YRPFQSELFAKRAYRE---LRLLKHMR 82
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKW---------------SQRFE-IIMDVAKA 193
             N   L+  + P+++L +  F+D  LV+ +                 R + ++  + K 
Sbjct: 83  HENVIGLLDVFTPDETLDD--FTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKG 140
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           L ++H      +IH D+KP N+ ++ DC  K+ DFGL+R
Sbjct: 141 LRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 81/184 (44%), Gaps = 27/184 (14%)
Query: 85  FDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTL 144
           +    VIG G  G VF     +   +AIK++    LQ +R    ELQI+  ++ P +V L
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDL 97
Query: 145 LGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVAK 192
             +      +       LV EY+P     E ++       K  Q   +++       + +
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 193 ALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLGK 250
           +L ++H  G    + H DIKP N+LLD      K+ DFG ++I + GE  +        +
Sbjct: 153 SLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYR 208
Query: 251 SQEL 254
           + EL
Sbjct: 209 APEL 212

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 79/152 (51%), Gaps = 14/152 (9%)
Query: 89  NVIGKGGSGTVFLGIARDG-KLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLL 145
           ++IG+G  G V+L   ++  K +AIK+++     L   +    E+ IL  L+S +++ L 
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 146 GYC-----MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
                   ++ ++  +V E + +  L+++  +   + L       I+ ++     F+H  
Sbjct: 92  DLIIPDDLLKFDELYIVLE-IADSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIH-- 146
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            +  +IH D+KP+N LL+ DC  KV DFGL+R
Sbjct: 147 -ESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L      G   A+K LD   +   +E +   NE +IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY P   +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+++D     +V+DFGL++ +V+G
Sbjct: 156 YLH-SLD--LIYRDLKPENLMIDQQGYIQVTDFGLAK-RVKG 193

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSP 139
             D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH- 198
            +V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 122
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            G    + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 123 IG----ITHRDIKPENLLLDERDNLKISDFGLATV 153

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSP 139
             D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L   
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH- 198
            +V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH 
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 121
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            G    + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 122 IG----ITHRDIKPENLLLDERDNLKISDFGLATV 152

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 129
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFG +++
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKL 168

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 76/159 (47%), Gaps = 10/159 (6%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           PFLV L     + +   +V EY+P   +   L   G      ++ +     +    E+LH
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYA--AQIVLTFEYLH 151
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
              D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 152 -SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 186

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSP 139
             D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH- 198
            +V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 122
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            G    + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 123 IG----ITHRDIKPENLLLDERDNLKISDFGLATV 153

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSP 139
             D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH- 198
            +V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 122
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            G    + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 123 IG----ITHRDIKPENLLLDERDNLKISDFGLATV 153

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+  G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSP 139
             D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH- 198
            +V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 122
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            G    + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 123 IG----ITHRDIKPENLLLDERDNLKISDFGLATV 153

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 129
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFG +++
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKL 168

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSP 139
             D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH- 198
            +V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 123
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            G    + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 124 IG----ITHRDIKPENLLLDERDNLKISDFGLATV 154

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+P   +    FS    + ++S+   RF     +    E
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 176
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 177 YLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 214

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSP 139
             D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH- 198
            +V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 122
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            G    + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 123 IG----ITHRDIKPENLLLDERDNLKISDFGLATV 153

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSP 139
             D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH- 198
            +V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 123
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            G    + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 124 IG----ITHRDIKPENLLLDERDNLKISDFGLATV 154

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSP 139
             D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH- 198
            +V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 123
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            G    + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 124 IG----ITHRDIKPENLLLDERDNLKISDFGLATV 154

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSP 139
             D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH- 198
            +V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 122
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            G    + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 123 IG----ITHRDIKPENLLLDERDNLKISDFGLATV 153

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSP 139
             D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH- 198
            +V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 123
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            G    + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 124 IG----ITHRDIKPENLLLDERDNLKISDFGLATV 154

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSP 139
             D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH- 198
            +V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 122
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            G    + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 123 IG----ITHRDIKPENLLLDERDNLKISDFGLATV 153

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFG +++
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKL 166

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 77/157 (49%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        + FQ+   I+   R+   + LL +  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SKPFQS---IIHAKRTYRELRLLKHMK 91
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 151
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 152 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+  G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 134
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 135 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 173

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 75/163 (46%), Gaps = 22/163 (13%)
Query: 89  NVIGKGGSGTVFLG----IARDGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVT 143
            VIGKG  G V+ G     A++    AIK L   + +Q    F  E  ++ GL  P ++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMD-------VAKALEF 196
           L+G        +L  E +P+  L  M   D    ++  QR   + D       VA+ +E+
Sbjct: 87  LIGI-------MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139
Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           L    +   +H D+   N +LD     KV+DFGL+R  ++ E+
Sbjct: 140 L---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AI  L +  S +  +E  +E  ++  +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 109 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 161
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFGL+++
Sbjct: 162 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 200

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLS-------RPFQS---IIHAKRTYRELRLLKHMK 108
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P  SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 109 HENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 168
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 169 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 202

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 27/162 (16%)
Query: 85  FDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +   IG G  G V        G  +A+K+L        R FQN+       R    + 
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-------RPFQNQTHAKRAYRE---LV 75
Query: 144 LLGYCMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFEIIMDV 190
           LL     +N   L+  + P K+L+E       M   D NL       L   +   ++  +
Sbjct: 76  LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM 135
Query: 191 AKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
              ++ LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 136 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSP 139
             D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH- 198
            +V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 122
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            G    + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 123 IG----ITHRDIKPENLLLDERDNLKISDFGLATV 153

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 72/167 (43%), Gaps = 37/167 (22%)
Query: 85  FDEANVIGKGGSGTV------FLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRS 138
           + +   IG G  G V       LGI      +A+K+L        R FQN+       R 
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGIN-----VAVKKLS-------RPFQNQTHAKRAYRE 71
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQE-------MLFSDGNLV------LKWSQRFE 185
              + LL     +N   L+  + P K+L+E       M   D NL       L   +   
Sbjct: 72  ---LVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSY 128
Query: 186 IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++  +   ++ LH      +IH D+KPSN+++ SDC  K+ DFGL+R
Sbjct: 129 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 172

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 83  NDFDEANVIGKGGSGTVFLG--IARDGKL---LAIKRL-DTFSLQTEREFQNELQILGGL 136
            +F +  V+G G  GTV+ G  I    K+   +AIK L +  S +  +E  +E  ++  +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-----GNLVLKWSQRFEIIMDVA 191
            +P +  LLG C+    + L+ + MP   L + +           +L W       + +A
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 134
Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           K + +L    D  ++H D+   NVL+ +    K++DFG +++
Sbjct: 135 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKL 173

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT-FSLQTEREFQNELQILGGLRSP 139
             D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH- 198
            +V   G+  E N + L  EY     L + +  D  +    +QRF     +   + +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 123
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            G    + H DIKP N+LLD     K+SDFGL+ +
Sbjct: 124 IG----ITHRDIKPENLLLDERDNLKISDFGLATV 154

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 77/156 (49%), Gaps = 14/156 (8%)
Query: 85  FDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFL 141
           +   + IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   +
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENI 85
Query: 142 V----TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
           +     +    +E+ K + + + +    L ++L +     L        +  + + L+++
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYI 142
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      V+H D+KPSN+LL++ C  K+ DFGL+R+
Sbjct: 143 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 175

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 88/214 (41%), Gaps = 49/214 (22%)
Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLV 142
           DF E  +IG GG G VF    R DGK   I+R+   + + ERE    ++ L  L    +V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIV 68
Query: 143 TLLG------YCMERNKRIL-VYEYMPNKS-----------LQEMLFSDGNLVLKWSQR- 183
              G      Y  E +   L   +Y P  S             +M F D   + +W ++ 
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 184 ----------FEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL--- 230
                      E+   + K ++++H      +IH D+KPSN+ L    + K+ DFGL   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 231 -----SRIKVEGEFGM----DLFSQDLGKSQELW 255
                 R + +G         + SQD GK  +L+
Sbjct: 186 LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLY 219

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 35/160 (21%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+ ++ +
Sbjct: 32  IGSGAQGIVVA--AYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKVVNH 82
Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKW-----SQRFEIIMDVAK---------- 192
              +N   L+  + P KSL+E  F D  +V++      SQ  ++ +D  +          
Sbjct: 83  ---KNIIGLLNVFTPQKSLEE--FQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV 137
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            ++ LH      +IH D+KPSN+++ SD   K+ DFGL+R
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 11/163 (6%)
Query: 83  NDFDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTER-EFQNELQILGGLRSPF 140
           +D++   VIG G +  V     A   + +AIKR++    QT   E   E+Q +     P 
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEML---FSDGNL---VLKWSQRFEIIMDVAKAL 194
           +V+     + +++  LV + +   S+ +++    + G     VL  S    I+ +V + L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           E+LH       IH D+K  N+LL  D   +++DFG+S     G
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 90  VIGKGGSGTVFLG--IARDGKLL--AIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTL 144
           VIG+G  G V+ G  +  DGK +  A+K L+  + +    +F  E  I+     P +++L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 145 LGYCME-RNKRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           LG C+      ++V  YM +  L+  + ++  N  +K    F   + VAK +++L     
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 150
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +H D+   N +LD     KV+DFGL+R   + E+
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 187

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 69/162 (42%), Gaps = 34/162 (20%)
Query: 90  VIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFL-------- 141
           +IG+G  G V+ G + D + +A+K    FS    + F NE  I    R P +        
Sbjct: 20  LIGRGRYGAVYKG-SLDERPVAVK---VFSFANRQNFINEKNIY---RVPLMEHDNIARF 72
Query: 142 ------VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALE 195
                 VT  G    R + +LV EY PN SL + L    +    W     +   V + L 
Sbjct: 73  IVGDERVTADG----RMEYLLVMEYYPNGSLXKYLSLHTS---DWVSSCRLAHSVTRGLA 125
Query: 196 FLHFGC------DPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           +LH          P + H D+   NVL+ +D    +SDFGLS
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 22/161 (13%)
Query: 83  NDFDEANVIGKGGSGTVF-LGIARDGKLLAIKRLDTFSL---QTEREFQNELQILGGLRS 138
           NDF    +IG+GG G V+    A  GK+ A+K LD   +   Q E    NE  +L  + +
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 139 ---PFLVTLLGYCMERNKRILVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEIIMDV 190
              PF+V +       +K   + + M    L     Q  +FS+ ++    +   EII+  
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA---EIIL-- 302
Query: 191 AKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              LE +H   +  V++ D+KP+N+LLD     ++SD GL+
Sbjct: 303 --GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA 338

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 22/161 (13%)
Query: 83  NDFDEANVIGKGGSGTVF-LGIARDGKLLAIKRLDTFSL---QTEREFQNELQILGGLRS 138
           NDF    +IG+GG G V+    A  GK+ A+K LD   +   Q E    NE  +L  + +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 139 ---PFLVTLLGYCMERNKRILVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEIIMDV 190
              PF+V +       +K   + + M    L     Q  +FS+ ++    +   EII+  
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA---EIIL-- 303
Query: 191 AKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              LE +H   +  V++ D+KP+N+LLD     ++SD GL+
Sbjct: 304 --GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA 339

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 13/156 (8%)
Query: 84  DFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREF---QNELQILGGLR 137
           DF    ++G+G   T  L  AR+    +  AIK L+   +  E +      E  ++  L 
Sbjct: 31  DFKFGKILGEGSFSTTVL--ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            PF V L     +  K      Y  N  L + +   G+   +   RF    ++  ALE+L
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRF-YTAEIVSALEYL 146
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      +IH D+KP N+LL+ D   +++DFG +++
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 179

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 11/163 (6%)
Query: 83  NDFDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTER-EFQNELQILGGLRSPF 140
           +D++   VIG G +  V     A   + +AIKR++    QT   E   E+Q +     P 
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEML---FSDGNL---VLKWSQRFEIIMDVAKAL 194
           +V+     + +++  LV + +   S+ +++    + G     VL  S    I+ +V + L
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           E+LH       IH D+K  N+LL  D   +++DFG+S     G
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATG 169

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 7/160 (4%)
Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQT---EREFQNELQILGGLRS 138
           N F +  V+GKGG G V     R  GK+ A K+L+   ++    E    NE QIL  + S
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
            F+V+L      ++   LV   M    L+  ++  G      ++      ++   LE LH
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
                 +++ D+KP N+LLD     ++SD GL+    EG+
Sbjct: 304 ---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ DF L+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLAR 173

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 22/161 (13%)
Query: 83  NDFDEANVIGKGGSGTVF-LGIARDGKLLAIKRLDTFSL---QTEREFQNELQILGGLRS 138
           NDF    +IG+GG G V+    A  GK+ A+K LD   +   Q E    NE  +L  + +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 139 ---PFLVTLLGYCMERNKRILVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEIIMDV 190
              PF+V +       +K   + + M    L     Q  +FS+ ++    +   EII+  
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA---EIIL-- 303
Query: 191 AKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              LE +H   +  V++ D+KP+N+LLD     ++SD GL+
Sbjct: 304 --GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA 339

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 22/161 (13%)
Query: 83  NDFDEANVIGKGGSGTVF-LGIARDGKLLAIKRLDTFSL---QTEREFQNELQILGGLRS 138
           NDF    +IG+GG G V+    A  GK+ A+K LD   +   Q E    NE  +L  + +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 139 ---PFLVTLLGYCMERNKRILVYEYMPNKSL-----QEMLFSDGNLVLKWSQRFEIIMDV 190
              PF+V +       +K   + + M    L     Q  +FS+ ++    +   EII+  
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA---EIIL-- 303
Query: 191 AKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              LE +H   +  V++ D+KP+N+LLD     ++SD GL+
Sbjct: 304 --GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA 339

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 90  VIGKGGSGTVFLG--IARDGKLL--AIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTL 144
           VIG+G  G V+ G  +  DGK +  A+K L+  + +    +F  E  I+     P +++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 145 LGYCME-RNKRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           LG C+      ++V  YM +  L+  + ++  N  +K    F   + VAK +++L     
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 151
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +H D+   N +LD     KV+DFGL+R   + E+
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 188

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTE-REFQNELQILGGLRSPFLVTLLG 146
           +G G  G+V  G+ R  K    +AIK L   + + +  E   E QI+  L +P++V L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 147 YCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVI 206
            C +    +LV E      L + L      +   S   E++  V+  +++L    +   +
Sbjct: 78  VC-QAEALMLVMEMAGGGPLHKFLVGKREEI-PVSNVAELLHQVSMGMKYLE---EKNFV 132
Query: 207 HGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H D+   NVLL +    K+SDFGLS+
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSK 158

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 90  VIGKGGSGTVFLG--IARDGKLL--AIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTL 144
           VIG+G  G V+ G  +  DGK +  A+K L+  + +    +F  E  I+     P +++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 145 LGYCME-RNKRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           LG C+      ++V  YM +  L+  + ++  N  +K    F   + VAK +++L     
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 151
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +H D+   N +LD     KV+DFGL+R   + E+
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 188

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L      G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+P   +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 156 YLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 7/160 (4%)
Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQT---EREFQNELQILGGLRS 138
           N F +  V+GKGG G V     R  GK+ A K+L+   ++    E    NE QIL  + S
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
            F+V+L      ++   LV   M    L+  ++  G      ++      ++   LE LH
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
                 +++ D+KP N+LLD     ++SD GL+    EG+
Sbjct: 304 ---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L      G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+P   +    FS    + ++S+   RF     +    E
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 156
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 157 YLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 194

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L      G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+P   +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 156 YLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L      G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY P   +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+++D     KV+DFG ++ +V+G
Sbjct: 156 YLH-SLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK-RVKG 193

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 90  VIGKGGSGTVFLG--IARDGKLL--AIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTL 144
           VIG+G  G V+ G  +  DGK +  A+K L+  + +    +F  E  I+     P +++L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 145 LGYCME-RNKRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           LG C+      ++V  YM +  L+  + ++  N  +K    F   + VAK +++L     
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 149
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +H D+   N +LD     KV+DFGL+R   + E+
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 186

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 90  VIGKGGSGTVFLG--IARDGKLL--AIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTL 144
           VIG+G  G V+ G  +  DGK +  A+K L+  + +    +F  E  I+     P +++L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 145 LGYCME-RNKRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           LG C+      ++V  YM +  L+  + ++  N  +K    F   + VAK +++L     
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 146
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +H D+   N +LD     KV+DFGL+R   + E+
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L      G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+P   +    FS    + ++S+   RF     +    E
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 156
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 157 YLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 194

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L      G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+P   +    FS    + ++S+   RF     +    E
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 141
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 142 YLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 179

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 14/147 (9%)
Query: 91  IGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTE--REFQNELQILGGLRSPFLVTLL 145
           IGKG    V L  AR    GK +A+K +D   L +   ++   E++I+  L  P +V L 
Sbjct: 22  IGKGNFAKVKL--ARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ-RFEIIMDVAKALEFLHFGCDPP 204
                     LV EY     + + L + G +  K ++ +F     +  A+++ H      
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCH---QKF 133
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           ++H D+K  N+LLD+D   K++DFG S
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 14/147 (9%)
Query: 91  IGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTE--REFQNELQILGGLRSPFLVTLL 145
           IGKG    V L  AR    GK +A+K +D   L +   ++   E++I+  L  P +V L 
Sbjct: 22  IGKGNFAKVKL--ARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ-RFEIIMDVAKALEFLHFGCDPP 204
                     LV EY     + + L + G +  K ++ +F     +  A+++ H      
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCH---QKF 133
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           ++H D+K  N+LLD+D   K++DFG S
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L      G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+P   +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 156 YLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 90  VIGKGGSGTVFLG--IARDGKLL--AIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTL 144
           VIG+G  G V+ G  +  DGK +  A+K L+  + +    +F  E  I+     P +++L
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 145 LGYCME-RNKRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           LG C+      ++V  YM +  L+  + ++  N  +K    F   + VAK +++L     
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 169
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +H D+   N +LD     KV+DFGL+R   + E+
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 206

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 90  VIGKGGSGTVFLG--IARDGKLL--AIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTL 144
           VIG+G  G V+ G  +  DGK +  A+K L+  + +    +F  E  I+     P +++L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 145 LGYCME-RNKRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           LG C+      ++V  YM +  L+  + ++  N  +K    F   + VAK +++L     
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 148
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +H D+   N +LD     KV+DFGL+R   + E+
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 185

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 90  VIGKGGSGTVFLG--IARDGKLL--AIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTL 144
           VIG+G  G V+ G  +  DGK +  A+K L+  + +    +F  E  I+     P +++L
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 145 LGYCME-RNKRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           LG C+      ++V  YM +  L+  + ++  N  +K    F   + VAK +++L     
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 143
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +H D+   N +LD     KV+DFGL+R   + E+
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 180

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 14/147 (9%)
Query: 91  IGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTE--REFQNELQILGGLRSPFLVTLL 145
           IGKG    V L  AR    GK +A+K +D   L +   ++   E++I+  L  P +V L 
Sbjct: 22  IGKGNFAKVKL--ARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ-RFEIIMDVAKALEFLHFGCDPP 204
                     LV EY     + + L + G +  K ++ +F     +  A+++ H      
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCH---QKF 133
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           ++H D+K  N+LLD+D   K++DFG S
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 72/154 (46%), Gaps = 7/154 (4%)
Query: 79  KNATNDFDEANVIGK---GGSGTVFLGIARDGKLLA-IKRLDTFSLQTEREFQNELQILG 134
           K++  DF + N + K     SG ++ G  +   ++  + ++  +S +  R+F  E   L 
Sbjct: 3   KHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 135 GLRSPFLVTLLGYCME--RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
               P ++ +LG C         L+  +MP  SL  +L    N V+  SQ  +  +D+A+
Sbjct: 63  IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVS 226
            + FLH   +P +    +   +V++D D   ++S
Sbjct: 123 GMAFLH-TLEPLIPRHALNSRSVMIDEDMTARIS 155

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L      G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           PFLV L     + +   +V EY+P   +   L   G      ++ +     +    E+LH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYA--AQIVLTFEYLH 158
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
              D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 159 -SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           PFLV L     + +   +V EY+    +   L   G      ++ +     +    E+LH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYA--AQIVLTFEYLH 158
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
                 +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 70/168 (41%), Gaps = 19/168 (11%)
Query: 83  NDFDEANVIGKGGSGTVF----LGIARDGKLL--AIKRLDTFSLQTERE-FQNELQILGG 135
           N+      +G G  G V      G+ ++  +L  A+K L + +   E+E   +EL+I+  
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 136 L-RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
           L +   +V LLG C      +++ EY     L   L      VL+    F I    A   
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR-VLETDPAFAIANSTASTR 164
Query: 195 EFLHFGCDPP----------VIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LHF                IH D+   NVLL +    K+ DFGL+R
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 90  VIGKGGSGTVFLG--IARDGKLL--AIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTL 144
           VIG+G  G V+ G  +  DGK +  A+K L+  + +    +F  E  I+     P +++L
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 145 LGYCME-RNKRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           LG C+      ++V  YM +  L+  + ++  N  +K    F   + VAK +++L     
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 170
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +H D+   N +LD     KV+DFGL+R   + E+
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 207

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L      G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           PFLV L     + +   +V EY+P   +   L   G      ++ +     +    E+LH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYA--AQIVLTFEYLH 158
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
              D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 159 -SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+    +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH      +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 35/160 (21%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+ ++ +
Sbjct: 32  IGSGAQGIV--CAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKVVNH 82
Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKW-----SQRFEIIMDVAK---------- 192
              +N   L+  + P KSL+E  F D  +V++      SQ  ++ +D  +          
Sbjct: 83  ---KNIIGLLNVFTPQKSLEE--FQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC 137
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            ++ LH      +IH D+KPSN+++ SD   K+ DFGL+R
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 53/113 (46%), Gaps = 6/113 (5%)
Query: 127 QNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEI 186
           + E+  L  LR P ++ L          ++V EY     L + +     +     +RF  
Sbjct: 57  EREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRF-- 113
Query: 187 IMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +  A+E+ H      ++H D+KP N+LLD +   K++DFGLS I  +G F
Sbjct: 114 FQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+    +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 156 YLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+    +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 156 YLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+    +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH      +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+    +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH      +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L      G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           PFLV L     + +   +V EY+P   +   L   G      ++ +     +    E+LH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYA--AQIVLTFEYLH 159
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
              D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 160 -SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 194

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+    +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 156 YLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 66/141 (46%), Gaps = 5/141 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  GTV+ G       + +  +   + Q  + F+NE+ +L   R   ++  +GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 90
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           + +  +V ++    SL   L +      +  +  +I    A+ +++LH      +IH D+
Sbjct: 91  KPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDL 146
Query: 211 KPSNVLLDSDCRGKVSDFGLS 231
           K +N+ L  D   K+ DFGL+
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLA 167

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 77/156 (49%), Gaps = 14/156 (8%)
Query: 85  FDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFL 141
           +   + IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   +
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 85
Query: 142 V----TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
           +     +    +E+ K + + + +    L ++L +     L        +  + + L+++
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYI 142
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      V+H D+KPSN+LL++ C  K+ DFGL+R+
Sbjct: 143 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 175

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+    +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH      +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+    +    FS    + ++S+   RF     +    E
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 156
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH      +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 157 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 194

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 75/150 (50%), Gaps = 14/150 (9%)
Query: 91  IGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFLV----T 143
           IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   ++     
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 89
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           +    +E+ K + + + +    L ++L +     L        +  + + L+++H     
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            V+H D+KPSN+LL++ C  K+ DFGL+R+
Sbjct: 145 -VLHRDLKPSNLLLNTTCDLKICDFGLARV 173

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 14/156 (8%)
Query: 85  FDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFL 141
           + +   IG+G  G V        K  +AIK++  F  QT  +R  + E+QIL   R   +
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR-EIQILLRFRHENV 103
Query: 142 V----TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
           +     L    +E  + + + + +    L ++L S     L        +  + + L+++
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQ---LSNDHICYFLYQILRGLKYI 160
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      V+H D+KPSN+L+++ C  K+ DFGL+RI
Sbjct: 161 HSAN---VLHRDLKPSNLLINTTCDLKICDFGLARI 193

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+    +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH      +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+    +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH      +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 35/160 (21%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+ ++ +
Sbjct: 32  IGSGAQGIV--CAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKVVNH 82
Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKW-----SQRFEIIMDVAK---------- 192
              +N   L+  + P KSL+E  F D  +V++      SQ  ++ +D  +          
Sbjct: 83  ---KNIIGLLNVFTPQKSLEE--FQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV 137
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            ++ LH      +IH D+KPSN+++ SD   K+ DFGL+R
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 16/165 (9%)
Query: 70  LQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTERE-FQN 128
           L    YKE+       +   V+G+G  G V     R  K +AIK++++   ++ER+ F  
Sbjct: 3   LHMIDYKEI-------EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES---ESERKAFIV 51
Query: 129 ELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNL-VLKWSQRFEII 187
           EL+ L  +  P +V L G C+  N   LV EY    SL  +L     L     +      
Sbjct: 52  ELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 109
Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLS 231
           +  ++ + +LH      +IH D+KP N+LL +     K+ DFG +
Sbjct: 110 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 154

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 35/160 (21%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+ ++ +
Sbjct: 32  IGSGAQGIV--CAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKVVNH 82
Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKW-----SQRFEIIMDVAK---------- 192
              +N   L+  + P KSL+E  F D  +V++      SQ  ++ +D  +          
Sbjct: 83  ---KNIIGLLNVFTPQKSLEE--FQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV 137
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            ++ LH      +IH D+KPSN+++ SD   K+ DFGL+R
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 11/158 (6%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRL-DTFSLQTEREFQNELQILGGLRS 138
              D  +   IG+G  G+V   + +  G+++A+KR+  T   + +++   +L ++  +RS
Sbjct: 20  TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV--MRS 77
Query: 139 ---PFLVTLLGYCMERNKRILVYEYMPNK--SLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
              P++V   G         +  E M        + ++S  + V+      +I +   KA
Sbjct: 78  SDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           L   H   +  +IH DIKPSN+LLD     K+ DFG+S
Sbjct: 138 LN--HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 10/159 (6%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L      G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           PFLV L     + +   +V EY P   +   L   G      ++ +     +    E+LH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYA--AQIVLTFEYLH 158
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
              D  +I+ D+KP N+++D     KV+DFG ++ +V+G
Sbjct: 159 -SLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK-RVKG 193

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 16/165 (9%)
Query: 70  LQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTERE-FQN 128
           L    YKE+       +   V+G+G  G V     R  K +AIK++++   ++ER+ F  
Sbjct: 2   LHMIDYKEI-------EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES---ESERKAFIV 50
Query: 129 ELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNL-VLKWSQRFEII 187
           EL+ L  +  P +V L G C+  N   LV EY    SL  +L     L     +      
Sbjct: 51  ELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108
Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLS 231
           +  ++ + +LH      +IH D+KP N+LL +     K+ DFG +
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+    +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH      +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 13/177 (7%)
Query: 64  SNAPLK-LQRFTYKELKNATNDFDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQ 121
           S++P + L       L++    F+   ++G G  G V+ G   + G+L AIK +D     
Sbjct: 4   SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-D 62
Query: 122 TEREFQNELQILGGL-RSPFLVTLLGYCMERN------KRILVYEYMPNKSLQEMLFSDG 174
            E E + E+ +L        + T  G  +++N      +  LV E+    S+ +++ +  
Sbjct: 63  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 175 NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              LK      I  ++ + L  LH      VIH DIK  NVLL  +   K+ DFG+S
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 77/158 (48%), Gaps = 13/158 (8%)
Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRL-DTFSLQT-EREFQNELQILGGLRSP 139
           ++++    IG G  G V     R  G+ +AIK++ + F + T  +    EL+IL   +  
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 140 FLVTLLGYCME-----RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
            ++ +             K + V   +    L +++ S   L L+  + F  +  + + L
Sbjct: 114 NIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYF--LYQLLRGL 171
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +++H      VIH D+KPSN+L++ +C  K+ DFG++R
Sbjct: 172 KYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           PFLV L     + +   +V EY+    +   L   G      ++ +     +    E+LH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYA--AQIVLTFEYLH 158
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
                 +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+    +    FS    + ++S+   RF     +    E
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 142
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH      +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 143 YLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAK-RVKG 180

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 83/185 (44%), Gaps = 28/185 (15%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +     ELQI+  L    +V 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVR 77
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVA 191
           L  +     ++       LV +Y+P     E ++       +  Q   +I        + 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           ++L ++H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        
Sbjct: 133 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 250 KSQEL 254
           ++ EL
Sbjct: 189 RAPEL 193

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 66/142 (46%), Gaps = 5/142 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAI-KRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G V+    ++  +LA  K +DT S +   ++  E+ IL     P +V LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             N   ++ E+    ++  ++  +    L  SQ   +      AL +LH   D  +IH D
Sbjct: 105 YENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRD 160
Query: 210 IKPSNVLLDSDCRGKVSDFGLS 231
           +K  N+L   D   K++DFG+S
Sbjct: 161 LKAGNILFTLDGDIKLADFGVS 182

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 12/150 (8%)
Query: 90  VIGKGGSGTVFLG--IARDGKLL--AIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTL 144
           VIG+G  G V+ G  +  DGK +  A+K L+  + +    +F  E  I+     P +++L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 145 LGYCME-RNKRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           LG C+      ++V  YM +  L+  + ++  N  +K    F   + VAK +++L     
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 150
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
              +H D+   N +LD     KV+DFGL+R
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           PFLV L     + +   +V EY+    +   L   G      ++ +     +    E+LH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYA--AQIVLTFEYLH 158
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
                 +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/146 (23%), Positives = 68/146 (46%), Gaps = 6/146 (4%)
Query: 91  IGKGGSG-TVFLGIARDGKLLAIKRLDT--FSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG+G  G  + +    DG+   IK ++    S +   E + E+ +L  ++ P +V     
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
             E     +V +Y     L + + +   ++ +  Q  +  + +  AL+ +H   D  ++H
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILH 148
Query: 208 GDIKPSNVLLDSDCRGKVSDFGLSRI 233
            DIK  N+ L  D   ++ DFG++R+
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARV 174

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           PFLV L     + +   +V EY+    +   L   G      ++ +     +    E+LH
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYA--AQIVLTFEYLH 153
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
                 +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 154 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 188

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 16/159 (10%)
Query: 85  FDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTF------SLQTEREFQNELQILGGLR 137
           ++   VIGKG    V   I R+ G+  A+K +D         L TE + + E  I   L+
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE-DLKREASICHMLK 84
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSL--QEMLFSDGNLVLKWSQRFEIIMDVAKALE 195
            P +V LL          +V+E+M    L  + +  +D   V   +     +  + +AL 
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLS 231
           + H   D  +IH D+KP NVLL S       K+ DFG++
Sbjct: 145 YCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVA 180

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+  FGL+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLAR 173

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 66/142 (46%), Gaps = 5/142 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAI-KRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G V+    ++  +LA  K +DT S +   ++  E+ IL     P +V LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             N   ++ E+    ++  ++  +    L  SQ   +      AL +LH   D  +IH D
Sbjct: 105 YENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRD 160
Query: 210 IKPSNVLLDSDCRGKVSDFGLS 231
           +K  N+L   D   K++DFG+S
Sbjct: 161 LKAGNILFTLDGDIKLADFGVS 182

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 83/185 (44%), Gaps = 28/185 (15%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +     ELQI+  L    +V 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVR 77
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM------DVA 191
           L  +     ++       LV +Y+P     E ++       +  Q   +I        + 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           ++L ++H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        
Sbjct: 133 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 250 KSQEL 254
           ++ EL
Sbjct: 189 RAPEL 193

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 75/150 (50%), Gaps = 14/150 (9%)
Query: 91  IGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFLV----T 143
           IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   ++     
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 97
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           +    +E+ K + + + +    L ++L +     L        +  + + L+++H     
Sbjct: 98  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSAN-- 152
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            V+H D+KPSN+LL++ C  K+ DFGL+R+
Sbjct: 153 -VLHRDLKPSNLLLNTTCDLKICDFGLARV 181

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 75/150 (50%), Gaps = 14/150 (9%)
Query: 91  IGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFLV----T 143
           IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   ++     
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 89
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           +    +E+ K + + + +    L ++L +     L        +  + + L+++H     
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            V+H D+KPSN+LL++ C  K+ DFGL+R+
Sbjct: 145 -VLHRDLKPSNLLLNTTCDLKICDFGLARV 173

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 77/158 (48%), Gaps = 13/158 (8%)
Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRL-DTFSLQT-EREFQNELQILGGLRSP 139
           ++++    IG G  G V     R  G+ +AIK++ + F + T  +    EL+IL   +  
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 140 FLVTLLGYCME-----RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
            ++ +             K + V   +    L +++ S   L L+  + F  +  + + L
Sbjct: 115 NIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYF--LYQLLRGL 172
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +++H      VIH D+KPSN+L++ +C  K+ DFG++R
Sbjct: 173 KYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 207

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           PFLV L     + +   +V EY+    +   L   G      ++ +     +    E+LH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYA--AQIVLTFEYLH 158
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
                 +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+    +    FS    + ++S+   RF     +    E
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 176
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH      +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 177 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 214

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 66/142 (46%), Gaps = 5/142 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAI-KRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G V+    ++  +LA  K +DT S +   ++  E+ IL     P +V LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
             N   ++ E+    ++  ++  +    L  SQ   +      AL +LH   D  +IH D
Sbjct: 105 YENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRD 160
Query: 210 IKPSNVLLDSDCRGKVSDFGLS 231
           +K  N+L   D   K++DFG+S
Sbjct: 161 LKAGNILFTLDGDIKLADFGVS 182

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +I   +  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY P   +    FS    + ++S+   RF     +    E
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 156
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+L+D     KV+DFG ++ +V+G
Sbjct: 157 YLH-SLD--LIYRDLKPENLLIDQQGYIKVADFGFAK-RVKG 194

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 68/152 (44%), Gaps = 7/152 (4%)
Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
           + +D    +G G  G V     R  G   A K + T     +   + E+Q +  LR P L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           V L     + N+ +++YE+M    L E +  + N  +   +  E +  V K L  +H   
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMH--- 166
Query: 202 DPPVIHGDIKPSNVLLDSDCRG--KVSDFGLS 231
           +   +H D+KP N++  +      K+ DFGL+
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 198

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 12/154 (7%)
Query: 84  DFDEANVIGKGGSGTVFLGIA-RDGKLLAIKRLD---TFSLQTEREFQNELQILGGLRSP 139
           DF   N++GKG    V+   +   G  +AIK +D    +     +  QNE++I   L+ P
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQR--FEIIMDVAKALEFL 197
            ++ L  Y  + N   LV E   N  +   L    N V  +S+      +  +   + +L
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYL 128
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           H      ++H D+  SN+LL  +   K++DFGL+
Sbjct: 129 H---SHGILHRDLTLSNLLLTRNMNIKIADFGLA 159

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 68/152 (44%), Gaps = 7/152 (4%)
Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
           + +D    +G G  G V     R  G   A K + T     +   + E+Q +  LR P L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           V L     + N+ +++YE+M    L E +  + N  +   +  E +  V K L  +H   
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMH--- 272
Query: 202 DPPVIHGDIKPSNVLLDSDCRG--KVSDFGLS 231
           +   +H D+KP N++  +      K+ DFGL+
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 304

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 77/156 (49%), Gaps = 14/156 (8%)
Query: 85  FDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFL 141
           +   + IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   +
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 81
Query: 142 V----TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
           +     +    +E+ K + + + +    L ++L +     L        +  + + L+++
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYI 138
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      V+H D+KPSN+LL++ C  K+ DFGL+R+
Sbjct: 139 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 171

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 75/150 (50%), Gaps = 14/150 (9%)
Query: 91  IGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFLV----T 143
           IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   ++     
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 87
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           +    +E+ K + + + +    L ++L +     L        +  + + L+++H     
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSAN-- 142
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            V+H D+KPSN+LL++ C  K+ DFGL+R+
Sbjct: 143 -VLHRDLKPSNLLLNTTCDLKICDFGLARV 171

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 67/129 (51%), Gaps = 7/129 (5%)
Query: 107 GKLLAIKRLDTFSLQTE-REFQNELQILGGLRSPFLVTLLGYCMER--NKRILVYEYMPN 163
           G+ +A+K L   S      + + E++IL  L    +V   G C E   N   L+ E++P+
Sbjct: 50  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 109
Query: 164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG 223
            SL+E L  + N +    Q+ +  + + K +++L        +H D+   NVL++S+ + 
Sbjct: 110 GSLKEYLPKNKNKI-NLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQV 165
Query: 224 KVSDFGLSR 232
           K+ DFGL++
Sbjct: 166 KIGDFGLTK 174

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           PFLV L     + +   +V EY+    +   L   G      ++ +     +    E+LH
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYA--AQIVLTFEYLH 179
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
                 +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 180 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 214

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 74/150 (49%), Gaps = 17/150 (11%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  GTV+ G       + +  +   + Q  + F+NE+ +L   R   ++  +GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 79
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEII--MDVAK----ALEFLHFGCDPP 204
           + +  +V ++    SL   L    +++     +FE+I  +D+A+     +++LH      
Sbjct: 80  KPQLAIVTQWCEGSSLYHHL----HII---ETKFEMIKLIDIARQTAQGMDYLH---AKS 129
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
           +IH D+K +N+ L  D   K+ DFGL+ +K
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 159

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 77/156 (49%), Gaps = 14/156 (8%)
Query: 85  FDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFL 141
           +   + IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   +
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 88
Query: 142 V----TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
           +     +    +E+ K + + + +    L ++L +     L        +  + + L+++
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYI 145
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      V+H D+KPSN+LL++ C  K+ DFGL+R+
Sbjct: 146 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 178

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 77/156 (49%), Gaps = 14/156 (8%)
Query: 85  FDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFL 141
           +   + IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   +
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 89
Query: 142 V----TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
           +     +    +E+ K + + + +    L ++L +     L        +  + + L+++
Sbjct: 90  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYI 146
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      V+H D+KPSN+LL++ C  K+ DFGL+R+
Sbjct: 147 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 179

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 77/156 (49%), Gaps = 14/156 (8%)
Query: 85  FDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFL 141
           +   + IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   +
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 80
Query: 142 V----TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
           +     +    +E+ K + + + +    L ++L +     L        +  + + L+++
Sbjct: 81  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYI 137
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      V+H D+KPSN+LL++ C  K+ DFGL+R+
Sbjct: 138 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 170

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 77/156 (49%), Gaps = 14/156 (8%)
Query: 85  FDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFL 141
           +   + IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 87
Query: 142 V----TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
           +     +    +E+ K + + + +    L ++L +     L        +  + + L+++
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYI 144
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      V+H D+KPSN+LL++ C  K+ DFGL+R+
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 77/156 (49%), Gaps = 14/156 (8%)
Query: 85  FDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFL 141
           +   + IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   +
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 103
Query: 142 V----TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
           +     +    +E+ K + + + +    L ++L +     L        +  + + L+++
Sbjct: 104 IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYI 160
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      V+H D+KPSN+LL++ C  K+ DFGL+R+
Sbjct: 161 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 193

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 75/150 (50%), Gaps = 14/150 (9%)
Query: 91  IGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFLV----T 143
           IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   ++     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           +    +E+ K + + + +    L ++L +     L        +  + + L+++H     
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            V+H D+KPSN+LL++ C  K+ DFGL+R+
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 75/150 (50%), Gaps = 14/150 (9%)
Query: 91  IGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFLV----T 143
           IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   ++     
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 94
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           +    +E+ K + + + +    L ++L +     L        +  + + L+++H     
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSAN-- 149
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            V+H D+KPSN+LL++ C  K+ DFGL+R+
Sbjct: 150 -VLHRDLKPSNLLLNTTCDLKICDFGLARV 178

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 74/150 (49%), Gaps = 17/150 (11%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  GTV+ G       + +  +   + Q  + F+NE+ +L   R   ++  +GY   
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 76
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEII--MDVAK----ALEFLHFGCDPP 204
           + +  +V ++    SL   L    +++     +FE+I  +D+A+     +++LH      
Sbjct: 77  KPQLAIVTQWCEGSSLYHHL----HII---ETKFEMIKLIDIARQTAQGMDYLH---AKS 126
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
           +IH D+K +N+ L  D   K+ DFGL+ +K
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 156

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ D GL+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLAR 173

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 91  IGKGGSGTVFLGIARD------GKLLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVT 143
           +G+G  G V+ G ARD         +A+K + ++ SL+   EF NE  ++ G     +V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFS--------DGNLVLKWSQRFEIIMDVAKALE 195
           LLG   +    ++V E M +  L+  L S         G       +  ++  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +L+       +H D+   N ++  D   K+ DFG++R
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 66/135 (48%), Gaps = 9/135 (6%)
Query: 107 GKLLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRI--LVYEYMPN 163
           G+++A+K L +    Q    +Q E++IL  L    +V   G C ++ ++   LV EY+P 
Sbjct: 38  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 97
Query: 164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG 223
            SL++ L       +  +Q       + + + +LH       IH  +   NVLLD+D   
Sbjct: 98  GSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLV 151
Query: 224 KVSDFGLSRIKVEGE 238
           K+ DFGL++   EG 
Sbjct: 152 KIGDFGLAKAVPEGH 166

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 74/150 (49%), Gaps = 17/150 (11%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  GTV+ G       + +  +   + Q  + F+NE+ +L   R   ++  +GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 79
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEII--MDVAK----ALEFLHFGCDPP 204
           + +  +V ++    SL   L    +++     +FE+I  +D+A+     +++LH      
Sbjct: 80  KPQLAIVTQWCEGSSLYHHL----HII---ETKFEMIKLIDIARQTAQGMDYLH---AKS 129
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
           +IH D+K +N+ L  D   K+ DFGL+ +K
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 159

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 22/163 (13%)
Query: 81  ATNDFDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGL 136
             ++F+   V+GKG  G V L  +   G L A+K L    +  + + +    E +IL   
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 137 RS-PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFE------IIMD 189
           R+ PFL  L       ++   V E++    L           ++ S+RF+         +
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLM--------FHIQKSRRFDEARARFYAAE 132
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +  AL FLH   D  +I+ D+K  NVLLD +   K++DFG+ +
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 172

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 91  IGKGGSGTVFLGIARD------GKLLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVT 143
           +G+G  G V+ G ARD         +A+K + ++ SL+   EF NE  ++ G     +V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFS--------DGNLVLKWSQRFEIIMDVAKALE 195
           LLG   +    ++V E M +  L+  L S         G       +  ++  ++A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +L+       +H D+   N ++  D   K+ DFG++R
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 175

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 10/168 (5%)
Query: 76  KELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQ-TEREFQNELQIL 133
           K+ ++    F+    +G G    V L   +  GKL A+K +   +L+  E   +NE+ +L
Sbjct: 15  KQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVL 74
Query: 134 GGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             ++   +V L       N   LV + +    L + +   G    K +    +I  V  A
Sbjct: 75  RKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAST--LIRQVLDA 132
Query: 194 LEFLHFGCDPPVIHGDIKPSNVLL---DSDCRGKVSDFGLSRIKVEGE 238
           + +LH      ++H D+KP N+L    D + +  +SDFGLS+++ +G+
Sbjct: 133 VYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD 177

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 74/150 (49%), Gaps = 17/150 (11%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  GTV+ G       + +  +   + Q  + F+NE+ +L   R   ++  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 74
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEII--MDVAK----ALEFLHFGCDPP 204
           + +  +V ++    SL   L    +++     +FE+I  +D+A+     +++LH      
Sbjct: 75  KPQLAIVTQWCEGSSLYHHL----HII---ETKFEMIKLIDIARQTAQGMDYLH---AKS 124
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
           +IH D+K +N+ L  D   K+ DFGL+ +K
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 74/164 (45%), Gaps = 18/164 (10%)
Query: 91  IGKGGSGTVFLGIARD------GKLLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVT 143
           +G+G  G V+ G ARD         +A+K + ++ SL+   EF NE  ++ G     +V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFS--------DGNLVLKWSQRFEIIMDVAKALE 195
           LLG   +    ++V E M +  L+  L S         G       +  ++  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           +L+       +H D+   N ++  D   K+ DFG++R   E ++
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 185

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 14/147 (9%)
Query: 91  IGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTE--REFQNELQILGGLRSPFLVTLL 145
           IGKG    V L  AR    GK +A++ +D   L +   ++   E++I+  L  P +V L 
Sbjct: 22  IGKGNFAKVKL--ARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ-RFEIIMDVAKALEFLHFGCDPP 204
                     LV EY     + + L + G +  K ++ +F     +  A+++ H      
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCH---QKF 133
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           ++H D+K  N+LLD+D   K++DFG S
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 67/129 (51%), Gaps = 7/129 (5%)
Query: 107 GKLLAIKRLDTFSLQTE-REFQNELQILGGLRSPFLVTLLGYCMER--NKRILVYEYMPN 163
           G+ +A+K L   S      + + E++IL  L    +V   G C E   N   L+ E++P+
Sbjct: 38  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 97
Query: 164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG 223
            SL+E L  + N +    Q+ +  + + K +++L        +H D+   NVL++S+ + 
Sbjct: 98  GSLKEYLPKNKNKI-NLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQV 153
Query: 224 KVSDFGLSR 232
           K+ DFGL++
Sbjct: 154 KIGDFGLTK 162

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 91  IGKGGSGTVFLGIARD------GKLLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVT 143
           +G+G  G V+ G ARD         +A+K + ++ SL+   EF NE  ++ G     +V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFS--------DGNLVLKWSQRFEIIMDVAKALE 195
           LLG   +    ++V E M +  L+  L S         G       +  ++  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +L+       +H D+   N ++  D   K+ DFG++R
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 64/141 (45%), Gaps = 5/141 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  GTV+ G       + +  +   + Q  + F+NE+ +L   R   ++  +GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
               I V ++    SL   L +      +  +  +I    A+ +++LH      +IH D+
Sbjct: 92  PQLAI-VTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDL 146
Query: 211 KPSNVLLDSDCRGKVSDFGLS 231
           K +N+ L  D   K+ DFGL+
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLA 167

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 14/147 (9%)
Query: 91  IGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTE--REFQNELQILGGLRSPFLVTLL 145
           IGKG    V L  AR    GK +A++ +D   L +   ++   E++I+  L  P +V L 
Sbjct: 22  IGKGNFAKVKL--ARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ-RFEIIMDVAKALEFLHFGCDPP 204
                     LV EY     + + L + G +  K ++ +F     +  A+++ H      
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCH---QKF 133
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           ++H D+K  N+LLD+D   K++DFG S
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 74/164 (45%), Gaps = 18/164 (10%)
Query: 91  IGKGGSGTVFLGIARD------GKLLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVT 143
           +G+G  G V+ G ARD         +A+K + ++ SL+   EF NE  ++ G     +V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFS--------DGNLVLKWSQRFEIIMDVAKALE 195
           LLG   +    ++V E M +  L+  L S         G       +  ++  ++A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           +L+       +H D+   N ++  D   K+ DFG++R   E ++
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 184

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 91  IGKGGSGTVFLGIARD------GKLLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVT 143
           +G+G  G V+ G ARD         +A+K + ++ SL+   EF NE  ++ G     +V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFS--------DGNLVLKWSQRFEIIMDVAKALE 195
           LLG   +    ++V E M +  L+  L S         G       +  ++  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +L+       +H D+   N ++  D   K+ DFG++R
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 66/135 (48%), Gaps = 9/135 (6%)
Query: 107 GKLLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRI--LVYEYMPN 163
           G+++A+K L +    Q    +Q E++IL  L    +V   G C ++ ++   LV EY+P 
Sbjct: 37  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 96
Query: 164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG 223
            SL++ L       +  +Q       + + + +LH       IH  +   NVLLD+D   
Sbjct: 97  GSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLV 150
Query: 224 KVSDFGLSRIKVEGE 238
           K+ DFGL++   EG 
Sbjct: 151 KIGDFGLAKAVPEGH 165

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + FD    +G G  G V L   ++ G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+    +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH      +I+ D+KP N+++D     +V+DFG ++ +V+G
Sbjct: 156 YLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAK-RVKG 193

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 74/150 (49%), Gaps = 17/150 (11%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  GTV+ G       + +  +   + Q  + F+NE+ +L   R   ++  +GY   
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 101
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEII--MDVAK----ALEFLHFGCDPP 204
           + +  +V ++    SL   L    +++     +FE+I  +D+A+     +++LH      
Sbjct: 102 KPQLAIVTQWCEGSSLYHHL----HII---ETKFEMIKLIDIARQTAQGMDYLHAKS--- 151
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
           +IH D+K +N+ L  D   K+ DFGL+ +K
Sbjct: 152 IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 181

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ D GL+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLAR 173

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 74/150 (49%), Gaps = 17/150 (11%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  GTV+ G       + +  +   + Q  + F+NE+ +L   R   ++  +GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 102
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEII--MDVAK----ALEFLHFGCDPP 204
           + +  +V ++    SL   L    +++     +FE+I  +D+A+     +++LH      
Sbjct: 103 KPQLAIVTQWCEGSSLYHHL----HII---ETKFEMIKLIDIARQTAQGMDYLH---AKS 152
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
           +IH D+K +N+ L  D   K+ DFGL+ +K
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 182

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L      G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY P   +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+++D     +V+DFG ++ +V+G
Sbjct: 156 YLH-SLD--LIYRDLKPENLMIDQQGYIQVTDFGFAK-RVKG 193

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 35/160 (21%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 32  IGSGAQGIV--CAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKW-----SQRFEIIMDVAK---------- 192
              +N   L+  + P KSL+E  F D  +V++      SQ  ++ +D  +          
Sbjct: 83  ---KNIIGLLNVFTPQKSLEE--FQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC 137
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            ++ LH      +IH D+KPSN+++ SD   K+ DFGL+R
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           IG G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 84
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ D   K+ DFGL+R
Sbjct: 145 YIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 76/169 (44%), Gaps = 14/169 (8%)
Query: 77  ELKNATNDFDEANVIGKGGSGTVFLG-IARDGKLLAIKRL--DTFSLQTEREFQN-ELQI 132
           ++K    DF+   ++GKG  G VFL    +  +  AIK L  D   +  + E    E ++
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 133 LG-GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMD 189
           L      PFL  +      +     V EY+    L   + S     L  +  +  EII+ 
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL- 130
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
               L+FLH      +++ D+K  N+LLD D   K++DFG+ +  + G+
Sbjct: 131 ---GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 173

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 66/146 (45%), Gaps = 12/146 (8%)
Query: 91  IGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTE--REFQNELQILGGLRSPFLVTLL 145
           IGKG    V L  AR    GK +A+K +D   L +   ++   E++I+  L  P +V L 
Sbjct: 15  IGKGNFAKVKL--ARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 72
Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPV 205
                     LV EY     + + L + G     W +  E      + +  + +     +
Sbjct: 73  EVIETEKTLYLVMEYASGGEVFDYLVAHG-----WMKEKEARAKFRQIVSAVQYCHQKFI 127
Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLS 231
           +H D+K  N+LLD+D   K++DFG S
Sbjct: 128 VHRDLKAENLLLDADMNIKIADFGFS 153

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R    + L+  
Sbjct: 32  IGSGAQGIV--CAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRE---LVLMKX 79
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNL--VLKWSQRFE----IIMDVAKAL 194
              +N   L+  + P K+L+E       M   D NL  V++     E    ++  +   +
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 139
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SD   K+ DFGL+R
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 73/155 (47%), Gaps = 8/155 (5%)
Query: 82  TNDFDEANVIGKGGSGTV-FLGIARDGKLLAIKRL-DTFSLQTEREFQNELQI-LGGLRS 138
            +D +    +G+G  G V        G++ A+KR+  T + Q ++    +L I    +  
Sbjct: 33  ADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDC 92
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEML--FSDGNLVLKWSQRFEIIMDVAKALEF 196
           PF VT  G  + R   + +   + + SL +      D    +      +I + + KALE 
Sbjct: 93  PFTVTFYG-ALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 151
Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           LH      VIH D+KPSNVL+++  + K  DFG+S
Sbjct: 152 LHSKLS--VIHRDVKPSNVLINALGQVKXCDFGIS 184

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ DC  K+ D GL+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLAR 173

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 76/156 (48%), Gaps = 14/156 (8%)
Query: 85  FDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFL 141
           +   + IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 87
Query: 142 V----TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
           +     +    +E+ K + + + +    L ++L       L        +  + + L+++
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQH---LSNDHICYFLYQILRGLKYI 144
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      V+H D+KPSN+LL++ C  K+ DFGL+R+
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 14/147 (9%)
Query: 91  IGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQ--TEREFQNELQILGGLRSPFLVTLL 145
           IGKG    V L  AR    G+ +AIK +D   L   + ++   E++I+  L  P +V L 
Sbjct: 23  IGKGNFAKVKL--ARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ-RFEIIMDVAKALEFLHFGCDPP 204
                     L+ EY     + + L + G +  K ++ +F     +  A+++ H      
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQYCH---QKR 134
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           ++H D+K  N+LLD+D   K++DFG S
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFS 161

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 85
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ D   K+ DFGL+R
Sbjct: 146 YIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR 179

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 30/158 (18%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE------IIMDVAKAL 194
             N   L+  + P +SL+E         ++ +D N ++K SQ+        +I  + + L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-SQKLTDDHVQFLIYQILRGL 138
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +++H      +IH D+KPSN+ ++ D   K+ DFGL R
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCR 173

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 10/176 (5%)
Query: 63  DSNAPLKLQRFTYKELKNATND-FDEANVIGKGGSGTVF-LGIARDGKLLAIKRLDTFSL 120
           DS   L+  ++ + E +    D F +  V+G+GG G VF   +   GKL A K+L+   L
Sbjct: 164 DSKYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL 223
Query: 121 QTEREFQN---ELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS--DGN 175
           +  + +Q    E +IL  + S F+V+L      +    LV   M    ++  +++  + N
Sbjct: 224 KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 176 LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              +  +       +   LE LH      +I+ D+KP NVLLD D   ++SD GL+
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 14/147 (9%)
Query: 91  IGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQ--TEREFQNELQILGGLRSPFLVTLL 145
           IGKG    V L  AR    G+ +AIK +D   L   + ++   E++I+  L  P +V L 
Sbjct: 20  IGKGNFAKVKL--ARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 77
Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ-RFEIIMDVAKALEFLHFGCDPP 204
                     L+ EY     + + L + G +  K ++ +F     +  A+++ H      
Sbjct: 78  EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQYCH---QKR 131
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           ++H D+K  N+LLD+D   K++DFG S
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFS 158

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L      G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFL  L     + +   +V EY P   +    FS    + ++S+   RF     +    E
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 156
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+++D     KV+DFG ++ +V+G
Sbjct: 157 YLH-SLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK-RVKG 194

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 81
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ D   K+ DFGL+R
Sbjct: 142 YIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR 175

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L      G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFL  L     + +   +V EY P   +    FS    + ++S+   RF     +    E
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 156
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH   D  +I+ D+KP N+++D     KV+DFG ++ +V+G
Sbjct: 157 YLH-SLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK-RVKG 194

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 59/131 (45%), Gaps = 16/131 (12%)
Query: 556 DMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHV 615
           D+  G  FS + ++  S+ GT  Y++PE         K+DI+SLG L+  + +       
Sbjct: 179 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA------- 231
Query: 616 LASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELR 675
           L SP   +K NL S C+ + Q           L  D+  E+    +N+   C+   PE R
Sbjct: 232 LQSPFYGDKMNLYSLCKKIEQCDY------PPLPSDHYSEELRQLVNM---CINPDPEKR 282
Query: 676 PDIGETVRILK 686
           PD+     + K
Sbjct: 283 PDVTYVYDVAK 293

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 17/150 (11%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  GTV+ G       + +  +   + Q  + F+NE+ +L   R   ++  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEII--MDVAK----ALEFLHFGCDPP 204
               I V ++    SL   L    +++     +FE+I  +D+A+     +++LH      
Sbjct: 76  PQLAI-VTQWCEGSSLYHHL----HII---ETKFEMIKLIDIARQTAQGMDYLH---AKS 124
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
           +IH D+K +N+ L  D   K+ DFGL+ +K
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 77/156 (49%), Gaps = 14/156 (8%)
Query: 85  FDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFL 141
           +   + IG+G  G V        K+ +AI+++  F  QT  +R  + E++IL   R   +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR-EIKILLRFRHENI 87
Query: 142 V----TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
           +     +    +E+ K + + + +    L ++L +     L        +  + + L+++
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYI 144
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      V+H D+KPSN+LL++ C  K+ DFGL+R+
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 78/161 (48%), Gaps = 14/161 (8%)
Query: 76  KELKNATNDFDEANVIGKGGSGTV-FLGIARDGKLLAIKRLDTFSLQTERE---FQNELQ 131
           K+++    DF+   VIG+G  G V  + +    K+ A+K L+ + +    E   F+ E  
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 132 ILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF---EIIM 188
           +L    S ++ TL     + N   LV +Y     L  +L    + + +   RF   E+++
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186
Query: 189 DVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
            +  ++  LH+      +H DIKP N+L+D +   +++DFG
Sbjct: 187 AI-DSVHQLHY------VHRDIKPDNILMDMNGHIRLADFG 220

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 79
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLK 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ D   K+ DFGL+R
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR 173

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 91  IGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTER----EFQNELQILGGLRSPFLVTLL 145
           +G+G   TV+ G ++    L+A+K +    L+ E         E+ +L  L+   +VTL 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPV 205
                     LV+EY+ +K L++ L   GN++   + +   +  + + L + H      V
Sbjct: 67  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKL-FLFQLLRGLAYCH---RQKV 121
Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
           +H D+KP N+L++     K++DFGL+R K
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAK 150

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 72/159 (45%), Gaps = 10/159 (6%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L      G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           PFL  L     + +   +V EY P   +   L   G      ++ +     +    E+LH
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYA--AQIVLTFEYLH 159
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
              D  +I+ D+KP N+++D     KV+DFG ++ +V+G
Sbjct: 160 -SLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK-RVKG 194

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 84
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ D   K+ DFGL+R
Sbjct: 145 YIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 32  IGSGAQGIV--CAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNL--VLKWSQRFE----IIMDVAKAL 194
              +N   L+  + P K+L+E       M   D NL  V++     E    ++  +   +
Sbjct: 83  ---KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 139
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SD   K+ DFGL+R
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTE-REFQNELQILGGLRSPFLVTLLG 146
           +G G  G+V  G+ R  K    +AIK L   + + +  E   E QI+  L +P++V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 147 YCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVI 206
            C +    +LV E      L + L      +   S   E++  V+  +++L    +   +
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKREEI-PVSNVAELLHQVSMGMKYLE---EKNFV 458
Query: 207 HGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H ++   NVLL +    K+SDFGLS+
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSK 484

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 28/157 (17%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           +G G  G+V      + G  +A+K+L        R FQ+   I+   R+   + LL +  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQS---IIHAKRTYRELRLLKHMK 90
Query: 150 ERNKRILVYEYMPNKSLQE---------MLFSDGNLVLKWSQRFE-----IIMDVAKALE 195
             N   L+  + P +SL+E         ++ +D N ++K  +  +     +I  + + L+
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 150
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++H      +IH D+KPSN+ ++ D   K+ DFGL+R
Sbjct: 151 YIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR 184

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 31/158 (19%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R   L+  + +
Sbjct: 25  IGSGAQGIV--CAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 75
Query: 148 CMERNKRILVYEYMPNKSLQE-------MLFSDGNL--VLKWSQRFE----IIMDVAKAL 194
              +N   L+  + P K+L+E       M   D NL  V++     E    ++  +   +
Sbjct: 76  ---KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 132
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + LH      +IH D+KPSN+++ SD   K+ DFGL+R
Sbjct: 133 KHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR 167

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/149 (23%), Positives = 69/149 (46%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++        +A+K +   S+  E  F  E  ++  L+   LV L    + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA-VVT 253
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    ++ E+M   SL + L SD        +  +    +A+ + F+        IH D+
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDL 310
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+ +    K++DFGL+R+  + E+
Sbjct: 311 RAANILVSASLVCKIADFGLARVIEDNEY 339

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 70/170 (41%), Gaps = 23/170 (13%)
Query: 83  NDFDEANVIGKGGSGTVF----LGIARDGKLL--AIKRLDTFSLQTERE-FQNELQILGG 135
           N+      +G G  G V      G+ ++  +L  A+K L + +   E+E   +EL+I+  
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 136 L-RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEML------------FSDGNLVLKWSQ 182
           L +   +V LLG C      +++ EY     L   L            F+  N  L    
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 183 RFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                  VA+ + FL        IH D+   NVLL +    K+ DFGL+R
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 11/154 (7%)
Query: 85  FDEANVIGKGGSGTVF-LGIARDGKLLAIKRLDTFSLQTEREFQN---ELQILGGLRSPF 140
           F +  V+G+GG G VF   +   GKL A K+L+   L+  + +Q    E +IL  + S F
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 141 LVTLLGYCME-RNKRILVYEYMPNKSLQEMLFS--DGNLVLKWSQRFEIIMDVAKALEFL 197
           +V+L  Y  E +    LV   M    ++  +++  + N   +  +       +   LE L
Sbjct: 247 IVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           H      +I+ D+KP NVLLD D   ++SD GL+
Sbjct: 306 H---QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 80  NATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQ-TEREFQNELQILGGLR 137
           ++++ F +   +G G   TV+ G+ +  G  +A+K +   S + T      E+ ++  L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVA---KAL 194
              +V L       NK  LV+E+M N   + M   D   V    +  E+ +      + L
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYM---DSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + L F  +  ++H D+KP N+L++   + K+ DFGL+R
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 18/180 (10%)
Query: 85  FDEANVIGKGGSGTVFLG-IARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +  VIG G  G V+   +   G+L+AIK++    LQ +     ELQI+  L    +V 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVR 77
Query: 144 LLGYCMERNKRI------LVYEYMPNKSLQ-EMLFSDGNLVLKWSQRFEIIMDVAKALEF 196
           L  +     ++       LV +Y+P    +    +S     L        +  + ++L +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 197 LH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGEFGMDLFSQDLGKSQEL 254
           +H FG    + H DIKP N+LLD D    K+ DFG ++  V GE  +        ++ EL
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 11/154 (7%)
Query: 85  FDEANVIGKGGSGTVF-LGIARDGKLLAIKRLDTFSLQTEREFQN---ELQILGGLRSPF 140
           F +  V+G+GG G VF   +   GKL A K+L+   L+  + +Q    E +IL  + S F
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 141 LVTLLGYCME-RNKRILVYEYMPNKSLQEMLFS--DGNLVLKWSQRFEIIMDVAKALEFL 197
           +V+L  Y  E +    LV   M    ++  +++  + N   +  +       +   LE L
Sbjct: 247 IVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           H      +I+ D+KP NVLLD D   ++SD GL+
Sbjct: 306 H---QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 14/147 (9%)
Query: 91  IGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQ--TEREFQNELQILGGLRSPFLVTLL 145
           IGKG    V L  AR    G+ +A+K +D   L   + ++   E++I+  L  P +V L 
Sbjct: 23  IGKGNFAKVKL--ARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ-RFEIIMDVAKALEFLHFGCDPP 204
                     LV EY     + + L + G +  K ++ +F     +  A+++ H      
Sbjct: 81  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCH---QKY 134
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           ++H D+K  N+LLD D   K++DFG S
Sbjct: 135 IVHRDLKAENLLLDGDMNIKIADFGFS 161

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 85  FDEANVIGKGGSGTVF-LGIARDGKLLAIKRLDTFSLQTEREFQN---ELQILGGLRSPF 140
           F +  V+G+GG G VF   +   GKL A K+L+   L+  + +Q    E +IL  + S F
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFS--DGNLVLKWSQRFEIIMDVAKALEFLH 198
           +V+L      +    LV   M    ++  +++  + N   +  +       +   LE LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
                 +I+ D+KP NVLLD D   ++SD GL+
Sbjct: 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 16/161 (9%)
Query: 81  ATNDFD-EANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRS 138
            T+D+     V+G G +G V     R  G+  A+K L   S +  +E  +  Q  GG   
Sbjct: 7   VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-SPKARQEVDHHWQASGG--- 62
Query: 139 PFLVTLLGYC--MERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
           P +V +L     M   KR  +++ E M    L   +   G+      +  EI+ D+  A+
Sbjct: 63  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 122
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLSR 232
           +FLH      + H D+KP N+L  S   D   K++DFG ++
Sbjct: 123 QFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 160

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/149 (23%), Positives = 69/149 (46%), Gaps = 5/149 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++        +A+K +   S+  E  F  E  ++  L+   LV L    + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA-VVT 80
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    ++ E+M   SL + L SD        +  +    +A+ + F+        IH D+
Sbjct: 81  KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDL 137
Query: 211 KPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           + +N+L+ +    K++DFGL+R+  + E+
Sbjct: 138 RAANILVSASLVCKIADFGLARVIEDNEY 166

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 9/153 (5%)
Query: 85  FDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQN---ELQILGGLRSPF 140
           F +   IG G  G V+     R+ +++AIK++     Q+  ++Q+   E++ L  LR P 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
            +   G  +  +   LV EY    +   +      L     Q  EI      AL+ L + 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPL-----QEVEIAAVTHGALQGLAYL 131
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               +IH D+K  N+LL      K+ DFG + I
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 72/160 (45%), Gaps = 35/160 (21%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R    + L+  
Sbjct: 32  IGSGAQGIV--CAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRE---LVLMKX 79
Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKW-----SQRFEIIMDVAK---------- 192
              +N   L+  + P K+L+E  F D  LV++       Q  ++ +D  +          
Sbjct: 80  VNHKNIISLLNVFTPQKTLEE--FQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLC 137
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            ++ LH      +IH D+KPSN+++ SD   K+ DFGL+R
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 16/161 (9%)
Query: 81  ATNDFD-EANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRS 138
            T+D+     V+G G +G V     R  G+  A+K L   S +  +E  +  Q  GG   
Sbjct: 26  VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-SPKARQEVDHHWQASGG--- 81
Query: 139 PFLVTLLGYC--MERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
           P +V +L     M   KR  +++ E M    L   +   G+      +  EI+ D+  A+
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLSR 232
           +FLH      + H D+KP N+L  S   D   K++DFG ++
Sbjct: 142 QFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 86/167 (51%), Gaps = 22/167 (13%)
Query: 75  YKELKNATNDFDEANVIGKGGSGTVFLGIAR----DGKLLAIKRL--DTFSLQTEREFQN 128
           Y+ +   +N F   + IG+G   +V+L  A+      + +A+K L   +  ++   E Q 
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQC 72
Query: 129 ELQILGGLRSPFLVTLLGYCMERNKRILV-YEYMPNKSLQEMLFSDGNLVLKWSQRFEII 187
            L + GG  +   V  + YC  +N  +++   Y+ ++S  ++L S     L + +  E +
Sbjct: 73  -LTVAGGQDN---VMGVKYCFRKNDHVVIAMPYLEHESFLDILNS-----LSFQEVREYM 123
Query: 188 MDVAKALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSR 232
           +++ KAL+ +H FG    ++H D+KPSN L +   +   + DFGL++
Sbjct: 124 LNLFKALKRIHQFG----IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 14/147 (9%)
Query: 91  IGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTE--REFQNELQILGGLRSPFLVTLL 145
           IGKG    V L  AR    GK +A+K +D   L +   ++   E++I   L  P +V L 
Sbjct: 22  IGKGNFAKVKL--ARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLF 79
Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ-RFEIIMDVAKALEFLHFGCDPP 204
                     LV EY     + + L + G    K ++ +F  I+    A+++ H      
Sbjct: 80  EVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVS---AVQYCH---QKF 133
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           ++H D+K  N+LLD+D   K++DFG S
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFS 160

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 9/153 (5%)
Query: 85  FDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQN---ELQILGGLRSPF 140
           F +   IG G  G V+     R+ +++AIK++     Q+  ++Q+   E++ L  LR P 
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
            +   G  +  +   LV EY    S  ++L     +  K  Q  EI      AL+ L + 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLG-SASDLL----EVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               +IH D+K  N+LL      K+ DFG + I
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 203

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 74/174 (42%), Gaps = 32/174 (18%)
Query: 88  ANVIGKGGSGTVF----LGIARDGKLL--AIKRLDTFSLQTERE-FQNELQILGGLRS-P 139
             V+G G  G V      GI++ G  +  A+K L   +  +ERE   +EL+++  L S  
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEML------FSDGNLVLKWSQRFE-------- 185
            +V LLG C       L++EY     L   L      FS+  +  +  +R E        
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 186 -------IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                      VAK +EFL F      +H D+   NVL+      K+ DFGL+R
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 71/157 (45%), Gaps = 29/157 (18%)
Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G V    A D  L   +AIK+L        R FQN+       R    + L+  
Sbjct: 32  IGSGAQGIV--CAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRE---LVLMKX 79
Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKW-----SQRFEIIMDVAKALEFLH-FGC 201
              +N   L+  + P K+L+E  F D  LV++       Q  ++ +D  +    L+   C
Sbjct: 80  VNHKNIISLLNVFTPQKTLEE--FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 137
Query: 202 ------DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                    +IH D+KPSN+++ SD   K+ DFGL+R
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 76  KELKNATNDFDEANVIGKGG-SGTVFLGIARDGKLLAIKRLDTFSLQTERE---FQNELQ 131
           KE++   +DF+   VIG+G  S    + + + G++ A+K ++ + +    E   F+ E  
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 132 ILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVA 191
           +L      ++  L     + N   LV EY     L  +L   G  +     RF  + ++ 
Sbjct: 114 VLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF-YLAEIV 172
Query: 192 KALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
            A++ +H  G     +H DIKP N+LLD     +++DFG
Sbjct: 173 MAIDSVHRLG----YVHRDIKPDNILLDRCGHIRLADFG 207

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 14/169 (8%)
Query: 77  ELKNATNDFDEANVIGKGGSGTVFLG-IARDGKLLAIKRL--DTFSLQTEREFQN-ELQI 132
           ++K    DF    ++GKG  G VFL    +  +  AIK L  D   +  + E    E ++
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 133 LG-GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMD 189
           L      PFL  +      +     V EY+    L   + S     L  +  +  EII+ 
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL- 129
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
               L+FLH      +++ D+K  N+LLD D   K++DFG+ +  + G+
Sbjct: 130 ---GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 65/135 (48%), Gaps = 9/135 (6%)
Query: 107 GKLLAIKRLDT-FSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL--VYEYMPN 163
           G+++A+K L      Q    ++ E+ IL  L    ++   G C ++ ++ L  V EY+P 
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG 223
            SL++ L       +  +Q       + + + +LH       IH ++   NVLLD+D   
Sbjct: 103 GSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLV 156
Query: 224 KVSDFGLSRIKVEGE 238
           K+ DFGL++   EG 
Sbjct: 157 KIGDFGLAKAVPEGH 171

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 91  IGKGGSGTVFLGIAR------DGKLLAIKRLDTFSLQTER-EFQNELQILGGLRSPFLVT 143
           +G+G  G V+ G+A+          +AIK ++  +   ER EF NE  ++       +V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFS-----DGNLVL---KWSQRFEIIMDVAKALE 195
           LLG   +    +++ E M    L+  L S     + N VL     S+  ++  ++A  + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +L+       +H D+   N ++  D   K+ DFG++R
Sbjct: 146 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 18/166 (10%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIARD------GKLLAIKRLDTFSLQTEREFQNELQILGG 135
           T+D+     +GKG    V   + +        K++  K+L   S +  ++ + E +I   
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKL---SARDHQKLEREARICRL 86
Query: 136 LRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALE 195
           L+ P +V L     E     LV++ +    L E + +      ++    +    + + LE
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-----EYYSEADASHCIHQILE 141
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRG---KVSDFGLSRIKVEGE 238
            ++      ++H D+KP N+LL S C+G   K++DFGL+ I+V+GE
Sbjct: 142 SVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGE 186

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 91  IGKGGSGTVFLGIAR------DGKLLAIKRLDTFSLQTER-EFQNELQILGGLRSPFLVT 143
           +G+G  G V+ G+A+          +AIK ++  +   ER EF NE  ++       +V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFS-----DGNLVL---KWSQRFEIIMDVAKALE 195
           LLG   +    +++ E M    L+  L S     + N VL     S+  ++  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +L+       +H D+   N ++  D   K+ DFG++R
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 83  NDFDEANVIGKGGSGTVFLGIARDG--KLLAIKRLDTFSLQTEREFQN---ELQILGGLR 137
            DF+   V+GKG  G V L   R G  +L AIK L    +  + + +    E ++L  L 
Sbjct: 19  TDFNFLMVLGKGSFGKVMLA-DRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLD 77
Query: 138 SPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEF 196
            P  +T L  C +   R+  V EY+    L   +   G    K  Q      +++  L F
Sbjct: 78  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKF--KEPQAVFYAAEISIGLFF 135
Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           LH      +I+ D+K  NV+LDS+   K++DFG+ +
Sbjct: 136 LH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK 168

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 77/175 (44%), Gaps = 18/175 (10%)
Query: 73  FTYKELKNATNDFDEANVIGKGGSGTVFLGIARD------GKLLAIKRLDTFSLQTER-E 125
           F   E + A      +  +G+G  G V+ G+A+          +AIK ++  +   ER E
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 65
Query: 126 FQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS-----DGNLVL-- 178
           F NE  ++       +V LLG   +    +++ E M    L+  L S     + N VL  
Sbjct: 66  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 125
Query: 179 -KWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
              S+  ++  ++A  + +L+       +H D+   N ++  D   K+ DFG++R
Sbjct: 126 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 23/159 (14%)
Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTL----- 144
           +G GG+G VF  +  D  K +AIK++     Q+ +    E++I+  L    +V +     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 145 ---------LGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALE 195
                    +G   E N   +V EYM    L  +L   G L+ + ++ F  +  + + L+
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVL-EQGPLLEEHARLF--MYQLLRGLK 134
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDS-DCRGKVSDFGLSRI 233
           ++H      V+H D+KP+N+ +++ D   K+ DFGL+RI
Sbjct: 135 YIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARI 170

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/143 (23%), Positives = 66/143 (46%), Gaps = 5/143 (3%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           +G G  G V++        +A+K +   S+  E  F  E  ++  L+   LV L    + 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA-VVT 247
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI 210
           +    ++ E+M   SL + L SD        +  +    +A+ + F+        IH D+
Sbjct: 248 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDL 304
Query: 211 KPSNVLLDSDCRGKVSDFGLSRI 233
           + +N+L+ +    K++DFGL+R+
Sbjct: 305 RAANILVSASLVCKIADFGLARV 327

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 91  IGKGGSGTVFLGIARD------GKLLAIKRLDTFSLQTER-EFQNELQILGGLRSPFLVT 143
           +G+G  G V+ G+A+          +AIK ++  +   ER EF NE  ++       +V 
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFS-----DGNLVL---KWSQRFEIIMDVAKALE 195
           LLG   +    +++ E M    L+  L S     + N VL     S+  ++  ++A  + 
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +L+       +H D+   N ++  D   K+ DFG++R
Sbjct: 138 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 65/131 (49%), Gaps = 18/131 (13%)
Query: 115 LDTFSLQTEREFQNELQI--LGGLRSPFLVTLLGYCMERNKRI-----LVYEYMPNKSLQ 167
           +  F +Q ++ +QNE ++  L G++   ++  +G   +R   +     L+  +    SL 
Sbjct: 52  VKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIG-AEKRGTSVDVDLWLITAFHEKGSLS 110
Query: 168 EMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF-------GCDPPVIHGDIKPSNVLLDSD 220
           + L ++   V+ W++   I   +A+ L +LH        G  P + H DIK  NVLL ++
Sbjct: 111 DFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167
Query: 221 CRGKVSDFGLS 231
               ++DFGL+
Sbjct: 168 LTACIADFGLA 178

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 91  IGKGGSGTVFLGIARD------GKLLAIKRLDTFSLQTER-EFQNELQILGGLRSPFLVT 143
           +G+G  G V+ G+A+          +AIK ++  +   ER EF NE  ++       +V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFS-----DGNLVL---KWSQRFEIIMDVAKALE 195
           LLG   +    +++ E M    L+  L S     + N VL     S+  ++  ++A  + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +L+       +H D+   N ++  D   K+ DFG++R
Sbjct: 147 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 72/147 (48%), Gaps = 17/147 (11%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  GTV+ G       + +  +   + Q  + F+NE+ +L   R   ++  +GY   
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 94
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEII--MDVAK----ALEFLHFGCDPP 204
           + +  +V ++    SL   L    +++     +FE+I  +D+A+     +++LH      
Sbjct: 95  KPQLAIVTQWCEGSSLYHHL----HII---ETKFEMIKLIDIARQTAQGMDYLHAKS--- 144
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           +IH D+K +N+ L  D   K+ DFGL+
Sbjct: 145 IIHRDLKSNNIFLHEDLTVKIGDFGLA 171

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 91  IGKGGSGTVFLGIARD------GKLLAIKRLDTFSLQTER-EFQNELQILGGLRSPFLVT 143
           +G+G  G V+ G+A+          +AIK ++  +   ER EF NE  ++       +V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFS-----DGNLVL---KWSQRFEIIMDVAKALE 195
           LLG   +    +++ E M    L+  L S     + N VL     S+  ++  ++A  + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +L+       +H D+   N ++  D   K+ DFG++R
Sbjct: 146 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 16/162 (9%)
Query: 83  NDFDEANVIGKGGSGTVFL-GIARDGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           + F+    +G G  G V L      G   A+K LD   +   ++ +   NE +IL  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ---RFEIIMDVAKALE 195
           PFLV L     + +   +V EY+    +    FS    + ++S+   RF     +    E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
           +LH      +I+ D+KP N+L+D     +V+DFG ++ +V+G
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKG 193

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 72/147 (48%), Gaps = 17/147 (11%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  GTV+ G       + +  +   + Q  + F+NE+ +L   R   ++  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 74
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEII--MDVAK----ALEFLHFGCDPP 204
           + +  +V ++    SL   L    +++     +FE+I  +D+A+     +++LH      
Sbjct: 75  KPQLAIVTQWCEGSSLYHHL----HII---ETKFEMIKLIDIARQTAQGMDYLH---AKS 124
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           +IH D+K +N+ L  D   K+ DFGL+
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 91  IGKGGSGTVFLGIARD------GKLLAIKRLDTFSLQTER-EFQNELQILGGLRSPFLVT 143
           +G+G  G V+ G+A+          +AIK ++  +   ER EF NE  ++       +V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFS-----DGNLVL---KWSQRFEIIMDVAKALE 195
           LLG   +    +++ E M    L+  L S     + N VL     S+  ++  ++A  + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +L+       +H D+   N ++  D   K+ DFG++R
Sbjct: 147 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 91  IGKGGSGTVFLGIARD------GKLLAIKRLDTFSLQTER-EFQNELQILGGLRSPFLVT 143
           +G+G  G V+ G+A+          +AIK ++  +   ER EF NE  ++       +V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFS-----DGNLVL---KWSQRFEIIMDVAKALE 195
           LLG   +    +++ E M    L+  L S     + N VL     S+  ++  ++A  + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +L+       +H D+   N ++  D   K+ DFG++R
Sbjct: 140 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 65/135 (48%), Gaps = 9/135 (6%)
Query: 107 GKLLAIKRLDT-FSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL--VYEYMPN 163
           G+++A+K L      Q    ++ E+ IL  L    ++   G C ++ ++ L  V EY+P 
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG 223
            SL++ L       +  +Q       + + + +LH       IH ++   NVLLD+D   
Sbjct: 103 GSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH---AQHYIHRNLAARNVLLDNDRLV 156
Query: 224 KVSDFGLSRIKVEGE 238
           K+ DFGL++   EG 
Sbjct: 157 KIGDFGLAKAVPEGH 171

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 91  IGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFLV----T 143
           IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   ++     
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGINDI 91
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           +    +E+ K + + + +    L ++L +     L        +  + + L+++H     
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSAN-- 146
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            V+H D+KPSN+LL++    K+ DFGL+R+
Sbjct: 147 -VLHRDLKPSNLLLNTTSDLKICDFGLARV 175

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 72/147 (48%), Gaps = 17/147 (11%)
Query: 91  IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME 150
           IG G  GTV+ G       + +  +   + Q  + F+NE+ +L   R   ++  +GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 102
Query: 151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEII--MDVAK----ALEFLHFGCDPP 204
           + +  +V ++    SL   L    +++     +FE+I  +D+A+     +++LH      
Sbjct: 103 KPQLAIVTQWCEGSSLYHHL----HII---ETKFEMIKLIDIARQTAQGMDYLHAKS--- 152
Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           +IH D+K +N+ L  D   K+ DFGL+
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 9/135 (6%)
Query: 107 GKLLAIKRLDTFSLQTERE-FQNELQILGGLRSPFLVTLLGYCMERNKRIL--VYEYMPN 163
           G+++A+K L   +    R  ++ E+ IL  L    ++   G C +     L  V EY+P 
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119
Query: 164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG 223
            SL++ L       +  +Q       + + + +LH       IH D+   NVLLD+D   
Sbjct: 120 GSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLV 173
Query: 224 KVSDFGLSRIKVEGE 238
           K+ DFGL++   EG 
Sbjct: 174 KIGDFGLAKAVPEGH 188

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 74/167 (44%), Gaps = 18/167 (10%)
Query: 88  ANVIGKGGSGTVFLGIAR--DGKLLAIK----RLDTFSLQTEREFQNELQILGGLRSPFL 141
             ++G+G  G+V  G  +  DG  L +     +LD  S +   EF +E   +     P +
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 142 VTLLGYCMERN-----KRILVYEYMPNKSLQEMLF----SDGNLVLKWSQRFEIIMDVAK 192
           + LLG C+E +     K +++  +M    L   L       G   +      + ++D+A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
            +E+L    +   +H D+   N +L  D    V+DFGLS+    G++
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY 202

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 12/160 (7%)
Query: 76  KELKNATNDFDEANVIGKGGSGTV-FLGIARDGKLLAIKRLDTFSLQTERE---FQNELQ 131
           KE++    DF+   VIG+G  G V  + +    ++ A+K L+ + +    E   F+ E  
Sbjct: 67  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 126
Query: 132 ILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEI--IMD 189
           +L      ++  L     + N   LV +Y     L  +L    + + +   RF I  ++ 
Sbjct: 127 VLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVL 186
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
              ++  LH+      +H DIKP NVLLD +   +++DFG
Sbjct: 187 AIDSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFG 220

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 91  IGKGGSGTVFLGIARD------GKLLAIKRLDTFSLQTER-EFQNELQILGGLRSPFLVT 143
           +G+G  G V+ G+A+          +AIK ++  +   ER EF NE  ++       +V 
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFS-----DGNLVL---KWSQRFEIIMDVAKALE 195
           LLG   +    +++ E M    L+  L S     + N VL     S+  ++  ++A  + 
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +L+       +H D+   N ++  D   K+ DFG++R
Sbjct: 175 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 208

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 36/150 (24%), Positives = 73/150 (48%), Gaps = 7/150 (4%)
Query: 85  FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           +D    +G G  G V   + +  G++   K ++T     +   +NE+ I+  L  P L+ 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           L     ++ + +L+ E++    L + + ++     K S+  E+I  + +A E L    + 
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAED---YKMSEA-EVINYMRQACEGLKHMHEH 168
Query: 204 PVIHGDIKPSNVLLDSDCRG--KVSDFGLS 231
            ++H DIKP N++ ++      K+ DFGL+
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLA 198

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 12/160 (7%)
Query: 76  KELKNATNDFDEANVIGKGGSGTV-FLGIARDGKLLAIKRLDTFSLQTERE---FQNELQ 131
           KE++    DF+   VIG+G  G V  + +    ++ A+K L+ + +    E   F+ E  
Sbjct: 83  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 142
Query: 132 ILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEI--IMD 189
           +L      ++  L     + N   LV +Y     L  +L    + + +   RF I  ++ 
Sbjct: 143 VLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVL 202
Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG 229
              ++  LH+      +H DIKP NVLLD +   +++DFG
Sbjct: 203 AIDSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFG 236

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 78/152 (51%), Gaps = 10/152 (6%)
Query: 85  FDEANVIGKGGSGTVFLGIARDG-KLLAIKR--LDTFSLQTEREFQNELQILGGLRSPFL 141
           +++   IG+G  GTVF    R+  +++A+KR  LD            E+ +L  L+   +
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           V L        K  LV+E+  ++ L++   S +G+L  +  + F  +  + K L F H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSF--LFQLLKGLGFCH-- 118
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               V+H D+KP N+L++ +   K++DFGL+R
Sbjct: 119 -SRNVLHRDLKPQNLLINRNGELKLADFGLAR 149

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 16/161 (9%)
Query: 91  IGKGGSGTVF-LGIARDGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           +G+G  G V  +   + G   A+K  RL+ F  +       EL    GL SP +V L G 
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-------ELMACAGLTSPRIVPLYGA 134
Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
             E     +  E +   SL +++   G   L   +    +    + LE+LH      ++H
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLVKEQG--CLPEDRALYYLGQALEGLEYLH---SRRILH 189
Query: 208 GDIKPSNVLLDSD-CRGKVSDFGLSRIKVEGEFGMDLFSQD 247
           GD+K  NVLL SD     + DFG +        G DL + D
Sbjct: 190 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGD 230

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 74/164 (45%), Gaps = 18/164 (10%)
Query: 91  IGKGGSGTVFLGIAR------DGKLLAIKRLDTFSLQTER-EFQNELQILGGLRSPFLVT 143
           +G+G  G V+ G+A+          +AIK ++  +   ER EF NE  ++       +V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFS-----DGNLVL---KWSQRFEIIMDVAKALE 195
           LLG   +    +++ E M    L+  L S       N VL     S+  ++  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           +L+       +H D+   N ++  D   K+ DFG++R   E ++
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDT--FSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           +G G  G+V     AR  + +A+K+L     SL   R    EL++L  L+   ++ LL  
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFE-----IIMDVAKALEFLHFGCD 202
                    + ++     +  ++ +D N ++K     +     ++  + + L+++H    
Sbjct: 88  FTPATS---IEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG- 143
Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
             +IH D+KPSNV ++ DC  ++ DFGL+R
Sbjct: 144 --IIHRDLKPSNVAVNEDCELRILDFGLAR 171

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 91  IGKGGSGTVFLGIARD------GKLLAIKRLDTFSLQTER-EFQNELQILGGLRSPFLVT 143
           +G+G  G V+ G+A+          +AIK ++  +   ER EF NE  ++       +V 
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFS-----DGNLVL---KWSQRFEIIMDVAKALE 195
           LLG   +    +++ E M    L+  L S       N VL     S+  ++  ++A  + 
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +L+       +H D+   N ++  D   K+ DFG++R
Sbjct: 143 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 66/147 (44%), Gaps = 9/147 (6%)
Query: 89  NVIGKGGSGTVFLGIARDGKLL-AIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           N IG+G  G V + + +  ++  A K++  + ++    F+ E++I+  L  P ++ L   
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
             +     LV E      L E +      V + S    I+ DV  A+ + H      V H
Sbjct: 75  FEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCH---KLNVAH 129
Query: 208 GDIKPSNVLLDSDCRG---KVSDFGLS 231
            D+KP N L  +D      K+ DFGL+
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLA 156

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 16/161 (9%)
Query: 91  IGKGGSGTVF-LGIARDGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           +G+G  G V  +   + G   A+K  RL+ F ++       EL    GL SP +V L G 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGA 118
Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
             E     +  E +   SL +++   G   L   +    +    + LE+LH      ++H
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLH---TRRILH 173
Query: 208 GDIKPSNVLLDSD-CRGKVSDFGLSRIKVEGEFGMDLFSQD 247
           GD+K  NVLL SD  R  + DFG +        G  L + D
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 66/147 (44%), Gaps = 9/147 (6%)
Query: 89  NVIGKGGSGTVFLGIARDGKLL-AIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           N IG+G  G V + + +  ++  A K++  + ++    F+ E++I+  L  P ++ L   
Sbjct: 32  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 91
Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
             +     LV E      L E +      V + S    I+ DV  A+ + H      V H
Sbjct: 92  FEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCH---KLNVAH 146
Query: 208 GDIKPSNVLLDSDCRG---KVSDFGLS 231
            D+KP N L  +D      K+ DFGL+
Sbjct: 147 RDLKPENFLFLTDSPDSPLKLIDFGLA 173

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 16/161 (9%)
Query: 91  IGKGGSGTVF-LGIARDGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           +G+G  G V  +   + G   A+K  RL+ F ++       EL    GL SP +V L G 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGA 134
Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
             E     +  E +   SL +++   G   L   +    +    + LE+LH      ++H
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLH---TRRILH 189
Query: 208 GDIKPSNVLLDSD-CRGKVSDFGLSRIKVEGEFGMDLFSQD 247
           GD+K  NVLL SD  R  + DFG +        G  L + D
Sbjct: 190 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 230

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 91  IGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFLV----T 143
           IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   ++     
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 89
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           +    +E+ K + + + +    L ++L +     L        +  + + L+++H     
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            V+H D+KPSN+LL++    K+ DFGL+R+
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKIXDFGLARV 173

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 91  IGKGGSGTVFLGIARD------GKLLAIKRLDTFSLQTER-EFQNELQILGGLRSPFLVT 143
           +G+G  G V+ G+A+          +AIK ++  +   ER EF NE  ++       +V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFS-----DGNLVL---KWSQRFEIIMDVAKALE 195
           LLG   +    +++ E M    L+  L S     + N VL     S+  ++  ++A  + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +L+       +H D+   N  +  D   K+ DFG++R
Sbjct: 140 YLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 91  IGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFLV----T 143
           IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   ++     
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 89
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           +    +E+ K + + + +    L ++L +     L        +  + + L+++H     
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            V+H D+KPSN+LL++    K+ DFGL+R+
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKICDFGLARV 173

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 91  IGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFLV----T 143
           IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   ++     
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 89
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           +    +E+ K + + + +    L ++L +     L        +  + + L+++H     
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            V+H D+KPSN+LL++    K+ DFGL+R+
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKICDFGLARV 173

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 14/174 (8%)
Query: 66  APLKLQRFTYKELKNATNDF---DEANVIGKGGSGTVF-LGIARDGKLLAIKRLDTFSLQ 121
           AP   +  T K+   A N F    +  ++G G  G V        G  LA K + T  ++
Sbjct: 71  APFDHRIVTAKQ--GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK 128
Query: 122 TEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDG-NLVLKW 180
            + E +NE+ ++  L    L+ L      +N  +LV EY+    L + +  +  NL    
Sbjct: 129 DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT--- 185
Query: 181 SQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVL-LDSDCRG-KVSDFGLSR 232
               + I+ + +  E +       ++H D+KP N+L ++ D +  K+ DFGL+R
Sbjct: 186 --ELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR 237

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 76/156 (48%), Gaps = 14/156 (8%)
Query: 85  FDEANVIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFL 141
           +   + IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   +
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 103
Query: 142 V----TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
           +     +    +E+ K + +  ++    L ++L +     L        +  + + L+++
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLKYI 160
Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H      V+H D+KPSN+LL++    K+ DFGL+R+
Sbjct: 161 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARV 193

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 81/185 (43%), Gaps = 16/185 (8%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGK----LLAIKRLDT-FSLQTEREFQNELQILGG 135
           A  D     ++G+G  G V+ G+  + K     +A+K      +L  + +F +E  I+  
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 136 LRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALE 195
           L  P +V L+G  +E     ++ E  P   L   L  + N  LK        + + KA+ 
Sbjct: 66  LDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMA 123
Query: 196 FLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQEL 254
           +L    C    +H DI   N+L+ S    K+ DFGLSR  +E E   D +   + +    
Sbjct: 124 YLESINC----VHRDIAVRNILVASPECVKLGDFGLSRY-IEDE---DYYKASVTRLPIK 175
Query: 255 WKSQE 259
           W S E
Sbjct: 176 WMSPE 180

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 16/161 (9%)
Query: 91  IGKGGSGTVF-LGIARDGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           +G+G  G V  +   + G   A+K  RL+ F ++       EL    GL SP +V L G 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGA 132
Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
             E     +  E +   SL +++   G   L   +    +    + LE+LH      ++H
Sbjct: 133 VREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLH---TRRILH 187
Query: 208 GDIKPSNVLLDSD-CRGKVSDFGLSRIKVEGEFGMDLFSQD 247
           GD+K  NVLL SD  R  + DFG +        G  L + D
Sbjct: 188 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 228

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 81/185 (43%), Gaps = 16/185 (8%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGKL----LAIKRLDT-FSLQTEREFQNELQILGG 135
           A  D     ++G+G  G V+ G+  + K     +A+K      +L  + +F +E  I+  
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 136 LRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALE 195
           L  P +V L+G  +E     ++ E  P   L   L  + N  LK        + + KA+ 
Sbjct: 82  LDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMA 139
Query: 196 FLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQEL 254
           +L    C    +H DI   N+L+ S    K+ DFGLSR  +E E   D +   + +    
Sbjct: 140 YLESINC----VHRDIAVRNILVASPECVKLGDFGLSRY-IEDE---DYYKASVTRLPIK 191
Query: 255 WKSQE 259
           W S E
Sbjct: 192 WMSPE 196

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 91  IGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFLV----T 143
           IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   ++     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR-EIKILLRFRHENIIGINDI 93
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           +    +E+ K + + + +    L ++L +     L        +  + + L+++H     
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            V+H D+KPSN+LL++    K+ DFGL+R+
Sbjct: 149 -VLHRDLKPSNLLLNTTXDLKICDFGLARV 177

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 91  IGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQT--EREFQNELQILGGLRSPFLV----T 143
           IG+G  G V        K+ +AIK++  F  QT  +R  + E++IL   R   ++     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           +    +E+ K + + + +    L ++L +     L        +  + + L+++H     
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            V+H D+KPSN+LL++    K+ DFGL+R+
Sbjct: 149 -VLHRDLKPSNLLLNTTXDLKICDFGLARV 177

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 68/141 (48%), Gaps = 7/141 (4%)
Query: 91  IGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           IG+G +G V L   +  G+ +A+K +D    Q      NE+ I+   +   +V +    +
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD 209
              +  ++ E++   +L +++     + L   Q   +   V +AL +LH      VIH D
Sbjct: 113 VGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRD 166
Query: 210 IKPSNVLLDSDCRGKVSDFGL 230
           IK  ++LL  D R K+SDFG 
Sbjct: 167 IKSDSILLTLDGRVKLSDFGF 187

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 81/185 (43%), Gaps = 16/185 (8%)
Query: 81  ATNDFDEANVIGKGGSGTVFLGIARDGKL----LAIKRLDT-FSLQTEREFQNELQILGG 135
           A  D     ++G+G  G V+ G+  + K     +A+K      +L  + +F +E  I+  
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 136 LRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALE 195
           L  P +V L+G  +E     ++ E  P   L   L  + N  LK        + + KA+ 
Sbjct: 70  LDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMA 127
Query: 196 FLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQEL 254
           +L    C    +H DI   N+L+ S    K+ DFGLSR  +E E   D +   + +    
Sbjct: 128 YLESINC----VHRDIAVRNILVASPECVKLGDFGLSRY-IEDE---DYYKASVTRLPIK 179
Query: 255 WKSQE 259
           W S E
Sbjct: 180 WMSPE 184

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 73/167 (43%), Gaps = 21/167 (12%)
Query: 83  NDFDEANVIGKGGSGTVF----LGIARDGKLL--AIKRLDTFSLQTERE-FQNELQILGG 135
           N+      +G G  G V      G+ ++  +L  A+K L + +   E+E   +EL+I+  
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 136 L-RSPFLVTLLGYCMERNKRILVYEY---------MPNKSLQEMLFSDGNLVLKWSQRFE 185
           L +   +V LLG C      +++ EY         +  K+  ++   DG   L+      
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGR-PLELRDLLH 156
Query: 186 IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               VA+ + FL        IH D+   NVLL +    K+ DFGL+R
Sbjct: 157 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 200

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 73/167 (43%), Gaps = 21/167 (12%)
Query: 83  NDFDEANVIGKGGSGTVF----LGIARDGKLL--AIKRLDTFSLQTERE-FQNELQILGG 135
           N+      +G G  G V      G+ ++  +L  A+K L + +   E+E   +EL+I+  
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 136 L-RSPFLVTLLGYCMERNKRILVYEY---------MPNKSLQEMLFSDGNLVLKWSQRFE 185
           L +   +V LLG C      +++ EY         +  K+  ++   DG   L+      
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGR-PLELRDLLH 164
Query: 186 IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               VA+ + FL        IH D+   NVLL +    K+ DFGL+R
Sbjct: 165 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 208

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 189 DVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           D+ K +E+LH+     +IH DIKPSN+L+  D   K++DFG+S
Sbjct: 145 DLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS 184

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 78/152 (51%), Gaps = 10/152 (6%)
Query: 85  FDEANVIGKGGSGTVFLGIARDG-KLLAIKR--LDTFSLQTEREFQNELQILGGLRSPFL 141
           +++   IG+G  GTVF    R+  +++A+KR  LD            E+ +L  L+   +
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFS-DGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           V L        K  LV+E+  ++ L++   S +G+L  +  + F  +  + K L F H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSF--LFQLLKGLGFCH-- 118
Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               V+H D+KP N+L++ +   K+++FGL+R
Sbjct: 119 -SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 14/112 (12%)
Query: 125 EFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKW 180
           E   E  ++  L +P++V ++G C E    +LV E       NK LQ+      N  +K 
Sbjct: 52  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKD 104
Query: 181 SQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               E++  V+  +++L    +   +H D+   NVLL +    K+SDFGLS+
Sbjct: 105 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK 153

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 14/112 (12%)
Query: 125 EFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKW 180
           E   E  ++  L +P++V ++G C E    +LV E       NK LQ+      N  +K 
Sbjct: 54  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKD 106
Query: 181 SQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               E++  V+  +++L    +   +H D+   NVLL +    K+SDFGLS+
Sbjct: 107 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK 155

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 14/112 (12%)
Query: 125 EFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKW 180
           E   E  ++  L +P++V ++G C E    +LV E       NK LQ+      N  +K 
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKD 116
Query: 181 SQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               E++  V+  +++L    +   +H D+   NVLL +    K+SDFGLS+
Sbjct: 117 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK 165

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 14/112 (12%)
Query: 125 EFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKW 180
           E   E  ++  L +P++V ++G C E    +LV E       NK LQ+      N  +K 
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKD 126
Query: 181 SQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               E++  V+  +++L    +   +H D+   NVLL +    K+SDFGLS+
Sbjct: 127 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK 175

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 14/112 (12%)
Query: 125 EFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKW 180
           E   E  ++  L +P++V ++G C E    +LV E       NK LQ+      N  +K 
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKD 126
Query: 181 SQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               E++  V+  +++L    +   +H D+   NVLL +    K+SDFGLS+
Sbjct: 127 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK 175

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 14/112 (12%)
Query: 125 EFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKW 180
           E   E  ++  L +P++V ++G C E    +LV E       NK LQ+      N  +K 
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKD 110
Query: 181 SQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               E++  V+  +++L    +   +H D+   NVLL +    K+SDFGLS+
Sbjct: 111 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK 159

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 14/112 (12%)
Query: 125 EFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKW 180
           E   E  ++  L +P++V ++G C E    +LV E       NK LQ+      N  +K 
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKD 110
Query: 181 SQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               E++  V+  +++L    +   +H D+   NVLL +    K+SDFGLS+
Sbjct: 111 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK 159

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 79/161 (49%), Gaps = 16/161 (9%)
Query: 83  NDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRS-PF 140
           +D+     +G+G    VF  I   + + + +K L       + + + E++IL  LR  P 
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KNKIKREIKILENLRGGPN 93
Query: 141 LVTLLGYCMERNKRI--LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           ++TL     +   R   LV+E++ N   +++       +  +  RF  + ++ KAL++ H
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRF-YMYEILKALDYCH 148
Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRG-KVSDFGLSRIKVEGE 238
                 ++H D+KP NV++D + R  ++ D+GL+     G+
Sbjct: 149 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 186

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 16/153 (10%)
Query: 74  TYKELKNATNDFDEANVIGKGGSGTVFLGIARD----GKL----LAIKRLDTFSLQTERE 125
            + +++N    F+E+  +G+G    +F G+ R+    G+L    + +K LD         
Sbjct: 1   VFHKIRNEDLIFNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES 58
Query: 126 FQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLV-LKWSQRF 184
           F     ++  L    LV   G C+  ++ ILV E++   SL   L  + N + + W  + 
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KL 116
Query: 185 EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL 217
           E+   +A A+ FL    +  +IHG++   N+LL
Sbjct: 117 EVAKQLAAAMHFLE---ENTLIHGNVCAKNILL 146

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 14/112 (12%)
Query: 125 EFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKW 180
           E   E  ++  L +P++V ++G C E    +LV E       NK LQ+      N  +K 
Sbjct: 72  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKD 124
Query: 181 SQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               E++  V+  +++L    +   +H D+   NVLL +    K+SDFGLS+
Sbjct: 125 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK 173

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 14/112 (12%)
Query: 125 EFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKW 180
           E   E  ++  L +P++V ++G C E    +LV E       NK LQ+      N  +K 
Sbjct: 417 ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKD 469
Query: 181 SQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               E++  V+  +++L    +   +H D+   NVLL +    K+SDFGLS+
Sbjct: 470 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK 518

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 69/145 (47%), Gaps = 15/145 (10%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQ------ILG 134
           T +F E   IG G  G+VF  + R DG + AIKR     L    + QN L+      +LG
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 66
Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLV--LKWSQRFEIIMDVAK 192
             +   +V       E +  ++  EY    SL + +  +  ++   K ++  ++++ V +
Sbjct: 67  --QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLL 217
            L ++H      ++H DIKPSN+ +
Sbjct: 125 GLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 14/112 (12%)
Query: 125 EFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP----NKSLQEMLFSDGNLVLKW 180
           E   E  ++  L +P++V ++G C E    +LV E       NK LQ+      N  +K 
Sbjct: 416 ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKD 468
Query: 181 SQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               E++  V+  +++L    +   +H D+   NVLL +    K+SDFGLS+
Sbjct: 469 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK 517

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 69/145 (47%), Gaps = 15/145 (10%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQ------ILG 134
           T +F E   IG G  G+VF  + R DG + AIKR     L    + QN L+      +LG
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKK-PLAGSVDEQNALREVYAHAVLG 66
Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLV--LKWSQRFEIIMDVAK 192
             +   +V       E +  ++  EY    SL + +  +  ++   K ++  ++++ V +
Sbjct: 67  --QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLL 217
            L ++H      ++H DIKPSN+ +
Sbjct: 125 GLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 68/161 (42%), Gaps = 16/161 (9%)
Query: 91  IGKGGSGTVF-LGIARDGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           +G+G  G V  +   + G   A+K  RL+ F  +       EL    GL SP +V L G 
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-------ELMACAGLTSPRIVPLYGA 153
Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
             E     +  E +   SL +++   G   L   +    +    + LE+LH      ++H
Sbjct: 154 VREGPWVNIFMELLEGGSLGQLVKEQG--CLPEDRALYYLGQALEGLEYLH---SRRILH 208
Query: 208 GDIKPSNVLLDSD-CRGKVSDFGLSRIKVEGEFGMDLFSQD 247
           GD+K  NVLL SD     + DFG +        G  L + D
Sbjct: 209 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGD 249

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 69/145 (47%), Gaps = 15/145 (10%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQ------ILG 134
           T +F E   IG G  G+VF  + R DG + AIKR     L    + QN L+      +LG
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 68
Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLV--LKWSQRFEIIMDVAK 192
             +   +V       E +  ++  EY    SL + +  +  ++   K ++  ++++ V +
Sbjct: 69  --QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLL 217
            L ++H      ++H DIKPSN+ +
Sbjct: 127 GLRYIH---SMSLVHMDIKPSNIFI 148

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 6/146 (4%)
Query: 90  VIGKGGSGTVFLGIARDGKL-LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
           V+GKG  G V+ G     ++ +AIK +     +  +    E+ +   L+   +V  LG  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM-DVAKALEFLHFGCDPPVIH 207
            E     +  E +P  SL  +L S    +    Q        + + L++LH   D  ++H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145
Query: 208 GDIKPSNVLLDS-DCRGKVSDFGLSR 232
            DIK  NVL+++     K+SDFG S+
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSK 171

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 69/145 (47%), Gaps = 15/145 (10%)
Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQ------ILG 134
           T +F E   IG G  G+VF  + R DG + AIKR     L    + QN L+      +LG
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKK-PLAGSVDEQNALREVYAHAVLG 64
Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLV--LKWSQRFEIIMDVAK 192
             +   +V       E +  ++  EY    SL + +  +  ++   K ++  ++++ V +
Sbjct: 65  --QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 122
Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLL 217
            L ++H      ++H DIKPSN+ +
Sbjct: 123 GLRYIH---SMSLVHMDIKPSNIFI 144

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 80/201 (39%), Gaps = 37/201 (18%)
Query: 66  APLKLQRFTYKELKNATNDFDEANVI----------GKGGSGTVFLGIARDG-KLLAIKR 114
            PL L    +K L++   +F   N++          GK    T F    R G   +A+K 
Sbjct: 1   GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM 60
Query: 115 LDTFSLQTE-REFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEML--- 170
           L   +  +E R+  +E  +L  +  P ++ L G C +    +L+ EY    SL+  L   
Sbjct: 61  LKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRES 120
Query: 171 --FSDGNL-----------------VLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIK 211
                G L                  L           +++ +++L    +  ++H D+ 
Sbjct: 121 RKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLA 177
Query: 212 PSNVLLDSDCRGKVSDFGLSR 232
             N+L+    + K+SDFGLSR
Sbjct: 178 ARNILVAEGRKMKISDFGLSR 198

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 80/201 (39%), Gaps = 37/201 (18%)
Query: 66  APLKLQRFTYKELKNATNDFDEANVI----------GKGGSGTVFLGIARDG-KLLAIKR 114
            PL L    +K L++   +F   N++          GK    T F    R G   +A+K 
Sbjct: 1   GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM 60
Query: 115 LDTFSLQTE-REFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEML--- 170
           L   +  +E R+  +E  +L  +  P ++ L G C +    +L+ EY    SL+  L   
Sbjct: 61  LKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRES 120
Query: 171 --FSDGNL-----------------VLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIK 211
                G L                  L           +++ +++L    +  ++H D+ 
Sbjct: 121 RKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLA 177
Query: 212 PSNVLLDSDCRGKVSDFGLSR 232
             N+L+    + K+SDFGLSR
Sbjct: 178 ARNILVAEGRKMKISDFGLSR 198

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 69/168 (41%), Gaps = 32/168 (19%)
Query: 91  IGKGGSGTVF----LGIARDG--KLLAIKRLDTFSLQTE-REFQNELQILGGLRSPF-LV 142
           +G+G  G V      GI +    + +A+K L   +  +E R   +EL+IL  +     +V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 143 TLLGYCMERNKRILVY------------------EYMPNKSLQEMLFSDGNLVLKWSQRF 184
            LLG C +    ++V                   E++P K   E L+ D    L      
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKD---FLTLEHLI 153
Query: 185 EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                VAK +EFL        IH D+   N+LL      K+ DFGL+R
Sbjct: 154 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 198

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 80/201 (39%), Gaps = 37/201 (18%)
Query: 66  APLKLQRFTYKELKNATNDFDEANVI----------GKGGSGTVFLGIARDG-KLLAIKR 114
            PL L    +K L++   +F   N++          GK    T F    R G   +A+K 
Sbjct: 1   GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM 60
Query: 115 LDTFSLQTE-REFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEML--- 170
           L   +  +E R+  +E  +L  +  P ++ L G C +    +L+ EY    SL+  L   
Sbjct: 61  LKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRES 120
Query: 171 --FSDGNL-----------------VLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIK 211
                G L                  L           +++ +++L    +  ++H D+ 
Sbjct: 121 RKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLA 177
Query: 212 PSNVLLDSDCRGKVSDFGLSR 232
             N+L+    + K+SDFGLSR
Sbjct: 178 ARNILVAEGRKMKISDFGLSR 198

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	718
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-71
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-35
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-71
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	9e-29
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-64
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-25
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-42
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-10
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-39
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-38
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-04
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-38
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-05
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-37
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-05
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-36
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-06
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-33
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-33
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-32
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-32
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-31
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-31
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-30
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-29
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-29
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-26
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-04
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-23
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-08
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-23
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-07
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-23
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-06
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-23
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-06
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-22
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-05
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-22
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-22
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-21
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-21
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-04
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-21
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-05
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-21
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-04
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-21
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-07
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-21
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-04
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-21
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-06
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-21
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-07
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-21
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-21
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-08
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-20
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-20
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-20
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-05
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-20
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-09
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-20
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-20
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-20
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-20
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-19
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-19
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-19
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-19
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-19
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-19
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-19
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-19
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-19
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-04
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-19
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-06
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-19
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-19
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-19
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-19
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-19
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-19
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-19
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-19
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-19
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-19
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-05
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-19
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-04
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-19
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-19
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-06
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-18
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-18
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-18
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-18
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-18
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-04
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-18
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-18
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-18
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-18
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-18
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-18
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-17
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-17
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-17
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-17
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-17
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-17
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-06
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-17
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-04
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-17
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-17
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-16
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-16
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-16
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-16
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-16
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-16
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-04
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-16
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-16
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-16
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-16
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-16
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-15
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-15
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-04
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-15
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-05
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-15
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-15
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-15
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-15
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-15
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-15
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-15
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-15
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	9e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-15
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-14
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-14
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-14
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-14
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-14
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-14
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-14
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-14
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-14
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-14
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-14
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-14
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-14
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-14
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-14
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-13
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-13
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-13
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-13
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-13
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-13
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-13
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-13
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-04
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-13
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-13
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-13
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-05
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	9e-13
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-05
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-12
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-12
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-12
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-06
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-12
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-12
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-04
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-12
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-12
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-12
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-11
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-11
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-11
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-04
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-11
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-11
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-11
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-11
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-11
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-11
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-11
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-11
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	8e-11
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-10
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-10
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-10
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-09
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-06
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-07
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	8e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-06
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-05
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-05
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-05

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  234 bits (600), Expect = 2e-71
 Identities = 64/166 (38%), Positives = 99/166 (59%), Gaps = 3/166 (1%)

Query: 70  LQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ-TEREFQN 128
           L+RF+ +EL+ A+++F   N++G+GG G V+ G   DG L+A+KRL     Q  E +FQ 
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 129 ELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLF--SDGNLVLKWSQRFEI 186
           E++++       L+ L G+CM   +R+LVY YM N S+   L    +    L W +R  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 187 IMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            +  A+ L +LH  CDP +IH D+K +N+LLD +    V DFGL++
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  135 bits (343), Expect = 2e-35
 Identities = 42/122 (34%), Positives = 69/122 (56%), Gaps = 1/122 (0%)

Query: 570 TTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLIS 629
           TT++RGT+ ++APEY   G   EK D++  GV++L +++G+R    LA     +   L+ 
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD-LARLANDDDVMLLD 250

Query: 630 WCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKGEM 689
           W + L +   +  LVD  L+ +Y  E+    I +AL C Q +P  RP + E VR+L+G+ 
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310

Query: 690 DL 691
             
Sbjct: 311 LA 312

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  233 bits (596), Expect = 7e-71
 Identities = 67/184 (36%), Positives = 104/184 (56%), Gaps = 5/184 (2%)

Query: 57  SRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLD 116
           +  +      P +  R    +L+ ATN+FD   +IG G  G V+ G+ RDG  +A+KR  
Sbjct: 13  NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT 72

Query: 117 TFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGN- 175
             S Q   EF+ E++ L   R P LV+L+G+C ERN+ IL+Y+YM N +L+  L+     
Sbjct: 73  PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132

Query: 176 -LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
            + + W QR EI +  A+ L +LH      +IH D+K  N+LLD +   K++DFG+S+  
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189

Query: 235 VEGE 238
            E +
Sbjct: 190 TELD 193

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  116 bits (293), Expect = 9e-29
 Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 3/122 (2%)

Query: 570 TTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLIS 629
           +T ++GTL Y+ PEY   G L EK+D+YS GV++  ++  R  +         E  NL  
Sbjct: 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR---EMVNLAE 254

Query: 630 WCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKGEM 689
           W       G + ++VD  L D    E      + A+ CL  + E RP +G+ +  L+  +
Sbjct: 255 WAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

Query: 690 DL 691
            L
Sbjct: 315 RL 316

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  215 bits (550), Expect = 2e-64
 Identities = 63/184 (34%), Positives = 97/184 (52%), Gaps = 15/184 (8%)

Query: 66  APLKLQRFTYKELKNATNDFDE------ANVIGKGGSGTVFLGIARDGKLLAIKRLDTF- 118
           +  +   F++ ELKN TN+FDE       N +G+GG G V+ G   +   +A+K+L    
Sbjct: 8   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMV 66

Query: 119 ---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLF-SDG 174
              + + +++F  E++++   +   LV LLG+  + +   LVY YMPN SL + L   DG
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126

Query: 175 NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
              L W  R +I    A  + FLH   +   IH DIK +N+LLD     K+SDFGL+R  
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183

Query: 235 VEGE 238
            +  
Sbjct: 184 EKFA 187

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  105 bits (265), Expect = 3e-25
 Identities = 31/119 (26%), Positives = 57/119 (47%), Gaps = 8/119 (6%)

Query: 570 TTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLIS 629
           T+ + GT  Y+APE    G +  K+DIYS GV++L I++G   +         E   L+ 
Sbjct: 192 TSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD-----EHREPQLLLD 245

Query: 630 WCR-HLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKG 687
                  +   I + +D+++ +D +        ++A  CL +    RPDI +  ++L+ 
Sbjct: 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  154 bits (390), Expect = 7e-42
 Identities = 41/179 (22%), Positives = 77/179 (43%), Gaps = 20/179 (11%)

Query: 73  FTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQI 132
              + L   +       V  +G  G V+       + +A+K    F +Q ++ +QNE ++
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKI---FPIQDKQSWQNEYEV 69

Query: 133 --LGGLRSPFLVTLLGYCMERNK----RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEI 186
             L G++   ++  +G             L+  +    SL + L ++   V+ W++   I
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHI 126

Query: 187 IMDVAKALEFLH-------FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
              +A+ L +LH        G  P + H DIK  NVLL ++    ++DFGL+     G+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 60.1 bits (146), Expect = 8e-10
 Identities = 21/126 (16%), Positives = 37/126 (29%), Gaps = 8/126 (6%)

Query: 569 STTSMRGTLCYVAPEYGGCGYLME-----KADIYSLGVLILVIVSGRRPLHVLASPMKLE 623
            T    GT  Y+APE        +     + D+Y++G+++  + S             L 
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248

Query: 624 KANLISWCRHLAQAGNI--LELVDERLKDDYNKEQASLCI-NLALTCLQKTPELRPDIGE 680
               I     L     +   +     L+D + K      +      C     E R   G 
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308

Query: 681 TVRILK 686
               + 
Sbjct: 309 VGERIT 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  147 bits (373), Expect = 1e-39
 Identities = 52/162 (32%), Positives = 76/162 (46%), Gaps = 5/162 (3%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRL--DTFSLQTEREFQNELQILGGLRSPF 140
            D +    IG G  GTV       G  +A+K L    F  +   EF  E+ I+  LR P 
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLF-SDGNLVLKWSQRFEIIMDVAKALEFLHF 199
           +V  +G   +     +V EY+   SL  +L  S     L   +R  +  DVAK + +LH 
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH- 154

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGM 241
             +PP++H ++K  N+L+D     KV DFGLSR+K       
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS 196

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  142 bits (361), Expect = 2e-38
 Identities = 35/159 (22%), Positives = 67/159 (42%), Gaps = 6/159 (3%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRL--DTFSLQTEREFQNELQILGGLRSPF 140
              +    + +  SG ++ G  + G  + +K L    +S +  R+F  E   L     P 
Sbjct: 10  KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 141 LVTLLGYCME--RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           ++ +LG C         L+  +MP  SL  +L    N V+  SQ  +  +D+A+ + FLH
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
              +P +    +   +V++D D   ++S   +       
Sbjct: 129 -TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP 166

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 42.6 bits (101), Expect = 2e-04
 Identities = 27/129 (20%), Positives = 40/129 (31%), Gaps = 26/129 (20%)

Query: 563 FSRELSSTTSMRGTLCYVAPE---YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASP 619
                 S   M     +VAPE             AD++S  VL+  +V+   P   L S 
Sbjct: 159 VKFSFQSPGRM-YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL-SN 216

Query: 620 MKLEKANLISWCRHLAQAGNILELVDERLK--DDYNKEQASLCINLALTCLQKTPELRPD 677
           M               + G  + L   R       +   + L       C+ + P  RP 
Sbjct: 217 M---------------EIGMKVALEGLRPTIPPGISPHVSKLMKI----CMNEDPAKRPK 257

Query: 678 IGETVRILK 686
               V IL+
Sbjct: 258 FDMIVPILE 266

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  143 bits (363), Expect = 5e-38
 Identities = 43/175 (24%), Positives = 67/175 (38%), Gaps = 20/175 (11%)

Query: 73  FTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQI 132
               E     ++     +IG+G  G V+ G     + +A+K    FS    + F NE  I
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKV---FSFANRQNFINEKNI 58

Query: 133 --LGGLRSPFLVTLLGYCME-----RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFE 185
             +  +    +   +          R + +LV EY PN SL + L         W     
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCR 115

Query: 186 IIMDVAKALEFLH------FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
           +   V + L +LH          P + H D+   NVL+ +D    +SDFGLS   
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 20/153 (13%), Positives = 48/153 (31%), Gaps = 21/153 (13%)

Query: 568 SSTTSMRGTLCYVAPEY-------GGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPM 620
           ++  S  GT+ Y+APE              +++ D+Y+LG++   I      L     P 
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL----FPG 238

Query: 621 KLEKANLISWCRHLAQAGNILELVDE--------RLKDDYNKEQASLCI--NLALTCLQK 670
           +      +++   +       ++           +  + + +   ++         C  +
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298

Query: 671 TPELRPDIGETVRILKGEMDLPPVPFEFSPSPS 703
             E R         +   M +       SP+  
Sbjct: 299 DAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  140 bits (355), Expect = 2e-37
 Identities = 52/167 (31%), Positives = 85/167 (50%), Gaps = 17/167 (10%)

Query: 83  NDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRL-------DTFSLQTEREFQNELQILG 134
           N+ +    IGKGG G V  G   +D  ++AIK L       +T  ++  +EFQ E+ I+ 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
            L  P +V L G      +  +V E++P   L   L  D    +KWS +  +++D+A  +
Sbjct: 79  NLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRL-LDKAHPIKWSVKLRLMLDIALGI 135

Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRG-----KVSDFGLSRIKVE 236
           E++    +PP++H D++  N+ L S         KV+DFGLS+  V 
Sbjct: 136 EYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH 181

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 28/127 (22%), Positives = 45/127 (35%), Gaps = 19/127 (14%)

Query: 563 FSRELSST-TSMRGTLCYVAPE--YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASP 619
            S++   + + + G   ++APE          EKAD YS  +++  I++G  P       
Sbjct: 175 LSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF----DE 230

Query: 620 MKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIG 679
               K   I+  R       I E    RL+            N+   C    P+ RP   
Sbjct: 231 YSYGKIKFINMIREEGLRPTIPEDCPPRLR------------NVIELCWSGDPKKRPHFS 278

Query: 680 ETVRILK 686
             V+ L 
Sbjct: 279 YIVKELS 285

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  138 bits (350), Expect = 1e-36
 Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 7/154 (4%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLV 142
            + +   V+G+G  G V     R  K +AIK+++  S    + F  EL+ L  +  P +V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLV-LKWSQRFEIIMDVAKALEFLHFGC 201
            L G C+  N   LV EY    SL  +L     L     +      +  ++ + +LH   
Sbjct: 65  KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 202 DPPVIHGDIKPSNVLLDSDCR-GKVSDFGLSRIK 234
              +IH D+KP N+LL +     K+ DFG +   
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 33/161 (20%), Positives = 61/161 (37%), Gaps = 28/161 (17%)

Query: 563 FSRELSST-TSMRGTLCYVAPE-YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPM 620
            + ++ +  T+ +G+  ++APE + G  Y  EK D++S G+++  +++ R+P   +  P 
Sbjct: 152 TACDIQTHMTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPA 210

Query: 621 KLEKANLISWCRHLAQAGNILELV--DERLK--DDYNKEQASLCINLALTCLQKTPELRP 676
                              I+  V    R     +  K   SL       C  K P  RP
Sbjct: 211 F-----------------RIMWAVHNGTRPPLIKNLPKPIESLMTR----CWSKDPSQRP 249

Query: 677 DIGETVRILKGEMDLPPVPFEFSPSPSKLYGKSRQKQKPNA 717
            + E V+I+   M   P   E    P +      +  +   
Sbjct: 250 SMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEP 290

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  128 bits (323), Expect = 2e-33
 Identities = 40/168 (23%), Positives = 68/168 (40%), Gaps = 16/168 (9%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRL----DTFSLQTEREFQNELQILGGLRS 138
            +     +IG GG G V+      G  +A+K      D    QT    + E ++   L+ 
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           P ++ L G C++     LV E+     L  +L       +         + +A+ + +LH
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLH 122

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRG--------KVSDFGLSRIKVEGE 238
                P+IH D+K SN+L+              K++DFGL+R      
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT 170

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  129 bits (325), Expect = 7e-33
 Identities = 44/204 (21%), Positives = 82/204 (40%), Gaps = 25/204 (12%)

Query: 53  LVNRSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAI 112
           L+ +S++    S  PL +QR   K+++           IGKG  G V++G  R G+ +A+
Sbjct: 14  LIEQSQSSGSGSGLPLLVQRTIAKQIQ-------MVKQIGKGRYGEVWMGKWR-GEKVAV 65

Query: 113 KRLDTFSLQTEREFQNELQI--LGGLRSPFLVTLLGYCMERNKRI----LVYEYMPNKSL 166
           K    F    E  +  E +I     +R   ++  +   ++         L+ +Y  N SL
Sbjct: 66  KV---FFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL 122

Query: 167 QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH-----FGCDPPVIHGDIKPSNVLLDSDC 221
            + L    +  L      ++       L  LH         P + H D+K  N+L+  + 
Sbjct: 123 YDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179

Query: 222 RGKVSDFGLSRIKVEGEFGMDLFS 245
              ++D GL+   +     +D+  
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPP 203

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  127 bits (322), Expect = 2e-32
 Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 25/204 (12%)

Query: 53  LVNRSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAI 112
           L+    T    S  PL +QR   + +        E   IGKG  G V+ G  R G+ +A+
Sbjct: 19  LIYDMTTSGSGSGLPLLVQRTIARTIV-----LQE--SIGKGRFGEVWRGKWR-GEEVAV 70

Query: 113 KRLDTFSLQTEREFQNELQI--LGGLRSPFLVTLLGYCMERNKRI----LVYEYMPNKSL 166
           K    FS + ER +  E +I     LR   ++  +    + N       LV +Y  + SL
Sbjct: 71  KI---FSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL 127

Query: 167 QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH-----FGCDPPVIHGDIKPSNVLLDSDC 221
            + L       +      ++ +  A  L  LH         P + H D+K  N+L+  + 
Sbjct: 128 FDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184

Query: 222 RGKVSDFGLSRIKVEGEFGMDLFS 245
              ++D GL+         +D+  
Sbjct: 185 TCCIADLGLAVRHDSATDTIDIAP 208

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  126 bits (318), Expect = 2e-32
 Identities = 40/185 (21%), Positives = 76/185 (41%), Gaps = 25/185 (13%)

Query: 70  LQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNE 129
           +QR   +++        E   +GKG  G V+ G  + G+ +A+K    FS + E+ +  E
Sbjct: 2   MQRTVARDIT-----LLE--CVGKGRYGEVWRGSWQ-GENVAVKI---FSSRDEKSWFRE 50

Query: 130 LQI--LGGLRSPFLVTLLGYCMERNKRI----LVYEYMPNKSLQEMLFSDGNLVLKWSQR 183
            ++     LR   ++  +   M          L+  Y    SL + L       L     
Sbjct: 51  TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSC 107

Query: 184 FEIIMDVAKALEFLH-----FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
             I++ +A  L  LH         P + H D+K  N+L+  + +  ++D GL+ +  +  
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167

Query: 239 FGMDL 243
             +D+
Sbjct: 168 NQLDV 172

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  124 bits (313), Expect = 2e-31
 Identities = 41/161 (25%), Positives = 79/161 (49%), Gaps = 5/161 (3%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
           +D     V+GKG  G       R+ G+++ +K L  F  +T+R F  E++++  L  P +
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69

Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           +  +G   +  +   + EY+   +L+ ++    +    WSQR     D+A  + +LH   
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLH--- 125

Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMD 242
              +IH D+   N L+  +    V+DFGL+R+ V+ +   +
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  120 bits (303), Expect = 4e-30
 Identities = 36/154 (23%), Positives = 71/154 (46%), Gaps = 9/154 (5%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRL--DTFSLQTEREFQNELQILGGLRSPF 140
              +   +IGKG  G V+ G    G++ AI+ +  +  +    + F+ E+      R   
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRWH-GEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V  +G CM      ++      ++L  ++  D  +VL  ++  +I  ++ K + +LH  
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLH-- 147

Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK 234
               ++H D+K  NV  D + +  ++DFGL  I 
Sbjct: 148 -AKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  117 bits (295), Expect = 3e-29
 Identities = 40/163 (24%), Positives = 67/163 (41%), Gaps = 9/163 (5%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRL--DTFSLQTEREFQNELQILGGLRSPF 140
                   IG G  GTV+ G       +A+K L     + Q  + F+NE+ +L   R   
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           ++  +GY       I V ++    SL   L +      +  +  +I    A+ +++LH  
Sbjct: 82  ILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLH-- 137

Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDL 243
               +IH D+K +N+ L  D   K+ DFGL+  K         
Sbjct: 138 -AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  107 bits (269), Expect = 9e-26
 Identities = 32/161 (19%), Positives = 59/161 (36%), Gaps = 18/161 (11%)

Query: 84  DFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLV 142
            +     +G+GG   V L     DG   A+KR+     Q   E Q E  +      P ++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 143 TLLGYCMERNKR----ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFE------IIMDVAK 192
            L+ YC+          L+  +    +L   +      +              +++ + +
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI----ERLKDKGNFLTEDQILWLLLGICR 145

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            LE +H        H D+KP+N+LL  + +  + D G    
Sbjct: 146 GLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 41.6 bits (98), Expect = 5e-04
 Identities = 21/113 (18%), Positives = 37/113 (32%), Gaps = 22/113 (19%)

Query: 572 SMRGTLCYVAPE----YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANL 627
           + R T+ Y APE       C    E+ D++SLG ++  ++ G  P        K +   L
Sbjct: 202 AQRCTISYRAPELFSVQSHCVI-DERTDVWSLGCVLYAMMFGEGPYD--MVFQKGDSVAL 258

Query: 628 ISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGE 680
                       +   +       ++         L  + +   P  RP I  
Sbjct: 259 A-----------VQNQLSIPQSPRHSSA----LWQLLNSMMTVDPHQRPHIPL 296

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  100 bits (251), Expect = 2e-23
 Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 9/157 (5%)

Query: 83  NDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTERE---FQNELQILGGLRS 138
            +F     IG+G    V+      DG  +A+K++  F L   +       E+ +L  L  
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEML--FSDGNLVLKWSQRFEIIMDVAKALEF 196
           P ++      +E N+  +V E      L  M+  F     ++     ++  + +  ALE 
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +H      V+H DIKP+NV + +    K+ D GL R 
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 33/136 (24%), Positives = 50/136 (36%), Gaps = 41/136 (30%)

Query: 560 GDL-FSRELSSTTSMR----GTLCYVAPE------YGGCGYLMEKADIYSLGVLILVIVS 608
           GDL   R  SS T+      GT  Y++PE      Y        K+DI+SLG L+  + +
Sbjct: 178 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN------FKSDIWSLGCLLYEMAA 231

Query: 609 GRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYN---KEQASLCI-NLA 664
            + P +                        N+  L  +  + DY     +  S  +  L 
Sbjct: 232 LQSPFY--------------------GDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 271

Query: 665 LTCLQKTPELRPDIGE 680
             C+   PE RPD+  
Sbjct: 272 NMCINPDPEKRPDVTY 287

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  100 bits (250), Expect = 5e-23
 Identities = 35/155 (22%), Positives = 70/155 (45%), Gaps = 8/155 (5%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
             +     IG+G  G   L  +  DG+   IK ++  S  + +E +    E+ +L  ++ 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN-ISRMSSKEREESRREVAVLANMKH 82

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           P +V       E     +V +Y     L + + +   ++ +  Q  +  + +  AL+ +H
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
              D  ++H DIK  N+ L  D   ++ DFG++R+
Sbjct: 143 ---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 26/135 (19%), Positives = 48/135 (35%), Gaps = 42/135 (31%)

Query: 560 GDL-FSRELSSTTSMR----GTLCYVAPE------YGGCGYLMEKADIYSLGVLILVIVS 608
           GD   +R L+ST  +     GT  Y++PE      Y        K+DI++LG ++  + +
Sbjct: 167 GDFGIARVLNSTVELARACIGTPYYLSPEICENKPYN------NKSDIWALGCVLYELCT 220

Query: 609 GRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNK--EQASL-CINLAL 665
            +                          AG++  LV + +   +       S    +L  
Sbjct: 221 LKHAFE----------------------AGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS 258

Query: 666 TCLQKTPELRPDIGE 680
              ++ P  RP +  
Sbjct: 259 QLFKRNPRDRPSVNS 273

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 99.0 bits (247), Expect = 5e-23
 Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 18/166 (10%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTERE-FQNELQILGGLRSPF 140
            DF+    +G+GG G VF    + D    AIKR+   + +  RE    E++ L  L  P 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 141 LVTLLGYCMERN---------KRILVY---EYMPNKSLQEMLFS-DGNLVLKWSQRFEII 187
           +V      +E+N          ++ +Y   +    ++L++ +         + S    I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           + +A+A+EFLH      ++H D+KPSN+    D   KV DFGL   
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 167

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 47.3 bits (113), Expect = 8e-06
 Identities = 30/152 (19%), Positives = 52/152 (34%), Gaps = 36/152 (23%)

Query: 564 SRELSSTTSMRGTLCYVAPE-YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPM-- 620
               +  T   GT  Y++PE   G  Y   K DI+SLG++          L  L  P   
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLI----------LFELLYPFST 229

Query: 621 KLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGE 680
           ++E+   ++         ++  L    L       +  +        L  +P  RP+   
Sbjct: 230 QMERVRTLT---------DVRNLKFPPLFTQKYPCEYVMV----QDMLSPSPMERPEAIN 276

Query: 681 TVRILKGEMDLPPVPFEFSPSPSKLYGKSRQK 712
              I++  +      FE    P K   + R +
Sbjct: 277 ---IIENAV------FEDLDFPGKTVLRQRSR 299

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 98.6 bits (246), Expect = 6e-23
 Identities = 40/153 (26%), Positives = 66/153 (43%), Gaps = 11/153 (7%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPFLVTLLG 146
            IG+G   TV+ G+       +A    +    +    + F+ E ++L GL+ P +V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 147 YCMERNKR----ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
                 K     +LV E M + +L+  L      V+K          + K L+FLH    
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLH-TRT 149

Query: 203 PPVIHGDIKPSNVLLDS-DCRGKVSDFGLSRIK 234
           PP+IH D+K  N+ +       K+ D GL+ +K
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 18/113 (15%), Positives = 41/113 (36%), Gaps = 18/113 (15%)

Query: 568 SSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANL 627
           S   ++ GT  ++APE     Y  E  D+Y+ G+ +L + +   P     +  ++ +   
Sbjct: 185 SFAKAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-- 241

Query: 628 ISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGE 680
                    +G      D+    +           +   C+++  + R  I +
Sbjct: 242 -------VTSGVKPASFDKVAIPE--------VKEIIEGCIRQNKDERYSIKD 279

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 38/187 (20%), Positives = 75/187 (40%), Gaps = 11/187 (5%)

Query: 64  SNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTE 123
           S   L  +   ++ +      +     IG GGS  VF  +    ++ AIK ++      +
Sbjct: 9   SGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ 68

Query: 124 --REFQNELQILGGLR--SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLK 179
               ++NE+  L  L+  S  ++ L  Y +      +V E   N  L   L    ++   
Sbjct: 69  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPW 127

Query: 180 WSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
             + +    ++ +A+  +H      ++H D+KP+N L+      K+ DFG++        
Sbjct: 128 ERKSY--WKNMLEAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTT 181

Query: 240 GMDLFSQ 246
            +   SQ
Sbjct: 182 SVVKDSQ 188

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 20/121 (16%), Positives = 44/121 (36%), Gaps = 28/121 (23%)

Query: 571 TSMRGTLCYVAPE-----------YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASP 619
            S  GT+ Y+ PE                 +  K+D++SLG ++  +  G+ P   + + 
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245

Query: 620 MKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIG 679
           +                   +  ++D   + ++         ++   CL++ P+ R  I 
Sbjct: 246 ISK-----------------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 288

Query: 680 E 680
           E
Sbjct: 289 E 289

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 7/148 (4%)

Query: 85  FDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
            D    IG+G +G V L   +  G+ +A+K +D    Q      NE+ I+   +   +V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           +    +   +  ++ E++   +L +++     + L   Q   +   V +AL +LH     
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLH---AQ 160

Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            VIH DIK  ++LL  D R K+SDFG  
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFC 188

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 97.3 bits (243), Expect = 6e-22
 Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 6/151 (3%)

Query: 90  VIGKGGSGTVFLGIARDGKLL-AIKRL-DTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
            IG+G  G VF G  R    L A+K   +T     + +F  E +IL     P +V L+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
           C ++    +V E +        L ++G   L+     +++ D A  +E+L        IH
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLE---SKCCIH 236

Query: 208 GDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
            D+   N L+      K+SDFG+SR + +G 
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGV 267

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 7/154 (4%)

Query: 79  KNATNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLR 137
            +    +     IG+G SGTV+  +    G+ +AI++++      +    NE+ ++   +
Sbjct: 16  GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
           +P +V  L   +  ++  +V EY+   SL +++       +   Q   +  +  +ALEFL
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFL 132

Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           H      VIH DIK  N+LL  D   K++DFG  
Sbjct: 133 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 96.0 bits (239), Expect = 1e-21
 Identities = 42/162 (25%), Positives = 65/162 (40%), Gaps = 18/162 (11%)

Query: 76  KELKNATNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILG 134
            E +   +       +G+G  G V      + G   A+K++       E     EL    
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVEELVACA 105

Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNL---VLKWSQRFEIIMDVA 191
           GL SP +V L G   E     +  E +   SL +++   G L      +      +    
Sbjct: 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY-----YLGQAL 160

Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSD-CRGKVSDFGLSR 232
           + LE+LH      ++HGD+K  NVLL SD  R  + DFG + 
Sbjct: 161 EGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHAL 199

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 21/124 (16%), Positives = 36/124 (29%), Gaps = 29/124 (23%)

Query: 559 SGDLFSRELSSTTSMRGTLCYVAPE------YGGCGYLMEKADIYSLGVLILVIVSGRRP 612
             D   + L +   + GT  ++APE               K DI+S   ++L +++G  P
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA------KVDIWSSCCMMLHMLNGCHP 255

Query: 613 LHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTP 672
                    L        C  +A     +  +                       L+K P
Sbjct: 256 WTQY-FRGPL--------CLKIASEPPPIREIPPSCAPL--------TAQAIQEGLRKEP 298

Query: 673 ELRP 676
             R 
Sbjct: 299 VHRA 302

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 95.5 bits (238), Expect = 2e-21
 Identities = 39/162 (24%), Positives = 69/162 (42%), Gaps = 11/162 (6%)

Query: 89  NVIGKGGSGTVFLGIARDGKLLAIKR--LDTFSLQTEREFQNELQILGGLR--SPFLVTL 144
             IG GGS  VF  +    ++ AIK   L+    QT   ++NE+  L  L+  S  ++ L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP 204
             Y +      +V E   N  L   L    ++     + +    ++ +A+  +H      
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSY--WKNMLEAVHTIH---QHG 128

Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQ 246
           ++H D+KP+N L+      K+ DFG++         +   SQ
Sbjct: 129 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ 169

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 23/160 (14%), Positives = 54/160 (33%), Gaps = 31/160 (19%)

Query: 571 TSMRGTLCYVAPE-----------YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASP 619
            S  GT+ Y+ PE                 +  K+D++SLG ++  +  G+ P   + + 
Sbjct: 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226

Query: 620 MKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIG 679
           +                   +  ++D   + ++         ++   CL++ P+ R  I 
Sbjct: 227 ISK-----------------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 269

Query: 680 ETVR---ILKGEMDLPPVPFEFSPSPSKLYGKSRQKQKPN 716
           E +    +      +  +    +     + G+      PN
Sbjct: 270 ELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPN 309

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 47/185 (25%), Positives = 72/185 (38%), Gaps = 12/185 (6%)

Query: 56  RSRTIPFDSNAPLKLQRFTYKELKNAT---NDFDEANVIGKGGSGTVFLGIAR-DGKLLA 111
           + R + F   A   LQ   Y   +  +     F   + +G G  G VF   ++ DG+L A
Sbjct: 27  QPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYA 86

Query: 112 IK--RLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILVYEYMPNKSLQE 168
           +K         +       E+     + + P  V L     E     L  E     SLQ+
Sbjct: 87  VKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQ 145

Query: 169 MLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDF 228
              + G   L  +Q +  + D   AL  LH      ++H D+KP+N+ L    R K+ DF
Sbjct: 146 HCEAWGAS-LPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDF 201

Query: 229 GLSRI 233
           GL   
Sbjct: 202 GLLVE 206

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 26/130 (20%), Positives = 41/130 (31%), Gaps = 36/130 (27%)

Query: 560 GDL-FSRELSSTTSMR---GTLCYVAPE-----YGGCGYLMEKADIYSLGVLILVIVSGR 610
           GD     EL +  +     G   Y+APE     YG        AD++SLG+ IL +    
Sbjct: 199 GDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYG------TAADVFSLGLTILEVACNM 252

Query: 611 RPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQK 670
              H      +L +  L                         + E      ++ +  L+ 
Sbjct: 253 ELPHGGEGWQQLRQGYL-----------------PPEFTAGLSSE----LRSVLVMMLEP 291

Query: 671 TPELRPDIGE 680
            P+LR     
Sbjct: 292 DPKLRATAEA 301

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 45/191 (23%), Positives = 84/191 (43%), Gaps = 19/191 (9%)

Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPF 140
            +DF+E  V+G+G  G V       D +  AIK++   + +      +E+ +L  L   +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63

Query: 141 LVTLLGYCMERNKRI-------------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEII 187
           +V      +ER   +             +  EY  N +L +++    NL  +  + + + 
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQRDEYWRLF 122

Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQD 247
             + +AL ++H      +IH D+KP N+ +D     K+ DFGL++        + L SQ+
Sbjct: 123 RQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 248 LGKSQELWKSQ 258
           L  S +   S 
Sbjct: 180 LPGSSDNLTSA 190

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 50.8 bits (122), Expect = 6e-07
 Identities = 29/141 (20%), Positives = 47/141 (33%), Gaps = 22/141 (15%)

Query: 547 KKNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPE-YGGCGYLMEKADIYSLGVLILV 605
           K    S+               + TS  GT  YVA E   G G+  EK D+YSLG++   
Sbjct: 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

Query: 606 IVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLAL 665
           ++          + +K  ++  I +                   D+  K +  + I L  
Sbjct: 224 MIYPFSTGMERVNILKKLRSVSIEF--------------PPDFDDNKMKVEKKI-IRL-- 266

Query: 666 TCLQKTPELRPDIGETVRILK 686
             +   P  RP       +L 
Sbjct: 267 -LIDHDPNKRPGART---LLN 283

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 95.2 bits (237), Expect = 3e-21
 Identities = 45/180 (25%), Positives = 83/180 (46%), Gaps = 28/180 (15%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREF---------------- 126
           ND+     + +G    + L   +D K  A+K+ +   L+ +R+F                
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 127 -QNELQILGGLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF 184
            +NELQI+  +++ + +T  G  +     + ++YEYM N S+ +       L   ++   
Sbjct: 90  FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 185 E------IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
                  II  V  +  ++H   +  + H D+KPSN+L+D + R K+SDFG S   V+ +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 16/57 (28%), Positives = 25/57 (43%), Gaps = 2/57 (3%)

Query: 568 SSTTSMRGTLCYVAPE--YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKL 622
                 RGT  ++ PE       Y   K DI+SLG+ + V+     P  +  S ++L
Sbjct: 205 KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 95.7 bits (238), Expect = 3e-21
 Identities = 43/196 (21%), Positives = 78/196 (39%), Gaps = 21/196 (10%)

Query: 55  NRSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKR 114
           +        +N  + ++   Y  LK           IG GGS  VF  +    ++ AIK 
Sbjct: 38  DDDDKASSSANECISVKGRIYSILK----------QIGSGGSSKVFQVLNEKKQIYAIKY 87

Query: 115 --LDTFSLQTEREFQNELQILGGLR--SPFLVTLLGYCMERNKRILVYEYMPNKSLQEML 170
             L+    QT   ++NE+  L  L+  S  ++ L  Y +      +V E   N  L   L
Sbjct: 88  VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL 146

Query: 171 FSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL 230
               ++     + +    ++ +A+  +H      ++H D+KP+N L+      K+ DFG+
Sbjct: 147 KKKKSIDPWERKSY--WKNMLEAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGI 200

Query: 231 SRIKVEGEFGMDLFSQ 246
           +         +   SQ
Sbjct: 201 ANQMQPDTTSVVKDSQ 216

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 48.3 bits (115), Expect = 6e-06
 Identities = 23/175 (13%), Positives = 58/175 (33%), Gaps = 37/175 (21%)

Query: 563 FSRELSSTT------SMRGTLCYVAPE-----------YGGCGYLMEKADIYSLGVLILV 605
            + ++   T      S  G + Y+ PE                 +  K+D++SLG ++  
Sbjct: 200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 259

Query: 606 IVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLAL 665
           +  G+ P   + + +                   +  ++D   + ++         ++  
Sbjct: 260 MTYGKTPFQQIINQISK-----------------LHAIIDPNHEIEFPDIPEKDLQDVLK 302

Query: 666 TCLQKTPELRPDIGETVR---ILKGEMDLPPVPFEFSPSPSKLYGKSRQKQKPNA 717
            CL++ P+ R  I E +    +      +  +    +     + G+      PN+
Sbjct: 303 CCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNS 357

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 41/172 (23%), Positives = 67/172 (38%), Gaps = 24/172 (13%)

Query: 79  KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLR 137
           K    DF E  +IG GG G VF    R DGK   IKR+         + + E++ L  L 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLD 62

Query: 138 SPFLVTLLGYCMERNKRI----------------LVYEYMPNKSLQEMLFSDGNLVLKWS 181
              +V   G     +                   +  E+    +L++ +       L   
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 182 QRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
              E+   + K ++++H      +I+ D+KPSN+ L    + K+ DFGL   
Sbjct: 123 LALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 31/137 (22%), Positives = 55/137 (40%), Gaps = 43/137 (31%)

Query: 560 GDL-FSRELSST---TSMRGTLCYVAPE------YGGCGYLMEKADIYSLGVLILVIVSG 609
           GD      L +    T  +GTL Y++PE      YG      ++ D+Y+LG+++  ++  
Sbjct: 164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYG------KEVDLYALGLILAELLHV 217

Query: 610 RRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQ 669
                        E +   +            +L D  + D ++K++ +L        L 
Sbjct: 218 CDTAF--------ETSKFFT------------DLRDGIISDIFDKKEKTLL----QKLLS 253

Query: 670 KTPELRPDIGETVRILK 686
           K PE RP+  E   IL+
Sbjct: 254 KKPEDRPNTSE---ILR 267

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 93.5 bits (233), Expect = 4e-21
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 11/160 (6%)

Query: 80  NATNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTERE-FQNELQILGGLR 137
              +D++   VIG G +  V     A   + +AIKR++    QT  +    E+Q +    
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFE------IIMDVA 191
            P +V+     + +++  LV + +   S+ +++          S   +      I+ +V 
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           + LE+LH       IH D+K  N+LL  D   +++DFG+S
Sbjct: 132 EGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS 168

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 93.5 bits (233), Expect = 4e-21
 Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 5/148 (3%)

Query: 85  FDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           ++    +G G  G V+       G L A K ++T S +   ++  E++IL     P++V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           LLG      K  ++ E+ P  ++  ++       L   Q   +   + +AL FLH     
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHSK--- 136

Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            +IH D+K  NVL+  +   +++DFG+S
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVS 164

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 93.3 bits (232), Expect = 9e-21
 Identities = 33/158 (20%), Positives = 62/158 (39%), Gaps = 11/158 (6%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRS-PFLVTLLGY 147
           V+ +GG   V+       G+  A+KRL +   +  R    E+  +  L   P +V     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 148 CMERNKR--------ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
                +         +L+ E    + ++ +   +    L      +I     +A++ +H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
              PP+IH D+K  N+LL +    K+ DFG +      
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 31/151 (20%), Positives = 50/151 (33%), Gaps = 31/151 (20%)

Query: 573 MRGTLCYVAPE----YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLI 628
              T  Y  PE    Y       EK DI++LG ++ ++   + P                
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHP---------------- 252

Query: 629 SWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKGE 688
                  + G  L +V+ +     +  Q ++  +L    LQ  PE R  I E V  L+  
Sbjct: 253 ------FEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306

Query: 689 MDL----PPVPFEFSPSPSKLYGKSRQKQKP 715
                  P  P       +  YG +   + P
Sbjct: 307 AAARNVNPKSPITELLEQNGGYGSATLSRGP 337

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 40/160 (25%), Positives = 80/160 (50%), Gaps = 17/160 (10%)

Query: 89  NVIGKGGSGTVFLGIAR-----DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
             +GKG  G+V +          G+++A+K+L   + +  R+F+ E++IL  L+   +V 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 144 LLGYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---H 198
             G C    +R   L+ EY+P  SL++ L       +   +  +    + K +E+L    
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGTKR 134

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
           +      IH D+   N+L++++ R K+ DFGL+++  + +
Sbjct: 135 Y------IHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 40/160 (25%), Positives = 80/160 (50%), Gaps = 17/160 (10%)

Query: 89  NVIGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
             +GKG  G+V +          G+++A+K+L   + +  R+F+ E++IL  L+   +V 
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 144 LLGYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---H 198
             G C    +R   L+ EY+P  SL++ L       +   +  +    + K +E+L    
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGTKR 165

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
           +      IH D+   N+L++++ R K+ DFGL+++  + +
Sbjct: 166 Y------IHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 44/203 (21%), Positives = 85/203 (41%), Gaps = 22/203 (10%)

Query: 44  YFLYHLWYN---LVNRSRTI-PFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTV 99
           Y+ +H  ++       +        + P +       E+  +     +  VIG G  G V
Sbjct: 3   YYHHHHHHDYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQK--VIGAGEFGEV 60

Query: 100 FLGIARDGKLL-----AIKRL-DTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNK 153
           + G+ +          AIK L   ++ +   +F  E  I+G      ++ L G   +   
Sbjct: 61  YKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120

Query: 154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGCDPPVIHGDI 210
            +++ EYM N +L + L           Q   ++  +A  +++L   ++      +H D+
Sbjct: 121 MMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLANMNY------VHRDL 173

Query: 211 KPSNVLLDSDCRGKVSDFGLSRI 233
              N+L++S+   KVSDFGLSR+
Sbjct: 174 AARNILVNSNLVCKVSDFGLSRV 196

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 41/147 (27%), Positives = 66/147 (44%), Gaps = 8/147 (5%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
           V+GKG  G V+ G    +   +AIK +     +  +    E+ +   L+   +V  LG  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 149 MERNKRILVYEYMPNKSLQEML-FSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
            E     +  E +P  SL  +L    G L             + + L++LH   D  ++H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145

Query: 208 GDIKPSNVLLDSDCRG--KVSDFGLSR 232
            DIK  NVL+++   G  K+SDFG S+
Sbjct: 146 RDIKGDNVLINTY-SGVLKISDFGTSK 171

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 44.2 bits (105), Expect = 8e-05
 Identities = 22/57 (38%), Positives = 30/57 (52%), Gaps = 4/57 (7%)

Query: 568 SSTTSMRGTLCYVAPE---YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMK 621
             T +  GTL Y+APE    G  GY    ADI+SLG  I+ + +G+ P + L  P  
Sbjct: 178 PCTETFTGTLQYMAPEIIDKGPRGYGK-AADIWSLGCTIIEMATGKPPFYELGEPQA 233

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 9/160 (5%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL-QTEREF-QNELQILGGLRSP 139
            D++    IG G  G       + DGK+L  K LD  S+ + E++   +E+ +L  L+ P
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 140 FLVTLLGYCMERNKRIL--VYEYMPNKSLQEML--FSDGNLVLKWSQRFEIIMDVAKALE 195
            +V      ++R    L  V EY     L  ++   +     L       ++  +  AL+
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 196 FLHFGCDPP--VIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             H   D    V+H D+KP+NV LD     K+ DFGL+RI
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 56.5 bits (137), Expect = 8e-09
 Identities = 31/139 (22%), Positives = 45/139 (32%), Gaps = 50/139 (35%)

Query: 560 GDL-FSRELSSTTSMR----GTLCYVAPE------YGGCGYLMEKADIYSLGVLILVIVS 608
           GD   +R L+  TS      GT  Y++PE      Y       EK+DI+SLG L+  + +
Sbjct: 158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYN------EKSDIWSLGCLLYELCA 211

Query: 609 GRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVD-------ERLKDDYNKEQASLCI 661
              P                        A +  EL          R+   Y+ E      
Sbjct: 212 LMPPF----------------------TAFSQKELAGKIREGKFRRIPYRYSDE----LN 245

Query: 662 NLALTCLQKTPELRPDIGE 680
            +    L      RP + E
Sbjct: 246 EIITRMLNLKDYHRPSVEE 264

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 49/155 (31%), Positives = 75/155 (48%), Gaps = 13/155 (8%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLD---TFSLQTEREFQNELQILGGL 136
            DF+    +GKG  G V+L  AR+     +LA+K L          E + + E++I   L
Sbjct: 9   EDFEIGRPLGKGKFGNVYL--AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66

Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEF 196
           R P ++ L GY  +  +  L+ EY P  ++   L        + +  +  I ++A AL +
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 124

Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            H      VIH DIKP N+LL S    K++DFG S
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 54/150 (36%), Positives = 75/150 (50%), Gaps = 17/150 (11%)

Query: 89  NVIGKGGSGTVFLGIARDGKLLAIKRL--DTFSLQTEREFQNELQILGGLRSPFLVTLLG 146
             IGKG  G V LG  R G  +A+K +  D     T + F  E  ++  LR   LV LLG
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLG 81

Query: 147 YCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGCD 202
             +E    + +V EYM   SL + L S G  VL      +  +DV +A+E+L   +F   
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF--- 138

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
              +H D+   NVL+  D   KVSDFGL++
Sbjct: 139 ---VHRDLAARNVLVSEDNVAKVSDFGLTK 165

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 38/170 (22%), Positives = 65/170 (38%), Gaps = 26/170 (15%)

Query: 90  VIGKGGSGTVFLGIARDGKLL--------AIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
            +G+G    +F G+ R+             +K LD         F     ++  L    L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---H 198
           V   G C+  ++ ILV E++   SL   L  + N  +    + E+   +A A+ FL    
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQLAAAMHFLEENT 133

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRG--------KVSDFGLSRIKVEGEFG 240
                  IHG++   N+LL  +           K+SD G+S   +  +  
Sbjct: 134 L------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 91.3 bits (227), Expect = 4e-20
 Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 17/155 (10%)

Query: 89  NVIGKGGSGTVFLGIAR-----DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT 143
           + +GKG  G+V L          G L+A+K+L       +R+FQ E+QIL  L S F+V 
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 144 LLGYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---H 198
             G      ++   LV EY+P+  L++ L       L  S+       + K +E+L    
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRR 147

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
                  +H D+   N+L++S+   K++DFGL+++
Sbjct: 148 C------VHRDLAARNILVESEAHVKIADFGLAKL 176

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 90.5 bits (225), Expect = 6e-20
 Identities = 46/176 (26%), Positives = 76/176 (43%), Gaps = 12/176 (6%)

Query: 64  SNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQT 122
            +    L       L++    F+   ++G G  G V+ G   + G+L AIK +D  +   
Sbjct: 5   DSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDE 63

Query: 123 EREFQNELQILGGL-RSPFLVTLLGYCMERNKRI------LVYEYMPNKSLQEMLFSDGN 175
           E E + E+ +L        + T  G  +++N         LV E+    S+ +++ +   
Sbjct: 64  EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG 123

Query: 176 LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
             LK      I  ++ + L  LH      VIH DIK  NVLL  +   K+ DFG+S
Sbjct: 124 NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 51/186 (27%), Positives = 82/186 (44%), Gaps = 17/186 (9%)

Query: 56  RSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGK----LLA 111
           +    P     P +  R   +E++ +    ++  +IG G SG V  G  R        +A
Sbjct: 24  QFYAEPHTYEEPGRAGRSFTREIEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVA 81

Query: 112 IKRL-DTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEML 170
           IK L   ++ +  R+F +E  I+G    P ++ L G        ++V EYM N SL   L
Sbjct: 82  IKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141

Query: 171 FSDGNLVLKWSQRFEIIMDVAKALEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSD 227
            +         Q   ++  V   + +L    +      +H D+   NVL+DS+   KVSD
Sbjct: 142 RTHDGQ-FTIMQLVGMLRGVGAGMRYLSDLGY------VHRDLAARNVLVDSNLVCKVSD 194

Query: 228 FGLSRI 233
           FGLSR+
Sbjct: 195 FGLSRV 200

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 49/155 (31%), Positives = 77/155 (49%), Gaps = 8/155 (5%)

Query: 79  KNATNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTERE-FQNELQILGGL 136
            +    F +   IGKG  G VF GI  R  K++AIK +D    + E E  Q E+ +L   
Sbjct: 18  ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77

Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEF 196
            SP++    G  ++  K  ++ EY+   S  ++L       L  +Q   I+ ++ K L++
Sbjct: 78  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDY 134

Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           LH       IH DIK +NVLL      K++DFG++
Sbjct: 135 LH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA 166

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 90.2 bits (224), Expect = 1e-19
 Identities = 36/157 (22%), Positives = 65/157 (41%), Gaps = 9/157 (5%)

Query: 79  KNATNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREF---QNELQILG 134
            +    F +   IG G  G V+     R+ +++AIK++     Q+  ++     E++ L 
Sbjct: 50  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109

Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
            LR P  +   G  +  +   LV EY    +   +        L+  +   +     + L
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGL 167

Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            +LH      +IH D+K  N+LL      K+ DFG +
Sbjct: 168 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA 201

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 39/162 (24%), Positives = 68/162 (41%), Gaps = 12/162 (7%)

Query: 84  DFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTER---EFQNELQILGGLRSP 139
            +     +GKGG    F    A   ++ A K +    L       +   E+ I   L   
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101

Query: 140 FLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
            +V   G+  E N  + +V E    +SL E+      L    ++ +  +  +    ++LH
Sbjct: 102 HVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY--LRQIVLGCQYLH 158

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS-RIKVEGEF 239
                 VIH D+K  N+ L+ D   K+ DFGL+ +++ +GE 
Sbjct: 159 RNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 39/162 (24%), Positives = 68/162 (41%), Gaps = 12/162 (7%)

Query: 84  DFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTER---EFQNELQILGGLRSP 139
            +     +GKGG    F    A   ++ A K +    L       +   E+ I   L   
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 140 FLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
            +V   G+  E N  + +V E    +SL E+      L    ++ +  +  +    ++LH
Sbjct: 76  HVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY--LRQIVLGCQYLH 132

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS-RIKVEGEF 239
                 VIH D+K  N+ L+ D   K+ DFGL+ +++ +GE 
Sbjct: 133 ---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 18/156 (11%)

Query: 89  NVIGKGGSGTVFLGIA-----RDGKLLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLV 142
             +G+G  G V L          G+ +A+K L          + + E++IL  L    +V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 143 TLLGYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL--- 197
              G C E       L+ E++P+ SL+E L  + N  +   Q+ +  + + K +++L   
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSR 145

Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            +      +H D+   NVL++S+ + K+ DFGL++ 
Sbjct: 146 QY------VHRDLAARNVLVESEHQVKIGDFGLTKA 175

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 41/149 (27%), Positives = 75/149 (50%), Gaps = 9/149 (6%)

Query: 85  FDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTE-REFQNELQILGGLRSPFLV 142
           FD    +G+G  G+V+  I    G+++AIK++    ++++ +E   E+ I+    SP +V
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQEIIKEISIMQQCDSPHVV 87

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
              G   +     +V EY    S+ +++       L   +   I+    K LE+LH    
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK-TLTEDEIATILQSTLKGLEYLH---F 143

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
              IH DIK  N+LL+++   K++DFG++
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVA 172

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 91.3 bits (227), Expect = 1e-19
 Identities = 53/148 (35%), Positives = 75/148 (50%), Gaps = 13/148 (8%)

Query: 89  NVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
             IGKG  G V LG  R G  +A+K +   +  T + F  E  ++  LR   LV LLG  
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 149 MERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGCDPP 204
           +E    + +V EYM   SL + L S G  VL      +  +DV +A+E+L   +F     
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF----- 310

Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            +H D+   NVL+  D   KVSDFGL++
Sbjct: 311 -VHRDLAARNVLVSEDNVAKVSDFGLTK 337

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 89.9 bits (223), Expect = 2e-19
 Identities = 48/181 (26%), Positives = 79/181 (43%), Gaps = 21/181 (11%)

Query: 62  FDSNAPLKLQRFTYKELKNA---TNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDT 117
            D     +L+ F  ++ K      +DF++ + +G G  G VF       G ++A K +  
Sbjct: 9   LDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL 68

Query: 118 FSLQTEREF-QNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNL 176
                 R     ELQ+L    SP++V   G      +  +  E+M   SL +        
Sbjct: 69  EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-------- 120

Query: 177 VLKWSQRFE------IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL 230
           VLK + R        + + V K L +L       ++H D+KPSN+L++S    K+ DFG+
Sbjct: 121 VLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV 178

Query: 231 S 231
           S
Sbjct: 179 S 179

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 11/149 (7%)

Query: 89  NVIGKGGSGTVFLGIARDGKLL-AIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           + +G G  G V+ G+ +   L  A+K L   +++ E EF  E  ++  ++ P LV LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 77

Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGCDPP 204
           C       ++ E+M   +L + L       +       +   ++ A+E+L   +F     
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF----- 132

Query: 205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            IH D+   N L+  +   KV+DFGLSR+
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRL 160

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 20/161 (12%)

Query: 89  NVIGKGGSGTVFLGIARD-----GKLLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLV 142
             +G+G  G V L          G+++A+K L      Q    ++ E+ IL  L    ++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 143 TLLGYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL--- 197
              G C +       LV EY+P  SL++ L       +  +Q       + + + +L   
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQ 153

Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
           H+      IH D+   NVLLD+D   K+ DFGL++   EG 
Sbjct: 154 HY------IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 16/158 (10%)

Query: 83  NDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLD-TFSLQTEREFQNELQI-LGGLRSP 139
           +D +    +G+G  G V        G+++A+KR+  T + Q ++    +L I +  +  P
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFE------IIMDVAKA 193
           F VT  G         +  E M + SL +        V+   Q         I + + KA
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFY----KQVIDKGQTIPEDILGKIAVSIVKA 121

Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           LE LH      VIH D+KPSNVL+++  + K+ DFG+S
Sbjct: 122 LEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS 157

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 42.2 bits (100), Expect = 3e-04
 Identities = 28/121 (23%), Positives = 46/121 (38%), Gaps = 26/121 (21%)

Query: 564 SRELSSTTSMR---GTLCYVAPE-----YGGCGYLMEKADIYSLGVLILVIVSGRRPLHV 615
           S  L    +     G   Y+APE         GY + K+DI+SLG+ ++ +   R P   
Sbjct: 157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSV-KSDIWSLGITMIELAILRFPYDS 215

Query: 616 LASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELR 675
             +P +            L Q   ++E    +L  D    +     +    CL+K  + R
Sbjct: 216 WGTPFQQ-----------LKQ---VVEEPSPQLPADKFSAEFVDFTS---QCLKKNSKER 258

Query: 676 P 676
           P
Sbjct: 259 P 259

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 88.3 bits (219), Expect = 3e-19
 Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 12/170 (7%)

Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTERE-FQNELQILGGL 136
             + + +  ++++G+G +  VF G  +  G L AIK  +  S     +    E ++L  L
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 137 RSPFLVTLLGYCMERNKR--ILVYEYMPNKSLQEMLFSDGNLV-LKWSQRFEIIMDVAKA 193
               +V L     E   R  +L+ E+ P  SL  +L    N   L  S+   ++ DV   
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 194 LEFLHFGCDPPVIHGDIKPSNVLL----DSDCRGKVSDFGLSRIKVEGEF 239
           +  L    +  ++H +IKP N++     D     K++DFG +R   + E 
Sbjct: 125 MNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 47.4 bits (113), Expect = 8e-06
 Identities = 23/133 (17%), Positives = 38/133 (28%), Gaps = 20/133 (15%)

Query: 563 FSRELSSTTSMR---GTLCYVAPE-YGGCGYLM-------EKADIYSLGVLILVIVSGRR 611
            +REL          GT  Y+ P+ Y                 D++S+GV      +G  
Sbjct: 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

Query: 612 PLHVLASP---------MKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCIN 662
           P      P         +   K +        A+ G I    D  +    ++    L   
Sbjct: 222 PFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281

Query: 663 LALTCLQKTPELR 675
           +    L+   E  
Sbjct: 282 VLANILEADQEKC 294

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 89.0 bits (221), Expect = 3e-19
 Identities = 50/197 (25%), Positives = 82/197 (41%), Gaps = 19/197 (9%)

Query: 47  YHLWYNLVNRSRTI--PFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIA 104
           +   +  +   RT   P     P +      KEL       D+  V+G G  G V  G  
Sbjct: 9   FGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDK--VVGAGEFGEVCSGRL 66

Query: 105 RDGK----LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE 159
           +        +AIK L   ++ +  R+F  E  I+G    P ++ L G   +    ++V E
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE 126

Query: 160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGCDPPVIHGDIKPSNVL 216
           YM N SL   L           Q   ++  +A  +++L    +      +H D+   N+L
Sbjct: 127 YMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDMGY------VHRDLAARNIL 179

Query: 217 LDSDCRGKVSDFGLSRI 233
           ++S+   KVSDFGL R+
Sbjct: 180 INSNLVCKVSDFGLGRV 196

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 89.8 bits (223), Expect = 4e-19
 Identities = 35/154 (22%), Positives = 70/154 (45%), Gaps = 11/154 (7%)

Query: 89  NVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
             +G G  G V++        +A+K +   S+ +   F  E  ++  L+   LV L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGCDPPV 205
            +    I + E+M   SL + L SD        +  +    +A+ + F+   ++      
Sbjct: 253 TKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY------ 305

Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           IH D++ +N+L+ +    K++DFGL+R+  + E+
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 87.2 bits (217), Expect = 4e-19
 Identities = 43/165 (26%), Positives = 76/165 (46%), Gaps = 15/165 (9%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQ---TEREFQNELQILGGL 136
            DF   N++GKG    V+   A     G  +AIK +D  ++      +  QNE++I   L
Sbjct: 11  EDFKVGNLLGKGSFAGVYR--AESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68

Query: 137 RSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALE 195
           + P ++ L  Y  E +  + LV E   N  +   L +      +   R   +  +   + 
Sbjct: 69  KHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH-FMHQIITGML 126

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS-RIKVEGEF 239
           +LH      ++H D+  SN+LL  +   K++DFGL+ ++K+  E 
Sbjct: 127 YLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 41/153 (26%), Positives = 66/153 (43%), Gaps = 16/153 (10%)

Query: 89  NVIGKGGSGTVFLGIARDGK----LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVT 143
            VIG+G  G V+ G   D        A+K L     +    +F  E  I+     P +++
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 144 LLGYCMERNKRIL-VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HF 199
           LLG C+      L V  YM +  L+  + ++ +            + VAK +++L    F
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYLASKKF 149

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                 +H D+   N +LD     KV+DFGL+R
Sbjct: 150 ------VHRDLAARNCMLDEKFTVKVADFGLAR 176

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 86.5 bits (215), Expect = 5e-19
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 11/153 (7%)

Query: 89  NVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
             IG G  G V LG   +   +AIK +   ++  E +F  E +++  L  P LV L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGCDPPV 205
           +E+    LV E+M +  L + L +   L         + +DV + + +L           
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLEEACV------ 125

Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
           IH D+   N L+  +   KVSDFG++R  ++ +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 86.9 bits (216), Expect = 5e-19
 Identities = 38/154 (24%), Positives = 74/154 (48%), Gaps = 11/154 (7%)

Query: 89  NVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
             +G G  G V++G       +A+K L   S+  +  F  E  ++  L+   LV L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVV 77

Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGCDPPV 205
            +    I + EYM N SL + L +   + L  ++  ++   +A+ + F+   ++      
Sbjct: 78  TQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY------ 130

Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           IH D++ +N+L+      K++DFGL+R+  + E+
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 86.5 bits (215), Expect = 5e-19
 Identities = 50/147 (34%), Positives = 69/147 (46%), Gaps = 11/147 (7%)

Query: 90  VIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
            +G G  G V LG  +    +A+K +   S+  + EF  E Q +  L  P LV   G C 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGCDPPVI 206
           +     +V EY+ N  L   L S G   L+ SQ  E+  DV + + FL    F      I
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLESHQF------I 126

Query: 207 HGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           H D+   N L+D D   KVSDFG++R 
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRY 153

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 89.8 bits (223), Expect = 6e-19
 Identities = 39/146 (26%), Positives = 69/146 (47%), Gaps = 5/146 (3%)

Query: 89  NVIGKGGSGTVFLGIARDGKLL-AIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           + +G G  G V+ G+ +   L  A+K L   +++ E EF  E  ++  ++ P LV LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 284

Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
           C       ++ E+M   +L + L       +       +   ++ A+E+L        IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341

Query: 208 GDIKPSNVLLDSDCRGKVSDFGLSRI 233
            ++   N L+  +   KV+DFGLSR+
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRL 367

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 88.8 bits (220), Expect = 6e-19
 Identities = 32/155 (20%), Positives = 65/155 (41%), Gaps = 8/155 (5%)

Query: 82  TNDFDEANVIGKGGS--GTVFLGI-ARDGKLLAIKRLDTFSLQTER--EFQNELQILGGL 136
              ++   VIGKG     TV L      G+ + ++R++  +   E     Q EL +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEF 196
             P +V      +  N+  +V  +M   S ++++ +     +       I+  V KAL++
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143

Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           +H       +H  +K S++L+  D +  +S    +
Sbjct: 144 IH---HMGYVHRSVKASHILISVDGKVYLSGLRSN 175

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 86.9 bits (216), Expect = 6e-19
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 13/155 (8%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLD---TFSLQTEREFQNELQILGGL 136
           +DFD    +GKG  G V+L  AR+     ++A+K L          E + + E++I   L
Sbjct: 14  DDFDIGRPLGKGKFGNVYL--AREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71

Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEF 196
           R P ++ +  Y  +R +  L+ E+ P   L + L   G    + S  F  + ++A AL +
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF--MEELADALHY 129

Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
            H   +  VIH DIKP N+L+      K++DFG S
Sbjct: 130 CH---ERKVIHRDIKPENLLMGYKGELKIADFGWS 161

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 86.5 bits (215), Expect = 6e-19
 Identities = 47/153 (30%), Positives = 71/153 (46%), Gaps = 11/153 (7%)

Query: 89  NVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
             +G G  G V  G  R    +AIK +   S+  + EF  E +++  L    LV L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGCDPPV 205
            ++    ++ EYM N  L   L    +   +  Q  E+  DV +A+E+L    F      
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQF------ 141

Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
           +H D+   N L++     KVSDFGLSR  ++ E
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 88.4 bits (219), Expect = 7e-19
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 12/159 (7%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTERE-FQNELQILGGLRSPFLVTLLGY 147
           ++G+G +  VF G  +  G L AIK  +  S     +    E ++L  L    +V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 148 CMERNKR--ILVYEYMPNKSLQEMLFSDGNLV-LKWSQRFEIIMDVAKALEFLHFGCDPP 204
             E   R  +L+ E+ P  SL  +L    N   L  S+   ++ DV   +  L    +  
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 205 VIHGDIKPSNVLLDSDCRG----KVSDFGLSRIKVEGEF 239
           ++H +IKP N++      G    K++DFG +R   + E 
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 23/133 (17%), Positives = 38/133 (28%), Gaps = 20/133 (15%)

Query: 563 FSRELSSTTSMR---GTLCYVAPE-YGGCGYLM-------EKADIYSLGVLILVIVSGRR 611
            +REL          GT  Y+ P+ Y                 D++S+GV      +G  
Sbjct: 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

Query: 612 PLHVLASP---------MKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCIN 662
           P      P         +   K +        A+ G I    D  +    ++    L   
Sbjct: 222 PFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281

Query: 663 LALTCLQKTPELR 675
           +    L+   E  
Sbjct: 282 VLANILEADQEKC 294

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 87.0 bits (216), Expect = 8e-19
 Identities = 36/159 (22%), Positives = 72/159 (45%), Gaps = 7/159 (4%)

Query: 76  KELKNATNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLD-TFSLQTEREFQNELQIL 133
           +  +   ND +    +G G  G V+     + G ++A+K++  + + +  +    +L ++
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77

Query: 134 -GGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
                 P++V   G  +      +  E M   + +      G +  +   +  + + + K
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK--MTVAIVK 135

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           AL +L       VIH D+KPSN+LLD   + K+ DFG+S
Sbjct: 136 ALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 41.6 bits (98), Expect = 7e-04
 Identities = 23/124 (18%), Positives = 44/124 (35%), Gaps = 30/124 (24%)

Query: 564 SRELSSTTSMR---GTLCYVAPE------YGGCGYLMEKADIYSLGVLILVIVSGRRPLH 614
           S  L    +     G   Y+APE           Y   +AD++SLG+ ++ + +G+ P  
Sbjct: 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELATGQFPYK 230

Query: 615 VLASPMKLEKANLISWCRHLAQAGNILELVDERLKDD--YNKEQASLCINLALTCLQKTP 672
              +  ++           L +   +L+     L     ++ +      +    CL K  
Sbjct: 231 NCKTDFEV-----------LTK---VLQEEPPLLPGHMGFSGD----FQSFVKDCLTKDH 272

Query: 673 ELRP 676
             RP
Sbjct: 273 RKRP 276

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 89.0 bits (221), Expect = 8e-19
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 11/154 (7%)

Query: 89  NVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
             +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGCDPPV 205
            E    I V EYM   SL + L  +    L+  Q  ++   +A  + ++   ++      
Sbjct: 249 SEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY------ 301

Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           +H D++ +N+L+  +   KV+DFGL+R+  + E+
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 86.2 bits (214), Expect = 9e-19
 Identities = 40/174 (22%), Positives = 72/174 (41%), Gaps = 17/174 (9%)

Query: 82  TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKR--LDTFSLQTEREFQNELQILGGL-R 137
           T +F E   IG G  G+VF  + R DG + AIKR          E+    E+     L +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEML--FSDGNLVLKWSQRFEIIMDVAKALE 195
              +V       E +  ++  EY    SL + +          K ++  ++++ V + L 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSD-------CRGKVSDFGLSRIKVE-GEFGM 241
           ++H      ++H DIKPSN+ +            G   D+  +++  + G+ G 
Sbjct: 130 YIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 24/125 (19%), Positives = 40/125 (32%), Gaps = 28/125 (22%)

Query: 560 GDL-FSRELSSTTSMRGTLCYVAPE--YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVL 616
           GDL     +SS     G   ++A E       +L  KADI++L + ++       PL   
Sbjct: 176 GDLGHVTRISSPQVEEGDSRFLANEVLQENYTHL-PKADIFALALTVVCAAGA-EPLPRN 233

Query: 617 ASPM-KLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELR 675
                ++ +  L                   R+    ++E       L    +   PE R
Sbjct: 234 GDQWHEIRQGRL------------------PRIPQVLSQE----FTELLKVMIHPDPERR 271

Query: 676 PDIGE 680
           P    
Sbjct: 272 PSAMA 276

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 89.2 bits (221), Expect = 1e-18
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 11/154 (7%)

Query: 89  NVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
             +G+G  G V++G       +AIK L   ++  E  F  E Q++  LR   LV L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGCDPPV 205
            E    I V EYM   SL + L  +    L+  Q  ++   +A  + ++   ++      
Sbjct: 332 SEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY------ 384

Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           +H D++ +N+L+  +   KV+DFGL+R+  + E+
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 42/157 (26%), Positives = 73/157 (46%), Gaps = 17/157 (10%)

Query: 90  VIGKGGSGTVFLGIARDGKLL---AIKRL--DTFSLQTEREFQNELQILGGLRSPFLVTL 144
            +G G  GTV  G  +  K++   A+K L  +      + E   E  ++  L +P++V +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGC 201
           +G C E    +LV E      L + L  + ++  K     E++  V+  +++L   +F  
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLEESNF-- 138

Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
               +H D+   NVLL +    K+SDFGLS+     E
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 87.1 bits (216), Expect = 2e-18
 Identities = 44/154 (28%), Positives = 66/154 (42%), Gaps = 18/154 (11%)

Query: 89  NVIGKGGSGTVFLGIARDGK----LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVT 143
            VIG+G  G V+ G   D        A+K L     +    +F  E  I+     P +++
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 144 LLGYCMERNKRIL-VYEYMPNKSLQEML-FSDGNLVLKWSQRFEIIMDVAKALEFL---H 198
           LLG C+      L V  YM +  L+  +     N  +K        + VAK ++FL    
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFLASKK 212

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           F      +H D+   N +LD     KV+DFGL+R
Sbjct: 213 F------VHRDLAARNCMLDEKFTVKVADFGLAR 240

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 86.6 bits (214), Expect = 2e-18
 Identities = 30/177 (16%), Positives = 56/177 (31%), Gaps = 23/177 (12%)

Query: 76  KELKNATNDFDEANVIGKGGSGTVFLGIARD------GKLLAIKRLDTFSLQTEREFQNE 129
            E +  +      +++G+G    V+     D       +   +K     +          
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 130 LQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNL---VLKWSQRFEI 186
           ++ L        +      + +N  +LV E     +L   +    N    V+        
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 187 IMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG-----------KVSDFGLSR 232
            M +   +E +H   D  +IHGDIKP N +L +                + D G S 
Sbjct: 178 AMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 16/152 (10%)

Query: 90  VIGKGGSGTVFLGIARDGKLL----AIKRL-DTFSLQTEREFQNELQILGGLRSPFLVTL 144
           ++G+G  G V+ G+  + K      A+K      +L  + +F +E  I+  L  P +V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGC 201
           +G   E    I + E  P   L   L  + N  LK        + + KA+ +L   +   
Sbjct: 79  IGIIEEEPTWI-IMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLESINC-- 134

Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               +H DI   N+L+ S    K+ DFGLSR 
Sbjct: 135 ----VHRDIAVRNILVASPECVKLGDFGLSRY 162

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 85.1 bits (211), Expect = 4e-18
 Identities = 39/158 (24%), Positives = 67/158 (42%), Gaps = 15/158 (9%)

Query: 83  NDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTERE-FQNELQI-LGGLRSP 139
            D  +   IG+G  G+V   +    G+++A+KR+ +   + E++    +L + +     P
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFE------IIMDVAKA 193
           ++V   G         +  E M + S  +       +               I +   KA
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFDKFY---KYVYSVLDDVIPEEILGKITLATVKA 137

Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           L  L    +  +IH DIKPSN+LLD     K+ DFG+S
Sbjct: 138 LNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 86.4 bits (214), Expect = 4e-18
 Identities = 36/172 (20%), Positives = 65/172 (37%), Gaps = 14/172 (8%)

Query: 84  DFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLV 142
            F   +V+G G  GT+      D + +A+KR+     +       E+Q+L      P ++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL---PECFSFADREVQLLRESDEHPNVI 81

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
                  +R  + +  E     +LQE +    +      +   ++      L  LH    
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYV-EQKDFAHLGLEPITLLQQTTSGLAHLH---S 136

Query: 203 PPVIHGDIKPSNVLL-----DSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLG 249
             ++H D+KP N+L+         +  +SDFGL +    G       S   G
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 84.6 bits (210), Expect = 5e-18
 Identities = 42/170 (24%), Positives = 68/170 (40%), Gaps = 25/170 (14%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
            DF    ++G+G   TV L       +  AIK L+   +  E +      E  ++  L  
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK------ 192
           PF V L     +  K      Y  N    E+L       ++    F+      +      
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNG---ELLK-----YIRKIGSFDE--TCTRFYTAEI 139

Query: 193 --ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFG 240
             ALE+LH G    +IH D+KP N+LL+ D   +++DFG +++       
Sbjct: 140 VSALEYLH-GKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 186

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 83.8 bits (208), Expect = 6e-18
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 15/149 (10%)

Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTERE----FQNELQILGGLRSPFLVT 143
           +G GG  TV+L  A D  L   +AIK +     + + E    F+ E+     L    +V+
Sbjct: 19  LGGGGMSTVYL--AEDTILNIKVAIKAIFI-PPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           ++    E +   LV EY+   +L E + S G   L           +   ++  H   D 
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAH---DM 130

Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            ++H DIKP N+L+DS+   K+ DFG+++
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAK 159

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 83.6 bits (207), Expect = 7e-18
 Identities = 26/146 (17%), Positives = 49/146 (33%), Gaps = 15/146 (10%)

Query: 90  VIGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTE---REFQNELQILGGLRSPFLVT 143
             G       +   A D  L   +A+  +D   +  +   +E  +    L  +  P +  
Sbjct: 38  FHGGVPPLQFWQ--ALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP 203
           +L     R   ++V E++   SLQE+   D +           +  +A A +  H     
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPV--GAIRAMQSLAAAADAAH---RA 148

Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFG 229
            V      PS V +  D    ++   
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA 174

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 84.2 bits (209), Expect = 8e-18
 Identities = 37/155 (23%), Positives = 71/155 (45%), Gaps = 19/155 (12%)

Query: 89  NVIGKGGSGTVFLGIARDGKL-----LAIKRL-DTFSLQTEREFQNELQILGGLRSPFLV 142
            V+G G  GTV+ G+           +AIK L +  S +  +E  +E  ++  + +P + 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEML-FSDGNLVLKWSQRFEIIMDVAKALEFL---H 198
            LLG C+  +   L+ + MP   L + +     N+  +        + +AK + +L    
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQIAKGMNYLEDRR 137

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
                  +H D+   NVL+ +    K++DFGL+++
Sbjct: 138 L------VHRDLAARNVLVKTPQHVKITDFGLAKL 166

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 83.5 bits (207), Expect = 9e-18
 Identities = 42/153 (27%), Positives = 63/153 (41%), Gaps = 16/153 (10%)

Query: 89  NVIGKGGSGTVFLGIARDGK----LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVT 143
            VIGKG  G V+ G   D        AIK L     +Q    F  E  ++ GL  P ++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 144 LLGYCMERNKRIL-VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HF 199
           L+G  +        +  YM +  L + + S               + VA+ +E+L    F
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR-NPTVKDLISFGLQVARGMEYLAEQKF 145

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                 +H D+   N +LD     KV+DFGL+R
Sbjct: 146 ------VHRDLAARNCMLDESFTVKVADFGLAR 172

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 83.5 bits (207), Expect = 9e-18
 Identities = 42/155 (27%), Positives = 68/155 (43%), Gaps = 15/155 (9%)

Query: 91  IGKGGSGTVFLGI--ARDGKLL-AIKRL-DTFSLQTEREFQNELQILGGLRSPFLVTLLG 146
           +G G  G+V  G+   R  ++  AIK L          E   E QI+  L +P++V L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 147 YCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGCDP 203
            C      + V E      L + L       +  S   E++  V+  +++L   +F    
Sbjct: 78  VCQAEALML-VMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNF---- 131

Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
             +H D+   NVLL +    K+SDFGLS+     +
Sbjct: 132 --VHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 40/162 (24%), Positives = 61/162 (37%), Gaps = 24/162 (14%)

Query: 89  NVIGKGGSGTVFLGIARDGK------LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFL 141
             +G G  G V+ G             +A+K L +  S Q E +F  E  I+       +
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEML-----FSDGNLVLKWSQRFEIIMDVAKALEF 196
           V  +G  ++   R ++ E M    L+  L            L       +  D+A   ++
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 197 L---HFGCDPPVIHGDIKPSNVLLDSDCRG---KVSDFGLSR 232
           L   HF      IH DI   N LL     G   K+ DFG++R
Sbjct: 156 LEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 44/167 (26%), Positives = 72/167 (43%), Gaps = 29/167 (17%)

Query: 89  NVIGKGGSGTVFLGIARDGK------LLAIKRLDTFSLQTEREFQNELQILGGLRSPFLV 142
             +G+G  G VFL    +        L+A+K L   +L   ++FQ E ++L  L+   +V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEML--------------FSDGNLVLKWSQRFEIIM 188
              G C + +  I+V+EYM +  L + L                     L  SQ   I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 189 DVAKALEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            +A  + +L   HF      +H D+   N L+ ++   K+ DFG+SR
Sbjct: 141 QIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSR 181

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 86.2 bits (213), Expect = 1e-17
 Identities = 42/156 (26%), Positives = 68/156 (43%), Gaps = 15/156 (9%)

Query: 90  VIGKGGSGTVFLGIARDGK---LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVTLL 145
            +G G  G+V  G+ R  K    +AIK L          E   E QI+  L +P++V L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGCD 202
           G C      + V E      L + L       +  S   E++  V+  +++L   +F   
Sbjct: 403 GVCQAEALML-VMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKNF--- 457

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
              +H ++   NVLL +    K+SDFGLS+     +
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 35/162 (21%), Positives = 68/162 (41%), Gaps = 24/162 (14%)

Query: 89  NVIGKGGSGTVFLGIARDGK------LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFL 141
             +G+G  G V+ G+A+          +AIK + +  S++   EF NE  ++       +
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEML--------FSDGNLVLKWSQRFEIIMDVAKA 193
           V LLG   +    +++ E M    L+  L         +        S+  ++  ++A  
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 194 LEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           + +L    F      +H D+   N ++  D   K+ DFG++R
Sbjct: 151 MAYLNANKF------VHRDLAARNCMVAEDFTVKIGDFGMTR 186

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 43/166 (25%), Positives = 66/166 (39%), Gaps = 28/166 (16%)

Query: 89  NVIGKGGSGTVFLGIARDGK------LLAIKRLDTFSLQTEREFQNELQILGGLRSPFLV 142
             +G+G  G VFL    +        L+A+K L   S    ++FQ E ++L  L+   +V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEML-------------FSDGNLVLKWSQRFEIIMD 189
              G C E    ++V+EYM +  L   L                    L   Q   +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 190 VAKALEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           VA  + +L   HF      +H D+   N L+      K+ DFG+SR
Sbjct: 167 VAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSR 206

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 40/162 (24%), Positives = 61/162 (37%), Gaps = 24/162 (14%)

Query: 89  NVIGKGGSGTVFLGIARDGK------LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFL 141
             +G G  G V+ G             +A+K L +  S Q E +F  E  I+       +
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEML-----FSDGNLVLKWSQRFEIIMDVAKALEF 196
           V  +G  ++   R ++ E M    L+  L            L       +  D+A   ++
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 197 L---HFGCDPPVIHGDIKPSNVLLDSDCRG---KVSDFGLSR 232
           L   HF      IH DI   N LL     G   K+ DFG++R
Sbjct: 197 LEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 39/162 (24%), Positives = 70/162 (43%), Gaps = 24/162 (14%)

Query: 89  NVIGKGGSGTVFLGIARDGKLL----AIKRL--DTFSLQTEREFQNELQILGGLRSPFLV 142
            ++G+G  G+V  G  +         A+K +  D  S +   EF +E   +     P ++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 143 TLLGYCMERN-----KRILVYEYMPNKSLQEML----FSDGNLVLKWSQRFEIIMDVAKA 193
            LLG C+E +     K +++  +M    L   L       G   +      + ++D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 194 LEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +E+L   +F      +H D+   N +L  D    V+DFGLS+
Sbjct: 160 MEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSK 195

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 84.1 bits (208), Expect = 3e-17
 Identities = 41/219 (18%), Positives = 82/219 (37%), Gaps = 27/219 (12%)

Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGL-R 137
           ++  N      ++G G SGTV    +  G+ +A+KR+    +        E+++L     
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDD 67

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFE-----IIMDVAK 192
            P ++             +  E   N +LQ+++ S          + E     ++  +A 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDS-------------DCRGKVSDFGLSRIKVEGEF 239
            +  LH      +IH D+KP N+L+ +             + R  +SDFGL +    G+ 
Sbjct: 127 GVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 240 GMDLFSQDLGKSQELWKSQELSGNLATATETPAISTPVD 278
                  +   +   W++ EL            ++  +D
Sbjct: 184 SFRTNLNNPSGT-SGWRAPELLEESNNLQTKRRLTRSID 221

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 84.8 bits (210), Expect = 3e-17
 Identities = 55/186 (29%), Positives = 86/186 (46%), Gaps = 18/186 (9%)

Query: 63  DSNAPLKLQRFTYKELKNAT-NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSL 120
           DS    +  ++ + E +  T N F +  V+GKGG G V     R  GK+ A K+L+   +
Sbjct: 163 DSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI 222

Query: 121 QTEREFQ---NELQILGGLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNL 176
           +  +      NE QIL  + S F+V+L  Y  E    + LV   M    L+  ++  G  
Sbjct: 223 KKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQA 281

Query: 177 VLKWSQ-RF---EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               ++  F   EI       LE LH      +++ D+KP N+LLD     ++SD GL+ 
Sbjct: 282 GFPEARAVFYAAEICC----GLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAV 334

Query: 233 IKVEGE 238
              EG+
Sbjct: 335 HVPEGQ 340

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 53/194 (27%), Positives = 78/194 (40%), Gaps = 30/194 (15%)

Query: 61  PFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLL---AIKRL-D 116
               +         Y  L    ND    +VIG+G  G V     +   L    AIKR+ +
Sbjct: 5   HHHHHGKNNPDPTIYPVLDW--NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE 62

Query: 117 TFSLQTEREFQNELQILGGLRS-PFLVTLLGYCMERNKRILVYEYMPNKSLQEML----- 170
             S    R+F  EL++L  L   P ++ LLG C  R    L  EY P+ +L + L     
Sbjct: 63  YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV 122

Query: 171 ---------FSDGNLVLKWSQRFEIIMDVAKALEFL---HFGCDPPVIHGDIKPSNVLLD 218
                     +     L   Q      DVA+ +++L    F      IH D+   N+L+ 
Sbjct: 123 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF------IHRDLAARNILVG 176

Query: 219 SDCRGKVSDFGLSR 232
            +   K++DFGLSR
Sbjct: 177 ENYVAKIADFGLSR 190

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 84.7 bits (209), Expect = 4e-17
 Identities = 44/162 (27%), Positives = 73/162 (45%), Gaps = 15/162 (9%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTERE-FQNELQILGGLRSPFLVTLL-- 145
            +G GG G V   I +D G+ +AIK+         RE +  E+QI+  L  P +V+    
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 146 ----GYCMERNKRILVYEYMPNKSLQEMLFSDGNL-VLKWSQRFEIIMDVAKALEFLHFG 200
                     +  +L  EY     L++ L    N   LK      ++ D++ AL +LH  
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH-- 138

Query: 201 CDPPVIHGDIKPSNVLLDSDCRG---KVSDFGLSRIKVEGEF 239
            +  +IH D+KP N++L    +    K+ D G ++   +GE 
Sbjct: 139 -ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 48.9 bits (116), Expect = 4e-06
 Identities = 18/66 (27%), Positives = 27/66 (40%), Gaps = 5/66 (7%)

Query: 563 FSRELSSTTSMR---GTLCYVAPE-YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLAS 618
           +++EL          GTL Y+APE      Y     D +S G L    ++G RP      
Sbjct: 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQ 228

Query: 619 PMKLEK 624
           P++   
Sbjct: 229 PVQWHG 234

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 81.9 bits (203), Expect = 4e-17
 Identities = 35/150 (23%), Positives = 64/150 (42%), Gaps = 15/150 (10%)

Query: 90  VIGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTERE----FQNELQILGGLRSPFLV 142
           ++G+GG G V+   A D      +A+K +   +L ++       Q E +  G L+ P +V
Sbjct: 41  LVGRGGMGDVYE--AEDTVRERIVALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
            +  +     +  +    +    L  ML   G L     +   I+  +  AL+  H    
Sbjct: 98  PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPP--RAVAIVRQIGSALDAAH---A 152

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               H D+KP N+L+ +D    + DFG++ 
Sbjct: 153 AGATHRDVKPENILVSADDFAYLVDFGIAS 182

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 42.2 bits (100), Expect = 3e-04
 Identities = 15/46 (32%), Positives = 25/46 (54%)

Query: 567 LSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRP 612
           L+   +  GTL Y+APE     +   +ADIY+L  ++   ++G  P
Sbjct: 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 81.1 bits (201), Expect = 5e-17
 Identities = 41/152 (26%), Positives = 60/152 (39%), Gaps = 16/152 (10%)

Query: 90  VIGKGGSGTVFLGIARDGK----LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVTL 144
            IG+G  G V  GI    +     +AIK   +  S     +F  E   +     P +V L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGC 201
           +G   E N   ++ E      L+  L       L  +        ++ AL +L    F  
Sbjct: 82  IGVITE-NPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKRF-- 137

Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               +H DI   NVL+ S+   K+ DFGLSR 
Sbjct: 138 ----VHRDIAARNVLVSSNDCVKLGDFGLSRY 165

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 83.3 bits (206), Expect = 8e-17
 Identities = 53/188 (28%), Positives = 89/188 (47%), Gaps = 20/188 (10%)

Query: 63  DSNAPLKLQRFTYKELKNAT-NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSL 120
           DS   L+  ++ + E +    + F +  V+G+GG G VF    +  GKL A K+L+   L
Sbjct: 164 DSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL 223

Query: 121 QTEREFQ---NELQILGGLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNL 176
           +  + +Q    E +IL  + S F+V+L  Y  E    + LV   M    ++  +++    
Sbjct: 224 KKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDED 282

Query: 177 VLKWSQ---RF---EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL 230
              + +    F   +I+      LE LH      +I+ D+KP NVLLD D   ++SD GL
Sbjct: 283 NPGFQEPRAIFYTAQIVS----GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGL 335

Query: 231 SRIKVEGE 238
           +     G+
Sbjct: 336 AVELKAGQ 343

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 81.2 bits (201), Expect = 8e-17
 Identities = 37/163 (22%), Positives = 63/163 (38%), Gaps = 25/163 (15%)

Query: 89  NVIGKGGSGTVFLGIARDGK----LLAIKRL--DTFSLQTEREFQNELQILGGLRSPFLV 142
            ++GKG  G+V     +        +A+K L  D  +     EF  E   +     P + 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 143 TLLGYCMERNKRI------LVYEYMPNKSLQEML----FSDGNLVLKWSQRFEIIMDVAK 192
            L+G  +    +       ++  +M +  L   L      +    L        ++D+A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 193 ALEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            +E+L   +F      IH D+   N +L  D    V+DFGLSR
Sbjct: 149 GMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSR 185

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 83.4 bits (206), Expect = 1e-16
 Identities = 32/153 (20%), Positives = 63/153 (41%), Gaps = 20/153 (13%)

Query: 90  VIGKGGSGTVFLGIARDGKLL----AIKRLDTFSLQTERE-FQNELQILGGLRSPFLVTL 144
            I  GG G ++L  A D  +      +K L        +     E Q L  +  P +V +
Sbjct: 87  CIAHGGLGWIYL--ALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 145 LGYCMERNKRI-----LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
             +    ++       +V EY+  +SL+        L    ++    ++++  AL +LH 
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKL--PVAEAIAYLLEILPALSYLH- 199

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                +++ D+KP N++L  + + K+ D G   
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 19/155 (12%)

Query: 89  NVIGKGGSGTVFLGIARDGKLL-----AIKRL-DTFSLQTEREFQNELQILGGLRSPFLV 142
            V+G G  GTV  G+             IK + D    Q+ +   + +  +G L    +V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEML-FSDGNLVLKWSQRFEIIMDVAKALEFL---H 198
            LLG C   + ++ V +Y+P  SL + +    G L  +        + +AK + +L    
Sbjct: 79  RLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQ--LLLNWGVQIAKGMYYLEEHG 135

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
                  +H ++   NVLL S  + +V+DFG++ +
Sbjct: 136 M------VHRNLAARNVLLKSPSQVQVADFGVADL 164

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 79.9 bits (198), Expect = 1e-16
 Identities = 38/168 (22%), Positives = 62/168 (36%), Gaps = 30/168 (17%)

Query: 89  NVIGKGGSGTVFLGIARDGK------LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFL 141
             +G+   G V+ G             +AIK L D        EF++E  +   L+ P +
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEML--------------FSDGNLVLKWSQRFEII 187
           V LLG   +     +++ Y  +  L E L                     L+      ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 188 MDVAKALEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
             +A  +E+L   H       +H D+   NVL+      K+SD GL R
Sbjct: 135 AQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFR 176

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 36/154 (23%), Positives = 70/154 (45%), Gaps = 17/154 (11%)

Query: 89  NVIGKGGSGTVFLGIARDGK-----LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLV 142
            V+G G  GTV+ G+           +AIK L +  S +  +E  +E  ++  + +P + 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HF 199
            LLG C+  +   L+ + MP   L + +    +  +         + +AK + +L     
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRL 138

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
                 +H D+   NVL+ +    K++DFGL+++
Sbjct: 139 ------VHRDLAARNVLVKTPQHVKITDFGLAKL 166

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 39/154 (25%), Positives = 59/154 (38%), Gaps = 18/154 (11%)

Query: 90  VIGKGGSGTVFLGI--ARDGKLL--AIKRL---DTFSLQTEREFQNELQILGGLRSPFLV 142
            +G G  G V  G   A  GK +  A+K L        +   +F  E+  +  L    L+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HF 199
            L G  +    ++ V E  P  SL + L                 + VA+ + +L    F
Sbjct: 85  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLESKRF 142

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
                 IH D+   N+LL +    K+ DFGL R 
Sbjct: 143 ------IHRDLAARNLLLATRDLVKIGDFGLMRA 170

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 80.5 bits (198), Expect = 2e-16
 Identities = 18/178 (10%), Positives = 39/178 (21%), Gaps = 39/178 (21%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTERE---FQNELQILGGLRSPFLVTLL 145
            +  G    VFL    +  +  A+K     +  +  E             L         
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 146 GYC--------------------------MERNKRILVYEYMPNKSLQEMLFSDGNLV-- 177
                                              +L+     +  L+ +  +   +   
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVF 187

Query: 178 ---LKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                      +   + +    L       ++HG   P N+ +  D R  + D     
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 6/47 (12%), Positives = 14/47 (29%), Gaps = 2/47 (4%)

Query: 568 SSTTSMRGTLCYVAPEYGGCGYLM--EKADIYSLGVLILVIVSGRRP 612
           +   +    + Y   E+            + + LG+ I  +     P
Sbjct: 246 TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 80.5 bits (199), Expect = 3e-16
 Identities = 45/179 (25%), Positives = 82/179 (45%), Gaps = 19/179 (10%)

Query: 76  KELKNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTERE---FQNELQ 131
           KE++   +DF+   VIG+G    V +   +  G++ A+K ++ + +    E   F+ E  
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113

Query: 132 ILGGLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF---EII 187
           +L      ++  L  +  +    + LV EY     L  +L   G  +     RF   EI+
Sbjct: 114 VLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIV 172

Query: 188 MDVAKALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS-RIKVEGEFGMDLF 244
           M    A++ +H  G     +H DIKP N+LLD     +++DFG   +++ +G     + 
Sbjct: 173 M----AIDSVHRLG----YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 78.8 bits (195), Expect = 4e-16
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 19/153 (12%)

Query: 91  IGKGGSGTVFLGIARDGKL---LAIKRLDTFSLQTERE----FQNELQILGGLRSPFLVT 143
           +G GG   V L  ARD +    +A+K L    L  +      F+ E Q    L  P +V 
Sbjct: 20  LGFGGMSEVHL--ARDLRDHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 144 LLGYCMERNKRI----LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
           +               +V EY+   +L++++ ++G   +   +  E+I D  +AL F H 
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH- 133

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                +IH D+KP+N+++ +    KV DFG++R
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIAR 164

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 79.1 bits (196), Expect = 4e-16
 Identities = 52/175 (29%), Positives = 79/175 (45%), Gaps = 35/175 (20%)

Query: 83  NDFDEANVIGKGGSGTVFL----GIARDGKLLAIKRL----------DTFSLQTEREFQN 128
             F+   V+GKGG G VF       A  GK+ A+K L          DT   + ER    
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER---- 72

Query: 129 ELQILGGLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF--- 184
              IL  ++ PF+V L+ Y  +   ++ L+ EY+    L   L  +G  +   +  F   
Sbjct: 73  --NILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-CFYLA 128

Query: 185 EIIMDVAKALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
           EI M    AL  LH  G    +I+ D+KP N++L+     K++DFGL +  +   
Sbjct: 129 EISM----ALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG 175

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 43/183 (23%), Positives = 75/183 (40%), Gaps = 26/183 (14%)

Query: 79  KNATNDFDEA----NVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQT---------ER 124
            ++T+ F E      ++G+G S  V   I +   K  A+K +D     +           
Sbjct: 9   SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68

Query: 125 EFQNELQILGGLRS-PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQR 183
               E+ IL  +   P ++ L           LV++ M    L + L     L    S++
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL----SEK 124

Query: 184 --FEIIMDVAKALEFLHF-GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFG 240
              +I+  + + +  LH       ++H D+KP N+LLD D   K++DFG S     GE  
Sbjct: 125 ETRKIMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 180

Query: 241 MDL 243
            ++
Sbjct: 181 REV 183

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 80.1 bits (198), Expect = 5e-16
 Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 48/203 (23%)

Query: 57  SRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRL 115
           +  +      P + Q  +Y + K          VIG G  G V+     D G+L+AIK++
Sbjct: 38  TTVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKV 87

Query: 116 DTFSLQTEREFQN-ELQILGGLRSPFLVTLLGYCMERNKRI------LVYEYMPNKSLQE 168
               LQ ++ F+N ELQI+  L    +V L  +     ++       LV +Y+P      
Sbjct: 88  ----LQ-DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP------ 136

Query: 169 MLFSDGNLVLKWSQRFEIIMD----------VAKALEFLH-FGCDPPVIHGDIKPSNVLL 217
                   V +   R +  +           + ++L ++H FG    + H DIKP N+LL
Sbjct: 137 ---ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG----ICHRDIKPQNLLL 189

Query: 218 DSDCRG-KVSDFGLSRIKVEGEF 239
           D D    K+ DFG ++  V GE 
Sbjct: 190 DPDTAVLKLCDFGSAKQLVRGEP 212

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 79.8 bits (197), Expect = 6e-16
 Identities = 42/171 (24%), Positives = 80/171 (46%), Gaps = 30/171 (17%)

Query: 76  KELKNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTERE---FQNELQ 131
           K+++    DF+   VIG+G  G V +   ++  K+ A+K L+ + +    E   F+ E  
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126

Query: 132 ILGGLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF------ 184
           +L    S ++ TL  Y  + +  + LV +Y       ++L     L+ K+  R       
Sbjct: 127 VLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGG---DLLT----LLSKFEDRLPEEMAR 178

Query: 185 ----EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
               E+++    A++ +H       +H DIKP N+L+D +   +++DFG  
Sbjct: 179 FYLAEMVI----AIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC 222

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 80.1 bits (198), Expect = 7e-16
 Identities = 41/192 (21%), Positives = 73/192 (38%), Gaps = 15/192 (7%)

Query: 55  NRSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK 113
           +    + F  +       F   +  + +  +     +G G  G V L   +      AIK
Sbjct: 9   SGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIK 68

Query: 114 RLDTFSLQTERE--FQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLF 171
            +   S+ T        E+ +L  L  P ++ L  +  ++    LV E      L + + 
Sbjct: 69  IIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII 128

Query: 172 SDGNLVLKWSQR--FEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS---DCRGKVS 226
                    ++     II  V   + +LH      ++H D+KP N+LL+S   D   K+ 
Sbjct: 129 HRMKF----NEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIV 181

Query: 227 DFGLSRIKVEGE 238
           DFGLS +    +
Sbjct: 182 DFGLSAVFENQK 193

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 78.5 bits (194), Expect = 7e-16
 Identities = 46/176 (26%), Positives = 70/176 (39%), Gaps = 38/176 (21%)

Query: 89  NVIGKGGSGTVFLGIARDGK------LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFL 141
             IG+G  G VF   A          ++A+K L +  S   + +FQ E  ++    +P +
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEML----------------------FSDGNLVLK 179
           V LLG C       L++EYM    L E L                       S G   L 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 180 WSQRFEIIMDVAKALEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            +++  I   VA  + +L    F      +H D+   N L+  +   K++DFGLSR
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSR 222

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 78.1 bits (193), Expect = 7e-16
 Identities = 42/171 (24%), Positives = 60/171 (35%), Gaps = 33/171 (19%)

Query: 89  NVIGKGGSGTVFLGIARDGK------LLAIKRL-DTFSLQTEREFQNELQILGGLRS-PF 140
             +G G  G V    A           +A+K L  +  L       +EL++L  L +   
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEML----------------FSDGNLVLKWSQRF 184
           +V LLG C      +++ EY     L   L                  D  L L      
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 185 EIIMDVAKALEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                VAK + FL   +       IH D+   N+LL      K+ DFGL+R
Sbjct: 149 SFSYQVAKGMAFLASKNC------IHRDLAARNILLTHGRITKICDFGLAR 193

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 78.5 bits (194), Expect = 8e-16
 Identities = 34/171 (19%), Positives = 66/171 (38%), Gaps = 33/171 (19%)

Query: 89  NVIGKGGSGTVFLGIARDGKLL--------AIKRL-DTFSLQTEREFQNELQILGGLRS- 138
             +G+G  G V +  A              A+K L D  + +   +  +E++++  +   
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEML--------------FSDGNLVLKWSQRF 184
             ++ LLG C +     ++ EY    +L+E L                     + +    
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 185 EIIMDVAKALEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                +A+ +E+L           IH D+   NVL+  +   K++DFGL+R
Sbjct: 161 SCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLAR 205

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 79.9 bits (197), Expect = 1e-15
 Identities = 41/151 (27%), Positives = 60/151 (39%), Gaps = 16/151 (10%)

Query: 90  VIGKGGSGTVFLGIARDGK----LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFLVTL 144
            IG+G  G V  GI    +     +AIK   +  S     +F  E   +     P +V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL---HFGC 201
           +G   E N   ++ E      L+  L       L  +        ++ AL +L    F  
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESKRF-- 512

Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               +H DI   NVL+ S+   K+ DFGLSR
Sbjct: 513 ----VHRDIAARNVLVSSNDCVKLGDFGLSR 539

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 49/195 (25%), Positives = 82/195 (42%), Gaps = 39/195 (20%)

Query: 57  SRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRL 115
           S    FD N  +              + F+    IGKG  G V +    D  K+ A+K +
Sbjct: 1   SMPPVFDENEDVNF------------DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYM 48

Query: 116 DTFSLQTEREFQN---ELQILGGLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSL----- 166
           +        E +N   ELQI+ GL  PFLV L  Y  +  + + +V + +    L     
Sbjct: 49  NKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQ 107

Query: 167 QEMLFSDGNLVLKWSQRF---EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG 223
           Q + F +       + +    E++M    AL++L    +  +IH D+KP N+LLD     
Sbjct: 108 QNVHFKEE------TVKLFICELVM----ALDYLQ---NQRIIHRDMKPDNILLDEHGHV 154

Query: 224 KVSDFGLSRIKVEGE 238
            ++DF ++ +     
Sbjct: 155 HITDFNIAAMLPRET 169

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 34/171 (19%), Positives = 66/171 (38%), Gaps = 33/171 (19%)

Query: 89  NVIGKGGSGTVFLGIARDGKLL--------AIKRL-DTFSLQTEREFQNELQILGGLRS- 138
             +G+G  G V +  A              A+K L D  + +   +  +E++++  +   
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEML--------------FSDGNLVLKWSQRF 184
             ++ LLG C +     ++ EY    +L+E L                     + +    
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 185 EIIMDVAKALEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                +A+ +E+L           IH D+   NVL+  +   K++DFGL+R
Sbjct: 207 SCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLAR 251

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 78.6 bits (193), Expect = 1e-15
 Identities = 25/181 (13%), Positives = 55/181 (30%), Gaps = 44/181 (24%)

Query: 90  VIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTE---REFQNELQILGGLR------ 137
           V+G+          A D   G+   +              ++ + E+  L  LR      
Sbjct: 85  VLGQEDPYAYLE--ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 142

Query: 138 ------------------SPFLVTLLGYCMERNKRILVYEYMP-----NKSLQEMLFSDG 174
                                 +  +         +  +   P      ++  E+L S  
Sbjct: 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202

Query: 175 NL--VLKWSQRFEIIMDVAKALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           +    L    R ++ + V + L  LH +G    ++H  ++P +++LD      ++ F   
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHL 258

Query: 232 R 232
            
Sbjct: 259 V 259

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 14/131 (10%), Positives = 33/131 (25%), Gaps = 34/131 (25%)

Query: 563 FSRELSSTTSMRGTLCYVAPEY----------GGCGYLMEKADIYSLGVLILVIVSGRRP 612
                 ++        +  PE                +    D ++LG+ I  I     P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

Query: 613 LHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTP 672
                + +   +  +   C+++ Q           ++             L    L+   
Sbjct: 317 NT-DDAALGGSEW-IFRSCKNIPQP----------VRA------------LLEGFLRYPK 352

Query: 673 ELRPDIGETVR 683
           E R    + + 
Sbjct: 353 EDRLLPLQAME 363

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 78.1 bits (192), Expect = 1e-15
 Identities = 19/178 (10%), Positives = 48/178 (26%), Gaps = 38/178 (21%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTERE----------------------- 125
           V+G+              G+   +                                    
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 126 -----FQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM----PNKSLQEMLFSDGNL 176
                F     ++   +   ++ +     +       + Y       ++  E+L S  + 
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 177 --VLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
              L    R ++ + V + L  LH      ++H  ++P +++LD      ++ F    
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 8/61 (13%), Positives = 16/61 (26%), Gaps = 11/61 (18%)

Query: 563 FSRELSSTTSMRGTLCYVAPEY-----------GGCGYLMEKADIYSLGVLILVIVSGRR 611
                 +      +  +  PE                 +    D ++LG++I  I     
Sbjct: 252 HLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311

Query: 612 P 612
           P
Sbjct: 312 P 312

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 46/181 (25%), Positives = 73/181 (40%), Gaps = 32/181 (17%)

Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLR 137
           +   + F    + G+G  GTV LG  +  G  +AIK++        RE Q  +Q L  L 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLH 77

Query: 138 SPFLVTLLGYCM----ERNKR----ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMD 189
            P +V L         ER++R     +V EY+P            +   +   R ++   
Sbjct: 78  HPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVP---------DTLHRCCRNYYRRQVAPP 127

Query: 190 VA----------KALEFLHFGCDPPVIHGDIKPSNVLLD-SDCRGKVSDFGLSRIKVEGE 238
                       +++  LH      V H DIKP NVL++ +D   K+ DFG ++     E
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186

Query: 239 F 239
            
Sbjct: 187 P 187

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 49/204 (24%), Positives = 81/204 (39%), Gaps = 47/204 (23%)

Query: 55  NRSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKR 114
           N+   +        + +   Y   K          VIG G  G VF     +   +AIK+
Sbjct: 22  NKVIKVLASDGKTGEQREIAYTNCK----------VIGNGSFGVVFQAKLVESDEVAIKK 71

Query: 115 LDTFSLQTEREFQN-ELQILGGLRSPFLVTLLGYCMERNKRI------LVYEYMPNKSLQ 167
           +    LQ ++ F+N ELQI+  ++ P +V L  +      +       LV EY+P     
Sbjct: 72  V----LQ-DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----- 121

Query: 168 EMLFSDGNLVLKWSQRFEIIMDVA----------KALEFLH-FGCDPPVIHGDIKPSNVL 216
                      +   + +  M +           ++L ++H  G    + H DIKP N+L
Sbjct: 122 ----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG----ICHRDIKPQNLL 173

Query: 217 LDSDCRG-KVSDFGLSRIKVEGEF 239
           LD      K+ DFG ++I + GE 
Sbjct: 174 LDPPSGVLKLIDFGSAKILIAGEP 197

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 41/167 (24%), Positives = 60/167 (35%), Gaps = 29/167 (17%)

Query: 89  NVIGKGGSGTVFLGIARD------GKLLAIKRL-DTFSLQTEREFQNELQILGGLRS-PF 140
             +G G  G V    A           +A+K L  T     +    +EL+I+  L     
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEML------------FSDGNLVLKWSQRFEIIM 188
           +V LLG C      +++ EY     L   L            F+  N             
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 189 DVAKALEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            VA+ + FL   +       IH D+   NVLL +    K+ DFGL+R
Sbjct: 172 QVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLAR 212

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 46/192 (23%), Positives = 83/192 (43%), Gaps = 21/192 (10%)

Query: 61  PFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFS 119
            +  +   + +   +   K     +D  +VIG+G S  V   + R  G   A+K ++  +
Sbjct: 72  LYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTA 131

Query: 120 LQTERE--------FQNELQILGGLRS-PFLVTLLGYCMERNKRILVYEYMPNKSLQEML 170
            +   E         + E  IL  +   P ++TL+      +   LV++ M    L + L
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL 191

Query: 171 FSDGNLVLKWSQR--FEIIMDVAKALEFLHF-GCDPPVIHGDIKPSNVLLDSDCRGKVSD 227
                L    S++    I+  + +A+ FLH       ++H D+KP N+LLD + + ++SD
Sbjct: 192 TEKVAL----SEKETRSIMRSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIRLSD 243

Query: 228 FGLSRIKVEGEF 239
           FG S     GE 
Sbjct: 244 FGFSCHLEPGEK 255

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 76.8 bits (190), Expect = 3e-15
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 21/167 (12%)

Query: 83  NDFDEANVIGKGGSGTVFL----GIARDGKLLAIKRL--DTFSLQTEREFQNELQILGGL 136
           + F+   V+G+G  G VFL      +   +L A+K L   T  ++     + E  IL  +
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83

Query: 137 RSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF---EIIMDVAK 192
             PF+V L  Y  +   ++ L+ +++    L   L  +     +   +F   E+ +    
Sbjct: 84  NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-KFYLAELAL---- 137

Query: 193 ALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
           AL+ LH  G    +I+ D+KP N+LLD +   K++DFGLS+  ++ E
Sbjct: 138 ALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 77.4 bits (191), Expect = 3e-15
 Identities = 37/171 (21%), Positives = 65/171 (38%), Gaps = 33/171 (19%)

Query: 89  NVIGKGGSGTVFLGIARDGKLL--------AIKRL-DTFSLQTEREFQNELQILGGLRS- 138
             +G+G  G V L  A              A+K L    + +   +  +E++++  +   
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEML--------------FSDGNLVLKWSQRF 184
             ++ LLG C +     ++ EY    +L+E L                +    L      
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 185 EIIMDVAKALEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                VA+ +E+L           IH D+   NVL+  D   K++DFGL+R
Sbjct: 195 SCAYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIADFGLAR 239

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 78.8 bits (194), Expect = 3e-15
 Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 20/167 (11%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
           NDF    +IG+GG G V+     D GK+ A+K LD   ++ ++      NE  +L  + +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 139 ---PFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF---EIIMDVA 191
              PF+V +  Y      ++  + + M    L   L   G        RF   EII+   
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-RFYAAEIIL--- 303

Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
             LE +H   +  V++ D+KP+N+LLD     ++SD GL+    + +
Sbjct: 304 -GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 77.8 bits (192), Expect = 3e-15
 Identities = 41/177 (23%), Positives = 74/177 (41%), Gaps = 16/177 (9%)

Query: 71  QRFTYKELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTERE---F 126
             F        ++ +    V+GKG  G V L   +  G+  A+K +    ++ + +    
Sbjct: 14  GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73

Query: 127 QNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQR--F 184
             E+Q+L  L  P ++ L  +  ++    LV E      L + + S        S+    
Sbjct: 74  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF----SEVDAA 129

Query: 185 EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLSRIKVEGE 238
            II  V   + ++H      ++H D+KP N+LL+S   D   ++ DFGLS      +
Sbjct: 130 RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 41/170 (24%), Positives = 62/170 (36%), Gaps = 32/170 (18%)

Query: 89  NVIGKGGSGTVFLGIARD------GKLLAIKRL-DTFSLQTEREFQNELQILGGLRS-PF 140
             +G+G  G V    A         + +A+K L +  +    R   +EL+IL  +     
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 141 LVTLLGYCMERNKRILV-YEYMPNKSLQEML--------------FSDGNLVLKWSQRFE 185
           +V LLG C +    ++V  E+    +L   L                     L       
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 186 IIMDVAKALEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
               VAK +EFL           IH D+   N+LL      K+ DFGL+R
Sbjct: 153 YSFQVAKGMEFLASRKC------IHRDLAARNILLSEKNVVKICDFGLAR 196

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 75.7 bits (187), Expect = 5e-15
 Identities = 42/156 (26%), Positives = 69/156 (44%), Gaps = 14/156 (8%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQN-----ELQILGGL 136
             +++   IG+G  G VF    RD G+++AIK+   F    +          E+++L  L
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKK---FLESEDDPVIKKIALREIRMLKQL 59

Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEF 196
           + P LV LL     + +  LV+EY  +  L E+      +     +         +A+ F
Sbjct: 60  KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSI--TWQTLQAVNF 117

Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            H       IH D+KP N+L+      K+ DFG +R
Sbjct: 118 CH---KHNCIHRDVKPENILITKHSVIKLCDFGFAR 150

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 75.3 bits (186), Expect = 5e-15
 Identities = 38/185 (20%), Positives = 73/185 (39%), Gaps = 17/185 (9%)

Query: 63  DSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQ 121
             +     +   ++        ++   ++GKG  G V     R   +  A+K ++  S +
Sbjct: 4   HHHHSSGRENLYFQ--GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61

Query: 122 TERE--FQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLK 179
            +       E+++L  L  P ++ L     + +   +V E      L + +         
Sbjct: 62  NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF--- 118

Query: 180 WSQRF--EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLSRIK 234
            S+     II  V   + ++H      ++H D+KP N+LL+S   DC  K+ DFGLS   
Sbjct: 119 -SEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174

Query: 235 VEGEF 239
            +   
Sbjct: 175 QQNTK 179

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 75.8 bits (187), Expect = 5e-15
 Identities = 38/197 (19%), Positives = 79/197 (40%), Gaps = 25/197 (12%)

Query: 63  DSNAPLKLQRFTYKELKNATNDFD-EANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSL 120
            S   L  +   ++ ++N  N +   +  +G+G    V   I++  G+  A K L     
Sbjct: 8   SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR 67

Query: 121 QTE--REFQNELQILGGLRS-PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLV 177
             +   E  +E+ +L   +S P ++ L       ++ IL+ EY     +  +       +
Sbjct: 68  GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC------L 121

Query: 178 LKWSQRF------EIIMDVAKALEFLHF-GCDPPVIHGDIKPSNVLL---DSDCRGKVSD 227
            + ++         +I  + + + +LH       ++H D+KP N+LL         K+ D
Sbjct: 122 PELAEMVSENDVIRLIKQILEGVYYLHQNN----IVHLDLKPQNILLSSIYPLGDIKIVD 177

Query: 228 FGLSRIKVEGEFGMDLF 244
           FG+SR         ++ 
Sbjct: 178 FGMSRKIGHACELREIM 194

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 75.3 bits (186), Expect = 5e-15
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 29/164 (17%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
           V+G G    VFL   R  GKL A+K +       +   +NE+ +L  ++   +VTL    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNL----VLKWSQRF------EIIMDVAKALEFLH 198
                  LV + +          S G L    + +    +       +I  V  A+++LH
Sbjct: 76  ESTTHYYLVMQLV----------SGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLH 123

Query: 199 FGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLSRIKVEGEF 239
              +  ++H D+KP N+L  +   + +  ++DFGLS+++  G  
Sbjct: 124 ---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM 164

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 75.8 bits (187), Expect = 6e-15
 Identities = 41/163 (25%), Positives = 66/163 (40%), Gaps = 14/163 (8%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTER-----EFQNELQILGGLRSPFLVT 143
           VIGKG    V   I R+ G+  A+K +D     +       + + E  I   L+ P +V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 144 LLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLHFGC 201
           LL          +V+E+M    L   +    +    +S+      +  + +AL + H   
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH--- 147

Query: 202 DPPVIHGDIKPSNVLLDS---DCRGKVSDFGLSRIKVEGEFGM 241
           D  +IH D+KP  VLL S       K+  FG++    E     
Sbjct: 148 DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA 190

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 36/168 (21%), Positives = 63/168 (37%), Gaps = 20/168 (11%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTER------EFQNELQILGGLRSPFLV 142
            +G G    V     +  G   A K +     +  R      E + E+ IL  +    ++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQR--FEIIMDVAKALEFLHFG 200
           TL      R   +L+ E +    L + L    +L    S+      I  +   + +LH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESL----SEEEATSFIKQILDGVNYLH-- 132

Query: 201 CDPPVIHGDIKPSNVLLDS----DCRGKVSDFGLSRIKVEGEFGMDLF 244
               + H D+KP N++L          K+ DFGL+    +G    ++F
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 37/176 (21%), Positives = 64/176 (36%), Gaps = 38/176 (21%)

Query: 89  NVIGKGGSGTVFLGIARDGK------LLAIKRL-DTFSLQTEREFQNELQILGGLRSPFL 141
             +G+G  G V    A   K       +A+K L +  S    R+  +E  +L  +  P +
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEML----------------------FSDGNLVLK 179
           + L G C +    +L+ EY    SL+  L                             L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 180 WSQRFEIIMDVAKALEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                     +++ +++L           +H D+   N+L+    + K+SDFGLSR
Sbjct: 149 MGDLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFGLSR 198

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 74.9 bits (185), Expect = 6e-15
 Identities = 38/170 (22%), Positives = 71/170 (41%), Gaps = 19/170 (11%)

Query: 82  TNDFDEA----NVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTERE--FQNELQILG 134
           +  F +       +GKG    V   + +  G   A K ++T  L        + E +I  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAK 192
            L+ P +V L     E +   LV++ +    L E + +        S+      I  + +
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY----SEADASHCIQQILE 116

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG---KVSDFGLSRIKVEGEF 239
           ++ + H      ++H ++KP N+LL S  +G   K++DFGL+    + E 
Sbjct: 117 SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 76.3 bits (188), Expect = 7e-15
 Identities = 50/165 (30%), Positives = 84/165 (50%), Gaps = 20/165 (12%)

Query: 76  KELKNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSL----QTEREFQNEL 130
           ++L+    D++   VIG+G  G V L   +   K+ A+K L  F +     +   F  E 
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEER 120

Query: 131 QILGGLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF---EI 186
            I+    SP++V L  Y  + ++ + +V EYMP   L  ++ S+ ++  KW+ RF   E+
Sbjct: 121 DIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWA-RFYTAEV 177

Query: 187 IMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           ++    AL+ +H       IH D+KP N+LLD     K++DFG  
Sbjct: 178 VL----ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 76.6 bits (189), Expect = 7e-15
 Identities = 38/185 (20%), Positives = 73/185 (39%), Gaps = 19/185 (10%)

Query: 63  DSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQ 121
             +     +   ++        ++   ++GKG  G V     R   +  A+K ++  S +
Sbjct: 4   HHHHSSGRENLYFQ--GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61

Query: 122 TE--REFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLK 179
            +       E+++L  L  P ++ L     + +   +V E      L + +         
Sbjct: 62  NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF--- 118

Query: 180 WSQR--FEIIMDVAKALEFLHF-GCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLSRI 233
            S+     II  V   + ++H       ++H D+KP N+LL+S   DC  K+ DFGLS  
Sbjct: 119 -SEHDAARIIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173

Query: 234 KVEGE 238
             +  
Sbjct: 174 FQQNT 178

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 75.4 bits (186), Expect = 9e-15
 Identities = 47/175 (26%), Positives = 77/175 (44%), Gaps = 26/175 (14%)

Query: 70  LQRFTYKELKNAT-NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ 127
           L+++       A  + FD    +G G  G V L   ++ G   A+K LD   +   ++ +
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86

Query: 128 ---NELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF 184
              NE +IL  +  PFLV L     + +   +V EY+    +    FS     L+   RF
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FS----HLRRIGRF 138

Query: 185 EIIMDVAK--------ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
                 A+          E+LH   D  +I+ D+KP N+L+D     +V+DFG +
Sbjct: 139 S--EPHARFYAAQIVLTFEYLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFA 188

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 74.9 bits (185), Expect = 9e-15
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 25/161 (15%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ---NELQILGGLRS 138
            DF     +G G  G V L  +R  G+  A+K L    +   ++ +   +E  +L  +  
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK------ 192
           PF++ + G   +  +  ++ +Y+        LFS    +L+ SQRF     VAK      
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGE----LFS----LLRKSQRFP--NPVAKFYAAEV 115

Query: 193 --ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
             ALE+LH   D  +I+ D+KP N+LLD +   K++DFG +
Sbjct: 116 CLALEYLH-SKD--IIYRDLKPENILLDKNGHIKITDFGFA 153

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 75.3 bits (186), Expect = 9e-15
 Identities = 51/172 (29%), Positives = 71/172 (41%), Gaps = 47/172 (27%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRL---------DTFSLQTEREFQNELQI 132
           NDFD   ++GKG  G V L   +  G+  A+K L         +     TE       ++
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES------RV 58

Query: 133 LGGLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLV--LKWSQRF----- 184
           L   R PFL  L  Y  + + R+  V EY             G L   L   + F     
Sbjct: 59  LQNTRHPFLTALK-YAFQTHDRLCFVMEYANG----------GELFFHLSRERVFTEERA 107

Query: 185 -----EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
                EI+     ALE+LH      V++ DIK  N++LD D   K++DFGL 
Sbjct: 108 RFYGAEIVS----ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC 152

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 41/164 (25%), Positives = 68/164 (41%), Gaps = 22/164 (13%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTERE--------FQNELQILGGLRSPF 140
            +G G  G V L   R   K +AI+ +                   + E++IL  L  P 
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLH 198
           ++ +  +  +     +V E M    L + +  +  L     +         +  A+++LH
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRL----KEATCKLYFYQMLLAVQYLH 256

Query: 199 FGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLSRIKVEGEF 239
              +  +IH D+KP NVLL S   DC  K++DFG S+I  E   
Sbjct: 257 ---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 74.5 bits (184), Expect = 1e-14
 Identities = 41/159 (25%), Positives = 76/159 (47%), Gaps = 13/159 (8%)

Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQN-----ELQIL 133
           +     + +   +G+G  G V+      G+++A+KR+    L  E E        E+ +L
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLL 73

Query: 134 GGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
             L  P +V+L+          LV+E+M  K L + +  +    L+ SQ    +  + + 
Sbjct: 74  KELHHPNIVSLIDVIHSERCLTLVFEFME-KDL-KKVLDENKTGLQDSQIKIYLYQLLRG 131

Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +   H      ++H D+KP N+L++SD   K++DFGL+R
Sbjct: 132 VAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 42/176 (23%), Positives = 61/176 (34%), Gaps = 38/176 (21%)

Query: 89  NVIGKGGSGTVFLGIARDGK------LLAIKRL-DTFSLQTEREFQNELQILGGLRS-PF 140
            V+G G  G V    A           +A+K L +           +EL+++  L S   
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEML---------------------FSDGNLVLK 179
           +V LLG C       L++EY     L   L                       +   VL 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 180 WSQRFEIIMDVAKALEFL---HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +         VAK +EFL           +H D+   NVL+      K+ DFGL+R
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKSC------VHRDLAARNVLVTHGKVVKICDFGLAR 220

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 40/156 (25%), Positives = 75/156 (48%), Gaps = 14/156 (8%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQN-----ELQILGGL 136
             ++   ++G+G  G V     +D G+++AIK+   F    + +        E+++L  L
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKK---FLESDDDKMVKKIAMREIKLLKQL 81

Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEF 196
           R   LV LL  C ++ +  LV+E++ +  L ++      L  +  Q++  +  +   + F
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKY--LFQIINGIGF 139

Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            H      +IH DIKP N+L+      K+ DFG +R
Sbjct: 140 CH---SHNIIHRDIKPENILVSQSGVVKLCDFGFAR 172

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 39/204 (19%), Positives = 70/204 (34%), Gaps = 28/204 (13%)

Query: 55  NRSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK 113
           +  R   +     +    +  K+       + +   +G G  G V L   +      AIK
Sbjct: 8   SSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIK 67

Query: 114 RLDTFSLQT-------------EREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY 160
            +                      E  NE+ +L  L  P ++ L     ++    LV E+
Sbjct: 68  VIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEF 127

Query: 161 MPNKSLQEMLFSDGNLVLKWSQR--FEIIMDVAKALEFLHF-GCDPPVIHGDIKPSNVLL 217
                L E + +         +     I+  +   + +LH       ++H DIKP N+LL
Sbjct: 128 YEGGELFEQIINRHKF----DECDAANIMKQILSGICYLHKHN----IVHRDIKPENILL 179

Query: 218 DS---DCRGKVSDFGLSRIKVEGE 238
           ++       K+ DFGLS    +  
Sbjct: 180 ENKNSLLNIKIVDFGLSSFFSKDY 203

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 75.5 bits (186), Expect = 1e-14
 Identities = 51/181 (28%), Positives = 81/181 (44%), Gaps = 38/181 (20%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRL---------DTFSLQTEREFQNELQI 132
           N+F+   ++GKG  G V L   +  G+  A+K L         +     TE       ++
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN------RV 201

Query: 133 LGGLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSL-----QEMLFSDGNLVLKWSQRF-- 184
           L   R PFL  L  Y  + + R+  V EY     L     +E +FS+         RF  
Sbjct: 202 LQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED------RARFYG 254

Query: 185 -EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDL 243
            EI+     AL++LH   +  V++ D+K  N++LD D   K++DFGL +  ++    M  
Sbjct: 255 AEIVS----ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308

Query: 244 F 244
           F
Sbjct: 309 F 309

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 38/179 (21%), Positives = 68/179 (37%), Gaps = 20/179 (11%)

Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTER------EFQNELQ 131
           +   + +D    +G G    V     +  G   A K +     +  R      E + E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67

Query: 132 ILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQR--FEIIMD 189
           IL  +  P ++TL      R   +L+ E +    L + L    +L    S+      I  
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL----SEEEATSFIKQ 123

Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDS----DCRGKVSDFGLSRIKVEGEFGMDLF 244
           +   + +LH      + H D+KP N++L          K+ DFGL+    +G    ++F
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 37/169 (21%), Positives = 69/169 (40%), Gaps = 22/169 (13%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTER------EFQNELQILGGLRSPFLV 142
            +G G    V     +  GK  A K +    L + R      E + E+ IL  +R P ++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQR--FEIIMDVAKALEFLHF- 199
           TL      +   +L+ E +    L + L    +L    ++    + +  +   + +LH  
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKESL----TEDEATQFLKQILDGVHYLHSK 127

Query: 200 GCDPPVIHGDIKPSNVLLDS----DCRGKVSDFGLSRIKVEGEFGMDLF 244
                + H D+KP N++L      + R K+ DFG++     G    ++F
Sbjct: 128 R----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 172

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 35/166 (21%), Positives = 69/166 (41%), Gaps = 14/166 (8%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRS-PFLVTLLGY 147
           V+G+G    V   I     +  A+K ++            E+++L   +    ++ L+ +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLHFGCDPPV 205
             E ++  LV+E M   S+   +    +     ++     ++ DVA AL+FLH   +  +
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHF----NELEASVVVQDVASALDFLH---NKGI 132

Query: 206 IHGDIKPSNVLL---DSDCRGKVSDFGLSRIKVEGEFGMDLFSQDL 248
            H D+KP N+L    +     K+ DF L            + + +L
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 37/156 (23%), Positives = 63/156 (40%), Gaps = 13/156 (8%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
            IG+G  G V + + +      A K++  + ++    F+ E++I+  L  P ++ L    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLHFGCDPPVI 206
            +     LV E      L E +           +     I+ DV  A+ + H      V 
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRVF----RESDAARIMKDVLSAVAYCH---KLNVA 128

Query: 207 HGDIKPSNVLLDS---DCRGKVSDFGLSRIKVEGEF 239
           H D+KP N L  +   D   K+ DFGL+     G+ 
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 38/158 (24%), Positives = 64/158 (40%), Gaps = 12/158 (7%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTERE-FQNELQILGGLRSPFLVTLLGY 147
            +G G  G V L   R  G    IK ++    Q   E  + E+++L  L  P ++ +   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLHF-GCDPP 204
             + +   +V E      L E + S        S+ +  E++  +  AL + H       
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---- 144

Query: 205 VIHGDIKPSNVLLDS---DCRGKVSDFGLSRIKVEGEF 239
           V+H D+KP N+L          K+ DFGL+ +    E 
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 42/164 (25%), Positives = 68/164 (41%), Gaps = 22/164 (13%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTERE--------FQNELQILGGLRSPF 140
            +G G  G V L   R   K +AIK +                   + E++IL  L  P 
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLH 198
           ++ +  +  +     +V E M    L + +  +  L     +         +  A+++LH
Sbjct: 77  IIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRL----KEATCKLYFYQMLLAVQYLH 131

Query: 199 FGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLSRIKVEGEF 239
              +  +IH D+KP NVLL S   DC  K++DFG S+I  E   
Sbjct: 132 ---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 73.3 bits (181), Expect = 2e-14
 Identities = 38/155 (24%), Positives = 72/155 (46%), Gaps = 13/155 (8%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQN-----ELQILGGLR 137
             +     IG+G  G V+      G+  A+K++    L+ E E        E+ IL  L+
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELK 58

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
              +V L      + + +LV+E++  + L + L       L+       ++ +   + + 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLD-QDL-KKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116

Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           H   D  V+H D+KP N+L++ +   K++DFGL+R
Sbjct: 117 H---DRRVLHRDLKPQNLLINREGELKIADFGLAR 148

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 75.6 bits (186), Expect = 2e-14
 Identities = 42/199 (21%), Positives = 80/199 (40%), Gaps = 15/199 (7%)

Query: 55  NRSRTIPFDSNAPLKLQRFTYKELKNATNDFDE----ANVIGKGGSGTVFLGIARD-GKL 109
             + +  +D+      +++  + ++   +   +       +G G  G V     R  G  
Sbjct: 125 KGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNN 184

Query: 110 LAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEM 169
            A K + T     +   + E+Q +  LR P LV L     + N+ +++YE+M    L E 
Sbjct: 185 FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEK 244

Query: 170 LFSDGNLVLKWSQR--FEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS--DCRGKV 225
           +  + N   K S+    E +  V K L  +H   +   +H D+KP N++  +      K+
Sbjct: 245 VADEHN---KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKL 298

Query: 226 SDFGLSRIKVEGEFGMDLF 244
            DFGL+      +      
Sbjct: 299 IDFGLTAHLDPKQSVKVTT 317

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 39/184 (21%), Positives = 75/184 (40%), Gaps = 15/184 (8%)

Query: 64  SNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQT 122
                +   F        ++++D    +GKG    V   + +  G   A K ++T  L  
Sbjct: 10  GQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA 69

Query: 123 ERE--FQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKW 180
                 + E +I   L+ P +V L     E +   LV++ +    L E + +        
Sbjct: 70  RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY---- 125

Query: 181 SQRF--EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG---KVSDFGLSRIKV 235
           S+      I  + +++ + H      ++H ++KP N+LL S  +G   K++DFGL+    
Sbjct: 126 SEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182

Query: 236 EGEF 239
           + E 
Sbjct: 183 DSEA 186

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 34/172 (19%), Positives = 69/172 (40%), Gaps = 14/172 (8%)

Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLR 137
           K     +  A  +G+G  G V   +     K    K +       +   + E+ IL   R
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIAR 59

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQR--FEIIMDVAKALE 195
              ++ L        + ++++E++    + E + +      + ++R     +  V +AL+
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQ 116

Query: 196 FLHF-GCDPPVIHGDIKPSNVLLDS--DCRGKVSDFGLSRIKVEGEFGMDLF 244
           FLH       + H DI+P N++  +      K+ +FG +R    G+    LF
Sbjct: 117 FLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 73.2 bits (180), Expect = 6e-14
 Identities = 40/196 (20%), Positives = 77/196 (39%), Gaps = 17/196 (8%)

Query: 54  VNRSRTIPFDSNAPLKLQRFTYKELKNATNDFDE------ANVIGKGGSGTVFLGIARD- 106
           V   RT     + P     F ++ +       +         ++G G  G V        
Sbjct: 54  VKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETAT 113

Query: 107 GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSL 166
           G  LA K + T  ++ + E +NE+ ++  L    L+ L      +N  +LV EY+    L
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173

Query: 167 QEMLFSDGNLVLKWSQR--FEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS--DCR 222
            + +  +       ++      +  + + +  +H      ++H D+KP N+L  +    +
Sbjct: 174 FDRIIDESY---NLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQ 227

Query: 223 GKVSDFGLSRIKVEGE 238
            K+ DFGL+R     E
Sbjct: 228 IKIIDFGLARRYKPRE 243

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 73.2 bits (180), Expect = 7e-14
 Identities = 34/171 (19%), Positives = 74/171 (43%), Gaps = 11/171 (6%)

Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLR 137
            +  + +D    +G G  G V   + +  G++   K ++T     +   +NE+ I+  L 
Sbjct: 47  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQR--FEIIMDVAKALE 195
            P L+ L     ++ + +L+ E++    L + + ++     K S+      +    + L+
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLK 163

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDS--DCRGKVSDFGLSRIKVEGEFGMDLF 244
            +H   +  ++H DIKP N++ ++      K+ DFGL+      E      
Sbjct: 164 HMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 211

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 56/176 (31%), Positives = 80/176 (45%), Gaps = 36/176 (20%)

Query: 83  NDFDEANVIGKGGSGTVFL----GIARDGKLLAIKRL----------DTFSLQTEREFQN 128
            +F+   V+G G  G VFL         GKL A+K L           T   +TER    
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER---- 109

Query: 129 ELQILGGL-RSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF-- 184
             Q+L  + +SPFLVTL  Y  +   ++ L+ +Y+    L   L            +   
Sbjct: 110 --QVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-QIYV 165

Query: 185 -EIIMDVAKALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
            EI++    ALE LH  G    +I+ DIK  N+LLDS+    ++DFGLS+  V  E
Sbjct: 166 GEIVL----ALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 39/226 (17%), Positives = 67/226 (29%), Gaps = 49/226 (21%)

Query: 69  KLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIK-----RLDTFSLQT 122
           +   F    L      +     IG+G  G V + I      + AIK     ++   + + 
Sbjct: 12  ENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD 71

Query: 123 EREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQ 182
               + E++++  L  P +  L     +     LV E      L + L    +       
Sbjct: 72  VERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCA 131

Query: 183 RF--------------------------------------EIIMDVAKALEFLHFGCDPP 204
                                                    I+  +  AL +LH   +  
Sbjct: 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQG 188

Query: 205 VIHGDIKPSNVLLDSD--CRGKVSDFGLSRIKVEGEFGMDLFSQDL 248
           + H DIKP N L  ++     K+ DFGLS+   +   G        
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK 234

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 71.8 bits (177), Expect = 1e-13
 Identities = 46/167 (27%), Positives = 90/167 (53%), Gaps = 21/167 (12%)

Query: 77  ELKNATNDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREFQN----- 128
           ++K+    +++ + +G+G   TV+   ARD    +++AIK++    L    E ++     
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYK--ARDKNTNQIVAIKKI---KLGHRSEAKDGINRT 58

Query: 129 ---ELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFE 185
              E+++L  L  P ++ LL     ++   LV+++M    L E++  D +LVL  S    
Sbjct: 59  ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDL-EVIIKDNSLVLTPSHIKA 116

Query: 186 IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            ++   + LE+LH      ++H D+KP+N+LLD +   K++DFGL++
Sbjct: 117 YMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 35/174 (20%), Positives = 62/174 (35%), Gaps = 37/174 (21%)

Query: 90  VIGKGGSGTVFLGIARDGKLLAIKRLD--TFSLQTEREFQN---------ELQILGGLRS 138
            I  G  G V  G+  +G  +AIKR+       +T     +         E+++L     
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 139 PFLVTLLG----YCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQ--------RFE 185
           P ++ L      +      ++ LV E M          +D   V+   +        ++ 
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMR---------TDLAQVIHDQRIVISPQHIQY- 138

Query: 186 IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
            +  +   L  LH      V+H D+ P N+LL  +    + DF L+R       
Sbjct: 139 FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 70.6 bits (174), Expect = 2e-13
 Identities = 42/156 (26%), Positives = 78/156 (50%), Gaps = 13/156 (8%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQN-----ELQILGGL 136
            +F +   IG+G  G V+    +  G+++A+K++    L TE E        E+ +L  L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI---RLDTETEGVPSTAIREISLLKEL 59

Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEF 196
             P +V LL      NK  LV+E++  + L++ + +     +        +  + + L F
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118

Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            H      V+H D+KP N+L++++   K++DFGL+R
Sbjct: 119 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 71.1 bits (175), Expect = 2e-13
 Identities = 47/164 (28%), Positives = 73/164 (44%), Gaps = 30/164 (18%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRL---------DTFSLQTEREFQNELQI 132
            DFD   VIG+G    V L   +   ++ A+K +         D   +QTE+       +
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEK------HV 62

Query: 133 LG-GLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF---EII 187
                  PFLV L   C +   R+  V EY+    L   +     L  + + RF   EI 
Sbjct: 63  FEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSAEIS 120

Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           +    AL +LH   +  +I+ D+K  NVLLDS+   K++D+G+ 
Sbjct: 121 L----ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 70.7 bits (174), Expect = 2e-13
 Identities = 38/189 (20%), Positives = 77/189 (40%), Gaps = 21/189 (11%)

Query: 55  NRSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIK 113
           +   T+   +  P  +         +    +     +G+G  G V+  I     + +AIK
Sbjct: 7   HHMGTLEAQTQGPGSMSVSAAPSATSIDR-YRRITKLGEGTYGEVYKAIDTVTNETVAIK 65

Query: 114 RLDTFSLQTEREFQN-----ELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQE 168
           R+    L+ E E        E+ +L  L+   ++ L       ++  L++EY     L++
Sbjct: 66  RI---RLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKK 121

Query: 169 MLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG----- 223
            +  + ++ ++  + F  +  +   + F H       +H D+KP N+LL           
Sbjct: 122 YMDKNPDVSMRVIKSF--LYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVL 176

Query: 224 KVSDFGLSR 232
           K+ DFGL+R
Sbjct: 177 KIGDFGLAR 185

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 69.5 bits (171), Expect = 3e-13
 Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 17/157 (10%)

Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQN---ELQILGGLRSPFLVTLLG 146
           +G G  G V +G     G  +A+K L+   +++         E+Q L   R P ++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76

Query: 147 Y-CMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLHFGCD 202
           Y  +       +V EY+    L + +   G +    ++R   +I+     A+++ H    
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL----SAVDYCHRHM- 131

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
             V+H D+KP NVLLD+    K++DFGLS +  +GEF
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 69.9 bits (172), Expect = 4e-13
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 16/162 (9%)

Query: 80  NATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIK--RLDT---FSLQTEREFQNELQIL 133
           ++++ F +   +G G   TV+ G+ +  G  +A+K  +LD+         RE    + ++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLM 57

Query: 134 GGLRSPFLVTLLGYCMERNKRILVYEYMPN---KSLQEMLFSDGNLVLKWSQRFEIIMDV 190
             L+   +V L       NK  LV+E+M N   K +      +    L+ +        +
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 191 AKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            + L F H      ++H D+KP N+L++   + K+ DFGL+R
Sbjct: 118 LQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 69.5 bits (171), Expect = 4e-13
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 14/156 (8%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQN-----ELQILGGL 136
             +++   IG+G  GTVF    R+  +++A+KR+    L  + E        E+ +L  L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKEL 58

Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEF 196
           +   +V L        K  LV+E+   + L +  F   N  L        +  + K L F
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCD-QDL-KKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            H      V+H D+KP N+L++ +   K+++FGL+R
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 37/173 (21%), Positives = 69/173 (39%), Gaps = 20/173 (11%)

Query: 79  KNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTER------EFQNELQ 131
           +N  + +D    +G G    V     +  G   A K +     ++ R      + + E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66

Query: 132 ILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQR--FEIIMD 189
           IL  ++ P ++TL      +   IL+ E +    L + L    +L    ++    E +  
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL----TEEEATEFLKQ 122

Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDS----DCRGKVSDFGLSRIKVEGE 238
           +   + +LH      + H D+KP N++L        R K+ DFGL+     G 
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 71.0 bits (174), Expect = 5e-13
 Identities = 40/202 (19%), Positives = 74/202 (36%), Gaps = 41/202 (20%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQN---------ELQILGGLRSP 139
           +IG G  G V       + +++AIK++        R F++         E+ IL  L   
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHD 112

Query: 140 FLVTLL----GYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFE------IIM 188
            +V +L       +E+   + +V E            SD   + +            ++ 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIAD---------SDFKKLFRTPVYLTELHIKTLLY 163

Query: 189 DVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR-IKVEGEFGMDLFSQD 247
           ++   ++++H      ++H D+KP+N L++ DC  KV DFGL+R +         L    
Sbjct: 164 NLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220

Query: 248 LGKSQELWKSQELSGNLATATE 269
                 L             T 
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTG 242

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 70.5 bits (173), Expect = 5e-13
 Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 30/164 (18%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRL---------DTFSLQTEREFQNELQI 132
            DFD   VIG+G    V L   +   ++ A++ +         D   +QTE+       +
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEK------HV 105

Query: 133 LG-GLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF---EII 187
                  PFLV L   C +   R+  V EY+    L   +     L  + + RF   EI 
Sbjct: 106 FEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSAEIS 163

Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           +    AL +LH   +  +I+ D+K  NVLLDS+   K++D+G+ 
Sbjct: 164 L----ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 42/166 (25%), Positives = 77/166 (46%), Gaps = 28/166 (16%)

Query: 82  TNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTE--REFQNELQILGGLRS 138
              +   + IG+G  G V       +   +AIK++  F  QT   R  + E++IL   R 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRH 84

Query: 139 PFLVTLLG----YCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFE------II 187
             ++ +        +E+ K + +V + M          +D   +LK +Q          +
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLME---------TDLYKLLK-TQHLSNDHICYFL 134

Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             + + L+++H      V+H D+KPSN+LL++ C  K+ DFGL+R+
Sbjct: 135 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 69.6 bits (171), Expect = 6e-13
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 16/156 (10%)

Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTERE--FQNELQILGGLRSPFLVTLLGY 147
           IGKG    V L      G+ +AIK +D   L          E++I+  L  P +V L  +
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80

Query: 148 -CMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLHFGCDP 203
             +E  K + L+ EY     + + L + G +  K ++    +I+     A+++ H     
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCHQKR-- 134

Query: 204 PVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
            ++H D+K  N+LLD+D   K++DFG S     G  
Sbjct: 135 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 41.1 bits (97), Expect = 9e-04
 Identities = 16/39 (41%), Positives = 23/39 (58%), Gaps = 1/39 (2%)

Query: 575 GTLCYVAPE-YGGCGYLMEKADIYSLGVLILVIVSGRRP 612
           G   Y APE + G  Y   + D++SLGV++  +VSG  P
Sbjct: 175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 70.0 bits (172), Expect = 6e-13
 Identities = 46/182 (25%), Positives = 82/182 (45%), Gaps = 28/182 (15%)

Query: 82  TNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTE--REFQNELQILGGLRS 138
           ++DF   +++G+G  G V        G+++AIK+++ F       R  + E++IL   + 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68

Query: 139 PFLVTLL----GYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFE------II 187
             ++T+         E    + ++ E M          +D + V+  +Q          I
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQ---------TDLHRVIS-TQMLSDDHIQYFI 118

Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQD 247
               +A++ LH      VIH D+KPSN+L++S+C  KV DFGL+RI  E        +  
Sbjct: 119 YQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175

Query: 248 LG 249
             
Sbjct: 176 QS 177

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 69.2 bits (170), Expect = 7e-13
 Identities = 39/156 (25%), Positives = 72/156 (46%), Gaps = 15/156 (9%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIK--RLDT---FSLQTEREFQNELQILGGL 136
             + + + +G+G   TV+ G ++    L+A+K  RL+          RE    + +L  L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 57

Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEF 196
           +   +VTL           LV+EY+ +K L +    D   ++        +  + + L +
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYL-DKDL-KQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            H      V+H D+KP N+L++     K++DFGL+R
Sbjct: 116 CH---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 69.6 bits (171), Expect = 8e-13
 Identities = 46/169 (27%), Positives = 68/169 (40%), Gaps = 40/169 (23%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRL---------DTFSLQTEREFQNELQI 132
            DF+   V+GKG  G V L   +   +L A+K L         D      E+      ++
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK------RV 73

Query: 133 LG-GLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSL-----QEMLFSDGNLVLKWSQRF- 184
           L    + PFL  L   C +   R+  V EY+    L     Q   F +          F 
Sbjct: 74  LALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFY 126

Query: 185 --EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
             EI +     L FL       +I+ D+K  NV+LDS+   K++DFG+ 
Sbjct: 127 AAEIAI----GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 68.9 bits (169), Expect = 9e-13
 Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 22/164 (13%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQN------ELQILGGLRS--PF 140
           ++G GG G+V+ GI   D   +AIK ++   +    E  N      E+ +L  + S    
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 141 LVTLLGYCMERNKRI-LVYEY-MPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEF 196
           ++ LL +  ER     L+ E   P + L + +   G L  + ++ F  +++    +A+  
Sbjct: 110 VIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL----EAVRH 164

Query: 197 LHFGCDPPVIHGDIKPSNVLLDSD-CRGKVSDFGLSRIKVEGEF 239
            H   +  V+H DIK  N+L+D +    K+ DFG   +  +  +
Sbjct: 165 CH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 205

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 44.6 bits (106), Expect = 7e-05
 Identities = 22/84 (26%), Positives = 34/84 (40%), Gaps = 13/84 (15%)

Query: 559 SGDLFSRELSSTTSMRGTLCYVAPEY-GGCGYLMEKADIYSLGVLILVIVSGRRPLH--- 614
           SG L    + +     GT  Y  PE+     Y    A ++SLG+L+  +V G  P     
Sbjct: 196 SGALLKDTVYTDFD--GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 253

Query: 615 -----VLASPMKL--EKANLISWC 631
                 +    ++  E  +LI WC
Sbjct: 254 EIIRGQVFFRQRVSSECQHLIRWC 277

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 68.4 bits (168), Expect = 9e-13
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 13/152 (8%)

Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTERE-FQNELQILGGLRSPFLVTLLGYC 148
           +G+G  G V L + R   + +A+K +D        E  + E+ I   L    +V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLH-FGCDPPV 205
            E N + L  EY     L + +  D  +    +QRF  +++      + +LH  G    +
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLHGIG----I 126

Query: 206 IHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEG 237
            H DIKP N+LLD     K+SDFGL+ +    
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYN 158

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 44.1 bits (105), Expect = 7e-05
 Identities = 14/49 (28%), Positives = 25/49 (51%), Gaps = 1/49 (2%)

Query: 575 GTLCYVAPE-YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKL 622
           GTL YVAPE      +  E  D++S G+++  +++G  P    +   + 
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 69.8 bits (171), Expect = 1e-12
 Identities = 47/201 (23%), Positives = 81/201 (40%), Gaps = 43/201 (21%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQN---------ELQILGGLRSP 139
           +IG+G  G V+L       K +AIK++        R F++         E+ IL  L+S 
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKV-------NRMFEDLIDCKRILREITILNRLKSD 85

Query: 140 FLVTLLGYCMERNKRI-----LVYEYMPNKSLQEMLFSDGNLVLKWSQRFE------IIM 188
           +++ L    +  +        +V E            SD   + K            I+ 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIAD---------SDLKKLFKTPIFLTEEHIKTILY 136

Query: 189 DVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI---KVEGEFGMDLFS 245
           ++     F+H      +IH D+KP+N LL+ DC  KV DFGL+R    + +     DL  
Sbjct: 137 NLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193

Query: 246 QDLGKSQELWKSQELSGNLAT 266
            +          ++L+ ++ T
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVT 214

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 44/176 (25%), Positives = 69/176 (39%), Gaps = 40/176 (22%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRL---------DTFSLQTEREFQNELQI 132
            DF    ++GKG  G VFL   +   +  AIK L         D      E+      ++
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK------RV 70

Query: 133 LG-GLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSL-----QEMLFSDGNLVLKWSQRF- 184
           L      PFL  +     +  + +  V EY+    L         F            F 
Sbjct: 71  LSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS------RATFY 123

Query: 185 --EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
             EII+     L+FLH      +++ D+K  N+LLD D   K++DFG+ +  + G+
Sbjct: 124 AAEIIL----GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 69.3 bits (170), Expect = 2e-12
 Identities = 37/159 (23%), Positives = 68/159 (42%), Gaps = 16/159 (10%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTERE--FQNELQILGGLRSPFLVTLLG 146
            +GKG    V   +    G+  A   ++T  L        + E +I   L+ P +V L  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 147 YCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLHFGCDPP 204
              E     L+++ +    L E + +       +S+      I  + +A+   H      
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCH---QMG 130

Query: 205 VIHGDIKPSNVLLDSDCRG---KVSDFGLSR-IKVEGEF 239
           V+H ++KP N+LL S  +G   K++DFGL+  ++ E + 
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 68.4 bits (168), Expect = 2e-12
 Identities = 50/164 (30%), Positives = 72/164 (43%), Gaps = 30/164 (18%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRL---------DTFSLQTEREFQNELQI 132
           ++F+   V+GKG  G V L   ++ G L A+K L         D     TE+      +I
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEK------RI 76

Query: 133 LG-GLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF---EII 187
           L      PFL  L   C +   R+  V E++    L   +          + RF   EII
Sbjct: 77  LSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-RFYAAEII 134

Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
                AL FLH   D  +I+ D+K  NVLLD +   K++DFG+ 
Sbjct: 135 S----ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 42/166 (25%), Positives = 73/166 (43%), Gaps = 24/166 (14%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQN------ELQILGGLRS---- 138
           ++GKGG GTVF G    D   +AIK +    +       +      E+ +L  + +    
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 139 PFLVTLLGYCMERNKRI-LVYEY-MPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKAL 194
           P ++ LL +  E  +   LV E  +P + L + +   G L    S+ F  +++     A+
Sbjct: 98  PGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV----AAI 152

Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSD-CRGKVSDFGLSRIKVEGEF 239
           +  H      V+H DIK  N+L+D      K+ DFG   +  +  +
Sbjct: 153 QHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY 195

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 34/148 (22%), Positives = 51/148 (34%), Gaps = 32/148 (21%)

Query: 559 SGDLFSRELSSTTSMRGTLCYVAPEY-GGCGYLMEKADIYSLGVLILVIVSGRRPLHVLA 617
           SG L   E  +     GT  Y  PE+     Y    A ++SLG+L+  +V G  P     
Sbjct: 186 SGALLHDEPYTDFD--GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE--- 240

Query: 618 SPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPD 677
              ++ +A L                    +  D        C  L   CL   P  RP 
Sbjct: 241 RDQEILEAEL--HFPA-------------HVSPD--------CCALIRRCLAPKPSSRPS 277

Query: 678 IGETVR---ILKGEMDLPPVPFEFSPSP 702
           + E +    +     D+P  P +  P+P
Sbjct: 278 LEEILLDPWMQTPAEDVPLNPSKGGPAP 305

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 47/166 (28%), Positives = 73/166 (43%), Gaps = 34/166 (20%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR---DGKLLAIKRL---------DTFSLQTEREFQNEL 130
           +DF    VIGKG  G V L  AR   +    A+K L         +   + +ER      
Sbjct: 38  SDFHFLKVIGKGSFGKVLL--ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSER------ 89

Query: 131 QILG-GLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF---E 185
            +L   ++ PFLV L  +  +   ++  V +Y+    L   L  +   +   + RF   E
Sbjct: 90  NVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-RFYAAE 147

Query: 186 IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           I      AL +LH      +++ D+KP N+LLDS     ++DFGL 
Sbjct: 148 IAS----ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLC 186

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 43/162 (26%), Positives = 69/162 (42%), Gaps = 21/162 (12%)

Query: 91  IGKGGSGTVFLGIARD-GKLLAIK-----RLDTFSLQTEREFQNELQILGGLRSPFLVTL 144
           +G+G  G V L + R   + +A+K     R        ++E    + I   L    +V  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70

Query: 145 LGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLH-FGC 201
            G+  E N + L  EY     L + +  D  +    +QRF  +++      + +LH  G 
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLHGIG- 125

Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDL 243
              + H DIKP N+LLD     K+SDFGL+ +         L
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 14/49 (28%), Positives = 25/49 (51%), Gaps = 1/49 (2%)

Query: 575 GTLCYVAPE-YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKL 622
           GTL YVAPE      +  E  D++S G+++  +++G  P    +   + 
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 68.3 bits (167), Expect = 3e-12
 Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 17/157 (10%)

Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQN---ELQILGGLRSPFLVTLLG 146
           +G G  G V +G     G  +A+K L+   +++         E+Q L   R P ++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81

Query: 147 Y-CMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLHFGCD 202
           Y  +     I +V EY+    L + +  +G L  K S+R   +I+      +++ H    
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL----SGVDYCHRHM- 136

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
             V+H D+KP NVLLD+    K++DFGLS +  +GEF
Sbjct: 137 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 68.5 bits (167), Expect = 4e-12
 Identities = 46/169 (27%), Positives = 69/169 (40%), Gaps = 40/169 (23%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRL---------DTFSLQTEREFQNELQI 132
            DF+   V+GKG  G V L   +   +L A+K L         D      E+      ++
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK------RV 394

Query: 133 LG-GLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSL-----QEMLFSDGNLVLKWSQRF- 184
           L    + PFL  L   C +   R+  V EY+    L     Q   F + +        F 
Sbjct: 395 LALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH------AVFY 447

Query: 185 --EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
             EI +     L FL       +I+ D+K  NV+LDS+   K++DFG+ 
Sbjct: 448 AAEIAI----GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 66.1 bits (162), Expect = 6e-12
 Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 21/156 (13%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREF----QNELQILGGLRSPFLVTL 144
           ++G+G  G V   + +      A+K L    L+         + E+Q+L  LR   ++ L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 145 LG--YCMERNKRILVYEYMPNKSLQEML--FSDGNLVLKWSQRF--EIIMDVAKALEFLH 198
           +   Y  E+ K  +V EY     +QEML    +    +  +  +  ++I      LE+LH
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVC-GMQEMLDSVPEKRFPVCQAHGYFCQLI----DGLEYLH 126

Query: 199 -FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             G    ++H DIKP N+LL +    K+S  G++  
Sbjct: 127 SQG----IVHKDIKPGNLLLTTGGTLKISALGVAEA 158

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 67.0 bits (164), Expect = 6e-12
 Identities = 44/192 (22%), Positives = 81/192 (42%), Gaps = 39/192 (20%)

Query: 63  DSNAPLKLQRFTYKELKNA---TNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRL--- 115
            S  P +   +  +  K A      + +   +G G  G V   +  R G  +AIK+L   
Sbjct: 2   SSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP 61

Query: 116 ---DTFSLQTEREFQNELQILGGLRSPFLVTLL-----GYCMERNKRI-LVYEYMPNKSL 166
              + F+ +  RE    L++L  +R   ++ LL        ++      LV  +M     
Sbjct: 62  FQSELFAKRAYRE----LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG---- 113

Query: 167 QEMLFSDGNLVLKWSQRFE------IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD 220
                +D   ++K  ++        ++  + K L ++H      +IH D+KP N+ ++ D
Sbjct: 114 -----TDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNED 164

Query: 221 CRGKVSDFGLSR 232
           C  K+ DFGL+R
Sbjct: 165 CELKILDFGLAR 176

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 66.2 bits (162), Expect = 8e-12
 Identities = 35/154 (22%), Positives = 60/154 (38%), Gaps = 13/154 (8%)

Query: 91  IGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           IG G  G   L   +   +L+A+K ++  +   E   Q E+     LR P +V      +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVIL 86

Query: 150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLHFGCDPPVIH 207
                 ++ EY     L E + + G      ++ F  +++      + + H      + H
Sbjct: 87  TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS----GVSYCHSMQ---ICH 139

Query: 208 GDIKPSNVLLDSDCRG--KVSDFGLSRIKVEGEF 239
            D+K  N LLD       K+ DFG S+  V    
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 66.8 bits (163), Expect = 8e-12
 Identities = 45/193 (23%), Positives = 83/193 (43%), Gaps = 30/193 (15%)

Query: 64  SNAPLKLQRFTYKELKNA---TNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRL-DTF 118
           S + +  Q ++ +   +       +     IG G  G V     A   + +AIK+L   F
Sbjct: 40  SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 99

Query: 119 SLQTE--REFQNELQILGGLRSPFLVTLL-----GYCMERNKRI-LVYEYMPNKSLQEML 170
             QT   R ++ EL ++  +    +++LL        +E  + + LV E M         
Sbjct: 100 QNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-------- 150

Query: 171 FSDGNLVLK---WSQRFEIIM-DVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVS 226
            ++   V++     +R   ++  +   ++ LH      +IH D+KPSN+++ SDC  K+ 
Sbjct: 151 -ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 206

Query: 227 DFGLSRIKVEGEF 239
           DFGL+R       
Sbjct: 207 DFGLARTAGTSFM 219

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 65.8 bits (161), Expect = 9e-12
 Identities = 39/175 (22%), Positives = 64/175 (36%), Gaps = 41/175 (23%)

Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
           IGKG  G V L     D    A+K L    L  +  F       G   +P         +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 150 ERNKR----------------------------ILVYEYMPNKSLQEMLFSDGNLVLKWS 181
           E+  +                             +V+E +    + E+  +   L    +
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQA 139

Query: 182 QRF--EIIMDVAKALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           + +  ++I      +E+LH       +IH DIKPSN+L+  D   K++DFG+S  
Sbjct: 140 RFYFQDLIK----GIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 37/184 (20%), Positives = 71/184 (38%), Gaps = 20/184 (10%)

Query: 69  KLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQ 127
            + +  ++     T+ ++    IG G        I +      A+K +D        E  
Sbjct: 8   SIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE-- 65

Query: 128 NELQILGGLRS-PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF-- 184
             ++IL      P ++TL     +     +V E M    L + +          S+R   
Sbjct: 66  --IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF----SEREAS 119

Query: 185 EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG----KVSDFGLSR-IKVEGEF 239
            ++  + K +E+LH      V+H D+KPSN+L   +       ++ DFG ++ ++ E   
Sbjct: 120 AVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176

Query: 240 GMDL 243
            M  
Sbjct: 177 LMTP 180

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 43/164 (26%), Positives = 70/164 (42%), Gaps = 27/164 (16%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
           V+G G +G V     R  G+  A+K L   S +  +E  +  Q  GG   P +V +L   
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYD-SPKARQEVDHHWQASGG---PHIVCILDVY 91

Query: 149 MERNKRI----LVYEYMPNKSLQEMLFSDGNLVLKWSQRF------EIIMDVAKALEFLH 198
              +       ++ E M    L    FS   +  +  Q F      EI+ D+  A++FLH
Sbjct: 92  ENMHHGKRCLLIIMECMEGGEL----FSR--IQERGDQAFTEREAAEIMRDIGTAIQFLH 145

Query: 199 FGCDPPVIHGDIKPSNVLL---DSDCRGKVSDFGLSRIKVEGEF 239
                 + H D+KP N+L    + D   K++DFG ++   +   
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL 186

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 29/161 (18%), Positives = 59/161 (36%), Gaps = 19/161 (11%)

Query: 91  IGKGGSGTVFLGI-ARDGKLLAIK-----RLDTFSLQTEREFQN---ELQILGGLRSPFL 141
           +G G  G V+  +     K + +K     ++       + +      E+ IL  +    +
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 142 VTLLGYCMERNKRILVYE-YMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLH 198
           + +L     +    LV E +     L   +     L    +     +++     A+ +L 
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV----SAVGYLR 147

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
                 +IH DIK  N+++  D   K+ DFG +     G+ 
Sbjct: 148 LKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 42.0 bits (99), Expect = 4e-04
 Identities = 14/39 (35%), Positives = 21/39 (53%), Gaps = 1/39 (2%)

Query: 575 GTLCYVAPE-YGGCGYLMEKADIYSLGVLILVIVSGRRP 612
           GT+ Y APE   G  Y   + +++SLGV +  +V    P
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 34/155 (21%), Positives = 62/155 (40%), Gaps = 17/155 (10%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRS-PFLVTLLGY 147
            +G+G        + +   +  A+K +     + E   Q E+  L      P +V L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEV 74

Query: 148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLHFGCDPPV 205
             ++    LV E +    L E +    +     S+     I+  +  A+  +H   D  V
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHF----SETEASYIMRKLVSAVSHMH---DVGV 127

Query: 206 IHGDIKPSNVLL---DSDCRGKVSDFGLSRIKVEG 237
           +H D+KP N+L    + +   K+ DFG +R+K   
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 50/187 (26%), Positives = 93/187 (49%), Gaps = 33/187 (17%)

Query: 89  NVIGKGGSGTVFLGI-ARDGKLLAIKRL------DTFSLQTEREFQNELQILGGLRS-PF 140
             +GKG  G V+  I  R G+++A+K++       T + +T RE    + IL  L     
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFRE----IMILTELSGHEN 70

Query: 141 LVTLLG-YCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFE------IIMDVAK 192
           +V LL     + ++ + LV++YM          +D + V++ +   E      ++  + K
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYME---------TDLHAVIR-ANILEPVHKQYVVYQLIK 120

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQ 252
            +++LH G    ++H D+KPSN+LL+++C  KV+DFGLSR  V      +     + ++ 
Sbjct: 121 VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 253 ELWKSQE 259
           E +   +
Sbjct: 178 ENFDDDQ 184

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 64.6 bits (158), Expect = 3e-11
 Identities = 40/168 (23%), Positives = 79/168 (47%), Gaps = 30/168 (17%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTERE-F----QNELQILG 134
           + +++   IG+G  G VF   AR    G+ +A+K++    ++ E+E F      E++IL 
Sbjct: 17  SKYEKLAKIGQGTFGEVFK--ARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQ 71

Query: 135 GLRSPFLVTLLGYCMERNKRI--------LVYEYMPN--KSLQEMLFSDGNLVLKWSQRF 184
            L+   +V L+  C  +            LV+++  +    L      +  +    S+  
Sbjct: 72  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIK 127

Query: 185 EIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            ++  +   L ++H      ++H D+K +NVL+  D   K++DFGL+R
Sbjct: 128 RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR 172

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 42/172 (24%), Positives = 74/172 (43%), Gaps = 27/172 (15%)

Query: 82  TNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRL-DTFSLQTE--REFQNELQILGGLR 137
              +     IG G  G V     A   + +AIK+L   F  QT   R ++ EL ++  + 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 82

Query: 138 SPFLVTLL-----GYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLK---WSQRFEIIM 188
              ++ LL        +E  + + +V E M          ++   V++     +R   ++
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMD---------ANLCQVIQMELDHERMSYLL 133

Query: 189 -DVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
             +   ++ LH      +IH D+KPSN+++ SDC  K+ DFGL+R       
Sbjct: 134 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 182

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 63.5 bits (155), Expect = 6e-11
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 18/157 (11%)

Query: 91  IGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQN---ELQILGGLRSPFLVTLLG 146
           +G+G  G V L    +  + +A+K +    L+          E+  L  LR P ++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74

Query: 147 Y-CMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLHFGCD 202
           Y  +     I +V EY     L + +     +     +RF  +II     A+E+ H    
Sbjct: 75  YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQII----CAIEYCHRHK- 128

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
             ++H D+KP N+LLD +   K++DFGLS I  +G F
Sbjct: 129 --IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 63.6 bits (155), Expect = 6e-11
 Identities = 41/206 (19%), Positives = 75/206 (36%), Gaps = 54/206 (26%)

Query: 78  LKNATNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGL 136
           L+ ++  +     +G G  G V        GK  A+K++        RE    L I+  L
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVL 57

Query: 137 RSPFLVTLLGYCMERNKRI--------------------------------------LVY 158
               ++ L+ Y                                              ++ 
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 159 EYMP---NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH-FGCDPPVIHGDIKPSN 214
           EY+P   +K L+  + S  ++ +     +  I  + +A+ F+H  G    + H DIKP N
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIY--IYQLFRAVGFIHSLG----ICHRDIKPQN 171

Query: 215 VLLDS-DCRGKVSDFGLSRIKVEGEF 239
           +L++S D   K+ DFG ++  +  E 
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKLIPSEP 197

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 63.5 bits (155), Expect = 7e-11
 Identities = 36/156 (23%), Positives = 69/156 (44%), Gaps = 15/156 (9%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
            +G+G +  V+    +   K  A+K L       ++  + E+ +L  L  P ++ L    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF--EIIMDVAKALEFLHFGCDPPVI 206
               +  LV E +    L + +   G     +S+R   + +  + +A+ +LH   +  ++
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLH---ENGIV 170

Query: 207 HGDIKPSNVLL---DSDCRGKVSDFGLSRIKVEGEF 239
           H D+KP N+L      D   K++DFGLS+I      
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 63.0 bits (154), Expect = 7e-11
 Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 28/171 (16%)

Query: 81  ATNDFDEANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREFQN--------E 129
           AT+ ++    IG G  GTV+   ARD   G  +A+K +    +                E
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYK--ARDPHSGHFVALKSV---RVPNGGGGGGGLPISTVRE 61

Query: 130 LQILGGLRS---PFLVTLLGYCMERNKRI-----LVYEYMPNKSLQEMLFSDGNLVLKWS 181
           + +L  L +   P +V L+  C            LV+E++ ++ L+  L       L   
Sbjct: 62  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAE 120

Query: 182 QRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
              +++    + L+FLH  C   ++H D+KP N+L+ S    K++DFGL+R
Sbjct: 121 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 63.1 bits (154), Expect = 8e-11
 Identities = 40/167 (23%), Positives = 73/167 (43%), Gaps = 31/167 (18%)

Query: 82  TNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRL-DTFSLQTE--REFQNELQILGGLR 137
              +     +G G  G+V   I  R G+ +AIK+L   F  +    R ++ EL +L  ++
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQ 81

Query: 138 SPFLVTLL-----GYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFE------ 185
              ++ LL        +       LV  +M          +D   ++    +F       
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPFMQ---------TDLQKIMG--LKFSEEKIQY 130

Query: 186 IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           ++  + K L+++H      V+H D+KP N+ ++ DC  K+ DFGL+R
Sbjct: 131 LVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 174

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 63.0 bits (154), Expect = 8e-11
 Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 22/165 (13%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD----GKLLAIK--RLDT----FSLQTEREFQNELQI 132
             ++    IG+G  G VF   ARD    G+ +A+K  R+ T      L T RE    L+ 
Sbjct: 11  QQYECVAEIGEGAYGKVFK--ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRH 67

Query: 133 LGGLRSPFLVTLL----GYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEII 187
           L     P +V L         +R  ++ LV+E++ ++ L   L       +      +++
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 126

Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
             + + L+FLH      V+H D+KP N+L+ S  + K++DFGL+R
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 63.7 bits (155), Expect = 9e-11
 Identities = 34/160 (21%), Positives = 75/160 (46%), Gaps = 24/160 (15%)

Query: 91  IGKGGSGTVFLGIARD---GKLLAIKRL--DTFSLQTEREFQNELQILGGLRSPFLVTLL 145
           +G+G  G V+    +D    K  A+K++     S+   RE    + +L  L+ P +++L 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 84

Query: 146 GYCMER-NKRI-LVYEYMPN------KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
              +   ++++ L+++Y  +      K  +    +   + L       ++  +   + +L
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 198 HFGCDPPVIHGDIKPSNVLLDSDC--RG--KVSDFGLSRI 233
           H      V+H D+KP+N+L+  +   RG  K++D G +R+
Sbjct: 145 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 41/170 (24%), Positives = 70/170 (41%), Gaps = 43/170 (25%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRL----DTFSLQTEREFQNELQILGGLRSPFLVTL 144
            +G GG+G VF  +     K +AIK++            RE    ++I+  L    +V +
Sbjct: 18  PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE----IKIIRRLDHDNIVKV 73

Query: 145 L--------------GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFE----- 185
                          G   E N   +V EYM          +D   VL+           
Sbjct: 74  FEILGPSGSQLTDDVGSLTELNSVYIVQEYME---------TDLANVLE-QGPLLEEHAR 123

Query: 186 -IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS-DCRGKVSDFGLSRI 233
             +  + + L+++H      V+H D+KP+N+ +++ D   K+ DFGL+RI
Sbjct: 124 LFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARI 170

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 41/188 (21%), Positives = 87/188 (46%), Gaps = 25/188 (13%)

Query: 63  DSNAPLKLQRFTYKELKNA---TNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTF 118
           D N     + + Y+         +D+     +G+G    VF  I   + + + +K L   
Sbjct: 13  DVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV 72

Query: 119 SLQ-TEREFQNELQILGGLRS-PFLVTLLGYCMERNKR--ILVYEYMPNKSLQEML--FS 172
             +  +RE    ++IL  LR  P ++TL     +   R   LV+E++ N   +++    +
Sbjct: 73  KKKKIKRE----IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT 128

Query: 173 DGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD-CRGKVSDFGLS 231
           D ++     + +  + ++ KAL++ H      ++H D+KP NV++D +  + ++ D+GL+
Sbjct: 129 DYDI-----RFY--MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLA 178

Query: 232 RIKVEGEF 239
                G+ 
Sbjct: 179 EFYHPGQE 186

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 41/170 (24%), Positives = 76/170 (44%), Gaps = 36/170 (21%)

Query: 82  TNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLD------TFSLQTEREFQNELQILG 134
              +   + +G G  G+V      + G  +A+K+L         + +T RE    L++L 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE----LRLLK 83

Query: 135 GLRSPFLVTLL-----GYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFE--- 185
            ++   ++ LL        +E    + LV   M          +D N ++K  Q+     
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG---------ADLNNIVK-CQKLTDDH 133

Query: 186 ---IIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
              +I  + + L+++H      +IH D+KPSN+ ++ DC  K+ DFGL+R
Sbjct: 134 VQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.2 bits (150), Expect = 5e-10
 Identities = 70/362 (19%), Positives = 122/362 (33%), Gaps = 85/362 (23%)

Query: 1   MPSRPLSPSSYNNLAK-PSFVNKTRVLF-LILTISSSVVIVF--TFL---Y-FLYHLW-- 50
           MP   LS    +++      V+ T  LF  +L+    +V  F    L   Y FL      
Sbjct: 41  MPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKT 100

Query: 51  --------YNLVNRSRTIPFDSN---APLKLQRF-TYKELKNA-TNDFDEANVI--GKGG 95
                     +    R   ++ N   A   + R   Y +L+ A        NV+  G  G
Sbjct: 101 EQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG 160

Query: 96  SG-TVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQI----LGGLRSP-----FLVTLL 145
           SG T           +A+    ++ +Q + +F    +I    L    SP      L  LL
Sbjct: 161 SGKTW----------VALDVCLSYKVQCKMDF----KIFWLNLKNCNSPETVLEMLQKLL 206

Query: 146 GYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFE---IIMD-V--AKALEFLHF 199
            Y ++ N      ++  N  L+          L  S+ +E   +++  V  AKA    + 
Sbjct: 207 -YQIDPNWTSRS-DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNL 264

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLG-KSQELWKSQ 258
            C   +     + ++  L +     +S    S      E    L  + L  + Q+L   +
Sbjct: 265 SCKILLTTRFKQVTDF-LSAATTTHISLDHHSMTLTPDE-VKSLLLKYLDCRPQDL-PRE 321

Query: 259 ELSGNLATATETP-AISTPVDSAHEVDFALALQ-ASSSSNNSRCYNVRALN------LNS 310
            L+ N       P  +S           A +++   ++ +N +  N   L       LN 
Sbjct: 322 VLTTN-------PRRLSI---------IAESIRDGLATWDNWKHVNCDKLTTIIESSLNV 365

Query: 311 LN 312
           L 
Sbjct: 366 LE 367

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.5 bits (130), Expect = 1e-07
 Identities = 87/600 (14%), Positives = 167/600 (27%), Gaps = 157/600 (26%)

Query: 62  FDSNAPLKLQRFTYKEL-----KNATNDFD-------EANVIGKGGSGTVFLGIARDGKL 109
           F++       ++ YK++         ++FD         +++ K     + +        
Sbjct: 9   FETGE----HQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGT 64

Query: 110 LAIKRLDTFSLQTEREFQNELQILGGLRS--PFLVTLLGY-CMERNKRILVYEYMPNKSL 166
           L +    T   + E   Q  ++    LR    FL++ +     + +    +Y    ++  
Sbjct: 65  LRL--FWTLLSKQEEMVQKFVE--EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR-- 118

Query: 167 QEMLFSDGNLVLKWS-QRFEIIMDVAKALEFLHFGCDPP---VIHGDI---KPSNVLLDS 219
              L++D  +  K++  R +  + + +AL  L     P    +I G +   K    +   
Sbjct: 119 ---LYNDNQVFAKYNVSRLQPYLKLRQALLEL----RPAKNVLIDGVLGSGK--TWVALD 169

Query: 220 DCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQE----LWKSQELSGNLATATETPAIST 275
            C      +     KV+ +    +F  +L         L   Q+L            I  
Sbjct: 170 VCL----SY-----KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ---------IDP 211

Query: 276 PVDSAHEVDFALALQASSSSNNSRCYNVRALNLNSLNYNANIASESEVKSGNGKGKE-VS 334
              S  +    + L+  S     R         N L    N+ +     + N   K  ++
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLT 271

Query: 335 GVDLGAVDWTSKFVAYEDELSSVDHSKELNVNANSVNDEAASTKQWGKDWWWRQDGSGEL 394
                  D+ S   A    +S   HS  L        DE                    L
Sbjct: 272 TRFKQVTDFLS--AATTTHISLDHHSMTLT------PDEVK-----------------SL 306

Query: 395 CSKDYVMEWIG-------SQICPSTNP-----------D----WDEEKKSTNEKIELDNS 432
             K     ++         ++  +TNP           D    WD  K    +K+     
Sbjct: 307 LLK-----YLDCRPQDLPREVL-TTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIE 360

Query: 433 TPLDNLE-DGHEPQLQELGFGKLEKGFEKKESKWKKNRKKRHKKMQEWW---KEEHLDEI 488
           + L+ LE   +      L        F         +       +   W    +  +  +
Sbjct: 361 SSLNVLEPAEYRKMFDRLSV------FP-------PSAHIPTILLSLIWFDVIKSDVMVV 407

Query: 489 SKKSSKLKKLETKWKKGFKIPHFDLARRFHF--------HRR-----NKFREQNQDDCDA 535
             K  K   L  K  K   I    +              HR      N  +  + DD   
Sbjct: 408 VNKLHK-YSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIP 466

Query: 536 NGE----FSFRRGWRKKNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLM 591
                  +S   G   KN      +     LF         +   + + +  +   G ++
Sbjct: 467 PYLDQYFYSH-IGHHLKNIEH--PERM--TLFRMVFLDFRFLEQKIRHDSTAWNASGSIL 521

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 60.9 bits (148), Expect = 5e-10
 Identities = 36/165 (21%), Positives = 67/165 (40%), Gaps = 31/165 (18%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRS-PFLVTLLGY 147
           V+G G +G V     +   +  A+K      LQ   + + E+++       P +V ++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDV 123

Query: 148 C----MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRF------EIIMDVAKALEFL 197
                  R   ++V E +    L    FS   +  +  Q F      EI+  + +A+++L
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FSR--IQDRGDQAFTEREASEIMKSIGEAIQYL 177

Query: 198 HF-GCDPPVIHGDIKPSNVLLDSDCRG---KVSDFGLSRIKVEGE 238
           H       + H D+KP N+L  S       K++DFG ++      
Sbjct: 178 HSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 60.3 bits (145), Expect = 8e-10
 Identities = 38/250 (15%), Positives = 68/250 (27%), Gaps = 61/250 (24%)

Query: 53  LVNRSRTIPFDSNAPLKLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAI 112
             ++   +PF    P              T        IG+G  G VF  IA D   +AI
Sbjct: 4   ECSQKGPVPFSHCLP--------------TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAI 48

Query: 113 KRL--------DTFSLQTEREFQNELQILGGL---------RSPFLVTLLGYCMERNKR- 154
           K +        +    +T  E   E+ I   L         R+   + L      +    
Sbjct: 49  KIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYP 108

Query: 155 ---ILVYEYMPNKSLQE---------------MLFSDGNLVLK--------WSQRFEIIM 188
              +  +++  +                    + F  G + L+         +    I+ 
Sbjct: 109 PLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILH 168

Query: 189 DVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDL 248
            +  +L            H D+   NVLL      K+      +       G+ +   D 
Sbjct: 169 QLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDY 226

Query: 249 GKSQELWKSQ 258
             S+      
Sbjct: 227 TLSRLERDGI 236

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 24/116 (20%), Positives = 46/116 (39%), Gaps = 4/116 (3%)

Query: 119 SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD-GNLV 177
           S         +++ +    +   V  L     +    +  +    ++L++ +        
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160

Query: 178 LKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            +      I + +A+A+EFLH      ++H D+KPSN+    D   KV DFGL   
Sbjct: 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 25/124 (20%), Positives = 50/124 (40%), Gaps = 26/124 (20%)

Query: 564 SRELSSTTSMRGTLCYVAPE-YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKL 622
               ++ T   GT  Y++PE   G  Y   K DI+SLG+++  +      L+  ++ M  
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIHGNNYS-HKVDIFSLGLILFEL------LYSFSTQM-- 277

Query: 623 EKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETV 682
           E+  +I+         ++  L    L      ++  +        L  +P  RP+  +  
Sbjct: 278 ERVRIIT---------DVRNLKFPLLFTQKYPQEHMMV----QDMLSPSPTERPEATD-- 322

Query: 683 RILK 686
            I++
Sbjct: 323 -IIE 325

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 44.9 bits (106), Expect = 6e-05
 Identities = 23/89 (25%), Positives = 34/89 (38%), Gaps = 2/89 (2%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTERE-FQNELQILGGLRSPF 140
            DF+    +G+GG G VF    + D    AIKR+   + +  RE    E++ L  L  P 
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEM 169
           +V      +E        E        E 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDES 94

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 35/161 (21%), Positives = 64/161 (39%), Gaps = 39/161 (24%)

Query: 90  VIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRS-PFLVTLLGY 147
           V+G G +G V     +   +  A+K      LQ   + + E+++       P +V ++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDV 79

Query: 148 C----MERNKRILVYEYMPNKSLQEMLFSDGNL----VLKWSQRF------EIIMDVAKA 193
                  R   ++V E +            G L      +  Q F      EI+  + +A
Sbjct: 80  YENLYAGRKCLLIVMECL----------DGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129

Query: 194 LEFLHF-GCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGL 230
           +++LH       + H D+KP N+L  S   +   K++DFG 
Sbjct: 130 IQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGF 166

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 50.8 bits (122), Expect = 6e-07
 Identities = 38/149 (25%), Positives = 65/149 (43%), Gaps = 16/149 (10%)

Query: 91  IGKGGSGTVFLGI-ARDGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G ++LG     G+ +AIK   + T   Q   E +   +++ G     + T+   
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI-YKMMQG--GVGIPTIRWC 73

Query: 148 CMERNKRILVYEYMPNKSLQEML-FSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVI 206
             E +  ++V E +   SL+++  F      LK        M     +E++H       I
Sbjct: 74  GAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQM--ISRIEYIH---SKNFI 127

Query: 207 HGDIKPSNVLLDSDCRGK---VSDFGLSR 232
           H D+KP N L+    +G    + DFGL++
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 51.2 bits (123), Expect = 8e-07
 Identities = 31/159 (19%), Positives = 63/159 (39%), Gaps = 18/159 (11%)

Query: 87  EANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLG 146
           EA++          +   R  K    +RLD  +++  R    E + L  ++   +     
Sbjct: 349 EADIKRDSYLDFDVIIKERVKKGYRDERLDE-NIRKSRT-AREARYLALVKDFGIPAPYI 406

Query: 147 YCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVI 206
           + ++ + + ++  Y+  K  ++++              +I   + + +  LH      VI
Sbjct: 407 FDVDLDNKRIMMSYINGKLAKDVI----------EDNLDIAYKIGEIVGKLH---KNDVI 453

Query: 207 HGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE-FGMDLF 244
           H D+  SN + D D    + DFGL +I    E   +DL 
Sbjct: 454 HNDLTTSNFIFDKDL--YIIDFGLGKISNLDEDKAVDLI 490

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 24/156 (15%)

Query: 90  VIGKGGSGTVFLGIARD---GKLLAIKRL---DTFSLQTEREFQNELQILGGLR------ 137
           VIGKG  G V    A D    + +A+K +     F  Q       E++IL  LR      
Sbjct: 104 VIGKGSFGQVVK--AYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDN 157

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
           +  ++ +L     RN   + +E + + +L E++  +           +    + + L+ L
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216

Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRG--KVSDFGLS 231
           H      +IH D+KP N+LL    R   KV DFG S
Sbjct: 217 H---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 33/169 (19%), Positives = 69/169 (40%), Gaps = 36/169 (21%)

Query: 90  VIGKGGSGTVFLGIARD---GKLLAIKRL---DTFSLQTEREFQNELQILGGLRSP---- 139
            +G G   TV+L  A+D      +A+K +     ++   E E    +++L  +       
Sbjct: 26  KLGWGHFSTVWL--AKDMVNNTHVAMKIVRGDKVYTEAAEDE----IKLLQRVNDADNTK 79

Query: 140 -------FLVTLLGYCMERNKRI----LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM 188
                   ++ LL +   +        +V+E +  ++L  ++    +  +      +I  
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISK 138

Query: 189 DVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG------KVSDFGLS 231
            +   L+++H  C   +IH DIKP NVL++           K++D G +
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 34/163 (20%), Positives = 65/163 (39%), Gaps = 27/163 (16%)

Query: 91  IGKGGSGTVFLGIARDG------KLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTL 144
           IG GG G ++L    +        ++ ++  +   L +E +F   +     ++       
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 145 LGY-------------CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVA 191
           L Y                R+ R +V E +    LQ++   +G          ++ + + 
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTV--LQLGIRML 161

Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKV--SDFGLSR 232
             LE++H       +HGDIK +N+LL      +V  +D+GLS 
Sbjct: 162 DVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 47.6 bits (113), Expect = 9e-06
 Identities = 39/152 (25%), Positives = 64/152 (42%), Gaps = 35/152 (23%)

Query: 91  IGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTEREFQNELQILGGLRS--------P 139
           +G G   TV+L  + D    K +A+K + +    TE    +E+++L  +R+         
Sbjct: 45  LGWGHFSTVWL--SWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNRE 101

Query: 140 FLVTLLGY-----------CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIM 188
            +V LL             CM       V+E +    L + +       L      +II 
Sbjct: 102 MVVQLLDDFKISGVNGTHICM-------VFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQ 153

Query: 189 DVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD 220
            V + L++LH  C   +IH DIKP N+LL  +
Sbjct: 154 QVLQGLDYLHTKCR--IIHTDIKPENILLSVN 183

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 31/164 (18%), Positives = 63/164 (38%), Gaps = 26/164 (15%)

Query: 91  IGKGGSGTVFLGI---------ARDGKLLAIK------RLDTFSLQTEREFQ----NELQ 131
             +   G ++                +  ++K      RL       +R  +    N+ +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 132 ILGGLRSPFLVTLLGYCMERNK-RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDV 190
            L       + T +G+ + ++K R LV   +  +SLQ  L      VL      ++   +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRL 168

Query: 191 AKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKV--SDFGLSR 232
             ALEFLH       +HG++   N+ +D + + +V  + +G + 
Sbjct: 169 LDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 32/151 (21%), Positives = 63/151 (41%), Gaps = 18/151 (11%)

Query: 91  IGKGGSGTVFLGI-ARDGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG+G  G +F G    + + +AIK     + + Q   E++   ++L G     +  +  +
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-YKLLAG--CTGIPNVYYF 74

Query: 148 CMERNKRILVYEYMPNKSLQEML-FSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVI 206
             E    +LV + +   SL+++L        +K        M     ++ +H   +  ++
Sbjct: 75  GQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSVKTVAMAAKQM--LARVQSIH---EKSLV 128

Query: 207 HGDIKPSNVLLDSDCRGK-----VSDFGLSR 232
           + DIKP N L+            V DFG+ +
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 34/161 (21%)

Query: 89  NVIGKGGSGTVFLGIARD---GKLLAIK---RLDTFSLQTEREFQNELQILGGLRSP--- 139
           ++IGKG  G V    A D    + +AIK       F  Q     Q E+++L  +      
Sbjct: 60  SLIGKGSFGQVVK--AYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTE 113

Query: 140 ---FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDG------NLVLKWSQRFEIIMDV 190
              ++V L  + M RN   LV+E + + +L ++L +        NL  K++Q+      +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQ------M 166

Query: 191 AKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG--KVSDFG 229
             AL FL    +  +IH D+KP N+LL +  R   K+ DFG
Sbjct: 167 CTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 32/165 (19%), Positives = 60/165 (36%), Gaps = 28/165 (16%)

Query: 91  IGKGGSGTVFLGIARDGKLLAIKRL--------DTFSLQTEREFQNELQILGGLRSPFLV 142
           IG+GG G ++L      + +             D   L TE +F         ++     
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 143 TLLGY-------------CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMD 189
             L Y                ++ R ++ +      LQ+ ++             ++ + 
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAKRFSRKTVLQLSLR 160

Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKV--SDFGLSR 232
           +   LE++H       +HGDIK SN+LL+     +V   D+GL+ 
Sbjct: 161 ILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 32/151 (21%), Positives = 59/151 (39%), Gaps = 18/151 (11%)

Query: 91  IGKGGSGTVFLGI-ARDGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G + LG      + +AIK   + + + Q   E++   + LG      +  +  +
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYR-FYKQLGS--GDGIPQVYYF 73

Query: 148 CMERNKRILVYEYMPNKSLQEML-FSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVI 206
                   +V E +   SL+++    D    LK      I +     +E++H      +I
Sbjct: 74  GPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQL--ISRMEYVH---SKNLI 127

Query: 207 HGDIKPSNVLLDSDCRGKVS-----DFGLSR 232
           + D+KP N L+              DF L++
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 33/153 (21%), Positives = 54/153 (35%), Gaps = 18/153 (11%)

Query: 89  NVIGKGGSGTVFLGIA------RDGKLLAIKRL-DTFSLQTEREFQNELQILGGLRS-PF 140
             +G+G  G V    A         + +A+K L +  +    R   +EL+IL  +     
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 141 LVTLLGYCMERNKRILV-YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
           +V LLG C +    ++V  E+    +L   L          S+R E +    K   F   
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL---------RSKRNEFVPYKTKGARFRQG 138

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                 I  D+K     + S      S F   +
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 22/109 (20%), Positives = 40/109 (36%), Gaps = 3/109 (2%)

Query: 124 REFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQR 183
           R+ ++ +  +       L ++       +   +  + + +   +E         L     
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195

Query: 184 FEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                 VAK +EFL        IH D+   N+LL      K+ DFGL+R
Sbjct: 196 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 16/149 (10%)

Query: 91  IGKGGSGTVFLGI-ARDGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPFLVTLLGY 147
           IG G  G ++LG   +  + +AIK   + T   Q   E +   +IL G     +  +  +
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK-IYRILQG--GTGIPNVRWF 71

Query: 148 CMERNKRILVYEYMPNKSLQEML-FSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVI 206
            +E +  +LV + +   SL+++  F    L LK        M     +EF+H       +
Sbjct: 72  GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM--INRVEFVHSKS---FL 125

Query: 207 HGDIKPSNVLLDSDCRGK---VSDFGLSR 232
           H DIKP N L+    R     + DFGL++
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	718
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.77
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.61
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.19
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.96
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.57
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.42
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.36
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.35
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.33
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.1
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.03
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.92
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.79
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.44
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.42
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.39
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.06
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.0
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.87
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.74
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.64
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.35
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.3
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.09
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.48
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.69
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.03
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	90.76
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.69
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	87.83

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.2e-54  Score=467.06  Aligned_cols=149  Identities=30%  Similarity=0.460  Sum_probs=132.5

Q ss_pred             cCccccceecccCceEEEEEEEc------CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      ++|.+.+.||+|+||+||+|.++      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..||
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            46778899999999999999864      478999999987777777889999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCE
Q 005033          157 VYEYMPNKSLQEMLFSDGN-------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG  223 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~-------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~v  223 (718)
                      |||||++|+|.++|+....             ..+++.+++.|+.||+.||.|||   +++||||||||+||||+.++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            9999999999999976431             35899999999999999999999   8999999999999999999999


Q ss_pred             EEeeccCceee
Q 005033          224 KVSDFGLSRIK  234 (718)
Q Consensus       224 KLsDFGLAr~~  234 (718)
                      ||+|||+|+..
T Consensus       198 Ki~DFGla~~~  208 (329)
T 4aoj_A          198 KIGDFGMSRDI  208 (329)
T ss_dssp             EECCCC-----
T ss_pred             EEcccccceec
Confidence            99999999864

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7e-55  Score=463.20  Aligned_cols=149  Identities=30%  Similarity=0.497  Sum_probs=135.0

Q ss_pred             cCccccceecccCceEEEEEEEc------CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      ++|.+.+.||+|+||+||+|.+.      ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..||
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            57888999999999999999864      477899999987777777889999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEE
Q 005033          157 VYEYMPNKSLQEMLFSDG-----------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKV  225 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~-----------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKL  225 (718)
                      |||||++|+|.++|+..+           ...+++.+++.|+.||+.||.|||   +++||||||||+||||+.++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            999999999999997643           246899999999999999999999   899999999999999999999999


Q ss_pred             eeccCceee
Q 005033          226 SDFGLSRIK  234 (718)
Q Consensus       226 sDFGLAr~~  234 (718)
                      +|||+|+..
T Consensus       170 ~DFGla~~~  178 (299)
T 4asz_A          170 GDFGMSRDV  178 (299)
T ss_dssp             CCCSCHHHH
T ss_pred             CCcccceec
Confidence            999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.9e-54  Score=457.84  Aligned_cols=149  Identities=25%  Similarity=0.373  Sum_probs=131.5

Q ss_pred             cCccccceecccCceEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~  155 (718)
                      .++++.+.||+|+||+||+|.+.      +++.||||+++... ....++|.+|+.+|++++|||||+++|+|..++..|
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34667889999999999999863      46799999996532 334578999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC
Q 005033          156 LVYEYMPNKSLQEMLFSDG--------------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC  221 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~--------------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~  221 (718)
                      ||||||++|||.++|....              ...+++..++.|+.|||.||.|||   +++||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence            9999999999999997542              135899999999999999999999   89999999999999999999


Q ss_pred             CEEEeeccCceee
Q 005033          222 RGKVSDFGLSRIK  234 (718)
Q Consensus       222 ~vKLsDFGLAr~~  234 (718)
                      .+||+|||+|+..
T Consensus       183 ~~Ki~DFGlar~~  195 (308)
T 4gt4_A          183 NVKISDLGLFREV  195 (308)
T ss_dssp             CEEECCSCCBCGG
T ss_pred             CEEECCcccceec
Confidence            9999999999864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.2e-53  Score=461.05  Aligned_cols=149  Identities=23%  Similarity=0.423  Sum_probs=131.9

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ++|++++.||+|+||+||+|++. +|+.||||++...  .....+.|.+|+.+|++|+|||||++++++.+++..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999986 6999999999643  33445789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+||+|.++|...+...+++..++.|+.||+.||.|||   +++||||||||+||||+.++.+||+|||+|+..
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  175 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL  175 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceee
Confidence            999999999998776667899999999999999999999   999999999999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-52  Score=447.71  Aligned_cols=146  Identities=26%  Similarity=0.441  Sum_probs=129.9

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .++|.+.+.||+|+||+||+|.+.  ..||||+++..  .....+.|.+|+.+|++++|||||+++|+|.. +..|||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            467788899999999999999875  36999998643  34456789999999999999999999999865 56899999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+||+|.++|..... .+++..++.|+.|||.||.|||   +++||||||||+||||+.++.+||+|||+|+..
T Consensus       112 y~~gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          112 WCEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             CCSSCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             cCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            9999999999976543 6899999999999999999999   899999999999999999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.5e-52  Score=448.87  Aligned_cols=146  Identities=29%  Similarity=0.431  Sum_probs=135.3

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      ..|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56999999999999999999987 69999999997554445567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +||+|.+++...   .+++..+..|+.||+.||.|||   +++||||||||+||||+.+|.+||+|||+|+..
T Consensus       154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  220 (346)
T 4fih_A          154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV  220 (346)
T ss_dssp             TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceec
Confidence            999999999764   5899999999999999999999   999999999999999999999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.7e-52  Score=448.40  Aligned_cols=143  Identities=28%  Similarity=0.361  Sum_probs=130.6

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      .+.|.+.+.||+|+||.||+|++. +|+.||||+++...     .+.+|+.+|+.++|||||+++++|.+++..||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            356888899999999999999987 69999999996532     135799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC-CEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC-RGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~-~vKLsDFGLAr~~  234 (718)
                      |+||+|.++|...+  .+++..+..|+.||+.||.|||   +++||||||||+||||+.+| .+||+|||+|+..
T Consensus       132 ~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~  201 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCL  201 (336)
T ss_dssp             CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred             cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence            99999999998765  5899999999999999999999   99999999999999999988 6999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.7e-52  Score=447.35  Aligned_cols=147  Identities=27%  Similarity=0.396  Sum_probs=135.5

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||+||+|++. +|+.||||++....   ....+.+.+|+++|+.++|||||+++++|.+.+..||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999986 69999999996432   233567999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+||+|.++|...+  .+++..+..++.||+.||.|||   +++||||||||+||||+.++.+||+|||+|+.+
T Consensus       112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~  182 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL  182 (311)
T ss_dssp             CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence            9999999999998765  5899999999999999999999   999999999999999999999999999999875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-51  Score=436.21  Aligned_cols=143  Identities=26%  Similarity=0.370  Sum_probs=126.9

Q ss_pred             cccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEee----CCeEEEEE
Q 005033           86 DEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCME----RNKRILVY  158 (718)
Q Consensus        86 ~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~~LVm  158 (718)
                      ++.+.||+|+||+||+|.+. +++.||||++...  .....+.|.+|+.+|++|+|||||+++++|..    .+.+||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            56678999999999999987 5899999998543  33445679999999999999999999999875    35689999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEECC-CCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP--VIHGDIKPSNVLLDS-DCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~g--IVHRDLKP~NILLd~-~~~vKLsDFGLAr~  233 (718)
                      |||+||+|.++|...+  .+++..+..|+.||+.||.|||   +++  ||||||||+||||+. ++.+||+|||+|+.
T Consensus       109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            9999999999998754  6899999999999999999999   776  999999999999974 79999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.5e-51  Score=451.64  Aligned_cols=146  Identities=29%  Similarity=0.431  Sum_probs=135.8

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      +.|++.+.||+|+||.||+|.+. +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999987 69999999997655555567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +||+|.+++...   .+++..+..|+.||+.||.|||   +++||||||||+||||+.+|.+||+|||+|+.+
T Consensus       231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~  297 (423)
T 4fie_A          231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV  297 (423)
T ss_dssp             TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred             CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceEC
Confidence            999999999765   5899999999999999999999   999999999999999999999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.3e-51  Score=431.60  Aligned_cols=146  Identities=25%  Similarity=0.461  Sum_probs=127.6

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++....   ......+.+|+.+|+.++|||||++++++.+.+..||||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999986 69999999996532   233467999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||| +|+|.+++...+  .+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  162 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM  162 (275)
T ss_dssp             ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred             eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeec
Confidence            999 789999998765  5899999999999999999999   999999999999999999999999999999763

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.1e-50  Score=428.37  Aligned_cols=147  Identities=22%  Similarity=0.281  Sum_probs=125.0

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC----eEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERN----KRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~----~~~LVm  158 (718)
                      .+|.+.+.||+|+||+||+|.+ +|+.||||++..... ....+..|+..+.+++|||||+++|+|...+    ..||||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4577889999999999999988 589999999965322 1222344566667899999999999998764    579999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG-----CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~-----~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |||++|+|.++|+..   .+++..++.++.|++.||+|||..     ..++||||||||+||||+.++++||+|||+|+.
T Consensus        81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            999999999999875   589999999999999999999932     134999999999999999999999999999987


Q ss_pred             e
Q 005033          234 K  234 (718)
Q Consensus       234 ~  234 (718)
                      .
T Consensus       158 ~  158 (303)
T 3hmm_A          158 H  158 (303)
T ss_dssp             E
T ss_pred             c
Confidence            5

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.8e-51  Score=445.18  Aligned_cols=159  Identities=26%  Similarity=0.346  Sum_probs=137.2

Q ss_pred             ccHHHHHHHhcCccccceecccCceEEEEEEEcC------CcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCC-CcceeE
Q 005033           73 FTYKELKNATNDFDEANVIGKGGSGTVFLGIARD------GKLLAIKRLDTFS-LQTEREFQNELQILGGLRS-PFLVTL  144 (718)
Q Consensus        73 ~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~~------g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~H-pNIV~L  144 (718)
                      +...+++...++|++.+.||+|+||+||+|.+..      ++.||||++.... ....+.|.+|+.+|.++.| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            3344556667899999999999999999998752      3689999997543 3445679999999999965 899999


Q ss_pred             EEEEeeC-CeEEEEEeccCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 005033          145 LGYCMER-NKRILVYEYMPNKSLQEMLFSDG--------------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD  209 (718)
Q Consensus       145 ~g~~~~~-~~~~LVmEy~~gGsL~~~L~~~~--------------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRD  209 (718)
                      +|+|... +..|||||||++|+|.++|+...              ...+++..++.|+.|||.||.|||   +++|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCc
Confidence            9999764 56899999999999999997642              235899999999999999999999   89999999


Q ss_pred             CCCCCEEECCCCCEEEeeccCceee
Q 005033          210 IKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       210 LKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+|||++.++.+||+|||+|+..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~  235 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDI  235 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCT
T ss_pred             cCccceeeCCCCCEEECcchhhhhc
Confidence            9999999999999999999999864

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.6e-51  Score=438.56  Aligned_cols=147  Identities=29%  Similarity=0.403  Sum_probs=127.3

Q ss_pred             cCccccceecccCceEEEEEEEc----CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR----DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~----~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      ++|++.+.||+|+||+||+|+..    +++.||||+++...  ......+.+|+.+|++++|||||++++++.+++..||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999873    47899999996432  1223468899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||||+||+|.++|...+  .+++..+..++.||+.||.|||   +++||||||||+|||++.++.+||+|||+|+..
T Consensus       104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            999999999999998765  5899999999999999999999   999999999999999999999999999999863

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.9e-49  Score=421.11  Aligned_cols=149  Identities=28%  Similarity=0.446  Sum_probs=127.6

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC--------
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERN--------  152 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~--------  152 (718)
                      ++|++++.||+|+||+||+|.+. +|+.||||++.... ....+.+.+|+.+|++|+|||||+++++|...+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46999999999999999999986 69999999996533 344567999999999999999999999997654        


Q ss_pred             ----eEEEEEeccCCCCHHHHHhhCCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEee
Q 005033          153 ----KRILVYEYMPNKSLQEMLFSDGNL-VLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSD  227 (718)
Q Consensus       153 ----~~~LVmEy~~gGsL~~~L~~~~~~-~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsD  227 (718)
                          ..|||||||++|+|.+++...... ..++..++.|+.||+.||.|||   +++||||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                369999999999999999876542 3456778899999999999999   89999999999999999999999999


Q ss_pred             ccCceee
Q 005033          228 FGLSRIK  234 (718)
Q Consensus       228 FGLAr~~  234 (718)
                      ||+|+..
T Consensus       162 FGla~~~  168 (299)
T 4g31_A          162 FGLVTAM  168 (299)
T ss_dssp             CCCC---
T ss_pred             Cccceec
Confidence            9999876

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.3e-47  Score=417.05  Aligned_cols=146  Identities=25%  Similarity=0.464  Sum_probs=131.2

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEee------CCe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCME------RNK  153 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~------~~~  153 (718)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++...  .....+.+.+|+.+|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999986 6999999999653  23445678999999999999999999999864      357


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +||||||| +|+|.+++...+  .+++..+..|+.||+.||.|||   +++||||||||+|||++.++.+||+|||+|+.
T Consensus       134 ~~ivmE~~-~g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLM-ESDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECC-SEEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEeCC-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence            89999999 578999997654  6899999999999999999999   99999999999999999999999999999986


Q ss_pred             e
Q 005033          234 K  234 (718)
Q Consensus       234 ~  234 (718)
                      +
T Consensus       208 ~  208 (398)
T 4b99_A          208 L  208 (398)
T ss_dssp             C
T ss_pred             c
Confidence            4

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.4e-46  Score=408.94  Aligned_cols=149  Identities=24%  Similarity=0.359  Sum_probs=132.9

Q ss_pred             HHHHHHhcCccccceecccCceEEEEEEEc----CCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEEee
Q 005033           76 KELKNATNDFDEANVIGKGGSGTVFLGIAR----DGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCME  150 (718)
Q Consensus        76 ~el~~at~~f~~~~~LG~G~FG~Vykg~~~----~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~  150 (718)
                      +.+....+.|++.+.||+|+||+||+|+++    +++.||||++....  ....+.+|+++|..+ +|||||+++++|.+
T Consensus        14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            344456688999999999999999999864    46799999986533  345688999999988 69999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC-CCEEEeecc
Q 005033          151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD-CRGKVSDFG  229 (718)
Q Consensus       151 ~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~-~~vKLsDFG  229 (718)
                      .++.|||||||++|+|.+++.     .+++..+..++.||+.||.|||   +++||||||||+|||++.+ +.+||+|||
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            999999999999999999994     4788999999999999999999   9999999999999999876 799999999


Q ss_pred             Cceee
Q 005033          230 LSRIK  234 (718)
Q Consensus       230 LAr~~  234 (718)
                      +|+..
T Consensus       164 la~~~  168 (361)
T 4f9c_A          164 LAQGT  168 (361)
T ss_dssp             TCEEC
T ss_pred             CCccc
Confidence            99975

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.4e-46  Score=396.25  Aligned_cols=166  Identities=38%  Similarity=0.708  Sum_probs=146.1

Q ss_pred             ccccccHHHHHHHhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCCh-hhHHHHHHHHHHHhCCCCCcceeEEEE
Q 005033           69 KLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL-QTEREFQNELQILGGLRSPFLVTLLGY  147 (718)
Q Consensus        69 ~l~~~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~  147 (718)
                      ....+++.++....++|++.+.||+|+||.||+|...+|+.||||++..... .....+.+|+.+++.++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            3567899999999999999999999999999999988899999999965332 222368999999999999999999999


Q ss_pred             EeeCCeEEEEEeccCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEE
Q 005033          148 CMERNKRILVYEYMPNKSLQEMLFSDGN--LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKV  225 (718)
Q Consensus       148 ~~~~~~~~LVmEy~~gGsL~~~L~~~~~--~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKL  225 (718)
                      +...+..++||||+++|+|.+++.....  ..+++..+..++.||+.||.|||..+..+|+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            9999999999999999999999986542  35899999999999999999999322239999999999999999999999


Q ss_pred             eeccCceee
Q 005033          226 SDFGLSRIK  234 (718)
Q Consensus       226 sDFGLAr~~  234 (718)
                      +|||+++..
T Consensus       176 ~Dfg~~~~~  184 (326)
T 3uim_A          176 GDFGLAKLM  184 (326)
T ss_dssp             CCCSSCEEC
T ss_pred             ccCcccccc
Confidence            999999864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2e-46  Score=430.73  Aligned_cols=149  Identities=27%  Similarity=0.405  Sum_probs=136.7

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      .++|++.+.||+|+||.||+|.++ +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+||||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            368999999999999999999987 6999999999776666677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC--CCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD--CRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~--~~vKLsDFGLAr~~  234 (718)
                      |+||+|.++|..... .+++..+..++.||+.||.|||   +++|+||||||+|||++.+  +.+||+|||+|+.+
T Consensus       236 ~~gg~L~~~i~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          236 MSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             CCCCBHHHHHTCTTS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             cCCCcHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            999999999965432 5899999999999999999999   9999999999999999854  89999999999874

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.8e-46  Score=394.18  Aligned_cols=160  Identities=41%  Similarity=0.719  Sum_probs=144.2

Q ss_pred             cccHHHHHHHhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC
Q 005033           72 RFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMER  151 (718)
Q Consensus        72 ~~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~  151 (718)
                      ++++.++...+++|++.+.||+|+||.||+|.+.+++.||||++........+.+.+|+.+++.++||||+++++++...
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            45555667788999999999999999999999888999999998776666677899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeecc
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDGN--LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG  229 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~~--~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFG  229 (718)
                      +..|+||||+++|+|.+++.....  ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999999975532  35899999999999999999999   8999999999999999999999999999


Q ss_pred             Cceee
Q 005033          230 LSRIK  234 (718)
Q Consensus       230 LAr~~  234 (718)
                      +++..
T Consensus       185 ~~~~~  189 (321)
T 2qkw_B          185 ISKKG  189 (321)
T ss_dssp             TCEEC
T ss_pred             ccccc
Confidence            98763

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.1e-45  Score=428.77  Aligned_cols=148  Identities=28%  Similarity=0.389  Sum_probs=130.8

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHH---HHHHHHHHHhCCCCCcceeEEEEEeeCCeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTER---EFQNELQILGGLRSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~---~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~  154 (718)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++.....   ....   ....++.+++.++|||||+++++|.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            368999999999999999999987 699999999964221   1122   233457778899999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||||||+||+|.++|...+  .+++..+..|+.||+.||.|||   +++||||||||+||||+.+|.+||+|||+|+..
T Consensus       268 ylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999998765  5899999999999999999999   999999999999999999999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.8e-44  Score=373.68  Aligned_cols=149  Identities=28%  Similarity=0.513  Sum_probs=138.6

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|.+........+.|.+|+.++..++||||+++++++...+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            367899999999999999999986 5899999998776677778899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++|+|.+++..... .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  158 (310)
T 3s95_A           89 IKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLM  158 (310)
T ss_dssp             CTTCBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred             cCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceec
Confidence            999999999987543 6899999999999999999999   899999999999999999999999999999875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.9e-43  Score=368.08  Aligned_cols=147  Identities=28%  Similarity=0.453  Sum_probs=135.5

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      .++|++.+.||+|+||.||+|.+. +++.||||++........+.+.+|+.+++.++||||+++++++...+..|+||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            468999999999999999999975 6899999998765555567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++|+|.+++...   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (297)
T ss_dssp             CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence            9999999999865   5889999999999999999999   899999999999999999999999999998764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.9e-44  Score=377.15  Aligned_cols=157  Identities=31%  Similarity=0.465  Sum_probs=133.0

Q ss_pred             ccHHHHHHHhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEee
Q 005033           73 FTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCME  150 (718)
Q Consensus        73 ~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~  150 (718)
                      ++..++....++|++.+.||+|+||.||+|.. +|+.||||++....  ....+.|.+|+.++++++||||+++++++..
T Consensus        27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  105 (309)
T 3p86_A           27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ  105 (309)
T ss_dssp             -----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            34444445567899999999999999999987 58899999986533  3445679999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEECCCCCEEEee
Q 005033          151 RNKRILVYEYMPNKSLQEMLFSDGN-LVLKWSQRFEIIMDVAKALEFLHFGCDPP--VIHGDIKPSNVLLDSDCRGKVSD  227 (718)
Q Consensus       151 ~~~~~LVmEy~~gGsL~~~L~~~~~-~~l~~~~~~~Ia~qIa~gL~yLH~~~~~g--IVHRDLKP~NILLd~~~~vKLsD  227 (718)
                      .+..|+||||+++|+|.+++..... ..+++..++.++.||+.||.|||   +.+  |+||||||+|||++.++.+||+|
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~D  182 (309)
T 3p86_A          106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCD  182 (309)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred             CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECC
Confidence            9999999999999999999986542 23889999999999999999999   888  99999999999999999999999


Q ss_pred             ccCcee
Q 005033          228 FGLSRI  233 (718)
Q Consensus       228 FGLAr~  233 (718)
                      ||+++.
T Consensus       183 fg~a~~  188 (309)
T 3p86_A          183 FGLSRL  188 (309)
T ss_dssp             CC----
T ss_pred             CCCCcc
Confidence            999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.1e-43  Score=377.32  Aligned_cols=148  Identities=26%  Similarity=0.402  Sum_probs=135.1

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+.+|+.++||||+++++++...+..|+|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            3468999999999999999999985 7999999998643  334456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |||+++|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  163 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNE  163 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred             EECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence            99999999999997654  5889999999999999999999   89999999999999999999999999999865

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.5e-42  Score=366.28  Aligned_cols=160  Identities=27%  Similarity=0.352  Sum_probs=143.2

Q ss_pred             ccccccHHHHHHHhcC----------ccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCC
Q 005033           69 KLQRFTYKELKNATND----------FDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLR  137 (718)
Q Consensus        69 ~l~~~s~~el~~at~~----------f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~  137 (718)
                      ....++++++..+++.          |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++
T Consensus        21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  100 (321)
T 2c30_A           21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ  100 (321)
T ss_dssp             ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred             cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence            3456889999888865          677789999999999999987 69999999997655556678999999999999


Q ss_pred             CCcceeEEEEEeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 005033          138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL  217 (718)
Q Consensus       138 HpNIV~L~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL  217 (718)
                      ||||+++++++...+..|+||||+++|+|.+++...   .+++..+..++.||+.||.|||   +.+|+||||||+|||+
T Consensus       101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll  174 (321)
T 2c30_A          101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILL  174 (321)
T ss_dssp             CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEE
T ss_pred             CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEE
Confidence            999999999999999999999999999999998754   5899999999999999999999   8999999999999999


Q ss_pred             CCCCCEEEeeccCceee
Q 005033          218 DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       218 d~~~~vKLsDFGLAr~~  234 (718)
                      +.++.+||+|||+++..
T Consensus       175 ~~~~~~kl~Dfg~~~~~  191 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQI  191 (321)
T ss_dssp             CTTCCEEECCCTTCEEC
T ss_pred             CCCCcEEEeeeeeeeec
Confidence            99999999999998764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.1e-42  Score=368.15  Aligned_cols=145  Identities=23%  Similarity=0.377  Sum_probs=129.6

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC----eEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERN----KRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~----~~~LV  157 (718)
                      .++|++.+.||+|+||.||+|.+. ++.||||++.... .....+.+|+.++.+++|||||++++++....    ..|+|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            468999999999999999999876 7999999996543 33445677999999999999999999998754    47999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CeEecCCCCCCEEECCCCCEEEee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP----------PVIHGDIKPSNVLLDSDCRGKVSD  227 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~----------gIVHRDLKP~NILLd~~~~vKLsD  227 (718)
                      |||+++|+|.+++...   .+++..+..++.||+.||.|||   +.          +|+||||||+|||++.++.+||+|
T Consensus       101 ~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            9999999999999875   4899999999999999999999   77          999999999999999999999999


Q ss_pred             ccCceee
Q 005033          228 FGLSRIK  234 (718)
Q Consensus       228 FGLAr~~  234 (718)
                      ||+++..
T Consensus       175 Fg~a~~~  181 (322)
T 3soc_A          175 FGLALKF  181 (322)
T ss_dssp             CTTCEEE
T ss_pred             CCccccc
Confidence            9999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=375.42  Aligned_cols=148  Identities=32%  Similarity=0.484  Sum_probs=133.8

Q ss_pred             cCccccceecccCceEEEEEEEc----CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR----DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~----~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ++|++.+.||+|+||.||+|.+.    .+..||||++... .....+.|.+|+.+++.++||||+++++++...+..|+|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            56888999999999999999985    3456999999754 344557899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++|+|.+++..... .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       129 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EECCTTCBHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             eeCCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            999999999999976533 6899999999999999999999   899999999999999999999999999999874

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.2e-42  Score=373.45  Aligned_cols=147  Identities=31%  Similarity=0.393  Sum_probs=133.6

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++|++.+.||+|+||.||+|... +|+.||||++....   ......+.+|+.+|..++||||+++++++...+..|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            368999999999999999999987 69999999986431   23346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |||+++|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  154 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence            99999999999997654  5789999999999999999999   89999999999999999999999999999875

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.2e-43  Score=379.65  Aligned_cols=150  Identities=22%  Similarity=0.386  Sum_probs=133.8

Q ss_pred             hcCccccceecccCceEEEEEEEc--------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeC
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR--------DGKLLAIKRLDTFS-LQTEREFQNELQILGGL-RSPFLVTLLGYCMER  151 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~--------~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~  151 (718)
                      .++|.+.+.||+|+||.||+|.+.        ++..||||++.... ......+.+|+.+|+.+ +||||++++++|...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467899999999999999999863        35679999997543 34456799999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDGN--------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL  217 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~~--------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL  217 (718)
                      +..|+||||+++|+|.+++.....              ..+++..++.++.||+.||.|||   +.+|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            999999999999999999986542              24788999999999999999999   8999999999999999


Q ss_pred             CCCCCEEEeeccCceee
Q 005033          218 DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       218 d~~~~vKLsDFGLAr~~  234 (718)
                      +.++.+||+|||+++..
T Consensus       237 ~~~~~~kl~DFG~a~~~  253 (370)
T 2psq_A          237 TENNVMKIADFGLARDI  253 (370)
T ss_dssp             CTTCCEEECCCSSCEET
T ss_pred             CCCCCEEEccccCCccc
Confidence            99999999999999864

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.1e-42  Score=358.66  Aligned_cols=162  Identities=38%  Similarity=0.671  Sum_probs=145.0

Q ss_pred             ccccccHHHHHHHhcCcccc------ceecccCceEEEEEEEcCCcEEEEEEcccC----ChhhHHHHHHHHHHHhCCCC
Q 005033           69 KLQRFTYKELKNATNDFDEA------NVIGKGGSGTVFLGIARDGKLLAIKRLDTF----SLQTEREFQNELQILGGLRS  138 (718)
Q Consensus        69 ~l~~~s~~el~~at~~f~~~------~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~----~~~~~~~f~~Ei~iL~~L~H  138 (718)
                      ....|++.++..++++|...      +.||+|+||.||+|.. +++.||||++...    .....+.+.+|+.+++.++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34679999999999999877      8999999999999987 5889999998642    23345679999999999999


Q ss_pred             CcceeEEEEEeeCCeEEEEEeccCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 005033          139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL  217 (718)
Q Consensus       139 pNIV~L~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~-~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL  217 (718)
                      |||+++++++...+..|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||   +.+|+||||||+|||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence            999999999999999999999999999999997432 235899999999999999999999   8999999999999999


Q ss_pred             CCCCCEEEeeccCceee
Q 005033          218 DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       218 d~~~~vKLsDFGLAr~~  234 (718)
                      +.++.+||+|||+++..
T Consensus       167 ~~~~~~kl~Dfg~~~~~  183 (307)
T 2nru_A          167 DEAFTAKISDFGLARAS  183 (307)
T ss_dssp             CTTCCEEECCCTTCEEC
T ss_pred             cCCCcEEEeeccccccc
Confidence            99999999999998764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3e-42  Score=360.42  Aligned_cols=148  Identities=26%  Similarity=0.399  Sum_probs=134.6

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++|++.+.||+|+||.||+|.+. +++.||||.+...   .....+.|.+|+.++..++||||+++++++...+..|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            367999999999999999999986 6899999998432   234456799999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  161 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL  161 (294)
T ss_dssp             EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred             EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence            99999999999998764  5889999999999999999999   899999999999999999999999999998753

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.3e-43  Score=358.59  Aligned_cols=148  Identities=29%  Similarity=0.480  Sum_probs=134.9

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      .++|++.+.||+|+||.||+|.+.+++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..|+||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            35789999999999999999999888999999997543 23467999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++|+|.+++..... .+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        88 ~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           88 EHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  156 (269)
T ss_dssp             TTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             CCCcHHHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccc
Confidence            99999999976543 5889999999999999999999   899999999999999999999999999998753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.7e-42  Score=373.17  Aligned_cols=149  Identities=23%  Similarity=0.323  Sum_probs=134.3

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChh------hHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQ------TEREFQNELQILGGLRSPFLVTLLGYCMERNK  153 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~  153 (718)
                      ..+.|.+.+.||+|+||.||+|... +|+.||||++......      ..+.+.+|+.+|..++||||+++++++...+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            3468999999999999999999987 6899999999653321      34679999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC----CEEEeecc
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC----RGKVSDFG  229 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~----~vKLsDFG  229 (718)
                      .|+||||+++|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++    .+||+|||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            999999999999999997654  6899999999999999999999   89999999999999998877    79999999


Q ss_pred             Cceee
Q 005033          230 LSRIK  234 (718)
Q Consensus       230 LAr~~  234 (718)
                      +++..
T Consensus       165 ~a~~~  169 (361)
T 2yab_A          165 LAHEI  169 (361)
T ss_dssp             SCEEC
T ss_pred             CceEc
Confidence            99764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.9e-43  Score=374.26  Aligned_cols=160  Identities=26%  Similarity=0.351  Sum_probs=138.6

Q ss_pred             cccHHHHHHHhcCccccceecccCceEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCC-CCCccee
Q 005033           72 RFTYKELKNATNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFS-LQTEREFQNELQILGGL-RSPFLVT  143 (718)
Q Consensus        72 ~~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~  143 (718)
                      .+...++....++|++.+.||+|+||.||+|.+.      +++.||||++.... ....+.+.+|+.++..+ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            4555666677889999999999999999999842      46899999997543 34456799999999999 7899999


Q ss_pred             EEEEEeeCC-eEEEEEeccCCCCHHHHHhhCCC-----------------------------------------------
Q 005033          144 LLGYCMERN-KRILVYEYMPNKSLQEMLFSDGN-----------------------------------------------  175 (718)
Q Consensus       144 L~g~~~~~~-~~~LVmEy~~gGsL~~~L~~~~~-----------------------------------------------  175 (718)
                      ++++|...+ ..++|||||++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999998765 48999999999999999976532                                               


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          176 -----------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       176 -----------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                                       ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  243 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI  243 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence                             12889999999999999999999   899999999999999999999999999998753

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=358.84  Aligned_cols=150  Identities=27%  Similarity=0.442  Sum_probs=132.7

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC--eEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERN--KRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~--~~~LV  157 (718)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++....  ..|+|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            357899999999999999999987 58999999996533 234567889999999999999999999998765  78999


Q ss_pred             EeccCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE----CCCCCEEEeeccCce
Q 005033          158 YEYMPNKSLQEMLFSDGN-LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL----DSDCRGKVSDFGLSR  232 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~-~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL----d~~~~vKLsDFGLAr  232 (718)
                      |||+++|+|.+++..... ..+++..++.++.||+.||.|||   +.+|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976532 23899999999999999999999   8999999999999999    778889999999998


Q ss_pred             ee
Q 005033          233 IK  234 (718)
Q Consensus       233 ~~  234 (718)
                      ..
T Consensus       165 ~~  166 (319)
T 4euu_A          165 EL  166 (319)
T ss_dssp             EC
T ss_pred             ec
Confidence            64

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.9e-43  Score=389.12  Aligned_cols=154  Identities=21%  Similarity=0.362  Sum_probs=137.2

Q ss_pred             HHHHHHhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEE
Q 005033           76 KELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        76 ~el~~at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~  155 (718)
                      .++....++|.+.+.||+|+||.||+|.+.++..||||++.... ...+.|.+|+.+|+.++|||||++++++. .+..|
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            34445667899999999999999999999888999999997643 34678999999999999999999999986 56789


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +|||||++|+|.+++.......+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            9999999999999997654345788899999999999999999   899999999999999999999999999999764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.2e-42  Score=355.63  Aligned_cols=148  Identities=34%  Similarity=0.451  Sum_probs=135.2

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      .++|++.+.||+|+||.||+|...++..||||++.... .....+.+|+.++..++||||+++++++...+..|+||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            46799999999999999999999888899999997543 23467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++++|.+++..... .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        86 ~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           86 SNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV  154 (268)
T ss_dssp             TTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred             CCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceec
Confidence            99999999976532 5899999999999999999999   899999999999999999999999999998764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.6e-42  Score=354.11  Aligned_cols=146  Identities=24%  Similarity=0.405  Sum_probs=126.2

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhC--CCCCcceeEEEEEeeC----CeEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGG--LRSPFLVTLLGYCMER----NKRI  155 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~--L~HpNIV~L~g~~~~~----~~~~  155 (718)
                      .++|++.+.||+|+||.||+|.+ +++.||||++...   ....+.+|.+++..  ++||||+++++++...    ...|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46899999999999999999988 5899999998653   34456667776665  8999999999997653    4689


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecCCCCCCEEECCCCCEEEeeccC
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC-----DPPVIHGDIKPSNVLLDSDCRGKVSDFGL  230 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~-----~~gIVHRDLKP~NILLd~~~~vKLsDFGL  230 (718)
                      +||||+++|+|.+++...   .+++..++.++.||+.||.|||...     +.+|+||||||+|||++.++.+||+|||+
T Consensus        83 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  159 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL  159 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence            999999999999999654   5899999999999999999999322     67999999999999999999999999999


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      ++..
T Consensus       160 a~~~  163 (301)
T 3q4u_A          160 AVMH  163 (301)
T ss_dssp             CEEE
T ss_pred             eeec
Confidence            9875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.5e-43  Score=380.85  Aligned_cols=148  Identities=29%  Similarity=0.455  Sum_probs=129.0

Q ss_pred             cCccccceecccCceEEEEEEEc----CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR----DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~----~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ++|++.+.||+|+||.||+|.+.    ++..||||++... .....+.|.+|+.+|++++||||+++++++...+..|+|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57899999999999999999875    4778999999754 344557899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++|+|.+++.... ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       125 ~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            99999999999997654 35899999999999999999999   899999999999999999999999999999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-42  Score=364.81  Aligned_cols=147  Identities=27%  Similarity=0.440  Sum_probs=133.7

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++|++.+.||+|+||.||+|... +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            367999999999999999999987 69999999986432   12345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |||+++|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        85 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~  155 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY  155 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCccee
Confidence            99999999999998764  5788999999999999999999   99999999999999999999999999999875

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-42  Score=367.32  Aligned_cols=148  Identities=20%  Similarity=0.310  Sum_probs=134.2

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|.+.... .....+.+|+.+|+.++||||+++++++.+.+..|+||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999987 58899999987543 3456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC--CCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS--DCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~--~~~vKLsDFGLAr~~  234 (718)
                      |++|+|.+++.... ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.  ++.+||+|||+++..
T Consensus        83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            99999999997643 35899999999999999999999   899999999999999987  789999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.8e-43  Score=380.13  Aligned_cols=151  Identities=28%  Similarity=0.452  Sum_probs=135.7

Q ss_pred             HHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ...++|.+.+.||+|+||.||+|.+. +++.||||.+.... ......|.+|+.+|+.++||||+++++++...+..|+|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            34568899999999999999999987 68999999986542 33445789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++|+|.+++...+. .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       191 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~  263 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE  263 (377)
T ss_dssp             EECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence            999999999999976532 5889999999999999999999   899999999999999999999999999998763

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.5e-42  Score=360.43  Aligned_cols=149  Identities=26%  Similarity=0.483  Sum_probs=133.6

Q ss_pred             hcCccccceecccCceEEEEEEEc-----CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC--CeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-----DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMER--NKR  154 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-----~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~  154 (718)
                      .++|++.+.||+|+||.||+|.+.     +++.||||++........+.|.+|+.++..++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            367899999999999999999842     5889999999876666677899999999999999999999999654  568


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++||||+++|+|.+++..... .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             EEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            999999999999999987643 5899999999999999999999   899999999999999999999999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1e-42  Score=368.14  Aligned_cols=155  Identities=30%  Similarity=0.457  Sum_probs=137.4

Q ss_pred             HHHHHhcCccccceecccCceEEEEEEEcC------CcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 005033           77 ELKNATNDFDEANVIGKGGSGTVFLGIARD------GKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCM  149 (718)
Q Consensus        77 el~~at~~f~~~~~LG~G~FG~Vykg~~~~------g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~  149 (718)
                      .+....++|.+.+.||+|+||.||+|.+.+      ++.||||++... .......|.+|+.+++.++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            334456889999999999999999999853      479999999754 3344567999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhCCC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 005033          150 ERNKRILVYEYMPNKSLQEMLFSDGN----------------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH  207 (718)
Q Consensus       150 ~~~~~~LVmEy~~gGsL~~~L~~~~~----------------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVH  207 (718)
                      ..+..|+||||+++|+|.+++.....                      ..+++..++.++.||+.||.|||   +.+|+|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence            99999999999999999999986421                      36889999999999999999999   899999


Q ss_pred             cCCCCCCEEECCCCCEEEeeccCceee
Q 005033          208 GDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       208 RDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||||+|||++.++.+||+|||+++..
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  224 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNI  224 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHH
T ss_pred             CCCCcceEEECCCCeEEEeecCCCccc
Confidence            999999999999999999999998753

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.1e-43  Score=367.17  Aligned_cols=147  Identities=29%  Similarity=0.330  Sum_probs=128.4

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++...  .......+..|+..+..+ +||||++++++|...+..||||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            67999999999999999999987 6999999988543  233344556666666555 9999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+ +++|.+++...+. .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       137 e~~-~~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGA-SLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             ECC-CCBHHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             ecc-CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            999 7899999876543 6899999999999999999999   889999999999999999999999999998753

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.6e-42  Score=351.58  Aligned_cols=147  Identities=23%  Similarity=0.388  Sum_probs=132.8

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC--CeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMER--NKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LV  157 (718)
                      .++|++.+.||+|+||.||+|.+. ++.||||++...  .....+.|.+|+.+++.++||||+++++++...  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            357889999999999999999985 889999998653  344456799999999999999999999999887  788999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP--VIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~g--IVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                      |||+++|+|.+++.......+++..++.++.||+.||.|||   +.+  |+||||||+|||++.++.++|+|||++.
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEecccee
Confidence            99999999999998876656899999999999999999999   788  9999999999999999999999998754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.6e-42  Score=359.89  Aligned_cols=150  Identities=27%  Similarity=0.404  Sum_probs=131.6

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC-------
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERN-------  152 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-------  152 (718)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+|++++||||++++++|.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467999999999999999999987 79999999986433 345578999999999999999999999986543       


Q ss_pred             --------------------------------------------------eEEEEEeccCCCCHHHHHhhCCC-CCCCHH
Q 005033          153 --------------------------------------------------KRILVYEYMPNKSLQEMLFSDGN-LVLKWS  181 (718)
Q Consensus       153 --------------------------------------------------~~~LVmEy~~gGsL~~~L~~~~~-~~l~~~  181 (718)
                                                                        ..|+|||||++|+|.+++..... ...++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              37999999999999999987653 345666


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          182 QRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       182 ~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      .++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  214 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM  214 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCccccc
Confidence            78899999999999999   899999999999999999999999999999875

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.2e-42  Score=369.95  Aligned_cols=150  Identities=21%  Similarity=0.254  Sum_probs=136.9

Q ss_pred             hcCccccceeccc--CceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           82 TNDFDEANVIGKG--GSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        82 t~~f~~~~~LG~G--~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      .++|++.+.||+|  +||.||+|.+. +|+.||||++...  .......+.+|+.+++.++|||||++++++...+..|+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999987 6999999999643  23445678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||||++|+|.+++.......+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            999999999999998765556899999999999999999999   899999999999999999999999999998764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3e-42  Score=359.69  Aligned_cols=151  Identities=24%  Similarity=0.401  Sum_probs=134.9

Q ss_pred             HhcCccccceecccCceEEEEEEEc------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNK  153 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~  153 (718)
                      ..++|.+.+.||+|+||.||+|.+.      ++..||||++... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            3568999999999999999999873      3579999999653 34455779999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhCCC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 005033          154 RILVYEYMPNKSLQEMLFSDGN----------------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIK  211 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~----------------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLK  211 (718)
                      .|+||||+++|+|.+++.....                      ..+++..++.++.||+.||.|||   +.+|+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccc
Confidence            9999999999999999986542                      24889999999999999999999   8999999999


Q ss_pred             CCCEEECCCCCEEEeeccCceee
Q 005033          212 PSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       212 P~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+|||++.++.+||+|||+++..
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~  200 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDV  200 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEEC
T ss_pred             hheEEEcCCCCEEEccccccccc
Confidence            99999999999999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.8e-42  Score=364.18  Aligned_cols=148  Identities=23%  Similarity=0.346  Sum_probs=133.5

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh------hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL------QTEREFQNELQILGGLRSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~  154 (718)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.....      .....+.+|+.+|+.++||||+++++++...+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356899999999999999999987 589999999864322      1356799999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC----CEEEeeccC
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC----RGKVSDFGL  230 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~----~vKLsDFGL  230 (718)
                      |+||||+++|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++    .+||+|||+
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            99999999999999997653  5889999999999999999999   89999999999999999887    799999999


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      ++..
T Consensus       165 a~~~  168 (326)
T 2y0a_A          165 AHKI  168 (326)
T ss_dssp             CEEC
T ss_pred             CeEC
Confidence            9764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=375.88  Aligned_cols=148  Identities=28%  Similarity=0.386  Sum_probs=132.7

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~  155 (718)
                      ..++|++.+.||+|+||.||+|... +|+.||||++....   ......+.+|+.++..+ +||||+++++++...+..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3478999999999999999999987 58999999986531   23345688999999988 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||||||++|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus       101 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceee
Confidence            9999999999999997754  5889999999999999999999   89999999999999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=9.5e-43  Score=359.31  Aligned_cols=149  Identities=32%  Similarity=0.428  Sum_probs=132.5

Q ss_pred             HhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ..++|++.+.||+|+||.||+|.+.++..||||++..... ..+.+.+|+.++..++||||+++++++...+..|+||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            4568999999999999999999998888999999976432 346799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++|+|.+++.... ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       101 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A          101 MANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             CTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred             cCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence            99999999997643 25899999999999999999999   899999999999999999999999999998753

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.4e-42  Score=366.04  Aligned_cols=147  Identities=24%  Similarity=0.336  Sum_probs=130.2

Q ss_pred             ccccccHHHHHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCC-----CCcce
Q 005033           69 KLQRFTYKELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLR-----SPFLV  142 (718)
Q Consensus        69 ~l~~~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-----HpNIV  142 (718)
                      ....+++++.....++|.+.+.||+|+||.||+|.+. +++.||||++... ......+..|+.++..+.     ||||+
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            3455677777777899999999999999999999986 6899999999643 344567788999999886     99999


Q ss_pred             eEEEEEeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC
Q 005033          143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD  220 (718)
Q Consensus       143 ~L~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~  220 (718)
                      ++++++...+..|+||||+ +++|.+++.......+++..+..++.||+.||.|||   +.+|+||||||+|||++..
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~  173 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDP  173 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCT
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccc
Confidence            9999999999999999999 999999998876556899999999999999999999   8999999999999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-43  Score=378.04  Aligned_cols=150  Identities=25%  Similarity=0.359  Sum_probs=132.0

Q ss_pred             hcCccccceecccCceEEEEEEEc------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~  154 (718)
                      .++|++.+.||+|+||.||+|.+.      ++..||||++... .......+.+|+.+++.++|||||++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467899999999999999999853      4678999999653 344556799999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC---CEEEe
Q 005033          155 ILVYEYMPNKSLQEMLFSDGN-----LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC---RGKVS  226 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~-----~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~---~vKLs  226 (718)
                      |+|||||++|+|.+++.....     ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999976432     35889999999999999999999   89999999999999999555   59999


Q ss_pred             eccCceee
Q 005033          227 DFGLSRIK  234 (718)
Q Consensus       227 DFGLAr~~  234 (718)
                      |||+++..
T Consensus       227 DFG~a~~~  234 (367)
T 3l9p_A          227 DFGMARDI  234 (367)
T ss_dssp             CCHHHHHH
T ss_pred             CCcccccc
Confidence            99998753

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.3e-42  Score=389.14  Aligned_cols=151  Identities=25%  Similarity=0.405  Sum_probs=137.8

Q ss_pred             HHhcCccccceecccCceEEEEEEEcC-CcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~~-g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ....+|.+.+.||+|+||.||+|.+.. +..||||++.... ...+.|.+|+.+|++++|||||+++++|...+..||||
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            345678899999999999999999874 8899999997543 34568999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||++|+|.+++.......+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence            9999999999998766557899999999999999999999   899999999999999999999999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.1e-42  Score=380.83  Aligned_cols=147  Identities=35%  Similarity=0.510  Sum_probs=133.5

Q ss_pred             HhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC-eEEEEEe
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERN-KRILVYE  159 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-~~~LVmE  159 (718)
                      ..++|++.+.||+|+||.||+|.+. |+.||||+++...  ..+.|.+|+.+|++++|||||++++++.... ..|||||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            4567899999999999999999886 7899999997643  4567999999999999999999999987765 7999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||++|+|.+++...+...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  338 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  338 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence            999999999998766555789999999999999999999   89999999999999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=8e-42  Score=353.07  Aligned_cols=146  Identities=32%  Similarity=0.553  Sum_probs=127.8

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhh-------HHHHHHHHHHHhCCCCCcceeEEEEEeeCCe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQT-------EREFQNELQILGGLRSPFLVTLLGYCMERNK  153 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~-------~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~  153 (718)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.......       .+.+.+|+.++..++||||+++++++.... 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            368999999999999999999986 68999999985432211       167899999999999999999999997665 


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEECCCCC-----EEEe
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP--VIHGDIKPSNVLLDSDCR-----GKVS  226 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~g--IVHRDLKP~NILLd~~~~-----vKLs  226 (718)
                       ++||||+++|+|.+++..... .+++..++.++.|++.||.|||   +.+  |+||||||+|||++.++.     +||+
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             -eEEEEecCCCCHHHHHhcccC-CccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence             799999999999999876543 6899999999999999999999   888  999999999999988776     9999


Q ss_pred             eccCcee
Q 005033          227 DFGLSRI  233 (718)
Q Consensus       227 DFGLAr~  233 (718)
                      |||+++.
T Consensus       172 Dfg~~~~  178 (287)
T 4f0f_A          172 DFGLSQQ  178 (287)
T ss_dssp             CCTTCBC
T ss_pred             CCCcccc
Confidence            9998864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=8e-43  Score=388.39  Aligned_cols=157  Identities=25%  Similarity=0.344  Sum_probs=139.1

Q ss_pred             cHHHHHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChh---hHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 005033           74 TYKELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQ---TEREFQNELQILGGLRSPFLVTLLGYCM  149 (718)
Q Consensus        74 s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~  149 (718)
                      .+.++...+++|++.+.||+|+||+||+|.+. +++.||||++......   ....+.+|+.++..++||||++++++|.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            45566677789999999999999999999987 4889999998642211   1234889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeecc
Q 005033          150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG  229 (718)
Q Consensus       150 ~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFG  229 (718)
                      +.+..|||||||++|+|.+++..... .+++..+..++.||+.||.|||   +.+||||||||+||||+.++.+||+|||
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~-~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFED-RLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchh
Confidence            99999999999999999999987432 6899999999999999999999   8999999999999999999999999999


Q ss_pred             Cceee
Q 005033          230 LSRIK  234 (718)
Q Consensus       230 LAr~~  234 (718)
                      +|+..
T Consensus       221 la~~~  225 (437)
T 4aw2_A          221 SCLKL  225 (437)
T ss_dssp             TCEEC
T ss_pred             hhhhc
Confidence            99764

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.6e-42  Score=367.73  Aligned_cols=150  Identities=27%  Similarity=0.374  Sum_probs=131.5

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-----hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-----LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~  155 (718)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++....     ....+.+.+|+.+++.++||||+++++++...+..|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            357999999999999999999986 68999999985321     123567999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC---EEEeeccC
Q 005033          156 LVYEYMPNKSLQEMLFSDG--NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR---GKVSDFGL  230 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~--~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~---vKLsDFGL  230 (718)
                      +|||||++|+|.+++....  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999998886432  235889999999999999999999   899999999999999987654   99999999


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      ++..
T Consensus       180 a~~~  183 (351)
T 3c0i_A          180 AIQL  183 (351)
T ss_dssp             CEEC
T ss_pred             eeEe
Confidence            9764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1e-41  Score=374.95  Aligned_cols=147  Identities=26%  Similarity=0.357  Sum_probs=131.4

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~L  156 (718)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....   ......+.+|..+|.++ +|||||+++++|...+..||
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            468999999999999999999987 58899999996532   22234578899999876 89999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |||||++|+|..++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus       131 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            999999999999998754  5899999999999999999999   89999999999999999999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.3e-41  Score=358.87  Aligned_cols=148  Identities=26%  Similarity=0.434  Sum_probs=131.9

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .++|++.+.||+|+||+||+|.+.+|+.||||++....  ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            47899999999999999999999889999999986432  2234678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |++ |+|.+++..... .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       100 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  169 (311)
T 3niz_A          100 FME-KDLKKVLDENKT-GLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAF  169 (311)
T ss_dssp             CCS-EEHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred             CCC-CCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence            996 689888876543 5899999999999999999999   899999999999999999999999999999763

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.9e-42  Score=364.66  Aligned_cols=148  Identities=27%  Similarity=0.383  Sum_probs=132.3

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999987 68999999986433 2234568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+++|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        86 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           86 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (323)
T ss_dssp             CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeecccee
Confidence            999999999997654  5889999999999999999999   899999999999999999999999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.5e-41  Score=366.31  Aligned_cols=147  Identities=28%  Similarity=0.398  Sum_probs=133.7

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||.||+|... +|+.||||++....   ......+.+|+.+|..++||||+++++++.+.+..|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57899999999999999999987 68999999986432   223467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~  191 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceec
Confidence            9999999999998754  5889999999999999999999   899999999999999999999999999998753

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.4e-42  Score=360.63  Aligned_cols=146  Identities=28%  Similarity=0.430  Sum_probs=125.1

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      ++|++.+.||+|+||.||+|... ++.||||.+...  ...+.|.+|+.++++++||||+++++++.  +..|+||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            57889999999999999999875 788999998653  34567999999999999999999999886  34799999999


Q ss_pred             CCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC-EEEeeccCcee
Q 005033          163 NKSLQEMLFSDGN-LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR-GKVSDFGLSRI  233 (718)
Q Consensus       163 gGsL~~~L~~~~~-~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~-vKLsDFGLAr~  233 (718)
                      +|+|.+++..... ..+++..++.++.||+.||.|||.....+|+||||||+|||++.++. +||+|||++..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            9999999986643 24788899999999999999999322289999999999999998887 79999998864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.1e-41  Score=364.32  Aligned_cols=146  Identities=27%  Similarity=0.369  Sum_probs=132.7

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ++|++.+.||+|+||.||+|... +++.||||++...   .......+.+|+.++..+ +||||+++++++...+..|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57899999999999999999987 5899999999653   233456688999999987 899999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |||+++|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence            99999999999997654  5889999999999999999999   89999999999999999999999999999875

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.9e-42  Score=369.64  Aligned_cols=149  Identities=23%  Similarity=0.359  Sum_probs=133.3

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4568999999999999999999987 6899999999643  234456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC---CEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC---RGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~---~vKLsDFGLAr~~  234 (718)
                      |||+++|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++   .+||+|||+++..
T Consensus       107 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            99999999999997654  5889999999999999999999   89999999999999998654   5999999998753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4e-42  Score=351.93  Aligned_cols=145  Identities=27%  Similarity=0.444  Sum_probs=123.0

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccCCh----hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL----QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~----~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++|++.+.||+|+||.||+|.+. ++.||||++.....    ...+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            367899999999999999999975 88999999865322    2246789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---eEecCCCCCCEEECC--------CCCEEEe
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP---VIHGDIKPSNVLLDS--------DCRGKVS  226 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~g---IVHRDLKP~NILLd~--------~~~vKLs  226 (718)
                      |||+++++|.+++...   .+++..+..++.|++.||.|||   +.+   |+||||||+|||++.        ++.+||+
T Consensus        85 ~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             EECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             EEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            9999999999999643   6889999999999999999999   666   999999999999986        6789999


Q ss_pred             eccCcee
Q 005033          227 DFGLSRI  233 (718)
Q Consensus       227 DFGLAr~  233 (718)
                      |||+++.
T Consensus       159 Dfg~~~~  165 (271)
T 3dtc_A          159 DFGLARE  165 (271)
T ss_dssp             CCCC---
T ss_pred             cCCcccc
Confidence            9998875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.6e-42  Score=357.97  Aligned_cols=151  Identities=26%  Similarity=0.403  Sum_probs=138.0

Q ss_pred             HHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ...++|++.+.||+|+||.||+|.+. ++..||||.+.... ...+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            35678999999999999999999987 48899999997543 34567999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++++|.+++.......+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus        89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            9999999999998876667899999999999999999999   899999999999999999999999999998753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=6.7e-42  Score=367.71  Aligned_cols=146  Identities=25%  Similarity=0.403  Sum_probs=131.4

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++.....   .....+.+|+.+++.++||||+++++++...+..|+|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            368999999999999999999985 689999999864221   1235789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |||+ +|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++..
T Consensus        88 ~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~  157 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI  157 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred             EECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEecccee
Confidence            9999 789999987654  5889999999999999999999   89999999999999999999999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.3e-41  Score=366.06  Aligned_cols=149  Identities=19%  Similarity=0.271  Sum_probs=126.8

Q ss_pred             HhcCccccceecccCceEEEEEEEcC------CcEEEEEEcccCChhhH-----------HHHHHHHHHHhCCCCCccee
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIARD------GKLLAIKRLDTFSLQTE-----------REFQNELQILGGLRSPFLVT  143 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~~------g~~VAVK~i~~~~~~~~-----------~~f~~Ei~iL~~L~HpNIV~  143 (718)
                      ..++|++.+.||+|+||.||+|.+..      ++.||||++........           ..+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34689999999999999999998864      47899999865432211           23455777888999999999


Q ss_pred             EEEEEeeC----CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEC-
Q 005033          144 LLGYCMER----NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD-  218 (718)
Q Consensus       144 L~g~~~~~----~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd-  218 (718)
                      +++++...    ...||||||+ +++|.+++.... ..+++..++.|+.||+.||.|||   +.+|+||||||+|||++ 
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEES
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEec
Confidence            99999775    4589999999 999999998753 36899999999999999999999   88999999999999999 


Q ss_pred             -CCCCEEEeeccCceee
Q 005033          219 -SDCRGKVSDFGLSRIK  234 (718)
Q Consensus       219 -~~~~vKLsDFGLAr~~  234 (718)
                       .++.+||+|||+++..
T Consensus       188 ~~~~~~kl~DFG~a~~~  204 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRY  204 (364)
T ss_dssp             SCTTCEEECCCTTCEES
T ss_pred             CCCCeEEEEECCcceec
Confidence             8899999999999875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.2e-42  Score=380.02  Aligned_cols=148  Identities=28%  Similarity=0.383  Sum_probs=125.1

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      ..++|++.+.||+|+||.||+|... +|+.||||++...   .......+.+|+.+++.++||||++++++|...+..||
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            3467999999999999999999986 6899999998642   22334567899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD-PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~-~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |||||++|+|.+++....  .+++..+..++.||+.||.|||   + .+|+||||||+|||++.++.+||+|||+|+.
T Consensus       226 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             EECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             EEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            999999999999997654  5889999999999999999999   7 8999999999999999999999999999874

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.1e-41  Score=362.23  Aligned_cols=147  Identities=29%  Similarity=0.457  Sum_probs=126.1

Q ss_pred             hcCccccceecccCceEEEEEEE----cCCcEEEEEEcccCC----hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIA----RDGKLLAIKRLDTFS----LQTEREFQNELQILGGLRSPFLVTLLGYCMERNK  153 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~----~~g~~VAVK~i~~~~----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~  153 (718)
                      .++|++.+.||+|+||.||+|..    .+|+.||||++....    ......+.+|+.+|+.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            36799999999999999999987    368999999997532    2234567899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .|+||||+++|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            999999999999999997654  5788899999999999999999   89999999999999999999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.2e-42  Score=365.46  Aligned_cols=147  Identities=27%  Similarity=0.510  Sum_probs=125.8

Q ss_pred             cCccccceecccCceEEEEEEEc-CCc----EEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGK----LLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~----~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      ++|++.+.||+|+||.||+|.+. +++    .||+|.+... .....+.|.+|+.++++++||||++++++|.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            57999999999999999999975 344    4688887543 2344578999999999999999999999998764 789


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+||+.+|+|.+++..... .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        94 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            9999999999999987543 6899999999999999999999   889999999999999999999999999998764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.3e-42  Score=352.38  Aligned_cols=148  Identities=27%  Similarity=0.415  Sum_probs=133.4

Q ss_pred             hcCccccceecccCceEEEEEEEcC-C-------cEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARD-G-------KLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNK  153 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~-g-------~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~  153 (718)
                      .++|.+.+.||+|+||.||+|.+.. +       ..||+|++........+.+.+|+.+++.++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3678999999999999999998763 3       4799999977666667889999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC--------EEE
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR--------GKV  225 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~--------vKL  225 (718)
                      .|+||||+++|+|.+++..... .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.        +||
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CEEEEECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeee
Confidence            9999999999999999987643 4889999999999999999999   899999999999999998887        999


Q ss_pred             eeccCcee
Q 005033          226 SDFGLSRI  233 (718)
Q Consensus       226 sDFGLAr~  233 (718)
                      +|||++..
T Consensus       163 ~Dfg~~~~  170 (289)
T 4fvq_A          163 SDPGISIT  170 (289)
T ss_dssp             CCCCSCTT
T ss_pred             ccCccccc
Confidence            99998754

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.9e-42  Score=357.63  Aligned_cols=147  Identities=31%  Similarity=0.404  Sum_probs=126.7

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChh--------------------------hHHHHHHHHHHHh
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQ--------------------------TEREFQNELQILG  134 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~--------------------------~~~~f~~Ei~iL~  134 (718)
                      .++|++.+.||+|+||.||+|.+. +++.||||++......                          ..+.+.+|+.+|+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            368999999999999999999986 6899999998643211                          1246889999999


Q ss_pred             CCCCCcceeEEEEEee--CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 005033          135 GLRSPFLVTLLGYCME--RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKP  212 (718)
Q Consensus       135 ~L~HpNIV~L~g~~~~--~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP  212 (718)
                      .++||||+++++++..  .+..|+||||+++++|.+++..   ..+++..+..++.||+.||.|||   +.+|+||||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp  165 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKP  165 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCH
Confidence            9999999999999987  5688999999999999886543   26899999999999999999999   89999999999


Q ss_pred             CCEEECCCCCEEEeeccCceee
Q 005033          213 SNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       213 ~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +|||++.++.+||+|||+++..
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~  187 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEF  187 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEEC
T ss_pred             HHEEECCCCCEEEecCCCcccc
Confidence            9999999999999999999764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.5e-41  Score=348.67  Aligned_cols=147  Identities=27%  Similarity=0.395  Sum_probs=130.6

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ++|++.+.||+|+||+||+|.+. +++.||||++...  .......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999987 5899999998643  23345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+. |+|.+++..... .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~~~-~~l~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           82 FCD-QDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             CCS-EEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cCC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            996 577776655432 6899999999999999999999   899999999999999999999999999999764

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3e-42  Score=383.53  Aligned_cols=152  Identities=26%  Similarity=0.402  Sum_probs=134.3

Q ss_pred             HHHHhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           78 LKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        78 l~~at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      +....++|++.+.||+|+||.||+|.+.++..||||++.... ...+.|.+|+.+|++++||||+++++++.. +..|||
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            334567899999999999999999999888889999997643 235679999999999999999999999876 678999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++|+|.+++.......+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence            99999999999997543335889999999999999999999   899999999999999999999999999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.9e-41  Score=351.98  Aligned_cols=146  Identities=24%  Similarity=0.419  Sum_probs=131.4

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcccCCh--hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL--QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ++|++.+.||+|+||.||+|...+|+.||||++.....  .....+.+|+.+++.++||||+++++++...+..|+||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57899999999999999999998899999999865332  2236788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ++ ++|.+++..... .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  149 (288)
T 1ob3_A           82 LD-QDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARA  149 (288)
T ss_dssp             CS-EEHHHHHHTSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred             cC-CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccc
Confidence            96 599999976532 5888999999999999999999   89999999999999999999999999998875

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-41  Score=371.33  Aligned_cols=149  Identities=21%  Similarity=0.403  Sum_probs=135.3

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      .++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+.+|..++||||+++++++......|+||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            468999999999999999999987 6899999999776555667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC--CCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS--DCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~--~~~vKLsDFGLAr~~  234 (718)
                      +++|+|.+++.... ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.  .+.+||+|||+++..
T Consensus       130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence            99999999997553 35899999999999999999999   899999999999999974  578999999999864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-42  Score=364.87  Aligned_cols=152  Identities=28%  Similarity=0.379  Sum_probs=132.1

Q ss_pred             HHhcCccccceecccCceEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeC
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFS-LQTEREFQNELQILGGL-RSPFLVTLLGYCMER  151 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~  151 (718)
                      ...++|.+.+.||+|+||.||+|.+.      ++..||||++.... ......+.+|+.++.++ +||||+++++++...
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            35578999999999999999999962      35689999996532 23346799999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDGN---------------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI  210 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~~---------------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDL  210 (718)
                      +..|+||||+++|+|.+++.....                     ..+++..++.++.||+.||.|||   +.+|+||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Di  198 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL  198 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCC
Confidence            999999999999999999976542                     23788999999999999999999   899999999


Q ss_pred             CCCCEEECCCCCEEEeeccCceee
Q 005033          211 KPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       211 KP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+|||++.++.+||+|||+++..
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~  222 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDI  222 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCG
T ss_pred             ChhhEEEcCCCcEEeCCCccCccc
Confidence            999999999999999999998764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.2e-42  Score=370.51  Aligned_cols=150  Identities=27%  Similarity=0.363  Sum_probs=132.8

Q ss_pred             HHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCe
Q 005033           79 KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGL-RSPFLVTLLGYCMERNK  153 (718)
Q Consensus        79 ~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~  153 (718)
                      ....++|.+.+.||+|+||.||+|... +|+.||||++....   ......+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345678999999999999999999987 68999999996532   22345678899999876 99999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .|+||||+++|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            999999999999999998654  5889999999999999999999   89999999999999999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.6e-42  Score=370.54  Aligned_cols=151  Identities=25%  Similarity=0.370  Sum_probs=134.5

Q ss_pred             HhcCccccceecccCceEEEEEEEc--------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCC-CCCcceeEEEEEee
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR--------DGKLLAIKRLDTF-SLQTEREFQNELQILGGL-RSPFLVTLLGYCME  150 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~--------~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~  150 (718)
                      ..++|.+.+.||+|+||.||+|.+.        .+..||||++... .......+.+|+++++.+ +|||||+++++|..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            3468999999999999999999863        2357999999654 334457799999999999 99999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEE
Q 005033          151 RNKRILVYEYMPNKSLQEMLFSDGN--------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVL  216 (718)
Q Consensus       151 ~~~~~LVmEy~~gGsL~~~L~~~~~--------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NIL  216 (718)
                      .+..|+||||+++|+|.+++.....              ..+++..++.++.||+.||.|||   +.+|+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEE
Confidence            9999999999999999999987542              34899999999999999999999   899999999999999


Q ss_pred             ECCCCCEEEeeccCceee
Q 005033          217 LDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       217 Ld~~~~vKLsDFGLAr~~  234 (718)
                      ++.++.+||+|||+++..
T Consensus       224 l~~~~~~kL~DFG~a~~~  241 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDI  241 (382)
T ss_dssp             ECTTCCEEECSCSCCCCS
T ss_pred             EcCCCcEEEcccCccccc
Confidence            999999999999998764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=377.98  Aligned_cols=149  Identities=22%  Similarity=0.307  Sum_probs=132.5

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.+|+.++|||||++++++.+.+..|+|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4578999999999999999999986 68999999986533  33456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEC---CCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD---SDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd---~~~~vKLsDFGLAr~~  234 (718)
                      ||||.+|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++   .++.+||+|||+++..
T Consensus        89 ~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            99999999999998765  5889999999999999999999   89999999999999998   4678999999998753

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=7.6e-41  Score=366.50  Aligned_cols=147  Identities=28%  Similarity=0.438  Sum_probs=133.8

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||.||+|... +++.||||++....   ......+.+|+.+|..++|||||+++++|...+..|+||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            57899999999999999999987 58899999986422   223467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+.+|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        95 e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  165 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML  165 (384)
T ss_dssp             CCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence            9999999999998754  5889999999999999999999   899999999999999999999999999999764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.3e-42  Score=352.93  Aligned_cols=149  Identities=26%  Similarity=0.356  Sum_probs=125.6

Q ss_pred             HhcCccccceecccCceEEEEEEEcC----CcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIARD----GKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~~----g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~  155 (718)
                      ..++|++.+.||+|+||.||+|.+..    +..||||.+... .....+.+.+|+.+++.++||||+++++++. .+..|
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            34678999999999999999998753    457999998653 3344567999999999999999999999984 56789


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +||||+++|+|.+++.... ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECcccccccc
Confidence            9999999999999998654 35889999999999999999999   899999999999999999999999999998764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.9e-42  Score=366.43  Aligned_cols=147  Identities=27%  Similarity=0.423  Sum_probs=127.1

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcE----EEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKL----LAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~----VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      ++|++.+.||+|+||.||+|.+. +++.    ||+|.+.... ......+.+|+.++..++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            57899999999999999999976 3443    8888875432 222346788999999999999999999986 566899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||||+.+|+|.+++.... ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        92 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence            999999999999997653 25788899999999999999999   899999999999999999999999999999864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.6e-41  Score=354.94  Aligned_cols=146  Identities=20%  Similarity=0.260  Sum_probs=130.7

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .++|++.+.||+|+||.||+|... +|+.||||++....  ....+.+|+.+++.+ +||||+++++++...+..|+|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            367999999999999999999975 68999999986432  223588999999999 99999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC-----EEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR-----GKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~-----vKLsDFGLAr~~  234 (718)
                      |+ +++|.+++.... ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.     +||+|||+++..
T Consensus        86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           86 LL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             eC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            99 999999998653 36899999999999999999999   899999999999999998887     999999999874

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6.5e-42  Score=357.00  Aligned_cols=151  Identities=28%  Similarity=0.402  Sum_probs=134.8

Q ss_pred             HhcCccccceecccCceEEEEEEE------cCCcEEEEEEcccCC-hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCC
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIA------RDGKLLAIKRLDTFS-LQTEREFQNELQILGGL-RSPFLVTLLGYCMERN  152 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~------~~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~  152 (718)
                      ..++|.+.+.||+|+||.||+|.+      .+++.||||++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            456899999999999999999985      246899999997543 34457799999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEE
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGN----------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVL  216 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~----------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NIL  216 (718)
                      ..++||||+++|+|.+++.....                ..+++..++.++.||+.||.|||   +.+|+||||||+|||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEE
Confidence            99999999999999999987542                24899999999999999999999   899999999999999


Q ss_pred             ECCCCCEEEeeccCceee
Q 005033          217 LDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       217 Ld~~~~vKLsDFGLAr~~  234 (718)
                      ++.++.+||+|||+++..
T Consensus       178 ~~~~~~~kl~Dfg~~~~~  195 (313)
T 1t46_A          178 LTHGRITKICDFGLARDI  195 (313)
T ss_dssp             EETTTEEEECCCGGGSCT
T ss_pred             EcCCCCEEEccccccccc
Confidence            999999999999998753

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.4e-42  Score=357.32  Aligned_cols=149  Identities=24%  Similarity=0.432  Sum_probs=133.1

Q ss_pred             HhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ..++|++.+.||+|+||.||+|...++..||||.+.... ...+.+.+|+.+++.++||||+++++++. .+..++||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence            446889999999999999999999888899999986543 34567999999999999999999999986 4568999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +++++|.+++.......+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence            99999999997543335889999999999999999999   899999999999999999999999999999864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.7e-42  Score=363.62  Aligned_cols=148  Identities=31%  Similarity=0.509  Sum_probs=134.3

Q ss_pred             cCccccceecccCceEEEEEEE-----cCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEe--eCCeEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM--ERNKRI  155 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~-----~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~--~~~~~~  155 (718)
                      ++|++.+.||+|+||.||+|.+     .+++.||||++........+.+.+|+.+++.++||||+++++++.  .....|
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5789999999999999999984     258899999998776667778999999999999999999999987  456789


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +||||+++++|.+++..... .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            99999999999999976432 5899999999999999999999   899999999999999999999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.5e-42  Score=363.35  Aligned_cols=154  Identities=23%  Similarity=0.391  Sum_probs=123.6

Q ss_pred             HHHHhcCccccceecccCceEEEEEEEcC-C---cEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC
Q 005033           78 LKNATNDFDEANVIGKGGSGTVFLGIARD-G---KLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMER  151 (718)
Q Consensus        78 l~~at~~f~~~~~LG~G~FG~Vykg~~~~-g---~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~  151 (718)
                      +....++|++.+.||+|+||.||+|.+.. +   ..||||++...  .....+.+.+|+.+++.++||||+++++++...
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            33455789999999999999999998764 3   28999998653  334467899999999999999999999999877


Q ss_pred             CeE------EEEEeccCCCCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC
Q 005033          152 NKR------ILVYEYMPNKSLQEMLFSDG----NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC  221 (718)
Q Consensus       152 ~~~------~LVmEy~~gGsL~~~L~~~~----~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~  221 (718)
                      ...      ++||||+.+|+|.+++....    ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTS
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCC
Confidence            655      99999999999999996432    125889999999999999999999   89999999999999999999


Q ss_pred             CEEEeeccCceee
Q 005033          222 RGKVSDFGLSRIK  234 (718)
Q Consensus       222 ~vKLsDFGLAr~~  234 (718)
                      .+||+|||+++..
T Consensus       175 ~~kl~Dfg~a~~~  187 (323)
T 3qup_A          175 TVCVADFGLSRKI  187 (323)
T ss_dssp             CEEECCCCC----
T ss_pred             CEEEeeccccccc
Confidence            9999999999764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=9.3e-41  Score=345.86  Aligned_cols=146  Identities=21%  Similarity=0.280  Sum_probs=130.9

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .++|++.+.||+|+||.||+|.+. +++.||||++....  ....+.+|+.++..+ +|+||+++++++......|+|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            467999999999999999999975 68999999986432  234578899999999 79999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC-----EEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR-----GKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~-----vKLsDFGLAr~~  234 (718)
                      |+ +++|.+++...+. .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.     +||+|||+++..
T Consensus        87 ~~-~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             ec-CCCHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            99 9999999987643 5899999999999999999999   999999999999999987776     999999999875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.3e-41  Score=367.73  Aligned_cols=148  Identities=28%  Similarity=0.351  Sum_probs=133.0

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~  155 (718)
                      ..++|++.+.||+|+||.||+|... +++.||||++....   ......+.+|..+|..+ +||||+++++++...+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3478999999999999999999987 48899999986532   23345688999999988 8999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +||||++||+|.+++...+  .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        98 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            9999999999999998654  5889999999999999999999   89999999999999999999999999999875

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.8e-42  Score=359.61  Aligned_cols=148  Identities=26%  Similarity=0.447  Sum_probs=130.1

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe----
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNK----  153 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~----  153 (718)
                      .++|++.+.||+|+||.||+|.+. +++.||||++....   ......+.+|+.++..++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            468999999999999999999985 68999999996532   3334678999999999999999999999876543    


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .|+||||+++|+|.+++...+  .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            499999999999999997654  5889999999999999999999   89999999999999999999999999999976


Q ss_pred             e
Q 005033          234 K  234 (718)
Q Consensus       234 ~  234 (718)
                      .
T Consensus       166 ~  166 (311)
T 3ork_A          166 I  166 (311)
T ss_dssp             -
T ss_pred             c
Confidence            4

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.9e-42  Score=360.44  Aligned_cols=159  Identities=23%  Similarity=0.388  Sum_probs=138.2

Q ss_pred             ccHHHHHHHhcCccccceecccCceEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEE
Q 005033           73 FTYKELKNATNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLL  145 (718)
Q Consensus        73 ~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~  145 (718)
                      +..+++....++|.+.+.||+|+||.||+|.+.      +++.||||.+.... ......+.+|+.+++.++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            334455566788999999999999999999865      36789999996533 34456799999999999999999999


Q ss_pred             EEEeeCCeEEEEEeccCCCCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 005033          146 GYCMERNKRILVYEYMPNKSLQEMLFSDG--------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL  217 (718)
Q Consensus       146 g~~~~~~~~~LVmEy~~gGsL~~~L~~~~--------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL  217 (718)
                      +++...+..|+||||+++|+|.+++....        ...+++..++.++.||+.||.|||   +.+|+||||||+|||+
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEE
Confidence            99999999999999999999999997532        135688999999999999999999   8999999999999999


Q ss_pred             CCCCCEEEeeccCceee
Q 005033          218 DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       218 d~~~~vKLsDFGLAr~~  234 (718)
                      +.++.+||+|||+++..
T Consensus       172 ~~~~~~kl~Dfg~~~~~  188 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDI  188 (322)
T ss_dssp             CTTCCEEECCTTCCCGG
T ss_pred             cCCCeEEECcCcccccc
Confidence            99999999999998753

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.9e-42  Score=347.68  Aligned_cols=148  Identities=29%  Similarity=0.473  Sum_probs=134.8

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      .++|++.+.||+|+||.||+|.+.+++.||||++..... ..+.+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            357889999999999999999998889999999976432 3467999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++++|.+++..... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        86 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  154 (267)
T 3t9t_A           86 EHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  154 (267)
T ss_dssp             TTCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             CCCcHHHHHhhCcc-cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccc
Confidence            99999999987543 5789999999999999999999   899999999999999999999999999988753

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-40  Score=349.52  Aligned_cols=145  Identities=24%  Similarity=0.358  Sum_probs=127.8

Q ss_pred             HHhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCC--CCCcceeEEEEEeeC----Ce
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGL--RSPFLVTLLGYCMER----NK  153 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L--~HpNIV~L~g~~~~~----~~  153 (718)
                      ...++|++.+.||+|+||.||+|.+. ++.||||++...   ....+.+|.+++..+  +||||+++++++...    ..
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            44578999999999999999999886 899999998542   234556666666655  999999999999887    78


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CeEecCCCCCCEEECCCCCEEE
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP--------PVIHGDIKPSNVLLDSDCRGKV  225 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~--------gIVHRDLKP~NILLd~~~~vKL  225 (718)
                      .|+||||+++|+|.+++...   .+++..++.++.|++.||.|||   ..        +|+||||||+|||++.++.+||
T Consensus       110 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             eEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence            99999999999999999765   5889999999999999999999   66        9999999999999999999999


Q ss_pred             eeccCceee
Q 005033          226 SDFGLSRIK  234 (718)
Q Consensus       226 sDFGLAr~~  234 (718)
                      +|||+++..
T Consensus       184 ~Dfg~a~~~  192 (337)
T 3mdy_A          184 ADLGLAVKF  192 (337)
T ss_dssp             CCCTTCEEC
T ss_pred             EeCCCceee
Confidence            999999764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=367.83  Aligned_cols=143  Identities=24%  Similarity=0.394  Sum_probs=125.6

Q ss_pred             cceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCCCCH
Q 005033           88 ANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSL  166 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL  166 (718)
                      .+.||+|+||.||+|... +|+.||||++........+.+.+|+.+|.+++||||+++++++...+..||||||+++|+|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            568999999999999986 6899999999876666677899999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE--CCCCCEEEeeccCceee
Q 005033          167 QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL--DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       167 ~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL--d~~~~vKLsDFGLAr~~  234 (718)
                      .+++.... ..+++..++.++.||+.||.|||   +.+|+||||||+|||+  +.++.+||+|||+++..
T Consensus       174 ~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~  239 (373)
T 2x4f_A          174 FDRIIDES-YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY  239 (373)
T ss_dssp             HHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence            99987653 35889999999999999999999   8999999999999999  66789999999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.5e-42  Score=364.19  Aligned_cols=146  Identities=25%  Similarity=0.352  Sum_probs=130.9

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCC--CcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTF--SLQTEREFQNELQILGGLRS--PFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~~~~~LV  157 (718)
                      .++|++.+.||+|+||.||++...+++.||||++...  .......+.+|+.+|..++|  +||+++++++...+..|||
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            3569999999999999999999988999999998643  33445779999999999976  9999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||| .+|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+++..
T Consensus        88 ~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             EeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            995 5899999998764  5888999999999999999999   89999999999999997 678999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-41  Score=353.38  Aligned_cols=149  Identities=29%  Similarity=0.442  Sum_probs=126.9

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-----hhhHHHHHHHHHHHhCC---CCCcceeEEEEEeeC
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-----LQTEREFQNELQILGGL---RSPFLVTLLGYCMER  151 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-----~~~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~~  151 (718)
                      ..++|++.+.||+|+||+||+|.+. +++.||||++....     ......+.+|+.+++.+   +||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4578999999999999999999975 68999999985321     11124567787777766   499999999999876


Q ss_pred             C-----eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEe
Q 005033          152 N-----KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVS  226 (718)
Q Consensus       152 ~-----~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLs  226 (718)
                      .     ..++||||+. |+|.+++.......+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            5     5799999995 69999998876656899999999999999999999   8999999999999999999999999


Q ss_pred             eccCcee
Q 005033          227 DFGLSRI  233 (718)
Q Consensus       227 DFGLAr~  233 (718)
                      |||+++.
T Consensus       163 Dfg~a~~  169 (308)
T 3g33_A          163 DFGLARI  169 (308)
T ss_dssp             SCSCTTT
T ss_pred             eCccccc
Confidence            9999875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.4e-41  Score=367.14  Aligned_cols=146  Identities=23%  Similarity=0.337  Sum_probs=131.1

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      .++|++.+.||+|+||.||++... +++.||||++.... .....+.+|+.+++.++||||+++++++...+..|+||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            468999999999999999999987 68999999996533 2335688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC--EEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR--GKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~--vKLsDFGLAr~  233 (718)
                      +++|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.  +||+|||+++.
T Consensus        98 ~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           98 ASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            99999999997654  5889999999999999999999   899999999999999987765  99999999874

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.2e-41  Score=345.23  Aligned_cols=149  Identities=26%  Similarity=0.398  Sum_probs=135.6

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|++........+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            3467999999999999999999987 478999999976555556789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE---CCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL---DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL---d~~~~vKLsDFGLAr~~  234 (718)
                      |+++++|.+++....  .+++..+..++.|++.||.|||   +.+|+||||||+|||+   +.++.+||+|||++...
T Consensus        87 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           87 LCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             CCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            999999999987654  5889999999999999999999   8999999999999999   78899999999998764

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.9e-41  Score=345.63  Aligned_cols=149  Identities=26%  Similarity=0.390  Sum_probs=134.0

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++|++.+.||+|+||.||+|... +|+.||||++.....   ...+.+.+|+.++..++||||+++++++...+..|+|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            467999999999999999999985 689999999854321   2246789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++++|.+++.... ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  162 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL  162 (278)
T ss_dssp             EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence            99999999999998653 36899999999999999999999   899999999999999999999999999998764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.5e-41  Score=346.24  Aligned_cols=139  Identities=26%  Similarity=0.402  Sum_probs=120.7

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~L  156 (718)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++...  .......+.+|+.++..+ +||||+++++++...+..|+
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3468999999999999999999987 6999999998653  234456788999999999 99999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC
Q 005033          157 VYEYMPNKSLQEMLFSDGN--LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR  222 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~--~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~  222 (718)
                      ||||+++|+|.+++.....  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~  153 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSI  153 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCC
Confidence            9999999999999976421  35899999999999999999999   899999999999999986653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=363.88  Aligned_cols=147  Identities=24%  Similarity=0.405  Sum_probs=123.3

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++....  ..+.+.+|+.+|.+++||||++++++|...+..|+|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4578999999999999999999987 58899999997532  34568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC---CCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~---~~~vKLsDFGLAr~~  234 (718)
                      |+++|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++..
T Consensus       129 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             CCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             eCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            999999999997654  5889999999999999999999   899999999999999975   889999999998753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.4e-42  Score=377.56  Aligned_cols=154  Identities=29%  Similarity=0.400  Sum_probs=137.0

Q ss_pred             HHHHHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHHHhCCCCCcceeEEEEEee
Q 005033           75 YKELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNELQILGGLRSPFLVTLLGYCME  150 (718)
Q Consensus        75 ~~el~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~  150 (718)
                      +.++....++|++.+.||+|+||.||+|.+. +++.||||++.....   .....+.+|+.++..++|||||+++++|.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            4455566789999999999999999999987 589999999864211   112347899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccC
Q 005033          151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL  230 (718)
Q Consensus       151 ~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGL  230 (718)
                      .+..|||||||+||+|.+++...   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccce
Confidence            99999999999999999999765   4788999999999999999999   89999999999999999999999999999


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      |+..
T Consensus       215 a~~~  218 (410)
T 3v8s_A          215 CMKM  218 (410)
T ss_dssp             CEEC
T ss_pred             eEee
Confidence            9864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.1e-41  Score=359.96  Aligned_cols=136  Identities=24%  Similarity=0.369  Sum_probs=118.1

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCC--------CCcceeEEEEEe---
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLR--------SPFLVTLLGYCM---  149 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~--------HpNIV~L~g~~~---  149 (718)
                      .++|++.+.||+|+||.||+|.+. +++.||||++... ......+.+|+.+|+.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            468999999999999999999876 5889999999753 344567899999999885        788999999997   


Q ss_pred             -eCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEECCCCC
Q 005033          150 -ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP-PVIHGDIKPSNVLLDSDCR  222 (718)
Q Consensus       150 -~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~-gIVHRDLKP~NILLd~~~~  222 (718)
                       .....||||||+ +++|.+++.......+++..++.++.||+.||.|||   +. +|+||||||+|||++.++.
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~  185 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccch
Confidence             556889999999 778877776655456899999999999999999999   77 9999999999999998764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.2e-41  Score=355.41  Aligned_cols=149  Identities=26%  Similarity=0.417  Sum_probs=118.5

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999986 58999999986533 2234678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDG----NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~----~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |++ |+|.+++....    ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            996 69999986532    135889999999999999999999   899999999999999999999999999998763

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.2e-41  Score=350.37  Aligned_cols=151  Identities=23%  Similarity=0.351  Sum_probs=133.2

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEee----CCeEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME----RNKRI  155 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~~  155 (718)
                      ..++|++.+.||+|+||.||++... +++.||||++........+.+.+|+.+++.++||||+++++++..    ....|
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            3468999999999999999999985 699999999876666667789999999999999999999999973    34789


Q ss_pred             EEEeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          156 LVYEYMPNKSLQEMLFSD--GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~--~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +||||+.+|+|.+++...  ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            999999999999999752  2236899999999999999999999   88999999999999999999999999999876


Q ss_pred             e
Q 005033          234 K  234 (718)
Q Consensus       234 ~  234 (718)
                      .
T Consensus       184 ~  184 (317)
T 2buj_A          184 A  184 (317)
T ss_dssp             S
T ss_pred             c
Confidence            4

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.2e-41  Score=346.84  Aligned_cols=148  Identities=32%  Similarity=0.480  Sum_probs=132.6

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      +.++|++.+.||+|+||.||+|.+. ++..||||++....   ......+.+|+.+++.++||||+++++++...+..|+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3468999999999999999999987 57899999985422   1224578999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||||+++|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.++|+|||++..
T Consensus        87 v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~  158 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH  158 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred             EEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEecccccc
Confidence            999999999999997654  5788999999999999999999   99999999999999999999999999998754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.9e-41  Score=353.50  Aligned_cols=148  Identities=22%  Similarity=0.301  Sum_probs=133.6

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh------hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL------QTEREFQNELQILGGLRSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~  154 (718)
                      .++|++.+.||+|+||.||+|.+. +|+.||||.+.....      .....+.+|+.++..++||||+++++++...+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467999999999999999999987 689999999864322      1356799999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC----CEEEeeccC
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC----RGKVSDFGL  230 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~----~vKLsDFGL  230 (718)
                      |+||||+++++|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++    .+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            99999999999999997654  5788999999999999999999   89999999999999999888    799999999


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      ++..
T Consensus       166 ~~~~  169 (321)
T 2a2a_A          166 AHEI  169 (321)
T ss_dssp             CEEC
T ss_pred             ceec
Confidence            8764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=359.41  Aligned_cols=143  Identities=28%  Similarity=0.437  Sum_probs=122.2

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHH--HhCCCCCcceeEEEEEee-----CCeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQI--LGGLRSPFLVTLLGYCME-----RNKR  154 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~i--L~~L~HpNIV~L~g~~~~-----~~~~  154 (718)
                      .++|++.+.||+|+||.||+|.. +++.||||++...   ....+..|.++  +..++||||+++++++..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46899999999999999999977 5899999998643   23345555555  445899999999986643     2357


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CeEecCCCCCCEEECCCCCEEE
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP---------PVIHGDIKPSNVLLDSDCRGKV  225 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~---------gIVHRDLKP~NILLd~~~~vKL  225 (718)
                      |+||||+++|+|.+++....   .++..+..++.||+.||.|||   +.         +|+||||||+|||++.++.+||
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEE
Confidence            89999999999999997763   588899999999999999999   77         9999999999999999999999


Q ss_pred             eeccCceee
Q 005033          226 SDFGLSRIK  234 (718)
Q Consensus       226 sDFGLAr~~  234 (718)
                      +|||+++..
T Consensus       162 ~DFG~a~~~  170 (336)
T 3g2f_A          162 SDFGLSMRL  170 (336)
T ss_dssp             CCCTTCEEC
T ss_pred             eeccceeec
Confidence            999999875

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1e-40  Score=375.28  Aligned_cols=148  Identities=26%  Similarity=0.454  Sum_probs=134.4

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++.....   .....+.+|+.+|+.++||||+++++++...+..|+|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            367999999999999999999987 799999999864321   2345789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        95 ~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             EECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence            99999999999997654  5899999999999999999999   999999999999999999999999999998764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.8e-42  Score=376.79  Aligned_cols=158  Identities=24%  Similarity=0.331  Sum_probs=140.2

Q ss_pred             ccHHHHHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHHHhCCCCCcceeEEEEE
Q 005033           73 FTYKELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNELQILGGLRSPFLVTLLGYC  148 (718)
Q Consensus        73 ~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~  148 (718)
                      ++++++....++|++.+.||+|+||.||+|... +|+.||||++.....   .....+.+|+.++..++||||++++++|
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            455666677889999999999999999999986 699999999965321   1223588999999999999999999999


Q ss_pred             eeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeec
Q 005033          149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDF  228 (718)
Q Consensus       149 ~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDF  228 (718)
                      .+.+..|||||||++|+|.+++...+. .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+||
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHSS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeec
Confidence            999999999999999999999976532 5889999999999999999999   899999999999999999999999999


Q ss_pred             cCceee
Q 005033          229 GLSRIK  234 (718)
Q Consensus       229 GLAr~~  234 (718)
                      |+++..
T Consensus       207 Gla~~~  212 (412)
T 2vd5_A          207 GSCLKL  212 (412)
T ss_dssp             TTCEEC
T ss_pred             hhheec
Confidence            999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.6e-41  Score=358.25  Aligned_cols=139  Identities=24%  Similarity=0.358  Sum_probs=125.0

Q ss_pred             cceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCCeEEEEEeccCCCC
Q 005033           88 ANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLR-SPFLVTLLGYCMERNKRILVYEYMPNKS  165 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmEy~~gGs  165 (718)
                      .+.||+|+||.||+|.+. +++.||||++..   .....+.+|+.++..+. ||||+++++++.+....|+||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            378999999999999987 689999999864   24457789999999997 9999999999999999999999999999


Q ss_pred             HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC---CEEEeeccCceee
Q 005033          166 LQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC---RGKVSDFGLSRIK  234 (718)
Q Consensus       166 L~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~---~vKLsDFGLAr~~  234 (718)
                      |.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++   .+||+|||+++..
T Consensus        93 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           93 LFERIKKKK--HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             HHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            999998764  6899999999999999999999   89999999999999997765   7999999999863

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.8e-41  Score=348.24  Aligned_cols=146  Identities=27%  Similarity=0.419  Sum_probs=130.9

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEee----------
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME----------  150 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----------  150 (718)
                      .++|++.+.||+|+||.||+|.+. +++.||||++....    ..+.+|+.++..++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            457999999999999999999987 79999999986543    256789999999999999999999864          


Q ss_pred             ------CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEE
Q 005033          151 ------RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGK  224 (718)
Q Consensus       151 ------~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vK  224 (718)
                            ....|+||||+++|+|.+++.......+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEE
Confidence                  445799999999999999997654457899999999999999999999   89999999999999999999999


Q ss_pred             EeeccCceee
Q 005033          225 VSDFGLSRIK  234 (718)
Q Consensus       225 LsDFGLAr~~  234 (718)
                      |+|||+++..
T Consensus       163 l~Dfg~~~~~  172 (284)
T 2a19_B          163 IGDFGLVTSL  172 (284)
T ss_dssp             ECCCTTCEES
T ss_pred             ECcchhheec
Confidence            9999998764

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.3e-41  Score=368.29  Aligned_cols=145  Identities=26%  Similarity=0.361  Sum_probs=130.0

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCC--CCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTF--SLQTEREFQNELQILGGLR--SPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~--HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      .+|++.+.||+|+||.||+|...+++.||||++...  .......+.+|+.+|..++  ||||+++++++...+..||||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            459999999999999999999888999999998643  3445578999999999996  599999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      | +.+++|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+++..
T Consensus       136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~  204 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  204 (390)
T ss_dssp             E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred             e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence            9 55899999998765  5788899999999999999999   99999999999999995 589999999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-41  Score=350.69  Aligned_cols=148  Identities=29%  Similarity=0.439  Sum_probs=130.7

Q ss_pred             hcCccccc-eecccCceEEEEEEEc---CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           82 TNDFDEAN-VIGKGGSGTVFLGIAR---DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        82 t~~f~~~~-~LG~G~FG~Vykg~~~---~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      .++|.+.. .||+|+||.||+|.+.   ++..||||++... .....+.+.+|+.++..++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            35666666 9999999999999864   5788999999764 334567899999999999999999999999 5567899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||||+++++|.+++.... ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            999999999999997543 35899999999999999999999   899999999999999999999999999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.1e-40  Score=343.54  Aligned_cols=148  Identities=24%  Similarity=0.374  Sum_probs=132.7

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      .++|++.+.||+|+||.||+|.+. +++.||||++...  .....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            578999999999999999999987 5899999998543  3344567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC---EEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR---GKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~---vKLsDFGLAr~~  234 (718)
                      ||+++++|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            9999999999887654  5889999999999999999999   899999999999999976655   999999998753

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3e-41  Score=357.75  Aligned_cols=154  Identities=25%  Similarity=0.338  Sum_probs=132.3

Q ss_pred             HHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC-----ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC
Q 005033           78 LKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF-----SLQTEREFQNELQILGGLRSPFLVTLLGYCMER  151 (718)
Q Consensus        78 l~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~-----~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~  151 (718)
                      +....++|++.+.||+|+||.||+|... ++..||||++...     .....+.+.+|+.+++.++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            4456678999999999999999999986 6889999998542     234456799999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCC--------------------------------------CCCCCHHHHHHHHHHHHHH
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDG--------------------------------------NLVLKWSQRFEIIMDVAKA  193 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~--------------------------------------~~~l~~~~~~~Ia~qIa~g  193 (718)
                      +..|+|||||++|+|.+++....                                      ...+++..+..++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999999985210                                      1123567788899999999


Q ss_pred             HHHHhcCCCCCeEecCCCCCCEEECCCC--CEEEeeccCceee
Q 005033          194 LEFLHFGCDPPVIHGDIKPSNVLLDSDC--RGKVSDFGLSRIK  234 (718)
Q Consensus       194 L~yLH~~~~~gIVHRDLKP~NILLd~~~--~vKLsDFGLAr~~  234 (718)
                      |.|||   +.+|+||||||+|||++.++  .+||+|||+++..
T Consensus       181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~  220 (345)
T 3hko_A          181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEF  220 (345)
T ss_dssp             HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEG
T ss_pred             HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccc
Confidence            99999   88999999999999998776  8999999999864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.4e-41  Score=366.94  Aligned_cols=145  Identities=23%  Similarity=0.415  Sum_probs=125.3

Q ss_pred             hcCcccc-ceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHH-hCCCCCcceeEEEEEee----CCeE
Q 005033           82 TNDFDEA-NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQIL-GGLRSPFLVTLLGYCME----RNKR  154 (718)
Q Consensus        82 t~~f~~~-~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL-~~L~HpNIV~L~g~~~~----~~~~  154 (718)
                      .++|.+. +.||+|+||+||+|.+. +|+.||||++...     ..+.+|+.++ +..+||||++++++|..    ....
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3567766 68999999999999987 6899999998642     3567888887 45589999999999876    5678


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC---CCCEEEeeccCc
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLS  231 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~---~~~vKLsDFGLA  231 (718)
                      |||||||++|+|.+++.......+++..+..|+.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            99999999999999998766556899999999999999999999   899999999999999987   789999999998


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      +..
T Consensus       212 ~~~  214 (400)
T 1nxk_A          212 KET  214 (400)
T ss_dssp             EEC
T ss_pred             ccc
Confidence            753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.5e-41  Score=355.75  Aligned_cols=144  Identities=28%  Similarity=0.456  Sum_probs=129.8

Q ss_pred             ccccceecccCceEEEEEEEc-----CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC--CeEEE
Q 005033           85 FDEANVIGKGGSGTVFLGIAR-----DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMER--NKRIL  156 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~~-----~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~L  156 (718)
                      |++.+.||+|+||.||++.+.     +++.||||++.... ......+.+|+.+++.++||||+++++++...  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488999999999999998753     58899999997543 34456799999999999999999999999874  67899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||||+++|+|.+++...   .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence            99999999999999765   4889999999999999999999   899999999999999999999999999999874

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.2e-41  Score=359.61  Aligned_cols=149  Identities=19%  Similarity=0.257  Sum_probs=132.9

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh--------hhHHHHHHHHHHHhCCCCCcceeEEEEEeeC
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL--------QTEREFQNELQILGGLRSPFLVTLLGYCMER  151 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~--------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~  151 (718)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++.....        .....+.+|+.+|+.++||||+++++++...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            3468999999999999999999976 689999999865321        1233577899999999999999999999999


Q ss_pred             CeEEEEEeccCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccC
Q 005033          152 NKRILVYEYMPNK-SLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL  230 (718)
Q Consensus       152 ~~~~LVmEy~~gG-sL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGL  230 (718)
                      +..++||||+.+| +|.+++....  .+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence            9999999999777 9999998764  5889999999999999999999   89999999999999999999999999999


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      ++..
T Consensus       177 a~~~  180 (335)
T 3dls_A          177 AAYL  180 (335)
T ss_dssp             CEEC
T ss_pred             ceEC
Confidence            8764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.6e-41  Score=357.59  Aligned_cols=151  Identities=22%  Similarity=0.390  Sum_probs=133.4

Q ss_pred             HhcCccccceecccCceEEEEEEEc--------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCC-CCCcceeEEEEEee
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR--------DGKLLAIKRLDTF-SLQTEREFQNELQILGGL-RSPFLVTLLGYCME  150 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~--------~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~  150 (718)
                      ..++|.+.+.||+|+||.||+|.+.        ++..||||++... .......+.+|+.+++.+ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3478999999999999999999873        4678999999754 334456799999999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEE
Q 005033          151 RNKRILVYEYMPNKSLQEMLFSDGN--------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVL  216 (718)
Q Consensus       151 ~~~~~LVmEy~~gGsL~~~L~~~~~--------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NIL  216 (718)
                      .+..|+||||+++|+|.+++.....              ..+++..++.++.||+.||.|||   +.+|+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEE
Confidence            9999999999999999999986542              24788999999999999999999   899999999999999


Q ss_pred             ECCCCCEEEeeccCceee
Q 005033          217 LDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       217 Ld~~~~vKLsDFGLAr~~  234 (718)
                      ++.++.+||+|||+++..
T Consensus       190 l~~~~~~kL~Dfg~~~~~  207 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDI  207 (334)
T ss_dssp             ECTTCCEEECCCTTCEEC
T ss_pred             EcCCCCEEEccccccccc
Confidence            999999999999999864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=354.30  Aligned_cols=146  Identities=23%  Similarity=0.322  Sum_probs=123.0

Q ss_pred             cCccccceecccCceEEEEEEEc----CCcEEEEEEcccCChhh-----------HHHHHHHHHHHhCCCCCcceeEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR----DGKLLAIKRLDTFSLQT-----------EREFQNELQILGGLRSPFLVTLLGY  147 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~----~g~~VAVK~i~~~~~~~-----------~~~f~~Ei~iL~~L~HpNIV~L~g~  147 (718)
                      ++|.+.+.||+|+||.||+|.+.    ++..||||++.......           ...+.+|+.++..++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            57999999999999999999986    57899999986543211           1246788999999999999999999


Q ss_pred             Eee----CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC--
Q 005033          148 CME----RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC--  221 (718)
Q Consensus       148 ~~~----~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~--  221 (718)
                      +..    ....|+||||+ +++|.+++...+  .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++  
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence            988    67899999999 999999997654  6899999999999999999999   88999999999999998877  


Q ss_pred             CEEEeeccCceee
Q 005033          222 RGKVSDFGLSRIK  234 (718)
Q Consensus       222 ~vKLsDFGLAr~~  234 (718)
                      .+||+|||+++..
T Consensus       191 ~~kL~Dfg~a~~~  203 (345)
T 2v62_A          191 QVYLADYGLSYRY  203 (345)
T ss_dssp             SEEECCCTTCEES
T ss_pred             cEEEEeCCCceec
Confidence            9999999999875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.9e-41  Score=369.36  Aligned_cols=147  Identities=29%  Similarity=0.425  Sum_probs=123.7

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHH-HhCCCCCcceeEEEEEeeCCeEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQI-LGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~i-L~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      .++|++.+.||+|+||.||+|... +++.||||++....   ......+.+|..+ ++.++||||+++++++...+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            367999999999999999999987 58899999996532   2233456777776 577899999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||||++||+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       117 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            999999999999997654  5788899999999999999999   89999999999999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.5e-41  Score=352.93  Aligned_cols=148  Identities=28%  Similarity=0.455  Sum_probs=129.4

Q ss_pred             cCccccceecccCceEEEEEEE-----cCCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC--CeE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIA-----RDGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMER--NKR  154 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~-----~~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~  154 (718)
                      ..|++.+.||+|+||.||+|.+     .+++.||||++.... ......+.+|+.++..++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588999999999999999984     358899999996432 23456789999999999999999999999876  668


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++||||+++|+|.+++..... .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            999999999999999965432 5889999999999999999999   899999999999999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.9e-41  Score=353.94  Aligned_cols=159  Identities=26%  Similarity=0.358  Sum_probs=137.4

Q ss_pred             ccHHHHHHHhcCccccceecccCceEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCC-CCCcceeE
Q 005033           73 FTYKELKNATNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFS-LQTEREFQNELQILGGL-RSPFLVTL  144 (718)
Q Consensus        73 ~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L  144 (718)
                      +...++....++|.+.+.||+|+||.||+|.+.      +++.||||++.... ....+.+.+|+.++..+ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            455556666789999999999999999999852      46899999997543 33456799999999999 79999999


Q ss_pred             EEEEeeCC-eEEEEEeccCCCCHHHHHhhCCCC--------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 005033          145 LGYCMERN-KRILVYEYMPNKSLQEMLFSDGNL--------------VLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGD  209 (718)
Q Consensus       145 ~g~~~~~~-~~~LVmEy~~gGsL~~~L~~~~~~--------------~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRD  209 (718)
                      ++++...+ ..|+||||+++|+|.+++......              .+++..++.++.||+.||.|||   +.+|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence            99998755 589999999999999999876431              2788999999999999999999   89999999


Q ss_pred             CCCCCEEECCCCCEEEeeccCceee
Q 005033          210 IKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       210 LKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+|||++.++.+||+|||+++..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~  198 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDI  198 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCT
T ss_pred             CccceEEECCCCCEEECCCcccccc
Confidence            9999999999999999999998753

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=346.66  Aligned_cols=147  Identities=28%  Similarity=0.427  Sum_probs=133.4

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ++|++.+.||+|+||.||+|.+. +|+.||||++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            68999999999999999999987 58999999885432  2335678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+++++|.+++....  .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        83 ~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  152 (311)
T 4agu_A           83 YCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLL  152 (311)
T ss_dssp             CCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             eCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence            999999999887654  5889999999999999999999   899999999999999999999999999999764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-40  Score=358.89  Aligned_cols=147  Identities=30%  Similarity=0.538  Sum_probs=124.1

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCC--eE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLR-SPFLVTLLGYCMERN--KR  154 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~--~~  154 (718)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++...  .......+.+|+.+|..+. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4578999999999999999999986 6899999998542  3344567889999999997 999999999997654  78


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+|||||. |+|.+++...   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus        87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            99999996 7999999864   5888999999999999999999   899999999999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.3e-41  Score=353.25  Aligned_cols=150  Identities=23%  Similarity=0.312  Sum_probs=131.9

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCC-CCcceeEEEEEe--------e
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLR-SPFLVTLLGYCM--------E  150 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~--------~  150 (718)
                      ...+|++.+.||+|+||.||+|.+. +++.||||++..........+.+|+.++.++. ||||+++++++.        .
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            3468999999999999999999986 68999999987666666778999999999996 999999999994        3


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEECCCCCEEEee
Q 005033          151 RNKRILVYEYMPNKSLQEMLFSD-GNLVLKWSQRFEIIMDVAKALEFLHFGCDPP--VIHGDIKPSNVLLDSDCRGKVSD  227 (718)
Q Consensus       151 ~~~~~LVmEy~~gGsL~~~L~~~-~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~g--IVHRDLKP~NILLd~~~~vKLsD  227 (718)
                      ....++||||+ +|+|.+++... ....+++..++.++.||+.||.|||   ..+  |+||||||+|||++.++.+||+|
T Consensus       106 ~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          106 QAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             SEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             CceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEec
Confidence            44589999999 58999998652 2235899999999999999999999   888  99999999999999999999999


Q ss_pred             ccCceee
Q 005033          228 FGLSRIK  234 (718)
Q Consensus       228 FGLAr~~  234 (718)
                      ||+++..
T Consensus       182 fg~~~~~  188 (337)
T 3ll6_A          182 FGSATTI  188 (337)
T ss_dssp             CTTCBCC
T ss_pred             Cccceec
Confidence            9999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2e-41  Score=357.92  Aligned_cols=154  Identities=27%  Similarity=0.390  Sum_probs=134.9

Q ss_pred             HHHHhcCccccceecccCceEEEEEEEcC-C-----cEEEEEEcccCC-hhhHHHHHHHHHHHhCC-CCCcceeEEEEEe
Q 005033           78 LKNATNDFDEANVIGKGGSGTVFLGIARD-G-----KLLAIKRLDTFS-LQTEREFQNELQILGGL-RSPFLVTLLGYCM  149 (718)
Q Consensus        78 l~~at~~f~~~~~LG~G~FG~Vykg~~~~-g-----~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~  149 (718)
                      +....++|.+.+.||+|+||.||+|.+.. +     ..||||.+.... ......+.+|+.++..+ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            34456789999999999999999999752 2     479999996543 34456799999999999 8999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 005033          150 ERNKRILVYEYMPNKSLQEMLFSDG------------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL  217 (718)
Q Consensus       150 ~~~~~~LVmEy~~gGsL~~~L~~~~------------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL  217 (718)
                      ..+..|+||||+++|+|.+++....            ...+++..++.++.||+.||.|||   +.+|+||||||+|||+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEE
Confidence            9999999999999999999997532            235788999999999999999999   8999999999999999


Q ss_pred             CCCCCEEEeeccCceee
Q 005033          218 DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       218 d~~~~vKLsDFGLAr~~  234 (718)
                      +.++.+||+|||+++..
T Consensus       198 ~~~~~~kl~Dfg~~~~~  214 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDI  214 (333)
T ss_dssp             EGGGEEEBCCCGGGCCG
T ss_pred             CCCCeEEECcccccccc
Confidence            99999999999998754

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=360.79  Aligned_cols=148  Identities=26%  Similarity=0.507  Sum_probs=127.0

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCc----EEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGK----LLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~----~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~  155 (718)
                      .++|++.+.||+|+||.||+|.+. +++    .||+|.+... .......+.+|+.++..++||||++++++|.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            367999999999999999999975 344    3577777542 3345678999999999999999999999998765 78


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +|+||+.+|+|.+++..... .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            99999999999999987543 5889999999999999999999   899999999999999999999999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.3e-40  Score=343.90  Aligned_cols=146  Identities=30%  Similarity=0.502  Sum_probs=132.2

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||.||+|... +++.||||++....   ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            67999999999999999999987 57899999985422   122467899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||+++|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++..
T Consensus        94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~  163 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVH  163 (284)
T ss_dssp             CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEeccccccc
Confidence            9999999999997654  5789999999999999999999   99999999999999999999999999998865

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.8e-40  Score=344.50  Aligned_cols=148  Identities=22%  Similarity=0.362  Sum_probs=131.6

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++|++.+.||+|+||.||+|.+. +++.||||++....   ....+.+.+|+.++..++||||+++++++...+..|+|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999986 68999999986532   23346789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++++|.+++....  .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus       113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            99999999999998654  5889999999999999999999   899999999999999999999999999998753

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.5e-40  Score=347.70  Aligned_cols=150  Identities=25%  Similarity=0.404  Sum_probs=128.0

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++|++.+.||+|+||.||+|... +|+.||||++...   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            357999999999999999999985 6899999998642   344556799999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSD--GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~--~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++|+|.+++...  ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999999642  2236889999999999999999999   899999999999999999999999999988753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.7e-40  Score=343.34  Aligned_cols=148  Identities=22%  Similarity=0.312  Sum_probs=134.1

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++...   .....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            367899999999999999999987 5889999998543   234456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++++|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        94 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  165 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  165 (294)
T ss_dssp             EECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence            99999999999987654  5889999999999999999999   899999999999999999999999999998764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-40  Score=354.78  Aligned_cols=148  Identities=27%  Similarity=0.427  Sum_probs=129.0

Q ss_pred             cCccccceecccCceEEEEEEEcC-----CcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARD-----GKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~-----g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      ++|.+.+.||+|+||.||+|....     +..||||++... .......+.+|+.++..++||||+++++++...+..|+
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            467778999999999999998753     246999999653 33445679999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||||+++|+|.+++..... .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       124 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTT-CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEeCCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            9999999999999986533 6889999999999999999999   899999999999999999999999999998764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.2e-40  Score=346.17  Aligned_cols=146  Identities=27%  Similarity=0.445  Sum_probs=123.9

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .++|++.+.||+|+||.||+|.+.  ..||||++...  .....+.|.+|+.+++.++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            467999999999999999999864  45999998643  344557799999999999999999999965 4566899999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+.+++|.+++.... ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A          100 WCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             ecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccc
Confidence            999999999996554 36889999999999999999999   899999999999999999999999999998753

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.3e-41  Score=347.42  Aligned_cols=146  Identities=36%  Similarity=0.513  Sum_probs=127.1

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC-CeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMER-NKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-~~~~LVmEy  160 (718)
                      .++|++.+.||+|+||.||+|... |+.||||++....  ..+.+.+|+.++..++||||+++++++... +..|+||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            467899999999999999999875 8899999997543  456799999999999999999999997654 478999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +++|+|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~  166 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  166 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccc
Confidence            99999999997654434788999999999999999999   89999999999999999999999999998864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.9e-41  Score=385.46  Aligned_cols=152  Identities=26%  Similarity=0.402  Sum_probs=135.1

Q ss_pred             HHHHhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           78 LKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        78 l~~at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      +....++|++.+.||+|+||.||+|.+.++..||||++.... ...+.|.+|+.+|++++|+|||++++++.. +..|||
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            334557789999999999999999999888889999997643 235679999999999999999999999876 678999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||||.+|+|.++|.......+++..++.|+.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            99999999999997543335889999999999999999999   899999999999999999999999999999764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.5e-41  Score=345.76  Aligned_cols=149  Identities=28%  Similarity=0.398  Sum_probs=130.7

Q ss_pred             HhcCccccceecccCceEEEEEEEcC----CcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIARD----GKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~~----g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~  155 (718)
                      ..++|.+.+.||+|+||.||+|.+..    +..||||.+... .....+.|.+|+.+++.++||||+++++++.. +..|
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            34689999999999999999998753    346999998754 34456789999999999999999999999865 4568


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +||||+++++|.+++..... .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence            99999999999999976532 5889999999999999999999   899999999999999999999999999998764

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=344.33  Aligned_cols=148  Identities=27%  Similarity=0.341  Sum_probs=130.7

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      +|.....||+|+||.||+|.+. +++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            4555669999999999999986 688999999976655566789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC-CCCEEEeeccCceee
Q 005033          163 NKSLQEMLFSDG-NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS-DCRGKVSDFGLSRIK  234 (718)
Q Consensus       163 gGsL~~~L~~~~-~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~-~~~vKLsDFGLAr~~  234 (718)
                      +++|.+++.... ...+++..+..++.||+.||.|||   +.+|+||||||+|||++. ++.+||+|||+++..
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            999999998653 345678888999999999999999   899999999999999987 899999999998763

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-40  Score=354.24  Aligned_cols=151  Identities=26%  Similarity=0.460  Sum_probs=125.5

Q ss_pred             HHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChh-----hHHHHHHHHHHHhCCCCCcceeEEEEEeeCC
Q 005033           79 KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQ-----TEREFQNELQILGGLRSPFLVTLLGYCMERN  152 (718)
Q Consensus        79 ~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~-----~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~  152 (718)
                      ....++|++.+.||+|+||.||+|.+. +|+.||||++......     ..+.+.+|+.+++.++||||+++++++...+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344578999999999999999999986 5899999998643211     1246889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                      ..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           86 NISLVFDFME-TDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CCEEEEECCS-EEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             ceEEEEEcCC-CCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            9999999996 49999987654 35778889999999999999999   8999999999999999999999999999987


Q ss_pred             ee
Q 005033          233 IK  234 (718)
Q Consensus       233 ~~  234 (718)
                      ..
T Consensus       161 ~~  162 (346)
T 1ua2_A          161 SF  162 (346)
T ss_dssp             TT
T ss_pred             ec
Confidence            53

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.1e-41  Score=360.79  Aligned_cols=147  Identities=25%  Similarity=0.386  Sum_probs=130.5

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .+.|+..+.||+|+||.||+|... +|+.||||++....   ....+.+.+|+.+++.++||||+++++++...+..|||
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            345889999999999999999975 68999999986432   23346789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |||+. |+|.+++.... ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       133 ~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  203 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI  203 (348)
T ss_dssp             EECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             EecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence            99996 78988886443 26899999999999999999999   88999999999999999999999999998865

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.6e-40  Score=341.63  Aligned_cols=149  Identities=27%  Similarity=0.352  Sum_probs=129.6

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC----hhhHHHHHHHHHHHhCCCCCcceeEEEEEe--eCCeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS----LQTEREFQNELQILGGLRSPFLVTLLGYCM--ERNKR  154 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~--~~~~~  154 (718)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++....    ......+.+|+.+++.++||||+++++++.  ..+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999986 68999999986532    234567999999999999999999999984  45678


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+||||+.++ |.+++.......+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999766 888887765557899999999999999999999   899999999999999999999999999998764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.1e-40  Score=344.98  Aligned_cols=148  Identities=27%  Similarity=0.455  Sum_probs=131.2

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ..++|.+.+.||+|+||.||+|... +|+.||||++..........+.+|+.++..++||||+++++++...+..|+|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3467999999999999999999987 689999999976544455678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE---CCCCCEEEeeccCcee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL---DSDCRGKVSDFGLSRI  233 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL---d~~~~vKLsDFGLAr~  233 (718)
                      |+++++|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++.
T Consensus        87 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~  158 (304)
T 2jam_A           87 LVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM  158 (304)
T ss_dssp             CCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred             cCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence            999999999997654  5788999999999999999999   8999999999999999   7889999999998864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.1e-40  Score=349.10  Aligned_cols=147  Identities=23%  Similarity=0.340  Sum_probs=131.0

Q ss_pred             cCcccc-ceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEEEe
Q 005033           83 NDFDEA-NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        83 ~~f~~~-~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      +.|.+. +.||+|+||.||+|.+. +++.||||++..........+.+|+.++.++ +||||+++++++...+..|+|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            567774 78999999999999976 6899999999765555567899999999885 79999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC---EEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR---GKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~---vKLsDFGLAr~~  234 (718)
                      |+++|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.   +||+|||+++..
T Consensus        92 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           92 KMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             cCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            999999999997654  5789999999999999999999   889999999999999988776   999999998764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.6e-40  Score=340.37  Aligned_cols=148  Identities=27%  Similarity=0.383  Sum_probs=134.3

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467999999999999999999987 68999999986432 3345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+++++|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus        86 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  155 (276)
T 2yex_A           86 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (276)
T ss_dssp             CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence            999999999987543  5889999999999999999999   899999999999999999999999999998764

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=8.3e-41  Score=353.28  Aligned_cols=148  Identities=34%  Similarity=0.571  Sum_probs=129.7

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcE--EEEEEcccC-ChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKL--LAIKRLDTF-SLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~--VAVK~i~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ++|++.+.||+|+||.||+|.+. ++..  ||||.+... .....+.+.+|+.++.++ +||||+++++++...+..|+|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57899999999999999999976 4654  499988653 233445789999999999 999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCE
Q 005033          158 YEYMPNKSLQEMLFSDG--------------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG  223 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~--------------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~v  223 (718)
                      |||+++|+|.+++....              ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999997653              236899999999999999999999   8999999999999999999999


Q ss_pred             EEeeccCcee
Q 005033          224 KVSDFGLSRI  233 (718)
Q Consensus       224 KLsDFGLAr~  233 (718)
                      ||+|||+++.
T Consensus       182 kL~Dfg~~~~  191 (327)
T 1fvr_A          182 KIADFGLSRG  191 (327)
T ss_dssp             EECCTTCEES
T ss_pred             EEcccCcCcc
Confidence            9999998864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=363.36  Aligned_cols=150  Identities=27%  Similarity=0.442  Sum_probs=132.2

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC--eEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERN--KRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~--~~~LV  157 (718)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|+++++.++||||+++++++...+  ..|+|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            357899999999999999999987 58999999996533 233567889999999999999999999998765  78999


Q ss_pred             EeccCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE----CCCCCEEEeeccCce
Q 005033          158 YEYMPNKSLQEMLFSDGN-LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL----DSDCRGKVSDFGLSR  232 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~-~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL----d~~~~vKLsDFGLAr  232 (718)
                      ||||++|+|.+++..... ..+++..++.++.||+.||.|||   +.+|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999976432 23899999999999999999999   8999999999999999    777889999999997


Q ss_pred             ee
Q 005033          233 IK  234 (718)
Q Consensus       233 ~~  234 (718)
                      ..
T Consensus       165 ~~  166 (396)
T 4eut_A          165 EL  166 (396)
T ss_dssp             EC
T ss_pred             Ec
Confidence            64

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.9e-40  Score=342.39  Aligned_cols=145  Identities=26%  Similarity=0.359  Sum_probs=128.1

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEee----CCeEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCME----RNKRIL  156 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~~L  156 (718)
                      .|.+.+.||+|+||.||+|.+. ++..||+|.+...  .....+.+.+|+.+++.++||||+++++++..    ....|+
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3677889999999999999986 5889999998643  34456779999999999999999999999875    356899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEEC-CCCCEEEeeccCcee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP--VIHGDIKPSNVLLD-SDCRGKVSDFGLSRI  233 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~g--IVHRDLKP~NILLd-~~~~vKLsDFGLAr~  233 (718)
                      ||||+++|+|.+++....  .+++..+..++.||+.||.|||   +.+  |+||||||+|||++ .++.+||+|||++..
T Consensus       107 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            999999999999998654  5788999999999999999999   777  99999999999997 789999999998864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.9e-40  Score=351.58  Aligned_cols=148  Identities=22%  Similarity=0.312  Sum_probs=134.4

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++|.+.+.||+|+||.||++.+. +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467999999999999999999987 5889999998543   234556789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+.+++|.+++....  .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       120 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  191 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  191 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence            99999999999987654  5889999999999999999999   899999999999999999999999999998764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.9e-41  Score=348.29  Aligned_cols=148  Identities=27%  Similarity=0.422  Sum_probs=129.7

Q ss_pred             HhcCccccc-eecccCceEEEEEEEc---CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeE
Q 005033           81 ATNDFDEAN-VIGKGGSGTVFLGIAR---DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        81 at~~f~~~~-~LG~G~FG~Vykg~~~---~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~  154 (718)
                      ..++|.+.+ .||+|+||.||+|.+.   +++.||||++....  ....+.+.+|+.+++.++||||+++++++ ..+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            346788887 9999999999999653   46899999986532  23356799999999999999999999999 66778


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+||||+++++|.+++....  .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            99999999999999998764  5889999999999999999999   899999999999999999999999999999864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.8e-40  Score=371.30  Aligned_cols=145  Identities=26%  Similarity=0.410  Sum_probs=125.8

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC------C
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMER------N  152 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~  152 (718)
                      .++|++.+.||+|+||.||+|.+. +++.||||++...  .....+.+.+|+.+|+.++|||||++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            478999999999999999999986 6899999999653  334456789999999999999999999999654      4


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                      ..|||||||. ++|.+.+..    .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+
T Consensus       141 ~~~lv~E~~~-~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCS-EEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             eEEEEEeCCC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            6799999995 567777743    3788999999999999999999   8999999999999999999999999999997


Q ss_pred             ee
Q 005033          233 IK  234 (718)
Q Consensus       233 ~~  234 (718)
                      ..
T Consensus       213 ~~  214 (464)
T 3ttj_A          213 TA  214 (464)
T ss_dssp             --
T ss_pred             ec
Confidence            53

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.3e-40  Score=342.82  Aligned_cols=147  Identities=23%  Similarity=0.381  Sum_probs=132.7

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh------hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL------QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~  155 (718)
                      ++|.+.+.||+|+||.||+|... +++.||||.+.....      ...+.+.+|+.+++.++||||+++++++...+..|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            57899999999999999999987 689999999864321      13567999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC----CEEEeeccCc
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC----RGKVSDFGLS  231 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~----~vKLsDFGLA  231 (718)
                      +||||+++++|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++    .+||+|||++
T Consensus        85 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            9999999999999997643  5889999999999999999999   89999999999999998877    8999999998


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      ...
T Consensus       160 ~~~  162 (283)
T 3bhy_A          160 HKI  162 (283)
T ss_dssp             EEC
T ss_pred             eec
Confidence            763

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-40  Score=368.08  Aligned_cols=147  Identities=23%  Similarity=0.461  Sum_probs=123.1

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC-----Ce
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMER-----NK  153 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~  153 (718)
                      .++|++.+.||+|+||.||+|.+. +++.||||++...  .....+.+.+|+.+|+.++|||||++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999987 6899999998642  334457799999999999999999999999543     56


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .|+||||+ +|+|.+++....  .+++..+..++.||+.||.|||   +.+||||||||+||||+.++.+||+|||+|+.
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence            89999998 689999997654  5899999999999999999999   89999999999999999999999999999987


Q ss_pred             e
Q 005033          234 K  234 (718)
Q Consensus       234 ~  234 (718)
                      .
T Consensus       206 ~  206 (458)
T 3rp9_A          206 V  206 (458)
T ss_dssp             T
T ss_pred             c
Confidence            5

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-40  Score=342.80  Aligned_cols=147  Identities=28%  Similarity=0.396  Sum_probs=128.5

Q ss_pred             CccccceecccCceEEEEEEEcC----CcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeE-EEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIARD----GKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKR-ILV  157 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~~----g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~-~LV  157 (718)
                      .|...+.||+|+||.||+|.+.+    +..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45567899999999999998643    2379999987533 34557899999999999999999999999876655 999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+.+|+|.+++.... ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       102 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             ECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             EecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            99999999999997643 36788999999999999999999   899999999999999999999999999998753

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.7e-40  Score=344.87  Aligned_cols=148  Identities=26%  Similarity=0.424  Sum_probs=129.3

Q ss_pred             cCccccceecccCceEEEEEEEcC----CcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEe-eCCeEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARD----GKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCM-ERNKRIL  156 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~----g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~-~~~~~~L  156 (718)
                      .+|++.+.||+|+||.||+|.+.+    ...||||.+... .....+.+.+|+.++++++||||+++++++. ..+..|+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            468889999999999999998652    336899998753 3345577999999999999999999999965 4567899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||||+++|+|.+++.... ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccc
Confidence            999999999999997643 35788999999999999999999   899999999999999999999999999998764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.8e-40  Score=341.33  Aligned_cols=150  Identities=24%  Similarity=0.357  Sum_probs=132.0

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .++|.+.+.||+|+||.||+|... ++..||||++.... ....+.+.+|+.+++.++||||+++++++......|+|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            357899999999999999999986 58999999986532 2345679999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE---CCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDG--NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL---DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~--~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL---d~~~~vKLsDFGLAr~~  234 (718)
                      |+++|+|.+++....  ...+++..+..++.||+.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++..
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            999999999985431  236899999999999999999999   8999999999999999   45678999999998753

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-40  Score=349.08  Aligned_cols=155  Identities=25%  Similarity=0.423  Sum_probs=127.8

Q ss_pred             HHHHHhcCccccceecccCceEEEEEEEc----CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEee
Q 005033           77 ELKNATNDFDEANVIGKGGSGTVFLGIAR----DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCME  150 (718)
Q Consensus        77 el~~at~~f~~~~~LG~G~FG~Vykg~~~----~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~  150 (718)
                      ++....++|.+.+.||+|+||.||+|...    ++..||||++...  .....+.+.+|+.+++.++||||+++++++..
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            33445578899999999999999999875    2458999998643  33445679999999999999999999999987


Q ss_pred             CC-----eEEEEEeccCCCCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC
Q 005033          151 RN-----KRILVYEYMPNKSLQEMLFSD----GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC  221 (718)
Q Consensus       151 ~~-----~~~LVmEy~~gGsL~~~L~~~----~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~  221 (718)
                      .+     ..|+||||+++|+|.+++...    ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTS
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCC
Confidence            65     359999999999999999542    2346899999999999999999999   89999999999999999999


Q ss_pred             CEEEeeccCceee
Q 005033          222 RGKVSDFGLSRIK  234 (718)
Q Consensus       222 ~vKLsDFGLAr~~  234 (718)
                      .+||+|||+++..
T Consensus       185 ~~kl~Dfg~~~~~  197 (313)
T 3brb_A          185 TVCVADFGLSKKI  197 (313)
T ss_dssp             CEEECSCSCC---
T ss_pred             cEEEeecCcceec
Confidence            9999999998764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-40  Score=356.45  Aligned_cols=146  Identities=28%  Similarity=0.440  Sum_probs=133.3

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++..++||||+++++++...+..|+||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            57999999999999999999987 6899999998654 344456799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP-PVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~-gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +++|+|.+++...+  .+++..+..++.||+.||.|||   .. +|+||||||+|||++.++.+||+|||+++.
T Consensus       113 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  181 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  181 (360)
T ss_dssp             CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence            99999999998754  5788999999999999999999   74 899999999999999999999999998864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.1e-41  Score=347.95  Aligned_cols=150  Identities=27%  Similarity=0.414  Sum_probs=131.3

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEee--CCeEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCME--RNKRIL  156 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~L  156 (718)
                      .++|++.+.||+|+||.||+|... +++.||+|.+...  .....+.+.+|+.+++.++||||+++++++..  ....|+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999987 6899999998643  33445679999999999999999999998854  568899


Q ss_pred             EEeccCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEecCCCCCCEEECCCCCEEEeecc
Q 005033          157 VYEYMPNKSLQEMLFSDG--NLVLKWSQRFEIIMDVAKALEFLHFGCDPP-----VIHGDIKPSNVLLDSDCRGKVSDFG  229 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~--~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~g-----IVHRDLKP~NILLd~~~~vKLsDFG  229 (718)
                      ||||+++|+|.+++....  ...+++..++.++.||+.||.|||   +.+     |+||||||+|||++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999997532  235899999999999999999999   777     9999999999999999999999999


Q ss_pred             Cceee
Q 005033          230 LSRIK  234 (718)
Q Consensus       230 LAr~~  234 (718)
                      +++..
T Consensus       162 ~~~~~  166 (279)
T 2w5a_A          162 LARIL  166 (279)
T ss_dssp             HHHHC
T ss_pred             hheee
Confidence            88753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.5e-40  Score=345.04  Aligned_cols=147  Identities=31%  Similarity=0.477  Sum_probs=133.6

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .+.|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            357899999999999999999876 68999999986432 3345789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+++++|.+++...   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  169 (303)
T 3a7i_A          101 YLGGGSALDLLEPG---PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL  169 (303)
T ss_dssp             CCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             eCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceec
Confidence            99999999999653   5889999999999999999999   899999999999999999999999999998764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.4e-40  Score=357.42  Aligned_cols=145  Identities=23%  Similarity=0.357  Sum_probs=127.8

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++.....    .+.+|++++.++ +||||+++++++.+.+..|+||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4568999999999999999999987 689999999965432    245688888887 7999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC----CCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD----CRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~----~~vKLsDFGLAr~~  234 (718)
                      |||++|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||+.++    +.+||+|||+++..
T Consensus        96 E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            9999999999997764  5899999999999999999999   8999999999999998543    35999999999864

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-40  Score=359.07  Aligned_cols=148  Identities=33%  Similarity=0.416  Sum_probs=132.1

Q ss_pred             hcCccccceecccCceEEEEEEEc----CCcEEEEEEcccCC----hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCC
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR----DGKLLAIKRLDTFS----LQTEREFQNELQILGGL-RSPFLVTLLGYCMERN  152 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~----~g~~VAVK~i~~~~----~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~  152 (718)
                      .++|++.+.||+|+||.||+|...    +++.||||++....    ......+.+|+.+|..+ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            368999999999999999999983    68999999986422    12334577899999999 6999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                      ..||||||+++|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            9999999999999999997654  5889999999999999999999   8999999999999999999999999999987


Q ss_pred             ee
Q 005033          233 IK  234 (718)
Q Consensus       233 ~~  234 (718)
                      ..
T Consensus       208 ~~  209 (355)
T 1vzo_A          208 EF  209 (355)
T ss_dssp             EC
T ss_pred             ec
Confidence            64

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.2e-40  Score=353.22  Aligned_cols=150  Identities=21%  Similarity=0.265  Sum_probs=131.1

Q ss_pred             HHHhcCccccceecccCceEEEEEE------EcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCC---CCcceeEEEEEe
Q 005033           79 KNATNDFDEANVIGKGGSGTVFLGI------ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLR---SPFLVTLLGYCM  149 (718)
Q Consensus        79 ~~at~~f~~~~~LG~G~FG~Vykg~------~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~  149 (718)
                      ....++|.+.+.||+|+||.||+|.      ..+++.||||++....   ..++..|+.++..++   |+||+++++++.
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            3445789999999999999999994      3368999999997543   446788888888886   999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC-------
Q 005033          150 ERNKRILVYEYMPNKSLQEMLFSD---GNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS-------  219 (718)
Q Consensus       150 ~~~~~~LVmEy~~gGsL~~~L~~~---~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~-------  219 (718)
                      ..+..|||||||++|+|.+++...   ....+++..++.|+.||+.||.|||   +.+||||||||+|||++.       
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC--
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccc
Confidence            999999999999999999999742   2236899999999999999999999   899999999999999998       


Q ss_pred             ----CCCEEEeeccCceee
Q 005033          220 ----DCRGKVSDFGLSRIK  234 (718)
Q Consensus       220 ----~~~vKLsDFGLAr~~  234 (718)
                          ++.+||+|||+|+..
T Consensus       215 ~~~~~~~~kl~DFG~a~~~  233 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDM  233 (365)
T ss_dssp             ----CTTEEECCCTTCEEG
T ss_pred             cccccCCEEEeeCchhhhh
Confidence                899999999999864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.4e-40  Score=341.92  Aligned_cols=147  Identities=22%  Similarity=0.372  Sum_probs=123.8

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEE-eeCCeEEEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC-MERNKRILVY  158 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~-~~~~~~~LVm  158 (718)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++....  ....+.+|+.++..++|++++..++++ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            4578999999999999999999985 68999999875432  223578899999999988776666555 6677889999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE---CCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL---DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL---d~~~~vKLsDFGLAr~~  234 (718)
                      ||+ +++|.+++..... .+++..+..++.||+.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 9999999985433 5899999999999999999999   8999999999999999   78899999999999875

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-40  Score=353.85  Aligned_cols=149  Identities=21%  Similarity=0.358  Sum_probs=128.1

Q ss_pred             HHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh--hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL--QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      ...++|++.+.||+|+||.||+|.+. +++.||||++.....  .....+.+|+.+++.++||||+++++++...+..||
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            44578999999999999999999976 689999999965432  224567899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEC-----CCCCEEEeeccCc
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD-----SDCRGKVSDFGLS  231 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd-----~~~~vKLsDFGLA  231 (718)
                      ||||+. |+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++     .++.+||+|||++
T Consensus       111 v~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            999996 69999998765  5889999999999999999999   89999999999999994     4556999999988


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      +..
T Consensus       185 ~~~  187 (329)
T 3gbz_A          185 RAF  187 (329)
T ss_dssp             HHH
T ss_pred             ccc
Confidence            753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7e-40  Score=354.14  Aligned_cols=155  Identities=27%  Similarity=0.430  Sum_probs=136.8

Q ss_pred             HHHHHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--------hhhHHHHHHHHHHHhCC-CCCcceeE
Q 005033           75 YKELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--------LQTEREFQNELQILGGL-RSPFLVTL  144 (718)
Q Consensus        75 ~~el~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--------~~~~~~f~~Ei~iL~~L-~HpNIV~L  144 (718)
                      +.......++|.+.+.||+|+||.||+|.+. +|+.||||++....        ....+.+.+|+.++..+ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            3344556678999999999999999999986 69999999985432        11235688999999999 79999999


Q ss_pred             EEEEeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEE
Q 005033          145 LGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGK  224 (718)
Q Consensus       145 ~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vK  224 (718)
                      ++++...+..|+||||+++++|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+|
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEE
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEE
Confidence            999999999999999999999999997653  5889999999999999999999   89999999999999999999999


Q ss_pred             EeeccCceee
Q 005033          225 VSDFGLSRIK  234 (718)
Q Consensus       225 LsDFGLAr~~  234 (718)
                      |+|||++...
T Consensus       241 l~DfG~~~~~  250 (365)
T 2y7j_A          241 LSDFGFSCHL  250 (365)
T ss_dssp             ECCCTTCEEC
T ss_pred             EEecCccccc
Confidence            9999998764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3e-40  Score=371.73  Aligned_cols=149  Identities=25%  Similarity=0.399  Sum_probs=131.0

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh-------------hhHHHHHHHHHHHhCCCCCcceeEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL-------------QTEREFQNELQILGGLRSPFLVTLLG  146 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~-------------~~~~~f~~Ei~iL~~L~HpNIV~L~g  146 (718)
                      ..++|.+.+.||+|+||+||+|... +++.||||++.....             ...+.+.+|+.+|+.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999987 588999999864321             23467899999999999999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC---CE
Q 005033          147 YCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC---RG  223 (718)
Q Consensus       147 ~~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~---~v  223 (718)
                      +|......|+|||||++|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++   .+
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccE
Confidence            9999999999999999999999997654  5899999999999999999999   89999999999999998776   69


Q ss_pred             EEeeccCceee
Q 005033          224 KVSDFGLSRIK  234 (718)
Q Consensus       224 KLsDFGLAr~~  234 (718)
                      ||+|||+++..
T Consensus       189 kl~Dfg~a~~~  199 (504)
T 3q5i_A          189 KIVDFGLSSFF  199 (504)
T ss_dssp             EECCCTTCEEC
T ss_pred             EEEECCCCEEc
Confidence            99999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.4e-40  Score=352.76  Aligned_cols=158  Identities=23%  Similarity=0.339  Sum_probs=137.2

Q ss_pred             cHHHHHHHhcCcccc-ceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCC-CCCcceeEEEEE
Q 005033           74 TYKELKNATNDFDEA-NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGL-RSPFLVTLLGYC  148 (718)
Q Consensus        74 s~~el~~at~~f~~~-~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~  148 (718)
                      -++......+.|.+. +.||+|+||.||+|... +++.||||++....  ......+.+|+.++..+ +||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            344445566778877 89999999999999987 58999999986532  23356789999999999 569999999999


Q ss_pred             eeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC---CCCEEE
Q 005033          149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS---DCRGKV  225 (718)
Q Consensus       149 ~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~---~~~vKL  225 (718)
                      ...+..|+||||+.+|+|.+++.......+++..++.++.||+.||.|||   +.+|+||||||+|||++.   ++.+||
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL  175 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKI  175 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEE
Confidence            99999999999999999999997655557899999999999999999999   899999999999999988   789999


Q ss_pred             eeccCceee
Q 005033          226 SDFGLSRIK  234 (718)
Q Consensus       226 sDFGLAr~~  234 (718)
                      +|||+++..
T Consensus       176 ~Dfg~a~~~  184 (327)
T 3lm5_A          176 VDFGMSRKI  184 (327)
T ss_dssp             CCGGGCEEC
T ss_pred             eeCcccccc
Confidence            999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.3e-40  Score=382.52  Aligned_cols=150  Identities=30%  Similarity=0.387  Sum_probs=136.1

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....   ......+.+|+.+|..++|||||++++++.+.+..|||
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999987 69999999986432   22345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||++||+|.+++...+...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence            99999999999998776556899999999999999999999   899999999999999999999999999999764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.7e-40  Score=349.16  Aligned_cols=147  Identities=27%  Similarity=0.452  Sum_probs=129.1

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhh-HHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQT-EREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ++|.+.+.||+|+||.||+|... +++.||||++....... ...+.+|+.+++.++||||+++++++...+..|+||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999987 68999999986533211 12456899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +. |+|.+++...+. .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  150 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAK  150 (324)
T ss_dssp             CS-EEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred             cc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence            96 699999987643 5889999999999999999999   899999999999999999999999999998753

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.5e-40  Score=352.00  Aligned_cols=143  Identities=19%  Similarity=0.326  Sum_probs=127.1

Q ss_pred             cCccccceecccCceEEEEEEEcC---------CcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCccee----------
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARD---------GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVT----------  143 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~---------g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~----------  143 (718)
                      ++|.+.+.||+|+||.||+|.+..         ++.||||++...     ..+.+|+.++.+++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            679999999999999999999863         789999998653     36889999999999999987          


Q ss_pred             -----EEEEEee-CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 005033          144 -----LLGYCME-RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL  217 (718)
Q Consensus       144 -----L~g~~~~-~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL  217 (718)
                           +++++.. .+..|+||||+ +++|.+++.......+++..++.++.||+.||.|||   +.+|+||||||+|||+
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEE
Confidence                 6777776 67889999999 999999998764447899999999999999999999   8999999999999999


Q ss_pred             CCCC--CEEEeeccCceee
Q 005033          218 DSDC--RGKVSDFGLSRIK  234 (718)
Q Consensus       218 d~~~--~vKLsDFGLAr~~  234 (718)
                      +.++  .+||+|||+++..
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~  211 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRY  211 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCS
T ss_pred             cCCCCceEEEecCcceeec
Confidence            9998  8999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.2e-40  Score=370.52  Aligned_cols=148  Identities=25%  Similarity=0.381  Sum_probs=128.3

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      .++|++.+.||+|+||+||+|.+. ++..||||++....  ......+.+|+.+|+.++|||||+++++|...+..|+||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999999987 68999999986532  233467899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC---CCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD---CRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~---~~vKLsDFGLAr~~  234 (718)
                      |||++|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++..   +.+||+|||+++..
T Consensus       116 e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            9999999999887654  5888999999999999999999   8999999999999999764   55999999999764

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.4e-40  Score=363.98  Aligned_cols=147  Identities=26%  Similarity=0.353  Sum_probs=130.3

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCC------CCCcceeEEEEEeeCCeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGL------RSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L------~HpNIV~L~g~~~~~~~~  154 (718)
                      ..+|++.+.||+|+||.||+|.+. +++.||||++... ......+.+|+.++..+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457999999999999999999887 5899999999753 33445677888887766      578999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC--EEEeeccCce
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR--GKVSDFGLSR  232 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~--vKLsDFGLAr  232 (718)
                      |+||||+ +++|.+++.......+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.  +||+|||+|+
T Consensus       175 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            9999999 579999998876556899999999999999999999   889999999999999999987  9999999986


Q ss_pred             e
Q 005033          233 I  233 (718)
Q Consensus       233 ~  233 (718)
                      .
T Consensus       251 ~  251 (429)
T 3kvw_A          251 Y  251 (429)
T ss_dssp             E
T ss_pred             e
Confidence            4

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.1e-40  Score=352.39  Aligned_cols=150  Identities=25%  Similarity=0.360  Sum_probs=129.5

Q ss_pred             hcCccccceecccCceEEEEEEEc------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~  154 (718)
                      .++|.+.+.||+|+||.||+|.+.      ++..||||.+... .......+.+|+.+++.++||||+++++++...+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            468999999999999999999842      4779999999643 344556799999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC---CCCEEEe
Q 005033          155 ILVYEYMPNKSLQEMLFSDGN-----LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS---DCRGKVS  226 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~-----~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~---~~~vKLs  226 (718)
                      |+||||+++|+|.+++.....     ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999987542     34889999999999999999999   899999999999999984   4569999


Q ss_pred             eccCceee
Q 005033          227 DFGLSRIK  234 (718)
Q Consensus       227 DFGLAr~~  234 (718)
                      |||+++..
T Consensus       186 Dfg~~~~~  193 (327)
T 2yfx_A          186 DFGMARDI  193 (327)
T ss_dssp             CCHHHHHH
T ss_pred             cccccccc
Confidence            99988753

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=349.40  Aligned_cols=148  Identities=26%  Similarity=0.489  Sum_probs=133.1

Q ss_pred             cCccccceecccCceEEEEEEE-----cCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC--eEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIA-----RDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERN--KRI  155 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~-----~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~--~~~  155 (718)
                      ++|++.+.||+|+||.||+|.+     .+++.||||++........+.+.+|+.+++.++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            5688999999999999999984     258899999998766666778999999999999999999999987654  689


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +||||+++|+|.+++..... .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       121 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             EEECCCTTCBHHHHHHHSTT-SSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEECCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            99999999999999987643 5889999999999999999999   899999999999999999999999999999874

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=100.00  E-value=1.5e-39  Score=337.44  Aligned_cols=147  Identities=26%  Similarity=0.465  Sum_probs=130.7

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh--hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL--QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ++|++.+.||+|+||.||+|... +|+.||||++.....  .....+.+|+.++++++||||+++++++...+..|+|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            57999999999999999999987 689999999865322  223578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+. |+|.+++.......+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++..
T Consensus        83 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  152 (299)
T 2r3i_A           83 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARA  152 (299)
T ss_dssp             CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred             ccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHeEEcCCCCEEECcchhhhh
Confidence            996 79999998775556889999999999999999999   89999999999999999999999999998865

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.9e-39  Score=342.97  Aligned_cols=149  Identities=24%  Similarity=0.355  Sum_probs=131.4

Q ss_pred             HHHhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhC--CCCCcceeEEEEEeeCC----
Q 005033           79 KNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGG--LRSPFLVTLLGYCMERN----  152 (718)
Q Consensus        79 ~~at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~--L~HpNIV~L~g~~~~~~----  152 (718)
                      ....++|.+.+.||+|+||.||+|.+ +|+.||||++...   ....+.+|++++..  ++||||+++++++....    
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            34557899999999999999999988 4899999998642   34567888888876  79999999999998876    


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecCCCCCCEEECCCCCEEEee
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC-----DPPVIHGDIKPSNVLLDSDCRGKVSD  227 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~-----~~gIVHRDLKP~NILLd~~~~vKLsD  227 (718)
                      ..|+||||+++|+|.+++...   .+++..++.++.||+.||.|||...     +.+|+||||||+|||++.++.+||+|
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  190 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  190 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred             eeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence            789999999999999999765   5889999999999999999999321     57899999999999999999999999


Q ss_pred             ccCceee
Q 005033          228 FGLSRIK  234 (718)
Q Consensus       228 FGLAr~~  234 (718)
                      ||+++..
T Consensus       191 fg~~~~~  197 (342)
T 1b6c_B          191 LGLAVRH  197 (342)
T ss_dssp             CTTCEEE
T ss_pred             CCCceec
Confidence            9999865

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.1e-40  Score=369.61  Aligned_cols=149  Identities=24%  Similarity=0.390  Sum_probs=132.6

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ..++|++.+.||+|+||+||+|.+. +++.||||++....  ......+.+|+.+|++++||||+++++++...+..|+|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3467999999999999999999987 68999999985421  23456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEC---CCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD---SDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd---~~~~vKLsDFGLAr~~  234 (718)
                      ||||.+|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++   .++.+||+|||+++..
T Consensus       100 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            99999999999987654  5889999999999999999999   89999999999999995   4567999999998753

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.2e-40  Score=342.09  Aligned_cols=149  Identities=26%  Similarity=0.433  Sum_probs=132.3

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++..........+.+|+.++..++||||+++++++...+..|+|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3468999999999999999999987 589999999976655566789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+++++|.+++..... .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++..
T Consensus        97 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK  166 (302)
T ss_dssp             CCTTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred             eCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence            9999999999876432 5889999999999999999999   89999999999999999999999999998753

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.6e-41  Score=351.53  Aligned_cols=160  Identities=28%  Similarity=0.410  Sum_probs=137.8

Q ss_pred             ccccHHHHHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEE
Q 005033           71 QRFTYKELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYC  148 (718)
Q Consensus        71 ~~~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~  148 (718)
                      ..+++.++....++|++.+.||+|+||.||+|.+. +|+.||||++.... .....+.+|+.++..+ +||||+++++++
T Consensus        12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            34455556667889999999999999999999985 68999999986533 3346789999999998 899999999999


Q ss_pred             ee------CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC
Q 005033          149 ME------RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR  222 (718)
Q Consensus       149 ~~------~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~  222 (718)
                      ..      .+..|+||||+++|+|.+++.......+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~  167 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAE  167 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCC
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCC
Confidence            87      467899999999999999998765557899999999999999999999   899999999999999999999


Q ss_pred             EEEeeccCceee
Q 005033          223 GKVSDFGLSRIK  234 (718)
Q Consensus       223 vKLsDFGLAr~~  234 (718)
                      +||+|||++...
T Consensus       168 ~kl~Dfg~~~~~  179 (326)
T 2x7f_A          168 VKLVDFGVSAQL  179 (326)
T ss_dssp             EEECCCTTTC--
T ss_pred             EEEeeCcCceec
Confidence            999999988753

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.6e-40  Score=371.01  Aligned_cols=148  Identities=26%  Similarity=0.411  Sum_probs=133.6

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++|++.+.||+|+||.||+|... +|+.||||++....   ......+.+|+.+|++++||||+++++++...+..|+|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467999999999999999999987 68999999985432   33457799999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE---CCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL---DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL---d~~~~vKLsDFGLAr~~  234 (718)
                      ||||.+|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++..
T Consensus       105 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            99999999999997664  5889999999999999999999   8999999999999999   56789999999998753

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4e-40  Score=384.91  Aligned_cols=148  Identities=28%  Similarity=0.351  Sum_probs=132.9

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~  155 (718)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++....   ......+..|..+|..+ +||||+.+++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3468999999999999999999987 58899999986421   22345688899999988 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |||||+++|+|.+++...+  .+++..++.|+.||+.||.|||   +.+||||||||+||||+.++.+||+|||+|+.
T Consensus       419 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            9999999999999998764  5889999999999999999999   89999999999999999999999999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-40  Score=354.57  Aligned_cols=145  Identities=26%  Similarity=0.428  Sum_probs=124.1

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC------
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERN------  152 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------  152 (718)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+.+|+.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            468999999999999999999986 6999999998542  2334567899999999999999999999998663      


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                      ..|+||||+ +++|.+++...   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            469999999 89999999864   5889999999999999999999   8999999999999999999999999999987


Q ss_pred             e
Q 005033          233 I  233 (718)
Q Consensus       233 ~  233 (718)
                      .
T Consensus       177 ~  177 (367)
T 1cm8_A          177 Q  177 (367)
T ss_dssp             E
T ss_pred             c
Confidence            5

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-40  Score=382.54  Aligned_cols=147  Identities=29%  Similarity=0.435  Sum_probs=128.9

Q ss_pred             cCccccc-eecccCceEEEEEEEc---CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           83 NDFDEAN-VIGKGGSGTVFLGIAR---DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        83 ~~f~~~~-~LG~G~FG~Vykg~~~---~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      +++.+.. .||+|+||.||+|.+.   ++..||||+++... ....+.|.+|+.+|+.++|||||+++++|.. +..|||
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            3444444 7999999999999875   46689999997643 3456789999999999999999999999976 568999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||||++|+|.+++.... ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       414 ~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             EECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             EEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence            99999999999997653 36899999999999999999999   899999999999999999999999999999864

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7.3e-40  Score=354.05  Aligned_cols=144  Identities=25%  Similarity=0.403  Sum_probs=126.2

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC------
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERN------  152 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------  152 (718)
                      .++|++.+.||+|+||.||+|.+. +++.||||++...  .......+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999986 6899999998642  3344567899999999999999999999997665      


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                      ..|+||||+. |+|.+++..    .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            7899999995 689888863    4788999999999999999999   8999999999999999999999999999987


Q ss_pred             e
Q 005033          233 I  233 (718)
Q Consensus       233 ~  233 (718)
                      .
T Consensus       176 ~  176 (371)
T 2xrw_A          176 T  176 (371)
T ss_dssp             -
T ss_pred             c
Confidence            5

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.1e-40  Score=374.68  Aligned_cols=149  Identities=30%  Similarity=0.397  Sum_probs=134.6

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|.+.+.||+|+||.||+|... +|+.||||++.....   .....+.+|+.+|..++||||+++++++......|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67889999999999999999986 699999999964321   23457889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDG--NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~--~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||++||+|.+++....  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.+|.+||+|||+++..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            9999999999997654  346899999999999999999999   899999999999999999999999999999864

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.3e-41  Score=366.12  Aligned_cols=148  Identities=16%  Similarity=0.230  Sum_probs=123.9

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEccc---CChhhHHHHHHHH---HHHhCCCCCcceeEE-------EE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDT---FSLQTEREFQNEL---QILGGLRSPFLVTLL-------GY  147 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~---~~~~~~~~f~~Ei---~iL~~L~HpNIV~L~-------g~  147 (718)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++..   ......+.|.+|+   .+|++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467889999999999999999975 699999999863   2334557899999   566667899999998       66


Q ss_pred             EeeCCe-----------------EEEEEeccCCCCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 005033          148 CMERNK-----------------RILVYEYMPNKSLQEMLFSDGN-----LVLKWSQRFEIIMDVAKALEFLHFGCDPPV  205 (718)
Q Consensus       148 ~~~~~~-----------------~~LVmEy~~gGsL~~~L~~~~~-----~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gI  205 (718)
                      +...+.                 .||||||+ +|+|.+++...+.     ..+++..++.|+.||+.||.|||   +.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            665532                 79999999 7899999976431     12335788889999999999999   8999


Q ss_pred             EecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          206 IHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       206 VHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +||||||+|||++.++.+||+|||+|+.
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~  255 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVR  255 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEE
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhhee
Confidence            9999999999999999999999999874

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.2e-40  Score=364.97  Aligned_cols=149  Identities=26%  Similarity=0.409  Sum_probs=127.8

Q ss_pred             HHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--------hhhHHHHHHHHHHHhCCCCCcceeEEEEEee
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--------LQTEREFQNELQILGGLRSPFLVTLLGYCME  150 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--------~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~  150 (718)
                      ...++|.+.+.||+|+||.||+|.+. +++.||||++....        ......+.+|+.+|++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            44678999999999999999999987 58999999986422        111234889999999999999999999975 


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC---CEEEee
Q 005033          151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC---RGKVSD  227 (718)
Q Consensus       151 ~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~---~vKLsD  227 (718)
                      .+..|+||||+++|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++   .+||+|
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             cCceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEee
Confidence            456899999999999999887654  5899999999999999999999   89999999999999997544   599999


Q ss_pred             ccCceee
Q 005033          228 FGLSRIK  234 (718)
Q Consensus       228 FGLAr~~  234 (718)
                      ||+++..
T Consensus       286 FG~a~~~  292 (419)
T 3i6u_A          286 FGHSKIL  292 (419)
T ss_dssp             SSTTTSC
T ss_pred             cccceec
Confidence            9998763

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.8e-39  Score=340.62  Aligned_cols=134  Identities=22%  Similarity=0.403  Sum_probs=119.1

Q ss_pred             hcCccccceecccCceEEEEEEEc--CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCC------cceeEEEEEeeCCe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR--DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSP------FLVTLLGYCMERNK  153 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~--~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~Hp------NIV~L~g~~~~~~~  153 (718)
                      .++|++.+.||+|+||.||+|.+.  +++.||||++... ......+.+|+.++..++|+      +|+++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            468999999999999999999873  5889999999653 34456788999999888765      49999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD  220 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~  220 (718)
                      .|+||||+ +++|.+++.......+++..+..++.||+.||.|||   +.+|+||||||+|||++..
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~  154 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQS  154 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCC
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEecc
Confidence            99999999 999999998876667899999999999999999999   8999999999999999873

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.9e-40  Score=345.21  Aligned_cols=141  Identities=25%  Similarity=0.472  Sum_probs=127.7

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCC-CCcceeEEEEEee--CCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLR-SPFLVTLLGYCME--RNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~--~~~~~LVm  158 (718)
                      ++|++.+.||+|+||.||+|.+. +++.||||++...   ..+.+.+|+.++..++ ||||+++++++..  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            67999999999999999999875 6899999998753   3457899999999997 9999999999988  66789999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC-CEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC-RGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~-~vKLsDFGLAr~~  234 (718)
                      ||+.+++|.+++.     .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++ .+||+|||+++..
T Consensus       113 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             ECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             eccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            9999999999985     3788899999999999999999   89999999999999999777 8999999999764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.1e-39  Score=335.39  Aligned_cols=146  Identities=22%  Similarity=0.369  Sum_probs=126.6

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEE-eeCCeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC-MERNKRILVYE  159 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~-~~~~~~~LVmE  159 (718)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.....  ...+.+|+.++..++|++++..+.++ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            468999999999999999999985 799999999865332  23688999999999988866655555 66778899999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE---CCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL---DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL---d~~~~vKLsDFGLAr~~  234 (718)
                      |+ +++|.+++..... .+++..++.++.||+.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++..
T Consensus        86 ~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             ec-CCCHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            99 9999999975433 6899999999999999999999   8999999999999999   48889999999999875

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=9e-40  Score=346.41  Aligned_cols=148  Identities=25%  Similarity=0.480  Sum_probs=131.1

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++....  ....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            357999999999999999999987 58999999985432  333466889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+++++|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       104 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  174 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL  174 (331)
T ss_dssp             ECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             ecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence            9999999988876554  5889999999999999999999   899999999999999999999999999998754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.1e-40  Score=337.88  Aligned_cols=148  Identities=26%  Similarity=0.452  Sum_probs=133.7

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++....   ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            368999999999999999999987 69999999986432   12345789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++++|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus        90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             EeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence            99999999999997654  5788999999999999999999   899999999999999999999999999988653

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.8e-40  Score=342.37  Aligned_cols=149  Identities=28%  Similarity=0.381  Sum_probs=121.7

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhh-HHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQT-EREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.... ... .+.+..+...++.++||||+++++++...+..|+||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            468999999999999999999985 68999999996532 222 233455556688899999999999999999999999


Q ss_pred             eccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSD--GNLVLKWSQRFEIIMDVAKALEFLHFGCDP-PVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~--~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~-gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||++ |+|.+++...  ....+++..+..++.||+.||.|||   +. +|+||||||+|||++.++.+||+|||+++..
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            9996 6998887541  2236899999999999999999999   76 9999999999999999999999999998764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.7e-40  Score=352.70  Aligned_cols=156  Identities=24%  Similarity=0.360  Sum_probs=134.9

Q ss_pred             ccHHHHHHHhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCC-----------hhhHHHHHHHHHHHhCCCCCcc
Q 005033           73 FTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFS-----------LQTEREFQNELQILGGLRSPFL  141 (718)
Q Consensus        73 ~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~-----------~~~~~~f~~Ei~iL~~L~HpNI  141 (718)
                      ....++....++|.+.+.||+|+||.||+|.+.+|+.||||++....           ....+.+.+|+.+++.++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            45678888899999999999999999999999889999999985421           1223679999999999999999


Q ss_pred             eeEEEEEee-----CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEE
Q 005033          142 VTLLGYCME-----RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVL  216 (718)
Q Consensus       142 V~L~g~~~~-----~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NIL  216 (718)
                      +++++++..     ....|+||||+. |+|.+++.... ..+++..+..++.||+.||.|||   +.+|+||||||+|||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNIL  166 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEE
Confidence            999999854     336899999996 79999887553 36899999999999999999999   889999999999999


Q ss_pred             ECCCCCEEEeeccCcee
Q 005033          217 LDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       217 Ld~~~~vKLsDFGLAr~  233 (718)
                      ++.++.+||+|||+++.
T Consensus       167 ~~~~~~~kl~Dfg~~~~  183 (362)
T 3pg1_A          167 LADNNDITICDFNLARE  183 (362)
T ss_dssp             ECTTCCEEECCTTC---
T ss_pred             EcCCCCEEEEecCcccc
Confidence            99999999999999874

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-40  Score=360.21  Aligned_cols=147  Identities=27%  Similarity=0.445  Sum_probs=123.6

Q ss_pred             CccccceecccCceEEEEEEEcC----CcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEee-CCeEEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIARD----GKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCME-RNKRILV  157 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~~----g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~~~LV  157 (718)
                      .|.+.+.||+|+||.||+|.+.+    +..||||.+... .....+.|.+|+.++++++||||++++++|.. .+..|+|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            46677899999999999998752    246899998653 33456789999999999999999999999764 4678999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+++|+|.+++..... .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       170 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             EECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EECCCCCCHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccc
Confidence            999999999999976543 5788899999999999999999   899999999999999999999999999999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.5e-40  Score=355.05  Aligned_cols=148  Identities=24%  Similarity=0.369  Sum_probs=123.8

Q ss_pred             HHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC------
Q 005033           79 KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMER------  151 (718)
Q Consensus        79 ~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------  151 (718)
                      ....++|++.+.||+|+||.||+|.+. +|+.||||++.....    ...+|+.+|+.++|||||+++++|...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            456688999999999999999999985 699999999854322    234799999999999999999998543      


Q ss_pred             --------------------------------CeEEEEEeccCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHH
Q 005033          152 --------------------------------NKRILVYEYMPNKSLQEMLFS--DGNLVLKWSQRFEIIMDVAKALEFL  197 (718)
Q Consensus       152 --------------------------------~~~~LVmEy~~gGsL~~~L~~--~~~~~l~~~~~~~Ia~qIa~gL~yL  197 (718)
                                                      ...++||||++ |+|.+.+..  .....+++..+..++.||+.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            34889999996 688887754  1223689999999999999999999


Q ss_pred             hcCCCCCeEecCCCCCCEEEC-CCCCEEEeeccCceee
Q 005033          198 HFGCDPPVIHGDIKPSNVLLD-SDCRGKVSDFGLSRIK  234 (718)
Q Consensus       198 H~~~~~gIVHRDLKP~NILLd-~~~~vKLsDFGLAr~~  234 (718)
                      |   +.+|+||||||+|||++ .++.+||+|||+|+..
T Consensus       158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  192 (383)
T 3eb0_A          158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL  192 (383)
T ss_dssp             H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCccc
Confidence            9   99999999999999997 6889999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.4e-39  Score=359.77  Aligned_cols=147  Identities=28%  Similarity=0.511  Sum_probs=132.6

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC-----Ce
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMER-----NK  153 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~  153 (718)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++...  .....+.+.+|+.+|+.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999987 5889999999653  334456899999999999999999999999776     57


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .|+||||+. |+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            899999994 79999997653  5899999999999999999999   89999999999999999999999999999997


Q ss_pred             e
Q 005033          234 K  234 (718)
Q Consensus       234 ~  234 (718)
                      .
T Consensus       179 ~  179 (432)
T 3n9x_A          179 I  179 (432)
T ss_dssp             C
T ss_pred             c
Confidence            5

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.9e-40  Score=343.74  Aligned_cols=152  Identities=26%  Similarity=0.385  Sum_probs=119.7

Q ss_pred             HHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ...++|.+.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.++..++||||+++++++...+..|+|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34578999999999999999999875 68999999986432 23346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCc
Q 005033          158 YEYMPNKSLQEMLFS------DGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS  231 (718)
Q Consensus       158 mEy~~gGsL~~~L~~------~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLA  231 (718)
                      |||+++++|.+++..      .....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999964      12235899999999999999999999   899999999999999999999999999988


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      ...
T Consensus       169 ~~~  171 (303)
T 2vwi_A          169 AFL  171 (303)
T ss_dssp             HHC
T ss_pred             hee
Confidence            764

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9.3e-40  Score=338.87  Aligned_cols=149  Identities=25%  Similarity=0.355  Sum_probs=133.7

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---------hhhHHHHHHHHHHHhCCC-CCcceeEEEEEe
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---------LQTEREFQNELQILGGLR-SPFLVTLLGYCM  149 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---------~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~  149 (718)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++....         ....+.+.+|+.++.++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999987 68999999986432         122456889999999995 999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeecc
Q 005033          150 ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG  229 (718)
Q Consensus       150 ~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFG  229 (718)
                      ..+..|+||||+++++|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence            9999999999999999999997653  5889999999999999999999   8999999999999999999999999999


Q ss_pred             Cceee
Q 005033          230 LSRIK  234 (718)
Q Consensus       230 LAr~~  234 (718)
                      ++...
T Consensus       170 ~~~~~  174 (298)
T 1phk_A          170 FSCQL  174 (298)
T ss_dssp             TCEEC
T ss_pred             chhhc
Confidence            98764

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.9e-39  Score=347.02  Aligned_cols=147  Identities=20%  Similarity=0.293  Sum_probs=128.6

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCC-----------CCcceeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLR-----------SPFLVTLLGYCM  149 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-----------HpNIV~L~g~~~  149 (718)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++... ......+.+|+.++.+++           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            368999999999999999999985 6899999999753 334567889999998886           899999999998


Q ss_pred             eCC----eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEEC------
Q 005033          150 ERN----KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP-PVIHGDIKPSNVLLD------  218 (718)
Q Consensus       150 ~~~----~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~-gIVHRDLKP~NILLd------  218 (718)
                      ..+    ..++||||+ +++|.+++.......+++..+..++.||+.||.|||   +. +|+||||||+|||++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence            654    789999999 999999998765556899999999999999999999   77 999999999999994      


Q ss_pred             CCCCEEEeeccCcee
Q 005033          219 SDCRGKVSDFGLSRI  233 (718)
Q Consensus       219 ~~~~vKLsDFGLAr~  233 (718)
                      ..+.+||+|||+++.
T Consensus       173 ~~~~~kl~Dfg~a~~  187 (373)
T 1q8y_A          173 NLIQIKIADLGNACW  187 (373)
T ss_dssp             TEEEEEECCCTTCEE
T ss_pred             CcceEEEcccccccc
Confidence            445799999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.7e-39  Score=336.54  Aligned_cols=148  Identities=28%  Similarity=0.449  Sum_probs=128.3

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||.+....  ....+.+|+.++..++||||+++++++...+..|+|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4568999999999999999999987 58999999986532  34578999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+++++|.+++.... ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus       105 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  175 (314)
T 3com_A          105 YCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL  175 (314)
T ss_dssp             CCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence            999999999997432 26889999999999999999999   899999999999999999999999999998764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.1e-39  Score=345.92  Aligned_cols=148  Identities=25%  Similarity=0.384  Sum_probs=129.3

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEee--------
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCME--------  150 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--------  150 (718)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++....  ......+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            368999999999999999999985 68999999985432  2234568899999999999999999999987        


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccC
Q 005033          151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL  230 (718)
Q Consensus       151 ~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGL  230 (718)
                      .+..|+||||+. |+|.+.+..... .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           96 KGSIYLVFDFCE-HDLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -CEEEEEEECCS-EEHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccC-CCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence            456899999996 588888865533 5899999999999999999999   89999999999999999999999999999


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      ++..
T Consensus       171 a~~~  174 (351)
T 3mi9_A          171 ARAF  174 (351)
T ss_dssp             CEEC
T ss_pred             cccc
Confidence            9875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.9e-40  Score=350.62  Aligned_cols=149  Identities=29%  Similarity=0.477  Sum_probs=133.7

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChh-----------------hHHHHHHHHHHHhCCCCCcceeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQ-----------------TEREFQNELQILGGLRSPFLVTL  144 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~-----------------~~~~f~~Ei~iL~~L~HpNIV~L  144 (718)
                      .++|.+.+.||+|+||.||+|.+ +|+.||||++......                 ....+.+|+.++..++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 8999999998542211                 11689999999999999999999


Q ss_pred             EEEEeeCCeEEEEEeccCCCCHHHH------HhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEE
Q 005033          145 LGYCMERNKRILVYEYMPNKSLQEM------LFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD-PPVIHGDIKPSNVLL  217 (718)
Q Consensus       145 ~g~~~~~~~~~LVmEy~~gGsL~~~------L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~-~gIVHRDLKP~NILL  217 (718)
                      ++++...+..|+||||+++|+|.++      +.......+++..+..++.||+.||.|||   + .+|+||||||+|||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      65543457899999999999999999999   7 999999999999999


Q ss_pred             CCCCCEEEeeccCceee
Q 005033          218 DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       218 d~~~~vKLsDFGLAr~~  234 (718)
                      +.++.+||+|||++...
T Consensus       186 ~~~~~~kl~dfg~~~~~  202 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYM  202 (348)
T ss_dssp             CTTSCEEECCCTTCEEC
T ss_pred             cCCCcEEEecccccccc
Confidence            99999999999998763

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=7.7e-40  Score=345.14  Aligned_cols=148  Identities=27%  Similarity=0.430  Sum_probs=127.1

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh--------hhHHHHHHHHHHHhCCCCCcceeEEEEEeeC
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL--------QTEREFQNELQILGGLRSPFLVTLLGYCMER  151 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~--------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~  151 (718)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||++.....        .....+.+|+.+|+.++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467999999999999999999986 588999999864321        1224588999999999999999999998765


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC---EEEeec
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR---GKVSDF  228 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~---vKLsDF  228 (718)
                      . .|+||||+++|+|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.   +||+||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             c-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            5 899999999999999997654  5889999999999999999999   899999999999999987664   999999


Q ss_pred             cCceee
Q 005033          229 GLSRIK  234 (718)
Q Consensus       229 GLAr~~  234 (718)
                      |+++..
T Consensus       162 g~~~~~  167 (322)
T 2ycf_A          162 GHSKIL  167 (322)
T ss_dssp             TTCEEC
T ss_pred             ccceec
Confidence            998764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.2e-40  Score=340.65  Aligned_cols=148  Identities=26%  Similarity=0.315  Sum_probs=123.4

Q ss_pred             hcCccccceecccCceEEEEEEEc--CCc--EEEEEEcccC---ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR--DGK--LLAIKRLDTF---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~--~g~--~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~  154 (718)
                      .++|++.+.||+|+||.||+|.+.  ++.  .||||++...   .....+.+.+|+.++..++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            357999999999999999999864  233  6999998653   2344567999999999999999999999998765 8


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++||||+++|+|.+++.... ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            99999999999999997653 25889999999999999999999   899999999999999999999999999999864

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7.1e-39  Score=338.74  Aligned_cols=134  Identities=19%  Similarity=0.308  Sum_probs=116.8

Q ss_pred             hcCccccceecccCceEEEEEEEc-CC-cEEEEEEcccCChhhHHHHHHHHHHHhCCCCCc------ceeEEEEEeeCCe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DG-KLLAIKRLDTFSLQTEREFQNELQILGGLRSPF------LVTLLGYCMERNK  153 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g-~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpN------IV~L~g~~~~~~~  153 (718)
                      .++|++.+.||+|+||.||+|.+. ++ +.||||++... ......+.+|+.+++.++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999986 34 78999999653 344567889999999887765      9999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD  220 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~  220 (718)
                      .||||||+ +++|.+++.......+++..+..++.||+.||.|||   +.+|+||||||+|||++..
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~  159 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNS  159 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecc
Confidence            99999999 788888887765556899999999999999999999   9999999999999999543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.6e-40  Score=354.13  Aligned_cols=146  Identities=14%  Similarity=0.119  Sum_probs=111.0

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHH---HHHhCCCCCcceeEE-------EE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNEL---QILGGLRSPFLVTLL-------GY  147 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei---~iL~~L~HpNIV~L~-------g~  147 (718)
                      ..+|.+.+.||+|+||.||+|.+. +|+.||||++.....   ...+.+.+|+   .+|+. +||||++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            345889999999999999999986 689999999976432   3345677784   55666 799988765       45


Q ss_pred             EeeC-----------------CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCC
Q 005033          148 CMER-----------------NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQR------FEIIMDVAKALEFLHFGCDPP  204 (718)
Q Consensus       148 ~~~~-----------------~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~------~~Ia~qIa~gL~yLH~~~~~g  204 (718)
                      +...                 ...|||||||+ |+|.+++...+. .+.+..+      ..++.||+.||.|||   +.+
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~  214 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQ---SKG  214 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHH---HCC
Confidence            5433                 34799999997 899999986432 2344455      677899999999999   899


Q ss_pred             eEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       205 IVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+||||||+|||++.++.+||+|||+|+.
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~  243 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWK  243 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEE
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeee
Confidence            99999999999999999999999999875

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.5e-39  Score=353.51  Aligned_cols=146  Identities=23%  Similarity=0.412  Sum_probs=117.1

Q ss_pred             cCccc-cceecccCceEEEEEEEc---CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEee--CCeEEE
Q 005033           83 NDFDE-ANVIGKGGSGTVFLGIAR---DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME--RNKRIL  156 (718)
Q Consensus        83 ~~f~~-~~~LG~G~FG~Vykg~~~---~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~L  156 (718)
                      +.|.+ .++||+|+||.||+|...   +++.||||++....  ....+.+|+.+|+.++|||||++++++..  ....||
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            34555 457999999999999975   47899999997543  23468899999999999999999999954  678999


Q ss_pred             EEeccCCCCHHHHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE----CCCCCEEE
Q 005033          157 VYEYMPNKSLQEMLFSDG-------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL----DSDCRGKV  225 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~-------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL----d~~~~vKL  225 (718)
                      ||||+. |+|.+++....       ...+++..++.|+.||+.||.|||   +.+|+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999995 68988885321       124889999999999999999999   8999999999999999    67789999


Q ss_pred             eeccCceee
Q 005033          226 SDFGLSRIK  234 (718)
Q Consensus       226 sDFGLAr~~  234 (718)
                      +|||+|+..
T Consensus       174 ~Dfg~a~~~  182 (405)
T 3rgf_A          174 ADMGFARLF  182 (405)
T ss_dssp             CCTTCCC--
T ss_pred             EECCCceec
Confidence            999999864

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.7e-39  Score=349.56  Aligned_cols=147  Identities=24%  Similarity=0.429  Sum_probs=131.2

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC-----Ce
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMER-----NK  153 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~  153 (718)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+|..++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3468999999999999999999986 68899999997533 33446789999999999999999999999765     36


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .|+||||+. |+|.+++...   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       105 ~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            899999995 6999999765   5889999999999999999999   89999999999999999999999999999986


Q ss_pred             e
Q 005033          234 K  234 (718)
Q Consensus       234 ~  234 (718)
                      .
T Consensus       178 ~  178 (364)
T 3qyz_A          178 A  178 (364)
T ss_dssp             C
T ss_pred             c
Confidence            4

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.8e-40  Score=380.58  Aligned_cols=140  Identities=28%  Similarity=0.442  Sum_probs=124.9

Q ss_pred             ceecccCceEEEEEEEc---CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIAR---DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~---~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||.||+|.+.   +++.||||+++...  ....+.|.+|+.+|..++|||||+++++|.. +..+||||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999764   46789999996532  2345789999999999999999999999964 568999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+|.+++....  .+++..++.|+.||+.||.|||   +.+||||||||+||||+.++.+||+|||+++..
T Consensus       454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~  519 (635)
T 4fl3_A          454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  519 (635)
T ss_dssp             EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred             CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence            99999998664  5889999999999999999999   899999999999999999999999999999864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.9e-39  Score=331.41  Aligned_cols=148  Identities=26%  Similarity=0.498  Sum_probs=132.3

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEee----------
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME----------  150 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----------  150 (718)
                      .++|++.+.||+|+||.||+|... +++.||||++... ......+.+|+.+++.++||||+++++++..          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            467999999999999999999986 6899999998643 3445679999999999999999999999865          


Q ss_pred             ---CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEee
Q 005033          151 ---RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSD  227 (718)
Q Consensus       151 ---~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsD  227 (718)
                         .+..|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEee
Confidence               456799999999999999998654 35788899999999999999999   89999999999999999999999999


Q ss_pred             ccCceee
Q 005033          228 FGLSRIK  234 (718)
Q Consensus       228 FGLAr~~  234 (718)
                      ||+++..
T Consensus       160 fg~~~~~  166 (303)
T 1zy4_A          160 FGLAKNV  166 (303)
T ss_dssp             CCCCSCT
T ss_pred             Ccchhhc
Confidence            9998764

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.5e-38  Score=344.67  Aligned_cols=152  Identities=26%  Similarity=0.338  Sum_probs=130.2

Q ss_pred             HHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCC-CC-----cceeEEEEEeeC
Q 005033           79 KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLR-SP-----FLVTLLGYCMER  151 (718)
Q Consensus        79 ~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-Hp-----NIV~L~g~~~~~  151 (718)
                      ....++|++.+.||+|+||.||+|.+. +++.||||++... ......+.+|+.++..++ |+     +|+++++++...
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            345679999999999999999999987 6889999999753 334566788888888774 44     599999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEC--CCCCEEEeecc
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD--SDCRGKVSDFG  229 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd--~~~~vKLsDFG  229 (718)
                      +..||||||+. |+|.+++.......+++..+..++.||+.||.|||.. ..+|+||||||+|||++  .++.+||+|||
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence            99999999995 6999999877555689999999999999999999932 46899999999999994  47889999999


Q ss_pred             Ccee
Q 005033          230 LSRI  233 (718)
Q Consensus       230 LAr~  233 (718)
                      +++.
T Consensus       207 ~a~~  210 (382)
T 2vx3_A          207 SSCQ  210 (382)
T ss_dssp             TCEE
T ss_pred             Ccee
Confidence            9875

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.2e-39  Score=338.15  Aligned_cols=151  Identities=28%  Similarity=0.456  Sum_probs=129.0

Q ss_pred             HHhcCccccceecccCceEEEEEEEc--CCcEEEEEEcccCCh--hhHHHHHHHHHHHhCC---CCCcceeEEEEEe---
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR--DGKLLAIKRLDTFSL--QTEREFQNELQILGGL---RSPFLVTLLGYCM---  149 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~--~g~~VAVK~i~~~~~--~~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~---  149 (718)
                      .+.++|++.+.||+|+||.||+|.+.  +|+.||||++.....  .....+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            35578999999999999999999984  588999999854221  1123466777777665   8999999999997   


Q ss_pred             --eCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEee
Q 005033          150 --ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSD  227 (718)
Q Consensus       150 --~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsD  227 (718)
                        .....++||||+. |+|.+++.......+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence              5567899999996 79999998776556899999999999999999999   89999999999999999999999999


Q ss_pred             ccCceee
Q 005033          228 FGLSRIK  234 (718)
Q Consensus       228 FGLAr~~  234 (718)
                      ||+++..
T Consensus       164 fg~~~~~  170 (326)
T 1blx_A          164 FGLARIY  170 (326)
T ss_dssp             CCSCCCC
T ss_pred             Ccccccc
Confidence            9998753

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.3e-40  Score=344.60  Aligned_cols=156  Identities=24%  Similarity=0.340  Sum_probs=134.2

Q ss_pred             cccHHHHHHHhcCccccceecccCceEEEEEEEcCCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCC--CCcceeEEEE
Q 005033           72 RFTYKELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTF--SLQTEREFQNELQILGGLR--SPFLVTLLGY  147 (718)
Q Consensus        72 ~~s~~el~~at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~--HpNIV~L~g~  147 (718)
                      .+.+..+....++|++.+.||+|+||.||++.+.+++.||||++...  .......+.+|+.++..++  |+||++++++
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            34444445556789999999999999999999988999999998643  3445578999999999997  5999999999


Q ss_pred             EeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEee
Q 005033          148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSD  227 (718)
Q Consensus       148 ~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsD  227 (718)
                      +...+..|+||| +.+++|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||+++ +.+||+|
T Consensus        97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~D  169 (313)
T 3cek_A           97 EITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLID  169 (313)
T ss_dssp             EECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECC
T ss_pred             eecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEee
Confidence            999999999999 45899999998764  5788999999999999999999   899999999999999964 8999999


Q ss_pred             ccCceee
Q 005033          228 FGLSRIK  234 (718)
Q Consensus       228 FGLAr~~  234 (718)
                      ||+++..
T Consensus       170 fg~~~~~  176 (313)
T 3cek_A          170 FGIANQM  176 (313)
T ss_dssp             CSSSCC-
T ss_pred             ccccccc
Confidence            9998764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.8e-39  Score=335.24  Aligned_cols=146  Identities=27%  Similarity=0.433  Sum_probs=125.6

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEe-----------
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM-----------  149 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~-----------  149 (718)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++........+.+.+|+.+++.++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            368999999999999999999987 48999999997766666788999999999999999999999884           


Q ss_pred             ---eCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEC-CCCCEEE
Q 005033          150 ---ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD-SDCRGKV  225 (718)
Q Consensus       150 ---~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd-~~~~vKL  225 (718)
                         ..+..|+||||+. |+|.+++...   .+++..+..++.||+.||.|||   +.+|+||||||+|||++ .++.+||
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEE
Confidence               3467899999996 7999999653   5788999999999999999999   89999999999999997 5679999


Q ss_pred             eeccCceee
Q 005033          226 SDFGLSRIK  234 (718)
Q Consensus       226 sDFGLAr~~  234 (718)
                      +|||+++..
T Consensus       163 ~Dfg~~~~~  171 (320)
T 2i6l_A          163 GDFGLARIM  171 (320)
T ss_dssp             CCCTTCBCC
T ss_pred             ccCcccccc
Confidence            999998864

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.5e-39  Score=355.60  Aligned_cols=144  Identities=28%  Similarity=0.381  Sum_probs=120.8

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC------CeEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMER------NKRI  155 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~~~~  155 (718)
                      .+|.+.+.||+|+||.||+|.+. +|+.||||++....    ..+.+|+++|+.++|||||+++++|...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46889999999999999999986 59999999985432    1235799999999999999999998542      2367


Q ss_pred             EEEeccCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC-CCEEEeeccCce
Q 005033          156 LVYEYMPNKSLQEMLFS--DGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD-CRGKVSDFGLSR  232 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~--~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~-~~vKLsDFGLAr  232 (718)
                      +||||++ ++|.+++..  .....+++..+..++.||+.||.|||   +.+|+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            9999996 577776643  12236899999999999999999999   9999999999999999965 568999999998


Q ss_pred             ee
Q 005033          233 IK  234 (718)
Q Consensus       233 ~~  234 (718)
                      ..
T Consensus       206 ~~  207 (420)
T 1j1b_A          206 QL  207 (420)
T ss_dssp             EC
T ss_pred             hc
Confidence            64

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=8.1e-39  Score=340.17  Aligned_cols=146  Identities=29%  Similarity=0.513  Sum_probs=131.2

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC-----CeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMER-----NKR  154 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~~  154 (718)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|+.+++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999987 68999999996533 34456788999999999999999999998764     678


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+||||+. |+|.+++...   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            99999995 7999999764   5889999999999999999999   899999999999999999999999999999875

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.1e-39  Score=351.56  Aligned_cols=145  Identities=26%  Similarity=0.457  Sum_probs=116.9

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC------C
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMER------N  152 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~  152 (718)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+.+|+.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999999976 6899999998642  334456789999999999999999999999754      5


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                      ..|+||||+ +++|.+++...   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             eEEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            679999999 79999998753   5899999999999999999999   8999999999999999999999999999987


Q ss_pred             e
Q 005033          233 I  233 (718)
Q Consensus       233 ~  233 (718)
                      .
T Consensus       181 ~  181 (367)
T 2fst_X          181 H  181 (367)
T ss_dssp             -
T ss_pred             c
Confidence            5

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.8e-39  Score=338.18  Aligned_cols=149  Identities=26%  Similarity=0.429  Sum_probs=127.2

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHH-HHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQ-ILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~-iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      .++|++.+.||+|+||.||+|... +|+.||||++.... ......+..|+. +++.++||||+++++++...+..|+||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            468999999999999999999986 68999999996542 334455666666 778889999999999999999999999


Q ss_pred             eccCCCCHHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFS---DGNLVLKWSQRFEIIMDVAKALEFLHFGCDP-PVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~---~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~-gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+. |+|.+++..   .....+++..+..++.|++.||.|||   .. +|+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            9996 588888753   22346889999999999999999999   77 9999999999999999999999999998753

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.5e-39  Score=342.10  Aligned_cols=147  Identities=27%  Similarity=0.419  Sum_probs=122.7

Q ss_pred             HhcCccccc-eecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEee----CCeE
Q 005033           81 ATNDFDEAN-VIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME----RNKR  154 (718)
Q Consensus        81 at~~f~~~~-~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~  154 (718)
                      ..++|.+.+ .||+|+||.||+|.+. +|+.||||++.... ...   ......+..+.||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            356898855 6999999999999987 69999999986532 222   222334566799999999999976    4568


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC---CCCEEEeeccCc
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLS  231 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~---~~~vKLsDFGLA  231 (718)
                      |+||||+++|+|.+++.......+++..+..++.||+.||.|||   ..+|+||||||+|||++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999998776567899999999999999999999   899999999999999976   455999999998


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      +..
T Consensus       179 ~~~  181 (336)
T 3fhr_A          179 KET  181 (336)
T ss_dssp             EEC
T ss_pred             eec
Confidence            753

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.7e-39  Score=342.86  Aligned_cols=156  Identities=26%  Similarity=0.350  Sum_probs=118.5

Q ss_pred             HHHHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe-
Q 005033           76 KELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNK-  153 (718)
Q Consensus        76 ~el~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~-  153 (718)
                      .+.....++|++.+.||+|+||.||+|.+. +|+.||||++.... .....+.+|+..+..++||||++++++|...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            445667789999999999999999999986 68999999885432 223456778888899999999999999976443 


Q ss_pred             ------EEEEEeccCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC-CCCEE
Q 005033          154 ------RILVYEYMPNKSLQEMLFS--DGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS-DCRGK  224 (718)
Q Consensus       154 ------~~LVmEy~~gGsL~~~L~~--~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~-~~~vK  224 (718)
                            .++||||+++ +|.+.+..  .....+++..+..++.||+.||.|||.. +.+|+||||||+|||++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEE
Confidence                  7899999965 66555432  2234678899999999999999999932 679999999999999997 89999


Q ss_pred             EeeccCceee
Q 005033          225 VSDFGLSRIK  234 (718)
Q Consensus       225 LsDFGLAr~~  234 (718)
                      |+|||+++..
T Consensus       173 l~Dfg~a~~~  182 (360)
T 3e3p_A          173 LCDFGSAKKL  182 (360)
T ss_dssp             ECCCTTCBCC
T ss_pred             EeeCCCceec
Confidence            9999998764

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=9.4e-39  Score=345.33  Aligned_cols=144  Identities=26%  Similarity=0.437  Sum_probs=127.3

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeE----
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKR----  154 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~----  154 (718)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++...  .......+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999986 6899999999653  233456789999999999999999999999877654    


Q ss_pred             --EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          155 --ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       155 --~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                        |+||||+. ++|.+++..    .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence              99999995 799888743    4889999999999999999999   8999999999999999999999999999887


Q ss_pred             e
Q 005033          233 I  233 (718)
Q Consensus       233 ~  233 (718)
                      .
T Consensus       193 ~  193 (371)
T 4exu_A          193 H  193 (371)
T ss_dssp             -
T ss_pred             c
Confidence            5

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.6e-39  Score=351.50  Aligned_cols=144  Identities=26%  Similarity=0.360  Sum_probs=120.3

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe------EEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNK------RIL  156 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~------~~L  156 (718)
                      .+|.+.+.||+|+||.||+|.+..+..||+|++.....    ...+|+.+|+.++||||++++++|...+.      .|+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            56999999999999999999998777799998854321    22479999999999999999999965443      789


Q ss_pred             EEeccCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEC-CCCCEEEeeccCcee
Q 005033          157 VYEYMPNKSLQEMLFS--DGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD-SDCRGKVSDFGLSRI  233 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~--~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd-~~~~vKLsDFGLAr~  233 (718)
                      ||||+++ +|.+.+..  .....+++..+..++.||+.||.|||   +.+|+||||||+|||++ .++.+||+|||+|+.
T Consensus       116 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          116 VLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999965 44444332  11236889999999999999999999   89999999999999999 799999999999986


Q ss_pred             e
Q 005033          234 K  234 (718)
Q Consensus       234 ~  234 (718)
                      .
T Consensus       192 ~  192 (394)
T 4e7w_A          192 L  192 (394)
T ss_dssp             C
T ss_pred             c
Confidence            4

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=339.37  Aligned_cols=152  Identities=26%  Similarity=0.362  Sum_probs=123.5

Q ss_pred             HHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChh------hHHHHHHHHHHHhCC----CCCcceeEEE
Q 005033           78 LKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQ------TEREFQNELQILGGL----RSPFLVTLLG  146 (718)
Q Consensus        78 l~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~------~~~~f~~Ei~iL~~L----~HpNIV~L~g  146 (718)
                      .....++|++.+.||+|+||.||+|.+. +++.||||++......      ....+.+|+.++.++    +|+||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3445678999999999999999999875 6889999999653321      223456789988888    8999999999


Q ss_pred             EEeeCCeEEEEEec-cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEC-CCCCEE
Q 005033          147 YCMERNKRILVYEY-MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD-SDCRGK  224 (718)
Q Consensus       147 ~~~~~~~~~LVmEy-~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd-~~~~vK  224 (718)
                      ++...+..++|||| +.+++|.+++....  .+++..++.++.||+.||.|||   +.+|+||||||+|||++ .++.+|
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEE
Confidence            99999999999999 78999999998754  5889999999999999999999   89999999999999999 889999


Q ss_pred             EeeccCceee
Q 005033          225 VSDFGLSRIK  234 (718)
Q Consensus       225 LsDFGLAr~~  234 (718)
                      |+|||+++..
T Consensus       181 l~dfg~~~~~  190 (312)
T 2iwi_A          181 LIDFGSGALL  190 (312)
T ss_dssp             ECCCSSCEEC
T ss_pred             EEEcchhhhc
Confidence            9999998764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.4e-40  Score=343.33  Aligned_cols=152  Identities=24%  Similarity=0.409  Sum_probs=129.2

Q ss_pred             HHHHHHhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe
Q 005033           76 KELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNK  153 (718)
Q Consensus        76 ~el~~at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~  153 (718)
                      .+.....++|++.+.||+|+||.||+|.+..  .||||++....  ....+.|.+|+.+++.++||||+++++++...+.
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            3334456789999999999999999998753  59999986432  2223467889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .++||||+++++|.+++.... ..+++..+..++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+++.
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             eEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            999999999999999997653 35788999999999999999999   89999999999999998 68999999999876


Q ss_pred             e
Q 005033          234 K  234 (718)
Q Consensus       234 ~  234 (718)
                      .
T Consensus       179 ~  179 (319)
T 2y4i_B          179 S  179 (319)
T ss_dssp             -
T ss_pred             c
Confidence            3

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.1e-38  Score=330.67  Aligned_cols=148  Identities=24%  Similarity=0.395  Sum_probs=132.1

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS--LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ..++|++.+.||+|+||.||+|... +++.||||++....  ......+.+|+.++++++||||+++++++...+..|+|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            4468999999999999999999987 68999999985432  23456799999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC---CCEEEeeccCcee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD---CRGKVSDFGLSRI  233 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~---~~vKLsDFGLAr~  233 (718)
                      |||+++++|.+++....  .+++..+..++.||+.||.|||   ..+|+||||||+|||++.+   +.+||+|||++..
T Consensus       100 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            99999999999987654  5789999999999999999999   8999999999999999764   4799999998865

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=7.8e-38  Score=352.46  Aligned_cols=146  Identities=23%  Similarity=0.351  Sum_probs=127.4

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCC-CcceeEEEEEeeCCeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRS-PFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~H-pNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.....  ...+.+|+.++..++| ++|+.+..++...+..|||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            468999999999999999999975 689999998764322  2357899999999987 566677777788889999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE---CCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL---DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL---d~~~~vKLsDFGLAr~~  234 (718)
                      |+ +++|.+++..... .+++..++.|+.||+.||.|||   ..+||||||||+||||   +.++.+||+|||+++..
T Consensus        84 ~~-g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             CC-CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            99 9999999976433 6899999999999999999999   8999999999999999   68899999999999875

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=338.63  Aligned_cols=144  Identities=26%  Similarity=0.434  Sum_probs=127.3

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe-----
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNK-----  153 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~-----  153 (718)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++...  .......+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367999999999999999999986 6899999998653  23345678999999999999999999999987654     


Q ss_pred             -EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          154 -RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       154 -~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                       .|+||||+. |+|.+++..    .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence             499999996 799887743    4889999999999999999999   8999999999999999999999999999886


Q ss_pred             e
Q 005033          233 I  233 (718)
Q Consensus       233 ~  233 (718)
                      .
T Consensus       175 ~  175 (353)
T 3coi_A          175 H  175 (353)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-38  Score=371.70  Aligned_cols=150  Identities=26%  Similarity=0.354  Sum_probs=131.6

Q ss_pred             HHhcCccccceecccCceEEEEEEEcC----CcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeE
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIARD----GKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~~----g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~  154 (718)
                      ...++|++.+.||+|+||.||+|.+..    +..||||.+... .....+.|.+|+.+|+.++||||+++++++. .+..
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            344678889999999999999998752    567999998653 3344567999999999999999999999985 4668


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+||||+++|+|.+++.... ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            99999999999999998654 35889999999999999999999   899999999999999999999999999999764

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.3e-39  Score=340.48  Aligned_cols=152  Identities=23%  Similarity=0.355  Sum_probs=131.3

Q ss_pred             HHHHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh------hhHHHHHHHHHHHhCCC--CCcceeEEEEE
Q 005033           78 LKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL------QTEREFQNELQILGGLR--SPFLVTLLGYC  148 (718)
Q Consensus        78 l~~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~------~~~~~f~~Ei~iL~~L~--HpNIV~L~g~~  148 (718)
                      .....++|++.+.||+|+||.||+|.+. +++.||||++.....      .....+.+|+.++..++  |+||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            3445678999999999999999999876 689999999864321      12245678999999996  59999999999


Q ss_pred             eeCCeEEEEEeccCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEC-CCCCEEEe
Q 005033          149 MERNKRILVYEYMPN-KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD-SDCRGKVS  226 (718)
Q Consensus       149 ~~~~~~~LVmEy~~g-GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd-~~~~vKLs  226 (718)
                      ...+..++||||+.+ ++|.+++....  .+++..+..++.||+.||.|||   +.+|+||||||+|||++ .++.+||+
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence            999999999999976 89999998654  5788999999999999999999   89999999999999999 78999999


Q ss_pred             eccCceee
Q 005033          227 DFGLSRIK  234 (718)
Q Consensus       227 DFGLAr~~  234 (718)
                      |||+++..
T Consensus       193 Dfg~~~~~  200 (320)
T 3a99_A          193 DFGSGALL  200 (320)
T ss_dssp             CCTTCEEC
T ss_pred             eCcccccc
Confidence            99998764

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4e-38  Score=348.51  Aligned_cols=144  Identities=24%  Similarity=0.298  Sum_probs=118.8

Q ss_pred             CccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           84 DFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      .|...+.||+|+||+||.+...+|+.||||++...   ....+.+|+.+|..+ +|||||++++++...+..||||||| 
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~-   91 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-   91 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC-
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC-
Confidence            44556889999999998776678999999998642   334678999999876 8999999999999999999999999 


Q ss_pred             CCCHHHHHhhCCCCC-----CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC-------------CCEE
Q 005033          163 NKSLQEMLFSDGNLV-----LKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD-------------CRGK  224 (718)
Q Consensus       163 gGsL~~~L~~~~~~~-----l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~-------------~~vK  224 (718)
                      +|+|.+++.......     .++..++.++.||+.||.|||   +.+|+||||||+|||++.+             +.+|
T Consensus        92 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           92 NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence            579999998654311     122345679999999999999   8999999999999999654             4899


Q ss_pred             EeeccCceee
Q 005033          225 VSDFGLSRIK  234 (718)
Q Consensus       225 LsDFGLAr~~  234 (718)
                      |+|||+++..
T Consensus       169 L~DFG~a~~~  178 (434)
T 2rio_A          169 ISDFGLCKKL  178 (434)
T ss_dssp             ECCCTTCEEC
T ss_pred             Ecccccceec
Confidence            9999999875

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=325.92  Aligned_cols=148  Identities=25%  Similarity=0.375  Sum_probs=117.5

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh-hh-HHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL-QT-EREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~-~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++..... .. .+.+..+..+++.++||||+++++++...+..|+||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467899999999999999999986 689999999965432 22 233445556788899999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDP-PVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~-gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+ ++.+..+..... ..+++..+..++.||+.||.|||   .. +|+||||||+|||++.++.+||+|||++...
T Consensus       104 e~~-~~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             CCC-SEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             ecc-CCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            999 666666654422 36889999999999999999999   74 9999999999999999999999999988753

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=344.71  Aligned_cols=146  Identities=23%  Similarity=0.341  Sum_probs=121.8

Q ss_pred             HhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEEEe
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ...+|...+.||+|+||+||.....+++.||||++.....   ..+.+|+.+|+.+ +|||||++++++.+....|||||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            3456888999999999997665556799999999865322   2356899999999 79999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC-----CCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS-----DCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~-----~~~vKLsDFGLAr~~  234 (718)
                      ||. |+|.+++..... ......++.++.||+.||.|||   +.+|+||||||+|||++.     ...+||+|||+|+..
T Consensus        99 ~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           99 LCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            995 799999976543 3344456789999999999999   899999999999999953     336889999999864

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3e-37  Score=360.11  Aligned_cols=144  Identities=22%  Similarity=0.428  Sum_probs=126.2

Q ss_pred             hcCccccceecccCceEEEEEEEc--CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCe-----
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR--DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNK-----  153 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~--~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~-----  153 (718)
                      .++|++.+.||+|+||.||+|.+.  +|+.||||++... .......|.+|+.+|..++|||||++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999986  5899999998643 33455678999999999999999999999987665     


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .||||||++|++|.+++..    .+++..++.|+.||+.||.|||   +.+||||||||+|||++.+ .+||+|||+++.
T Consensus       159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence            7999999999999988754    5899999999999999999999   8999999999999999875 899999999875

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=6.4e-36  Score=312.99  Aligned_cols=137  Identities=16%  Similarity=0.106  Sum_probs=122.1

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||.||+|.+. +++.||||++....   ....+.|.+|+.++..++||||+++++++...+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            67999999999999999999987 48999999996542   334477999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEe
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVS  226 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLs  226 (718)
                      ||++|++|.+++...    .....+..|+.||+.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus       111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~  171 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLA  171 (286)
T ss_dssp             ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEEC
T ss_pred             EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEE
Confidence            999999999999543    345578889999999999999   8999999999999999988877765

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.4e-35  Score=309.87  Aligned_cols=144  Identities=23%  Similarity=0.417  Sum_probs=127.9

Q ss_pred             hcCcccc-ceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHH-hCCCCCcceeEEEEEee----CCeE
Q 005033           82 TNDFDEA-NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQIL-GGLRSPFLVTLLGYCME----RNKR  154 (718)
Q Consensus        82 t~~f~~~-~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL-~~L~HpNIV~L~g~~~~----~~~~  154 (718)
                      .++|.+. +.||+|+||.||+|.+. +++.||||++...     ..+.+|+.++ +.++||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            4577777 78999999999999986 6899999998642     3567888887 66699999999999987    6778


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC---CCCEEEeeccCc
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLS  231 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~---~~~vKLsDFGLA  231 (718)
                      |+||||+++|+|.+++.......+++..+..++.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999998876557899999999999999999999   899999999999999998   788999999988


Q ss_pred             ee
Q 005033          232 RI  233 (718)
Q Consensus       232 r~  233 (718)
                      ..
T Consensus       168 ~~  169 (299)
T 3m2w_A          168 KE  169 (299)
T ss_dssp             EE
T ss_pred             cc
Confidence            64

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.7e-37  Score=357.70  Aligned_cols=150  Identities=27%  Similarity=0.382  Sum_probs=129.0

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEee------CCe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCME------RNK  153 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~------~~~  153 (718)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++... .......+.+|+.++..++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            368999999999999999999886 6899999998653 34456779999999999999999999999765      667


Q ss_pred             EEEEEeccCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC---EEEeecc
Q 005033          154 RILVYEYMPNKSLQEMLFSDGN-LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR---GKVSDFG  229 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~-~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~---vKLsDFG  229 (718)
                      .|+|||||++|+|.+++..... ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999986542 35788889999999999999999   899999999999999997765   9999999


Q ss_pred             Cceee
Q 005033          230 LSRIK  234 (718)
Q Consensus       230 LAr~~  234 (718)
                      +++..
T Consensus       170 ~a~~~  174 (676)
T 3qa8_A          170 YAKEL  174 (676)
T ss_dssp             CCCBT
T ss_pred             ccccc
Confidence            98753

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=9.9e-37  Score=335.31  Aligned_cols=149  Identities=16%  Similarity=0.213  Sum_probs=114.6

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHHHhCCCC-Ccc----------e---
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQNELQILGGLRS-PFL----------V---  142 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~~Ei~iL~~L~H-pNI----------V---  142 (718)
                      .+..|...+.||+|+||.||+|.+. +|+.||||++.....   ...+.|.+|+.++..++| .|+          +   
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            3445778899999999999999976 699999999873322   224678999999999987 221          1   


Q ss_pred             --------eEEEEEee-----CCeEEEEEeccCCCCHHHHHh-----hCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 005033          143 --------TLLGYCME-----RNKRILVYEYMPNKSLQEMLF-----SDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP  204 (718)
Q Consensus       143 --------~L~g~~~~-----~~~~~LVmEy~~gGsL~~~L~-----~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~g  204 (718)
                              .+..++..     ....+++|+++ +++|.+++.     ......+++..++.++.||+.||.|||   +.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYG  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence                    11111111     12457788877 799999985     222345778889999999999999999   899


Q ss_pred             eEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       205 IVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |+||||||+|||++.++.+||+|||+++.
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~  260 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVR  260 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEE
T ss_pred             cccCCcccceEEEecCCeEEEEeccceee
Confidence            99999999999999999999999999875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.6e-37  Score=325.05  Aligned_cols=134  Identities=22%  Similarity=0.226  Sum_probs=111.5

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccCC--------hhhHHHHHHHHHHHhCCC---------CCcceeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFS--------LQTEREFQNELQILGGLR---------SPFLVTL  144 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~--------~~~~~~f~~Ei~iL~~L~---------HpNIV~L  144 (718)
                      .++|++.+.||+|+||.||+|.+ +|+.||||++....        ....+.+.+|+.+|+.++         |||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46789999999999999999998 68999999996532        223367889999988885         7888877


Q ss_pred             EEEEe------------------------------eCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHH
Q 005033          145 LGYCM------------------------------ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL  194 (718)
Q Consensus       145 ~g~~~------------------------------~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL  194 (718)
                      .+++.                              ..+..|||||||++|+|.+.+...   .+++..+..++.||+.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~---~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT---CCCHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc---CCCHHHHHHHHHHHHHHH
Confidence            77653                              267899999999999776666442   578999999999999999


Q ss_pred             HHHhcCCCCCeEecCCCCCCEEECCCC
Q 005033          195 EFLHFGCDPPVIHGDIKPSNVLLDSDC  221 (718)
Q Consensus       195 ~yLH~~~~~gIVHRDLKP~NILLd~~~  221 (718)
                      .|||+  +.+|+||||||+|||++.++
T Consensus       175 ~~lH~--~~~ivHrDlKp~NILl~~~~  199 (336)
T 2vuw_A          175 AVAEA--SLRFEHRDLHWGNVLLKKTS  199 (336)
T ss_dssp             HHHHH--HHCCBCSCCCGGGEEEEECS
T ss_pred             HHHHH--hCCEeECCCCHHHEEEeccC
Confidence            99992  36899999999999998876

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=1.1e-30  Score=299.86  Aligned_cols=137  Identities=20%  Similarity=0.189  Sum_probs=109.9

Q ss_pred             eecccCceEEEEEEEc-CCcEEEEEEcccCC----------hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEE
Q 005033           90 VIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS----------LQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        90 ~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~----------~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++.|++|.+..++.. .|+.||||++....          ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            3456666666554432 58899999985421          22345799999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||++|++|.++|...+  .++..   .|+.||+.||.|||   ++|||||||||+||||+.+|.+||+|||+|+..
T Consensus       321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~  389 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTT  389 (569)
T ss_dssp             EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred             EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence            99999999999998765  45543   48899999999999   999999999999999999999999999999864

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=6.3e-26  Score=258.76  Aligned_cols=133  Identities=19%  Similarity=0.257  Sum_probs=106.2

Q ss_pred             cccceecccCceEEEEEEEcCCcEEEEEEcccCCh--------hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           86 DEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL--------QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        86 ~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~--------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ...+.||+|+||.||+|.. .+..+|+|+......        ...+.|.+|+++|++++||||+++..++...+..|||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3457899999999999944 578899998643211        1134589999999999999999666666677788999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||||++++|.+++..          ++.++.||+.||.|||   +.+|+||||||+|||++.  .+||+|||+|+..
T Consensus       418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~  479 (540)
T 3en9_A          418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS  479 (540)
T ss_dssp             EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred             EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence            999999999999865          4578999999999999   899999999999999998  9999999999875

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=7.7e-22  Score=206.83  Aligned_cols=142  Identities=17%  Similarity=0.147  Sum_probs=115.0

Q ss_pred             HHHHHHhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCCh------------------hhHHHHHHHHHHHhCCC
Q 005033           76 KELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL------------------QTEREFQNELQILGGLR  137 (718)
Q Consensus        76 ~el~~at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~------------------~~~~~f~~Ei~iL~~L~  137 (718)
                      ..+......|.+.+.||+|+||.||+|.+.+|+.||||.+.....                  .....+.+|+.+|+.++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344445556778899999999999999997799999999864221                  13456899999999999


Q ss_pred             CCcceeEEEEEeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 005033          138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL  217 (718)
Q Consensus       138 HpNIV~L~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL  217 (718)
                      |   +++.+++.. +..|+||||++||+|.+ +..        .....++.||+.||.|||   +.+|+||||||+|||+
T Consensus       163 ~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl  226 (282)
T 1zar_A          163 G---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLV  226 (282)
T ss_dssp             T---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEE
T ss_pred             C---CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEE
Confidence            4   555555433 55699999999999988 421        123468999999999999   9999999999999999


Q ss_pred             CCCCCEEEeeccCceee
Q 005033          218 DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       218 d~~~~vKLsDFGLAr~~  234 (718)
                      + ++.+||+|||+|+..
T Consensus       227 ~-~~~vkl~DFG~a~~~  242 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVEV  242 (282)
T ss_dssp             E-TTEEEECCCTTCEET
T ss_pred             E-CCcEEEEECCCCeEC
Confidence            9 999999999999875

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.77  E-value=4.6e-19  Score=182.79  Aligned_cols=137  Identities=21%  Similarity=0.220  Sum_probs=106.9

Q ss_pred             ccccceecccCceEEEEEEE-cCCcE--EEEEEcccCCh------------------------hhHHHHHHHHHHHhCCC
Q 005033           85 FDEANVIGKGGSGTVFLGIA-RDGKL--LAIKRLDTFSL------------------------QTEREFQNELQILGGLR  137 (718)
Q Consensus        85 f~~~~~LG~G~FG~Vykg~~-~~g~~--VAVK~i~~~~~------------------------~~~~~f~~Ei~iL~~L~  137 (718)
                      |.+.+.||+|+||.||+|.+ .+|+.  ||||+++....                        .....+.+|+.+|..++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56789999999999999998 57888  99998743211                        11236789999999998


Q ss_pred             CCcc--eeEEEEEeeCCeEEEEEeccCC-C----CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 005033          138 SPFL--VTLLGYCMERNKRILVYEYMPN-K----SLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDI  210 (718)
Q Consensus       138 HpNI--V~L~g~~~~~~~~~LVmEy~~g-G----sL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDL  210 (718)
                      |++|  ..++++    +..+|||||+.+ |    +|.+++..     .++..+..++.||+.||.|||.  ..+|+||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl  197 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ--EAELVHADL  197 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence            8754  444432    356899999942 3    77776542     1234567899999999999994  468999999


Q ss_pred             CCCCEEECCCCCEEEeeccCceee
Q 005033          211 KPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       211 KP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+|||++.  .++|+|||+|...
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEET
T ss_pred             CHHHEEEcC--cEEEEECcccccC
Confidence            999999988  9999999999875

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.61  E-value=1.2e-16  Score=175.32  Aligned_cols=138  Identities=13%  Similarity=0.148  Sum_probs=99.7

Q ss_pred             CccccceecccCceEEEEEEEcCCcEEEEEEcccCCh--------------hhHH--------HHHHHHHHHhCCCCCcc
Q 005033           84 DFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL--------------QTER--------EFQNELQILGGLRSPFL  141 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~--------------~~~~--------~f~~Ei~iL~~L~HpNI  141 (718)
                      -|++...||+|+||.||+|...+|+.||||+++....              ....        ...+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3899999999999999999998999999998743110              0011        12346666766654443


Q ss_pred             eeEEEEEeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC
Q 005033          142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC  221 (718)
Q Consensus       142 V~L~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~  221 (718)
                      ....-+...  ..+|||||++|++|.++...        .....++.||+.+|.|||   ..+||||||||.|||+++++
T Consensus       176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          176 PVPEPIAQS--RHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             SCCCEEEEE--TTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEE
T ss_pred             CCCeeeecc--CceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCC
Confidence            211111111  23799999999888655321        123467899999999999   88999999999999998876


Q ss_pred             ----------CEEEeeccCceee
Q 005033          222 ----------RGKVSDFGLSRIK  234 (718)
Q Consensus       222 ----------~vKLsDFGLAr~~  234 (718)
                                .+.|+||+-+-..
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEET
T ss_pred             CcccccccccceEEEEeCCcccC
Confidence                      3899999977653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.31  E-value=4.3e-12  Score=129.27  Aligned_cols=148  Identities=16%  Similarity=0.097  Sum_probs=115.2

Q ss_pred             HHHhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCCeEEEE
Q 005033           79 KNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLR-SPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        79 ~~at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .....+|.+...++.|+++.||++... ++.+++|+...........+.+|+.+|..+. |..+.++++++...+..|+|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            344567888888999999999998754 6899999986422122335888999998884 67788999999998999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG-------------------------------------  200 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~-------------------------------------  200 (718)
                      |||++|.+|.+.+...       .....++.+++.+|..||..                                     
T Consensus        89 ~e~i~G~~l~~~~~~~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           89 MSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EECCSSEEHHHHCCTT-------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEecCCeehhhccCCc-------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            9999999998764211       12346788999999999951                                     


Q ss_pred             -------------------CCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          201 -------------------CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       201 -------------------~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                                         ....++|+|++|.|||++++..+.|+||+.+...
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence                               0145999999999999987666679999988764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.19  E-value=2e-11  Score=122.70  Aligned_cols=139  Identities=22%  Similarity=0.157  Sum_probs=101.9

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCc--ceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPF--LVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~L~g~~~~~~~~~LVmEy  160 (718)
                      .++.+....+.|..+.||++...+|..++||.....   ....+.+|+.++..+.+.+  +.++++++..++..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            445543333456669999998777888999987543   2235778999988885444  56689988888889999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC---------------------------------------  201 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~---------------------------------------  201 (718)
                      ++|.+|.  ...     ..   ...++.+++..|..||...                                       
T Consensus        97 i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           97 VPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             CSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             cCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            9998884  211     11   1256778888888888321                                       


Q ss_pred             ----------------CCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          202 ----------------DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       202 ----------------~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                                      ...++|+|++|.|||++.++.+.|+|||.+...
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                            112999999999999987766779999998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.96  E-value=1.2e-09  Score=116.85  Aligned_cols=143  Identities=15%  Similarity=0.269  Sum_probs=106.4

Q ss_pred             ccceecccCceEEEEEEEcCCcEEEEEEcc--cCC-hhhHHHHHHHHHHHhCCC--CCcceeEEEEEeeC---CeEEEEE
Q 005033           87 EANVIGKGGSGTVFLGIARDGKLLAIKRLD--TFS-LQTEREFQNELQILGGLR--SPFLVTLLGYCMER---NKRILVY  158 (718)
Q Consensus        87 ~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~--~~~-~~~~~~f~~Ei~iL~~L~--HpNIV~L~g~~~~~---~~~~LVm  158 (718)
                      .++.|+.|.++.||+.... +..+++|+..  ... ......+.+|+.+++.+.  +..+.+++.++.+.   +..|+||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3567899999999998775 4678888775  322 122346788999998886  45688999998776   4589999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC-------------------------------------  201 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~-------------------------------------  201 (718)
                      ||++|..|.+..    ...++......++.+++..|..||...                                     
T Consensus       121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            999988874321    113567778889999999999999520                                     


Q ss_pred             ------------------CCCeEecCCCCCCEEECCCCC--EEEeeccCceee
Q 005033          202 ------------------DPPVIHGDIKPSNVLLDSDCR--GKVSDFGLSRIK  234 (718)
Q Consensus       202 ------------------~~gIVHRDLKP~NILLd~~~~--vKLsDFGLAr~~  234 (718)
                                        ...++|+|+++.|||++.++.  +.|+||+.+..-
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                              257999999999999987753  689999998863

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.42  E-value=3.8e-07  Score=95.24  Aligned_cols=137  Identities=19%  Similarity=0.226  Sum_probs=98.8

Q ss_pred             cceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCC-CCc--ceeEEEEEeeCC---eEEEEEecc
Q 005033           88 ANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLR-SPF--LVTLLGYCMERN---KRILVYEYM  161 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-HpN--IV~L~g~~~~~~---~~~LVmEy~  161 (718)
                      ++.++.|.+..||+..    ..+++|+...  ......+.+|+.+|..+. +..  +.+++......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999863    5688887543  234567889999998773 322  445555543333   348999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG-----------------------------------------  200 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~-----------------------------------------  200 (718)
                      +|.+|.+....    .++..++..++.+++..|..||..                                         
T Consensus        99 ~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           99 KGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             CCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            99888754332    356666777888888888888831                                         


Q ss_pred             --------------CCCCeEecCCCCCCEEECC--CCCEEEeeccCceee
Q 005033          201 --------------CDPPVIHGDIKPSNVLLDS--DCRGKVSDFGLSRIK  234 (718)
Q Consensus       201 --------------~~~gIVHRDLKP~NILLd~--~~~vKLsDFGLAr~~  234 (718)
                                    ....++|+|++|.|||++.  ...+.|+||+.+...
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                          1245899999999999988  456789999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.36  E-value=2.4e-06  Score=86.85  Aligned_cols=136  Identities=22%  Similarity=0.187  Sum_probs=97.6

Q ss_pred             eecccCce-EEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCCeEEEEEeccCCCCH
Q 005033           90 VIGKGGSG-TVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLR-SPFLVTLLGYCMERNKRILVYEYMPNKSL  166 (718)
Q Consensus        90 ~LG~G~FG-~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmEy~~gGsL  166 (718)
                      .+..|..| .||+.... ++..+.+|+-..   .....+.+|..+|+.+. +--+.++++++.+.+..|+|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556555 68987765 466788997643   23456788999888774 33467889999999999999999999888


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 005033          167 QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG----------------------------------------------  200 (718)
Q Consensus       167 ~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~----------------------------------------------  200 (718)
                      .+......      .....++.+++..|.-||..                                              
T Consensus       108 ~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          108 FQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            87654321      12234555666666666631                                              


Q ss_pred             ---------CCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          201 ---------CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       201 ---------~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                               ....++|+|+.+.|||++.++.+-|+||+.+..-
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                     0223899999999999998777779999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.33  E-value=3e-06  Score=89.04  Aligned_cols=137  Identities=20%  Similarity=0.225  Sum_probs=93.7

Q ss_pred             cceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCC---cceeEEEEEe-eCCeEEEEEeccCC
Q 005033           88 ANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSP---FLVTLLGYCM-ERNKRILVYEYMPN  163 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~Hp---NIV~L~g~~~-~~~~~~LVmEy~~g  163 (718)
                      +..++.|....||+.    |..++||+-.  .......+.+|..+|..|.+.   .|.+.+.++. ..+..|+||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456888988899987    5678888743  233456789999999988652   3566777764 45567899999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG-------------------------------------------  200 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~-------------------------------------------  200 (718)
                      ..|.+....    .++......++.+++..|..||..                                           
T Consensus        98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            888763211    123333334444444444444421                                           


Q ss_pred             --------------CCCCeEecCCCCCCEEECC---CCC-EEEeeccCceee
Q 005033          201 --------------CDPPVIHGDIKPSNVLLDS---DCR-GKVSDFGLSRIK  234 (718)
Q Consensus       201 --------------~~~gIVHRDLKP~NILLd~---~~~-vKLsDFGLAr~~  234 (718)
                                    ....++|+|++|.|||++.   ++. +.|+||+.+..-
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                          2446799999999999987   455 489999988764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.03  E-value=4.6e-06  Score=88.63  Aligned_cols=80  Identities=8%  Similarity=0.053  Sum_probs=54.9

Q ss_pred             ccee-cccCceEEEEEEEc-------CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCC---CcceeEEEEEeeC--
Q 005033           88 ANVI-GKGGSGTVFLGIAR-------DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRS---PFLVTLLGYCMER--  151 (718)
Q Consensus        88 ~~~L-G~G~FG~Vykg~~~-------~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~H---pNIV~L~g~~~~~--  151 (718)
                      .+.| +.|....+|+....       ++..+++|+.....   ......+.+|+.+|..|..   -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 88889999988764       26678888764322   0012356788888887742   3577888887665  


Q ss_pred             -CeEEEEEeccCCCCHH
Q 005033          152 -NKRILVYEYMPNKSLQ  167 (718)
Q Consensus       152 -~~~~LVmEy~~gGsL~  167 (718)
                       +..|+||||++|..|.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999886653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.92  E-value=3.3e-05  Score=83.47  Aligned_cols=75  Identities=19%  Similarity=0.183  Sum_probs=49.2

Q ss_pred             cceecccCceEEEEEEEc-CCcEEEEEEcccCCh-------hhHHHHHHHHHHHhCCCC--C-cceeEEEEEeeCCeEEE
Q 005033           88 ANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL-------QTEREFQNELQILGGLRS--P-FLVTLLGYCMERNKRIL  156 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~-------~~~~~f~~Ei~iL~~L~H--p-NIV~L~g~~~~~~~~~L  156 (718)
                      .+.||.|.++.||++... +++.++||.......       .....+..|.++|..+..  + .+.+++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467999999999999765 468899997643211       112356778888876632  3 34566654  3445689


Q ss_pred             EEeccCCC
Q 005033          157 VYEYMPNK  164 (718)
Q Consensus       157 VmEy~~gG  164 (718)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.79  E-value=9.4e-05  Score=77.11  Aligned_cols=140  Identities=17%  Similarity=0.197  Sum_probs=79.1

Q ss_pred             ceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCC-----CCCcceeEE-E--EEeeCCeEEEEEec
Q 005033           89 NVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGL-----RSPFLVTLL-G--YCMERNKRILVYEY  160 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L-----~HpNIV~L~-g--~~~~~~~~~LVmEy  160 (718)
                      ..|+.|..+.||+....+| .+++|+.... .   ..+..|..++..|     ..|.++... |  +....+..++||||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677899999887654 5899988652 1   2233444444433     334444310 1  12346678999999


Q ss_pred             cCCCCHH-----------HH---Hhh--C-C--C-------CCCCHHHH-------------------------------
Q 005033          161 MPNKSLQ-----------EM---LFS--D-G--N-------LVLKWSQR-------------------------------  183 (718)
Q Consensus       161 ~~gGsL~-----------~~---L~~--~-~--~-------~~l~~~~~-------------------------------  183 (718)
                      ++|..+.           ..   ++.  . .  .       ....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9886542           11   111  0 0  0       01122211                               


Q ss_pred             HHHHHHHHHHHHHHhc----------CCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          184 FEIIMDVAKALEFLHF----------GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       184 ~~Ia~qIa~gL~yLH~----------~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ..+..++..++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            0111223345666652          0257899999999999998888999999998865

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.44  E-value=0.00046  Score=73.23  Aligned_cols=137  Identities=17%  Similarity=0.173  Sum_probs=92.1

Q ss_pred             cceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCC---CCcceeEEEEEeeCCeEEEEEeccCCC
Q 005033           88 ANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLR---SPFLVTLLGYCMERNKRILVYEYMPNK  164 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~LVmEy~~gG  164 (718)
                      .+.|+.|.+..+|+... ++..++||+....   ....|..|...|+.|.   ...+.+++.++...+..|+||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            46789999999999876 4678889976532   3456888988888773   356888998888888899999999987


Q ss_pred             CHH--------HH---HhhCCC---C-----------------CCCHHHHH---HHH----------------HHHHHHH
Q 005033          165 SLQ--------EM---LFSDGN---L-----------------VLKWSQRF---EII----------------MDVAKAL  194 (718)
Q Consensus       165 sL~--------~~---L~~~~~---~-----------------~l~~~~~~---~Ia----------------~qIa~gL  194 (718)
                      .+.        ..   |+....   .                 .-+|....   ++.                ..++..+
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            642        11   222111   0                 12454322   111                1122122


Q ss_pred             -HHHh-cCCCCCeEecCCCCCCEEECCCCCEEEeecc
Q 005033          195 -EFLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG  229 (718)
Q Consensus       195 -~yLH-~~~~~gIVHRDLKP~NILLd~~~~vKLsDFG  229 (718)
                       ..|. ....+.+||+|+.+.|||++.++ +.|.||.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             2342 12357899999999999999887 8899984

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.42  E-value=0.00034  Score=72.22  Aligned_cols=79  Identities=18%  Similarity=0.167  Sum_probs=56.7

Q ss_pred             CccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCC---CcceeEEEEEeeCCeEEEEEec
Q 005033           84 DFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRS---PFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~H---pNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ....+..+|.|..+.||+....+|+.|.||+-..........|..|+..|+.|.-   --+.+++++.    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            3455678999999999999999999999998654333333467889988887742   2345555542    34799999


Q ss_pred             cCCCCH
Q 005033          161 MPNKSL  166 (718)
Q Consensus       161 ~~gGsL  166 (718)
                      +.++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.39  E-value=0.00072  Score=73.88  Aligned_cols=32  Identities=28%  Similarity=0.439  Sum_probs=29.0

Q ss_pred             CCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       202 ~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ...++|+|++|.|||++.++ +.|+||+.+..-
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            67899999999999998876 999999998864

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.06  E-value=0.0035  Score=65.72  Aligned_cols=141  Identities=14%  Similarity=0.069  Sum_probs=73.0

Q ss_pred             ceecccCceE-EEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCC--CCcceeEEEEEeeCCeEEEEEeccCCCC
Q 005033           89 NVIGKGGSGT-VFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLR--SPFLVTLLGYCMERNKRILVYEYMPNKS  165 (718)
Q Consensus        89 ~~LG~G~FG~-Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~--HpNIV~L~g~~~~~~~~~LVmEy~~gGs  165 (718)
                      +.|+.|+... +|+....+|..+++|.......   ..+..|+.++..+.  .-.+.+++.+....+  +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            3465554444 6676554467777776543211   22345566655553  223566776644333  78999997767


Q ss_pred             HHHHHhhCC------------------------CCCCCHHHHH-------H-H------------HHHHHHHHHHHh---
Q 005033          166 LQEMLFSDG------------------------NLVLKWSQRF-------E-I------------IMDVAKALEFLH---  198 (718)
Q Consensus       166 L~~~L~~~~------------------------~~~l~~~~~~-------~-I------------a~qIa~gL~yLH---  198 (718)
                      +.+.+....                        -..++.....       . +            ...+...+..+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            655442210                        0011111100       0 0            001111122221   


Q ss_pred             cCCCCCeEecCCCCCCEEECCC----CCEEEeeccCceee
Q 005033          199 FGCDPPVIHGDIKPSNVLLDSD----CRGKVSDFGLSRIK  234 (718)
Q Consensus       199 ~~~~~gIVHRDLKP~NILLd~~----~~vKLsDFGLAr~~  234 (718)
                      ......++|+|+.+.|||++.+    +.+.|+||+.+..-
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            1125689999999999999875    67999999998864

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.00  E-value=0.0023  Score=66.56  Aligned_cols=159  Identities=16%  Similarity=0.218  Sum_probs=86.6

Q ss_pred             ccHHHHHHHhcCccc-----cceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCC-----CCcce
Q 005033           73 FTYKELKNATNDFDE-----ANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLR-----SPFLV  142 (718)
Q Consensus        73 ~s~~el~~at~~f~~-----~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-----HpNIV  142 (718)
                      ++.+++......|.+     .+.|+.|....+|+....+| .+++|......  ....+..|+.++..|.     -|.++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            455666665555654     34567788899999887655 67889876521  1223455666665553     23333


Q ss_pred             eEE-E--EEeeCCeEEEEEeccCCCCHHH-----------H---HhhC----CCC---C---CCHHHHHH----------
Q 005033          143 TLL-G--YCMERNKRILVYEYMPNKSLQE-----------M---LFSD----GNL---V---LKWSQRFE----------  185 (718)
Q Consensus       143 ~L~-g--~~~~~~~~~LVmEy~~gGsL~~-----------~---L~~~----~~~---~---l~~~~~~~----------  185 (718)
                      ... |  +....+..+++|+|++|..+..           .   ++..    ...   .   ..|.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            210 1  1123456799999998765310           0   1110    000   0   11222100          


Q ss_pred             --HHHHHHHHHHHHhc----CCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          186 --IIMDVAKALEFLHF----GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       186 --Ia~qIa~gL~yLH~----~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                        +...+...+.+++.    .....++|+|+.+.|||++.++.+.|+||+.+..-
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~g  218 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACND  218 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccCc
Confidence              00113344455542    12457999999999999988766689999988763

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.87  E-value=0.0085  Score=62.37  Aligned_cols=159  Identities=12%  Similarity=0.104  Sum_probs=87.5

Q ss_pred             cccHHHHHHHhcCcc-----ccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCC--cceeE
Q 005033           72 RFTYKELKNATNDFD-----EANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSP--FLVTL  144 (718)
Q Consensus        72 ~~s~~el~~at~~f~-----~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~Hp--NIV~L  144 (718)
                      .++.+++......|.     ....|+ |....||+....+|+.+++|...... .....+..|..++..+...  .++++
T Consensus        10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~   87 (328)
T 1zyl_A           10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAP   87 (328)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred             CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecce
Confidence            344455544443332     234576 88889999877677789999886321 1234566677777665321  23333


Q ss_pred             EEE-----EeeCCeEEEEEeccCCCCHH-----HH---------Hhh----CC---CCCCCHHHH---------------
Q 005033          145 LGY-----CMERNKRILVYEYMPNKSLQ-----EM---------LFS----DG---NLVLKWSQR---------------  183 (718)
Q Consensus       145 ~g~-----~~~~~~~~LVmEy~~gGsL~-----~~---------L~~----~~---~~~l~~~~~---------------  183 (718)
                      +..     ....+..++||||++|..+.     .+         ++.    ..   ....++...               
T Consensus        88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  167 (328)
T 1zyl_A           88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP  167 (328)
T ss_dssp             CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred             eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence            332     22345678999999875431     11         111    00   011222111               


Q ss_pred             -------HHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          184 -------FEIIMDVAKALEFLHF-GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       184 -------~~Ia~qIa~gL~yLH~-~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                             ...+..++..+.-+-. .....++|+|+++.|||++ + .+.|+||+.+..-
T Consensus       168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence                   0111122222222111 1256789999999999998 4 8999999988753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.74  E-value=0.0022  Score=70.73  Aligned_cols=72  Identities=21%  Similarity=0.180  Sum_probs=48.7

Q ss_pred             cceecccCceEEEEEEEcC--------CcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCc-ceeEEEEEeeCCeEEEEE
Q 005033           88 ANVIGKGGSGTVFLGIARD--------GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPF-LVTLLGYCMERNKRILVY  158 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~--------g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpN-IV~L~g~~~~~~~~~LVm  158 (718)
                      .+.|+.|....||++...+        +..+.+|+....  .....+.+|..++..|...+ ..++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4568888889999998753        478889887431  11135567888888774333 3677776643    2899


Q ss_pred             eccCCCC
Q 005033          159 EYMPNKS  165 (718)
Q Consensus       159 Ey~~gGs  165 (718)
                      ||++|.+
T Consensus       152 e~l~G~~  158 (429)
T 1nw1_A          152 EYIPSRP  158 (429)
T ss_dssp             CCCCEEE
T ss_pred             EEeCCcc
Confidence            9997644

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.64  E-value=0.0039  Score=64.62  Aligned_cols=138  Identities=16%  Similarity=0.094  Sum_probs=74.2

Q ss_pred             cceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcc-eeEEEEEeeCCeEEEEEecc-CCCC
Q 005033           88 ANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFL-VTLLGYCMERNKRILVYEYM-PNKS  165 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LVmEy~-~gGs  165 (718)
                      ++.|+.|....+|+.     ..+++|+........ -...+|+.++..+...++ .++++++  ...-++|+||+ +|.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            678889999999998     557888765421111 112457776665532222 4555543  33457899999 6654


Q ss_pred             HHHH------------------HhhCCC---CCCCH-HHHHHHHH--------------HHHHHH----HHHh-cCCCCC
Q 005033          166 LQEM------------------LFSDGN---LVLKW-SQRFEIIM--------------DVAKAL----EFLH-FGCDPP  204 (718)
Q Consensus       166 L~~~------------------L~~~~~---~~l~~-~~~~~Ia~--------------qIa~gL----~yLH-~~~~~g  204 (718)
                      |...                  ++....   ..... .....+..              .+...+    ..+. ......
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            4310                  111110   00111 11111100              011111    1111 112456


Q ss_pred             eEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          205 VIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       205 IVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++|+|+.+.||| ..++.+.|+||..+..-
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            899999999999 56677899999988763

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.35  E-value=0.0077  Score=67.15  Aligned_cols=74  Identities=14%  Similarity=0.046  Sum_probs=46.3

Q ss_pred             cceecccCceEEEEEEEcC-CcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcc-eeEEEEEeeCCeEEEEEeccCCCC
Q 005033           88 ANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFL-VTLLGYCMERNKRILVYEYMPNKS  165 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~-g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LVmEy~~gGs  165 (718)
                      ++.|+.|-...+|++...+ +..+++|+......... .-.+|..++..|...++ .++++++.  +  .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4568888889999998765 47788887643211110 11478888887754444 57777763  2  25999998744


Q ss_pred             H
Q 005033          166 L  166 (718)
Q Consensus       166 L  166 (718)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.30  E-value=0.0056  Score=66.65  Aligned_cols=141  Identities=17%  Similarity=0.176  Sum_probs=82.0

Q ss_pred             ceecccCceEEEEEEEc--------CCcEEEEEEcccCChhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCCeEEEEEe
Q 005033           89 NVIGKGGSGTVFLGIAR--------DGKLLAIKRLDTFSLQTEREFQNELQILGGLR-SPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~--------~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      +.|..|-...+|++...        +++.+.+++.... ......+.+|..+++.|. +.-..++++++.++    +|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence            45666778889998864        2468888875321 123445668988887774 22236677766542    9999


Q ss_pred             ccCCCCHHH--------------HH---hhCC---CCCCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 005033          160 YMPNKSLQE--------------ML---FSDG---NLVLK--WSQRFEIIMDVAK-------------------ALEFL-  197 (718)
Q Consensus       160 y~~gGsL~~--------------~L---~~~~---~~~l~--~~~~~~Ia~qIa~-------------------gL~yL-  197 (718)
                      |++|..|..              .|   +...   .....  +.++..+..++..                   .+..| 
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            998755421              11   1111   01111  3444444433321                   12222 


Q ss_pred             ---h-cCCCCCeEecCCCCCCEEECCC----CCEEEeeccCceee
Q 005033          198 ---H-FGCDPPVIHGDIKPSNVLLDSD----CRGKVSDFGLSRIK  234 (718)
Q Consensus       198 ---H-~~~~~gIVHRDLKP~NILLd~~----~~vKLsDFGLAr~~  234 (718)
                         . ......++|+|+.+.|||++.+    +.+.|+||..|...
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~  255 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN  255 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence               2 1224579999999999999876    78999999998864

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.09  E-value=0.0051  Score=65.66  Aligned_cols=74  Identities=11%  Similarity=0.027  Sum_probs=42.8

Q ss_pred             cceecccCceEEEEEEEcC---------CcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCc-ceeEEEEEeeCCeEEEE
Q 005033           88 ANVIGKGGSGTVFLGIARD---------GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPF-LVTLLGYCMERNKRILV  157 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~---------g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpN-IV~L~g~~~~~~~~~LV  157 (718)
                      ...|+.|....+|+....+         +..+++|+...... .......|..++..+...+ +.++++.+  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            3467778888999988653         26788887644221 1112356777777664333 44666554  2  2689


Q ss_pred             EeccCCCCH
Q 005033          158 YEYMPNKSL  166 (718)
Q Consensus       158 mEy~~gGsL  166 (718)
                      |||++|..|
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.48  E-value=0.09  Score=55.68  Aligned_cols=33  Identities=21%  Similarity=0.280  Sum_probs=29.2

Q ss_pred             CCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       202 ~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ...++|+|+.+.|||++.++.+.|+||+.+...
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            457999999999999998888999999888764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.03  E-value=0.1  Score=57.54  Aligned_cols=141  Identities=11%  Similarity=0.137  Sum_probs=81.8

Q ss_pred             cceecccCceEEEEEEEcC--------CcEEEEEEcccCChhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCCeEEEEE
Q 005033           88 ANVIGKGGSGTVFLGIARD--------GKLLAIKRLDTFSLQTEREFQNELQILGGLR-SPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~--------g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++.|..|-...+|+....+        +..+.+++........ -.-.+|..+++.+. +.-..++++.+.    -++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            4567778888999988753        5788888864322111 11246777776663 222456665442    27899


Q ss_pred             eccCCCCHHH-------H-------H---hh--------C---CCCCCCHHHHHHHHHHH-------------------H
Q 005033          159 EYMPNKSLQE-------M-------L---FS--------D---GNLVLKWSQRFEIIMDV-------------------A  191 (718)
Q Consensus       159 Ey~~gGsL~~-------~-------L---~~--------~---~~~~l~~~~~~~Ia~qI-------------------a  191 (718)
                      ||++|..|..       .       |   +.        .   ...+.-+.++..+..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            9998865321       0       1   00        0   11111233333333221                   1


Q ss_pred             HHHHHHh---------------------cCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          192 KALEFLH---------------------FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       192 ~gL~yLH---------------------~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ..+.+|.                     ......++|+|+.+.||| +.++.+.|+||..|...
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~  292 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN  292 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence            2223332                     111356899999999999 78889999999998864

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=90.76  E-value=0.086  Score=60.12  Aligned_cols=81  Identities=11%  Similarity=-0.118  Sum_probs=51.6

Q ss_pred             hhcccccccccccccccCCCCCcccccccccccCCCCCCCCCccCcccccccccccccccCccccCccccCCCCCccccc
Q 005033          516 RFHFHRRNKFREQNQDDCDANGEFSFRRGWRKKNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKAD  595 (718)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~k~D  595 (718)
                      .-++|++.||.|+.++.                +..+|++|||+++......+...+.+||++|||||++.+ .+..++|
T Consensus       358 ~GIIHRDIKPeNILL~~----------------dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d  420 (569)
T 4azs_A          358 QGFWHDDVRPWNVMVDA----------------RQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGF  420 (569)
T ss_dssp             TTCEESCCCGGGEEECT----------------TSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC----------
T ss_pred             CCceeccCchHhEEECC----------------CCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCccc
Confidence            34799999999988865                347899999999988877777788999999999998764 5778899


Q ss_pred             ccchhhhHHHhhhCCCCC
Q 005033          596 IYSLGVLILVIVSGRRPL  613 (718)
Q Consensus       596 v~S~Gv~l~elltG~~p~  613 (718)
                      +||+||+++++.+|..|+
T Consensus       421 ~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          421 WRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             --------CCCCTTHHHH
T ss_pred             ccccccchhhhccccchh
Confidence            999999999998876554

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=88.69  E-value=0.96  Score=48.90  Aligned_cols=31  Identities=26%  Similarity=0.348  Sum_probs=26.4

Q ss_pred             CeEecCCCCCCEEE------CCCCCEEEeeccCceee
Q 005033          204 PVIHGDIKPSNVLL------DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       204 gIVHRDLKP~NILL------d~~~~vKLsDFGLAr~~  234 (718)
                      .++|+|+.+.|||+      +++..+.++||-.|..-
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            46799999999999      45677999999998874

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=87.83  E-value=1.3  Score=44.90  Aligned_cols=60  Identities=13%  Similarity=0.038  Sum_probs=38.9

Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEE
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKV  225 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKL  225 (718)
                      .-+|.++|...+. ++++.+++.++.|.+.+|.-+-.  ...-..+=+-|..|++..+|.+..
T Consensus        32 ~vSL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f   91 (229)
T 2yle_A           32 ALSLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTL   91 (229)
T ss_dssp             EEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEE
T ss_pred             cccHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceec
Confidence            3489999987765 79999999999999999876620  000011222346666666655543

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	718
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-39
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-09
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-38
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-11
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-38
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-12
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-38
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-12
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-37
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-07
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-37
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-11
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-37
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-09
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-37
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-12
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-36
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-10
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-35
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-10
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-35
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-10
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-35
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-11
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-34
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-13
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-34
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-08
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-33
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-10
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-33
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-11
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-33
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-08
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-32
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-11
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-32
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-07
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-32
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-10
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-32
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-10
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-32
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-06
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-32
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-11
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-32
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-10
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-31
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-12
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-31
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-06
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-30
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-30
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-08
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-30
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-12
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-30
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-15
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-29
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-08
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-29
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-05
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-29
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-09
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-29
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-09
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-29
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-05
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-28
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-04
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-28
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-10
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-28
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-05
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-28
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-06
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-27
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-07
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-27
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-04
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-27
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-06
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-26
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-07
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-26
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-06
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-25
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-07
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-25
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-08
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-25
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-05
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-05
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-25
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	0.004
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-24
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	0.002
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-24
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-08
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-24
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-23
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-06
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-22
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-09
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-21
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-21
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-05
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-21
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-08
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	8e-21
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	0.002
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-19
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-04
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-19
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-19
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-09
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-18
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-04
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-13

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 4e-39
 Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 8/158 (5%)

Query: 77  ELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTERE-FQNELQILG 134
           ELK+  +DF++ + +G G  G VF    +  G ++A K +        R     ELQ+L 
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59

Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
              SP++V   G      +  +  E+M   SL ++L   G   +      ++ + V K L
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGL 117

Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            +L       ++H D+KPSN+L++S    K+ DFG+S 
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG 153

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 28/144 (19%), Positives = 50/144 (34%), Gaps = 26/144 (18%)

Query: 563 FSRELSS--TTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRP-------- 612
            S +L      S  GT  Y++PE     +   ++DI+S+G+ ++ +  GR P        
Sbjct: 151 VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

Query: 613 ------------LHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASL- 659
                               +     L S+         I EL+D  + +   K  + + 
Sbjct: 211 LELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVF 270

Query: 660 ---CINLALTCLQKTPELRPDIGE 680
                +    CL K P  R D+ +
Sbjct: 271 SLEFQDFVNKCLIKNPAERADLKQ 294

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 3e-38
 Identities = 36/159 (22%), Positives = 71/159 (44%), Gaps = 5/159 (3%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLV 142
                   +G G  G V++G       +A+K L      +   F  E  ++  L+   LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
            L     +     ++ EYM N SL + L +   + L  ++  ++   +A+ + F+    +
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGM 241
              IH D++ +N+L+      K++DFGL+R+  + E+  
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.4 bits (151), Expect = 3e-11
 Identities = 23/129 (17%), Positives = 48/129 (37%), Gaps = 18/129 (13%)

Query: 558 WSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLA 617
            +  +   E ++    +  + + APE    G    K+D++S G+L+  IV+  R  +   
Sbjct: 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214

Query: 618 SPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPD 677
           +  ++ +              N+         D+  +E       L   C ++ PE RP 
Sbjct: 215 TNPEVIQ--------------NLERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPT 256

Query: 678 IGETVRILK 686
                 +L+
Sbjct: 257 FDYLRSVLE 265

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  140 bits (354), Expect = 8e-38
 Identities = 45/175 (25%), Positives = 79/175 (45%), Gaps = 18/175 (10%)

Query: 73  FTYKELKNATNDFDEA---------NVIGKGGSGTVFLGI----ARDGKLLAIKRLDT-F 118
           FT+++   A  +F +           VIG G  G V  G      +    +AIK L + +
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 119 SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVL 178
           + +  R+F +E  I+G    P ++ L G   +    +++ E+M N SL        +   
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLRQNDGQF 125

Query: 179 KWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
              Q   ++  +A  +++L        +H D+   N+L++S+   KVSDFGLSR 
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 65.5 bits (159), Expect = 4e-12
 Identities = 22/138 (15%), Positives = 46/138 (33%), Gaps = 18/138 (13%)

Query: 555 SDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLH 614
           S     D      +S    +  + + APE          +D++S G+++  ++S     +
Sbjct: 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234

Query: 615 VLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPEL 674
              +                    +++  +++  +     +  S    L L C QK    
Sbjct: 235 WDMTNQ------------------DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNH 276

Query: 675 RPDIGETVRILKGEMDLP 692
           RP  G+ V  L   +  P
Sbjct: 277 RPKFGQIVNTLDKMIRNP 294

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 8e-38
 Identities = 36/156 (23%), Positives = 66/156 (42%), Gaps = 5/156 (3%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLV 142
                   IG G  GTV+ G       + +  +   + Q  + F+NE+ +L   R   ++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
             +GY     +  +V ++    SL   L        +  +  +I    A+ +++LH    
Sbjct: 68  LFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHA--- 122

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
             +IH D+K +N+ L  D   K+ DFGL+ +K    
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 17/122 (13%), Positives = 47/122 (38%), Gaps = 17/122 (13%)

Query: 568 SSTTSMRGTLCYVAPEY---GGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEK 624
                + G++ ++APE            ++D+Y+ G+++  +++G+ P   + +  ++  
Sbjct: 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 220

Query: 625 ANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRI 684
                           L     +++ +  K        L   CL+K  + RP   + +  
Sbjct: 221 ----------MVGRGYLSPDLSKVRSNCPKA----MKRLMAECLKKKRDERPLFPQILAS 266

Query: 685 LK 686
           ++
Sbjct: 267 IE 268

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 2e-37
 Identities = 41/168 (24%), Positives = 71/168 (42%), Gaps = 8/168 (4%)

Query: 75  YKELK---NATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNEL 130
           Y+ +    N  + ++    +G G  G V+    ++   L A K +DT S +   ++  E+
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 131 QILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDV 190
            IL     P +V LL      N   ++ E+    ++  ++       L  SQ   +    
Sbjct: 61  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQT 119

Query: 191 AKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
             AL +LH   D  +IH D+K  N+L   D   K++DFG+S       
Sbjct: 120 LDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (116), Expect = 9e-07
 Identities = 25/123 (20%), Positives = 40/123 (32%), Gaps = 22/123 (17%)

Query: 563 FSRELSSTTSMRGTLCYVAPEYGGCGYLM-----EKADIYSLGVLILVIVSGRRPLHVLA 617
            +R +    S  GT  ++APE   C          KAD++SLG+ ++ +     P H L 
Sbjct: 160 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219

Query: 618 SPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPD 677
               L K                     E          +S   +    CL+K  + R  
Sbjct: 220 PMRVLLKI-----------------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWT 262

Query: 678 IGE 680
             +
Sbjct: 263 TSQ 265

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 2e-37
 Identities = 47/157 (29%), Positives = 71/157 (45%), Gaps = 5/157 (3%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLV 142
            D      +G G  G V  G  R    +AIK +      +E EF  E +++  L    LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
            L G C ++    ++ EYM N  L   L    +   +  Q  E+  DV +A+E+L     
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLES--- 118

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +H D+   N L++     KVSDFGLSR  ++ E+
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.6 bits (154), Expect = 1e-11
 Identities = 18/129 (13%), Positives = 42/129 (32%), Gaps = 18/129 (13%)

Query: 558 WSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLA 617
            S  +   E +S+   +  + +  PE         K+DI++ GVL+  I S  +  +   
Sbjct: 146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205

Query: 618 SPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPD 677
           +  +                    E + + L+       +     +  +C  +  + RP 
Sbjct: 206 TNSE------------------TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPT 247

Query: 678 IGETVRILK 686
               +  + 
Sbjct: 248 FKILLSNIL 256

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  138 bits (349), Expect = 5e-37
 Identities = 36/159 (22%), Positives = 65/159 (40%), Gaps = 9/159 (5%)

Query: 79  KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTE---REFQNELQILG 134
            +    F +   IG G  G V+      + +++AIK++     Q+    ++   E++ L 
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
            LR P  +   G  +  +   LV EY    +   +        L+  +   +     + L
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGL 128

Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            +LH      +IH D+K  N+LL      K+ DFG + I
Sbjct: 129 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 56.2 bits (135), Expect = 4e-09
 Identities = 25/121 (20%), Positives = 44/121 (36%), Gaps = 21/121 (17%)

Query: 563 FSRELSSTTSMRGTLCYVAPEY---GGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASP 619
            +  ++   S  GT  ++APE       G    K D++SLG+  + +   + PL      
Sbjct: 161 SASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF----- 215

Query: 620 MKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIG 679
                         ++   +I +     L+  +  E      N   +CLQK P+ RP   
Sbjct: 216 ----------NMNAMSALYHIAQNESPALQSGHWSEYF---RNFVDSCLQKIPQDRPTSE 262

Query: 680 E 680
            
Sbjct: 263 V 263

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 8e-37
 Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 5/157 (3%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLV 142
           ++      IG G  G V LG   +   +AIK +      +E +F  E +++  L  P LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
            L G C+E+    LV+E+M +  L + L +   L         + +DV +    + +  +
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEG---MAYLEE 119

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
             VIH D+   N L+  +   KVSDFG++R  ++ ++
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.7 bits (157), Expect = 4e-12
 Identities = 22/133 (16%), Positives = 48/133 (36%), Gaps = 19/133 (14%)

Query: 555 SDMWSGDLF-SRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPL 613
           SD          + +S+T  +  + + +PE         K+D++S GVL+  + S  +  
Sbjct: 143 SDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 202

Query: 614 HVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPE 673
           +   S  +                  ++E +    +    +  ++    +   C ++ PE
Sbjct: 203 YENRSNSE------------------VVEDISTGFRLYKPRLASTHVYQIMNHCWKERPE 244

Query: 674 LRPDIGETVRILK 686
            RP     +R L 
Sbjct: 245 DRPAFSRLLRQLA 257

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 4e-36
 Identities = 51/152 (33%), Positives = 73/152 (48%), Gaps = 7/152 (4%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLV 142
            +      IGKG  G V LG    G  +A+K +   +  T + F  E  ++  LR   LV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 63

Query: 143 TLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
            LLG  +E    + +V EYM   SL + L S G  VL      +  +DV +A+E+L    
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120

Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               +H D+   NVL+  D   KVSDFGL++ 
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 152

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.9 bits (142), Expect = 4e-10
 Identities = 22/125 (17%), Positives = 43/125 (34%), Gaps = 19/125 (15%)

Query: 563 FSRELSST-TSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMK 621
            ++E SST  + +  + + APE         K+D++S G+L+  I S  R  +       
Sbjct: 149 LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK- 207

Query: 622 LEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGET 681
                            +++  V++  K D           +   C      +RP   + 
Sbjct: 208 -----------------DVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQL 250

Query: 682 VRILK 686
              L+
Sbjct: 251 REQLE 255

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-35
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 9/159 (5%)

Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL--QTEREFQNELQILGGLRSPF 140
           D++    IG G  G       + DGK+L  K LD  S+    ++   +E+ +L  L+ P 
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 141 LVTLLGYCMERNKRIL--VYEYMPNKSLQEMLFSDGNL--VLKWSQRFEIIMDVAKALEF 196
           +V      ++R    L  V EY     L  ++         L       ++  +  AL+ 
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 197 LH--FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            H        V+H D+KP+NV LD     K+ DFGL+RI
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.0 bits (145), Expect = 1e-10
 Identities = 27/126 (21%), Positives = 42/126 (33%), Gaps = 19/126 (15%)

Query: 555 SDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLH 614
            D     + + + S   +  GT  Y++PE        EK+DI+SLG L+  + +   P  
Sbjct: 156 GDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215

Query: 615 VLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPEL 674
                                 AG I E    R+   Y+ E       +    L      
Sbjct: 216 ---------------AFSQKELAGKIREGKFRRIPYRYSDE----LNEIITRMLNLKDYH 256

Query: 675 RPDIGE 680
           RP + E
Sbjct: 257 RPSVEE 262

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 3e-35
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 10/163 (6%)

Query: 76  KELKNATNDFDEANV-IGKGGSGTVFLGIAR---DGKLLAIKRLDTFSLQTERE-FQNEL 130
           K+L    ++   A++ +G G  G+V  G+ R       +AIK L   + + + E    E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 131 QILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDV 190
           QI+  L +P++V L+G C +    +LV E      L + L       +  S   E++  V
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQV 118

Query: 191 AKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +  +++L        +H D+   NVLL +    K+SDFGLS+ 
Sbjct: 119 SMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.2 bits (140), Expect = 8e-10
 Identities = 18/142 (12%), Positives = 45/142 (31%), Gaps = 21/142 (14%)

Query: 548 KNKNSMGSDMWSGDLFSRE---LSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLIL 604
               +  SD         +    ++ ++ +  L + APE         ++D++S GV + 
Sbjct: 144 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 203

Query: 605 VIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLA 664
             +S  +  +      +                  ++  +++  + +   E       L 
Sbjct: 204 EALSYGQKPYKKMKGPE------------------VMAFIEQGKRMECPPECPPELYALM 245

Query: 665 LTCLQKTPELRPDIGETVRILK 686
             C     E RPD     + ++
Sbjct: 246 SDCWIYKWEDRPDFLTVEQRMR 267

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  132 bits (334), Expect = 4e-35
 Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 5/164 (3%)

Query: 71  QRFTYKELKNATNDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNE 129
               Y + +    D    + +G G  G V+ G+ +     +A+K L   +++ E EF  E
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE 63

Query: 130 LQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMD 189
             ++  ++ P LV LLG C       ++ E+M   +L + L       +       +   
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123

Query: 190 VAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           ++ A+E+L        IH D+   N L+  +   KV+DFGLSR+
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 164

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 61.3 bits (148), Expect = 9e-11
 Identities = 19/129 (14%), Positives = 42/129 (32%), Gaps = 18/129 (13%)

Query: 558 WSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLA 617
            S  +     ++    +  + + APE         K+D+++ GVL+  I +     +   
Sbjct: 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 220

Query: 618 SPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPD 677
              +                  + EL+++  + +  +        L   C Q  P  RP 
Sbjct: 221 DLSQ------------------VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS 262

Query: 678 IGETVRILK 686
             E  +  +
Sbjct: 263 FAEIHQAFE 271

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 1e-34
 Identities = 39/157 (24%), Positives = 69/157 (43%), Gaps = 5/157 (3%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLV 142
                   +G+G  G V++G       +AIK L      +   F  E Q++  LR   LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
            L           +V EYM   SL + L  +    L+  Q  ++   +A  + ++     
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +H D++ +N+L+  +   KV+DFGL+R+  + E+
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.0 bits (168), Expect = 2e-13
 Identities = 22/140 (15%), Positives = 47/140 (33%), Gaps = 18/140 (12%)

Query: 558 WSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLA 617
            +  +   E ++    +  + + APE    G    K+D++S G+L+  + +  R  +   
Sbjct: 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 218

Query: 618 SPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPD 677
              +                  +L+ V+   +     E      +L   C +K PE RP 
Sbjct: 219 VNRE------------------VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 260

Query: 678 IGETVRILKGEMDLPPVPFE 697
                  L+         ++
Sbjct: 261 FEYLQAFLEDYFTSTEPQYQ 280

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 5e-34
 Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 9/154 (5%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQT---EREFQNELQILGGLRS 138
            DF+    +GKG  G V+L   +    +LA+K L    L+    E + + E++I   LR 
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           P ++ L GY  +  +  L+ EY P  ++   L           +    I ++A AL + H
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 123

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                 VIH DIKP N+LL S    K++DFG S 
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSV 154

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 29/120 (24%), Positives = 42/120 (35%), Gaps = 22/120 (18%)

Query: 563 FSRELSSTTSMR--GTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPM 620
           +S    S+      GTL Y+ PE        EK D++SLGVL    + G+ P     +  
Sbjct: 152 WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQ 210

Query: 621 KLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGE 680
           +  K       R         + V E  +D            L    L+  P  RP + E
Sbjct: 211 ETYK-------RISRVEFTFPDFVTEGARD------------LISRLLKHNPSQRPMLRE 251

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (323), Expect = 1e-33
 Identities = 47/194 (24%), Positives = 76/194 (39%), Gaps = 32/194 (16%)

Query: 75  YKELKNATNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLD-TFSLQTEREFQ 127
              L+   N+ +    IG+G  G VF   A          ++A+K L    S   + +FQ
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 128 NELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFS--------------- 172
            E  ++    +P +V LLG C       L++EYM    L E L S               
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 173 -------DGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKV 225
                   G   L  +++  I   VA  + +L    +   +H D+   N L+  +   K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKI 181

Query: 226 SDFGLSRIKVEGEF 239
           +DFGLSR     ++
Sbjct: 182 ADFGLSRNIYSADY 195

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 58.3 bits (140), Expect = 8e-10
 Identities = 21/123 (17%), Positives = 43/123 (34%), Gaps = 18/123 (14%)

Query: 564 SRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLE 623
           +    +  +    + ++ PE         ++D+++ GV++  I S     +   +  ++ 
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV- 251

Query: 624 KANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVR 683
                    +  + GNIL   +    +           NL   C  K P  RP      R
Sbjct: 252 --------IYYVRDGNILACPENCPLE---------LYNLMRLCWSKLPADRPSFCSIHR 294

Query: 684 ILK 686
           IL+
Sbjct: 295 ILQ 297

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 1e-33
 Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 11/152 (7%)

Query: 87  EANVIGKGGSGTVFLGIARD---GKLLAIKRLDTFSLQTE--REFQNELQILGGLRSPFL 141
           E   +G G  GTV  G  +     K +A+K L   +       E   E  ++  L +P++
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           V ++G C E    +LV E      L + L  + ++  K     E++  V+  +++L    
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV--KDKNIIELVHQVSMGMKYLEE-- 125

Query: 202 DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               +H D+   NVLL +    K+SDFGLS+ 
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKA 156

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.6 bits (154), Expect = 1e-11
 Identities = 17/119 (14%), Positives = 36/119 (30%), Gaps = 18/119 (15%)

Query: 568 SSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANL 627
            + T  +  + + APE         K+D++S GVL+    S  +  +      +      
Sbjct: 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------ 218

Query: 628 ISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILK 686
                       +  ++++  +            +L   C     E RP        L+
Sbjct: 219 ------------VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 2e-33
 Identities = 40/158 (25%), Positives = 66/158 (41%), Gaps = 7/158 (4%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLD-TFSLQTEREFQNELQILGGLRSPF 140
            D+D    +G+G  G V L + R   + +A+K +D   ++      + E+ I   L    
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V   G+  E N + L  EY     L + +  D    +           +   + +LH  
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH-- 120

Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
               + H DIKP N+LLD     K+SDFGL+ +     
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 22/119 (18%), Positives = 44/119 (36%), Gaps = 18/119 (15%)

Query: 563 FSRELSSTTSMRGTLCYVAPEY-GGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMK 621
           ++        M GTL YVAPE      +  E  D++S G+++  +++G  P    +   +
Sbjct: 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214

Query: 622 LEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGE 680
                               +  +++   +  K+  S  + L    L + P  R  I +
Sbjct: 215 E-----------------YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPD 256

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 1e-32
 Identities = 46/174 (26%), Positives = 62/174 (35%), Gaps = 27/174 (15%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFSLQTERE-FQNELQILGG 135
           N       +G G  G V    A           +A+K L   +  TERE   +EL++L  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 136 L-RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEML----------------FSDGNLVL 178
           L     +V LLG C      +++ EY     L   L                  D  L L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 179 KWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                      VAK + FL        IH D+   N+LL      K+ DFGL+R
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLAR 193

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.9 bits (152), Expect = 3e-11
 Identities = 16/147 (10%), Positives = 46/147 (31%), Gaps = 19/147 (12%)

Query: 545 WRKKNKNSMGSDMWSGDLFSRE--LSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVL 602
                + +   D         +       + R  + ++APE         ++D++S G+ 
Sbjct: 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236

Query: 603 ILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCIN 662
           +  + S                         +       +++ E  +    +   +   +
Sbjct: 237 LWELFSLGSS-----------------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYD 279

Query: 663 LALTCLQKTPELRPDIGETVRILKGEM 689
           +  TC    P  RP   + V++++ ++
Sbjct: 280 IMKTCWDADPLKRPTFKQIVQLIEKQI 306

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  127 bits (319), Expect = 1e-32
 Identities = 40/153 (26%), Positives = 67/153 (43%), Gaps = 7/153 (4%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
           + +D    +G G  G V     R  G   A K + T     +   + E+Q +  LR P L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           V L     + N+ +++YE+M    L E +  + N  +   +  E +  V K L  +H   
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN 144

Query: 202 DPPVIHGDIKPSNVLLDSDCRG--KVSDFGLSR 232
               +H D+KP N++  +      K+ DFGL+ 
Sbjct: 145 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTA 174

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 49.7 bits (118), Expect = 6e-07
 Identities = 31/157 (19%), Positives = 48/157 (30%), Gaps = 20/157 (12%)

Query: 563 FSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKL 622
                 S     GT  + APE      +    D++S+GVL  +++SG  P         L
Sbjct: 175 HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 234

Query: 623 EKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETV 682
                       +   N+ +     + +D          +     L   P  R  I +  
Sbjct: 235 RN--------VKSCDWNMDDSAFSGISED--------GKDFIRKLLLADPNTRMTIHQ-- 276

Query: 683 RILKGE-MDLPPVPFEFSPSPSKLYGKSRQKQKPNAD 718
             L+   +     P   S  PS  Y K R   K   D
Sbjct: 277 -ALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYD 312

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 3e-32
 Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 7/157 (4%)

Query: 77  ELKNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGG 135
            + +    +     IG+G SGTV+  +    G+ +AI++++      +    NE+ ++  
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 136 LRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALE 195
            ++P +V  L   +  ++  +V EY+   SL +++           Q   +  +  +ALE
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALE 130

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           FLH      VIH DIK  N+LL  D   K++DFG   
Sbjct: 131 FLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.8 bits (142), Expect = 6e-10
 Identities = 23/126 (18%), Positives = 43/126 (34%), Gaps = 17/126 (13%)

Query: 555 SDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLH 614
           +D       + E S  ++M GT  ++APE         K DI+SLG++ + ++ G  P  
Sbjct: 158 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217

Query: 615 VLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPEL 674
                  L                      +   +    ++ +++  +    CL    E 
Sbjct: 218 NENPLRALYLI-----------------ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEK 260

Query: 675 RPDIGE 680
           R    E
Sbjct: 261 RGSAKE 266

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 5e-32
 Identities = 46/185 (24%), Positives = 68/185 (36%), Gaps = 32/185 (17%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD------GKLLAIKRLDTFSLQTERE-FQNELQILGG 135
            + +   V+G G  G V    A           +A+K L   +  +ERE   +EL+++  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 136 LRS-PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNL------------------ 176
           L S   +V LLG C       L++EY     L   L S                      
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 177 ---VLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
              VL +         VAK +EFL        +H D+   NVL+      K+ DFGL+R 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 234 KVEGE 238
            +   
Sbjct: 214 IMSDS 218

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.0 bits (142), Expect = 5e-10
 Identities = 22/144 (15%), Positives = 40/144 (27%), Gaps = 19/144 (13%)

Query: 548 KNKNSMGSDMWSGDLFSRELSST--TSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILV 605
             K     D         + +     + R  + ++APE    G    K+D++S G+L+  
Sbjct: 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 258

Query: 606 IVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLAL 665
           I S     +                        N  +L+    K D           +  
Sbjct: 259 IFSLGVNPYPGIPVDA-----------------NFYKLIQNGFKMDQPFYATEEIYIIMQ 301

Query: 666 TCLQKTPELRPDIGETVRILKGEM 689
           +C       RP        L  ++
Sbjct: 302 SCWAFDSRKRPSFPNLTSFLGCQL 325

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 7e-32
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 9/164 (5%)

Query: 79  KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTE---REFQNELQILG 134
           K    DF    ++G+G   TV L       +  AIK L+   +  E        E  ++ 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 135 GLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKAL 194
            L  PF V L     +  K      Y  N  L + +   G+     +       ++  AL
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSAL 121

Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
           E+LH      +IH D+KP N+LL+ D   +++DFG +++     
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.5 bits (115), Expect = 1e-06
 Identities = 20/115 (17%), Positives = 39/115 (33%), Gaps = 20/115 (17%)

Query: 566 ELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKA 625
           + +   S  GT  YV+PE        + +D+++LG +I  +V+G  P     +   + + 
Sbjct: 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQ- 220

Query: 626 NLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGE 680
                 + +    +  E    + +D            L    L      R    E
Sbjct: 221 ------KIIKLEYDFPEKFFPKARD------------LVEKLLVLDATKRLGCEE 257

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 7e-32
 Identities = 41/154 (26%), Positives = 67/154 (43%), Gaps = 11/154 (7%)

Query: 89  NVIGKGGSGTVFLGIARD-GKLLAIKRLD--TFSLQTEREFQNELQILGGLRSPFLVTLL 145
             IG+G   TV+ G+  +    +A   L     +    + F+ E ++L GL+ P +V   
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 146 GYCMERNKR----ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
                  K     +LV E M + +L+  L      V+K          + K L+FLH   
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT 132

Query: 202 DPPVIHGDIKPSNVLLDS-DCRGKVSDFGLSRIK 234
            PP+IH D+K  N+ +       K+ D GL+ +K
Sbjct: 133 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.2 bits (148), Expect = 7e-11
 Identities = 17/113 (15%), Positives = 40/113 (35%), Gaps = 18/113 (15%)

Query: 568 SSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANL 627
           S   ++ GT  ++APE     Y  E  D+Y+ G+ +L + +   P     +  ++ +   
Sbjct: 168 SFAKAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-- 224

Query: 628 ISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGE 680
                          +        ++K        +   C+++  + R  I +
Sbjct: 225 ---------------VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 262

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 8e-32
 Identities = 51/170 (30%), Positives = 74/170 (43%), Gaps = 22/170 (12%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKLL---AIKRLDTF-SLQTEREFQNELQILGGL-R 137
           ND    +VIG+G  G V     +   L    AIKR+  + S    R+F  EL++L  L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNL--------------VLKWSQR 183
            P ++ LLG C  R    L  EY P+ +L + L     L               L   Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 184 FEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
                DVA+ +++L        IH D+   N+L+  +   K++DFGLSR 
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG 176

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.0 bits (142), Expect = 5e-10
 Identities = 20/119 (16%), Positives = 39/119 (32%), Gaps = 18/119 (15%)

Query: 568 SSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANL 627
              T  R  + ++A E          +D++S GVL+  IVS     +   +  +L     
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----- 235

Query: 628 ISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILK 686
                         E + +  + +          +L   C ++ P  RP   + +  L 
Sbjct: 236 -------------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 1e-31
 Identities = 34/165 (20%), Positives = 64/165 (38%), Gaps = 14/165 (8%)

Query: 90  VIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCM 149
            IGKG  G V+ G    G+ +A+K   +   +     + E+     LR   ++  +    
Sbjct: 10  SIGKGRFGEVWRGK-WRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67

Query: 150 ERN----KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC---- 201
           + N    +  LV +Y  + SL + L       +      ++ +  A  L  LH       
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 202 -DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFS 245
             P + H D+K  N+L+  +    ++D GL+         +D+  
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 169

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.0 bits (160), Expect = 3e-12
 Identities = 17/141 (12%), Positives = 38/141 (26%), Gaps = 8/141 (5%)

Query: 554 GSDMWSGDLFSRELSSTTSMRGTLCYVAPEY------GGCGYLMEKADIYSLGVLILVIV 607
           G  +           +     GT  Y+APE              ++ADIY++G++   I 
Sbjct: 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

Query: 608 SGRRPLHVLAS-PMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCI-NLAL 665
                  +     +               +     + +   + + +   +A   +  +  
Sbjct: 213 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 272

Query: 666 TCLQKTPELRPDIGETVRILK 686
            C       R       + L 
Sbjct: 273 ECWYANGAARLTALRIKKTLS 293

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  123 bits (309), Expect = 3e-31
 Identities = 33/182 (18%), Positives = 79/182 (43%), Gaps = 7/182 (3%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFL 141
           + +D    +G G  G V   + +  G++   K ++T     +   +NE+ I+  L  P L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 142 VTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGC 201
           + L     ++ + +L+ E++    L + + ++    +  ++    +    + L+ +H   
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMH--- 144

Query: 202 DPPVIHGDIKPSNVLLDSDCRG--KVSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQE 259
           +  ++H DIKP N++ ++      K+ DFGL+      E      +     + E+   + 
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 204

Query: 260 LS 261
           + 
Sbjct: 205 VG 206

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 33/152 (21%), Positives = 49/152 (32%), Gaps = 23/152 (15%)

Query: 568 SSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANL 627
                   T  + APE      +    D++++GVL  V++SG  P               
Sbjct: 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA------------- 229

Query: 628 ISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVR--IL 685
                 L    N+    D    +D     +    +     LQK P  R  + + +    L
Sbjct: 230 --GEDDLETLQNVKR-CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 286

Query: 686 KGEMDLPPVPFEFSPSPSKLYGKSRQKQKPNA 717
           KG+          S  PS  Y K RQK K   
Sbjct: 287 KGDHSNLT-----SRIPSSRYNKIRQKIKEKY 313

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  122 bits (306), Expect = 1e-30
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 12/157 (7%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTE------REFQNELQILGG 135
           NDF    +IG+GG G V+     D GK+ A+K LD   ++ +         +  L ++  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 136 LRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALE 195
              PF+V +       +K   + + M    L   L   G      +       ++   LE
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLE 121

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
            +H   +  V++ D+KP+N+LLD     ++SD GL+ 
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC 155

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  120 bits (301), Expect = 1e-30
 Identities = 38/166 (22%), Positives = 71/166 (42%), Gaps = 4/166 (2%)

Query: 75  YKELKNATNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTERE-FQNELQI 132
           +K+ ++  + +D  +V+G G    V L    R  KL+AIK +   +L+ +    +NE+ +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 133 LGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
           L  ++ P +V L           L+ + +    L + +   G           +I  V  
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLD 118

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
           A+++LH                  LD D +  +SDFGLS+++  G 
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 32/153 (20%), Positives = 58/153 (37%), Gaps = 19/153 (12%)

Query: 568 SSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANL 627
           S  ++  GT  YVAPE        +  D +S+GV+  +++ G  P +        E+   
Sbjct: 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ--- 220

Query: 628 ISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVR--IL 685
                       IL+  +      Y  + +    +     ++K PE R    + ++   +
Sbjct: 221 ------------ILK-AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267

Query: 686 KGEMDLP-PVPFEFSPSPSKLYGKSRQKQKPNA 717
            G+  L   +    S    K + KS+ KQ  NA
Sbjct: 268 AGDTALDKNIHQSVSEQIKKNFAKSKWKQAFNA 300

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 2e-30
 Identities = 42/157 (26%), Positives = 69/157 (43%), Gaps = 10/157 (6%)

Query: 89  NVIGKGGSGTVFLGIARDGK----LLAIKRLDTFSLQTE-REFQNELQILGGLRSPFLVT 143
            VIG+G  G V+ G   D        A+K L+  +   E  +F  E  I+     P +++
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 144 LLGYCMER-NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
           LLG C+      ++V  YM +  L+  + ++ +            + VAK +    F   
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGM---KFLAS 148

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
              +H D+   N +LD     KV+DFGL+R   + EF
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.6 bits (159), Expect = 4e-12
 Identities = 25/136 (18%), Positives = 46/136 (33%), Gaps = 22/136 (16%)

Query: 553 MGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRP 612
            G      D     + + T  +  + ++A E         K+D++S GVL+  +++   P
Sbjct: 174 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

Query: 613 LHVLASPMKLEKANLISWCRHLAQAGNIL--ELVDERLKDDYNKEQASLCINLALTCLQK 670
            +           N      +L Q   +L  E   + L +            + L C   
Sbjct: 234 PY--------PDVNTFDITVYLLQGRRLLQPEYCPDPLYE------------VMLKCWHP 273

Query: 671 TPELRPDIGETVRILK 686
             E+RP   E V  + 
Sbjct: 274 KAEMRPSFSELVSRIS 289

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 4e-30
 Identities = 38/162 (23%), Positives = 71/162 (43%), Gaps = 10/162 (6%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDG-----KLLAIKRLDTFSLQTER-EFQNELQILGGL 136
           +      VIG G  G V+ G+ +         +AIK L     + +R +F  E  I+G  
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEF 196
               ++ L G   +    +++ EYM N +  +    + +      Q   ++  +A  +  
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGM-- 123

Query: 197 LHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
             +  +   +H D+   N+L++S+   KVSDFGLSR+  +  
Sbjct: 124 -KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.6 bits (185), Expect = 1e-15
 Identities = 20/142 (14%), Positives = 50/142 (35%), Gaps = 21/142 (14%)

Query: 555 SDMWSGDLFSRE---LSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRR 611
           SD     +   +     +T+  +  + + APE          +D++S G+++  +++   
Sbjct: 152 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE 211

Query: 612 PLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKT 671
             +   S  +                  +++ +++  +     +  S    L + C Q+ 
Sbjct: 212 RPYWELSNHE------------------VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQE 253

Query: 672 PELRPDIGETVRILKGEMDLPP 693
              RP   + V IL   +  P 
Sbjct: 254 RARRPKFADIVSILDKLIRAPD 275

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 2e-29
 Identities = 37/163 (22%), Positives = 59/163 (36%), Gaps = 12/163 (7%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR----DGKLLAIKRLDTFSL---QTEREFQNELQILGG 135
            D      +G G  G V  G           +A+K L    L   +   +F  E+  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 136 LRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALE 195
           L    L+ L G  +    ++ V E  P  SL + L                 + VA+ + 
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMG 125

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
           +L        IH D+   N+LL +    K+ DFGL R   + +
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.4 bits (130), Expect = 1e-08
 Identities = 14/119 (11%), Positives = 34/119 (28%), Gaps = 17/119 (14%)

Query: 568 SSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANL 627
                 +    + APE          +D +  GV +  + +  +   +  +  ++     
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----- 223

Query: 628 ISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILK 686
                       + ++  E  +    ++      N+ + C    PE RP        L 
Sbjct: 224 ------------LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  116 bits (291), Expect = 2e-29
 Identities = 40/191 (20%), Positives = 75/191 (39%), Gaps = 16/191 (8%)

Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---------QTEREFQNELQIL 133
           +++   ++G+G S  V   I +   K  A+K +D             +       E+ IL
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 134 GGLRS-PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAK 192
             +   P ++ L           LV++ M    L + L     L     +  +I+  + +
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL--SEKETRKIMRALLE 121

Query: 193 ALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQ 252
            +  LH      ++H D+KP N+LLD D   K++DFG S     GE   ++       + 
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178

Query: 253 ELWKSQELSGN 263
           E+ +      +
Sbjct: 179 EIIECSMNDNH 189

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 43.9 bits (103), Expect = 4e-05
 Identities = 19/119 (15%), Positives = 38/119 (31%), Gaps = 22/119 (18%)

Query: 568 SSTTSMRGTLCYVAPEY------GGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMK 621
                + GT  Y+APE              ++ D++S GV++  +++G  P         
Sbjct: 164 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-------- 215

Query: 622 LEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGE 680
                   W R       ++   + +       + +    +L    L   P+ R    E
Sbjct: 216 --------WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 266

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 3e-29
 Identities = 38/161 (23%), Positives = 75/161 (46%), Gaps = 11/161 (6%)

Query: 84  DFDEANVIGKGGSGTVFLGIARD-----GKLLAIKRL-DTFSLQTEREFQNELQILGGLR 137
           +F +  V+G G  GTV+ G+           +AIK L +  S +  +E  +E  ++  + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
           +P +  LLG C+    + L+ + MP   L + +    + +          + +AK + +L
Sbjct: 70  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYL 127

Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
                  ++H D+   NVL+ +    K++DFGL+++    E
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.9 bits (139), Expect = 1e-09
 Identities = 12/140 (8%), Positives = 36/140 (25%), Gaps = 18/140 (12%)

Query: 564 SRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLE 623
             +       +  + ++A E         ++D++S GV +  +++     +      +  
Sbjct: 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-- 221

Query: 624 KANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVR 683
                           I  ++++  +             + + C     + RP   E + 
Sbjct: 222 ----------------ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELII 265

Query: 684 ILKGEMDLPPVPFEFSPSPS 703
                   P           
Sbjct: 266 EFSKMARDPQRYLVIQGDER 285

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 6e-29
 Identities = 40/156 (25%), Positives = 59/156 (37%), Gaps = 10/156 (6%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARD----GKLLAIKRLDTFSLQTERE-FQNELQILGGLR 137
              +    IG+G  G V  GI          +AIK     +  + RE F  E   +    
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            P +V L+G   E N   ++ E      L+          L  +        ++ AL +L
Sbjct: 67  HPHIVKLIGVITE-NPVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
                   +H DI   NVL+ S+   K+ DFGLSR 
Sbjct: 125 E---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.7 bits (136), Expect = 2e-09
 Identities = 18/134 (13%), Positives = 34/134 (25%), Gaps = 18/134 (13%)

Query: 553 MGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRP 612
           +G    S  +        +  +  + ++APE          +D++  GV +  I+     
Sbjct: 149 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 208

Query: 613 LHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTP 672
                    +               G I       +  +          +L   C    P
Sbjct: 209 PFQGVKNNDV--------------IGRIENGERLPMPPNCPPT----LYSLMTKCWAYDP 250

Query: 673 ELRPDIGETVRILK 686
             RP   E    L 
Sbjct: 251 SRRPRFTELKAQLS 264

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  114 bits (285), Expect = 9e-29
 Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 7/153 (4%)

Query: 83  NDFDEANVIGKGGSGTVFLGIARDGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPF 140
             +     IG+G  G V+      G+  A+K  RL+            E+ IL  L+   
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V L      + + +LV+E++     + +   +G L  +       ++ +   + + H  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGL--ESVTAKSFLLQLLNGIAYCH-- 117

Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
            D  V+H D+KP N+L++ +   K++DFGL+R 
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARA 149

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 44.1 bits (103), Expect = 3e-05
 Identities = 26/143 (18%), Positives = 46/143 (32%), Gaps = 10/143 (6%)

Query: 548 KNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPE-YGGCGYLMEKADIYSLGVLILVI 606
           +      +D      F   +   T    TL Y AP+   G        DI+S+G +   +
Sbjct: 135 REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194

Query: 607 VSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLK---------DDYNKEQA 657
           V+G      ++   +L +   I    +     N+ EL               + + K   
Sbjct: 195 VNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLD 254

Query: 658 SLCINLALTCLQKTPELRPDIGE 680
              I+L    L+  P  R    +
Sbjct: 255 ESGIDLLSKMLKLDPNQRITAKQ 277

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  115 bits (288), Expect = 1e-28
 Identities = 34/155 (21%), Positives = 67/155 (43%), Gaps = 9/155 (5%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLD---TFSLQTEREFQNELQILGGLRS 138
            DF     +G G  G V L  +R +G+  A+K L       L+      +E  +L  +  
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           PF++ + G   +  +  ++ +Y+    L  +L          ++ +   +        L 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALE 118

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
           +     +I+ D+KP N+LLD +   K++DFG ++ 
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY 153

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 40.8 bits (95), Expect = 4e-04
 Identities = 22/109 (20%), Positives = 40/109 (36%), Gaps = 20/109 (18%)

Query: 568 SSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANL 627
             T ++ GT  Y+APE        +  D +S G+LI  +++G  P +  ++ MK      
Sbjct: 156 DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKT----- 209

Query: 628 ISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRP 676
             + + L          +E +KD            L    + +    R 
Sbjct: 210 --YEKILNAELRFPPFFNEDVKD------------LLSRLITRDLSQRL 244

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 1e-28
 Identities = 36/171 (21%), Positives = 71/171 (41%), Gaps = 18/171 (10%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLD-TFSLQTEREFQNELQILGG 135
                +  +G+G  G V+ G+A+          +AIK ++   S++   EF NE  ++  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 136 LRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLV--------LKWSQRFEII 187
                +V LLG   +    +++ E M    L+  L S    +           S+  ++ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
            ++A  + +L        +H D+   N ++  D   K+ DFG++R   E +
Sbjct: 140 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 187

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.1 bits (142), Expect = 5e-10
 Identities = 26/139 (18%), Positives = 47/139 (33%), Gaps = 20/139 (14%)

Query: 564 SRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLE 623
           +            + +++PE    G     +D++S GV++  I +     +   S  +  
Sbjct: 186 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 243

Query: 624 KANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVR 683
                           +L  V E    D       +   L   C Q  P++RP   E + 
Sbjct: 244 ----------------VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287

Query: 684 ILKGEMD--LPPVPFEFSP 700
            +K EM+     V F +S 
Sbjct: 288 SIKEEMEPGFREVSFYYSE 306

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 3e-28
 Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 16/167 (9%)

Query: 84  DFDEANVIGKGGSGTVFLGIARD-GKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLV 142
            + +  VIG G  G V+     D G+L+AIK++    LQ +R    ELQI+  L    +V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76

Query: 143 TLLGYCMERNKR------ILVYEYMPNKSLQEML-FSDGNLVLKWSQRFEIIMDVAKALE 195
            L  +     ++       LV +Y+P    +    +S     L        +  + ++L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 196 FLHFGCDPPVIHGDIKPSNVLLDSDCR-GKVSDFGLSRIKVEGEFGM 241
           ++H      + H DIKP N+LLD D    K+ DFG ++  V GE  +
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (101), Expect = 6e-05
 Identities = 17/145 (11%), Positives = 33/145 (22%), Gaps = 9/145 (6%)

Query: 545 WRKKNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLIL 604
                      D  S     R   + + +            G        D++S G ++ 
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214

Query: 605 VIVSGRRP---------LHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKE 655
            ++ G+           L  +   +       I             ++        +   
Sbjct: 215 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPR 274

Query: 656 QASLCINLALTCLQKTPELRPDIGE 680
                I L    L+ TP  R    E
Sbjct: 275 TPPEAIALCSRLLEYTPTARLTPLE 299

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 9e-28
 Identities = 29/147 (19%), Positives = 60/147 (40%), Gaps = 8/147 (5%)

Query: 90  VIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
            +G+G  G V   +     K    K +       +   + E+ IL   R   ++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHG 208
               + ++++E++    + E + +     L   +    +  V +AL+FLH      + H 
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLH---SHNIGHF 126

Query: 209 DIKPSNVLLDSDCRG--KVSDFGLSRI 233
           DI+P N++  +      K+ +FG +R 
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQ 153

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 21/113 (18%), Positives = 39/113 (34%), Gaps = 16/113 (14%)

Query: 568 SSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANL 627
            +   +     Y APE      +    D++SLG L+ V++SG  P     +   +E    
Sbjct: 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN--- 214

Query: 628 ISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGE 680
                       I+   +    ++  KE +   ++     L K  + R    E
Sbjct: 215 ------------IMN-AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASE 254

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  109 bits (273), Expect = 4e-27
 Identities = 39/179 (21%), Positives = 79/179 (44%), Gaps = 13/179 (7%)

Query: 79  KNATNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTE---REFQNELQILG 134
            + ++ ++   ++G GG   V L    R  + +A+K L     +       F+ E Q   
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 135 GLRSPFLVTLLGYCMERNKRI----LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDV 190
            L  P +V +               +V EY+   +L++++ ++G +     +  E+I D 
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM--TPKRAIEVIADA 120

Query: 191 AKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLG 249
            +AL F        +IH D+KP+N+++ +    KV DFG++R   +    +   +  +G
Sbjct: 121 CQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 176

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 51.3 bits (122), Expect = 1e-07
 Identities = 26/120 (21%), Positives = 48/120 (40%), Gaps = 16/120 (13%)

Query: 564 SRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLE 623
              ++ T ++ GT  Y++PE      +  ++D+YSLG ++  +++G  P     SP+ + 
Sbjct: 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSV- 222

Query: 624 KANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVR 683
                   +H+ +         E L  D           + L  L K PE R      +R
Sbjct: 223 ------AYQHVREDPIPPSARHEGLSAD--------LDAVVLKALAKNPENRYQTAAEMR 268

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 4e-27
 Identities = 38/176 (21%), Positives = 78/176 (44%), Gaps = 12/176 (6%)

Query: 80  NATNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTERE-FQNELQILGGLR 137
           +    +   + IG+G  G V       +   +AIK++  F  QT  +    E++IL   R
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64

Query: 138 SPFLVTLLGYC----MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
              ++ +        +E+ K + +  ++    L ++L +     L        +  + + 
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRG 121

Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEFGMDLFSQDLG 249
           L+++H      V+H D+KPSN+LL++ C  K+ DFGL+R+           ++ + 
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.1 bits (98), Expect = 2e-04
 Identities = 29/169 (17%), Positives = 52/169 (30%), Gaps = 28/169 (16%)

Query: 568 SSTTSMRGTLCYVAPEYGGCG-YLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEK-- 624
              T    T  Y APE         +  DI+S+G ++  ++S R          +L    
Sbjct: 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 226

Query: 625 ANLISWCRHLAQAGNILELVDERLKDDYNKEQA---------SLCINLALTCLQKTPELR 675
             L S  +        L+  +  L   +  +           S  ++L    L   P  R
Sbjct: 227 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 286

Query: 676 PDIGETVRILK----------GEMDLPPVPFEFSPSPSKLYGKSRQKQK 714
            ++ +    L            +  +   PF+F      L    ++K K
Sbjct: 287 IEVEQ---ALAHPYLEQYYDPSDEPIAEAPFKFDMELDDL---PKEKLK 329

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 5e-27
 Identities = 39/150 (26%), Positives = 75/150 (50%), Gaps = 11/150 (7%)

Query: 89  NVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQT-----EREFQNELQILGGLRSPFLV 142
           + +G+G   TV+    +   +++AIK++             R    E+++L  L  P ++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 143 TLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD 202
            LL     ++   LV+++M        +  D +LVL  S     ++   + LE+LH    
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEV--IIKDNSLVLTPSHIKAYMLMTLQGLEYLH---Q 118

Query: 203 PPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
             ++H D+KP+N+LLD +   K++DFGL++
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAK 148

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.5 bits (112), Expect = 2e-06
 Identities = 25/161 (15%), Positives = 45/161 (27%), Gaps = 15/161 (9%)

Query: 555 SDMWSGDLFSRELSSTTSMRGTLCYVAPE-YGGCGYLMEKADIYSLGVLILVIVSGRRP- 612
           +D      F     + T    T  Y APE   G        D++++G ++  ++      
Sbjct: 142 ADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL 201

Query: 613 -----LHVLASPMK-LEKANLISWCRHLAQAGNILELVDERLKDDYNKEQAS-LCINLAL 665
                L  L    + L       W    +    +       +   +    A    ++L  
Sbjct: 202 PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ 261

Query: 666 TCLQKTPELRPDIGETVRILKGE---MDLPPVPFEFSPSPS 703
                 P  R    +    LK +       P P    P P+
Sbjct: 262 GLFLFNPCARITATQ---ALKMKYFSNRPGPTPGCQLPRPN 299

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 3e-26
 Identities = 41/153 (26%), Positives = 77/153 (50%), Gaps = 7/153 (4%)

Query: 84  DFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSPF 140
           +F +   IG+G  G V+    +  G+++A+K  RLDT +         E+ +L  L  P 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           +V LL      NK  LV+E++ ++ L++ + +     +        +  + + L F    
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC--- 118

Query: 201 CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
               V+H D+KP N+L++++   K++DFGL+R 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARA 151

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.0 bits (121), Expect = 2e-07
 Identities = 26/147 (17%), Positives = 44/147 (29%), Gaps = 18/147 (12%)

Query: 548 KNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPE-YGGCGYLMEKADIYSLGVLILVI 606
                  +D      F   + + T    TL Y APE   GC Y     DI+SLG +   +
Sbjct: 137 TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196

Query: 607 VSGRRP-------------LHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYN 653
           V+ R                  L +P ++    + S   +             ++    +
Sbjct: 197 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 256

Query: 654 KEQASLCINLALTCLQKTPELRPDIGE 680
           ++      +L    L   P  R     
Sbjct: 257 ED----GRSLLSQMLHYDPNKRISAKA 279

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 8e-26
 Identities = 39/161 (24%), Positives = 67/161 (41%), Gaps = 10/161 (6%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTERE---FQNELQILG-GLR 137
            DF    ++GKG  G VFL   +   +  AIK L    +  + +      E ++L     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFL 197
            PFL  +      +     V EY+    L   + S        S+      ++   L+FL
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF--DLSRATFYAAEIILGLQFL 119

Query: 198 HFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGE 238
                  +++ D+K  N+LLD D   K++DFG+ +  + G+
Sbjct: 120 ---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.6 bits (115), Expect = 1e-06
 Identities = 30/160 (18%), Positives = 53/160 (33%), Gaps = 32/160 (20%)

Query: 548 KNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIV 607
           K+ +   +D           + T +  GT  Y+APE           D +S GVL+  ++
Sbjct: 138 KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 197

Query: 608 SGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTC 667
            G+ P H        ++  L    R           +++  KD            L +  
Sbjct: 198 IGQSPFH------GQDEEELFHSIRM--DNPFYPRWLEKEAKD------------LLVKL 237

Query: 668 LQKTPELRPDIGETVR------------ILKGEMDLPPVP 695
             + PE R  +   +R            + + E+D P  P
Sbjct: 238 FVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRP 277

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 3e-25
 Identities = 43/174 (24%), Positives = 65/174 (37%), Gaps = 26/174 (14%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFSLQTE-REFQNELQILG- 134
           +       +G+G  G V    A         + +A+K L   +  +E R   +EL+IL  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 135 GLRSPFLVTLLGYCMERNKRI-LVYEYMPNKSLQEMLFSDGNL--------------VLK 179
                 +V LLG C +    + ++ E+    +L   L S  N                L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 180 WSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
                     VAK +EFL        IH D+   N+LL      K+ DFGL+R 
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD 183

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.5 bits (117), Expect = 6e-07
 Identities = 22/121 (18%), Positives = 35/121 (28%), Gaps = 17/121 (14%)

Query: 566 ELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKA 625
           +       R  L ++APE         ++D++S GVL+  I S     +           
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--------PGV 240

Query: 626 NLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRIL 685
            +        + G  +   D    +              L C    P  RP   E V  L
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 686 K 686
            
Sbjct: 292 G 292

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 4e-25
 Identities = 37/175 (21%), Positives = 70/175 (40%), Gaps = 27/175 (15%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR--------DGKLLAIKRLDTFSLQTE-REFQNELQIL 133
           +       +G+G  G V L  A             +A+K L + + + +  +  +E++++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 134 GGL-RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLF--------------SDGNLVL 178
             + +   ++ LLG C +     ++ EY    +L+E L                +    L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 179 KWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
                      VA+ +E+L        IH D+   NVL+  D   K++DFGL+R 
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.9 bits (131), Expect = 1e-08
 Identities = 35/212 (16%), Positives = 67/212 (31%), Gaps = 26/212 (12%)

Query: 480 WKEEHLDEISKKSSKLKKLETKWKKGFKIPHFDLARRFHFHRRNKFREQNQDDCDANGEF 539
            +     E S   S   + +   K       + +AR   +    K    ++D    N   
Sbjct: 112 ARRPPGLEYSYNPSHNPEEQLSSKDLVSC-AYQVARGMEYLASKKCI--HRDLAARNVLV 168

Query: 540 SFRRGWRKKNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSL 599
           +      K     +  D+   D + +    TT+ R  + ++APE         ++D++S 
Sbjct: 169 T-EDNVMKIADFGLARDIHHIDYYKK----TTNGRLPVKWMAPEALFDRIYTHQSDVWSF 223

Query: 600 GVLILVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASL 659
           GVL+  I +     +      +L                   +L+ E  + D      + 
Sbjct: 224 GVLLWEIFTLGGSPYPGVPVEEL------------------FKLLKEGHRMDKPSNCTNE 265

Query: 660 CINLALTCLQKTPELRPDIGETVRILKGEMDL 691
              +   C    P  RP   + V  L   + L
Sbjct: 266 LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 4e-25
 Identities = 35/180 (19%), Positives = 70/180 (38%), Gaps = 15/180 (8%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
           V+G G +G V      R  +  A+K L     +  RE +   +     + P +V ++   
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCP-KARREVELHWRAS---QCPHIVRIVDVY 74

Query: 149 ----MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP 204
                 R   ++V E +    L   +   G+      +  EI+  + +A+++LH      
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 131

Query: 205 VIHGDIKPSNVLLDS---DCRGKVSDFGLSRIKVEGEFGMDLFSQDLGKSQELWKSQELS 261
           + H D+KP N+L  S   +   K++DFG ++                  + E+   ++  
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 191

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.7 bits (105), Expect = 3e-05
 Identities = 26/149 (17%), Positives = 49/149 (32%), Gaps = 14/149 (9%)

Query: 568 SSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANL 627
           +S T+   T  YVAPE  G     +  D++SLGV++ +++ G  P +             
Sbjct: 168 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN----------- 216

Query: 628 ISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVR--IL 685
                        + +      +    E +     L    L+  P  R  I E +    +
Sbjct: 217 -HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 275

Query: 686 KGEMDLPPVPFEFSPSPSKLYGKSRQKQK 714
                +P  P   S    +   +    ++
Sbjct: 276 MQSTKVPQTPLHTSRVLKEDKERWEDVKE 304

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 7e-25
 Identities = 40/154 (25%), Positives = 72/154 (46%), Gaps = 8/154 (5%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIK--RLDTFSLQTEREFQNELQILGGLRSP 139
             +++   IG+G  GTVF    R   +++A+K  RLD            E+ +L  L+  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 140 FLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF 199
            +V L        K  LV+E+      +     +G+L  +  + F     + + L+ L F
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGF 116

Query: 200 GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
                V+H D+KP N+L++ +   K+++FGL+R 
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARA 150

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.3 bits (106), Expect = 1e-05
 Identities = 23/144 (15%), Positives = 46/144 (31%), Gaps = 11/144 (7%)

Query: 548 KNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPE-YGGCGYLMEKADIYSLGVLILVI 606
           +N     ++      F   +   ++   TL Y  P+   G        D++S G +   +
Sbjct: 136 RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195

Query: 607 VSGRRPLHVLASPMK-LEKANLISWCRHLAQAGNILELVDERLKDDYNKEQA-------- 657
            +  RPL         L++   +       Q  ++ +L D +    Y    +        
Sbjct: 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKL 255

Query: 658 -SLCINLALTCLQKTPELRPDIGE 680
            +   +L    L+  P  R    E
Sbjct: 256 NATGRDLLQNLLKCNPVQRISAEE 279

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 8e-25
 Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 9/154 (5%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTERE---FQNELQILGGLRS 138
           NDFD   ++GKG  G V L   +  G+  A+K L    +  + E      E ++L   R 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           PFL  L       ++   V EY     L   L  +     + ++ +      A+ +  L 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-----GAEIVSALE 119

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
           +     V++ DIK  N++LD D   K++DFGL +
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (86), Expect = 0.004
 Identities = 22/122 (18%), Positives = 40/122 (32%), Gaps = 20/122 (16%)

Query: 555 SDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLH 614
           +D         + ++  +  GT  Y+APE           D + LGV++  ++ GR P +
Sbjct: 147 TDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206

Query: 615 VLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPEL 674
                 +L +         L +       +    K             L    L+K P+ 
Sbjct: 207 N-QDHERLFE-------LILMEEIRFPRTLSPEAKS------------LLAGLLKKDPKQ 246

Query: 675 RP 676
           R 
Sbjct: 247 RL 248

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 2e-24
 Identities = 36/162 (22%), Positives = 71/162 (43%), Gaps = 16/162 (9%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQT--EREFQNELQILGGLRSP 139
           + +++   IG+G  G VF    R  G+ +A+K++   + +         E++IL  L+  
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 140 FLVTLLGYCMERNKRI--------LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVA 191
            +V L+  C  +            LV+++  +     +        L   +R      + 
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-----MQ 124

Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             L  L++     ++H D+K +NVL+  D   K++DFGL+R 
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (89), Expect = 0.002
 Identities = 18/123 (14%), Positives = 38/123 (30%), Gaps = 13/123 (10%)

Query: 571 TSMRGTLCYVAPE-YGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLIS 629
           T+   TL Y  PE   G        D++  G ++  + +    +       +L   + + 
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238

Query: 630 WC-----------RHLAQAGNILELVDERLKDDYNKEQAS-LCINLALTCLQKTPELRPD 677
                          L +   +++    ++KD           ++L    L   P  R D
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298

Query: 678 IGE 680
             +
Sbjct: 299 SDD 301

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 3e-24
 Identities = 35/165 (21%), Positives = 68/165 (41%), Gaps = 16/165 (9%)

Query: 79  KNATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTER------EFQNELQ 131
           +N  + +D    +G G    V     +  G   A K +     ++ R      + + E+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 132 ILGGLRSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVA 191
           IL  ++ P ++TL      +   IL+ E +    L + L    +L  + +  F     + 
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LK 120

Query: 192 KALEFLHFGCDPPVIHGDIKPSNVLLDSD----CRGKVSDFGLSR 232
           + L  +++     + H D+KP N++L        R K+ DFGL+ 
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.2 bits (127), Expect = 3e-08
 Identities = 25/113 (22%), Positives = 46/113 (40%), Gaps = 16/113 (14%)

Query: 568 SSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANL 627
           +   ++ GT  +VAPE      L  +AD++S+GV+  +++SG  P         L     
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN--- 227

Query: 628 ISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGE 680
                        +  V+   +D+Y    ++L  +     L K P+ R  I +
Sbjct: 228 -------------VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 267

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  101 bits (251), Expect = 9e-24
 Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 9/154 (5%)

Query: 83  NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTERE---FQNELQILGGLRS 138
           + FD    +G G  G V L   +  G   A+K LD   +   ++     NE +IL  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
           PFLV L     + +   +V EY+    +   L   G               +    E+LH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--SEPHARFYAAQIVLTFEYLH 158

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                 +I+ D+KP N+L+D     +V+DFG ++
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.1 bits (241), Expect = 5e-23
 Identities = 35/154 (22%), Positives = 62/154 (40%), Gaps = 14/154 (9%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRL------DTFSLQTEREFQNELQILGGLRS--PF 140
           ++G GG G+V+ GI   D   +AIK +      D   L        E+ +L  + S    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 141 LVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG 200
           ++ LL +    +  +L+ E            ++    L+          V +A+      
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHC--- 126

Query: 201 CDPPVIHGDIKPSNVLLDSD-CRGKVSDFGLSRI 233
            +  V+H DIK  N+L+D +    K+ DFG   +
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.2 bits (109), Expect = 5e-06
 Identities = 24/114 (21%), Positives = 37/114 (32%), Gaps = 27/114 (23%)

Query: 568 SSTTSMRGTLCYVAPEY-GGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKAN 626
           +  T   GT  Y  PE+     Y    A ++SLG+L+  +V G  P       ++ +   
Sbjct: 164 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV-- 221

Query: 627 LISWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGE 680
                                 +   + E    C +L   CL   P  RP   E
Sbjct: 222 --------------------FFRQRVSSE----CQHLIRWCLALRPSDRPTFEE 251

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.7 bits (237), Expect = 3e-22
 Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 18/166 (10%)

Query: 81  ATNDFDEANVIGKGGSGTVFLGIAR--DGKLLAIKRL------DTFSLQTEREFQNELQI 132
           A   ++    IG+G  G VF        G+ +A+KR+      +   L T RE    L+ 
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRH 63

Query: 133 LGGLRSPFLVTLLGYCM-----ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEII 187
           L     P +V L   C         K  LV+E++       +        +      +++
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMM 122

Query: 188 MDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI 233
             + + L+FLH      V+H D+KP N+L+ S  + K++DFGL+RI
Sbjct: 123 FQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.7 bits (133), Expect = 6e-09
 Identities = 25/140 (17%), Positives = 46/140 (32%), Gaps = 8/140 (5%)

Query: 548 KNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIV 607
            +     +D     ++S +  + TS+  TL Y APE           D++S+G +   + 
Sbjct: 151 SSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 209

Query: 608 SGRRPLHVLASPMKLEK-------ANLISWCRHLAQAGNILELVDERLKDDYNKEQASLC 660
             +      +   +L K            W R +A           +  + +  +   L 
Sbjct: 210 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 269

Query: 661 INLALTCLQKTPELRPDIGE 680
            +L L CL   P  R     
Sbjct: 270 KDLLLKCLTFNPAKRISAYS 289

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.1 bits (233), Expect = 1e-21
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 14/158 (8%)

Query: 83  NDFDEANVIGKGGSGTVFLGIA----RDGKLLAIKRLDTFSL----QTEREFQNELQILG 134
            +F+   V+G G  G VFL         GKL A+K L   ++    +T    + E Q+L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 135 GLR-SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
            +R SPFLVTL        K  L+ +Y+    L   L               + + V + 
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEI 138

Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
           +  L       +I+ DIK  N+LLDS+    ++DFGLS
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.0 bits (230), Expect = 4e-21
 Identities = 41/173 (23%), Positives = 68/173 (39%), Gaps = 20/173 (11%)

Query: 73  FTYKELKNATNDFDEA----NVIGKGGSGTVFLGI-ARDGKLLAIKRL--DTFSLQTERE 125
           F  +E+     +          +G G  G V   +  R G  +AIK+L     S    + 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 126 FQNELQILGGLRSPFLVTLLGYCMERNKR------ILVYEYMPNKSLQEMLFSDGNLVLK 179
              EL++L  +R   ++ LL                LV  +M        L       L 
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT--DLGKLMKHEK--LG 119

Query: 180 WSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
             +   ++  + K L ++H      +IH D+KP N+ ++ DC  K+ DFGL+R
Sbjct: 120 EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 169

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.4 bits (104), Expect = 3e-05
 Identities = 34/169 (20%), Positives = 59/169 (34%), Gaps = 21/169 (12%)

Query: 551 NSMGSDMWSGDLFSRELSS-TTSMRGTLCYVAPE-YGGCGYLMEKADIYSLGVLILVIVS 608
           N            +R+  S  T    T  Y APE         +  DI+S+G ++  +++
Sbjct: 155 NEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 214

Query: 609 GRRP------LHVLASPMKLEKANLISWCRHLA--QAGNILELVDERLKDDYN---KEQA 657
           G+        L  L   MK+       + + L   +A N ++ + E  K D+       +
Sbjct: 215 GKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNAS 274

Query: 658 SLCINLALTCLQKTPELRPDIGE--------TVRILKGEMDLPPVPFEF 698
            L +NL    L    E R   GE        ++   + E  +      F
Sbjct: 275 PLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSF 323

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 91.8 bits (227), Expect = 5e-21
 Identities = 28/166 (16%), Positives = 61/166 (36%), Gaps = 12/166 (7%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
            IG+G  G +F G    + + +AIK     S     + ++E +    L     +  + Y 
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 149 MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHG 208
            +     ++   +   SL+++L   G               +   ++ +H   +  +++ 
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIH---EKSLVYR 125

Query: 209 DIKPSNVLLDSDCRG-----KVSDFGLSRIKVEGEFGMDLFSQDLG 249
           DIKP N L+            V DFG+ +   +      +  ++  
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 54.4 bits (130), Expect = 1e-08
 Identities = 14/118 (11%), Positives = 30/118 (25%), Gaps = 12/118 (10%)

Query: 569 STTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLILVIVSGRRPLHVLASPMKLEKANLI 628
              ++ GT  Y++           + D+ +LG + +  + G  P   L +    +K   I
Sbjct: 169 EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228

Query: 629 SWCRHLAQAGNILELVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILK 686
              +       +     E                          +  PD      +  
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYK------------YMHYARNLAFDATPDYDYLQGLFS 274

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 91.8 bits (227), Expect = 8e-21
 Identities = 43/192 (22%), Positives = 89/192 (46%), Gaps = 20/192 (10%)

Query: 55  NRSRTIPFDSNAPLKLQRFTYKELKNAT---NDFDEANVIGKGGSGTVFLGIAR-DGKLL 110
           +R+R +  D N     + + Y+         +D+     +G+G    VF  I   + + +
Sbjct: 5   SRAR-VYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 63

Query: 111 AIKRLDTFSLQTEREFQNELQILGGLR-SPFLVTLLGYCMERNKR--ILVYEYMPNKSLQ 167
            +K L       +++ + E++IL  LR  P ++TL     +   R   LV+E++ N   +
Sbjct: 64  VVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFK 120

Query: 168 EMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG-KVS 226
           ++  +     L        + ++ KAL++ H      ++H D+KP NV++D + R  ++ 
Sbjct: 121 QLYQT-----LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLI 172

Query: 227 DFGLSRIKVEGE 238
           D+GL+     G+
Sbjct: 173 DWGLAEFYHPGQ 184

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 38.7 bits (89), Expect = 0.002
 Identities = 21/137 (15%), Positives = 39/137 (28%), Gaps = 19/137 (13%)

Query: 563 FSRELSSTTSMRGTLCYVAPEYG-GCGYLMEKADIYSLGVLILVIVSGRRPLH------- 614
           F            +  +  PE            D++SLG ++  ++  + P         
Sbjct: 179 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238

Query: 615 -------VLASPM---KLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQAS-LCINL 663
                  VL +      ++K N+    R     G       ER     N+   S   ++ 
Sbjct: 239 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298

Query: 664 ALTCLQKTPELRPDIGE 680
               L+   + R    E
Sbjct: 299 LDKLLRYDHQSRLTARE 315

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.8 bits (219), Expect = 1e-19
 Identities = 38/166 (22%), Positives = 64/166 (38%), Gaps = 17/166 (10%)

Query: 83  NDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRL--DTFSLQTEREFQNELQILGGLRSP 139
             +     IG G  G V     A   + +AIK+L     +    +    EL ++  +   
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 140 FLVTLLGYC------MERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKA 193
            +++LL          E     LV E M     Q +            +   ++  +   
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCG 131

Query: 194 LEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIKVEGEF 239
           ++ LH      +IH D+KPSN+++ SDC  K+ DFGL+R       
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 174

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.6 bits (99), Expect = 1e-04
 Identities = 32/193 (16%), Positives = 59/193 (30%), Gaps = 27/193 (13%)

Query: 545 WRKKNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLIL 604
             K +      D              T    T  Y APE        E  DI+S+G ++ 
Sbjct: 151 VVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209

Query: 605 VIVSGRRP-------------LHVLASPMKLEKANLISWCRHLAQA---------GNILE 642
            +V  +               +  L +P       L    R+  +            +  
Sbjct: 210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 269

Query: 643 LVDERLKDDYNKEQASLCINLALTCLQKTPELRPDIGETVRILKGE-MDLPPVPFEFSPS 701
                   ++NK +AS   +L    L   P  R  + +    L+   +++   P E    
Sbjct: 270 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD---ALQHPYINVWYDPAEVEAP 326

Query: 702 PSKLYGKSRQKQK 714
           P ++Y K   +++
Sbjct: 327 PPQIYDKQLDERE 339

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 84.1 bits (207), Expect = 3e-19
 Identities = 24/154 (15%), Positives = 53/154 (34%), Gaps = 19/154 (12%)

Query: 89  NVIGKGGSGTVFLGIARDGKLLAIK--RLDTFSLQT--------EREFQNELQILGGLRS 138
            ++G+G    VF   +       +K  ++   S +         +  F            
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 139 PFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLH 198
             L  L G  + +      Y +  N  L E++ +     ++     E++  + + +   +
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 199 FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR 232
                 ++HGD+   NVL+  +    + DF  S 
Sbjct: 121 ---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 86.4 bits (213), Expect = 3e-19
 Identities = 31/165 (18%), Positives = 62/165 (37%), Gaps = 12/165 (7%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYC 148
            IG G  G ++LG     G+ +AIK     +     +   E +I   ++    +  + +C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 149 M-ERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIH 207
             E +  ++V E +         F              +   +   +E++H       IH
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH---SKNFIH 126

Query: 208 GDIKPSNVLLDSDCRGKV---SDFGLSRIKVEGEFGMDLFSQDLG 249
            D+KP N L+    +G +    DFGL++   +      +  ++  
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 57.9 bits (139), Expect = 1e-09
 Identities = 22/143 (15%), Positives = 43/143 (30%), Gaps = 19/143 (13%)

Query: 544 GWRKKNKNSMGSDMWSGDLFSRELSSTTSMRGTLCYVAPEYGGCGYLMEKADIYSLGVLI 603
           G  KK +++                   ++ GT  Y +           + D+ SLG ++
Sbjct: 151 GLAKKYRDARTHQHI-------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 203

Query: 604 LVIVSGRRPLHVLASPMKLEKANLISWCRHLAQAGNILELVDERLKDDYNKEQASLCINL 663
           +    G  P   L +  K +K        +   +   +    E L   Y  E        
Sbjct: 204 MYFNLGSLPWQGLKAATKRQK--------YERISEKKMSTPIEVLCKGYPSE----FATY 251

Query: 664 ALTCLQKTPELRPDIGETVRILK 686
              C     + +PD     ++ +
Sbjct: 252 LNFCRSLRFDDKPDYSYLRQLFR 274

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.4 bits (205), Expect = 7e-18
 Identities = 36/171 (21%), Positives = 72/171 (42%), Gaps = 18/171 (10%)

Query: 73  FTYKELK----NATNDFDEANVIGKGGSGTVFLGI-ARDGKLLAIKRL--DTFSLQTERE 125
           F  +EL          +   + +G G  G+V      + G  +A+K+L     S+   + 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 126 FQNELQILGGLRSPFLVTLLGYCMERNK-----RILVYEYMPNKSLQEMLFSDGNLVLKW 180
              EL++L  ++   ++ LL              + +  ++    L  ++       L  
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTD 120

Query: 181 SQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS 231
                +I  + + L+++H      +IH D+KPSN+ ++ DC  K+ DFGL+
Sbjct: 121 DHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA 168

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (93), Expect = 6e-04
 Identities = 24/150 (16%), Positives = 51/150 (34%), Gaps = 17/150 (11%)

Query: 548 KNKNSMGSDMWSGDLFSRELS-----STTSMRGTLCYVAPE-YGGCGYLMEKADIYSLGV 601
           K  N   ++     +    L+       T    T  Y APE      +  +  DI+S+G 
Sbjct: 148 KPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 207

Query: 602 LILVIVSGRRP------LHVLASPMKLEKA--NLISWCRHLAQAGNILELVDERLKDDYN 653
           ++  +++GR        +  L   ++L       +        A N ++ + +  K ++ 
Sbjct: 208 IMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA 267

Query: 654 K---EQASLCINLALTCLQKTPELRPDIGE 680
                   L ++L    L    + R    +
Sbjct: 268 NVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 69.7 bits (169), Expect = 2e-13
 Identities = 27/160 (16%), Positives = 63/160 (39%), Gaps = 19/160 (11%)

Query: 90  VIGKGGSGTVFLGI-ARDGKLLAIKRLDTFSLQTEREFQNELQIL-----------GGLR 137
            +G G   TV+L     +   +A+K +    + TE   ++E+++L             + 
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSMG 78

Query: 138 SPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSD---GNLVLKWSQRFEIIMDVAKAL 194
           +  ++ LL +   +    +    +     + +L       +  +      +I   +   L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 195 EFLHFGCDPPVIHGDIKPSNVLLDS-DCRGKVSDFGLSRI 233
           +++H      +IH DIKP NVL++  D    +    ++ +
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 176

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	718
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.38
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.83
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.13
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.77
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.51
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.95

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.4e-52  Score=436.30  Aligned_cols=160  Identities=29%  Similarity=0.473  Sum_probs=133.7

Q ss_pred             ccccHHHHHHHhc---------CccccceecccCceEEEEEEEc-CC---cEEEEEEcccC-ChhhHHHHHHHHHHHhCC
Q 005033           71 QRFTYKELKNATN---------DFDEANVIGKGGSGTVFLGIAR-DG---KLLAIKRLDTF-SLQTEREFQNELQILGGL  136 (718)
Q Consensus        71 ~~~s~~el~~at~---------~f~~~~~LG~G~FG~Vykg~~~-~g---~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L  136 (718)
                      ..+||+++..++.         +|++.+.||+|+||+||+|.++ ++   ..||||.+... .....+.|.+|+.+|+++
T Consensus         5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l   84 (299)
T d1jpaa_           5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF   84 (299)
T ss_dssp             CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred             CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence            3566666666654         4556789999999999999986 23   36899998653 344567899999999999


Q ss_pred             CCCcceeEEEEEeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEE
Q 005033          137 RSPFLVTLLGYCMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVL  216 (718)
Q Consensus       137 ~HpNIV~L~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NIL  216 (718)
                      +|||||+++|+|...+..|+|||||++|+|.+++..... .+++..++.++.||+.||.|||   +++|+||||||+|||
T Consensus        85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NIL  160 (299)
T d1jpaa_          85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNIL  160 (299)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred             CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEE
Confidence            999999999999999999999999999999999876543 5899999999999999999999   899999999999999


Q ss_pred             ECCCCCEEEeeccCceee
Q 005033          217 LDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       217 Ld~~~~vKLsDFGLAr~~  234 (718)
                      |+.++.+||+|||+|+..
T Consensus       161 l~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         161 VNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             ECTTCCEEECCC------
T ss_pred             ECCCCcEEECCcccceEc
Confidence            999999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=425.49  Aligned_cols=147  Identities=29%  Similarity=0.483  Sum_probs=131.7

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      ++|++.+.||+|+||+||+|.+.+++.||||+++... ...++|.+|+.++++++|||||+++|+|...+..|+|||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5788999999999999999999888999999997643 345689999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +|+|.+++..... .+++..++.++.|||.||.|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        84 ~g~L~~~l~~~~~-~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  151 (263)
T d1sm2a_          84 HGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  151 (263)
T ss_dssp             TCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred             CCcHHHHhhcccc-CCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheec
Confidence            9999999876543 6889999999999999999999   899999999999999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.4e-52  Score=434.36  Aligned_cols=151  Identities=26%  Similarity=0.403  Sum_probs=138.4

Q ss_pred             HHhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           80 NATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        80 ~at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ...++|++.+.||+|+||+||+|.+. +++.||||+++... ...++|.+|+.+|++++|||||+++++|.+++..||||
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            34568899999999999999999987 58899999997543 34567999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||++|+|.+++.......+++..++.|+.||+.||.|||   +++|+||||||+||||+.++.+||+|||+|+..
T Consensus        93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeec
Confidence            9999999999998776668999999999999999999999   899999999999999999999999999999864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=425.10  Aligned_cols=146  Identities=32%  Similarity=0.484  Sum_probs=133.6

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||+||+|+++ +++.||||++....   ......+.+|+.+|+.++|||||++++++.+++..||||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999987 68999999986422   233567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |||++|+|.+++...+  .+++..+..++.||+.||.|||   +++||||||||+|||++.++.+||+|||+|+.
T Consensus        86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~  155 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH  155 (263)
T ss_dssp             ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred             eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeee
Confidence            9999999999998654  5899999999999999999999   89999999999999999999999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-50  Score=424.15  Aligned_cols=146  Identities=28%  Similarity=0.456  Sum_probs=135.4

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|+.+|+.++|||||+++++|...+..|||||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999986 69999999997654455678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +||+|.+++...   .+++..+..++.||+.||.|||   +++||||||||+|||++.++.+||+|||+|+..
T Consensus       100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~  166 (293)
T d1yhwa1         100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (293)
T ss_dssp             TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheee
Confidence            999999998765   5899999999999999999999   899999999999999999999999999999864

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-51  Score=427.40  Aligned_cols=148  Identities=27%  Similarity=0.383  Sum_probs=133.0

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..|||||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            368999999999999999999986 69999999986533 2334578999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||++|+|.++|....  .+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        84 y~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          84 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVF  153 (271)
T ss_dssp             CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheee
Confidence            999999999997654  6899999999999999999999   899999999999999999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-52  Score=429.64  Aligned_cols=149  Identities=24%  Similarity=0.432  Sum_probs=134.1

Q ss_pred             HhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ..++|++.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|+.+|++++|||||+++|++.+ +..||||||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            346789999999999999999999888999999997543 345679999999999999999999998854 567999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |++|+|.+++.......+++..++.|+.||+.||.|||   +++|+||||||+||||+.++.+||+|||+|+..
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEc
Confidence            99999999886654446899999999999999999999   899999999999999999999999999999875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-51  Score=423.32  Aligned_cols=146  Identities=27%  Similarity=0.440  Sum_probs=130.0

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      .++|++.+.||+|+||+||+|+.+  ..||||+++..  .....+.|.+|+.+|++++|||||++++++.. +..|||||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            468999999999999999999864  46999998643  34556789999999999999999999998754 56899999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||++|+|.+++..... .+++..++.|+.||+.||.|||   +++||||||||+||||+.++.+||+|||+|+..
T Consensus        84 y~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~  154 (276)
T d1uwha_          84 WCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK  154 (276)
T ss_dssp             CCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred             cCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeec
Confidence            9999999999976543 5899999999999999999999   899999999999999999999999999999864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-51  Score=426.35  Aligned_cols=149  Identities=26%  Similarity=0.377  Sum_probs=136.8

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      .+.|++.+.||+|+||+||+|.+. +|+.||||++........+.|.+|+++|++++|||||++++++.+.+..||||||
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            357899999999999999999986 6899999999776656667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |++|+|.+++..... .+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        91 ~~~g~L~~~~~~~~~-~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~  160 (288)
T d2jfla1          91 CAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN  160 (288)
T ss_dssp             CTTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhcc
Confidence            999999999865432 6899999999999999999999   899999999999999999999999999999763

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-51  Score=423.12  Aligned_cols=152  Identities=27%  Similarity=0.398  Sum_probs=124.8

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEee--CCeEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCME--RNKRILV  157 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LV  157 (718)
                      ++|++.+.||+|+||+||+|.+. +|+.||||.+...  .....+.|.+|+++|++++|||||++++++.+  .+..|||
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            68999999999999999999986 6899999998653  33445679999999999999999999999965  4568999


Q ss_pred             EeccCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          158 YEYMPNKSLQEMLFSDG--NLVLKWSQRFEIIMDVAKALEFLHFGC--DPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~--~~~l~~~~~~~Ia~qIa~gL~yLH~~~--~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||||++|+|.+++....  ...+++..++.++.||+.||.|||...  ..+||||||||+||||+.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999986431  236899999999999999999999321  23599999999999999999999999999986


Q ss_pred             e
Q 005033          234 K  234 (718)
Q Consensus       234 ~  234 (718)
                      .
T Consensus       164 ~  164 (269)
T d2java1         164 L  164 (269)
T ss_dssp             C
T ss_pred             c
Confidence            4

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=429.66  Aligned_cols=148  Identities=28%  Similarity=0.432  Sum_probs=135.1

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ..++|++++.||+|+||+||+|.+. +|+.||||+++.. .......+.+|+.+|+.++|||||+++++|.+.+..||||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3578999999999999999999986 6899999998653 3344567999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCD-PPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~-~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |||+||+|.+++...+  .+++..+..++.||+.||.|||   + ++|+||||||+||||+.++.+||+|||+|+.
T Consensus        84 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~  154 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  154 (322)
T ss_dssp             ECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             EcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence            9999999999998764  5889999999999999999999   6 4899999999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-50  Score=418.48  Aligned_cols=148  Identities=27%  Similarity=0.430  Sum_probs=129.8

Q ss_pred             cCccccceecccCceEEEEEEEcCC-----cEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDG-----KLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g-----~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      +.|+..++||+|+||.||+|.+++.     ..||||++... .......|.+|+.+|++++|||||+++|+|...+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            5688899999999999999987642     47999999653 33445679999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||||.+|+|.+++..... .+++..++.++.||+.||.|||   +++|+||||||+||||+.++.+||+|||+|+..
T Consensus        87 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTT-CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEecccCcchhhhhcccc-cccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcc
Confidence            9999999999998876543 6899999999999999999999   899999999999999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-50  Score=419.75  Aligned_cols=148  Identities=29%  Similarity=0.456  Sum_probs=129.8

Q ss_pred             hcCccccce-ecccCceEEEEEEEc---CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           82 TNDFDEANV-IGKGGSGTVFLGIAR---DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        82 t~~f~~~~~-LG~G~FG~Vykg~~~---~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      .++|.+.+. ||+|+||+||+|.++   ++..||||+++... ....+.|.+|+++|++++|||||+++|+|.. +..||
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            356667774 999999999999875   35589999997543 4456789999999999999999999999865 56899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||||++|+|.+++..... .+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        86 vmE~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTT-TSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEeCCCCcHHHHhhcccc-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence            9999999999999865533 6899999999999999999999   899999999999999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-50  Score=411.91  Aligned_cols=147  Identities=32%  Similarity=0.433  Sum_probs=135.3

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccC
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMP  162 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~  162 (718)
                      ++|++.+.||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++|||||+++|+|.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            6899999999999999999999888899999997644 345689999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          163 NKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       163 gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +|+|.+++..... .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus        83 ~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~  150 (258)
T d1k2pa_          83 NGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  150 (258)
T ss_dssp             TEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBC
T ss_pred             CCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheec
Confidence            9999999866543 5788999999999999999999   899999999999999999999999999999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=411.92  Aligned_cols=143  Identities=26%  Similarity=0.370  Sum_probs=126.2

Q ss_pred             cccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEee----CCeEEEEE
Q 005033           86 DEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCME----RNKRILVY  158 (718)
Q Consensus        86 ~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~~LVm  158 (718)
                      +..+.||+|+||+||+|.+. +++.||||.+...  .....+.|.+|+++|++++|||||+++++|..    ...+||||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            56678999999999999987 6889999998643  33445679999999999999999999999875    34689999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEEC-CCCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPP--VIHGDIKPSNVLLD-SDCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~g--IVHRDLKP~NILLd-~~~~vKLsDFGLAr~  233 (718)
                      |||++|+|.+++....  .+++..++.++.||+.||.|||   +++  |+||||||+|||++ .++.+||+|||+|+.
T Consensus        92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            9999999999997754  5889999999999999999999   777  99999999999996 578999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=423.83  Aligned_cols=147  Identities=27%  Similarity=0.396  Sum_probs=134.6

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++....   ....+.+.+|+++|++++|||||++++++.+.+..||||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999986 69999999986422   233467999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||++|+|.+++...+  .+++..+..++.||+.||.|||   +++||||||||+|||++.++.+||+|||+|+..
T Consensus        88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~  158 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL  158 (288)
T ss_dssp             CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceec
Confidence            9999999999988765  5899999999999999999999   999999999999999999999999999999875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-50  Score=426.35  Aligned_cols=151  Identities=28%  Similarity=0.394  Sum_probs=130.4

Q ss_pred             HhcCccccceecccCceEEEEEEEcC-C-----cEEEEEEcccC-ChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCC
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIARD-G-----KLLAIKRLDTF-SLQTEREFQNELQILGGL-RSPFLVTLLGYCMERN  152 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~~-g-----~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~  152 (718)
                      ..++|++.+.||+|+||+||+|++.. +     ..||||.+... .......|.+|+.+|.++ +|||||+++++|.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            34689999999999999999998753 2     36999998643 233446789999999998 8999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGN---------------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIK  211 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~---------------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLK  211 (718)
                      ..|||||||++|+|.++|.....                     ..+++..++.|+.||+.||.|||   +++|||||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCc
Confidence            99999999999999999976532                     24789999999999999999999   8999999999


Q ss_pred             CCCEEECCCCCEEEeeccCceee
Q 005033          212 PSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       212 P~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+|||++.++.+||+|||+|+..
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~  214 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDI  214 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCG
T ss_pred             hhccccccCCeEEEeeccccccc
Confidence            99999999999999999999864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-50  Score=425.79  Aligned_cols=149  Identities=27%  Similarity=0.446  Sum_probs=125.2

Q ss_pred             HhcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ..+.|++.+.||+|+||+||+|.+. +|+.||||++.... ......+.+|+.+|+.++|||||++++++.+++..||||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3467999999999999999999987 68999999996533 223456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEC---CCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD---SDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd---~~~~vKLsDFGLAr~~  234 (718)
                      |||+||+|.++|...+  .+++..+..++.||+.||.|||   +++|+||||||+|||+.   .++.+||+|||+|+..
T Consensus        87 E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             eccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            9999999999998754  6899999999999999999999   89999999999999994   5789999999999753

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-50  Score=416.07  Aligned_cols=140  Identities=28%  Similarity=0.440  Sum_probs=123.9

Q ss_pred             ceecccCceEEEEEEEcC---CcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEeccCC
Q 005033           89 NVIGKGGSGTVFLGIARD---GKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYMPN  163 (718)
Q Consensus        89 ~~LG~G~FG~Vykg~~~~---g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g  163 (718)
                      +.||+|+||+||+|.+++   ++.||||+++..  .....+.|.+|+.+|++++|||||+++|+|.. +..|||||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            479999999999998753   568999999643  23345679999999999999999999999965 467899999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          164 KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       164 GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+|.+++....  .+++..++.|+.||+.||.|||   +++||||||||+|||++.++.+||+|||+|+..
T Consensus        92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~  157 (277)
T d1xbba_          92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  157 (277)
T ss_dssp             EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhc
Confidence            99999998765  5899999999999999999999   899999999999999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-50  Score=419.11  Aligned_cols=148  Identities=26%  Similarity=0.418  Sum_probs=132.7

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEecc
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEYM  161 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~  161 (718)
                      .++|++.+.||+|+||.||+|.+++++.||||++.... ...+.|.+|+.+|++++|||||+++|+|.+ +..|+|||||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            46799999999999999999999888899999996543 345689999999999999999999999854 5689999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++|+|.+++.......+++.+++.|+.||+.||.|||   .++|+||||||+||||+.++.+||+|||+|+..
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~  163 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI  163 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhc
Confidence            9999999987654446899999999999999999999   899999999999999999999999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-49  Score=420.37  Aligned_cols=146  Identities=24%  Similarity=0.377  Sum_probs=132.1

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ..|+.++.||+|+||+||+|.+. +|+.||||++....   ....+.|.+|+.+|++++|||||++++++.+.+..||||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35899999999999999999986 68999999986533   233467999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |||.+|+|..++....  .+++..+..++.||+.||.|||   +++||||||||+|||++.++.+||+|||+|+.
T Consensus        95 E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~  164 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (309)
T ss_dssp             ECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             EecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccc
Confidence            9999999987776554  6899999999999999999999   89999999999999999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.1e-49  Score=423.97  Aligned_cols=149  Identities=27%  Similarity=0.405  Sum_probs=136.4

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            468999999999999999999986 6999999999876666677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC--CCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS--DCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~--~~~vKLsDFGLAr~~  234 (718)
                      |+||+|.+++..... .+++..+..|+.||+.||.|||   +++||||||||+|||++.  ++.+||+|||+|+..
T Consensus       105 ~~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         105 MSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             CCSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             CCCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            999999999965433 5899999999999999999999   999999999999999964  678999999999864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9.9e-49  Score=422.03  Aligned_cols=149  Identities=21%  Similarity=0.399  Sum_probs=136.4

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++..........+.+|+.+|++++|||||+++++|.+++..||||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999986 6999999999776666667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEC--CCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLD--SDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd--~~~~vKLsDFGLAr~~  234 (718)
                      |+||+|.+++...+ ..+++..++.|+.||+.||.|||   +.+||||||||+||||+  .++.+||+|||+|+..
T Consensus       108 ~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         108 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             CCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceec
Confidence            99999999886553 35899999999999999999999   99999999999999997  5789999999999864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=409.02  Aligned_cols=148  Identities=23%  Similarity=0.339  Sum_probs=133.7

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC------hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS------LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~------~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~  154 (718)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++....      ....+.|.+|+.+|++++|||||+++++|.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            367999999999999999999986 69999999985422      12356899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC----CEEEeeccC
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC----RGKVSDFGL  230 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~----~vKLsDFGL  230 (718)
                      |||||||++|+|.++|...+  .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++    .+||+|||+
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhh
Confidence            99999999999999997764  6899999999999999999999   99999999999999998876    499999999


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      |+..
T Consensus       164 a~~~  167 (293)
T d1jksa_         164 AHKI  167 (293)
T ss_dssp             CEEC
T ss_pred             hhhc
Confidence            9864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=417.18  Aligned_cols=148  Identities=30%  Similarity=0.388  Sum_probs=135.0

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      .++|++++.||+|+||.||+|... +|+.||||++....   ......+.+|+.+|+.++|||||++++++.+.+..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            367999999999999999999986 69999999996432   22356789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||||+||+|.+++...+  .+++..+..++.||+.||.|||   +++||||||||+|||++.+|.+||+|||+|+..
T Consensus        84 ~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~  155 (337)
T d1o6la_          84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             eeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccccccc
Confidence            99999999999998765  5788999999999999999999   999999999999999999999999999999853

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.3e-48  Score=410.21  Aligned_cols=147  Identities=27%  Similarity=0.439  Sum_probs=133.9

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++....   ....+.+.+|+.+|+.++|||||++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999986 69999999986422   233567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+||+|..++....  .+++..+..++.||+.||.|||   +++||||||||+||||+.++.+||+|||+|+..
T Consensus        84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~  154 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV  154 (316)
T ss_dssp             CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEe
Confidence            9999999999998765  5678888899999999999999   999999999999999999999999999999763

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.1e-49  Score=412.70  Aligned_cols=156  Identities=29%  Similarity=0.445  Sum_probs=137.7

Q ss_pred             HHHHHHhcCccccceecccCceEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEE
Q 005033           76 KELKNATNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYC  148 (718)
Q Consensus        76 ~el~~at~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~  148 (718)
                      .+++..+++|++.+.||+|+||+||+|+++      +++.||||+++... ....+.|.+|+++|+.++||||++++++|
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            345556789999999999999999999875      35789999997543 34456799999999999999999999999


Q ss_pred             eeCCeEEEEEeccCCCCHHHHHhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 005033          149 MERNKRILVYEYMPNKSLQEMLFSDG----------------------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVI  206 (718)
Q Consensus       149 ~~~~~~~LVmEy~~gGsL~~~L~~~~----------------------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIV  206 (718)
                      ...+..++||||+++|+|.++|....                      ...+++..++.|+.||+.||+|||   +++||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeE
Confidence            99999999999999999999996532                      124788999999999999999999   99999


Q ss_pred             ecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          207 HGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       207 HRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||||||+|||++.++.+||+|||+|+..
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~  190 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNI  190 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHH
T ss_pred             eeEEcccceEECCCCcEEEccchhheec
Confidence            9999999999999999999999999764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=404.37  Aligned_cols=146  Identities=36%  Similarity=0.516  Sum_probs=127.4

Q ss_pred             hcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEee-CCeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCME-RNKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~~~LVmEy  160 (718)
                      .++|++.+.||+|+||.||+|.++ |..||||+++..  ...+.|.+|+++|++++|||||+++|+|.+ .+..||||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            357888999999999999999985 788999999653  345679999999999999999999999965 4568999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      +++|+|.++|.......+++..++.|+.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~  152 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  152 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeeccccccee
Confidence            99999999997655446899999999999999999999   89999999999999999999999999999875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-48  Score=401.40  Aligned_cols=148  Identities=26%  Similarity=0.354  Sum_probs=125.4

Q ss_pred             hcCccccceecccCceEEEEEEEcC----CcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARD----GKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~----g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      .++|++.+.||+|+||.||+|.+..    +..||||.+.... ....+.|.+|+.+|++++|||||++++++. .+..|+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4679999999999999999998752    4579999986533 344567999999999999999999999996 467899


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||||++|+|.+++..... .+++..++.++.||+.||.|||   +++||||||||+|||++.++.+||+|||+|+..
T Consensus        85 v~E~~~~g~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTT-TSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEeccCCcHHhhhhccCC-CCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheec
Confidence            9999999999998876543 6899999999999999999999   999999999999999999999999999999864

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-48  Score=409.58  Aligned_cols=147  Identities=27%  Similarity=0.509  Sum_probs=127.8

Q ss_pred             cCccccceecccCceEEEEEEEc-CCc----EEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGK----LLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~----~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L  156 (718)
                      .+|++++.||+|+||+||+|.+. +|+    .||||.+... .....+.|.+|+.+|++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            47999999999999999999876 343    6899988643 344567899999999999999999999999865 5678


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +|||+.+|+|.+++..... .+++..++.++.||+.||.|||   +++||||||||+|||++.++.+||+|||+|+..
T Consensus        88 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEeccCCccccccccccc-CCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence            8999999999999877643 6899999999999999999999   899999999999999999999999999999864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=407.14  Aligned_cols=145  Identities=23%  Similarity=0.405  Sum_probs=127.3

Q ss_pred             hcCccccc-eecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhC-CCCCcceeEEEEEee----CCeE
Q 005033           82 TNDFDEAN-VIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGG-LRSPFLVTLLGYCME----RNKR  154 (718)
Q Consensus        82 t~~f~~~~-~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~-L~HpNIV~L~g~~~~----~~~~  154 (718)
                      .++|.+.. .||+|+||+||+|.+. +++.||||+++..     ..+.+|+.++.+ ++|||||+++++|.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46898875 5999999999999985 6899999998642     357789998755 589999999999875    4678


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC---CCCEEEeeccCc
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLS  231 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~---~~~vKLsDFGLA  231 (718)
                      |||||||+||+|.++|...+...+++.++..|+.||+.||.|||   +.+|+||||||+|||++.   .+.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            99999999999999998766567999999999999999999999   999999999999999985   567999999999


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      +..
T Consensus       162 ~~~  164 (335)
T d2ozaa1         162 KET  164 (335)
T ss_dssp             EEC
T ss_pred             eec
Confidence            864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.7e-47  Score=393.57  Aligned_cols=148  Identities=26%  Similarity=0.424  Sum_probs=132.8

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC----e
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERN----K  153 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~----~  153 (718)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++....   ......|.+|+.+|+.++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            367999999999999999999986 69999999996532   334567999999999999999999999998654    3


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .|||||||+||+|.+++...+  .+++..++.++.||+.||.|||   +.+||||||||+|||++.++..+|+|||+++.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhh
Confidence            799999999999999997765  5899999999999999999999   89999999999999999999999999998876


Q ss_pred             e
Q 005033          234 K  234 (718)
Q Consensus       234 ~  234 (718)
                      .
T Consensus       161 ~  161 (277)
T d1o6ya_         161 I  161 (277)
T ss_dssp             C
T ss_pred             h
Confidence            4

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-48  Score=404.37  Aligned_cols=154  Identities=27%  Similarity=0.359  Sum_probs=124.2

Q ss_pred             HHHHhcCccccceecccCceEEEEEEEc------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCC-CCCcceeEEEEEe
Q 005033           78 LKNATNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTF-SLQTEREFQNELQILGGL-RSPFLVTLLGYCM  149 (718)
Q Consensus        78 l~~at~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~  149 (718)
                      +....++|++.+.||+|+||.||+|.+.      +++.||||+++.. .....+.+.+|..++.++ +|+|||.+++++.
T Consensus         8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~   87 (299)
T d1ywna1           8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   87 (299)
T ss_dssp             HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence            3344578999999999999999999874      2468999999653 334456788888888776 6899999999987


Q ss_pred             eC-CeEEEEEeccCCCCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 005033          150 ER-NKRILVYEYMPNKSLQEMLFSDGN--------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSN  214 (718)
Q Consensus       150 ~~-~~~~LVmEy~~gGsL~~~L~~~~~--------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~N  214 (718)
                      .. +..++|||||++|+|.++|.....              ..+++..++.++.||+.||.|||   +++||||||||+|
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~N  164 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARN  164 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccc
Confidence            65 468999999999999999976431              24889999999999999999999   8999999999999


Q ss_pred             EEECCCCCEEEeeccCceee
Q 005033          215 VLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       215 ILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||+.++.+||+|||+|+..
T Consensus       165 ILl~~~~~~Kl~DFGla~~~  184 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDI  184 (299)
T ss_dssp             EEECGGGCEEECC------C
T ss_pred             eeECCCCcEEEccCcchhhc
Confidence            99999999999999999864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.7e-47  Score=410.31  Aligned_cols=147  Identities=28%  Similarity=0.398  Sum_probs=134.3

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++|++++.||+|+||.||+|.++ +|+.||||++....   ....+.+.+|+.+|+.++|||||++++++......|+||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999986 69999999986422   233467899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||+.+|+|.+++...+  .+++..+..++.||+.||.|||   +++||||||||+||||+.++.+||+|||+|+..
T Consensus       121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~  191 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence            9999999999997765  5899999999999999999999   999999999999999999999999999999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.3e-47  Score=410.05  Aligned_cols=148  Identities=28%  Similarity=0.377  Sum_probs=130.1

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHH---HHHHHHhCCCCCcceeEEEEEeeCCeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---QTEREFQ---NELQILGGLRSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---~~~~~f~---~Ei~iL~~L~HpNIV~L~g~~~~~~~~  154 (718)
                      .++|++.+.||+|+||.||+|++. +|+.||||++.....   .....+.   .|+.+++.++|||||+++++|...+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            368999999999999999999987 699999999854221   1122333   457788889999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |||||||+||+|.++|....  .+++..+..++.||+.||.|||   +++||||||||+|||++.++.+||+|||+|+..
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999998764  5788999999999999999999   999999999999999999999999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-47  Score=401.70  Aligned_cols=148  Identities=20%  Similarity=0.308  Sum_probs=133.5

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      .++|.+.+.||+|+||+||+|.+. +|+.||||+++... .....+.+|+++|+.++|||||++++++.+.+..||||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            468999999999999999999987 68999999997654 3345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCC--CCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSD--CRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~--~~vKLsDFGLAr~~  234 (718)
                      |+||+|.++|...+ ..+++.++..|+.||+.||.|||   +.+|+||||||+|||++.+  ..+||+|||+++..
T Consensus        83 ~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            99999999997654 25899999999999999999999   9999999999999999854  58999999998764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-47  Score=404.98  Aligned_cols=147  Identities=27%  Similarity=0.386  Sum_probs=131.2

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHh-CCCCCcceeEEEEEeeCCeEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS---LQTEREFQNELQILG-GLRSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~---~~~~~~f~~Ei~iL~-~L~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ++|.+.+.||+|+||+||+|.+. +|+.||||++....   ....+.+..|..++. .++|||||++++++.+++..|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            58999999999999999999987 69999999996422   223456777777765 68999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          158 YEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ||||++|+|.+++....  .+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~  153 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  153 (320)
T ss_dssp             EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhc
Confidence            99999999999998765  5788999999999999999999   899999999999999999999999999999753

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=401.62  Aligned_cols=149  Identities=34%  Similarity=0.567  Sum_probs=130.1

Q ss_pred             cCccccceecccCceEEEEEEEc-CCc--EEEEEEcccC-ChhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCCeEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGK--LLAIKRLDTF-SLQTEREFQNELQILGGL-RSPFLVTLLGYCMERNKRILV  157 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~--~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV  157 (718)
                      ++|++.+.||+|+||+||+|.++ +|.  .||||++... .....+.|.+|+++|.++ +|||||+++|+|...+..|+|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            57888999999999999999986 344  5788888543 333456799999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCE
Q 005033          158 YEYMPNKSLQEMLFSDG--------------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRG  223 (718)
Q Consensus       158 mEy~~gGsL~~~L~~~~--------------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~v  223 (718)
                      |||+++|+|.++|+...              ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            99999999999997542              246899999999999999999999   8999999999999999999999


Q ss_pred             EEeeccCceee
Q 005033          224 KVSDFGLSRIK  234 (718)
Q Consensus       224 KLsDFGLAr~~  234 (718)
                      ||+|||+|+..
T Consensus       167 kl~DfG~a~~~  177 (309)
T d1fvra_         167 KIADFGLSRGQ  177 (309)
T ss_dssp             EECCTTCEESS
T ss_pred             EEccccccccc
Confidence            99999999753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=394.66  Aligned_cols=142  Identities=27%  Similarity=0.420  Sum_probs=122.1

Q ss_pred             ccceecccCceEEEEEEEc-CCcEEEEEEcccCChh-----hHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           87 EANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQ-----TEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        87 ~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~-----~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      .+++||+|+||+||+|.+. +|+.||||+++.....     ..+.+.+|+.+|++++|||||++++++..++..||||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999986 6999999998643221     124688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      |.++++..++...  ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.
T Consensus        82 ~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~  149 (299)
T d1ua2a_          82 METDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS  149 (299)
T ss_dssp             CSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             hcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccc
Confidence            9887776665433  35788889999999999999999   99999999999999999999999999999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=401.96  Aligned_cols=151  Identities=28%  Similarity=0.399  Sum_probs=134.3

Q ss_pred             HhcCccccceecccCceEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeCC
Q 005033           81 ATNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTFS-LQTEREFQNELQILGGL-RSPFLVTLLGYCMERN  152 (718)
Q Consensus        81 at~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~  152 (718)
                      ..++|++.+.||+|+||.||+|++.      +++.||||+++... ......|.+|+.+++.+ +|||||+++++|.+.+
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            3478899999999999999999863      36789999997543 34456799999999999 6999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEE
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGN----------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVL  216 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~----------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NIL  216 (718)
                      ..|||||||++|+|.++++....                ..+++..++.++.||+.||.|||   +++||||||||+|||
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccc
Confidence            99999999999999999976431                35889999999999999999999   999999999999999


Q ss_pred             ECCCCCEEEeeccCceee
Q 005033          217 LDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       217 Ld~~~~vKLsDFGLAr~~  234 (718)
                      ++.++.+||+|||+++..
T Consensus       178 ~~~~~~~ki~DfG~~~~~  195 (311)
T d1t46a_         178 LTHGRITKICDFGLARDI  195 (311)
T ss_dssp             EETTTEEEECCCGGGSCT
T ss_pred             ccccCcccccccchheec
Confidence            999999999999998864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2e-46  Score=390.94  Aligned_cols=147  Identities=25%  Similarity=0.363  Sum_probs=133.7

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh---------hhHHHHHHHHHHHhCCC-CCcceeEEEEEeeC
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL---------QTEREFQNELQILGGLR-SPFLVTLLGYCMER  151 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~---------~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~  151 (718)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.....         ...+.+.+|+.+|++++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            68999999999999999999986 689999999854321         12346889999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCc
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS  231 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLA  231 (718)
                      +..|||||||++|+|.++|...+  .+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhe
Confidence            99999999999999999998765  6899999999999999999999   899999999999999999999999999999


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      +..
T Consensus       158 ~~~  160 (277)
T d1phka_         158 CQL  160 (277)
T ss_dssp             EEC
T ss_pred             eEc
Confidence            864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-47  Score=397.42  Aligned_cols=147  Identities=24%  Similarity=0.299  Sum_probs=123.2

Q ss_pred             cCccccceecccCceEEEEEEEcC----CcEEEEEEcccC---ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARD----GKLLAIKRLDTF---SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRI  155 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~----g~~VAVK~i~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~  155 (718)
                      ++|++.+.||+|+||.||+|.+..    +..||||++...   .....+.|.+|+.+|++++|||||+++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            579999999999999999998752    247899998643   23445689999999999999999999999976 4678


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +|||||++|+|.+++..... .+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999999998876543 5899999999999999999999   899999999999999999999999999999875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-47  Score=398.44  Aligned_cols=150  Identities=25%  Similarity=0.372  Sum_probs=128.1

Q ss_pred             hcCccccceecccCceEEEEEEEcC--------CcEEEEEEcccCC-hhhHHHHHHHHHHHhCC-CCCcceeEEEEEeeC
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIARD--------GKLLAIKRLDTFS-LQTEREFQNELQILGGL-RSPFLVTLLGYCMER  151 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~~--------g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~  151 (718)
                      .++|.+.+.||+|+||.||+|+...        +..||||+++... ......+.+|...+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4688999999999999999998642        3479999996643 34457789999999888 899999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 005033          152 NKRILVYEYMPNKSLQEMLFSDGN--------------LVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLL  217 (718)
Q Consensus       152 ~~~~LVmEy~~gGsL~~~L~~~~~--------------~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILL  217 (718)
                      +..|+|||||++|+|.++|.....              ..+++..++.++.||+.||.|||   +.+||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence            999999999999999999975532              35899999999999999999999   9999999999999999


Q ss_pred             CCCCCEEEeeccCceee
Q 005033          218 DSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       218 d~~~~vKLsDFGLAr~~  234 (718)
                      +.++.+||+|||+++..
T Consensus       169 ~~~~~~kl~dfg~~~~~  185 (299)
T d1fgka_         169 TEDNVMKIADFGLARDI  185 (299)
T ss_dssp             CTTCCEEECSTTCCCCG
T ss_pred             cCCCCeEeccchhhccc
Confidence            99999999999999864

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=396.92  Aligned_cols=143  Identities=28%  Similarity=0.467  Sum_probs=126.6

Q ss_pred             cceecccCceEEEEEEEcC----CcEEEEEEccc-CChhhHHHHHHHHHHHhCCCCCcceeEEEEEee-CCeEEEEEecc
Q 005033           88 ANVIGKGGSGTVFLGIARD----GKLLAIKRLDT-FSLQTEREFQNELQILGGLRSPFLVTLLGYCME-RNKRILVYEYM  161 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~----g~~VAVK~i~~-~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~~~LVmEy~  161 (718)
                      .++||+|+||+||+|.+.+    ...||||+++. ......++|.+|+++|++++|||||+++|++.. ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4689999999999999753    23699999964 345556789999999999999999999999876 46889999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          162 PNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       162 ~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++|+|.+++..... .+++..++.++.|++.||.|||   +.+|+||||||+||||++++.+||+|||+++..
T Consensus       112 ~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~  180 (311)
T d1r0pa_         112 KHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  180 (311)
T ss_dssp             TTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred             ecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhc
Confidence            99999999876543 5778889999999999999999   899999999999999999999999999999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-46  Score=390.34  Aligned_cols=145  Identities=24%  Similarity=0.330  Sum_probs=124.3

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHH--HHHHHhCCCCCcceeEEEEEeeCC----eEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQN--ELQILGGLRSPFLVTLLGYCMERN----KRIL  156 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~--Ei~iL~~L~HpNIV~L~g~~~~~~----~~~L  156 (718)
                      .+|.+.+.||+|+||.||+|++ +|+.||||++...   ..+.+.+  |+..+..++|||||+++++|...+    ..|+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            4677889999999999999987 5889999998653   2334444  455556789999999999998654    5799


Q ss_pred             EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCEEECCCCCEEEeeccCc
Q 005033          157 VYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG-----CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLS  231 (718)
Q Consensus       157 VmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~-----~~~gIVHRDLKP~NILLd~~~~vKLsDFGLA  231 (718)
                      |||||++|+|.++|++.   .+++..++.++.|++.||.|||..     ..++||||||||+||||+.++.+||+|||++
T Consensus        79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            99999999999999875   589999999999999999999942     1379999999999999999999999999999


Q ss_pred             eee
Q 005033          232 RIK  234 (718)
Q Consensus       232 r~~  234 (718)
                      +..
T Consensus       156 ~~~  158 (303)
T d1vjya_         156 VRH  158 (303)
T ss_dssp             EEE
T ss_pred             ccc
Confidence            875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=397.70  Aligned_cols=150  Identities=23%  Similarity=0.398  Sum_probs=133.2

Q ss_pred             hcCccccceecccCceEEEEEEEc------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR------DGKLLAIKRLDTF-SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKR  154 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~------~g~~VAVK~i~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~  154 (718)
                      .++|++.+.||+|+||+||+|.+.      +++.||||+++.. .......|.+|+.++++++|||||+++++|...+..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            468899999999999999999874      2578999999753 334456799999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEe
Q 005033          155 ILVYEYMPNKSLQEMLFSDG--------NLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVS  226 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~--------~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLs  226 (718)
                      ++|||||++|+|.+++....        ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence            99999999999999986431        134688999999999999999999   8899999999999999999999999


Q ss_pred             eccCceee
Q 005033          227 DFGLSRIK  234 (718)
Q Consensus       227 DFGLAr~~  234 (718)
                      |||+|+..
T Consensus       176 DFGla~~~  183 (308)
T d1p4oa_         176 DFGMTRDI  183 (308)
T ss_dssp             CTTCCCGG
T ss_pred             ecccceec
Confidence            99999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-46  Score=388.52  Aligned_cols=148  Identities=26%  Similarity=0.455  Sum_probs=129.9

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh--hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL--QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ++|++++.||+|+||+||+|.+. +|+.||||++.....  .....+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            58999999999999999999986 699999999964322  234678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+. |++.+++.......+++..+..++.||+.||.|||   +.+||||||||+|||++.++.+||+|||+|+..
T Consensus        82 ~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~  152 (298)
T d1gz8a_          82 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF  152 (298)
T ss_dssp             CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred             ecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceec
Confidence            995 56666665554557999999999999999999999   899999999999999999999999999988753

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=390.33  Aligned_cols=148  Identities=24%  Similarity=0.364  Sum_probs=128.6

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCCh------hhHHHHHHHHHHHhCCC--CCcceeEEEEEeeCC
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSL------QTEREFQNELQILGGLR--SPFLVTLLGYCMERN  152 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~------~~~~~f~~Ei~iL~~L~--HpNIV~L~g~~~~~~  152 (718)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++.....      .....+.+|+.+|++++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            357999999999999999999986 689999999864211      11234678999999886  899999999999999


Q ss_pred             eEEEEEeccCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC-CCCEEEeeccC
Q 005033          153 KRILVYEYMPN-KSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS-DCRGKVSDFGL  230 (718)
Q Consensus       153 ~~~LVmEy~~g-GsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~-~~~vKLsDFGL  230 (718)
                      ..|+||||+.+ ++|.+++....  .+++..+..++.||+.||.|||   +++|+||||||+|||++. ++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             eEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcccc
Confidence            99999999975 68888887654  5899999999999999999999   999999999999999985 47999999999


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      |+..
T Consensus       158 a~~~  161 (273)
T d1xwsa_         158 GALL  161 (273)
T ss_dssp             CEEC
T ss_pred             ceec
Confidence            9753

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.5e-45  Score=380.32  Aligned_cols=147  Identities=23%  Similarity=0.404  Sum_probs=131.9

Q ss_pred             cCccccceecccCceEEEEEEEcCCcEEEEEEcccCCh--hhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL--QTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ++|++++.||+|+||+||+|.+++|+.||||++.....  ...+.+.+|+.+|++++|||||+++++|...+..|++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            58999999999999999999999999999999965432  2346899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      +.++.+..+....+  .+++..+..++.||+.||.|||   +.+||||||||+|||++.++.+||+|||+|...
T Consensus        82 ~~~~~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          82 LDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (286)
T ss_dssp             CSEEHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             ehhhhHHHHHhhcC--CcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceec
Confidence            97766666655443  6899999999999999999999   899999999999999999999999999988753

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-45  Score=383.13  Aligned_cols=148  Identities=27%  Similarity=0.438  Sum_probs=122.2

Q ss_pred             hcCccccceecccCceEEEEEEEc-C-CcEEEEEEcccCC--hhhHHHHHHHHHHHhCC---CCCcceeEEEEEee----
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-D-GKLLAIKRLDTFS--LQTEREFQNELQILGGL---RSPFLVTLLGYCME----  150 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~-g~~VAVK~i~~~~--~~~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~----  150 (718)
                      .++|++++.||+|+||+||+|.+. + ++.||||++....  ......+.+|+.+|+.|   +|||||+++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            478999999999999999999984 4 6789999985422  12223466777776655   89999999999863    


Q ss_pred             -CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeecc
Q 005033          151 -RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFG  229 (718)
Q Consensus       151 -~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFG  229 (718)
                       ....|++||||.++++...... ....+++..+..++.||+.||+|||   +++||||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchh
Confidence             3468999999987766554443 3346899999999999999999999   8999999999999999999999999999


Q ss_pred             Ccee
Q 005033          230 LSRI  233 (718)
Q Consensus       230 LAr~  233 (718)
                      +++.
T Consensus       162 ~~~~  165 (305)
T d1blxa_         162 LARI  165 (305)
T ss_dssp             SCCC
T ss_pred             hhhh
Confidence            8875

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-44  Score=379.37  Aligned_cols=145  Identities=26%  Similarity=0.428  Sum_probs=124.2

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC------
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERN------  152 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------  152 (718)
                      .++|++++.||+|+||+||+|.+. +|+.||||++...  .....+.+.+|+.+|+.++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999986 6999999999643  3344567899999999999999999999998655      


Q ss_pred             eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCce
Q 005033          153 KRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSR  232 (718)
Q Consensus       153 ~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr  232 (718)
                      ..||||||| +++|..+++..   .+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccccee
Confidence            569999999 77888888654   5899999999999999999999   9999999999999999999999999999997


Q ss_pred             e
Q 005033          233 I  233 (718)
Q Consensus       233 ~  233 (718)
                      .
T Consensus       170 ~  170 (346)
T d1cm8a_         170 Q  170 (346)
T ss_dssp             E
T ss_pred             c
Confidence            5

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-43  Score=371.42  Aligned_cols=148  Identities=24%  Similarity=0.359  Sum_probs=125.4

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEee--------
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCME--------  150 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--------  150 (718)
                      .++|++++.||+|+||+||+|.+. +|+.||||++...  .......+.+|+.+|+.++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            378999999999999999999986 7999999998543  22334678999999999999999999999865        


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccC
Q 005033          151 RNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGL  230 (718)
Q Consensus       151 ~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGL  230 (718)
                      .+..|+|||||.++.+..+....  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~--~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhhhcc--cccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecce
Confidence            34689999999776665444333  36788899999999999999999   99999999999999999999999999999


Q ss_pred             ceee
Q 005033          231 SRIK  234 (718)
Q Consensus       231 Ar~~  234 (718)
                      ++..
T Consensus       164 ~~~~  167 (318)
T d3blha1         164 ARAF  167 (318)
T ss_dssp             CEEC
T ss_pred             eeec
Confidence            9864

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-43  Score=376.83  Aligned_cols=147  Identities=24%  Similarity=0.419  Sum_probs=125.4

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCC----eEE
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFS-LQTEREFQNELQILGGLRSPFLVTLLGYCMERN----KRI  155 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~----~~~  155 (718)
                      +.+|++++.||+|+||+||+|.+. +|+.||||++.... ....+.+.+|+.+|+.++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            457999999999999999999986 79999999996533 344567899999999999999999999997653    224


Q ss_pred             EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          156 LVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       156 LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      ++++|+.+|+|.+++...   .+++..++.++.||+.||.|||   +++||||||||+|||++.++.+||+|||+|+..
T Consensus        87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            444556699999999765   5899999999999999999999   899999999999999999999999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-43  Score=378.09  Aligned_cols=144  Identities=28%  Similarity=0.365  Sum_probs=120.2

Q ss_pred             CccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC------CeEEE
Q 005033           84 DFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFLVTLLGYCMER------NKRIL  156 (718)
Q Consensus        84 ~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~~~~L  156 (718)
                      +|+..++||+|+||+||+|++. +|+.||||++.....    .+.+|+.+|++++|||||+++++|...      .+.||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5788899999999999999987 699999999965332    235799999999999999999998643      35799


Q ss_pred             EEeccCCCCHHHHHh-hCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC-CEEEeeccCceee
Q 005033          157 VYEYMPNKSLQEMLF-SDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC-RGKVSDFGLSRIK  234 (718)
Q Consensus       157 VmEy~~gGsL~~~L~-~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~-~vKLsDFGLAr~~  234 (718)
                      |||||+++.+..+.. ......+++..+..++.||+.||.|||   +++|+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999997654333332 122346899999999999999999999   99999999999999999775 8999999998764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-43  Score=364.21  Aligned_cols=147  Identities=26%  Similarity=0.381  Sum_probs=133.9

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeCCeEEEEEe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMERNKRILVYE  159 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE  159 (718)
                      ++|++++.||+|+||+||+|++. +|+.||||+++..  .......+.+|+.+|+.++|||||+++++|......++|||
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999986 6899999998543  23446789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          160 YMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       160 y~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                      |+.+++|..++...+  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus        82 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~  151 (292)
T d1unla_          82 FCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             CCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ecccccccccccccc--ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcc
Confidence            999999988887654  5788999999999999999999   899999999999999999999999999999864

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-42  Score=362.78  Aligned_cols=145  Identities=22%  Similarity=0.334  Sum_probs=122.4

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCc-ceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPF-LVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpN-IV~L~g~~~~~~~~~LVmEy  160 (718)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++....  ...++..|+++++.++|+| |+.+.+++...+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            46999999999999999999986 68999999886532  2235789999999998766 45556666778889999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC---CCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS---DCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~---~~~vKLsDFGLAr~~  234 (718)
                      + +|+|.+.+..... .+++..++.++.|++.||+|||   +++||||||||+|||++.   +..+||+|||+|+..
T Consensus        85 ~-~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          85 L-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             C-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             c-CCchhhhhhhccC-CCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            9 6778777765443 6899999999999999999999   899999999999999864   557999999999975

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7.5e-43  Score=369.55  Aligned_cols=141  Identities=25%  Similarity=0.470  Sum_probs=125.3

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeC--CeEEEEE
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLR-SPFLVTLLGYCMER--NKRILVY  158 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~--~~~~LVm  158 (718)
                      ++|++++.||+|+||+||+|++. +|+.||||+++...   .+.+.+|+.+|..++ ||||++++++|...  ...|+||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999986 69999999997533   457889999999995 99999999999754  5689999


Q ss_pred             eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCC-CEEEeeccCceee
Q 005033          159 EYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDC-RGKVSDFGLSRIK  234 (718)
Q Consensus       159 Ey~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~-~vKLsDFGLAr~~  234 (718)
                      |||.+++|..+.+     .+++..+..++.||+.||.|||   +++||||||||+|||++.++ .+||+|||+|+..
T Consensus       112 e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         112 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             ECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             eecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceec
Confidence            9999999977642     5889999999999999999999   99999999999999998655 5899999999864

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.4e-42  Score=358.99  Aligned_cols=145  Identities=21%  Similarity=0.284  Sum_probs=128.6

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCCC-CcceeEEEEEeeCCeEEEEEec
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLRS-PFLVTLLGYCMERNKRILVYEY  160 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~H-pNIV~L~g~~~~~~~~~LVmEy  160 (718)
                      ++|++.+.||+|+||+||+|++. +|+.||||++....  ....+.+|++++..++| +||+.+++++......|+||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            57999999999999999999986 68999999885432  22357788999999965 8999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECC-----CCCEEEeeccCceee
Q 005033          161 MPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDS-----DCRGKVSDFGLSRIK  234 (718)
Q Consensus       161 ~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~-----~~~vKLsDFGLAr~~  234 (718)
                      + +++|.+++...+. .+++..+..++.|++.||.|||   +.+|+||||||+|||++.     ++.+||+|||+|+..
T Consensus        83 ~-~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          83 L-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             C-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             c-CCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            9 7999999977654 6889999999999999999999   999999999999999974     578999999999975

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-43  Score=370.45  Aligned_cols=147  Identities=33%  Similarity=0.423  Sum_probs=131.1

Q ss_pred             cCccccceecccCceEEEEEEEc----CCcEEEEEEcccCC----hhhHHHHHHHHHHHhCCCC-CcceeEEEEEeeCCe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR----DGKLLAIKRLDTFS----LQTEREFQNELQILGGLRS-PFLVTLLGYCMERNK  153 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~----~g~~VAVK~i~~~~----~~~~~~f~~Ei~iL~~L~H-pNIV~L~g~~~~~~~  153 (718)
                      ++|++.+.||+|+||+||+|...    +|+.||||+++...    ....+.+.+|+++|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999863    48899999986422    1234568899999999966 899999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .++||||+.+|+|.+++...+  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            999999999999999998765  4677888999999999999999   89999999999999999999999999999986


Q ss_pred             e
Q 005033          234 K  234 (718)
Q Consensus       234 ~  234 (718)
                      .
T Consensus       179 ~  179 (322)
T d1vzoa_         179 F  179 (322)
T ss_dssp             C
T ss_pred             h
Confidence            4

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-42  Score=367.31  Aligned_cols=146  Identities=23%  Similarity=0.425  Sum_probs=124.9

Q ss_pred             hcCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEeeC-----Ce
Q 005033           82 TNDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCMER-----NK  153 (718)
Q Consensus        82 t~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~  153 (718)
                      .++|++++.||+|+||+||+|.+. +|+.||||++...  .....+.+.+|+.+|+.++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            568999999999999999999986 6999999999653  234456789999999999999999999999643     23


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .+++|+|+.+|+|.+++...   .+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+|++|||+|..
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcc
Confidence            46667777899999999654   5899999999999999999999   89999999999999999999999999998864

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-41  Score=365.47  Aligned_cols=143  Identities=26%  Similarity=0.409  Sum_probs=121.5

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhCCCCCcceeEEEEEee------CCe
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTF--SLQTEREFQNELQILGGLRSPFLVTLLGYCME------RNK  153 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~------~~~  153 (718)
                      ++|++++.||+|+||+||+|.+. +|+.||||++...  .......+.+|+.+|+.++|||||+++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999987 6999999999643  23445678999999999999999999999964      368


Q ss_pred             EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          154 RILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       154 ~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      .|+|||||.+ +|.+.+..    .+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+|++|||+++.
T Consensus        97 ~~iv~Ey~~~-~l~~~~~~----~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eEEEEeccch-HHHHhhhc----CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhc
Confidence            8999999955 55555532    4789999999999999999999   99999999999999999999999999998875

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.4e-38  Score=334.02  Aligned_cols=148  Identities=20%  Similarity=0.223  Sum_probs=118.7

Q ss_pred             cCccccceecccCceEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhCCC-----------CCcceeEEEEEee
Q 005033           83 NDFDEANVIGKGGSGTVFLGIAR-DGKLLAIKRLDTFSLQTEREFQNELQILGGLR-----------SPFLVTLLGYCME  150 (718)
Q Consensus        83 ~~f~~~~~LG~G~FG~Vykg~~~-~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-----------HpNIV~L~g~~~~  150 (718)
                      ++|++++.||+|+||+||+|++. +|+.||||+++... ...+.+.+|+.+++.++           |+|||++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35999999999999999999986 79999999997643 33457788999888775           5789999998864


Q ss_pred             C--CeEEEEEeccCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCC-----
Q 005033          151 R--NKRILVYEYMPNK-SLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCR-----  222 (718)
Q Consensus       151 ~--~~~~LVmEy~~gG-sL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~-----  222 (718)
                      .  ...+++|+++..+ +............+++..+..++.||+.||.|||+  ..+|+||||||+||||+.++.     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence            3  4667777766544 44444445555578889999999999999999993  389999999999999986653     


Q ss_pred             -EEEeeccCcee
Q 005033          223 -GKVSDFGLSRI  233 (718)
Q Consensus       223 -vKLsDFGLAr~  233 (718)
                       ++|+|||.|..
T Consensus       170 ~~kl~dfg~s~~  181 (362)
T d1q8ya_         170 QIKIADLGNACW  181 (362)
T ss_dssp             EEEECCCTTCEE
T ss_pred             eeeEeecccccc
Confidence             89999998764

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=7.3e-22  Score=192.26  Aligned_cols=133  Identities=17%  Similarity=0.176  Sum_probs=106.2

Q ss_pred             cccceecccCceEEEEEEEcCCcEEEEEEcccCCh------------------hhHHHHHHHHHHHhCCCCCcceeEEEE
Q 005033           86 DEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSL------------------QTEREFQNELQILGGLRSPFLVTLLGY  147 (718)
Q Consensus        86 ~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~------------------~~~~~f~~Ei~iL~~L~HpNIV~L~g~  147 (718)
                      .+.+.||+|+||+||+|.+.+|+.||||+++....                  .....+.+|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            46789999999999999998999999998743110                  112345678899999999999998866


Q ss_pred             EeeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEECCCCCEEEee
Q 005033          148 CMERNKRILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFGCDPPVIHGDIKPSNVLLDSDCRGKVSD  227 (718)
Q Consensus       148 ~~~~~~~~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~~~~gIVHRDLKP~NILLd~~~~vKLsD  227 (718)
                      ..    .+++|||+++..+.+         ++......++.|++.||.|||   +.+|+||||||+|||+++++ ++|+|
T Consensus        83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~~-~~liD  145 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEG-IWIID  145 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETTE-EEECC
T ss_pred             cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCCC-EEEEE
Confidence            42    379999998766543         233345678999999999999   89999999999999998654 89999


Q ss_pred             ccCceeee
Q 005033          228 FGLSRIKV  235 (718)
Q Consensus       228 FGLAr~~~  235 (718)
                      ||+|....
T Consensus       146 FG~a~~~~  153 (191)
T d1zara2         146 FPQSVEVG  153 (191)
T ss_dssp             CTTCEETT
T ss_pred             CCCcccCC
Confidence            99998753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.38  E-value=5.8e-07  Score=88.59  Aligned_cols=151  Identities=17%  Similarity=0.113  Sum_probs=101.4

Q ss_pred             HHHHHHhcCccccceecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCCeE
Q 005033           76 KELKNATNDFDEANVIGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLR-SPFLVTLLGYCMERNKR  154 (718)
Q Consensus        76 ~el~~at~~f~~~~~LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~  154 (718)
                      .++......|+..+..+-++.+.||+... +++.+.||+...........+.+|...+..+. +--+.+++.++..++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            35555566777665544445578998764 46667888875433333334677888776653 33367788888888999


Q ss_pred             EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 005033          155 ILVYEYMPNKSLQEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHFG----------------------------------  200 (718)
Q Consensus       155 ~LVmEy~~gGsL~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~~----------------------------------  200 (718)
                      |+||++++|.++.+......       ....++.+++..|..||..                                  
T Consensus        86 ~lv~~~l~G~~~~~~~~~~~-------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDEQ-------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTCS-------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEEecccccccccccccc-------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            99999999988866543211       1122445555555555520                                  


Q ss_pred             ----------------------CCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          201 ----------------------CDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       201 ----------------------~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                                            ....++|+|+.|.|||+++++.+-|+||+.+..-
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence                                  0224899999999999998776779999988864

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.83  E-value=3.5e-05  Score=75.00  Aligned_cols=132  Identities=25%  Similarity=0.220  Sum_probs=84.8

Q ss_pred             eecccCc-eEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCC--CCcceeEEEEEeeCCeEEEEEeccCCCCH
Q 005033           90 VIGKGGS-GTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLR--SPFLVTLLGYCMERNKRILVYEYMPNKSL  166 (718)
Q Consensus        90 ~LG~G~F-G~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~--HpNIV~L~g~~~~~~~~~LVmEy~~gGsL  166 (718)
                      .+..|.. +.||+....++..+.+|.-.....   ..+..|+..|+.+.  .-.+.+++.++.+++..++||+|++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3445543 679999887788889997654332   23566777776553  23367788888888899999999987665


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhc-----------------------------------------------
Q 005033          167 QEMLFSDGNLVLKWSQRFEIIMDVAKALEFLHF-----------------------------------------------  199 (718)
Q Consensus       167 ~~~L~~~~~~~l~~~~~~~Ia~qIa~gL~yLH~-----------------------------------------------  199 (718)
                      .+..       ....   .++.+++..|.-||.                                               
T Consensus        94 ~~~~-------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          94 LSSH-------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             TTSC-------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             cccc-------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence            3210       0000   011122222222221                                               


Q ss_pred             --------CCCCCeEecCCCCCCEEECCCCCEEEeeccCceee
Q 005033          200 --------GCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRIK  234 (718)
Q Consensus       200 --------~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~~  234 (718)
                              .....++|+|+.|.|||++.+..+-|+||+.+..-
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g  206 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  206 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence                    01234899999999999998766789999988763

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.13  E-value=0.00051  Score=72.24  Aligned_cols=76  Identities=17%  Similarity=0.108  Sum_probs=47.8

Q ss_pred             cceecccCceEEEEEEEcC-CcEEEEEEcccC-------ChhhHHHHHHHHHHHhCCC---CCcceeEEEEEeeCCeEEE
Q 005033           88 ANVIGKGGSGTVFLGIARD-GKLLAIKRLDTF-------SLQTEREFQNELQILGGLR---SPFLVTLLGYCMERNKRIL  156 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~-g~~VAVK~i~~~-------~~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~L  156 (718)
                      .+.||.|....||++...+ ++.|+||.-...       ......+...|.+.|..+.   ...+.+++.+.  ....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            3578999999999998764 678999964321       0111223456777776552   24566676553  445689


Q ss_pred             EEeccCCCC
Q 005033          157 VYEYMPNKS  165 (718)
Q Consensus       157 VmEy~~gGs  165 (718)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.77  E-value=0.011  Score=59.91  Aligned_cols=134  Identities=14%  Similarity=0.115  Sum_probs=75.8

Q ss_pred             eEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCCCcc-----eeE--EEEEeeCCeEEEEEeccCCCCH---
Q 005033           97 GTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRSPFL-----VTL--LGYCMERNKRILVYEYMPNKSL---  166 (718)
Q Consensus        97 G~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~HpNI-----V~L--~g~~~~~~~~~LVmEy~~gGsL---  166 (718)
                      -.||++...+|..|++|+.+... ....++..|...|..|....|     +..  -..+...+..+.+++++.|..+   
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            47999999899999999876532 234557778877766542211     111  1122345677899999876332   


Q ss_pred             --HHH------H---hh----C---CCCCCCHH----------------------HHHHHHHHHHHHHHHH-hcCCCCCe
Q 005033          167 --QEM------L---FS----D---GNLVLKWS----------------------QRFEIIMDVAKALEFL-HFGCDPPV  205 (718)
Q Consensus       167 --~~~------L---~~----~---~~~~l~~~----------------------~~~~Ia~qIa~gL~yL-H~~~~~gI  205 (718)
                        ..+      +   +.    .   .....++.                      .....+.++...+.-+ ......++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence              111      1   00    0   00111111                      1112222233322221 12234679


Q ss_pred             EecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          206 IHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       206 VHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ||+|+.+.|||++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999743  45899998875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.51  E-value=0.011  Score=61.25  Aligned_cols=73  Identities=22%  Similarity=0.222  Sum_probs=47.4

Q ss_pred             cceecccCceEEEEEEEcC--------CcEEEEEEcccCChhhHHHHHHHHHHHhCCC-CCcceeEEEEEeeCCeEEEEE
Q 005033           88 ANVIGKGGSGTVFLGIARD--------GKLLAIKRLDTFSLQTEREFQNELQILGGLR-SPFLVTLLGYCMERNKRILVY  158 (718)
Q Consensus        88 ~~~LG~G~FG~Vykg~~~~--------g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVm  158 (718)
                      ++.|+-|-.-.+|++...+        ...|.+++... . .......+|..+++.+. +.-..++++++.+    .+||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3578878888999998753        24566665432 2 12234457888888774 3334578887743    5899


Q ss_pred             eccCCCCH
Q 005033          159 EYMPNKSL  166 (718)
Q Consensus       159 Ey~~gGsL  166 (718)
                      ||++|..|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.95  E-value=0.055  Score=53.56  Aligned_cols=158  Identities=18%  Similarity=0.155  Sum_probs=82.8

Q ss_pred             ccHHHHHHHhcCccccce-----ecccCceEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhCCCC-----Ccce
Q 005033           73 FTYKELKNATNDFDEANV-----IGKGGSGTVFLGIARDGKLLAIKRLDTFSLQTEREFQNELQILGGLRS-----PFLV  142 (718)
Q Consensus        73 ~s~~el~~at~~f~~~~~-----LG~G~FG~Vykg~~~~g~~VAVK~i~~~~~~~~~~f~~Ei~iL~~L~H-----pNIV  142 (718)
                      +|-+|+.....+|.+.+.     |..|---+.|+....+|+ +++|+.....  ...++..|+.+|..|..     |..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            567788888888876443     335555778998876654 8899875431  12233445555555432     2222


Q ss_pred             eEE-E--EEeeCCeEEEEEeccCCCCHHH-----H---------Hhh----CC---CCCCCH------------------
Q 005033          143 TLL-G--YCMERNKRILVYEYMPNKSLQE-----M---------LFS----DG---NLVLKW------------------  180 (718)
Q Consensus       143 ~L~-g--~~~~~~~~~LVmEy~~gGsL~~-----~---------L~~----~~---~~~l~~------------------  180 (718)
                      ... |  +.......+.++.++.+.....     .         ++.    ..   ......                  
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            110 0  1122345566666665533211     0         000    00   000000                  


Q ss_pred             HHHHHHHHHHHHHHHHHh-cCCCCCeEecCCCCCCEEECCCCCEEEeeccCcee
Q 005033          181 SQRFEIIMDVAKALEFLH-FGCDPPVIHGDIKPSNVLLDSDCRGKVSDFGLSRI  233 (718)
Q Consensus       181 ~~~~~Ia~qIa~gL~yLH-~~~~~gIVHRDLKP~NILLd~~~~vKLsDFGLAr~  233 (718)
                      ......+..+...+.-.+ .....++||+|+.+.||+++.+...-|.||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            001112222223333332 12357899999999999999888778999998875